,Conditions,Drug,Smiles,Phases,Disease
0,Metastatic Colorectal Cancer,Irinotecan,CCC1=C2CN3C(=CC4=C(C3=O)COC(=O)C4(CC)O)C2=NC5=C1C=C(C=C5)OC(=O)N6CCC(CC6)N7CCCCC7,PHASE1|PHASE2,digestive_system_disease
1,Ulcerative Colitis|Left-sided Ulcerative Colitis|Distal Ulcerative Colitis,Mesalazine,C1=CC(=C(C=C1N)C(=O)O)O,PHASE2,digestive_system_disease
2,Ulcerative Colitis|Left-sided Ulcerative Colitis|Distal Ulcerative Colitis,Mesalamine,C1=CC(=C(C=C1N)C(=O)O)O,PHASE2,digestive_system_disease
3,HER-2 Positive Gastric Cancer|Metastatic Cancer,Capecitabine,CCCCCOC(=O)NC1=NC(=O)N(C=C1F)C2C(C(C(O2)C)O)O,PHASE2,digestive_system_disease
4,HER-2 Positive Gastric Cancer|Metastatic Cancer,Cisplatin,N.N.Cl[Pt]Cl,PHASE2,digestive_system_disease
5,Minimal Hepatic Encephalopathy,Rifaximin,CC1C=CC=C(C(=O)NC2=C(C3=C(C4=C(C(=C3O)C)OC(C4=O)(OC=CC(C(C(C(C(C(C1O)C)O)C)OC(=O)C)C)OC)C)C5=C2N6C=CC(=CC6=N5)C)O)C,PHASE1|PHASE2,digestive_system_disease
6,"Cancer|Pancreatic Cancer|Sarcoma|Renal Cancer|Refractory Cancer|Refractory Neoplasm|Refractory Non-Hodgkin Lymphoma|Pancreatic Adenocarcinoma|Resistant Cancer|Neoplasm Metastasis|Neoplasm of Bone|Neoplasm, Breast|Neoplasm of Lung|Neoplasms,Colorectal|Neoplasms Pancreatic|Malignant Glioma|Malignancies|Malignancies Multiple|Bone Metastases|Bone Neoplasm|Bone Cancer|Pancreas Cancer|Pancreatic Neoplasms|Breast Neoplasms|Acute T Cell Leukemia Lymphoma",Gemcitabine,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)(F)F,PHASE2,digestive_system_disease
7,"Cancer|Pancreatic Cancer|Sarcoma|Renal Cancer|Refractory Cancer|Refractory Neoplasm|Refractory Non-Hodgkin Lymphoma|Pancreatic Adenocarcinoma|Resistant Cancer|Neoplasm Metastasis|Neoplasm of Bone|Neoplasm, Breast|Neoplasm of Lung|Neoplasms,Colorectal|Neoplasms Pancreatic|Malignant Glioma|Malignancies|Malignancies Multiple|Bone Metastases|Bone Neoplasm|Bone Cancer|Pancreas Cancer|Pancreatic Neoplasms|Breast Neoplasms|Acute T Cell Leukemia Lymphoma",Doxorubicin,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)N)O,PHASE2,digestive_system_disease
8,"Cancer|Pancreatic Cancer|Sarcoma|Renal Cancer|Refractory Cancer|Refractory Neoplasm|Refractory Non-Hodgkin Lymphoma|Pancreatic Adenocarcinoma|Resistant Cancer|Neoplasm Metastasis|Neoplasm of Bone|Neoplasm, Breast|Neoplasm of Lung|Neoplasms,Colorectal|Neoplasms Pancreatic|Malignant Glioma|Malignancies|Malignancies Multiple|Bone Metastases|Bone Neoplasm|Bone Cancer|Pancreas Cancer|Pancreatic Neoplasms|Breast Neoplasms|Acute T Cell Leukemia Lymphoma",Lomustine,C1CCC(CC1)NC(=O)N(CCCl)N=O,PHASE2,digestive_system_disease
9,"Cancer|Pancreatic Cancer|Sarcoma|Renal Cancer|Refractory Cancer|Refractory Neoplasm|Refractory Non-Hodgkin Lymphoma|Pancreatic Adenocarcinoma|Resistant Cancer|Neoplasm Metastasis|Neoplasm of Bone|Neoplasm, Breast|Neoplasm of Lung|Neoplasms,Colorectal|Neoplasms Pancreatic|Malignant Glioma|Malignancies|Malignancies Multiple|Bone Metastases|Bone Neoplasm|Bone Cancer|Pancreas Cancer|Pancreatic Neoplasms|Breast Neoplasms|Acute T Cell Leukemia Lymphoma",Carboplatin,C1CC(C1)(C(=O)O)C(=O)O.[NH2-].[NH2-].[Pt+2],PHASE2,digestive_system_disease
10,"Cancer|Pancreatic Cancer|Sarcoma|Renal Cancer|Refractory Cancer|Refractory Neoplasm|Refractory Non-Hodgkin Lymphoma|Pancreatic Adenocarcinoma|Resistant Cancer|Neoplasm Metastasis|Neoplasm of Bone|Neoplasm, Breast|Neoplasm of Lung|Neoplasms,Colorectal|Neoplasms Pancreatic|Malignant Glioma|Malignancies|Malignancies Multiple|Bone Metastases|Bone Neoplasm|Bone Cancer|Pancreas Cancer|Pancreatic Neoplasms|Breast Neoplasms|Acute T Cell Leukemia Lymphoma",Paclitaxel,CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C,PHASE2,digestive_system_disease
11,Hepatocellular Carcinoma,Cyclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,PHASE2|PHASE3,digestive_system_disease
12,Pancreatic Cancer|Pancreas Cancer|Ampullary Cancer|Pancreas Neuroendocrine Tumor|Pancreatitis|Distal Extrahepatic Cholangiocarcinoma|Duodenal Cancer,Pantoprazole,COC1=C(C(=NC=C1)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC(F)F)OC,PHASE2,digestive_system_disease
13,Hepatocellular Carcinoma,Sorafenib,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,PHASE1,digestive_system_disease
14,Irritable Bowel Syndrome,Ciclosporin,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,PHASE2,digestive_system_disease
15,Irritable Bowel Syndrome,Chloroquine,CCN(CC)CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl,PHASE2,digestive_system_disease
16,Glioma|Hematopoietic and Lymphoid Cell Neoplasm|Lymphoma|Metastatic Malignant Solid Neoplasm|Neuroendocrine Neoplasm|Recurrent Adult Soft Tissue Sarcoma|Recurrent Bladder Carcinoma|Recurrent Breast Carcinoma|Recurrent Chronic Lymphocytic Leukemia|Recurrent Colorectal Carcinoma|Recurrent Head and Neck Carcinoma|Recurrent Lung Carcinoma|Recurrent Malignant Solid Neoplasm|Recurrent Melanoma|Recurrent Pancreatic Carcinoma|Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma|Recurrent Prostate Carcinoma|Recurrent Renal Cell Carcinoma|Recurrent Thyroid Gland Carcinoma|Refractory Chronic Lymphocytic Leukemia|Refractory Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma|Refractory Primary Cutaneous T-Cell Non-Hodgkin Lymphoma|Stage III Breast Cancer AJCC v7|Stage III Colorectal Cancer AJCC v7|Stage III Cutaneous Melanoma AJCC v7|Stage III Lung Cancer AJCC v7|Stage III Pancreatic Cancer AJCC v6 and v7|Stage III Prostate Cancer AJCC v7|Stage III Renal Cell Cancer AJCC v7|Stage III Soft Tissue Sarcoma AJCC v7|Stage IIIA Breast Cancer AJCC v7|Stage IIIA Colorectal Cancer AJCC v7|Stage IIIA Cutaneous Melanoma AJCC v7|Stage IIIB Breast Cancer AJCC v7|Stage IIIB Colorectal Cancer AJCC v7|Stage IIIB Cutaneous Melanoma AJCC v7|Stage IIIC Breast Cancer AJCC v7|Stage IIIC Colorectal Cancer AJCC v7|Stage IIIC Cutaneous Melanoma AJCC v7|Stage IV Breast Cancer AJCC v6 and v7|Stage IV Colorectal Cancer AJCC v7|Stage IV Cutaneous Melanoma AJCC v6 and v7|Stage IV Lung Cancer AJCC v7|Stage IV Pancreatic Cancer AJCC v6 and v7|Stage IV Prostate Cancer AJCC v7|Stage IV Renal Cell Cancer AJCC v7|Stage IV Soft Tissue Sarcoma AJCC v7|Stage IVA Colorectal Cancer AJCC v7|Stage IVB Colorectal Cancer AJCC v7|Unresectable Solid Neoplasm,Romidepsin,CC=C1C(=O)NC(C(=O)OC2CC(=O)NC(C(=O)NC(CSSCCC=C2)C(=O)N1)C(C)C)C(C)C,PHASE1,digestive_system_disease
17,Colorectal Cancer,Cabozantinib,COC1=CC2=C(C=CN=C2C=C1OC)OC3=CC=C(C=C3)NC(=O)C4(CC4)C(=O)NC5=CC=C(C=C5)F,PHASE1,digestive_system_disease
18,Portal Hypertension,Alverine,CCN(CCCC1=CC=CC=C1)CCCC2=CC=CC=C2,PHASE2,digestive_system_disease
19,Hemorrhoids,Iferanserin,CN1CCCCC1CCC2=CC=CC=C2NC(=O)C=CC3=CC=CC=C3,PHASE2,digestive_system_disease
20,SHR-1210|Anlotinib|Advanced Esophageal Squamous Cell Cancer,Anlotinib,CC1=CC2=C(N1)C=CC(=C2F)OC3=C4C=C(C(=CC4=NC=C3)OCC5(CC5)N)OC,PHASE2,digestive_system_disease
21,Esophageal Carcinoma|Neoadjuvant Immunotherapy,Nedaplatin,C(C(=O)O)O.N.N.[Pt],PHASE1|PHASE2,digestive_system_disease
22,Colorectal Cancer,Simvastatin,CCC(C)(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,PHASE2,digestive_system_disease
23,Colorectal Neoplasms|Adenocarcinoma of the Colon|Adenocarcinoma of the Rectum,Regorafenib,CNC(=O)C1=NC=CC(=C1)OC2=CC(=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F)F,PHASE2,digestive_system_disease
24,Stomach Cancer,Docetaxel,CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O,PHASE2|PHASE3,digestive_system_disease
25,Locally Advanced Biliary Tract Cancer|Metastatic Biliary Tract Cancer,Rivoceranib,C1CCC(C1)(C#N)C2=CC=C(C=C2)NC(=O)C3=C(N=CC=C3)NCC4=CC=NC=C4,PHASE1|PHASE2,digestive_system_disease
26,Gastric Cancer|Gastroesophageal Junction Adenocarcinoma,Oxaliplatin,C1CCC(C(C1)[NH-])[NH-].C(=O)(C(=O)O)O.[Pt+2],PHASE2,digestive_system_disease
27,Chronic Hepatitis C,Simeprevir,CC1=C(C=CC2=C1N=C(C=C2OC3CC4C(C3)C(=O)N(CCCCC=CC5CC5(NC4=O)C(=O)NS(=O)(=O)C6CC6)C)C7=NC(=CS7)C(C)C)OC,PHASE2,digestive_system_disease
28,Chronic Hepatitis C,Sofosbuvir,CC(C)OC(=O)C(C)NP(=O)(OCC1C(C(C(O1)N2C=CC(=O)NC2=O)(C)F)O)OC3=CC=CC=C3,PHASE2,digestive_system_disease
29,"Rectal Cancer, Adenocarcinoma|Locally Advanced Malignant Neoplasm|Chemoradiation",Aspirin,CC(=O)OC1=CC=CC=C1C(=O)O,PHASE2,digestive_system_disease
30,Ovarian Neoplasms|Neoplasms|Solid Tumor|Hepatic Impairment,Niraparib,C1CC(CNC1)C2=CC=C(C=C2)N3C=C4C=CC=C(C4=N3)C(=O)N,PHASE1,digestive_system_disease
31,Metastatic Malignant Neoplasm in the Liver|Stage IV Colorectal Cancer AJCC v8|Stage IVA Colorectal Cancer AJCC v8|Stage IVB Colorectal Cancer AJCC v8|Stage IVC Colorectal Cancer AJCC v8,Vactosertib,CC1=NC(=CC=C1)C2=C(N=C(N2)CNC3=CC=CC=C3F)C4=CN5C(=NC=N5)C=C4,PHASE2,digestive_system_disease
32,"Hepatitis C, Chronic",Ribavirin,C1=NC(=NN1C2C(C(C(O2)CO)O)O)C(=O)N,PHASE2,digestive_system_disease
33,Hepatitis C Virus Genotype 4 Infection,Asunaprevir,CC(C)(C)C(C(=O)N1CC(CC1C(=O)NC2(CC2C=C)C(=O)NS(=O)(=O)C3CC3)OC4=NC=C(C5=C4C=C(C=C5)Cl)OC)NC(=O)OC(C)(C)C,PHASE2,digestive_system_disease
34,Hepatitis C Virus Genotype 4 Infection,Daclatasvir,CC(C)C(C(=O)N1CCCC1C2=NC=C(N2)C3=CC=C(C=C3)C4=CC=C(C=C4)C5=CN=C(N5)C6CCCN6C(=O)C(C(C)C)NC(=O)OC)NC(=O)OC,PHASE2,digestive_system_disease
35,Colorectal Adenocarcinoma Metastatic to the Liver,Floxuridine,C1C(C(OC1N2C=C(C(=O)NC2=O)F)CO)O,PHASE2,digestive_system_disease
36,Colorectal Adenocarcinoma Metastatic to the Liver,Fluorouracil,C1=C(C(=O)NC(=O)N1)F,PHASE2,digestive_system_disease
37,Colorectal Adenocarcinoma Metastatic to the Liver,Dexamethasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,PHASE2,digestive_system_disease
38,Colorectal Adenocarcinoma Metastatic to the Liver,Leucovorin,C1C(N(C2=C(N1)N=C(NC2=O)N)C=O)CNC3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,PHASE2,digestive_system_disease
39,BRAF V600E|Metastatic Colorectal Cancer,Encorafenib,CC(C)N1C=C(C(=N1)C2=C(C(=CC(=C2)Cl)NS(=O)(=O)C)F)C3=NC(=NC=C3)NCC(C)NC(=O)OC,PHASE2,digestive_system_disease
40,Idiopathic Pruritus Ani,Mebendazole,COC(=O)NC1=NC2=C(N1)C=C(C=C2)C(=O)C3=CC=CC=C3,PHASE2,digestive_system_disease
41,Rectal Cancer,Tecemotide,CCCCCCCCCCCCCCCC(=O)NCCCCC(C(=O)NCC(=O)O)NC(=O)C1CCCN1C(=O)C2CCCN2C(=O)C(C)NC(=O)C(C(C)O)NC(=O)C(CO)NC(=O)CNC(=O)C3CCCN3C(=O)C(C)NC(=O)C4CCCN4C(=O)C(CCCNC(=N)N)NC(=O)C(C(C)O)NC(=O)C(CC(=O)O)NC(=O)C5CCCN5C(=O)C(C)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C(C(C)C)NC(=O)CNC(=O)C(CC6=CN=CN6)NC(=O)C(C)NC(=O)C7CCCN7C(=O)C8CCCN8C(=O)C(C)NC(=O)C(C(C)O)NC(=O)C(CO)N,PHASE2,digestive_system_disease
42,Nonalcoholic Steatohepatitis (NASH),Miricorilant,C1CC(CCC1C2=CC=CC=C2)C3=C(C(=O)NC(=O)N3)CC4=CC(=CC=C4)C(F)(F)F,PHASE2,digestive_system_disease
43,Gastric Cancer,Raltitrexed,CC1=NC2=C(C=C(C=C2)CN(C)C3=CC=C(S3)C(=O)NC(CCC(=O)O)C(=O)O)C(=O)N1,PHASE2,digestive_system_disease
44,Spatial Neglect|Dysphagia,Modafinil,C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N,PHASE2,digestive_system_disease
45,Adult Glioblastoma|Endometrial Clear Cell Adenocarcinoma|Endometrial Serous Adenocarcinoma|Ovarian Clear Cell Cystadenocarcinoma|Ovarian Endometrioid Adenocarcinoma|Ovarian Mucinous Cystadenocarcinoma|Ovarian Serous Cystadenocarcinoma|Recurrent Fallopian Tube Carcinoma|Recurrent Ovarian Carcinoma|Recurrent Primary Peritoneal Carcinoma|Recurrent Uterine Corpus Cancer|Solid Neoplasm|Stage IIIA Fallopian Tube Cancer AJCC v7|Stage IIIA Ovarian Cancer AJCC v6 and v7|Stage IIIA Primary Peritoneal Cancer AJCC v7|Stage IIIB Fallopian Tube Cancer AJCC v7|Stage IIIB Ovarian Cancer AJCC v6 and v7|Stage IIIB Primary Peritoneal Cancer AJCC v7|Stage IIIC Fallopian Tube Cancer AJCC v7|Stage IIIC Ovarian Cancer AJCC v6 and v7|Stage IIIC Primary Peritoneal Cancer AJCC v7|Stage IV Fallopian Tube Cancer AJCC v6 and v7|Stage IV Ovarian Cancer AJCC v6 and v7|Stage IV Primary Peritoneal Cancer AJCC v7,Sapanisertib,CC(C)N1C2=NC=NC(=C2C(=N1)C3=CC4=C(C=C3)OC(=N4)N)N,PHASE1,digestive_system_disease
46,GERD,Esomeprazole,CC1=CN=C(C(=C1OC)C)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC,PHASE2,digestive_system_disease
47,Gastrointestinal Problems|Autism Spectrum Disorders,Vancomycin,CC1C(C(CC(O1)OC2C(C(C(OC2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)C(C(C(=O)NC(C(=O)NC5C(=O)NC7C8=CC(=C(C=C8)O)C9=C(C=C(C=C9O)O)C(NC(=O)C(C(C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)CC(=O)N)NC(=O)C(CC(C)C)NC)O)Cl)CO)O)O)(C)N)O,PHASE1|PHASE2,digestive_system_disease
48,Gastrointestinal Problems|Autism Spectrum Disorders,Omeprazole,CC1=CN=C(C(=C1OC)C)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC,PHASE1|PHASE2,digestive_system_disease
49,Nasopharyngeal Neoplasms|Salivary Gland Diseases|Bone Marrow Diseases|Mucositis,Amifostine,C(CN)CNCCSP(=O)(O)O,PHASE2,digestive_system_disease
50,Colorectal Cancer,Tocotrienol,CC(=CCCC(=CCCC(=CCCC1(CCC2=C(O1)C=CC(=C2)O)C)C)C)C,PHASE2,digestive_system_disease
51,Hepatitis C Virus,Escitalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,PHASE1,digestive_system_disease
52,Hepatitis B,Clevudine,CC1=CN(C(=O)NC1=O)C2C(C(C(O2)CO)O)F,PHASE2,digestive_system_disease
53,Cystic Fibrosis,Lansoprazole,CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCC(F)(F)F,PHASE1,digestive_system_disease
54,Liver Cancer,Gefitinib,COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4,PHASE2,digestive_system_disease
55,Pancreatic Cancer,Erlotinib,COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC,PHASE2,digestive_system_disease
56,Cystic Fibrosis,Tiotropium,C[N+]1(C2CC(CC1C3C2O3)OC(=O)C(C4=CC=CS4)(C5=CC=CS5)O)C,PHASE2,digestive_system_disease
57,"Healthy, Hepatic Insufficiency",Palbociclib,CC1=C(C(=O)N(C2=NC(=NC=C12)NC3=NC=C(C=C3)N4CCNCC4)C5CCCC5)C(=O)C,PHASE1,digestive_system_disease
58,Metastatic or Recurrent Squamous Cell Carcinoma of the Esophagus,Lapatinib,CS(=O)(=O)CCNCC1=CC=C(O1)C2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=CC(=CC=C5)F)Cl,PHASE2,digestive_system_disease
59,Pancreatic Cancer,Etoposide,CC1OCC2C(O1)C(C(C(O2)OC3C4COC(=O)C4C(C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)O)OC)O)O,PHASE2,digestive_system_disease
60,Low Anterior Resection Syndrome,Melatonin,CC(=O)NCCC1=CNC2=C1C=C(C=C2)OC,PHASE2,digestive_system_disease
61,HCV,Ravidasvir,CC(C)C(C(=O)N1CCCC1C2=NC3=C(N2)C=C(C=C3)C4=CC5=C(C=C4)C=C(C=C5)C6=CN=C(N6)C7CCCN7C(=O)C(C(C)C)NC(=O)OC)NC(=O)OC,PHASE2|PHASE3,digestive_system_disease
62,HCV,Danoprevir,CC(C)(C)OC(=O)NC1CCCCCC=CC2CC2(NC(=O)C3CC(CN3C1=O)OC(=O)N4CC5=C(C4)C(=CC=C5)F)C(=O)NS(=O)(=O)C6CC6,PHASE2|PHASE3,digestive_system_disease
63,HCV,Ritonavir,CC(C)C1=NC(=CS1)CN(C)C(=O)NC(C(C)C)C(=O)NC(CC2=CC=CC=C2)CC(C(CC3=CC=CC=C3)NC(=O)OCC4=CN=CS4)O,PHASE2|PHASE3,digestive_system_disease
64,Hepatitis C,Grazoprevir,CC(C)(C)C1C(=O)N2CC(CC2C(=O)NC3(CC3C=C)C(=O)NS(=O)(=O)C4CC4)OC5=NC6=C(C=CC(=C6)OC)N=C5CCCCCC7CC7OC(=O)N1,PHASE2|PHASE3,digestive_system_disease
65,Hepatitis C,Elbasvir,CC(C)C(C(=O)N1CCCC1C2=NC=C(N2)C3=CC4=C(C=C3)N5C(OC6=C(C5=C4)C=CC(=C6)C7=CN=C(N7)C8CCCN8C(=O)C(C(C)C)NC(=O)OC)C9=CC=CC=C9)NC(=O)OC,PHASE2|PHASE3,digestive_system_disease
66,Dumping Syndrome,Lanreotide,CC(C)C1C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=C(C=C4)O)NC(=O)C(CC5=CC6=CC=CC=C6C=C5)N)C(=O)NC(C(C)O)C(=O)N,PHASE2,digestive_system_disease
67,Gastrointestinal Bleeding of Unknown Origin|Gastrointestinal Vascular Malformation|Thalidomide Efficiency,Thalidomide,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O,PHASE2,digestive_system_disease
68,HIV Infections|Hepatitis B,Adefovir,C1=NC(=C2C(=N1)N(C=N2)CCOCP(=O)(O)O)N,PHASE2,digestive_system_disease
69,HIV Infections|Hepatitis B,Tenofovir,CC(CN1C=NC2=C(N=CN=C21)N)OCP(=O)(O)O,PHASE2,digestive_system_disease
70,Pancreatic Neoplasms,Surufatinib,CC1=CC2=C(N1)C=CC(=C2)OC3=NC(=NC=C3)NC4=CC=CC(=C4)CS(=O)(=O)NCCN(C)C,PHASE2,digestive_system_disease
71,Pancreatic Neuroendocrine Tumour Metastatic,Sunitinib,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C,PHASE2,digestive_system_disease
72,Peritoneal Carcinomatosis|Peritoneal Mesothelioma|Ovarian Cancer|Gastrointestinal Cancer|Appendiceal Cancer,Mitomycin C,CC1=C(C(=O)C2=C(C1=O)N3CC4C(C3(C2COC(=O)N)OC)N4)N,PHASE1,digestive_system_disease
73,Peritoneal Carcinomatosis|Peritoneal Mesothelioma|Ovarian Cancer|Gastrointestinal Cancer|Appendiceal Cancer,Mitomycin,CC1=C(C(=O)C2=C(C1=O)N3CC4C(C3(C2COC(=O)N)OC)N4)N,PHASE1,digestive_system_disease
74,Pancreatic Adenocarcinoma|Stage III Pancreatic Cancer AJCC v6 and v7,Triapine,C1=CC(=C(N=C1)C=NNC(=S)N)N,PHASE1,digestive_system_disease
75,Colorectal Neoplasm|Hereditary Nonpolyposis,Celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,PHASE1,digestive_system_disease
76,"Hepatitis B, Chronic",Entecavir,C=C1C(CC(C1CO)O)N2C=NC3=C2N=C(NC3=O)N,PHASE2,digestive_system_disease
77,Non-alcoholic Steatohepatitis,Mebrofenin,CC1=CC(=C(C(=C1NC(=O)CN(CC(=O)O)CC(=O)O)C)Br)C,PHASE1,digestive_system_disease
78,"Carcinoma, Hepatocellular",Idarubicin,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=CC=CC=C5C4=O)O)(C(=O)C)O)N)O,PHASE2,digestive_system_disease
79,Gastroesophageal Reflux Disease|Heartburn,Amiloride,C1(=C(N=C(C(=N1)Cl)N)N)C(=O)N=C(N)N,PHASE1,digestive_system_disease
80,Adenocarcinoma - GEJ|Cancer of Esophagus,Temozolomide,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N,PHASE2,digestive_system_disease
81,Crohn's Disease,Nitazoxanide,CC(=O)OC1=CC=CC=C1C(=O)NC2=NC=C(S2)[N+](=O)[O-],PHASE2,digestive_system_disease
82,Hepatocellular Carcinoma,Chiauranib,COC1=CC2=NC=CC(=C2C=C1)OC3=CC4=C(C=C3)C(=CC=C4)C(=O)NC5=CC=CC=C5N,PHASE1|PHASE2,digestive_system_disease
83,Hepatitis C,Telaprevir,CCCC(C(=O)C(=O)NC1CC1)NC(=O)C2C3CCCC3CN2C(=O)C(C(C)(C)C)NC(=O)C(C4CCCCC4)NC(=O)C5=NC=CN=C5,PHASE2,digestive_system_disease
84,Lung Cancer|Esophageal Cancer|Mesothelioma|Gastrointestinal Neoplasms|Breast Cancer,Plicamycin,CC1C(C(CC(O1)OC2CC(OC(C2O)C)OC3=CC4=CC5=C(C(=O)C(C(C5)C(C(=O)C(C(C)O)O)OC)OC6CC(C(C(O6)C)O)OC7CC(C(C(O7)C)O)OC8CC(C(C(O8)C)O)(C)O)C(=C4C(=C3C)O)O)O)O,PHASE2,digestive_system_disease
85,Hepatocellular Carcinoma,Lenvatinib,COC1=CC2=NC=CC(=C2C=C1C(=O)N)OC3=CC(=C(C=C3)NC(=O)NC4CC4)Cl,PHASE2,digestive_system_disease
86,Gastric Cancer,Telatinib,CNC(=O)C1=NC=CC(=C1)COC2=NN=C(C3=C2OC=C3)NC4=CC=C(C=C4)Cl,PHASE2,digestive_system_disease
87,Eosinophilic Esophagitis,Fluticasone,CC1CC2C3CC(C4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)SCF)O)C)O)F)C)F,PHASE2,digestive_system_disease
88,Polycystic Liver Disease|Autosomal Dominant Polycystic Kidney,Leuprorelin,CCNC(=O)C1CCCN1C(=O)C(CCCN=C(N)N)NC(=O)C(CC(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC2=CC=C(C=C2)O)NC(=O)C(CO)NC(=O)C(CC3=CNC4=CC=CC=C43)NC(=O)C(CC5=CN=CN5)NC(=O)C6CCC(=O)N6,PHASE2,digestive_system_disease
89,Polycystic Liver Disease|Autosomal Dominant Polycystic Kidney,Leuprolide,CCNC(=O)C1CCCN1C(=O)C(CCCN=C(N)N)NC(=O)C(CC(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC2=CC=C(C=C2)O)NC(=O)C(CO)NC(=O)C(CC3=CNC4=CC=CC=C43)NC(=O)C(CC5=CN=CN5)NC(=O)C6CCC(=O)N6,PHASE2,digestive_system_disease
90,Pancreatic Cancer,Enzalutamide,CC1(C(=O)N(C(=S)N1C2=CC(=C(C=C2)C(=O)NC)F)C3=CC(=C(C=C3)C#N)C(F)(F)F)C,PHASE1,digestive_system_disease
91,"Hepatitis C, Chronic",Taribavirin,C1=NC(=NN1C2C(C(C(O2)CO)O)O)C(=N)N,PHASE2,digestive_system_disease
92,Hepatic Impairment,Tivozanib,CC1=CC(=NO1)NC(=O)NC2=C(C=C(C=C2)OC3=C4C=C(C(=CC4=NC=C3)OC)OC)Cl,PHASE1,digestive_system_disease
93,Gastrointestinal Neoplasms,Ulixertinib,CC(C)NC1=NC=C(C(=C1)C2=CNC(=C2)C(=O)NC(CO)C3=CC(=CC=C3)Cl)Cl,PHASE1,digestive_system_disease
94,Gastrointestinal Neoplasms,Hydroxychloroquine,CCN(CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl)CCO,PHASE1,digestive_system_disease
95,Advanced Solid Tumors|Hematologic Malignancies,Ixazomib,B(C(CC(C)C)NC(=O)CNC(=O)C1=C(C=CC(=C1)Cl)Cl)(O)O,PHASE1,digestive_system_disease
96,"Hepatitis C, Chronic",Cyclosporine,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,PHASE2,digestive_system_disease
97,"Hepatitis C, Chronic",Tacrolimus,CC1CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC(=O)C(C=C(C1)C)CC=C)O)C)C(=CC4CCC(C(C4)OC)O)C)O)C)OC)OC,PHASE2,digestive_system_disease
98,Metastatic Pancreatic Cancer,Disulfiram,CCN(CC)C(=S)SSC(=S)N(CC)CC,PHASE2,digestive_system_disease
99,Advanced Pancreatic Carcinoma|Locally Advanced Pancreatic Carcinoma|Metastatic Pancreatic Carcinoma|Pancreatic Neoplasm|Stage II Pancreatic Cancer AJCC v8|Stage III Pancreatic Cancer AJCC v8|Stage IV Pancreatic Cancer AJCC v8|Unresectable Pancreatic Carcinoma,Verteporfin,CC1=C(C2=CC3=NC(=CC4=C(C(=C(N4)C=C5C6(C(C(=CC=C6C(=N5)C=C1N2)C(=O)OC)C(=O)OC)C)C)CCC(=O)OC)C(=C3C)CCC(=O)O)C=C.CC1=C(C2=CC3=NC(=CC4=C(C(=C(N4)C=C5C6(C(C(=CC=C6C(=N5)C=C1N2)C(=O)OC)C(=O)OC)C)C)CCC(=O)O)C(=C3C)CCC(=O)OC)C=C,PHASE2,digestive_system_disease
100,"Ovarian, Fallopian Tube, and Primary Peritoneal Cancer",Metformin,CN(C)C(=N)N=C(N)N,PHASE2,digestive_system_disease
101,Colorectal Cancer,Pyrotinib,CCOC1=C(C=C2C(=C1)N=CC(=C2NC3=CC(=C(C=C3)OCC4=CC=CC=N4)Cl)C#N)NC(=O)C=CC5CCCN5C,PHASE2,digestive_system_disease
102,Cirrhosis,Catechin,C1C(C(OC2=CC(=CC(=C21)O)O)C3=CC(=C(C=C3)O)O)O,PHASE1,digestive_system_disease
103,Cirrhosis,Cianidanol,C1C(C(OC2=CC(=CC(=C21)O)O)C3=CC(=C(C=C3)O)O)O,PHASE1,digestive_system_disease
104,Gastroenteropancreatic Neuroendocrine Tumor,Dotatate,CC(C1C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=C(C=C4)O)NC(=O)C(CC5=CC=CC=C5)NC(=O)CN6CCN(CCN(CCN(CC6)CC(=O)O)CC(=O)O)CC(=O)O)C(=O)NC(C(C)O)C(=O)O)O,PHASE1,digestive_system_disease
105,Indolent B-cell Lymphoma|Hepatitis C,Ledipasvir,CC(C)C(C(=O)N1CC2(CC2)CC1C3=NC=C(N3)C4=CC5=C(C=C4)C6=C(C5(F)F)C=C(C=C6)C7=CC8=C(C=C7)N=C(N8)C9C1CCC(C1)N9C(=O)C(C(C)C)NC(=O)OC)NC(=O)OC,PHASE2,digestive_system_disease
106,Indolent B-cell Lymphoma|Hepatitis C,Velpatasvir,CC1CCC(N1C(=O)C(C(C)C)NC(=O)OC)C2=NC3=C(N2)C=CC4=CC5=C(C=C43)OCC6=C5C=CC(=C6)C7=CN=C(N7)C8CC(CN8C(=O)C(C9=CC=CC=C9)NC(=O)OC)COC,PHASE2,digestive_system_disease
107,Acute Pancreatitis,Meropenem,CC1C2C(C(=O)N2C(=C1SC3CC(NC3)C(=O)N(C)C)C(=O)O)C(C)O,PHASE1|PHASE2,digestive_system_disease
108,Clinical Stage I Gastroesophageal Junction Adenocarcinoma AJCC v8|Clinical Stage II Gastroesophageal Junction Adenocarcinoma AJCC v8|Clinical Stage IIA Gastroesophageal Junction Adenocarcinoma AJCC v8|Clinical Stage IIB Gastroesophageal Junction Adenocarcinoma AJCC v8|Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8|Clinical Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8|Esophageal Adenocarcinoma|Esophageal Squamous Cell Carcinoma|Pathologic Stage I Gastroesophageal Junction Adenocarcinoma AJCC v8|Pathologic Stage IA Gastroesophageal Junction Adenocarcinoma AJCC v8|Pathologic Stage IB Gastroesophageal Junction Adenocarcinoma AJCC v8|Pathologic Stage IC Gastroesophageal Junction Adenocarcinoma AJCC v8|Pathologic Stage II Gastroesophageal Junction Adenocarcinoma AJCC v8|Pathologic Stage IIA Gastroesophageal Junction Adenocarcinoma AJCC v8|Pathologic Stage IIB Gastroesophageal Junction Adenocarcinoma AJCC v8|Pathologic Stage IIIA Gastroesophageal Junction Adenocarcinoma AJCC v8|Pathologic Stage IIIB Gastroesophageal Junction Adenocarcinoma AJCC v8|Pathologic Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8|Pathologic Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8,Tricyclazole,CC1=C2C(=CC=C1)SC3=NN=CN23,PHASE2,digestive_system_disease
109,Bladder Cancer|Breast Cancer|Colorectal Cancer|Gastrointestinal Neoplasm|Head and Neck Cancer|Lung Cancer|Ovarian Cancer|Pancreatic Cancer|Prostate Cancer,Picoplatin,CC1=CC=CC=N1.N.[Cl-].[Cl-].[Pt+2],PHASE1,digestive_system_disease
110,Hemorrhoids|Liver Cirrhosis,Polidocanol,CCCCCCCCCCCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO,PHASE2|PHASE3,digestive_system_disease
111,Ulcerative Colitis|Fecal Microbiota Transplantation,Prednisone,CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C,PHASE2|PHASE3,digestive_system_disease
112,"Hepatitis B, Chronic",Lamivudine,C1C(OC(S1)CO)N2C=CC(=NC2=O)N,PHASE1,digestive_system_disease
113,Diabetic Gastroenteropathy,Mosapride,CCOC1=CC(=C(C=C1C(=O)NCC2CN(CCO2)CC3=CC=C(C=C3)F)Cl)N,PHASE1|PHASE2,digestive_system_disease
114,Hepatitis D,Lonafarnib,C1CN(CCC1CC(=O)N2CCC(CC2)C3C4=C(CCC5=C3N=CC(=C5)Br)C=C(C=C4Br)Cl)C(=O)N,PHASE2,digestive_system_disease
115,Breast Cancer|Ovarian Cancer|Colon Cancer|Lung Cancer|Gastric Cancer|Solid Tumors,Veliparib,CC1(CCCN1)C2=NC3=C(C=CC=C3N2)C(=O)N,PHASE1,digestive_system_disease
116,Irritable Bowel Syndrome,Ethosuximide,CCC1(CC(=O)NC1=O)C,PHASE2,digestive_system_disease
117,Colorectal Cancer,Trifluridine,C1C(C(OC1N2C=C(C(=O)NC2=O)C(F)(F)F)CO)O,PHASE2,digestive_system_disease
118,Colorectal Cancer,Tipiracil,C1CC(=N)N(C1)CC2=C(C(=O)NC(=O)N2)Cl,PHASE2,digestive_system_disease
119,High Grade Squamous Intra-epithelial Lesion (HSIL),Pomalidomide,C1CC(=O)NC(=O)C1N2C(=O)C3=C(C2=O)C(=CC=C3)N,PHASE2,digestive_system_disease
120,Metastatic Colorectal Cancer,Dabrafenib,CC(C)(C)C1=NC(=C(S1)C2=NC(=NC=C2)N)C3=C(C(=CC=C3)NS(=O)(=O)C4=C(C=CC=C4F)F)F,PHASE2,digestive_system_disease
121,Metastatic Colorectal Cancer,Trametinib,CC1=C2C(=C(N(C1=O)C)NC3=C(C=C(C=C3)I)F)C(=O)N(C(=O)N2C4=CC=CC(=C4)NC(=O)C)C5CC5,PHASE2,digestive_system_disease
122,Pancreatic Adenocarcinoma Metastatic|BRCA1 Mutation|BRCA2 Mutation|Pancreatic Acinar Cell Carcinoma|Pancreatic Ductal Adenocarcinoma|Pancreatic Cancer|Metastatic Pancreatic Cancer|Metastatic Pancreatic Ductal Adenocarcinoma|Breast Cancer Metastatic|Breast Cancer Stage IV|Pancreatic Cancer Stage IV|HER2-negative Breast Cancer|HER2 Negative Breast Carcinoma|Adenocarcinoma of the Breast|PALB2 Gene Mutation,Melphalan,C1=CC(=CC=C1CC(C(=O)O)N)N(CCCl)CCCl,PHASE1,digestive_system_disease
123,Hepatobiliary Disorders|Non-alcoholic Steatohepatitis,Semaglutide,CCC(C)C(C(=O)NC(C)C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(CC(C)C)C(=O)NC(C(C)C)C(=O)NC(CCCNC(=N)N)C(=O)NCC(=O)NC(CCCNC(=N)N)C(=O)NCC(=O)O)NC(=O)C(CC3=CC=CC=C3)NC(=O)C(CCC(=O)O)NC(=O)C(CCCCNC(=O)COCCOCCNC(=O)COCCOCCNC(=O)CCC(C(=O)O)NC(=O)CCCCCCCCCCCCCCCCC(=O)O)NC(=O)C(C)NC(=O)C(C)NC(=O)C(CCC(=O)N)NC(=O)CNC(=O)C(CCC(=O)O)NC(=O)C(CC(C)C)NC(=O)C(CC4=CC=C(C=C4)O)NC(=O)C(CO)NC(=O)C(CO)NC(=O)C(C(C)C)NC(=O)C(CC(=O)O)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C(CC5=CC=CC=C5)NC(=O)C(C(C)O)NC(=O)CNC(=O)C(CCC(=O)O)NC(=O)C(C)(C)NC(=O)C(CC6=CN=CN6)N,PHASE2,digestive_system_disease
124,Hepatocellular Carcinoma,Fludarabine,C1=NC2=C(N=C(N=C2N1C3C(C(C(O3)CO)O)O)F)N,PHASE1,digestive_system_disease
125,Hepatocellular Carcinoma,Resminostat,CN(C)CC1=CC=C(C=C1)S(=O)(=O)N2C=CC(=C2)C=CC(=O)NO,PHASE1|PHASE2,digestive_system_disease
126,Irritable Bowel Syndrome,Lubiprostone,CCCCC(C1(CCC2C(O1)CC(=O)C2CCCCCCC(=O)O)O)(F)F,PHASE1,digestive_system_disease
127,Cirrhosis|Refractory/Recurrent Ascites,Tolvaptan,CC1=CC=CC=C1C(=O)NC2=CC(=C(C=C2)C(=O)N3CCCC(C4=C3C=CC(=C4)Cl)O)C,PHASE2|PHASE3,digestive_system_disease
128,Cirrhosis|Refractory/Recurrent Ascites,Midodrine,COC1=CC(=C(C=C1)OC)C(CNC(=O)CN)O,PHASE2|PHASE3,digestive_system_disease
129,Hepatic Impairment,Betrixaban,CN(C)C(=N)C1=CC=C(C=C1)C(=O)NC2=C(C=C(C=C2)OC)C(=O)NC3=NC=C(C=C3)Cl,PHASE1,digestive_system_disease
130,Hepatitis C|HIV,Atazanavir,CC(C)(C)C(C(=O)NC(CC1=CC=CC=C1)C(CN(CC2=CC=C(C=C2)C3=CC=CC=N3)NC(=O)C(C(C)(C)C)NC(=O)OC)O)NC(=O)OC,PHASE1,digestive_system_disease
131,Hepatitis C|HIV,Cobicistat,CC(C)C1=NC(=CS1)CN(C)C(=O)NC(CCN2CCOCC2)C(=O)NC(CCC(CC3=CC=CC=C3)NC(=O)OCC4=CN=CS4)CC5=CC=CC=C5,PHASE1,digestive_system_disease
132,"Non-Alcoholic Fatty Liver Disease|Obesity|Obesity, Abdominal|Liver Fat|Fatty Liver",Tesamorelin,CCC=CCC(=O)NC(CC1=CC=C(C=C1)O)C(=O)NC(C)C(=O)NC(CC(=O)O)C(=O)NC(C)C(=O)NC(C(C)CC)C(=O)NC(CC2=CC=CC=C2)C(=O)NC(C(C)O)C(=O)NC(CC(=O)N)C(=O)NC(CO)C(=O)NC(CC3=CC=C(C=C3)O)C(=O)NC(CCCNC(=N)N)C(=O)NC(CCCCN)C(=O)NC(C(C)C)C(=O)NC(CC(C)C)C(=O)NCC(=O)NC(CCC(=O)N)C(=O)NC(CC(C)C)C(=O)NC(CO)C(=O)NC(C)C(=O)NC(CCCNC(=N)N)C(=O)NC(CCCCN)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(CCC(=O)N)C(=O)NC(CC(=O)O)C(=O)NC(C(C)CC)C(=O)NC(CCSC)C(=O)NC(CO)C(=O)NC(CCCNC(=N)N)C(=O)NC(CCC(=O)N)C(=O)NC(CCC(=O)N)C(=O)NCC(=O)NC(CCC(=O)O)C(=O)NC(CO)C(=O)NC(CC(=O)N)C(=O)NC(CCC(=O)N)C(=O)NC(CCC(=O)O)C(=O)NC(CCCNC(=N)N)C(=O)NCC(=O)NC(C)C(=O)NC(CCCNC(=N)N)C(=O)NC(C)C(=O)NC(CCCNC(=N)N)C(=O)NC(CC(C)C)C(=O)N,PHASE2,digestive_system_disease
133,Healthy|Hepatic Insufficiency,Canagliflozin,CC1=C(C=C(C=C1)C2C(C(C(C(O2)CO)O)O)O)CC3=CC=C(S3)C4=CC=C(C=C4)F,PHASE1,digestive_system_disease
134,Microsatellite Unstable Colorectal Cancer|Microsatellite Stable Colorectal Cancer|Mismatch Repair Proficient Colorectal Cancer|Mismatch Repair Deficient Colorectal Cancer,Cobimetinib,C1CCNC(C1)C2(CN(C2)C(=O)C3=C(C(=C(C=C3)F)F)NC4=C(C=C(C=C4)I)F)O,PHASE2,digestive_system_disease
135,Liver Diseases|Hepatic Insufficiency,Baricitinib,CCS(=O)(=O)N1CC(C1)(CC#N)N2C=C(C=N2)C3=C4C=CNC4=NC=N3,PHASE1,digestive_system_disease
136,Crohn's Disease,Teduglutide,CCC(C)C(C(=O)NC(C(C)O)C(=O)NC(CC(=O)O)C(=O)O)NC(=O)C(CCCCN)NC(=O)C(C(C)O)NC(=O)C(CCC(=O)N)NC(=O)C(C(C)CC)NC(=O)C(CC(C)C)NC(=O)C(CC1=CNC2=CC=CC=C21)NC(=O)C(CC(=O)N)NC(=O)C(C(C)CC)NC(=O)C(CC3=CC=CC=C3)NC(=O)C(CC(=O)O)NC(=O)C(CCCNC(=N)N)NC(=O)C(C)NC(=O)C(C)NC(=O)C(CC(C)C)NC(=O)C(CC(=O)N)NC(=O)C(CC(=O)O)NC(=O)C(CC(C)C)NC(=O)C(C(C)CC)NC(=O)C(C(C)O)NC(=O)C(CC(=O)N)NC(=O)C(CCSC)NC(=O)C(CCC(=O)O)NC(=O)C(CC(=O)O)NC(=O)C(CO)NC(=O)C(CC4=CC=CC=C4)NC(=O)C(CO)NC(=O)CNC(=O)C(CC(=O)O)NC(=O)CNC(=O)C(CC5=CN=CN5)N,PHASE2,digestive_system_disease
137,Irritable Bowel Syndrome,Asimadoline,CN(C(CN1CCC(C1)O)C2=CC=CC=C2)C(=O)C(C3=CC=CC=C3)C4=CC=CC=C4,PHASE2,digestive_system_disease
138,Unresectable Gastrointestinal Stromal Tumor (GIST)|Locally Advanced Gastrointestinal Stromal Tumor (GIST)|Metastatic Gastrointestinal Stromal Tumor,Imatinib,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,PHASE2,digestive_system_disease
139,Gastroesophageal Reflux Disease,Atovaquone,C1CC(CCC1C2=CC=C(C=C2)Cl)C3=C(C4=CC=CC=C4C(=O)C3=O)O,PHASE1,digestive_system_disease
140,Gastroesophageal Reflux Disease,Proguanil,CC(C)N=C(N)N=C(N)NC1=CC=C(C=C1)Cl,PHASE1,digestive_system_disease
141,Gastroesophageal Reflux Disease,Tegoprazan,CC1=NC2=C(N1)C=C(C=C2OC3CCOC4=C3C(=CC(=C4)F)F)C(=O)N(C)C,PHASE1,digestive_system_disease
142,Gastroesophageal Reflux Disease,Vonoprazan,CNCC1=CN(C(=C1)C2=CC=CC=C2F)S(=O)(=O)C3=CN=CC=C3,PHASE1,digestive_system_disease
143,Metastatic Pancreatic Adenocarcinoma|Pancreatic Ductal Adenocarcinoma|Stage IV Pancreatic Cancer AJCC v6 and v7,Olaparib,C1CC1C(=O)N2CCN(CC2)C(=O)C3=C(C=CC(=C3)CC4=NNC(=O)C5=CC=CC=C54)F,PHASE2,digestive_system_disease
144,HIV Infections|Cachexia|Anorexia|AIDS Wasting Syndrome|HIV Wasting Syndrome,Megestrol,CC1=CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C,PHASE2,digestive_system_disease
145,Colonic Neoplasms,Levoleucovorin,C1C(N(C2=C(N1)N=C(NC2=O)N)C=O)CNC3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,PHASE1|PHASE2,digestive_system_disease
146,Primary Biliary Cirrhosis,Pentoxifylline,CC(=O)CCCCN1C(=O)C2=C(N=CN2C)N(C1=O)C,PHASE2,digestive_system_disease
147,Gastroparesis,Metoclopramide,CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl,PHASE2,digestive_system_disease
148,Hepatorenal Syndrome|Acute Kidney Injury,Terlipressin,C1CC(N(C1)C(=O)C2CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N2)CC(=O)N)CCC(=O)N)CC3=CC=CC=C3)CC4=CC=C(C=C4)O)NC(=O)CNC(=O)CNC(=O)CN)C(=O)NC(CCCCN)C(=O)NCC(=O)N,PHASE2,digestive_system_disease
149,Colorectal Cancer Metastatic,Vemurafenib,CCCS(=O)(=O)NC1=C(C(=C(C=C1)F)C(=O)C2=CNC3=C2C=C(C=N3)C4=CC=C(C=C4)Cl)F,PHASE1|PHASE2,digestive_system_disease
150,Chronic Diarrhea|Irritable Bowel Syndrome With Diarrhea|Bile Acid Malabsorption,Colesevelam,CCCCCCCCCCNCC=C.C[N+](C)(C)CCCCCCNCC=C.C=CCN.C1C(O1)CCl.Cl.[Cl-],PHASE2,digestive_system_disease
151,Advanced Hepatocellular Carcinoma,Itacitinib,C1CN(CCC1N2CC(C2)(CC#N)N3C=C(C=N3)C4=C5C=CNC5=NC=N4)C(=O)C6=C(C(=NC=C6)C(F)(F)F)F,PHASE1,digestive_system_disease
152,Islet Cell Carcinoma|Neuroendocrine Carcinoma|Neuroendocrine Tumor|Pancreatic Neoplasms,Everolimus,CC1CCC2CC(C(=CC=CC=CC(CC(C(=O)C(C(C(=CC(C(=O)CC(OC(=O)C3CCCCN3C(=O)C(=O)C1(O2)O)C(C)CC4CCC(C(C4)OC)OCCO)C)C)O)OC)C)C)C)OC,PHASE2,digestive_system_disease
153,Islet Cell Carcinoma|Neuroendocrine Carcinoma|Neuroendocrine Tumor|Pancreatic Neoplasms,Octreotide,CC(C1C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=CC=C4)NC(=O)C(CC5=CC=CC=C5)N)C(=O)NC(CO)C(C)O)O,PHASE2,digestive_system_disease
154,Colorectal Cancer,Decitabine,C1C(C(OC1N2C=NC(=NC2=O)N)CO)O,PHASE1,digestive_system_disease
155,Advanced Solid Malignancies|Non-Small Cell Lung Cancer (NSCLC)|Metastatic Castrate-Resistant Prostate Carcinoma (mCRPC)|Colorectal Carcinoma (CRC),Abiraterone,CC12CCC(CC1=CCC3C2CCC4(C3CC=C4C5=CN=CC=C5)C)O,PHASE1,digestive_system_disease
156,Gastric Cancer,Fruquintinib,CC1=C(C2=C(O1)C=C(C=C2)OC3=NC=NC4=CC(=C(C=C43)OC)OC)C(=O)NC,PHASE2,digestive_system_disease
157,Pancreatitis,Aprotinin,CCC(C)C1C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NCC(=O)NC(C(=O)NC2CSSCC3C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)N4CCCC4C(=O)N5CCCC5C(=O)NC(C(=O)NC(C(=O)NCC(=O)N6CCCC6C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N3)CC(=O)O)CCC(=O)O)C)CO)CCCCN)CC7=CC=CC=C7)CC(=O)N)CC(=O)N)CCCNC(=N)N)CCCCN)C)CCCNC(=N)N)NC(=O)CNC(=O)CNC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC2=O)CCC(=O)N)C(C)O)CC8=CC=CC=C8)C(C)C)CC9=CC=C(C=C9)O)C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCNC(=N)N)C)CCCCN)C(C)O)CC1=CC=C(C=C1)O)CCC(=O)O)CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C(CC(=O)O)NC(=O)C1CCCN1C(=O)C(CCCNC(=N)N)N)C(=O)NCC(=O)NCC(=O)NC(C)C(=O)O)C(C)O)CCCNC(=N)N)CCSC)CC(C)C)C)CCCCN)C)CC(=O)N)CC1=CC=C(C=C1)O)CC1=CC=CC=C1)CC1=CC=C(C=C1)O)CCCNC(=N)N)C(C)CC,PHASE1,digestive_system_disease
158,Colorectal|Cancer,Vandetanib,CN1CCC(CC1)COC2=C(C=C3C(=C2)N=CN=C3NC4=C(C=C(C=C4)Br)F)OC,PHASE2,digestive_system_disease
159,Primary Sclerosing Cholangitis,Cenicriviroc,CCCCOCCOC1=CC=C(C=C1)C2=CC3=C(C=C2)N(CCCC(=C3)C(=O)NC4=CC=C(C=C4)S(=O)CC5=CN=CN5CCC)CC(C)C,PHASE2,digestive_system_disease
160,Liver Metastasis|Colorectal Neoplasms|Liver Neoplasms|Neoplasm Metastasis,Talaporfin,CCC1=C(C2=CC3=C(C(=C(N3)C=C4C(C(C(=N4)C(=C5C(=C(C(=N5)C=C1N2)C)C(=O)O)CC(=O)NC(CC(=O)O)C(=O)O)CCC(=O)O)C)C)C=C)C,PHASE2,digestive_system_disease
161,Postoperative Ileus,Pyridostigmine,C[N+]1=CC=CC(=C1)OC(=O)N(C)C,PHASE2|PHASE3,digestive_system_disease
162,Hepatic Insufficiency,Evacetrapib,CC1=CC(=C2C(=C1)C(CCCN2CC3CCC(CC3)C(=O)O)N(CC4=CC(=CC(=C4)C(F)(F)F)C(F)(F)F)C5=NN(N=N5)C)C,PHASE1,digestive_system_disease
163,Anastomotic Leak|Rectal Cancer,Ciprofloxacin,C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O,PHASE2,digestive_system_disease
164,Fecal Incontinence,Oxymetazoline,CC1=CC(=C(C(=C1CC2=NCCN2)C)O)C(C)(C)C,PHASE1,digestive_system_disease
165,Metastatic Pancreatic Cancer,Enoxaparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,PHASE2,digestive_system_disease
166,Lung Cancer|Melanoma|Head and Neck Carcinoma|Gastroesophageal Cancer|Breast Cancer|Pancreatic Adenocarcinoma|Colorectal Cancer|Biliary Tract Cancer,Selumetinib,CN1C=NC2=C1C=C(C(=C2F)NC3=C(C=C(C=C3)Br)Cl)C(=O)NOCCO,PHASE1,digestive_system_disease
167,Post-ERCP Acute Pancreatitis,Indomethacin,CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)Cl)C=CC(=C2)OC)CC(=O)O,PHASE2|PHASE3,digestive_system_disease
168,Hepatitis C Infection,Ruzasvir,CC(C)C(C(=O)N1CCCC1C2=NC=C(N2)C3=CC4=C(C=C3)N5C(OC6=C(C5=C4)C(=CC(=C6)C7=CN=C(N7)C8CCCN8C(=O)C(C(C)C)NC(=O)OC)F)C9=CN=C(S9)C1CC1)NC(=O)OC,PHASE1,digestive_system_disease
169,Cystic Fibrosis,Cysteamine,C(CS)N,PHASE2,digestive_system_disease
170,HIV|Hepatitis C|Liver Fibrosis,Raltegravir,CC1=NN=C(O1)C(=O)NC(C)(C)C2=NC(=C(C(=O)N2C)O)C(=O)NCC3=CC=C(C=C3)F,PHASE2,digestive_system_disease
171,Nonalcoholic Steatohepatitis,Cilofexor,C1CC1C2=C(C(=NO2)C3=C(C=CC=C3Cl)Cl)COC4=CC(=C(C=C4)C5(CN(C5)C6=NC=CC(=C6)C(=O)O)O)Cl,PHASE2,digestive_system_disease
172,Nonalcoholic Steatohepatitis,Firsocostat,CC1=C(SC2=C1C(=O)N(C(=O)N2CC(C3=CC=CC=C3OC)OC4CCOCC4)C(C)(C)C(=O)O)C5=NC=CO5,PHASE2,digestive_system_disease
173,Gastritis,Rebamipide,C1=CC=C2C(=C1)C(=CC(=O)N2)CC(C(=O)O)NC(=O)C3=CC=C(C=C3)Cl,PHASE2,digestive_system_disease
174,Osteoarthritis,Ibuprofen,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O,PHASE2,digestive_system_disease
175,Colorectal Neoplasms,Nintedanib,CN1CCN(CC1)CC(=O)N(C)C2=CC=C(C=C2)N=C(C3=CC=CC=C3)C4=C(NC5=C4C=CC(=C5)C(=O)OC)O,PHASE2,digestive_system_disease
176,Hepatorenal Syndrome,Ifetroban,CCCCCNC(=O)C1=COC(=N1)C2C3CCC(C2CC4=CC=CC=C4CCC(=O)O)O3,PHASE2,digestive_system_disease
177,Colorectal Neoplasms,Pemetrexed,C1=CC(=CC=C1CCC2=CNC3=C2C(=O)NC(=N3)N)C(=O)NC(CCC(=O)O)C(=O)O,PHASE2,digestive_system_disease
178,NAFLD|PCOS,Bicalutamide,CC(CS(=O)(=O)C1=CC=C(C=C1)F)(C(=O)NC2=CC(=C(C=C2)C#N)C(F)(F)F)O,PHASE1,digestive_system_disease
179,Immunotherapy|Gastrict Cancer,Tegafur,C1CC(OC1)N2C=C(C(=O)NC2=O)F,PHASE2,digestive_system_disease
180,Inoperable or Recurrent or Metastatic Esophageal Squamous Carcinoma,Poziotinib,COC1=C(C=C2C(=C1)N=CN=C2NC3=C(C(=C(C=C3)Cl)Cl)F)OC4CCN(CC4)C(=O)C=C,PHASE2,digestive_system_disease
181,NAFLD|NASH With Fibrosis|Liver Fibrosis,Dasatinib,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=CC(=NC(=N3)C)N4CCN(CC4)CCO,PHASE1|PHASE2,digestive_system_disease
182,NAFLD|NASH With Fibrosis|Liver Fibrosis,Quercetin,C1=CC(=C(C=C1C2=C(C(=O)C3=C(C=C(C=C3O2)O)O)O)O)O,PHASE1|PHASE2,digestive_system_disease
183,Prematurity|Iron-deficiency|Iron Deficiency Anemia|Iron Malabsorption,Ferumoxytol,O[Fe]=O.O[Fe]=O.[Fe],PHASE2,digestive_system_disease
184,Thrombocytopenia,Avatrombopag,C1CCC(CC1)N2CCN(CC2)C3=C(N=C(S3)NC(=O)C4=CC(=C(N=C4)N5CCC(CC5)C(=O)O)Cl)C6=CC(=CS6)Cl,PHASE2,digestive_system_disease
185,Solid Tumor|Gastrointestinal Cancer|Breast Cancer,Azacitidine,C1=NC(=NC(=O)N1C2C(C(C(O2)CO)O)O)N,PHASE1|PHASE2,digestive_system_disease
186,Immunoglobulin G Subclass 4 Related Disease|IgG4-related Disease|Autoimmune Pancreatitis|IgG4-related Sclerosing Cholangitis|Retroperitoneal Fibrosis,Lenalidomide,C1CC(=O)NC(=O)C1N2CC3=C(C2=O)C=CC=C3N,PHASE1,digestive_system_disease
187,"Ischemic Reperfusion Injury|Insufficiency; Hepatic, Postoperative|Liver Tumour",Methylprednisolone,CC1CC2C3CCC(C3(CC(C2C4(C1=CC(=O)C=C4)C)O)C)(C(=O)CO)O,PHASE2,digestive_system_disease
188,Ulcerative Colitis|Inflammatory Bowel Diseases|Acute Severe Colitis,Ceftriaxone,CN1C(=NC(=O)C(=O)N1)SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)O,PHASE2,digestive_system_disease
189,Ulcerative Colitis|Inflammatory Bowel Diseases|Acute Severe Colitis,Metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-],PHASE2,digestive_system_disease
190,Cystic Fibrosis,Losartan,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl,PHASE2,digestive_system_disease
191,Non-erosive Reflux Disease,Fluoxetine,CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F,PHASE2|PHASE3,digestive_system_disease
192,"Carcinoma, Renal Cell|Glioblastoma|Carcinoma, Hepatocellular",Crizotinib,CC(C1=C(C=CC(=C1Cl)F)Cl)OC2=C(N=CC(=C2)C3=CN(N=C3)C4CCNCC4)N,PHASE1,digestive_system_disease
193,Colorectal Cancer|Pancreas Cancer,Dovitinib,CN1CCN(CC1)C2=CC3=C(C=C2)N=C(N3)C4=C(C5=C(C=CC=C5F)NC4=O)N,PHASE2,digestive_system_disease
194,Clear Cell Renal Cell Carcinoma|Locally Advanced Pancreatic Cancer|Locally Advanced Malignant Solid Neoplasm|Metastatic Malignant Solid Neoplasm|Metastatic Renal Cell Carcinoma|Metastatic Urothelial Carcinoma|Metastatic Pancreatic Cancer|Stage III Pancreatic Cancer|Stage III Renal Cell Cancer|Stage IV Pancreatic Cancer|Stage IV Renal Cell Cancer|Endometrial Cancer|Metastatic Castration-resistant Prostate Cancer,Ceralasertib,CC1COCCN1C2=NC(=NC(=C2)C3(CC3)S(=N)(=O)C)C4=C5C=CNC5=NC=C4,PHASE2,digestive_system_disease
195,Ulcerative Colitis|Inflammatory Bowel Diseases,Psyllium,CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC(=O)O,PHASE2,digestive_system_disease
196,Achalasia,Olinciguat,C1=CC=C(C(=C1)CN2C(=CC(=N2)C3=NC=C(C(=N3)NCC(C(=O)N)(C(F)(F)F)O)F)C4=NOC=C4)F,PHASE2,digestive_system_disease
197,Liver Cirrhosis|Portal Hypertension|Anticoagulant-induced Bleeding|Thrombosis,Rivaroxaban,C1COCC(=O)N1C2=CC=C(C=C2)N3CC(OC3=O)CNC(=O)C4=CC=C(S4)Cl,PHASE1|PHASE2,digestive_system_disease
198,Colorectal Cancer|Metastatic Colorectal Cancer|Thymalfasin,Thymalfasin,CCC(C)C(C(=O)NC(C(C)O)C(=O)NC(C(C)O)C(=O)NC(CCCCN)C(=O)NC(CC(=O)O)C(=O)NC(CC(C)C)C(=O)NC(CCCCN)C(=O)NC(CCC(=O)O)C(=O)NC(CCCCN)C(=O)NC(CCCCN)C(=O)NC(CCC(=O)O)C(=O)NC(C(C)C)C(=O)NC(C(C)C)C(=O)NC(CCC(=O)O)C(=O)NC(CCC(=O)O)C(=O)NC(C)C(=O)NC(CCC(=O)O)C(=O)NC(CC(=O)N)C(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(CO)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C(CC(=O)O)NC(=O)C(C(C)C)NC(=O)C(C)NC(=O)C(C)NC(=O)C(CC(=O)O)NC(=O)C(CO)NC(=O)C,PHASE2,digestive_system_disease
199,Advanced Gastrointestinal Tumors,Minnelide,CC(C)C12C(O1)C3C4(O3)C5(CCC6=C(C5CC7C4(C2OCOP(=O)([O-])[O-])O7)COC6=O)C.[Na+].[Na+],PHASE1,digestive_system_disease
200,Irritable Bowel Syndrome,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,PHASE2,digestive_system_disease
201,Hepatitis C,Ombitasvir,CC(C)C(C(=O)N1CCCC1C(=O)NC2=CC=C(C=C2)C3CCC(N3C4=CC=C(C=C4)C(C)(C)C)C5=CC=C(C=C5)NC(=O)C6CCCN6C(=O)C(C(C)C)NC(=O)OC)NC(=O)OC,PHASE1,digestive_system_disease
202,Hepatitis C,Paritaprevir,CC1=CN=C(C=N1)C(=O)NC2CCCCCC=CC3CC3(NC(=O)C4CC(CN4C2=O)OC5=NC6=CC=CC=C6C7=CC=CC=C75)C(=O)NS(=O)(=O)C8CC8,PHASE1,digestive_system_disease
203,Gastroparesis|Dyspepsia,Cannabidiol,CCCCCC1=CC(=C(C(=C1)O)C2C=C(CCC2C(=C)C)C)O,PHASE2,digestive_system_disease
204,Cholangiocarcinoma|Tumor|Klatskin Tumor,Temoporfin,C1CC2=NC1=C(C3=CC=C(N3)C(=C4C=CC(=N4)C(=C5C=CC(=C2C6=CC(=CC=C6)O)N5)C7=CC(=CC=C7)O)C8=CC(=CC=C8)O)C9=CC(=CC=C9)O,PHASE2,digestive_system_disease
205,Hepatitis C,Moxifloxacin,COC1=C2C(=CC(=C1N3CC4CCCNC4C3)F)C(=O)C(=CN2C5CC5)C(=O)O,PHASE1,digestive_system_disease
206,Non-alcoholic Fatty Liver Disease,Mitoquinone,CC1=C(C(=O)C(=C(C1=O)OC)OC)CCCCCCCCCC[P+](C2=CC=CC=C2)(C3=CC=CC=C3)C4=CC=CC=C4,PHASE2,digestive_system_disease
207,Acute Appendicitis,Ertapenem,CC1C2C(C(=O)N2C(=C1SC3CC(NC3)C(=O)NC4=CC=CC(=C4)C(=O)O)C(=O)O)C(C)O,PHASE2,digestive_system_disease
208,Acute Appendicitis,Levofloxacin,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O,PHASE2,digestive_system_disease
209,Pancreas Cancer,Lurbinectedin,CC1=CC2=C(C3C4C5C6=C(C(=C7C(=C6C(N4C(C(C2)N3C)O)COC(=O)C8(CS5)C9=C(CCN8)C2=C(N9)C=CC(=C2)OC)OCO7)C)OC(=O)C)C(=C1OC)O,PHASE2,digestive_system_disease
210,Pancreatic Cancer|Unresectable Pancreatic Cancer|Metastatic Pancreatic Cancer|KRAS P.G12C,Sotorasib,CC1CN(CCN1C2=NC(=O)N(C3=NC(=C(C=C32)F)C4=C(C=CC=C4F)O)C5=C(C=CN=C5C(C)C)C)C(=O)C=C,PHASE1|PHASE2,digestive_system_disease
211,Pancreatic Cancer,Vatalanib,C1=CC=C2C(=C1)C(=NN=C2NC3=CC=C(C=C3)Cl)CC4=CC=NC=C4,PHASE1|PHASE2,digestive_system_disease
212,Ulcerative Colitis|Inflammatory Bowel Disease,Rosiglitazone,CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3,PHASE2,digestive_system_disease
213,Oral Mucositis (Ulcerative) Due to Radiation,Dexpanthenol,CC(C)(CO)C(C(=O)NCCCO)O,PHASE2,digestive_system_disease
214,Appendicitis,Ropivacaine,CCCN1CCCCC1C(=O)NC2=C(C=CC=C2C)C,PHASE1|PHASE2,digestive_system_disease
215,Stress Urinary Incontinence|Fecal Incontinence,Reboxetine,CCOC1=CC=CC=C1OC(C2CNCCO2)C3=CC=CC=C3,PHASE1,digestive_system_disease
216,Hepatitis B|HIV Infections,Emtricitabine,C1C(OC(S1)CO)N2C=C(C(=NC2=O)N)F,PHASE2|PHASE3,digestive_system_disease
217,Small Cell Lung Cancer|Pancreatic Cancer|Head and Neck Cancer|Gastric Cancer|Esophageal Cancer,Topotecan,CCC1(C2=C(COC1=O)C(=O)N3CC4=CC5=C(C=CC(=C5CN(C)C)O)N=C4C3=C2)O,PHASE1,digestive_system_disease
218,Hepatitis C|HCV|HIV|AIDS,Efavirenz,C1CC1C#CC2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F,PHASE1,digestive_system_disease
219,Chronic Hepatitis C,Colchicine,CC(=O)NC1CCC2=CC(=C(C(=C2C3=CC=C(C(=O)C=C13)OC)OC)OC)OC,PHASE2,digestive_system_disease
220,Gastrointestinal Stromal Tumors,Ripretinib,CCN1C2=CC(=NC=C2C=C(C1=O)C3=CC(=C(C=C3Br)F)NC(=O)NC4=CC=CC=C4)NC,PHASE1|PHASE2,digestive_system_disease
221,Cancer of Head and Neck|Mucositis Oral|Pharyngeal Mucositis,Ketamine,CNC1(CCCCC1=O)C2=CC=CC=C2Cl,PHASE2,digestive_system_disease
222,Colorectal Carcinoma,Doxycycline,CC1C2C(C3C(C(=O)C(=C(C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O,PHASE2,digestive_system_disease
223,Primary Sclerosing Cholangitis,Minocycline,CN(C)C1C2CC3CC4=C(C=CC(=C4C(=C3C(=O)C2(C(=C(C1=O)C(=O)N)O)O)O)O)N(C)C,PHASE1,digestive_system_disease
224,Chronic Hepatitis C,Vaniprevir,CCC1CC1(C(=O)NS(=O)(=O)C2CC2)NC(=O)C3CC4CN3C(=O)C(NC(=O)OCC(CCCCC5=C6CN(CC6=CC=C5)C(=O)O4)(C)C)C(C)(C)C,PHASE1,digestive_system_disease
225,Hepatic Insufficiency,Neratinib,CCOC1=C(C=C2C(=C1)N=CC(=C2NC3=CC(=C(C=C3)OCC4=CC=CC=N4)Cl)C#N)NC(=O)C=CCN(C)C,PHASE1,digestive_system_disease
226,Non-cirrhotic Non-alcoholic Steatohepatitis With Fibrosis,Cotadutide,CCCCCCCCCCCCCCCC(=O)NC(CCC(=O)NCCCCC(C(=O)NC(CO)C(=O)NC(CCC(=O)O)C(=O)NC(CC1=CC=C(C=C1)O)C(=O)NC(CC(C)C)C(=O)NC(CC(=O)O)C(=O)NC(CO)C(=O)NC(CCC(=O)O)C(=O)NC(CCCNC(=N)N)C(=O)NC(C)C(=O)NC(CCCNC(=N)N)C(=O)NC(CC(=O)O)C(=O)NC(CC2=CC=CC=C2)C(=O)NC(C(C)C)C(=O)NC(C)C(=O)NC(CC3=CNC4=CC=CC=C43)C(=O)NC(CC(C)C)C(=O)NC(CCC(=O)O)C(=O)NC(C)C(=O)NCC(=O)NCC(=O)O)NC(=O)C(CC(=O)O)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C(CC5=CC=CC=C5)NC(=O)C(C(C)O)NC(=O)CNC(=O)C(CCC(=O)N)NC(=O)C(CO)NC(=O)C(CC6=CNC=N6)N)C(=O)O,PHASE2|PHASE3,digestive_system_disease
227,Hepatic Impairment,Pimodivir,C1CC2CCC1C(C2NC3=NC(=NC=C3F)C4=CNC5=C4C=C(C=N5)F)C(=O)O,PHASE1,digestive_system_disease
228,Metastatic Colorectal Carcinoma|Metastatic Lung Small Cell Carcinoma|Metastatic Malignant Solid Neoplasm|Metastatic Pancreatic Carcinoma|Refractory Colorectal Carcinoma|Refractory Lung Small Cell Carcinoma|Refractory Malignant Solid Neoplasm|Refractory Pancreatic Carcinoma|Stage III Colorectal Cancer AJCC v8|Stage III Lung Cancer AJCC v8|Stage III Pancreatic Cancer AJCC v8|Stage IV Colorectal Cancer AJCC v8|Stage IV Lung Cancer AJCC v8|Stage IV Pancreatic Cancer AJCC v8|Unresectable Colorectal Carcinoma|Unresectable Lung Small Cell Carcinoma|Unresectable Malignant Solid Neoplasm|Unresectable Pancreatic Carcinoma,Berzosertib,CC(C)S(=O)(=O)C1=CC=C(C=C1)C2=CN=C(C(=N2)C3=CC(=NO3)C4=CC=C(C=C4)CNC)N,PHASE1,digestive_system_disease
229,Metastatic Colorectal Cancer,Pimasertib,C1=CC(=C(C=C1I)F)NC2=C(C=CN=C2)C(=O)NCC(CO)O,PHASE1|PHASE2,digestive_system_disease
230,Pancreatic Cancer,Paricalcitol,CC(C=CC(C)C(C)(C)O)C1CCC2C1(CCCC2=CC=C3CC(CC(C3)O)O)C,PHASE1,digestive_system_disease
231,Cystic Fibrosis,Ivacaftor,CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C,PHASE2,digestive_system_disease
232,Gastritis,Irsogladine,C1=CC(=C(C=C1Cl)C2=NC(=NC(=N2)N)N)Cl,PHASE1,digestive_system_disease
233,Gastritis,Nizatidine,CNC(=C[N+](=O)[O-])NCCSCC1=CSC(=N1)CN(C)C,PHASE1,digestive_system_disease
234,Gastro Oesophageal Cancer,Epirubicin,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)N)O,PHASE2,digestive_system_disease
235,Metastatic Colorectal Cancer,Cediranib,CC1=CC2=C(N1)C=CC(=C2F)OC3=NC=NC4=CC(=C(C=C43)OC)OCCCN5CCCC5,PHASE1|PHASE2,digestive_system_disease
236,Ulcerative Colitis,Alicaforsen,CC1=CN(C(=O)NC1=O)C2CC(C(O2)COP(=S)([O-])OC3CC(OC3COP(=S)([O-])OC4CC(OC4COP(=S)([O-])OC5CC(OC5COP(=S)([O-])OC6CC(OC6COP(=S)([O-])OC7CC(OC7COP(=S)([O-])OC8CC(OC8COP(=S)([O-])OC9CC(OC9COP(=S)([O-])OC1CC(OC1CO)N1C=NC2=C1N=C(NC2=O)N)N1C=CC(=NC1=O)N)N1C=CC(=NC1=O)N)N1C=CC(=NC1=O)N)N1C=NC2=C(N=CN=C21)N)N1C=NC2=C(N=CN=C21)N)N1C=NC2=C1N=C(NC2=O)N)N1C=CC(=NC1=O)N)OP(=S)([O-])OCC1C(CC(O1)N1C=NC2=C1N=C(NC2=O)N)OP(=S)([O-])OCC1C(CC(O1)N1C=NC2=C1N=C(NC2=O)N)OP(=S)([O-])OCC1C(CC(O1)N1C=CC(=NC1=O)N)OP(=S)([O-])OCC1C(CC(O1)N1C=NC2=C(N=CN=C21)N)OP(=S)([O-])OCC1C(CC(O1)N1C=C(C(=O)NC1=O)C)OP(=S)([O-])OCC1C(CC(O1)N1C=CC(=NC1=O)N)OP(=S)([O-])OCC1C(CC(O1)N1C=CC(=NC1=O)N)OP(=S)([O-])OCC1C(CC(O1)N1C=NC2=C1N=C(NC2=O)N)OP(=S)([O-])OCC1C(CC(O1)N1C=C(C(=O)NC1=O)C)OP(=S)([O-])OCC1C(CC(O1)N1C=CC(=NC1=O)N)OP(=S)([O-])OCC1C(CC(O1)N1C=NC2=C(N=CN=C21)N)O,PHASE2,digestive_system_disease
237,Advanced Cancer,Gimeracil,C1=C(C(=CNC1=O)Cl)O,PHASE2,digestive_system_disease
238,Advanced Cancer,Oteracil,C1(=NC(=O)NC(=O)N1)C(=O)O,PHASE2,digestive_system_disease
239,Hepatic Insufficiency,Tipranavir,CCCC1(CC(=C(C(=O)O1)C(CC)C2=CC(=CC=C2)NS(=O)(=O)C3=NC=C(C=C3)C(F)(F)F)O)CCC4=CC=CC=C4,PHASE1,digestive_system_disease
240,Alcoholic Hepatitis (AH),Selonsertib,CC1=CC(=C(C=C1N2C=C(N=C2)C3CC3)C(=O)NC4=CC=CC(=N4)C5=NN=CN5C(C)C)F,PHASE2,digestive_system_disease
241,Alcoholic Hepatitis (AH),Prednisolone,CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O,PHASE2,digestive_system_disease
242,Metastatic Colorectal Adenocarcinoma|Microsatellite Stable|Mismatch Repair Proficient|Refractory Colorectal Adenocarcinoma|Stage III Colorectal Cancer AJCC v8|Stage IIIA Colorectal Cancer AJCC v8|Stage IIIB Colorectal Cancer AJCC v8|Stage IIIC Colorectal Cancer AJCC v8|Stage IV Colorectal Cancer AJCC v8|Stage IVA Colorectal Cancer AJCC v8|Stage IVB Colorectal Cancer AJCC v8|Stage IVC Colorectal Cancer AJCC v8|Unresectable Colorectal Carcinoma,Rintatolimod,C1=CN(C(=O)N=C1N)C2C(C(C(O2)COP(=O)(O)O)O)O.C1=CN(C(=O)NC1=O)C2C(C(C(O2)COP(=O)(O)O)O)O.C1=NC2=C(C(=O)N1)N=CN2C3C(C(C(O3)COP(=O)(O)O)O)O,PHASE2,digestive_system_disease
243,Gastric Cancer,Ipatasertib,CC1CC(C2=C1C(=NC=N2)N3CCN(CC3)C(=O)C(CNC(C)C)C4=CC=C(C=C4)Cl)O,PHASE2,digestive_system_disease
244,Nausea|Vomiting|Familial Dysautonomia,Dronabinol,CCCCCC1=CC(=C2C3C=C(CCC3C(OC2=C1)(C)C)C)O,PHASE2,digestive_system_disease
245,Non-Alcoholic Fatty Liver Disease|Nonalcoholic Steatohepatitis,Saroglitazar,CCOC(CC1=CC=C(C=C1)OCCN2C(=CC=C2C3=CC=C(C=C3)SC)C)C(=O)O,PHASE2,digestive_system_disease
246,Pancreatic Cancer|Cancer of Pancreas|Cancer of the Pancreas|Pancreas Cancer,Tosedostat,CC(C)CC(C(C(=O)NO)O)C(=O)NC(C1=CC=CC=C1)C(=O)OC2CCCC2,PHASE1|PHASE2,digestive_system_disease
247,Crohn's Disease,Artesunate,CC1CCC2C(C(OC3C24C1CCC(O3)(OO4)C)OC(=O)CCC(=O)O)C,PHASE2,digestive_system_disease
248,Non-alcoholic Fatty Liver Disease,Acarbose,CC1C(C(C(C(O1)OC2C(OC(C(C2O)O)OC3C(OC(C(C3O)O)O)CO)CO)O)O)NC4C=C(C(C(C4O)O)O)CO,PHASE2,digestive_system_disease
249,"Liver Diseases|Hypertension, Portal",Empagliflozin,C1COCC1OC2=CC=C(C=C2)CC3=C(C=CC(=C3)C4C(C(C(C(O4)CO)O)O)O)Cl,PHASE2,digestive_system_disease
250,Cancer of Pancreas,Bemcentinib,C1CCN(C1)C2CCC3=C(CC2)C=C(C=C3)NC4=NN(C(=N4)N)C5=NN=C6C(=C5)CCCC7=CC=CC=C76,PHASE1|PHASE2,digestive_system_disease
251,Hepatocellular Carcinoma|Liver Cirrhoses,Pravastatin,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O,PHASE2,digestive_system_disease
252,Gastroesophageal Reflux,Dexlansoprazole,CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCC(F)(F)F,PHASE1,digestive_system_disease
253,Onchocerciasis,Albendazole,CCCSC1=CC2=C(C=C1)N=C(N2)NC(=O)OC,PHASE2,digestive_system_disease
254,Onchocerciasis,Ivermectin,CCC(C)C1C(CCC2(O1)CC3CC(O2)CC=C(C(C(C=CC=C4COC5C4(C(C=C(C5O)C)C(=O)O3)O)C)OC6CC(C(C(O6)C)OC7CC(C(C(O7)C)O)OC)OC)C)C,PHASE2,digestive_system_disease
255,Gastric Cancer|Histone Deacetylase Inhibitor,Vorinostat,C1=CC=C(C=C1)NC(=O)CCCCCCC(=O)NO,PHASE1|PHASE2,digestive_system_disease
256,Advanced Gastric Cancer,Pazopanib,CC1=C(C=C(C=C1)NC2=NC=CC(=N2)N(C)C3=CC4=NN(C(=C4C=C3)C)C)S(=O)(=O)N,PHASE2,digestive_system_disease
257,Advanced Cancer|Anorexia|Weight Loss|Insomnia,Mirtazapine,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4,PHASE2,digestive_system_disease
258,"Hepatitis B, Chronic",Hydronidone,CC1=CN(C(=O)C=C1)C2=CC=C(C=C2)O,PHASE2,digestive_system_disease
259,"Hepatitis C, Chronic",Sovaprevir,CC(C)(C)C(CC(=O)N1CCCCC1)C(=O)N2CC(CC2C(=O)NC3(CC3C=C)C(=O)NS(=O)(=O)C4CC4)OC5=CC(=NC6=C5C=CC(=C6)OC)C7=CC=CC=C7,PHASE2,digestive_system_disease
260,Prolonged Postoperative Ileus,Diatrizoate,CC(=O)NC1=C(C(=C(C(=C1I)C(=O)O)I)NC(=O)C)I,PHASE2|PHASE3,digestive_system_disease
261,Cystic Fibrosis,Miglustat,CCCCN1CC(C(C(C1CO)O)O)O,PHASE2|PHASE3,digestive_system_disease
262,Hepatitis C Virus,Rosuvastatin,CC(C)C1=NC(=NC(=C1C=CC(CC(CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C,PHASE1,digestive_system_disease
263,Hepatitis C Virus,Digoxin,CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,PHASE1,digestive_system_disease
264,Gastroparesis,Buspirone,C1CCC2(C1)CC(=O)N(C(=O)C2)CCCCN3CCN(CC3)C4=NC=CC=N4,PHASE2,digestive_system_disease
265,"Short Bowel Syndrome|Infection, Bacterial",Amoxicillin,CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=C(C=C3)O)N)C(=O)O)C,PHASE1,digestive_system_disease
266,"Short Bowel Syndrome|Infection, Bacterial",Ofloxacin,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O,PHASE1,digestive_system_disease
267,"Short Bowel Syndrome|Infection, Bacterial",Sulfamethoxazole,CC1=CC(=NO1)NS(=O)(=O)C2=CC=C(C=C2)N,PHASE1,digestive_system_disease
268,"Hepatitis B|HBV|Hepatitis B, Chronic",Inarigivir,COC1C(C(OC1N2C=CC(=O)NC2=O)CO)OP(=S)(O)OCC3C(CC(O3)N4C=NC5=C(N=CN=C54)N)O,PHASE2,digestive_system_disease
269,Breast Cancer|Gastrointestinal Cancer|Non Small Cell Lung Cancer|Other Cancer,Alectinib,CCC1=CC2=C(C=C1N3CCC(CC3)N4CCOCC4)C(C5=C(C2=O)C6=C(N5)C=C(C=C6)C#N)(C)C,PHASE2,digestive_system_disease
270,Breast Cancer|Gastrointestinal Cancer|Non Small Cell Lung Cancer|Other Cancer,Brigatinib,CN1CCN(CC1)C2CCN(CC2)C3=CC(=C(C=C3)NC4=NC=C(C(=N4)NC5=CC=CC=C5P(=O)(C)C)Cl)OC,PHASE2,digestive_system_disease
271,Breast Cancer|Gastrointestinal Cancer|Non Small Cell Lung Cancer|Other Cancer,Ponatinib,CC1=C(C=C(C=C1)C(=O)NC2=CC(=C(C=C2)CN3CCN(CC3)C)C(F)(F)F)C#CC4=CN=C5N4N=CC=C5,PHASE2,digestive_system_disease
272,Breast Cancer|Gastrointestinal Cancer|Non Small Cell Lung Cancer|Other Cancer,Entrectinib,CN1CCN(CC1)C2=CC(=C(C=C2)C(=O)NC3=NNC4=C3C=C(C=C4)CC5=CC(=CC(=C5)F)F)NC6CCOCC6,PHASE2,digestive_system_disease
273,Breast Cancer|Gastrointestinal Cancer|Non Small Cell Lung Cancer|Other Cancer,Pemigatinib,CCN1C2=C3C=C(NC3=NC=C2CN(C1=O)C4=C(C(=CC(=C4F)OC)OC)F)CN5CCOCC5,PHASE2,digestive_system_disease
274,Breast Cancer|Gastrointestinal Cancer|Non Small Cell Lung Cancer|Other Cancer,Pralsetinib,CC1=CC(=NN1)NC2=NC(=NC(=C2)C)C3CCC(CC3)(C(=O)NC(C)C4=CN=C(C=C4)N5C=C(C=N5)F)OC,PHASE2,digestive_system_disease
275,Breast Cancer|Gastrointestinal Cancer|Non Small Cell Lung Cancer|Other Cancer,Selpercatinib,CC(C)(COC1=CN2C(=C(C=N2)C#N)C(=C1)C3=CN=C(C=C3)N4CC5CC(C4)N5CC6=CN=C(C=C6)OC)O,PHASE2,digestive_system_disease
276,Breast Cancer|Gastrointestinal Cancer|Non Small Cell Lung Cancer|Other Cancer,Talazoparib,CN1C(=NC=N1)C2C(NC3=CC(=CC4=C3C2=NNC4=O)F)C5=CC=C(C=C5)F,PHASE2,digestive_system_disease
277,Breast Cancer|Gastrointestinal Cancer|Non Small Cell Lung Cancer|Other Cancer,Tepotinib,CN1CCC(CC1)COC2=CN=C(N=C2)C3=CC=CC(=C3)CN4C(=O)C=CC(=N4)C5=CC=CC(=C5)C#N,PHASE2,digestive_system_disease
278,Breast Cancer|Gastrointestinal Cancer|Non Small Cell Lung Cancer|Other Cancer,Alpelisib,CC1=C(SC(=N1)NC(=O)N2CCCC2C(=O)N)C3=CC(=NC=C3)C(C)(C)C(F)(F)F,PHASE2,digestive_system_disease
279,Primary Biliary Cirrhosis,Fenofibrate,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl,PHASE2,digestive_system_disease
280,Pancreatic Cancer,Gimatecan,CCC1(C2=C(COC1=O)C(=O)N3CC4=C(C5=CC=CC=C5N=C4C3=C2)C=NOC(C)(C)C)O,PHASE2,digestive_system_disease
281,Hepatitis C|Chronic Hepatitis C,Miravirsen,CC1=CN(C(=O)NC1=O)C2CC(C(O2)COP(=S)(O)OC3C4C(OC3(CO4)COP(=S)(O)OC5CC(OC5COP(=S)(O)OC6C7C(OC6(CO7)CO)N8C=CC(=NC8=O)N)N9C=CC(=NC9=O)N)N1C=NC2=C(N=CN=C21)N)OP(=S)(O)OCC1C(CC(O1)N1C=C(C(=O)NC1=O)C)OP(=S)(O)OCC12COC(C1OP(=S)(O)OCC13COC(C1OP(=S)(O)OCC1C(CC(O1)N1C=CC(=NC1=O)N)OP(=S)(O)OCC1C(CC(O1)N1C=NC4=C(N=CN=C41)N)OP(=S)(O)OCC14COC(C1OP(=S)(O)OCC1C(CC(O1)N1C=NC5=C(N=CN=C51)N)OP(=S)(O)OCC15COC(C1OP(=S)(O)OCC1C(CC(O1)N1C=C(C(=O)NC1=O)C)OP(=S)(O)OCC16COC(C1OP(=S)(O)OCC17COC(C1O)C(O7)N1C=CC(=NC1=O)N)C(O6)N1C=CC(=NC1=O)N)C(O5)N1C=CC(=NC1=O)N)C(O4)N1C=CC(=NC1=O)N)C(O3)N1C=C(C(=O)NC1=O)C)C(O2)N1C=NC2=C1N=C(NC2=O)N,PHASE1,digestive_system_disease
282,Advanced Solid Tumor|Non-Small Cell Lung Cancer|Colorectal Cancer,Abemaciclib,CCN1CCN(CC1)CC2=CN=C(C=C2)NC3=NC=C(C(=N3)C4=CC5=C(C(=C4)F)N=C(N5C(C)C)C)F,PHASE1|PHASE2,digestive_system_disease
283,Opioid Induced Bowel Dysfunction,Naldemedine,CC(C)(C1=NC(=NO1)C2=CC=CC=C2)NC(=O)C3=C(C4C56CCN(C(C5(C3)O)CC7=C6C(=C(C=C7)O)O4)CC8CC8)O,PHASE2,digestive_system_disease
284,Colorectal Cancer,Desflurane,C(C(F)(F)F)(OC(F)F)F,PHASE2,digestive_system_disease
285,Metastatic Colon Adenocarcinoma|Metastatic Colorectal Adenocarcinoma|Metastatic Microsatellite Stable Colorectal Carcinoma|Metastatic Rectal Adenocarcinoma|Stage III Colon Cancer|Stage III Colorectal Cancer|Stage III Rectal Cancer|Stage IIIA Colon Cancer|Stage IIIA Colorectal Cancer|Stage IIIA Rectal Cancer|Stage IIIB Colon Cancer|Stage IIIB Colorectal Cancer|Stage IIIB Rectal Cancer|Stage IIIC Colon Cancer|Stage IIIC Colorectal Cancer|Stage IIIC Rectal Cancer|Stage IV Colon Cancer|Stage IV Colorectal Cancer|Stage IV Rectal Cancer|Stage IVA Colon Cancer|Stage IVA Colorectal Cancer|Stage IVA Rectal Cancer|Stage IVB Colon Cancer|Stage IVB Colorectal Cancer|Stage IVB Rectal Cancer|Stage IVC Colon Cancer|Stage IVC Colorectal Cancer|Stage IVC Rectal Cancer,Binimetinib,CN1C=NC2=C1C=C(C(=C2F)NC3=C(C=C(C=C3)Br)F)C(=O)NOCCO,PHASE1,digestive_system_disease
286,Infectious Diarrhoea,Rifamycin,CC1C=CC=C(C(=O)NC2=CC(=C3C(=C2O)C(=C(C4=C3C(=O)C(O4)(OC=CC(C(C(C(C(C(C1O)C)O)C)OC(=O)C)C)OC)C)C)O)O)C,PHASE2,digestive_system_disease
287,Acute Liver Failure|Fulminant Hepatic Failure|Hepatic Encephalopathy|Acute Liver Injury|Immune Dysregulation,Diphenhydramine,CN(C)CCOC(C1=CC=CC=C1)C2=CC=CC=C2,PHASE2,digestive_system_disease
288,Non-alcoholic Fatty Liver Disease,Pioglitazone,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3,PHASE1,digestive_system_disease
289,Unresectable or Metastatic Hepatocellular Carcinoma,Temsirolimus,CC1CCC2CC(C(=CC=CC=CC(CC(C(=O)C(C(C(=CC(C(=O)CC(OC(=O)C3CCCCN3C(=O)C(=O)C1(O2)O)C(C)CC4CCC(C(C4)OC)OC(=O)C(C)(CO)CO)C)C)O)OC)C)C)C)OC,PHASE2,digestive_system_disease
290,Advanced Hepatocellular Carcinoma (HCC),Brivanib,CC1=CC2=C(N1)C=CC(=C2F)OC3=NC=NN4C3=C(C(=C4)OCC(C)O)C,PHASE1|PHASE2,digestive_system_disease
291,Wilson Disease,Tetrathiomolybdate,[SH-].[SH-].S=[Mo]=S,PHASE2,digestive_system_disease
292,Spinal Cord Injuries|Constipation|Neurogenic Bowel,Neostigmine,CN(C)C(=O)OC1=CC=CC(=C1)[N+](C)(C)C,PHASE1,digestive_system_disease
293,Spinal Cord Injuries|Constipation|Neurogenic Bowel,Glycopyrrolate,C[N+]1(CCC(C1)OC(=O)C(C2CCCC2)(C3=CC=CC=C3)O)C.[Br-],PHASE1,digestive_system_disease
294,"Hepatitis C Virus Infection|Infection|Herpesvirus 2, Human",Valaciclovir,CC(C)C(C(=O)OCCOCN1C=NC2=C1N=C(NC2=O)N)N,PHASE1,digestive_system_disease
295,"Hepatitis C Virus Infection|Infection|Herpesvirus 2, Human",Valacyclovir,CC(C)C(C(=O)OCCOCN1C=NC2=C1N=C(NC2=O)N)N,PHASE1,digestive_system_disease
296,"Carcinoma, Hepatocellular",Meclizine,CC1=CC(=CC=C1)CN2CCN(CC2)C(C3=CC=CC=C3)C4=CC=C(C=C4)Cl,PHASE1,digestive_system_disease
297,Gastric Cancer,Propranolol,CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O,PHASE2,digestive_system_disease
298,Pancreatectomy for Chronic Pancreatitis,Reparixin,CC(C)CC1=CC=C(C=C1)C(C)C(=O)NS(=O)(=O)C,PHASE2|PHASE3,digestive_system_disease
299,Antipsychotic Induced Weight Gain|Non-alcoholic Steatohepatitis (NASH),Fluvoxamine,COCCCCC(=NOCCN)C1=CC=C(C=C1)C(F)(F)F,PHASE1,digestive_system_disease
300,Fecal Incontinence|Accidental Bowel Leakage|Anal Incontinence|Diarrhea|Urge Incontinence,Eluxadoline,CC1=CC(=CC(=C1CC(C(=O)N(CC2=CC(=C(C=C2)OC)C(=O)O)C(C)C3=NC=C(N3)C4=CC=CC=C4)N)C)C(=O)N,PHASE2,digestive_system_disease
301,Hepatic Impairment,Molnupiravir,CC(C)C(=O)OCC1C(C(C(O1)N2C=CC(=NC2=O)NO)O)O,PHASE1,digestive_system_disease
302,Prader-Willi Syndrome|Hyperphagia,Livoletide,CC(C)C1C(=O)NC(C(=O)NC(C(=O)N2CCCC2C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCN=C(N)N)CCC(=O)N)CC3=CN=CN3)CCC(=O)O)CO)CCC(=O)N,PHASE2|PHASE3,digestive_system_disease
303,"Liver Dysfunction|Rejection, Transplant|Transplantation, Liver",Mycophenolate,CC1=C2COC(=O)C2=C(C(=C1OC)CC=C(C)CCC(=O)O)O,PHASE2,digestive_system_disease
304,"Cirrhosis, Liver|Ascites Hepatic",Ularitide,CCC(C)C1C(=O)NCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)NCC(=O)NC(C(=O)NCC(=O)NC(CSSCC(C(=O)NC(C(=O)NCC(=O)NCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCNC(=N)N)CC(=O)O)CCSC)CCCNC(=N)N)CC2=CC=CC=C2)NC(=O)C(CO)NC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC(=O)C(CCCNC(=N)N)NC(=O)C(CC(C)C)NC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC(=O)C3CCCN3C(=O)C(C)NC(=O)C(C(C)O)N)C(=O)NC(CC(=O)N)C(=O)NC(CO)C(=O)NC(CC4=CC=CC=C4)C(=O)NC(CCCNC(=N)N)C(=O)NC(CC5=CC=C(C=C5)O)C(=O)O)CC(C)C)CO)CCC(=O)N)C,PHASE2,digestive_system_disease
305,"Carcinoma, Hepatocellular",Refametinib,COC1=CC(=C(C(=C1NS(=O)(=O)C2(CC2)CC(CO)O)NC3=C(C=C(C=C3)I)F)F)F,PHASE2,digestive_system_disease
306,Wilson Disease,Bupropion,CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C,PHASE1,digestive_system_disease
307,Chronic Hepatitis C,Odalasvir,CC(C)C(C(=O)N1C2CCCCC2CC1C3=NC4=C(N3)C=C(C=C4)C5=C6CCC7=CC(=C(CCC(=C5)C=C6)C=C7)C8=CC9=C(C=C8)N=C(N9)C1CC2CCCCC2N1C(=O)C(C(C)C)NC(=O)OC)NC(=O)OC,PHASE2,digestive_system_disease
308,"Liver Cirrhosis, Biliary",Ursodiol,CC(CCC(=O)O)C1CCC2C1(CCC3C2C(CC4C3(CCC(C4)O)C)O)C,PHASE2,digestive_system_disease
309,Esophageal Cancer|Gastric Cancer|Stomach Cancer,Vinorelbine,CCC1=CC2CC(C3=C(CN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC,PHASE2,digestive_system_disease
310,Sarcoma|Oral Mucositis,Ifosfamide,C1CN(P(=O)(OC1)NCCCl)CCCl,PHASE2,digestive_system_disease
311,Sarcoma|Oral Mucositis,Vincristine,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O,PHASE2,digestive_system_disease
312,Bulimia Nervosa,Lisdexamfetamine,CC(CC1=CC=CC=C1)NC(=O)C(CCCCN)N,PHASE2,digestive_system_disease
313,Healthy|NAFLD,Itraconazole,CCC(C)N1C(=O)N(C=N1)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(C=C4)OCC5COC(O5)(CN6C=NC=N6)C7=C(C=C(C=C7)Cl)Cl,PHASE1,digestive_system_disease
314,Healthy|NAFLD,Phenytoin,C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=CC=C3,PHASE1,digestive_system_disease
315,Nonalcoholic Fatty Liver Disease,Exenatide,CCC(C)C(C(=O)NC(CCC(=O)O)C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(CC(C)C)C(=O)NC(CCCCN)C(=O)NC(CC(=O)N)C(=O)NCC(=O)NCC(=O)N3CCCC3C(=O)NC(CO)C(=O)NC(CO)C(=O)NCC(=O)NC(C)C(=O)N4CCCC4C(=O)N5CCCC5C(=O)N6CCCC6C(=O)NC(CO)C(=O)N)NC(=O)C(CC7=CC=CC=C7)NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(C(C)C)NC(=O)C(C)NC(=O)C(CCC(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(CCSC)NC(=O)C(CCC(=O)N)NC(=O)C(CCCCN)NC(=O)C(CO)NC(=O)C(CC(C)C)NC(=O)C(CC(=O)O)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C(CC8=CC=CC=C8)NC(=O)C(C(C)O)NC(=O)CNC(=O)C(CCC(=O)O)NC(=O)CNC(=O)C(CC9=CNC=N9)N,PHASE2|PHASE3,digestive_system_disease
316,Hepatic Impairment,Telotristat,CC1=NN(C=C1)C2=C(C=CC(=C2)Cl)C(C(F)(F)F)OC3=NC(=NC(=C3)C4=CC=C(C=C4)CC(C(=O)O)N)N,PHASE1,digestive_system_disease
317,Metastatic Colorectal Cancer|KRAS Gene Mutation,Onvansertib,CN1CCN(CC1)C2=CC(=C(C=C2)OC(F)(F)F)NC3=NC=C4CCC5=C(C4=N3)N(N=C5C(=O)N)CCO,PHASE1|PHASE2,digestive_system_disease
318,D842-related Mutant GIST,Crenolanib,CC1(COC1)COC2=CC3=C(C=C2)N(C=N3)C4=NC5=C(C=CC=C5N6CCC(CC6)N)C=C4,PHASE2,digestive_system_disease
319,Solid Tumor|Pancreatic Cancer,Evofosfamide,CN1C(=CN=C1[N+](=O)[O-])COP(=O)(NCCBr)NCCBr,PHASE1,digestive_system_disease
320,Hepatocellular Carcinoma (HCC),Icaritin,CC(=CCC1=C2C(=C(C=C1O)O)C(=O)C(=C(O2)C3=CC=C(C=C3)OC)O)C,PHASE2,digestive_system_disease
321,Liver Transplant With Clinically Significant Portal Hypertension,Somatostatin,CC(C1C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=CC=C4)CC5=CC=CC=C5)CC(=O)N)CCCCN)NC(=O)CNC(=O)C(C)N)C(=O)O)CO)C(C)O)CC6=CC=CC=C6)O,PHASE1,digestive_system_disease
322,Short Bowel Syndrome,Liraglutide,CCCCCCCCCCCCCCCC(=O)NC(CCC(=O)NCCCCC(C(=O)NC(CCC(=O)O)C(=O)NC(CC1=CC=CC=C1)C(=O)NC(C(C)CC)C(=O)NC(C)C(=O)NC(CC2=CNC3=CC=CC=C32)C(=O)NC(CC(C)C)C(=O)NC(C(C)C)C(=O)NC(CCCNC(=N)N)C(=O)NCC(=O)NC(CCCNC(=N)N)C(=O)NCC(=O)O)NC(=O)C(C)NC(=O)C(C)NC(=O)C(CCC(=O)N)NC(=O)CNC(=O)C(CCC(=O)O)NC(=O)C(CC(C)C)NC(=O)C(CC4=CC=C(C=C4)O)NC(=O)C(CO)NC(=O)C(CO)NC(=O)C(C(C)C)NC(=O)C(CC(=O)O)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C(CC5=CC=CC=C5)NC(=O)C(C(C)O)NC(=O)CNC(=O)C(CCC(=O)O)NC(=O)C(C)NC(=O)C(CC6=CN=CN6)N)C(=O)O,PHASE2,digestive_system_disease
323,Non-alcoholic Steatohepatitis|Fibrosis|Liver Diseases,Emricasan,CC(C(=O)NC(CC(=O)O)C(=O)COC1=C(C(=CC(=C1F)F)F)F)NC(=O)C(=O)NC2=CC=CC=C2C(C)(C)C,PHASE2,digestive_system_disease
324,Cystic Fibrosis,Lucinactant,CC(C)CC(C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(CCCCN)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(CCCCN)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(CCCCN)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(CCCCN)C(=O)O)NC(=O)C(CCCCN)N.CC(=O)O,PHASE2,digestive_system_disease
325,Chronic Hepatitis B,Rifampin,CC1C=CC=C(C(=O)NC2=C(C(=C3C(=C2O)C(=C(C4=C3C(=O)C(O4)(OC=CC(C(C(C(C(C(C1O)C)O)C)OC(=O)C)C)OC)C)C)O)O)C=NN5CCN(CC5)C)C,PHASE1,digestive_system_disease
326,Chronic Hepatitis B,Rifampicin,CC1C=CC=C(C(=O)NC2=C(C(=C3C(=C2O)C(=C(C4=C3C(=O)C(O4)(OC=CC(C(C(C(C(C(C1O)C)O)C)OC(=O)C)C)OC)C)C)O)O)C=NN5CCN(CC5)C)C,PHASE1,digestive_system_disease
327,Chronic Hepatitis B,Midazolam,CC1=NC=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4F,PHASE1,digestive_system_disease
328,Chronic Hepatitis B,Levonorgestrel,CCC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34,PHASE1,digestive_system_disease
329,Cystic Fibrosis,Lumacaftor,CC1=C(N=C(C=C1)NC(=O)C2(CC2)C3=CC4=C(C=C3)OC(O4)(F)F)C5=CC(=CC=C5)C(=O)O,PHASE1,digestive_system_disease
330,Hepatic Impairment,Erdafitinib,CC(C)NCCN(C1=CC2=NC(=CN=C2C=C1)C3=CN(N=C3)C)C4=CC(=CC(=C4)OC)OC,PHASE1,digestive_system_disease
331,Fecal Incontinence,Loperamide,CN(C)C(=O)C(CCN1CCC(CC1)(C2=CC=C(C=C2)Cl)O)(C3=CC=CC=C3)C4=CC=CC=C4,PHASE2|PHASE3,digestive_system_disease
332,Fibrosis|Hepatitis C Chronic,Pirfenidone,CC1=CN(C(=O)C=C1)C2=CC=CC=C2,PHASE2,digestive_system_disease
333,Brain Cancer,Palonosetron,C1CC2CN(C(=O)C3=CC=CC(=C23)C1)C4CN5CCC4CC5,PHASE2,digestive_system_disease
334,Colorectal Cancer,Idasanutlin,CC(C)(C)CC1C(C(C(N1)C(=O)NC2=C(C=C(C=C2)C(=O)O)OC)C3=C(C(=CC=C3)Cl)F)(C#N)C4=C(C=C(C=C4)Cl)F,PHASE1|PHASE2,digestive_system_disease
335,Metastatic Colorectal Adenocarcinoma|Metastatic Pancreatic Ductal Adenocarcinoma|Stage IV Colorectal Cancer AJCC v7|Stage IV Pancreatic Cancer AJCC v6 and v7|Stage IVA Colorectal Cancer AJCC v7|Stage IVB Colorectal Cancer AJCC v7,Imiquimod,CC(C)CN1C=NC2=C1C3=CC=CC=C3N=C2N,PHASE1,digestive_system_disease
336,Asthma,Budesonide,CCCC1OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C,PHASE1,digestive_system_disease
337,Pancreatic Neoplasms,Aroplatin,CC(C)(C)CCCCCC(=O)[O-].CC(C)(C)CCCCCC(=O)[O-].C1CCC(C(C1)N)N.[Pt+2],PHASE1|PHASE2,digestive_system_disease
338,Cancer|Gastrointestinal Neoplasms,Tamoxifen,CCC(=C(C1=CC=CC=C1)C2=CC=C(C=C2)OCCN(C)C)C3=CC=CC=C3,PHASE1,digestive_system_disease
339,NAFLD|TYPE 2 DIABETES|METABOLIC SYNDROME,Resveratrol,C1=CC(=CC=C1C=CC2=CC(=CC(=C2)O)O)O,PHASE2|PHASE3,digestive_system_disease
340,Mucositis,Triamcinolone,CC12CC(C3(C(C1CC(C2(C(=O)CO)O)O)CCC4=CC(=O)C=CC43C)F)O,PHASE1|PHASE2,digestive_system_disease
341,Gastric Cancer,Cabazitaxel,CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)OC)C)OC,PHASE2,digestive_system_disease
342,Metastatic Pancreatic Cancer,Ixabepilone,CC1CCCC2(C(O2)CC(NC(=O)CC(C(C(=O)C(C1O)C)(C)C)O)C(=CC3=CSC(=N3)C)C)C,PHASE2,digestive_system_disease
343,Hepatic Impairment,Aramchol,CCCCCCCCCCCCCCCCCCCC(=O)NC1CCC2(C(C1)CC(C3C2CC(C4(C3CCC4C(C)CCC(=O)O)C)O)O)C,PHASE1,digestive_system_disease
344,Ulcerative Colitis,Etrasimod,C1CCC(C1)C2=C(C=C(C=C2)COC3=CC4=C(C=C3)NC5=C4CCC5CC(=O)O)C(F)(F)F,PHASE2,digestive_system_disease
345,Cystic Fibrosis,Trimethoprim,COC1=CC(=CC(=C1OC)OC)CC2=CN=C(N=C2N)N,PHASE2,digestive_system_disease
346,Cystic Fibrosis,Mupirocin,CC(C1C(O1)CC2COC(C(C2O)O)CC(=CC(=O)OCCCCCCCCC(=O)O)C)C(C)O,PHASE2,digestive_system_disease
347,Duodenal Polyposis,Rofecoxib,CS(=O)(=O)C1=CC=C(C=C1)C2=C(C(=O)OC2)C3=CC=CC=C3,PHASE2|PHASE3,digestive_system_disease
348,Cystic Fibrosis,Brensocatib,CN1C2=C(C=CC(=C2)C3=CC=C(C=C3)CC(C#N)NC(=O)C4CNCCCO4)OC1=O,PHASE2,digestive_system_disease
349,Insomnia|Hepatic Insufficiency,Suvorexant,CC1CCN(CCN1C(=O)C2=C(C=CC(=C2)C)N3N=CC=N3)C4=NC5=C(O4)C=CC(=C5)Cl,PHASE1,digestive_system_disease
350,Hepato Carcinoma,Sitagliptin,C1CN2C(=NN=C2C(F)(F)F)CN1C(=O)CC(CC3=CC(=C(C=C3F)F)F)N,PHASE1,digestive_system_disease
351,Crohn's Disease|Inflammatory Bowel Disease,Ranolazine,CC1=C(C(=CC=C1)C)NC(=O)CN2CCN(CC2)CC(COC3=CC=CC=C3OC)O,PHASE2,digestive_system_disease
352,Irritable Bowel Syndrome,Vibegron,C1CC(NC1CC2=CC=C(C=C2)NC(=O)C3CCC4=NC=CC(=O)N34)C(C5=CC=CC=C5)O,PHASE2,digestive_system_disease
353,Pancreas Cancer,Bethanechol,CC(C[N+](C)(C)C)OC(=O)N,PHASE2,digestive_system_disease
354,Liver Diseases|Healthy,Afatinib,CN(C)CC=CC(=O)NC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC(=C(C=C3)F)Cl)OC4CCOC4,PHASE1,digestive_system_disease
355,Cystic Fibrosis,Lefamulin,CC1CCC23CCC(=O)C2C1(C(CC(C(C3C)O)(C)C=C)OC(=O)CSC4CCC(CC4O)N)C,PHASE1,digestive_system_disease
356,Colorectal Cancer Metastatic,Anisodamine,CN1C2CC(CC1C(C2)O)OC(=O)C(CO)C3=CC=CC=C3,PHASE2,digestive_system_disease
357,"Myelodysplastic Syndromes|Leukemia, Myelomonocytic, Chronic|Leukemia, Myeloid, Acute|Renal Insufficiency|Liver Disease|Neoplasms",Pevonedistat,C1CC2=CC=CC=C2C1NC3=C4C=CN(C4=NC=N3)C5CC(C(C5)O)COS(=O)(=O)N,PHASE1,digestive_system_disease
358,Cystic Fibrosis,Aztreonam,CC1C(C(=O)N1S(=O)(=O)O)NC(=O)C(=NOC(C)(C)C(=O)O)C2=CSC(=N2)N,PHASE2,digestive_system_disease
359,Hepatocellular Carcinoma|Gastrointestinal Cancer Metastatic|Neuroendocrine Tumors,Tirapazamine,C1=CC=C2C(=C1)[N+](=C(N=[N+]2[O-])N)[O-],PHASE1|PHASE2,digestive_system_disease
360,Adult Solid Neoplasm|Pancreatic Acinar Cell Carcinoma|Pancreatic Ductal Adenocarcinoma|Recurrent Pancreatic Carcinoma|Stage IV Pancreatic Cancer AJCC v6 and v7,Vismodegib,CS(=O)(=O)C1=CC(=C(C=C1)C(=O)NC2=CC(=C(C=C2)Cl)C3=CC=CC=N3)Cl,PHASE1,digestive_system_disease
361,Crohn's Disease,Glutamine,C(CC(=O)N)C(C(=O)O)N,PHASE1,digestive_system_disease
362,Ulcerative Colitis,Methotrexate,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,PHASE2,digestive_system_disease
363,Head and Neck Cancer|Oral Mucositis,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,PHASE1,digestive_system_disease
364,"Hepatitis C, Chronic",Uprifosbuvir,CC(C)OC(=O)C(C)NP(=O)(OCC1C(C(C(O1)N2C=CC(=O)NC2=O)(C)Cl)O)OC3=CC=CC=C3,PHASE2,digestive_system_disease
365,Gastroparesis,Tradipitant,C1=CC=C(C(=C1)C(=O)C2=C(N=CC=C2)C3=C(N(N=N3)CC4=CC(=CC(=C4)C(F)(F)F)C(F)(F)F)C5=CC=NC=C5)Cl,PHASE2,digestive_system_disease
366,Liver Diseases|Digestive System Diseases,Ozanimod,CC(C)OC1=C(C=C(C=C1)C2=NC(=NO2)C3=C4CCC(C4=CC=C3)NCCO)C#N,PHASE1,digestive_system_disease
367,Hepatocellular Carcinoma|Metastatic Cancer,Thymidine,CC1=CN(C(=O)NC1=O)C2CC(C(O2)CO)O,PHASE1,digestive_system_disease
368,Oral Mucositis,Cobiprostone,CCC(C)CC(C1(CCC2C(O1)CC(=O)C2CCCCCCC(=O)O)O)(F)F,PHASE2,digestive_system_disease
369,Colitis|HIV Infections,Ganciclovir,C1=NC2=C(N1COC(CO)CO)N=C(NC2=O)N,PHASE1,digestive_system_disease
370,Chronic Hepatitis C,Boceprevir,CC1(C2C1C(N(C2)C(=O)C(C(C)(C)C)NC(=O)NC(C)(C)C)C(=O)NC(CC3CCC3)C(=O)C(=O)N)C,PHASE2,digestive_system_disease
371,Peptic Ulcer Hemorrhage,Ilaprazole,CC1=C(C=CN=C1CS(=O)C2=NC3=C(N2)C=C(C=C3)N4C=CC=C4)OC,PHASE2,digestive_system_disease
372,Postoperative Complications|Postoperative Pancreatitis,Hydrocortisone,CC12CCC(=O)C=C1CCC3C2C(CC4(C3CCC4(C(=O)CO)O)C)O,PHASE2,digestive_system_disease
373,Muscle Cramps|Cirrhosis,Baclofen,C1=CC(=CC=C1C(CC(=O)O)CN)Cl,PHASE2,digestive_system_disease
374,Non-Resectable Cholangiocarcinoma|Recurrent Cholangiocarcinoma|Stage III Extrahepatic Bile Duct Cancer|Stage III Intrahepatic Cholangiocarcinoma|Stage IIIA Hilar Cholangiocarcinoma|Stage IIIB Hilar Cholangiocarcinoma|Stage IVA Extrahepatic Bile Duct Cancer|Stage IVA Hilar Cholangiocarcinoma|Stage IVA Intrahepatic Cholangiocarcinoma|Stage IVB Extrahepatic Bile Duct Cancer|Stage IVB Hilar Cholangiocarcinoma|Stage IVB Intrahepatic Cholangiocarcinoma|Unresectable Extrahepatic Bile Duct Carcinoma,Ricolinostat,C1=CC=C(C=C1)N(C2=CC=CC=C2)C3=NC=C(C=N3)C(=O)NCCCCCCC(=O)NO,PHASE1,digestive_system_disease
375,Hepatocellular Carcinoma,Sirolimus,CC1CCC2CC(C(=CC=CC=CC(CC(C(=O)C(C(C(=CC(C(=O)CC(OC(=O)C3CCCCN3C(=O)C(=O)C1(O2)O)C(C)CC4CCC(C(C4)OC)O)C)C)O)OC)C)C)C)OC,PHASE2,digestive_system_disease
376,Metastatic Colorectal Cancer,Perindopril,CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O,PHASE2,digestive_system_disease
377,NASH - Nonalcoholic Steatohepatitis,Fluconazole,C1=CC(=C(C=C1F)F)C(CN2C=NC=N2)(CN3C=NC=N3)O,PHASE1,digestive_system_disease
378,NASH - Nonalcoholic Steatohepatitis,Quinidine,COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O,PHASE1,digestive_system_disease
379,Colorectal Neoplasm,Selinexor,C1=CN=C(C=N1)NNC(=O)C=CN2C=NC(=N2)C3=CC(=CC(=C3)C(F)(F)F)C(F)(F)F,PHASE1,digestive_system_disease
380,Gastrointestinal Stromal Tumors,Pexidartinib,C1=CC(=NC=C1CC2=CNC3=C2C=C(C=N3)Cl)NCC4=CN=C(C=C4)C(F)(F)F,PHASE1|PHASE2,digestive_system_disease
381,Hepatic Impairment|Healthy Volunteers,Mobocertinib,CC(C)OC(=O)C1=CN=C(N=C1C2=CN(C3=CC=CC=C32)C)NC4=C(C=C(C(=C4)NC(=O)C=C)N(C)CCN(C)C)OC,PHASE1,digestive_system_disease
382,Solid Tumor,Osimertinib,CN1C=C(C2=CC=CC=C21)C3=NC(=NC=C3)NC4=C(C=C(C(=C4)NC(=O)C=C)N(C)CCN(C)C)OC,PHASE1|PHASE2,digestive_system_disease
383,Gastric Carcinoma,Tesetaxel,CC1=C2C3C(C4(CCC5C(C4C(C(C2(C)C)(CC1OC(=O)C(C(C6=C(C=CC=N6)F)NC(=O)OC(C)(C)C)O)O)OC(=O)C7=CC=CC=C7)(CO5)OC(=O)C)C)OC(O3)CN(C)C,PHASE2,digestive_system_disease
384,Erythropoietic Protoporphyria,Colestipol,C1C(O1)CCl.C(CNCCNCCNCCN)N,PHASE2|PHASE3,digestive_system_disease
385,Colorectal Cancer,Niclosamide,C1=CC(=C(C=C1[N+](=O)[O-])Cl)NC(=O)C2=C(C=CC(=C2)Cl)O,PHASE2,digestive_system_disease
386,Hepatocellular Carcinoma,Pentamidine,C1=CC(=CC=C1C(=N)N)OCCCCCOC2=CC=C(C=C2)C(=N)N,PHASE1,digestive_system_disease
387,Cystic Fibrosis,Sildenafil,CCCC1=NN(C2=C1N=C(NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C,PHASE2,digestive_system_disease
388,Binge-Eating Disorder,Methylphenidate,COC(=O)C(C1CCCCN1)C2=CC=CC=C2,PHASE2,digestive_system_disease
389,Diabetes Mellitus|Diabetes Mellitus Complications|Gastroparesis,Relamorelin,C1CC(CNC1)C(=O)NC(CC2=CSC3=CC=CC=C32)C(=O)NC(CC4=CNC5=CC=CC=C54)C(=O)NC(CC6=CC=CC=C6)C(=O)NC7(CCNCC7)C(=O)N,PHASE2,digestive_system_disease
390,Osteoarthritis,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,PHASE2|PHASE3,digestive_system_disease
391,Alagille Syndrome,Maralixibat,CCCCC1(CS(=O)(=O)C2=C(C=C(C=C2)N(C)C)C(C1O)C3=CC=C(C=C3)OCC4=CC=C(C=C4)C[N+]56CCN(CC5)CC6)CCCC,PHASE2,digestive_system_disease
392,Amoebic Dysentery|Giardiasis,Auranofin,CCP(CC)CC.CC(=O)OCC1C(C(C(C(O1)[S-])OC(=O)C)OC(=O)C)OC(=O)C.[Au+],PHASE2,digestive_system_disease
393,Gastrointestinal Stromal Tumor,Nilotinib,CC1=C(C=C(C=C1)C(=O)NC2=CC(=CC(=C2)C(F)(F)F)N3C=C(N=C3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,PHASE2,digestive_system_disease
394,Pancreatic Cancer|Chronic Pancreatitis,Lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C,PHASE2,digestive_system_disease
395,Acid Dyspepsia|Gastritis,Clarithromycin,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)O)(C)O,PHASE2,digestive_system_disease
396,Primary Biliary Cholangitis,Bezafibrate,CC(C)(C(=O)O)OC1=CC=C(C=C1)CCNC(=O)C2=CC=C(C=C2)Cl,PHASE2,digestive_system_disease
397,Epithelial Ovarian Cancer|Peritoneal Neoplasms|Fallopian Tube Neoplasms,Birinapant,CCC(C(=O)N1CC(CC1CC2=C(NC3=C2C=CC(=C3)F)C4=C(C5=C(N4)C=C(C=C5)F)CC6CC(CN6C(=O)C(CC)NC(=O)C(C)NC)O)O)NC(=O)C(C)NC,PHASE2,digestive_system_disease
398,Cystic Fibrosis (CF),Galicaftor,C1CC1(C2=CC3=C(C=C2)OC(O3)(F)F)C(=O)NC4CC(OC5=C4C=CC(=C5)OC(F)F)C6=CC=C(C=C6)C(=O)O,PHASE2,digestive_system_disease
399,Acetaminophen|Drug Overdose|Acetaminophen Overdose|Acetaminophen Poisoning|Drug-induced Liver Injury|Liver Failure|Liver Toxicity,Fomepizole,CC1=CNN=C1,PHASE2,digestive_system_disease
400,Gastroesophageal Reflux Disease,Rabeprazole,CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCCCOC,PHASE1,digestive_system_disease
401,Inflammatory Bowel Diseases,Atorvastatin,CC(C)C1=C(C(=C(N1CCC(CC(CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4,PHASE2,digestive_system_disease
402,Hepatitis C,Silibinin,COC1=C(C=CC(=C1)C2C(OC3=C(O2)C=C(C=C3)C4C(C(=O)C5=C(C=C(C=C5O4)O)O)O)CO)O,PHASE2,digestive_system_disease
403,Solid Tumors|Hematologic Malignancies|Hepatic Impairment,Carfilzomib,CC(C)CC(C(=O)C1(CO1)C)NC(=O)C(CC2=CC=CC=C2)NC(=O)C(CC(C)C)NC(=O)C(CCC3=CC=CC=C3)NC(=O)CN4CCOCC4,PHASE1,digestive_system_disease
404,Inflammatory Bowel Disease,Azathioprine,CN1C=NC(=C1SC2=NC=NC3=C2NC=N3)[N+](=O)[O-],PHASE1,digestive_system_disease
405,Inflammatory Bowel Disease,Allopurinol,C1=NNC2=C1C(=O)NC=N2,PHASE1,digestive_system_disease
406,Pancreatitis|Cholangitis,Propofol,CC(C)C1=C(C(=CC=C1)C(C)C)O,PHASE2,digestive_system_disease
407,Colorectal Neoplasms,Pelitrexol,CC1=C(SC(=C1)C(=O)NC(CCC(=O)O)C(=O)O)CCC2CC3=C(NC2)N=C(NC3=O)N,PHASE2,digestive_system_disease
408,Hepatic Impairment|Normal Hepatic Function,Esketamine,CNC1(CCCCC1=O)C2=CC=CC=C2Cl,PHASE1,digestive_system_disease
409,Advanced Hepatocellular Carcinoma,Tegavivint,CC1CC(CN(C1)S(=O)(=O)C2=CC3=C(C=C2)C(=C4C=CC(=CC4=C3N=O)S(=O)(=O)N5CC(CC(C5)C)C)NO)C,PHASE1|PHASE2,digestive_system_disease
410,Hepatic Impairment|Healthy,Lazertinib,CN(C)CC1=CN(N=C1C2=CC=CC=C2)C3=NC(=NC=C3)NC4=C(C=C(C(=C4)NC(=O)C=C)N5CCOCC5)OC,PHASE1,digestive_system_disease
411,Metastatic Colorectal Cancer,Dabigatran,CN1C2=C(C=C(C=C2)C(=O)N(CCC(=O)O)C3=CC=CC=N3)N=C1CNC4=CC=C(C=C4)C(=N)N,PHASE1,digestive_system_disease
412,Hepatitis C Virus,Methadone,CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2,PHASE1,digestive_system_disease
413,Nonalcoholic Fatty Liver|Nonalcoholic Steatohepatitis,Elobixibat,CCCCC1(CN(C2=CC(=C(C=C2S(=O)(=O)C1)OCC(=O)NC(C3=CC=CC=C3)C(=O)NCC(=O)O)SC)C4=CC=CC=C4)CCCC,PHASE2,digestive_system_disease
414,"KRAS G12C Mutant Solid Tumors|Carcinoma, Non-Small Cell Lung|Carcinoma, Non-Small-Cell Lung|Non-Small Cell Lung Cancer|Non-Small Cell Lung Carcinoma|Nonsmall Cell Lung Cancer|Colorectal Cancer|Colorectal Carcinoma|Colorectal Neoplasms|Colorectal Tumors|Neoplasms, Colorectal",Ribociclib,CN(C)C(=O)C1=CC2=CN=C(N=C2N1C3CCCC3)NC4=NC=C(C=C4)N5CCNCC5,PHASE1|PHASE2,digestive_system_disease
415,Irritable Bowel Syndrome With Constipation,Plecanatide,CC1C(=O)NC2CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(NC(=O)CNC(=O)C(NC2=O)C(C)O)C(=O)NC(CC(C)C)C(=O)O)C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)C(C)C)CC(=O)N)C(C)C)CC(C)C)CCC(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(CC(=O)O)NC(=O)C(CC(=O)N)N,PHASE2,digestive_system_disease
416,Hepatic Insufficiency,Alisporivir,CCC1C(=O)N(C(C(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)C(C)C)CC)C)C,PHASE1,digestive_system_disease
417,Hepatocellular Carcinoma (HCC),Tucidinostat,C1=CC(=CN=C1)C=CC(=O)NCC2=CC=C(C=C2)C(=O)NC3=C(C=C(C=C3)F)N,PHASE1|PHASE2,digestive_system_disease
418,Chronic Hepatitis B,Vesatolimod,CCCCOC1=NC(=C2C(=N1)N(CC(=O)N2)CC3=CC=CC(=C3)CN4CCCC4)N,PHASE2,digestive_system_disease
419,Neoplasm Metastases|Hepatic Insufficiency,Trabectedin,CC1=CC2=C(C3C4C5C6=C(C(=C7C(=C6C(N4C(C(C2)N3C)O)COC(=O)C8(CS5)C9=CC(=C(C=C9CCN8)O)OC)OCO7)C)OC(=O)C)C(=C1OC)O,PHASE1,digestive_system_disease
420,"Acute, Perforated Appendicitis",Povidone,C=CN1CCCC1=O,PHASE2,digestive_system_disease
421,Hermanski-Pudlak Syndrome|Colitis|Cytokines|Lymphocytes|Drug Evaluation,Mercaptopurine,C1=NC2=C(N1)C(=S)N=CN2,PHASE2,digestive_system_disease
422,Hepatic Impairment|Healthy Participants,Linzagolix,COC1=C(C(=C(C=C1)F)F)COC2=C(C=C(C(=C2)N3C(=O)C4=C(SC=C4NC3=O)C(=O)O)F)OC,PHASE1,digestive_system_disease
423,Chemoradiotherapy-Induced Severe Oral Mucositis,Clonidine,C1CN=C(N1)NC2=C(C=CC=C2Cl)Cl,PHASE2|PHASE3,digestive_system_disease
424,Mucositis,Chlorhexidine,C1=CC(=CC=C1NC(=NC(=NCCCCCCN=C(N)N=C(N)NC2=CC=C(C=C2)Cl)N)N)Cl,PHASE2,digestive_system_disease
425,Irritable Bowel Syndrome,Prucalopride,COCCCN1CCC(CC1)NC(=O)C2=CC(=C(C3=C2OCC3)N)Cl,PHASE2|PHASE3,digestive_system_disease
426,Anatomic Stage III Breast Cancer AJCC v8|Anatomic Stage IIIA Breast Cancer AJCC v8|Anatomic Stage IIIB Breast Cancer AJCC v8|Anatomic Stage IIIC Breast Cancer AJCC v8|Anatomic Stage IV Breast Cancer AJCC v8|Hormone Receptor Positive Breast Carcinoma|Locally Advanced Breast Carcinoma|Metastatic Breast Carcinoma|Metastatic Endometrioid Adenocarcinoma|Metastatic Fallopian Tube Carcinoma|Metastatic HER2 Negative Breast Carcinoma|Metastatic Malignant Solid Neoplasm|Metastatic Ovarian Carcinoma|Metastatic Primary Peritoneal Carcinoma|Prognostic Stage III Breast Cancer AJCC v8|Prognostic Stage IIIA Breast Cancer AJCC v8|Prognostic Stage IIIB Breast Cancer AJCC v8|Prognostic Stage IIIC Breast Cancer AJCC v8|Prognostic Stage IV Breast Cancer AJCC v8|Recurrent Fallopian Tube Carcinoma|Recurrent Ovarian Carcinoma|Recurrent Primary Peritoneal Carcinoma|Refractory Breast Carcinoma|Stage IV Fallopian Tube Cancer AJCC v8|Stage IV Ovarian Cancer AJCC v8|Stage IV Primary Peritoneal Cancer AJCC v8|Stage IV Uterine Corpus Cancer AJCC v8|Stage IVA Fallopian Tube Cancer AJCC v8|Stage IVA Ovarian Cancer AJCC v8|Stage IVA Primary Peritoneal Cancer AJCC v8|Stage IVA Uterine Corpus Cancer AJCC v8|Stage IVB Fallopian Tube Cancer AJCC v8|Stage IVB Ovarian Cancer AJCC v8|Stage IVB Primary Peritoneal Cancer AJCC v8|Stage IVB Uterine Corpus Cancer AJCC v8,Abexinostat,CN(C)CC1=C(OC2=CC=CC=C21)C(=O)NCCOC3=CC=C(C=C3)C(=O)NO,PHASE1,digestive_system_disease
427,Anatomic Stage III Breast Cancer AJCC v8|Anatomic Stage IIIA Breast Cancer AJCC v8|Anatomic Stage IIIB Breast Cancer AJCC v8|Anatomic Stage IIIC Breast Cancer AJCC v8|Anatomic Stage IV Breast Cancer AJCC v8|Hormone Receptor Positive Breast Carcinoma|Locally Advanced Breast Carcinoma|Metastatic Breast Carcinoma|Metastatic Endometrioid Adenocarcinoma|Metastatic Fallopian Tube Carcinoma|Metastatic HER2 Negative Breast Carcinoma|Metastatic Malignant Solid Neoplasm|Metastatic Ovarian Carcinoma|Metastatic Primary Peritoneal Carcinoma|Prognostic Stage III Breast Cancer AJCC v8|Prognostic Stage IIIA Breast Cancer AJCC v8|Prognostic Stage IIIB Breast Cancer AJCC v8|Prognostic Stage IIIC Breast Cancer AJCC v8|Prognostic Stage IV Breast Cancer AJCC v8|Recurrent Fallopian Tube Carcinoma|Recurrent Ovarian Carcinoma|Recurrent Primary Peritoneal Carcinoma|Refractory Breast Carcinoma|Stage IV Fallopian Tube Cancer AJCC v8|Stage IV Ovarian Cancer AJCC v8|Stage IV Primary Peritoneal Cancer AJCC v8|Stage IV Uterine Corpus Cancer AJCC v8|Stage IVA Fallopian Tube Cancer AJCC v8|Stage IVA Ovarian Cancer AJCC v8|Stage IVA Primary Peritoneal Cancer AJCC v8|Stage IVA Uterine Corpus Cancer AJCC v8|Stage IVB Fallopian Tube Cancer AJCC v8|Stage IVB Ovarian Cancer AJCC v8|Stage IVB Primary Peritoneal Cancer AJCC v8|Stage IVB Uterine Corpus Cancer AJCC v8,Fulvestrant,CC12CCC3C(C1CCC2O)C(CC4=C3C=CC(=C4)O)CCCCCCCCCS(=O)CCCC(C(F)(F)F)(F)F,PHASE1,digestive_system_disease
428,Erectile Dysfunction|Sigmoid Colon Cancer|Rectal Cancer,Udenafil,CCCC1=NN(C2=C1N=C(NC2=O)C3=C(C=CC(=C3)S(=O)(=O)NCCC4CCCN4C)OCCC)C,PHASE2,digestive_system_disease
429,Graft-versus-host Disease Prevention,Nystatin,CC1C=CC=CCCC=CC=CC=CC=CC(CC2C(C(CC(O2)(CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)O)C(=O)O)OC3C(C(C(C(O3)C)O)N)O,PHASE2,digestive_system_disease
430,Graft-versus-host Disease Prevention,Piperacillin,CCN1CCN(C(=O)C1=O)C(=O)NC(C2=CC=CC=C2)C(=O)NC3C4N(C3=O)C(C(S4)(C)C)C(=O)O,PHASE2,digestive_system_disease
431,Graft-versus-host Disease Prevention,Tazobactam,CC1(C(N2C(S1(=O)=O)CC2=O)C(=O)O)CN3C=CN=N3,PHASE2,digestive_system_disease
432,Primary Peritoneal Cancer|Advanced Epithelial Ovarian Cancer,Iniparib,C1=CC(=C(C=C1C(=O)N)[N+](=O)[O-])I,PHASE2,digestive_system_disease
433,Gastrointestinal Motility Disorder,Acetaminophen,CC(=O)NC1=CC=C(C=C1)O,PHASE1,digestive_system_disease
434,Gastrointestinal Motility Disorder,Talinolol,CC(C)(C)NCC(COC1=CC=C(C=C1)NC(=O)NC2CCCCC2)O,PHASE1,digestive_system_disease
435,Renal Insufficiency|Hepatic Insufficiency,Nevirapine,CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4,PHASE1,digestive_system_disease
436,Adult Subjects With Anal Fissures.,Diltiazem,CC(=O)OC1C(SC2=CC=CC=C2N(C1=O)CCN(C)C)C3=CC=C(C=C3)OC,PHASE1,digestive_system_disease
437,Crohn's Disease,Tamibarotene,CC1(CCC(C2=C1C=CC(=C2)NC(=O)C3=CC=C(C=C3)C(=O)O)(C)C)C,PHASE2,digestive_system_disease
438,Hepatic Impairment,Phentermine,CC(C)(CC1=CC=CC=C1)N,PHASE1,digestive_system_disease
439,Hepatic Impairment,Topiramate,CC1(OC2COC3(C(C2O1)OC(O3)(C)C)COS(=O)(=O)N)C,PHASE1,digestive_system_disease
440,Irritable Bowel Syndrome With Constipation,Linaclotide,CC1C(=O)NC2CSSCC3C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(NC(=O)CNC(=O)C(NC2=O)C(C)O)C(=O)NC(CC4=CC=C(C=C4)O)C(=O)O)C(=O)NC(CSSCC(C(=O)N3)N)C(=O)NC(C(=O)N5CCCC5C(=O)N1)CC(=O)N)CC6=CC=C(C=C6)O)CCC(=O)O,PHASE2,digestive_system_disease
441,Hepatocellular Carcinoma,Clemizole,C1CCN(C1)CC2=NC3=CC=CC=C3N2CC4=CC=C(C=C4)Cl,PHASE2,digestive_system_disease
442,Chronic Anal Fissure,Nifedipine,CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC,PHASE2|PHASE3,digestive_system_disease
443,Opioid-Induced Disorders|Esophagus Disorder,Naloxegol,COCCOCCOCCOCCOCCOCCOCCOC1CCC2(C3CC4=C5C2(C1OC5=C(C=C4)O)CCN3CC=C)O,PHASE2,digestive_system_disease
444,Pancreatic Neoplasms (Locally Advanced Non-metastatic),Nelfinavir,CC1=C(C=CC=C1O)C(=O)NC(CSC2=CC=CC=C2)C(CN3CC4CCCCC4CC3C(=O)NC(C)(C)C)O,PHASE1|PHASE2,digestive_system_disease
445,Fatty Liver|Liver Dysfunction|Insulin Resistance,Azithromycin,CCC1C(C(C(N(CC(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)C)O)(C)O,PHASE2,digestive_system_disease
446,Immune-Mediated Colitis,Tofacitinib,CC1CCN(CC1N(C)C2=NC=NC3=C2C=CN3)C(=O)CC#N,PHASE2,digestive_system_disease
447,Crohn's Disease,Methoxsalen,COC1=C2C(=CC3=C1OC=C3)C=CC(=O)O2,PHASE2,digestive_system_disease
448,Colorectal Cancer Metastatic|C-met Overexpression,Tivantinib,C1CC2=C3C(=CC=C2)C(=CN3C1)C4C(C(=O)NC4=O)C5=CNC6=CC=CC=C65,PHASE2,digestive_system_disease
449,Hepatitis C|Hepatitis,Merimepodib,COC1=C(C=CC(=C1)NC(=O)NC2=CC=CC(=C2)CNC(=O)OC3CCOC3)C4=CN=CO4,PHASE2,digestive_system_disease
450,Hypercholesterolemia,Ezetimibe,C1=CC(=CC=C1C2C(C(=O)N2C3=CC=C(C=C3)F)CCC(C4=CC=C(C=C4)F)O)O,PHASE2,digestive_system_disease
451,Crohn's Disease,Naltrexone,C1CC1CN2CCC34C5C(=O)CCC3(C2CC6=C4C(=C(C=C6)O)O5)O,PHASE2,digestive_system_disease
452,Hepatic Impairment,Narlaprevir,CCCCC(C(=O)C(=O)NC1CC1)NC(=O)C2C3C(C3(C)C)CN2C(=O)C(C(C)(C)C)NC(=O)NC4(CCCCC4)CS(=O)(=O)C(C)(C)C,PHASE1,digestive_system_disease
453,Crohn's Disease,Thiotepa,C1CN1P(=S)(N2CC2)N3CC3,PHASE1|PHASE2,digestive_system_disease
454,Crohn's Disease,Mesna,C(CS(=O)(=O)[O-])S.[Na+],PHASE1|PHASE2,digestive_system_disease
455,Primary Sclerosing Cholangitis,Volixibat,CCCCC1(CS(=O)(=O)C2=C(C=C(C=C2)N(C)C)C(C1O)C3=CC(=CC=C3)NC(=O)NC4C(C(C(C(O4)COS(=O)(=O)O)O)OCC5=CC=CC=C5)O)CC,PHASE2,digestive_system_disease
456,HEPATOCELLULAR CARCINOMA,Darinaparsin,C[As](C)SCC(C(=O)NCC(=O)O)NC(=O)CCC(C(=O)O)N,PHASE2,digestive_system_disease
457,Hepatitis C|Hepatitis C Virus,Fluvastatin,CC(C)N1C2=CC=CC=C2C(=C1C=CC(CC(CC(=O)O)O)O)C3=CC=C(C=C3)F,PHASE2,digestive_system_disease
458,Irritable Bowel Syndrome,Doxepin,CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31,PHASE2,digestive_system_disease
459,Irritable Bowel Syndrome,Nortriptyline,CNCCC=C1C2=CC=CC=C2CCC3=CC=CC=C31,PHASE2,digestive_system_disease
460,Colon Cancer|Colorectal Cancer|Rectal Cancer,Pegfilgrastim,CC(C(C(=O)O)N)OC1C(C(C(C(O1)COC2(CC(C(C(O2)C(C(CO)O)O)NC(=O)CNC(=O)OCCOC)O)C(=O)O)O)O)NC(=O)C,PHASE2,digestive_system_disease
461,Hyperinsulinemic Hypoglycemia|Post Gastrointestinal Tract Surgery Hypoglycaemia,Pasireotide,C1C(CN2C1C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C2=O)CC3=CC=CC=C3)CC4=CC=C(C=C4)OCC5=CC=CC=C5)CCCCN)CC6=CNC7=CC=CC=C76)C8=CC=CC=C8)OC(=O)NCCN,PHASE1,digestive_system_disease
462,Chronic Hepatitis C Infection,Dasabuvir,CC(C)(C)C1=CC(=CC(=C1OC)C2=CC3=C(C=C2)C=C(C=C3)NS(=O)(=O)C)N4C=CC(=O)NC4=O,PHASE2|PHASE3,digestive_system_disease
463,MALT Lymphoma,Bortezomib,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O,PHASE2,digestive_system_disease
464,Metastatic Colorectal Cancer|MSS,Maraviroc,CC1=NN=C(N1C2CC3CCC(C2)N3CCC(C4=CC=CC=C4)NC(=O)C5CCC(CC5)(F)F)C(C)C,PHASE1,digestive_system_disease
465,"Esophagus Cancer, Adenocarcinoma|Stomach Cancer, Adenocarcinoma",Rucaparib,CNCC1=CC=C(C=C1)C2=C3CCNC(=O)C4=C3C(=CC(=C4)F)N2,PHASE1|PHASE2,digestive_system_disease
466,Metastatic Colorectal Cancer,Napabucasin,CC(=O)C1=CC2=C(O1)C(=O)C3=CC=CC=C3C2=O,PHASE1|PHASE2,digestive_system_disease
467,Ulcerative Colitis,Apremilast,CCOC1=C(C=CC(=C1)C(CS(=O)(=O)C)N2C(=O)C3=C(C2=O)C(=CC=C3)NC(=O)C)OC,PHASE2,digestive_system_disease
468,Pancreatic Cancer,Ruxolitinib,C1CCC(C1)C(CC#N)N2C=C(C=N2)C3=C4C=CNC4=NC=N3,PHASE2,digestive_system_disease
469,Chronic Hepatitis C Virus,Samatasvir,CC(C)C(C(=O)N1CCCC1C2=NC3=C(N2)C=C(C=C3)C4=CSC5=C4SC=C5C6=CC=C(C=C6)C7=CN=C(N7)C8CCCN8C(=O)C(C9=CC=CC=C9)NC(=O)OC)NC(=O)OC,PHASE2,digestive_system_disease
470,Hepatic Impairment,Deferasirox,C1=CC=C(C(=C1)C2=NN(C(=N2)C3=CC=CC=C3O)C4=CC=C(C=C4)C(=O)O)O,PHASE1,digestive_system_disease
471,HCV Infection,Norgestimate,CCC12CCC3C(C1CCC2(C#C)OC(=O)C)CCC4=CC(=NO)CCC34,PHASE1,digestive_system_disease
472,Cystic Fibrosis,Cavosonstat,C1=CC(=C(C=C1C(=O)O)Cl)C2=NC3=C(C=C2)C=C(C=C3)O,PHASE2,digestive_system_disease
473,Non-Alcoholic Fatty Liver Disease,Cholecalciferol,CC(C)CCCC(C)C1CCC2C1(CCCC2=CC=C3CC(CCC3=C)O)C,PHASE2,digestive_system_disease
474,Crohn Disease,Neomycin,C1C(C(C(C(C1N)OC2C(C(C(C(O2)CN)O)O)N)OC3C(C(C(O3)CO)OC4C(C(C(C(O4)CN)O)O)N)O)O)N,PHASE2,digestive_system_disease
475,Primary Biliary Cholangitis (PBC),Elafibranor,CC1=CC(=CC(=C1OC(C)(C)C(=O)O)C)C=CC(=O)C2=CC=C(C=C2)SC,PHASE2,digestive_system_disease
476,Moderate Hepatic Impairment|Severe Hepatic Impairment|Healthy Volunteers,Lorlatinib,CC1C2=C(C=CC(=C2)F)C(=O)N(CC3=NN(C(=C3C4=CC(=C(N=C4)N)O1)C#N)C)C,PHASE1,digestive_system_disease
477,Crohn Disease|Ulcerative Colitis,Warfarin,CC(=O)CC(C1=CC=CC=C1)C2=C(C3=CC=CC=C3OC2=O)O,PHASE1,digestive_system_disease
478,Crohn Disease|Ulcerative Colitis,Dextromethorphan,CN1CCC23CCCCC2C1CC4=C3C=C(C=C4)OC,PHASE1,digestive_system_disease
479,Hepatocellular Carcinoma,Sonidegib,CC1CN(CC(O1)C)C2=NC=C(C=C2)NC(=O)C3=CC=CC(=C3C)C4=CC=C(C=C4)OC(F)(F)F,PHASE1,digestive_system_disease
480,Cystic Fibrosis,Tezacaftor,CC(C)(CO)C1=CC2=CC(=C(C=C2N1CC(CO)O)F)NC(=O)C3(CC3)C4=CC5=C(C=C4)OC(O5)(F)F,PHASE2,digestive_system_disease
481,Hepatic Impairment,Deflazacort,CC1=NC2(C(O1)CC3C2(CC(C4C3CCC5=CC(=O)C=CC45C)O)C)C(=O)COC(=O)C,PHASE1,digestive_system_disease
482,Gastroenteritis Escherichia Coli,Aspartame,COC(=O)C(CC1=CC=CC=C1)NC(=O)C(CC(=O)O)N,PHASE1,digestive_system_disease
483,Hepatitis C,Pibrentasvir,CC(C(C(=O)N1CCCC1C2=NC3=C(N2)C=C(C(=C3)F)C4CCC(N4C5=CC(=C(C(=C5)F)N6CCC(CC6)C7=CC=C(C=C7)F)F)C8=CC9=C(C=C8F)N=C(N9)C1CCCN1C(=O)C(C(C)OC)NC(=O)OC)NC(=O)OC)OC,PHASE2,digestive_system_disease
484,Pancreatic Adenocarcinoma|Recurrent Pancreatic Carcinoma|Stage III Pancreatic Cancer AJCC v6 and v7|Stage IV Pancreatic Cancer AJCC v6 and v7|Unresectable Pancreatic Carcinoma,Dinaciclib,CCC1=C2N=C(C=C(N2N=C1)NCC3=C[N+](=CC=C3)[O-])N4CCCCC4CCO,PHASE1,digestive_system_disease
485,Mucositis|Nephrotoxicity|Ototoxicity,Tempol,CC1(CC(CC(N1[O])(C)C)O)C,PHASE2,digestive_system_disease
486,"Hepatitis C, Chronic",Celgosivir,CCCC(=O)OC1CN2CCC(C2C(C1O)O)O,PHASE2,digestive_system_disease
487,Digestive Oncology|Supportive Care,Donepezil,COC1=C(C=C2C(=C1)CC(C2=O)CC3CCN(CC3)CC4=CC=CC=C4)OC,PHASE2,digestive_system_disease
488,Functional Abdominal Pain|Irritable Bowel Syndrome|Functional Dyspepsia,Simethicone,CO[Si](C)(C)O[Si](C)(C)C.O=[Si]=O,PHASE1,digestive_system_disease
489,Colorectal Neoplasm|Digestive System Neoplasm,Flucytosine,C1=NC(=O)NC(=C1F)N,PHASE1|PHASE2,digestive_system_disease
490,Esophageal Achalasia,Ceftazidime,CC(C)(C(=O)O)ON=C(C1=CSC(=N1)N)C(=O)NC2C3N(C2=O)C(=C(CS3)C[N+]4=CC=CC=C4)C(=O)[O-],PHASE2|PHASE3,digestive_system_disease
491,Healthy Volunteers,Clopidogrel,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,PHASE1,digestive_system_disease
492,Irritable Bowel Syndrome,Milnacipran,CCN(CC)C(=O)C1(CC1CN)C2=CC=CC=C2,PHASE2,digestive_system_disease
493,Nonalcoholic Fatty Liver Disease (NAFLD)|Type 2 Diabetes (T2DM),Lanifibranor,C1=CC2=C(C=C1S(=O)(=O)N3C4=C(C=C(C=C4)Cl)C=C3CCCC(=O)O)SC=N2,PHASE2,digestive_system_disease
494,Acquired Hyperinsulinemic Hypoglycemia,Avexitide,CCC(C)C(C(=O)NC(CCC(=O)O)C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(CC(C)C)C(=O)NC(CCCCN)C(=O)NC(CC(=O)N)C(=O)NCC(=O)NCC(=O)N3CCCC3C(=O)NC(CO)C(=O)NC(CO)C(=O)NCC(=O)NC(C)C(=O)N4CCCC4C(=O)N5CCCC5C(=O)N6CCCC6C(=O)NC(CO)C(=O)N)NC(=O)C(CC7=CC=CC=C7)NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(C(C)C)NC(=O)C(C)NC(=O)C(CCC(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(CCSC)NC(=O)C(CCC(=O)N)NC(=O)C(CCCCN)NC(=O)C(CO)NC(=O)C(CC(C)C)NC(=O)C(CC(=O)O)N,PHASE2,digestive_system_disease
495,Pancreas Cancer|Pancreatic Cancer|Cancer of the Pancreas,Dapagliflozin,CCOC1=CC=C(C=C1)CC2=C(C=CC(=C2)C3C(C(C(C(O3)CO)O)O)O)Cl,PHASE1,digestive_system_disease
496,Anatomic Stage I Breast Cancer AJCC v8|Anatomic Stage IA Breast Cancer AJCC v8|Anatomic Stage IB Breast Cancer AJCC v8|Anatomic Stage II Breast Cancer AJCC v8|Anatomic Stage IIA Breast Cancer AJCC v8|Anatomic Stage IIB Breast Cancer AJCC v8|Anatomic Stage III Breast Cancer AJCC v8|Anatomic Stage IIIA Breast Cancer AJCC v8|Anatomic Stage IIIB Breast Cancer AJCC v8|Anatomic Stage IIIC Breast Cancer AJCC v8|Anatomic Stage IV Breast Cancer AJCC v8|Chemotherapy-Induced Peripheral Neuropathy|Digestive System Carcinoma|Prognostic Stage I Breast Cancer AJCC v8|Prognostic Stage IA Breast Cancer AJCC v8|Prognostic Stage IB Breast Cancer AJCC v8|Prognostic Stage II Breast Cancer AJCC v8|Prognostic Stage IIA Breast Cancer AJCC v8|Prognostic Stage IIB Breast Cancer AJCC v8|Prognostic Stage III Breast Cancer AJCC v8|Prognostic Stage IIIA Breast Cancer AJCC v8|Prognostic Stage IIIB Breast Cancer AJCC v8|Prognostic Stage IIIC Breast Cancer AJCC v8|Prognostic Stage IV Breast Cancer AJCC v8,Lorcaserin,CC1CNCCC2=C1C=C(C=C2)Cl,PHASE1,digestive_system_disease
497,Hepatic Impairment,Hydrocodone,CN1CCC23C4C1CC5=C2C(=C(C=C5)OC)OC3C(=O)CC4,PHASE1,digestive_system_disease
498,Non-Small Cell Lung Cancer|Breast Cancer|Pancreatic Cancer,Ibrutinib,C=CC(=O)N1CCCC(C1)N2C3=NC=NC(=C3C(=N2)C4=CC=C(C=C4)OC5=CC=CC=C5)N,PHASE1|PHASE2,digestive_system_disease
499,Advanced Lymphoma|Advanced Malignant Solid Neoplasm|Advanced Pancreatic Carcinoma|B-Cell Non-Hodgkin Lymphoma|Metastatic Pancreatic Carcinoma|Refractory B-Cell Non-Hodgkin Lymphoma|Refractory Lymphoma|Refractory Malignant Solid Neoplasm|Refractory Pancreatic Carcinoma|Refractory T-Cell Non-Hodgkin Lymphoma|Stage II Pancreatic Cancer AJCC v8|Stage III Pancreatic Cancer AJCC v8|Stage IV Pancreatic Cancer AJCC v8|Unresectable Pancreatic Carcinoma,Entinostat,C1=CC=C(C(=C1)N)NC(=O)C2=CC=C(C=C2)CNC(=O)OCC3=CN=CC=C3,PHASE1|PHASE2,digestive_system_disease
500,Chronic Hepatitis B,Telbivudine,CC1=CN(C(=O)NC1=O)C2CC(C(O2)CO)O,PHASE1|PHASE2,digestive_system_disease
501,Cryptosporidiosis|HIV Infections,Paromomycin,C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)O)N)OC3C(C(C(O3)CO)OC4C(C(C(C(O4)CN)O)O)N)O)O)N,PHASE2,digestive_system_disease
502,Hepatic Impairment,Danicopan,CC1=NC=C(C=N1)C2=CC3=C(C=C2)N(N=C3C(=O)C)CC(=O)N4CC(CC4C(=O)NC5=NC(=CC=C5)Br)F,PHASE1,digestive_system_disease
503,Irritable Bowel Syndrome (IBS),Solabegron,C1=CC(=CC(=C1)C(=O)O)C2=CC(=CC=C2)NCCNCC(C3=CC(=CC=C3)Cl)O,PHASE1,digestive_system_disease
504,Liver Cirrhosis,Apixaban,COC1=CC=C(C=C1)N2C3=C(CCN(C3=O)C4=CC=C(C=C4)N5CCCCC5=O)C(=N2)C(=O)N,PHASE2,digestive_system_disease
505,Liver Cirrhosis,Edoxaban,CN1CCC2=C(C1)SC(=N2)C(=O)NC3CC(CCC3NC(=O)C(=O)NC4=NC=C(C=C4)Cl)C(=O)N(C)C,PHASE2,digestive_system_disease
506,Hepatocellular Carcinoma,Pirarubicin,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)N)OC6CCCCO6,PHASE2|PHASE3,digestive_system_disease
507,Crohn Disease,Xanthohumol,CC(=CCC1=C(C(=C(C=C1O)OC)C(=O)C=CC2=CC=C(C=C2)O)O)C,PHASE2,digestive_system_disease
508,Non-Small Cell Lung Cancer,Pralatrexate,C#CCC(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,PHASE1,digestive_system_disease
509,Hepatic Encephalopathy|Acute-On-Chronic Liver Failure,Lactulose,C(C1C(C(C(C(O1)OC2C(OC(C2O)(CO)O)CO)O)O)O)O,PHASE1,digestive_system_disease
510,"Urinary Incontinence, Stress|Fecal Incontinence",Imipramine,CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31,PHASE1,digestive_system_disease
511,Non Alcoholic Steatohepatitis (NASH),Icosabutate,CCC=CCC=CCC=CCC=CCC=CCCCCOC(CC)C(=O)O,PHASE2,digestive_system_disease
512,Inflammatory Bowel Disease,Filgotinib,C1CC1C(=O)NC2=NN3C(=N2)C=CC=C3C4=CC=C(C=C4)CN5CCS(=O)(=O)CC5,PHASE2,digestive_system_disease
513,Nalbuphine|Hepatic Impairment,Nalbuphine,C1CC(C1)CN2CCC34C5C(CCC3(C2CC6=C4C(=C(C=C6)O)O5)O)O,PHASE1,digestive_system_disease
514,Esophageal Cancer,Endostar,CN(CC(=O)C1=CC=CC=C1)N=O,PHASE2,digestive_system_disease
515,Cystic Fibrosis,Tobramycin,C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(CC(C(O3)CN)O)N)N,PHASE1,digestive_system_disease
516,Crohn's Disease|Abdominal Pain,Olorinab,CC(C)(C)C(CO)NC(=O)C1=NN(C2=C1CC3C2C3)C4=NC=C[N+](=C4)[O-],PHASE2,digestive_system_disease
517,Congenital Hyperinsulinism|Insulinoma,Fluorodopa,C1=C(C(=CC(=C1O)O)F)CC(C(=O)O)N,PHASE1,digestive_system_disease
518,"Melanoma|Solid Tumor|CRAF Gene Amplification|RAF1 Gene Amplification|BRAF Gene Fusion|BRAF Fusion|CRAF Gene Fusion|CRAF Fusion|RAF1 Gene Fusion|RAF1 Fusion|Thyroid Cancer, Papillary|Spitzoid Melanoma|Pilocytic Astrocytoma|Pilocytic Astrocytoma, Adult|Non Small Cell Lung Cancer|Non-Small Cell Adenocarcinoma|Colorectal Cancer|Pancreatic Acinar Carcinoma|Spitzoid Malignant Melanoma|Bladder Cancer|Bladder Urothelial Carcinoma|MAP Kinase Family Gene Mutation|RAS Mutation|RAF Mutation|MEK Mutation",Tovorafenib,CC(C1=NC=C(S1)C(=O)NC2=NC=C(C(=C2)C(F)(F)F)Cl)NC(=O)C3=C(C(=NC=N3)N)Cl,PHASE1|PHASE2,digestive_system_disease
519,HepatoCellular Carcinoma|Portal Vein Tumor Thrombosis,Lipotecan,CCC1(C2=C(COC1=O)C(=O)N3CC4=CC5=C(C=CC(=C5CN(C)C)O)N=C4C3=C2)OC(=O)C(C)ON=C6C7=C(C(=CC(=C7)[N+](=O)[O-])[N+](=O)[O-])C8=C6C=C(C=C8[N+](=O)[O-])[N+](=O)[O-],PHASE1|PHASE2,digestive_system_disease
520,Severe Hepatic Impairment,Vortioxetine,CC1=CC(=C(C=C1)SC2=CC=CC=C2N3CCNCC3)C,PHASE1,digestive_system_disease
521,Anatomic Stage IV Breast Cancer AJCC v8|Clinical Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8|Clinical Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8|Clinical Stage IVB Gastroesophageal Junction Adenocarcinoma AJCC v8|Locally Advanced Malignant Solid Neoplasm|Locally Advanced Melanoma|Locally Advanced Primary Malignant Central Nervous System Neoplasm|Locally Advanced Sarcoma|Metastatic Malignant Solid Neoplasm|Metastatic Melanoma|Metastatic Primary Malignant Central Nervous System Neoplasm|Metastatic Sarcoma|Pathologic Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8|Pathologic Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8|Pathologic Stage IVB Gastroesophageal Junction Adenocarcinoma AJCC v8|Postneoadjuvant Therapy Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8|Postneoadjuvant Therapy Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8|Postneoadjuvant Therapy Stage IVB Gastroesophageal Junction Adenocarcinoma AJCC v8|Prognostic Stage IIIC Breast Cancer AJCC v8|Prognostic Stage IV Breast Cancer AJCC v8|Stage IIIC Colorectal Cancer AJCC v8|Stage IIIC Lung Cancer AJCC v8|Stage IV Colorectal Cancer AJCC v8|Stage IV Lung Cancer AJCC v8|Stage IVA Colorectal Cancer AJCC v8|Stage IVA Lung Cancer AJCC v8|Stage IVB Colorectal Cancer AJCC v8|Stage IVB Lung Cancer AJCC v8|Stage IVC Colorectal Cancer AJCC v8,Avapritinib,CC(C1=CC=C(C=C1)F)(C2=CN=C(N=C2)N3CCN(CC3)C4=NC=NN5C4=CC(=C5)C6=CN(N=C6)C)N,PHASE2,digestive_system_disease
522,Non-Alcoholic Fatty Liver Disease,Gemcabene,CC(C)(CCCCOCCCCC(C)(C)C(=O)O)C(=O)O,PHASE2,digestive_system_disease
523,Hepatic Impairment,Enasidenib,CC(C)(CNC1=NC(=NC(=N1)C2=NC(=CC=C2)C(F)(F)F)NC3=CC(=NC=C3)C(F)(F)F)O,PHASE1,digestive_system_disease
524,Gastroparesis,Erythromycin,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)O)(C)O,PHASE2,digestive_system_disease
525,Eosinophilic Esophagitis,Montelukast,CC(C)(C1=CC=CC=C1CCC(C2=CC=CC(=C2)C=CC3=NC4=C(C=CC(=C4)Cl)C=C3)SCC5(CC5)CC(=O)O)O,PHASE1,digestive_system_disease
526,Ulcerative Colitis|Pouchitis|Ileitis|Inflammatory Bowel Disease,Clotrimazole,C1=CC=C(C=C1)C(C2=CC=CC=C2)(C3=CC=CC=C3Cl)N4C=CN=C4,PHASE1|PHASE2,digestive_system_disease
527,Gastroesophageal Reflux Disease,Lesogaberan,C(C(C[P+](=O)O)F)N,PHASE2,digestive_system_disease
528,Rectal Cancer,Epacadostat,C1=CC(=C(C=C1N=C(C2=NON=C2NCCNS(=O)(=O)N)NO)Br)F,PHASE1|PHASE2,digestive_system_disease
529,Gastroparesis,Lisinopril,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,PHASE1,digestive_system_disease
530,Pancreas Cancer,Plerixafor,C1CNCCNCCCN(CCNC1)CC2=CC=C(C=C2)CN3CCCNCCNCCCNCC3,PHASE1,digestive_system_disease
531,ERCP|Pancreatitis,Valdecoxib,CC1=C(C(=NO1)C2=CC=CC=C2)C3=CC=C(C=C3)S(=O)(=O)N,PHASE2|PHASE3,digestive_system_disease
532,Colorectal Adenocarcinoma|CpG Island Methylator Phenotype|Metastatic Microsatellite Stable Colorectal Carcinoma|Refractory Colorectal Carcinoma|Stage IV Colorectal Cancer AJCC v8|Stage IVA Colorectal Cancer AJCC v8|Stage IVB Colorectal Cancer AJCC v8|Stage IVC Colorectal Cancer AJCC v8,Guadecitabine,C1C(C(OC1N2C=NC3=C2N=C(NC3=O)N)COP(=O)(O)OC4CC(OC4CO)N5C=NC(=NC5=O)N)O,PHASE1|PHASE2,digestive_system_disease
533,Hepatitis C,Buprenorphine,CC(C)(C)C(C)(C1CC23CCC1(C4C25CCN(C3CC6=C5C(=C(C=C6)O)O4)CC7CC7)OC)O,PHASE1,digestive_system_disease
534,Hepatitis C,Naloxone,C=CCN1CCC23C4C(=O)CCC2(C1CC5=C3C(=C(C=C5)O)O4)O,PHASE1,digestive_system_disease
535,Colorectal Cancer,Pacritinib,C1CCN(C1)CCOC2=C3COCC=CCOCC4=CC(=CC=C4)C5=NC(=NC=C5)NC(=C3)C=C2,PHASE2,digestive_system_disease
536,Mucositis,Bupivacaine,CCCCN1CCCCC1C(=O)NC2=C(C=CC=C2C)C,PHASE2,digestive_system_disease
537,Mucositis,Morphine,CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O,PHASE2,digestive_system_disease
538,Appendicitis Acute,Epinephrine,CNCC(C1=CC(=C(C=C1)O)O)O,PHASE2,digestive_system_disease
539,Unresectable Hepatocellular Carcinoma,Bumetanide,CCCCNC1=C(C(=CC(=C1)C(=O)O)S(=O)(=O)N)OC2=CC=CC=C2,PHASE1|PHASE2,digestive_system_disease
540,Hepatitis C,Darunavir,CC(C)CN(CC(C(CC1=CC=CC=C1)NC(=O)OC2COC3C2CCO3)O)S(=O)(=O)C4=CC=C(C=C4)N,PHASE1,digestive_system_disease
541,Hepatitis C,Lopinavir,CC1=C(C(=CC=C1)C)OCC(=O)NC(CC2=CC=CC=C2)C(CC(CC3=CC=CC=C3)NC(=O)C(C(C)C)N4CCCNC4=O)O,PHASE1,digestive_system_disease
542,Hepatitis B,Alendronate,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,PHASE1,digestive_system_disease
543,Neoplasms|Pancreatic Neoplasms,Glufosfamide,C(CCl)NP(=O)(NCCCl)OC1C(C(C(C(O1)CO)O)O)O,PHASE1|PHASE2,digestive_system_disease
544,Hepatopulmonary Syndrome,Norfloxacin,CCN1C=C(C(=O)C2=CC(=C(C=C21)N3CCNCC3)F)C(=O)O,PHASE2,digestive_system_disease
545,Colorectal Cancer|Rectal Bleeding,Desmopressin,C1CC(N(C1)C(=O)C2CSSCCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N2)CC(=O)N)CCC(=O)N)CC3=CC=CC=C3)CC4=CC=C(C=C4)O)C(=O)NC(CCCN=C(N)N)C(=O)NCC(=O)N,PHASE2,digestive_system_disease
546,HCV Infection,Voxilaprevir,CCC1C2CN(C1C(=O)NC3(CC3C(F)F)C(=O)NS(=O)(=O)C4(CC4)C)C(=O)C(NC(=O)OC5CC5CCCCC(C6=NC7=C(C=C(C=C7)OC)N=C6O2)(F)F)C(C)(C)C,PHASE1,digestive_system_disease
547,Sickle Cell Disease|Thalassemia|Severe Congenital Neutropenia|Diamond-Blackfan Anemia|Shwachman-Diamond Syndrome,Busulfan,CS(=O)(=O)OCCCCOS(=O)(=O)C,PHASE2|PHASE3,digestive_system_disease
548,Colorectal Cancer|Colorectal Cancer Metastatic|Colorectal Cancer Recurrent,Famitinib,CCN(CC)CCN1CCC2=C(C1=O)C(=C(N2)C=C3C4=C(C=CC(=C4)F)NC3=O)C,PHASE2,digestive_system_disease
549,"Hepatitis C, Chronic",Faldaprevir,CC(C)C(=O)NC1=NC(=CS1)C2=NC3=C(C=CC(=C3Br)OC)C(=C2)OC4CC(N(C4)C(=O)C(C(C)(C)C)NC(=O)OC5CCCC5)C(=O)NC6(CC6C=C)C(=O)O,PHASE2,digestive_system_disease
550,Hyperinsulinemic Hypoglycemia,Glucagon,CC(C)CC(C(=O)NC(CCSC)C(=O)NC(CC(=O)N)C(=O)NC(C(C)O)C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)NC(=O)C(CCC(=O)N)NC(=O)C(C(C)C)NC(=O)C(CC3=CC=CC=C3)NC(=O)C(CC(=O)O)NC(=O)C(CCC(=O)N)NC(=O)C(C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C(CC(=O)O)NC(=O)C(CC(C)C)NC(=O)C(CC4=CC=C(C=C4)O)NC(=O)C(CCCCN)NC(=O)C(CO)NC(=O)C(CC5=CC=C(C=C5)O)NC(=O)C(CC(=O)O)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C(CC6=CC=CC=C6)NC(=O)C(C(C)O)NC(=O)CNC(=O)C(CCC(=O)N)NC(=O)C(CO)NC(=O)C(CC7=CN=CN7)N,PHASE2,digestive_system_disease
551,Hepatic Impairment,Midostaurin,CC12C(C(CC(O1)N3C4=CC=CC=C4C5=C6C(=C7C8=CC=CC=C8N2C7=C53)CNC6=O)N(C)C(=O)C9=CC=CC=C9)OC,PHASE1,digestive_system_disease
552,Gastric Cancer|Stomach Cancer,Famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,PHASE2,digestive_system_disease
553,Hepatic Impairment,Istradefylline,CCN1C2=C(C(=O)N(C1=O)CC)N(C(=N2)C=CC3=CC(=C(C=C3)OC)OC)C,PHASE1,digestive_system_disease
554,Metastatic Colorectal Carcinoma|Stage IV Colorectal Cancer AJCC v8|Stage IVA Colorectal Cancer AJCC v8|Stage IVB Colorectal Cancer AJCC v8|Stage IVC Colorectal Cancer AJCC v8,Riluzole,C1=CC2=C(C=C1OC(F)(F)F)SC(=N2)N,PHASE1,digestive_system_disease
555,Liver Cancer,Bleomycin,CC1=C(N=C(N=C1N)C(CC(=O)N)NCC(C(=O)N)N)C(=O)NC(C(C2=CN=CN2)OC3C(C(C(C(O3)CO)O)O)OC4C(C(C(C(O4)CO)O)OC(=O)N)O)C(=O)NC(C)C(C(C)C(=O)NC(C(C)O)C(=O)NCCC5=NC(=CS5)C6=NC(=CS6)C(=O)NCCC[S+](C)C)O,PHASE1|PHASE2,digestive_system_disease
556,Hepatocellular Carcinoma,Menatetrenone,CC1=C(C(=O)C2=CC=CC=C2C1=O)CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C,PHASE2|PHASE3,digestive_system_disease
557,"Alcoholism,|Alcoholic Liver Disease",Metadoxine,CC1=NC=C(C(=C1O)CO)CO.C1CC(=O)NC1C(=O)O,PHASE2,digestive_system_disease
558,Breast Cancer|Breast Neoplasms|Colon Cancer|Colonic Cancer|Colon Neoplasms|Lung Cancer|Melanoma|Kidney Cancer,Dacarbazine,CN(C)N=NC1=C(NC=N1)C(=O)N,PHASE1,digestive_system_disease
559,Healthy Subjects|Hepatic Impairment,Selatogrel,CCCCOC(=O)N1CCN(CC1)C(=O)C(CP(=O)(O)O)NC(=O)C2=CC(=NC(=N2)C3=CC=CC=C3)N4CCC(C4)OC,PHASE1,digestive_system_disease
560,HIV Infections|Hepatitis C,Zidovudine,CC1=CN(C(=O)NC1=O)C2CC(C(O2)CO)N=[N+]=[N-],PHASE1,digestive_system_disease
561,HIV Infections|Hepatitis C,Zalcitabine,C1CC(OC1CO)N2C=CC(=NC2=O)N,PHASE1,digestive_system_disease
562,HIV Infections|Hepatitis C,Didanosine,C1CC(OC1CO)N2C=NC3=C2N=CNC3=O,PHASE1,digestive_system_disease
563,Carney Complex|Chondrosarcoma|Gastrointestinal Stromal Tumor|Paraganglioma,Linsitinib,CC1(CC(C1)C2=NC(=C3N2C=CN=C3N)C4=CC5=C(C=C4)C=CC(=N5)C6=CC=CC=C6)O,PHASE2,digestive_system_disease
564,Liver Cancer,Irofulven,CC1=C(C2=C(C3(CC3)C(C(=O)C2=C1)(C)O)C)CO,PHASE1|PHASE2,digestive_system_disease
565,Pancreatic Cancer,Methylnaltrexone,C[N+]1(CCC23C4C(=O)CCC2(C1CC5=C3C(=C(C=C5)O)O4)O)CC6CC6,PHASE2|PHASE3,digestive_system_disease
566,Cystic Fibrosis,Amikacin,C1C(C(C(C(C1NC(=O)C(CCN)O)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(C(C(C(O3)CN)O)O)O)N,PHASE2,digestive_system_disease
567,Hepatic Insufficiency,Tirzepatide,CCC(C)C(C(=O)NC(C)C(=O)NC(CCC(=O)N)C(=O)NC(CCCCNC(=O)COCCOCCNC(=O)COCCOCCNC(=O)CCC(C(=O)O)NC(=O)CCCCCCCCCCCCCCCCCCC(=O)O)C(=O)NC(C)C(=O)NC(CC1=CC=CC=C1)C(=O)NC(C(C)C)C(=O)NC(CCC(=O)N)C(=O)NC(CC2=CNC3=CC=CC=C32)C(=O)NC(CC(C)C)C(=O)NC(C(C)CC)C(=O)NC(C)C(=O)NCC(=O)NCC(=O)N4CCCC4C(=O)NC(CO)C(=O)NC(CO)C(=O)NCC(=O)NC(C)C(=O)N5CCCC5C(=O)N6CCCC6C(=O)N7CCCC7C(=O)NC(CO)C(=O)N)NC(=O)C(CCCCN)NC(=O)C(CC(=O)O)NC(=O)C(CC(C)C)NC(=O)C(C)(C)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(CC8=CC=C(C=C8)O)NC(=O)C(CC(=O)O)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C(CC9=CC=CC=C9)NC(=O)C(C(C)O)NC(=O)CNC(=O)C(CCC(=O)O)NC(=O)C(C)(C)NC(=O)C(CC1=CC=C(C=C1)O)N,PHASE1,digestive_system_disease
568,Hepatic Impairment,Iloperidone,CC(=O)C1=CC(=C(C=C1)OCCCN2CCC(CC2)C3=NOC4=C3C=CC(=C4)F)OC,PHASE1,digestive_system_disease
569,Hepatocellular Carcinoma,Axitinib,CNC(=O)C1=CC=CC=C1SC2=CC3=C(C=C2)C(=NN3)C=CC4=CC=CC=N4,PHASE2,digestive_system_disease
570,Pruritus With Chronic Liver Disease,Nalfurafine,CN(C1CCC2(C3CC4=C5C2(C1OC5=C(C=C4)O)CCN3CC6CC6)O)C(=O)C=CC7=COC=C7,PHASE2,digestive_system_disease
571,Non-alcoholic Fatty Liver Disease|Nonalcoholic Steatohepatitis,Tropifexor,C1CC1C2=C(C(=NO2)C3=CC=CC=C3OC(F)(F)F)COC4CC5CCC(C4)N5C6=NC7=C(C=C(C=C7S6)C(=O)O)F,PHASE2,digestive_system_disease
572,Hepatitis C,Candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,PHASE2,digestive_system_disease
573,Advanced or Metastatic Hepatocellular Cancer|Advanced or Metastatic Ovarian Cancer|Metastatic Renal Cell Cancer|Advanced or Metastatic Gastric Carcinoma,Tasquinimod,CN1C2=C(C(=CC=C2)OC)C(=C(C1=O)C(=O)N(C)C3=CC=C(C=C3)C(F)(F)F)O,PHASE2,digestive_system_disease
574,Hepatic Encephalopathy|Liver Cirrhosis,Flumazenil,CCOC(=O)C1=C2CN(C(=O)C3=C(N2C=N1)C=CC(=C3)F)C,PHASE1|PHASE2,digestive_system_disease
575,Diabetes Mellitus|Gastroparesis,Lixisenatide,CCC(C)C(C(=O)NC(CCC(=O)O)C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(CC(C)C)C(=O)NC(CCCCN)C(=O)NC(CC(=O)N)C(=O)NCC(=O)NCC(=O)N3CCCC3C(=O)NC(CO)C(=O)NC(CO)C(=O)NCC(=O)NC(C)C(=O)N4CCCC4C(=O)N5CCCC5C(=O)NC(CO)C(=O)NC(CCCCN)C(=O)NC(CCCCN)C(=O)NC(CCCCN)C(=O)NC(CCCCN)C(=O)NC(CCCCN)C(=O)NC(CCCCN)C(=O)N)NC(=O)C(CC6=CC=CC=C6)NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(C(C)C)NC(=O)C(C)NC(=O)C(CCC(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(CCSC)NC(=O)C(CCC(=O)N)NC(=O)C(CCCCN)NC(=O)C(CO)NC(=O)C(CC(C)C)NC(=O)C(CC(=O)O)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C(CC7=CC=CC=C7)NC(=O)C(C(C)O)NC(=O)CNC(=O)C(CCC(=O)O)NC(=O)CNC(=O)C(CC8=CNC=N8)N,PHASE1|PHASE2,digestive_system_disease
576,Cryptosporidiosis,Clofazimine,CC(C)N=C1C=C2C(=NC3=CC=CC=C3N2C4=CC=C(C=C4)Cl)C=C1NC5=CC=C(C=C5)Cl,PHASE2,digestive_system_disease
577,Esophageal Cancer,Armodafinil,C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N,PHASE2,digestive_system_disease
578,Advanced Hepatocellular Carcinoma,Mitoxantrone,C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO,PHASE1,digestive_system_disease
579,Stem Cell Transplantation|Graft vs Host Disease,Voriconazole,CC(C1=NC=NC=C1F)C(CN2C=NC=N2)(C3=C(C=C(C=C3)F)F)O,PHASE1,digestive_system_disease
580,Stem Cell Transplantation|Graft vs Host Disease,Micafungin,CCCCCOC1=CC=C(C=C1)C2=CC(=NO2)C3=CC=C(C=C3)C(=O)NC4CC(C(NC(=O)C5C(C(CN5C(=O)C(NC(=O)C(NC(=O)C6CC(CN6C(=O)C(NC4=O)C(C)O)O)C(C(C7=CC(=C(C=C7)O)OS(=O)(=O)O)O)O)C(CC(=O)N)O)C)O)O)O,PHASE1,digestive_system_disease
581,Gastroesophageal Reflux|Respiratory Aspiration|Idiopathic Pulmonary Fibrosis|Lung Transplantation,Cromolyn,C1=CC2=C(C(=C1)OCC(COC3=CC=CC4=C3C(=O)C=C(O4)C(=O)O)O)C(=O)C=C(O2)C(=O)O,PHASE1,digestive_system_disease
582,Colon Adenocarcinoma|Rectal Adenocarcinoma|Stage III Colorectal Cancer AJCC v7|Stage IIIA Colorectal Cancer AJCC v7|Stage IIIB Colorectal Cancer AJCC v7|Stage IIIC Colorectal Cancer AJCC v7|Stage IV Colorectal Cancer AJCC v7|Stage IVA Colorectal Cancer AJCC v7|Stage IVB Colorectal Cancer AJCC v7,Clobetasol,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CCl)O)C)O)F)C,PHASE2,digestive_system_disease
583,Hepatic Impairment,Imeglimin,CC1N=C(NC(=N1)N(C)C)N,PHASE1,digestive_system_disease
584,Metastatic Pancreatic Cancer,Azeliragon,CCCCC1=NC(=CN1C2=CC=C(C=C2)OC3=CC=C(C=C3)Cl)C4=CC=C(C=C4)OCCCN(CC)CC,PHASE1|PHASE2,digestive_system_disease
585,Gastric Cancer|Chemotherapy Effect|Surgery|Metastasis|Survival,Lobaplatin,CC(C(=O)[O-])[O-].C1CC(C1CN)CN.[Pt+4],PHASE2,digestive_system_disease
586,Drug-Induced Liver Injury,Tiopronin,CC(C(=O)NCC(=O)O)S,PHASE2,digestive_system_disease
587,Hepatocellular Carcinoma,Sitravatinib,COCCNCC1=CN=C(C=C1)C2=CC3=NC=CC(=C3S2)OC4=C(C=C(C=C4)NC(=O)C5(CC5)C(=O)NC6=CC=C(C=C6)F)F,PHASE2,digestive_system_disease
588,Liver Dysfunction,Evogliptin,CC(C)(C)OCC1C(=O)NCCN1C(=O)CC(CC2=CC(=C(C=C2F)F)F)N,PHASE1,digestive_system_disease
589,Hepatic Impairment,Vadadustat,C1=CC(=CC(=C1)Cl)C2=CC(=C(N=C2)C(=O)NCC(=O)O)O,PHASE1,digestive_system_disease
590,Colorectal Cancer|Liver Metastasis|Colorectal Adenocarcinoma,Sulindac,CC1=C(C2=C(C1=CC3=CC=C(C=C3)S(=O)C)C=CC(=C2)F)CC(=O)O,PHASE2,digestive_system_disease
591,Hepatic Impairment,Gemigliptin,C1CC(CN(C1=O)CC(CC(=O)N2CCC3=C(C2)N=C(N=C3C(F)(F)F)C(F)(F)F)N)(F)F,PHASE1,digestive_system_disease
592,"Gastroesophageal Reflux Disease|Reflux, Gastroesophageal",Ranitidine,CNC(=C[N+](=O)[O-])NCCSCC1=CC=C(O1)CN(C)C,PHASE2,digestive_system_disease
593,Primary Biliary Cirrhosis (PBC),Seladelpar,CCOC(COC1=CC=C(C=C1)C(F)(F)F)CSC2=CC(=C(C=C2)OCC(=O)O)C,PHASE2,digestive_system_disease
594,Gastroesophageal Junction Adenocarcinoma|Malignant Neoplasm of the Cervical Esophagus|Malignant Neoplasm of the Thoracic Esophagus|Stage IIA Esophageal Cancer AJCC v7|Stage IIB Esophageal Cancer AJCC v7|Stage IIIA Esophageal Cancer AJCC v7|Stage IIIB Esophageal Cancer AJCC v7|Stage IIIC Esophageal Cancer AJCC v7,Ganetespib,CC(C)C1=C(C=C(C(=C1)C2=NNC(=O)N2C3=CC4=C(C=C3)N(C=C4)C)O)O,PHASE1,digestive_system_disease
595,Metastatic Pancreatic Cancer,Proglumide,CCCN(CCC)C(=O)C(CCC(=O)O)NC(=O)C1=CC=CC=C1,PHASE1,digestive_system_disease
596,Cystic Fibrosis,Riociguat,CN(C1=C(N=C(N=C1N)C2=NN(C3=C2C=CC=N3)CC4=CC=CC=C4F)N)C(=O)OC,PHASE2,digestive_system_disease
597,"Carcinoma, Hepatocellular",Foretinib,COC1=CC2=C(C=CN=C2C=C1OCCCN3CCOCC3)OC4=C(C=C(C=C4)NC(=O)C5(CC5)C(=O)NC6=CC=C(C=C6)F)F,PHASE1,digestive_system_disease
598,Fatty Liver Disease|Fatty Liver,Itopride,CN(C)CCOC1=CC=C(C=C1)CNC(=O)C2=CC(=C(C=C2)OC)OC,PHASE2,digestive_system_disease
599,Hepatic Impairment,Remibrutinib,CC1=C(C=C(C=C1NC(=O)C2=C(C=C(C=C2)C3CC3)F)F)C4=C(C(=NC=N4)N)OCCN(C)C(=O)C=C,PHASE1,digestive_system_disease
600,Diabetes Mellitus Type 2|Non Alcoholic Fatty Liver Disease|Obesity,Amlexanox,CC(C)C1=CC2=C(C=C1)OC3=NC(=C(C=C3C2=O)C(=O)O)N,PHASE2,digestive_system_disease
601,Postoperative Nausea and Vomiting|Post Operative Pain|Emergence Delirium,Ondansetron,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C,PHASE1,digestive_system_disease
602,Postoperative Nausea and Vomiting|Post Operative Pain|Emergence Delirium,Dexmedetomidine,CC1=C(C(=CC=C1)C(C)C2=CN=CN2)C,PHASE1,digestive_system_disease
603,Hepatic Impairment,Delafloxacin,C1C(CN1C2=C(C=C3C(=C2Cl)N(C=C(C3=O)C(=O)O)C4=C(C=C(C(=N4)N)F)F)F)O,PHASE1,digestive_system_disease
604,Stage II Colorectal Cancer AJCC v8|Stage III Colorectal Cancer AJCC v8,Duloxetine,CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32,PHASE2|PHASE3,digestive_system_disease
605,Kidney Transplant|Hepatitis C|HCV,Glecaprevir,CC1(CC1)S(=O)(=O)NC(=O)C2(CC2C(F)F)NC(=O)C3CC4CN3C(=O)C(NC(=O)OC5CCCC5OCC=CC(C6=NC7=CC=CC=C7N=C6O4)(F)F)C(C)(C)C,PHASE2|PHASE3,digestive_system_disease
606,Oral Mucositis Due to Chemotherapy,Miconazole,C1=CC(=C(C=C1Cl)Cl)COC(CN2C=CN=C2)C3=C(C=C(C=C3)Cl)Cl,PHASE2,digestive_system_disease
607,Infantile Colic|Infantile Functional Gastrointestinal Disorders,Nepadutant,CC(C)CC1C(=O)NC(C(=O)NC2CC(=O)NCC(C(=O)N1)NC(=O)C(NC(=O)C(NC2=O)CC3=CNC4=CC=CC=C43)CC5=CC=CC=C5)CC(=O)NC6C(C(C(C(O6)CO)O)O)NC(=O)C,PHASE1,digestive_system_disease
608,Irritable Bowel Syndrome,Ibodutant,CC1=CC2=C(C=C1)C=C(S2)C(=O)NC3(CCCC3)C(=O)NC(CC4=CC=CC=C4)C(=O)NCC5CCN(CC5)CC6CCOCC6,PHASE2,digestive_system_disease
609,Ileus,Alvimopan,CC1CN(CCC1(C)C2=CC(=CC=C2)O)CC(CC3=CC=CC=C3)C(=O)NCC(=O)O,PHASE2,digestive_system_disease
610,Non-erosive Reflux Disease,Revaprazan,CC1C2=CC=CC=C2CCN1C3=NC(=NC(=C3C)C)NC4=CC=C(C=C4)F,PHASE2,digestive_system_disease
611,Celiac Disease,Teriflunomide,CC(=C(C#N)C(=O)NC1=CC=C(C=C1)C(F)(F)F)O,PHASE1|PHASE2,digestive_system_disease
612,Colonic Neoplasms,Enzastaurin,CN1C=C(C2=CC=CC=C21)C3=C(C(=O)NC3=O)C4=CN(C5=CC=CC=C54)C6CCN(CC6)CC7=CC=CC=N7,PHASE2,digestive_system_disease
613,Anaemia,Daprodustat,C1CCC(CC1)N2C(=O)C(C(=O)N(C2=O)C3CCCCC3)C(=O)NCC(=O)O,PHASE1,digestive_system_disease
614,Colorectal Cancer,Oxycodone,CN1CCC23C4C(=O)CCC2(C1CC5=C3C(=C(C=C5)OC)O4)O,PHASE1,digestive_system_disease
615,Crohn's Disease,Dehydroepiandrosterone,CC12CCC3C(C1CCC2=O)CC=C4C3(CCC(C4)O)C,PHASE2,digestive_system_disease
616,Crohn's Disease,Prasterone,CC12CCC3C(C1CCC2=O)CC=C4C3(CCC(C4)O)C,PHASE2,digestive_system_disease
617,Chronic Hepatitis B,Selgantolimod,CCCCC(C)(CO)NC1=NC(=NC2=C1N=CC(=C2)F)N,PHASE2,digestive_system_disease
618,Hepatic Impairment|Healthy Volunteers|Pharmacokinetics|Amount of R406 in Blood,Fostamatinib,CC1(C(=O)N(C2=C(O1)C=CC(=N2)NC3=NC(=NC=C3F)NC4=CC(=C(C(=C4)OC)OC)OC)COP(=O)(O)O)C,PHASE1,digestive_system_disease
619,Chronic Hepatitis C,Chlorcyclizine,CN1CCN(CC1)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,PHASE1|PHASE2,digestive_system_disease
620,Hepatitis C|Telaprevir|HIV,Fosamprenavir,CC(C)CN(CC(C(CC1=CC=CC=C1)NC(=O)OC2CCOC2)OP(=O)(O)O)S(=O)(=O)C3=CC=C(C=C3)N,PHASE1,digestive_system_disease
621,Thrombocytopenia|Hepatitis C,Eltrombopag,CC1=C(C=C(C=C1)N2C(=O)C(=C(N2)C)N=NC3=CC=CC(=C3O)C4=CC(=CC=C4)C(=O)O)C,PHASE2|PHASE3,digestive_system_disease
622,Eosinophilic Esophagitis,Loratadine,CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1,PHASE2,digestive_system_disease
623,"Neuroectodermal Tumors, Primitive|Liver Neoplasms|Osteosarcoma|Other Childhood Cancers Using Cisplatin-based Regimens",Acetylcysteine,CC(=O)NC(CS)C(=O)O,PHASE1,digestive_system_disease
624,Esophageal Squamous Cell Carcinoma,Icotinib,C#CC1=CC(=CC=C1)NC2=NC=NC3=CC4=C(C=C32)OCCOCCOCCO4,PHASE2,digestive_system_disease
625,Gastroparesis,Velusetrag,CC(C)N1C2=CC=CC=C2C=C(C1=O)C(=O)NC3CC4CCC(C3)N4CC(CN(C)S(=O)(=O)C)O,PHASE2,digestive_system_disease
626,Cancer,Afuresertib,CN1C(=C(C=N1)Cl)C2=C(SC(=C2)C(=O)NC(CC3=CC(=CC=C3)F)CN)Cl,PHASE1,digestive_system_disease
627,Acute-On-Chronic Liver Failure,Trimetazidine,COC1=C(C(=C(C=C1)CN2CCNCC2)OC)OC,PHASE1,digestive_system_disease
628,NASH - Nonalcoholic Steatohepatitis,Spironolactone,CC(=O)SC1CC2=CC(=O)CCC2(C3C1C4CCC5(C4(CC3)C)CCC(=O)O5)C,PHASE1|PHASE2,digestive_system_disease
629,Hepatocellular Carcinoma,Patupilone,CC1CCCC2(C(O2)CC(OC(=O)CC(C(C(=O)C(C1O)C)(C)C)O)C(=CC3=CSC(=N3)C)C)C,PHASE2,digestive_system_disease
630,Solid Tumors|Non-small Cell Lung Cancer|Castration Resistant Prostate Cancer|Microsatellite Stable Colorectal Cancer,Navarixin,CCC(C1=CC=C(O1)C)NC2=C(C(=O)C2=O)NC3=CC=CC(=C3O)C(=O)N(C)C,PHASE2,digestive_system_disease
631,Chronic Hepatic Impairment,Preladenant,COCCOC1=CC=C(C=C1)N2CCN(CC2)CCN3C4=C(C=N3)C5=NC(=NN5C(=N4)N)C6=CC=CO6,PHASE1,digestive_system_disease
632,Digestive System Disorders,Ulimorelin,CC1CNC(C(=O)N(C(C(=O)NC(C(=O)NCCCC2=CC=CC=C2O1)CC3=CC=C(C=C3)F)C)C)C4CC4,PHASE1,digestive_system_disease
633,Chronic Hepatitis B,Antroquinonol,CC1C(C(C(=C(C1=O)OC)OC)O)CC=C(C)CCC=C(C)CCC=C(C)C,PHASE2,digestive_system_disease
634,Inflammatory Bowel Diseases|Clostridioides Difficile Infection,Sucralose,C(C1C(C(C(C(O1)OC2(C(C(C(O2)CCl)O)O)CCl)O)O)Cl)O,PHASE1,digestive_system_disease
635,Radiation Enteritis,Sapropterin,CC(C(C1CNC2=C(N1)C(=O)NC(=N2)N)O)O,PHASE2,digestive_system_disease
636,Radiation Enteritis,Tetrahydrobiopterin,CC(C(C1CNC2=C(N1)C(=O)NC(=N2)N)O)O,PHASE2,digestive_system_disease
637,Gastroesophageal Junction Adenocarcinoma|Stage IB Esophageal Adenocarcinoma AJCC v7|Stage II Esophageal Adenocarcinoma AJCC v7|Stage IIA Esophageal Adenocarcinoma AJCC v7|Stage IIB Esophageal Adenocarcinoma AJCC v7|Stage IIIA Esophageal Adenocarcinoma AJCC v7|Stage IIIB Esophageal Adenocarcinoma AJCC v7,Taladegib,CN1C(=CC=N1)C2=NN=C(C3=CC=CC=C32)N4CCC(CC4)N(C)C(=O)C5=C(C=C(C=C5)F)C(F)(F)F,PHASE1|PHASE2,digestive_system_disease
638,Chronic Hepatitis C|Chronic Hepatitis B,Hymecromone,CC1=CC(=O)OC2=C1C=CC(=C2)O,PHASE2,digestive_system_disease
639,Advanced Biliary Tract Carcinoma|Advanced Colorectal Carcinoma|Advanced Gastroesophageal Junction Adenocarcinoma|Advanced Lung Adenocarcinoma|Advanced Malignant Solid Neoplasm|Advanced Ovarian Carcinoma|Advanced Pancreatic Carcinoma|Advanced Urothelial Carcinoma|Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8|Clinical Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8|Metastatic Biliary Tract Carcinoma|Metastatic Colorectal Carcinoma|Metastatic Gastroesophageal Junction Adenocarcinoma|Metastatic Lung Adenocarcinoma|Metastatic Ovarian Carcinoma|Metastatic Pancreatic Carcinoma|Metastatic Urothelial Carcinoma|Refractory Biliary Tract Carcinoma|Refractory Colorectal Carcinoma|Refractory Gastroesophageal Junction Adenocarcinoma|Refractory Lung Adenocarcinoma|Refractory Ovarian Carcinoma|Refractory Pancreatic Carcinoma|Refractory Urothelial Carcinoma|Stage II Pancreatic Cancer AJCC v8|Stage III Colorectal Cancer AJCC v8|Stage III Lung Cancer AJCC v8|Stage III Ovarian Cancer AJCC v8|Stage III Pancreatic Cancer AJCC v8|Stage IV Colorectal Cancer AJCC v8|Stage IV Lung Cancer AJCC v8|Stage IV Ovarian Cancer AJCC v8|Stage IV Pancreatic Cancer AJCC v8,Devimistat,C1=CC=C(C=C1)CSCCC(CCCCC(=O)O)SCC2=CC=CC=C2,PHASE2,digestive_system_disease
640,Gastric Cancer,Olanzapine,CC1=CC2=C(S1)NC3=CC=CC=C3N=C2N4CCN(CC4)C,PHASE2,digestive_system_disease
641,Cirrhosis|Portal Hypertension|Ascites,Ambrisentan,CC1=CC(=NC(=N1)OC(C(=O)O)C(C2=CC=CC=C2)(C3=CC=CC=C3)OC)C,PHASE2,digestive_system_disease
642,Self Efficacy,Ginsenosides,CC(=CCCC(C)(C1CCC2(C1CCC3C2(CCC4C3(CCC(C4(C)C)O)C)C)C)O)C,PHASE2,digestive_system_disease
643,Gastrointestinal Diseases,Paracetamol,CC(=O)NC1=CC=C(C=C1)O,PHASE2,digestive_system_disease
644,Crohn's Disease,Semapimod,CC(=NN=C(N)N)C1=CC(=CC(=C1)NC(=O)CCCCCCCCC(=O)NC2=CC(=CC(=C2)C(=NN=C(N)N)C)C(=NN=C(N)N)C)C(=NN=C(N)N)C,PHASE2,digestive_system_disease
645,Alpha 1-Antitrypsin Deficiency|Emphysema|COPD,Alvelestat,CC1=C(C=C(C(=O)N1C2=CC=CC(=C2)C(F)(F)F)C(=O)NCC3=NC=C(C=C3)S(=O)(=O)C)C4=CC=NN4C,PHASE2,digestive_system_disease
646,"Carcinoma, Non-small-cell Lung|Mesothelioma|Pancreatic Neoplasms",Defactinib,CNC(=O)C1=CC=C(C=C1)NC2=NC=C(C(=N2)NCC3=NC=CN=C3N(C)S(=O)(=O)C)C(F)(F)F,PHASE1|PHASE2,digestive_system_disease
647,Metastatic Biliary Tract Carcinoma|Metastatic Colorectal Carcinoma|Metastatic Gastroesophageal Junction Adenocarcinoma|Metastatic Malignant Digestive System Neoplasm|Metastatic Pancreatic Adenocarcinoma|Stage IV Colorectal Cancer AJCC v7|Stage IV Pancreatic Cancer AJCC v6 and v7|Stage IVA Colorectal Cancer AJCC v7|Stage IVB Colorectal Cancer AJCC v7,Sucrosofate,C(C1C(C(C(C(O1)OC2(C(C(C(O2)COS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)COS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O,PHASE1|PHASE2,digestive_system_disease
648,Hepatic Impairment,Fosmanogepix,C1=CC=NC(=C1)OCC2=CC=C(C=C2)CC3=NOC(=C3)C4=C([N+](=CC=C4)COP(=O)(O)[O-])N,PHASE1,digestive_system_disease
649,Hepatic Failure,Icenticaftor,CC(CNC(=O)C1=C(C=C(C(=N1)OC)C(F)(F)F)N)(C(F)(F)F)O,PHASE1,digestive_system_disease
650,Solid Tumor|Hepatocellular Carcinoma|Gastric Cancer|Gastroesophageal Junction Adenocarcinoma,Vorolanib,CC1=C(NC(=C1C(=O)NC2CCN(C2)C(=O)N(C)C)C)C=C3C4=C(C=CC(=C4)F)NC3=O,PHASE1,digestive_system_disease
651,Gastroparesis,Camicinal,CC1CN(CCN1)CC2=CC=C(C=C2)CC(=O)N3CCC(CC3)NC4=CC(=CC=C4)F,PHASE2,digestive_system_disease
652,Hepatitis|Hepatitis C,Filibuvir,CCC1=CC(=CC(=N1)CC)CCC2(CC(=C(C(=O)O2)CC3=NN4C(=CC(=NC4=N3)C)C)O)C5CCCC5,PHASE2,digestive_system_disease
653,Metastatic Colorectal Cancer,Idelalisib,CCC(C1=NC2=C(C(=CC=C2)F)C(=O)N1C3=CC=CC=C3)NC4=NC=NC5=C4NC=N5,PHASE2,digestive_system_disease
654,Metastatic Colorectal Cancer,Larotrectinib,C1CC(N(C1)C2=NC3=C(C=NN3C=C2)NC(=O)N4CCC(C4)O)C5=C(C=CC(=C5)F)F,PHASE2,digestive_system_disease
655,Metastatic Colorectal Cancer,Panobinostat,CC1=C(C2=CC=CC=C2N1)CCNCC3=CC=C(C=C3)C=CC(=O)NO,PHASE2,digestive_system_disease
656,Metastatic Colorectal Cancer,Venetoclax,CC1(CCC(=C(C1)C2=CC=C(C=C2)Cl)CN3CCN(CC3)C4=CC(=C(C=C4)C(=O)NS(=O)(=O)C5=CC(=C(C=C5)NCC6CCOCC6)[N+](=O)[O-])OC7=CN=C8C(=C7)C=CN8)C,PHASE2,digestive_system_disease
657,Advanced Hepatocellular Carcinoma,Oprozomib,CC1=NC=C(S1)C(=O)NC(COC)C(=O)NC(COC)C(=O)NC(CC2=CC=CC=C2)C(=O)C3(CO3)C,PHASE1|PHASE2,digestive_system_disease
658,"Hepatitis C, Chronic|Fibrosis",Prazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4=CC=CO4)N)OC,PHASE2,digestive_system_disease
659,Liver Cancer|Metastatic Cancer,Pyrazoloacridine,CN(C)CCCN1C2=C3C(=C(C=C2)[N+](=O)[O-])NC4=C(C3=N1)C=C(C=C4)OC,PHASE2,digestive_system_disease
660,Lung Cancer|Gastro-intestinal Cancer,Adagrasib,CN1CCCC1COC2=NC3=C(CCN(C3)C4=CC=CC5=C4C(=CC=C5)Cl)C(=N2)N6CCN(C(C6)CC#N)C(=O)C(=C)F,PHASE1,digestive_system_disease
661,Solid Tumor|Non-Small Cell Lung Cancer Recurrent|Hepatocellular Carcinoma Recurrent,Galunisertib,CC1=NC(=CC=C1)C2=NN3CCCC3=C2C4=C5C=C(C=CC5=NC=C4)C(=O)N,PHASE1|PHASE2,digestive_system_disease
662,Hepatocellular Carcinoma Non-resectable,Deferoxamine,CC(=O)N(CCCCCNC(=O)CCC(=O)N(CCCCCNC(=O)CCC(=O)N(CCCCCN)O)O)O,PHASE1,digestive_system_disease
663,"Fatty Liver, Nonalcoholic",Cilostazol,C1CCC(CC1)N2C(=NN=N2)CCCCOC3=CC4=C(C=C3)NC(=O)CC4,PHASE1|PHASE2,digestive_system_disease
664,Hepatic Veno-Occlusive Disease,Defibrotide,CC(C)C1=C(C=C(C(=C1)C2=NNC(=O)N2C3=CC4=C(C=C3)N(C=C4)C)O)OP(=O)(O)O,PHASE2|PHASE3,digestive_system_disease
665,Symptomatic Gastroespohageal Reflux Disease,Tegaserod,CCCCCN=C(N)NN=CC1=CNC2=C1C=C(C=C2)OC,PHASE2,digestive_system_disease
666,Diabetic Gastroparesis,Promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C,PHASE2,digestive_system_disease
667,Type 2 Diabetes Mellitus|Hepatic Impairment,Ertugliflozin,CCOC1=CC=C(C=C1)CC2=C(C=CC(=C2)C34C(C(C(C(O3)(CO4)CO)O)O)O)Cl,PHASE1,digestive_system_disease
668,"Cancer-associated Thrombosis|Esophageal Cancer|Stomach Cancer|Hepatocellular Carcinoma|Pancreatic Cancer|Duodenal Cancer|Esophagogastric Junction Cancer|Malignant Gastrointestinal Stromal Tumor|Ampulla of Vater Cancer|Biliary Cancer (Cholangiocarcinoma, Gall Bladder Cancer)",Dalteparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,PHASE2,digestive_system_disease
669,"Locally Advanced Gastrointestinal Stromal Tumor|Locally Advanced Sarcoma|Metastatic Gastrointestinal Stromal Tumor|Metastatic Sarcoma|Stage III Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8|Stage III Small Intestinal, Esophageal, Colorectal, Mesenteric, and Peritoneal Gastrointestinal Stromal Tumor AJCC v8|Stage IV Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8|Stage IV Small Intestinal, Esophageal, Colorectal, Mesenteric, and Peritoneal Gastrointestinal Stromal Tumor AJCC v8",Rogaratinib,CC1=CC2=C(C(=C1)OC)SC(=C2)C3=C4C(=NC=NN4C(=C3COC)CN5CCNC(=O)C5)N,PHASE2,digestive_system_disease
670,Advanced Hepatocellular Carcinoma|BCLC Stage A Hepatocellular Carcinoma|BCLC Stage B Hepatocellular Carcinoma|BCLC Stage C Hepatocellular Carcinoma|Metastatic Hepatocellular Carcinoma,Futibatinib,COC1=CC(=CC(=C1)C#CC2=NN(C3=NC=NC(=C23)N)C4CCN(C4)C(=O)C=C)OC,PHASE2,digestive_system_disease
671,Gastric or Duodenal Ulcers Caused by Low-dose Aspirin,Teprenone,CC(=CCCC(=CCCC(=CCCC(=CCCC(=O)C)C)C)C)C,PHASE2|PHASE3,digestive_system_disease
672,Neoplasm Metastasis|Colorectal Neoplasms|Breast Cancer,Prexasertib,COC1=C(C(=CC=C1)OCCCN)C2=CC(=NN2)NC3=NC=C(N=C3)C#N,PHASE1,digestive_system_disease
673,Hepatic Impairment,Fevipiprant,CC1=C(C2=C(N1CC3=C(C=C(C=C3)S(=O)(=O)C)C(F)(F)F)N=CC=C2)CC(=O)O,PHASE1,digestive_system_disease
674,"Hepatitis C, Chronic",Tegobuvir,C1=CC=C(C(=C1)C2=NC3=CN(C=CC3=N2)CC4=NN=C(C=C4)C5=C(C=C(C=C5)C(F)(F)F)C(F)(F)F)F,PHASE2,digestive_system_disease
675,"Non-Alcoholic Fatty Liver Disease|Diabetes Mellitus, Type 2",Levothyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,PHASE2,digestive_system_disease
676,Constipation|Fecal Incontinence|Multiple Sclerosis,Bisacodyl,CC(=O)OC1=CC=C(C=C1)C(C2=CC=C(C=C2)OC(=O)C)C3=CC=CC=N3,PHASE2,digestive_system_disease
677,Colorectal Neoplasms,Vicriviroc,CC1CN(CCN1C(COC)C2=CC=C(C=C2)C(F)(F)F)C3(CCN(CC3)C(=O)C4=C(N=CN=C4C)C)C,PHASE2,digestive_system_disease
678,Carcinoid Syndrome|Carcinoid|Carcinoid Tumor|Carcinoid Tumor of Ileum|Carcinoid Tumor of Cecum|Carcinoid Syndrome Diarrhea|Carcinoid Intestine Tumor|Carcinoid Tumor of Liver|Carcinoid Tumor of Pancreas,Paltusotine,C1CN(CCC1N)C2=C3C=C(C=CC3=NC=C2C4=CC(=CC(=C4)F)F)C5=CC=CC(=C5O)C#N,PHASE2,digestive_system_disease
679,Metastatic Colon Adenocarcinoma|Metastatic Colorectal Adenocarcinoma|Metastatic Rectal Adenocarcinoma|Stage IV Colon Cancer AJCC v8|Stage IV Colorectal Cancer AJCC v8|Stage IV Rectal Cancer AJCC v8,Tucatinib,CC1=C(C=CC(=C1)NC2=NC=NC3=C2C=C(C=C3)NC4=NC(CO4)(C)C)OC5=CC6=NC=NN6C=C5,PHASE2,digestive_system_disease
680,Hepatitis C,Mericitabine,CC(C)C(=O)OCC1C(C(C(O1)N2C=CC(=NC2=O)N)(C)F)OC(=O)C(C)C,PHASE2,digestive_system_disease
681,Irritable Bowel Syndrome,Pregabalin,CC(C)CC(CC(=O)O)CN,PHASE2,digestive_system_disease
682,Hepatocellular Carcinoma,Perflutren,C(C(F)(F)F)(C(F)(F)F)(F)F,PHASE1,digestive_system_disease
683,Hepatocellular Carcinoma,Orantinib,CC1=C(NC(=C1CCC(=O)O)C)C=C2C3=CC=CC=C3NC2=O,PHASE1|PHASE2,digestive_system_disease
684,"Hypertension, Portal",Perflubutane,C(C(C(F)(F)F)(F)F)(C(F)(F)F)(F)F,PHASE2,digestive_system_disease
685,"Renal Insufficiency, Chronic|Hepatic Insufficiency|Healthy",Diclofenac,C1=CC=C(C(=C1)CC(=O)O)NC2=C(C=CC=C2Cl)Cl,PHASE1,digestive_system_disease
686,Gastric Cancer,Varlitinib,CC1COC(=N1)NC2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=NC=CS5)Cl,PHASE2|PHASE3,digestive_system_disease
687,Bone Marrow Failure Syndrome|Congenital Amegakaryocytic Thrombocytopenia|Congenital Pure Red Cell Aplasia|Hereditary Sideroblastic Anemia|Myeloid Neoplasms With Germline GATA2 Mutation|Paroxysmal Nocturnal Hemoglobinuria|Shwachman-Diamond Syndrome,Treosulfan,CS(=O)(=O)OCC(C(COS(=O)(=O)C)O)O,PHASE2,digestive_system_disease
688,Biliary Carcinoma|Gall Bladder Carcinoma|Cholangiocarcinoma|Gastrointestinal Tumor,Copanlisib,COC1=C(C=CC2=C3NCCN3C(=NC(=O)C4=CN=C(N=C4)N)N=C21)OCCCN5CCOCC5,PHASE2,digestive_system_disease
689,Non-alcoholic Fatty Liver Disease,Oltipraz,CC1=C(SSC1=S)C2=NC=CN=C2,PHASE2,digestive_system_disease
690,Platinum-Sensitive Biliary Tract Cancer,Pamiparib,CC12CCCN1CC3=NNC(=O)C4=C5C3=C2NC5=CC(=C4)F,PHASE2,digestive_system_disease
691,Herpes Simplex|HIV Infections|Hepatitis B,Fialuridine,C1=C(C(=O)NC(=O)N1C2C(C(C(O2)CO)O)F)I,PHASE2,digestive_system_disease
692,Hepatic Impairment,Glasdegib,CN1CCC(CC1C2=NC3=CC=CC=C3N2)NC(=O)NC4=CC=C(C=C4)C#N,PHASE1,digestive_system_disease
693,Ulcerative Colitis,Rivenprost,COCC1=CC=CC(=C1)CC(C=CC2C(CC(=O)C2CCSCCCC(=O)OC)O)O,PHASE2,digestive_system_disease
694,Pediatric Ulcerative Colitis,Vamorolone,CC1CC2C3CCC4=CC(=O)C=CC4(C3=CCC2(C1(C(=O)CO)O)C)C,PHASE1|PHASE2,digestive_system_disease
695,Gastrointestinal Stromal Tumors,Perifosine,CCCCCCCCCCCCCCCCCCOP(=O)([O-])OC1CC[N+](CC1)(C)C,PHASE2,digestive_system_disease
696,HIV-1 Infection,Doravirine,CN1C(=NNC1=O)CN2C=CC(=C(C2=O)OC3=CC(=CC(=C3)C#N)Cl)C(F)(F)F,PHASE1,digestive_system_disease
697,Hepatic Insufficiency & Healthy Subjects,Zanubrutinib,C=CC(=O)N1CCC(CC1)C2CCNC3=C(C(=NN23)C4=CC=C(C=C4)OC5=CC=CC=C5)C(=O)N,PHASE1,digestive_system_disease
698,Advanced or Metastatic Gastric Cancer|Advanced or Metastatic Liver Cancer|Advanced or Metastatic CRC|Advanced or Metastatic Non Squamous NSCLC,Tromethamine,C(C(CO)(CO)N)O,PHASE1,digestive_system_disease
699,Gastroesophageal Reflux,Fexofenadine,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,PHASE2,digestive_system_disease
700,Crohn Disease|Ulcerative Colitis,Deucravacitinib,CNC(=O)C1=NN=C(C=C1NC2=CC=CC(=C2OC)C3=NN(C=N3)C)NC(=O)C4CC4,PHASE2,digestive_system_disease
701,Common Cold,Phenylephrine,CNCC(C1=CC(=CC=C1)O)O,PHASE1,digestive_system_disease
702,Hepatocellular Carcinoma (HCC),Fisogatinib,COC1=CC(=C(C(=C1Cl)C2=CC3=CN=C(N=C3C=C2)NC4COCCC4NC(=O)C=C)Cl)OC,PHASE1,digestive_system_disease
703,Cirrhosis|Portal Hypertension|Variceal Hemorrhage,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,PHASE2|PHASE3,digestive_system_disease
704,Eosinophilic Esophagitis,Mometasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CCl)O)C)O)Cl)C,PHASE2,digestive_system_disease
705,Hepatic Impairment|Healthy Volunteers,Soticlestat,C1CN(CCC1(CC2=CC=CC=C2)O)C(=O)C3=C(N=CC=C3)C4=CC=NC=C4,PHASE1,digestive_system_disease
706,Pheochromocytoma/Paraganglioma|Pancreatic Neuroendocrine Tumor|Von Hippel-Lindau Disease|Advanced Gastrointestinal Stromal Tumor|HIF-2 Mutated Cancers,Belzutifan,CS(=O)(=O)C1=C2C(C(C(C2=C(C=C1)OC3=CC(=CC(=C3)C#N)F)F)F)O,PHASE2,digestive_system_disease
707,Colorectal Cancer Metastatic,Masitinib,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC(=CS4)C5=CN=CC=C5,PHASE2|PHASE3,digestive_system_disease
708,Mesothelioma|Adenocarcinoma of Lung|Pancreatic Neoplasms,Pentostatin,C1C(C(OC1N2C=NC3=C2NC=NCC3O)CO)O,PHASE1|PHASE2,digestive_system_disease
709,"Colitis, Ulcerative",Tetomilast,CCOC1=C(C=C(C=C1)C2=NC(=CS2)C3=NC(=CC=C3)C(=O)O)OCC,PHASE2,digestive_system_disease
710,Pancreatic Cancer,Rubitecan,CCC1(C2=C(COC1=O)C(=O)N3CC4=CC5=C(C=CC=C5[N+](=O)[O-])N=C4C3=C2)O,PHASE2|PHASE3,digestive_system_disease
711,Hyperinsulinemia|Insulin Resistance|Non-Alcoholic Fatty Liver Disease|Prediabetic State,Diazoxide,CC1=NS(=O)(=O)C2=C(N1)C=CC(=C2)Cl,PHASE1,digestive_system_disease
712,"Liver Cirrhosis|Hypertension, Portal",Serelaxin,CCC(C)C1C(=O)NC(CSSCC(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C2CSSCC(C(=O)NC(CSSCC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)C)C(C)CC)CCC(=O)N)C)CCCNC(=N)N)C(C)C)CC(C)C)CCC(=O)O)CCCNC(=N)N)NC(=O)C(CC(C)C)NC(=O)C(CCCCN)NC(=O)C(C(C)CC)NC(=O)C(C(C)C)NC(=O)C(CCC(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(CCSC)NC(=O)C(CC3=CNC4=CC=CC=C43)NC(=O)C(CO)NC(=O)C(CC(=O)O)N)C(=O)NC(C(=O)NC(C(=O)NCC(=O)N2)C(C)C)CC5=CN=CN5)NC(=O)C(CCCCN)NC(=O)C(CC(=O)N)NC(=O)C(C)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CO)NC(=O)C(CC6=CC=C(C=C6)O)NC(=O)C(CC(C)C)NC(=O)C7CCC(=O)N7)C(C)O)CCCCN)CCCNC(=N)N)CO)CC(C)C)C)CCCNC(=N)N)CC8=CC=CC=C8)C(=O)O)C(=O)NCC(=O)NC(CCSC)C(=O)NC(CO)C(=O)NC(C(C)O)C(=O)NC(CC9=CNC1=CC=CC=C19)C(=O)NC(CO)C(=O)O,PHASE2,digestive_system_disease
713,"Drug/Agent Toxicity by Tissue/Organ|Lymphoma|Neutropenia|Small Intestine Cancer|Unspecified Adult Solid Tumor, Protocol Specific",Phenobarbital,CCC1(C(=O)NC(=O)NC1=O)C2=CC=CC=C2,PHASE1,digestive_system_disease
714,Cystic Fibrosis,Linezolid,CC(=O)NCC1CN(C(=O)O1)C2=CC(=C(C=C2)N3CCOCC3)F,PHASE2,digestive_system_disease
715,Stomach Neoplasms,Edotecarin,C1=CC2=C(C=C1O)NC3=C4C(=C5C(=C23)C(=O)N(C5=O)NC(CO)CO)C6=C(N4C7C(C(C(C(O7)CO)O)O)O)C=C(C=C6)O,PHASE2,digestive_system_disease
716,"Cirrhosis, Liver|Cytopenia",Danazol,CC12CCC3C(C1CCC2(C#C)O)CCC4=CC5=C(CC34C)C=NO5,PHASE2,digestive_system_disease
717,Peptic Ulcer,Lafutidine,C1CCN(CC1)CC2=CC(=NC=C2)OCC=CCNC(=O)CS(=O)CC3=CC=CO3,PHASE1,digestive_system_disease
718,Hepatic Impairment|Healthy Subjects,Aprocitentan,C1=CC(=CC=C1C2=C(N=CN=C2OCCOC3=NC=C(C=N3)Br)NS(=O)(=O)N)Br,PHASE1,digestive_system_disease
719,Chemotherapy|Colon Cancer,Mangafodipir,[H+].[H+].[H+].[H+].CC1=NC=C(C(=C1O)CN(CCN(CC2=C(C(=NC=C2COP(=O)([O-])[O-])C)O)CC(=O)[O-])CC(=O)[O-])COP(=O)([O-])[O-].[Mn+2],PHASE2,digestive_system_disease
720,Hepatitis C|Hypertension,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,PHASE1,digestive_system_disease
721,Advanced Hepatocellular Carcinoma,Capmatinib,CNC(=O)C1=C(C=C(C=C1)C2=NN3C(=CN=C3N=C2)CC4=CC5=C(C=C4)N=CC=C5)F,PHASE1|PHASE2,digestive_system_disease
722,Nonalcoholic Steatohapatitis,Roflumilast,C1CC1COC2=C(C=CC(=C2)C(=O)NC3=C(C=NC=C3Cl)Cl)OC(F)F,PHASE2,digestive_system_disease
723,Colorectal Cancer,Endostatin,CN(CC(=O)C1=CC=CC=C1)N=O,PHASE2,digestive_system_disease
724,Healthy|Hepatic Impairment,Cenerimod,CCC1=C(C(=CC(=C1)C2=NOC(=N2)C3=CC(=NC(=C3)OC)C4CCCC4)C)OCC(CO)O,PHASE1,digestive_system_disease
725,Healthy Volunteers|Hepatic Impairment,Fedratinib,CC1=CN=C(N=C1NC2=CC(=CC=C2)S(=O)(=O)NC(C)(C)C)NC3=CC=C(C=C3)OCCN4CCCC4,PHASE1,digestive_system_disease
726,Gastroparesis,Domperidone,C1CN(CCC1N2C3=C(C=C(C=C3)Cl)NC2=O)CCCN4C5=CC=CC=C5NC4=O,PHASE2,digestive_system_disease
727,Biliary Tract Cancer|Metastatic Cancer|Advanced Cancer,Merestinib,CC1=CC=C(C(=O)N1C2=CC=C(C=C2)F)C(=O)NC3=CC(=C(C=C3)OC4=C(C=C5C(=C4)C=NN5C)C6=CNN=C6)F,PHASE2,digestive_system_disease
728,"Acute Intermittent Porphyria (AIP)|Acute Hepatic Porphyria (AHP)|Porphyria, Acute Intermittent|Acute Porphyria",Givosiran,CC1CC(CN1C(=O)CCCCCCCCCCC(=O)NC(COCCC(=O)NCCCNC(=O)CCCCOC2C(C(C(C(O2)CO)O)O)NC(=O)C)(COCCC(=O)NCCCNC(=O)CCCCOC3C(C(C(C(O3)CO)O)O)NC(=O)C)COCCC(=O)NCCCNC(=O)CCCCOC4C(C(C(C(O4)CO)O)O)NC(=O)C)O,PHASE1,digestive_system_disease
729,Cystic Fibrosis,Macrogol,C(CO)O,PHASE2,digestive_system_disease
730,Cardiac Steatosis|Hepatic Steatosis,Eplerenone,CC12CCC(=O)C=C1CC(C3C24C(O4)CC5(C3CCC56CCC(=O)O6)C)C(=O)OC,PHASE2,digestive_system_disease
731,Hepatic Impairment,Tavapadon,CC1=C(C=CC(=C1)OC2=C(C=CC=N2)C(F)(F)F)C3=C(C(=O)NC(=O)N3C)C,PHASE1,digestive_system_disease
732,Colorectal Adenomatous Polyp|Colorectal Carcinoma|Familial Adenomatous Polyposis|Multiple Adenomatous Polyps,Dordaviprone,CC1=CC=CC=C1CN2C(=O)C3=C(CCN(C3)CC4=CC=CC=C4)N5C2=NCC5,PHASE1,digestive_system_disease
733,"Urinary Incontinence,Stress|Fecal Incontinence",Tadalafil,CN1CC(=O)N2C(C1=O)CC3=C(C2C4=CC5=C(C=C4)OCO5)NC6=CC=CC=C36,PHASE1,digestive_system_disease
734,Diabetes Mellitus|Iron Metabolism Disorders|Gastroduodenal Ulcer|Optic Atrophy|Sensorineural Hearing Loss|Platelet Dysfunction,Deferiprone,CC1=C(C(=O)C=CN1C)O,PHASE2|PHASE3,digestive_system_disease
735,Nasopharyngeal Carcinoma|EBV-Related Gastric Carcinoma|EBV-Related Leiomyosarcoma|EBV Related Carcinoma|EBV-Related Sarcoma,Nanatinostat,C1C2C(C2NCC3=NC4=C(C=C3)C=C(C=C4)F)CN1C5=NC=C(C=N5)C(=O)NO,PHASE1|PHASE2,digestive_system_disease
736,Nasopharyngeal Carcinoma|EBV-Related Gastric Carcinoma|EBV-Related Leiomyosarcoma|EBV Related Carcinoma|EBV-Related Sarcoma,Valganciclovir,CC(C)C(C(=O)OCC(CO)OCN1C=NC2=C1N=C(NC2=O)N)N,PHASE1|PHASE2,digestive_system_disease
737,Cancer of Stomach|Gastroesophageal Cancer,Pegamotecan,CCC1(C2=C(COC1=O)C(=O)N3CC4=CC5=CC=CC=C5N=C4C3=C2)OC(=O)C(C)NC(=O)COCCOCC(=O)NC(C)C(=O)OC6(C7=C(COC6=O)C(=O)N8CC9=CC1=CC=CC=C1N=C9C8=C7)CC,PHASE2,digestive_system_disease
738,Hepatitis C Infection,Sertraline,CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl,PHASE1,digestive_system_disease
739,Cystic Fibrosis|Pneumonia,Amitriptyline,CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31,PHASE2,digestive_system_disease
740,Hyperinsulinemic Hypoglycemia|Postprandial Hypoglycemia,Dasiglucagon,CC(C)CC(C(=O)NC(CCC(=O)O)C(=O)NC(CO)C(=O)NC(C(C)O)C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)NC(=O)C(CCCCN)NC(=O)C(C(C)C)NC(=O)C(CC3=CC=CC=C3)NC(=O)C(CCC(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(C)NC(=O)C(CCCNC(=N)N)NC(=O)C(C)NC(=O)C(C)(C)NC(=O)C(CC(=O)O)NC(=O)C(CC(C)C)NC(=O)C(CC4=CC=C(C=C4)O)NC(=O)C(CCCCN)NC(=O)C(CO)NC(=O)C(CC5=CC=C(C=C5)O)NC(=O)C(CC(=O)O)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C(CC6=CC=CC=C6)NC(=O)C(C(C)O)NC(=O)CNC(=O)C(CCC(=O)N)NC(=O)C(CO)NC(=O)C(CC7=CNC=N7)N,PHASE2,digestive_system_disease
741,Celiac Disease,Larazotide,CC(C)CC(C(=O)NC(C(C)C)C(=O)NC(CCC(=O)N)C(=O)N1CCCC1C(=O)NCC(=O)O)NC(=O)C(C(C)C)NC(=O)CNC(=O)CN,PHASE2,digestive_system_disease
742,Crohn's Disease,Laquinimod,CCN(C1=CC=CC=C1)C(=O)C2=C(C3=C(C=CC=C3Cl)N(C2=O)C)O,PHASE2,digestive_system_disease
743,Gastric Cancer|Esophagogastric Junction Disorder,Savolitinib,CC(C1=CN2C=CN=C2C=C1)N3C4=NC(=CN=C4N=N3)C5=CN(N=C5)C,PHASE2,digestive_system_disease
744,Hepatic Failure,Latrepirdine,CC1=CC2=C(C=C1)N(C3=C2CN(CC3)C)CCC4=CN=C(C=C4)C,PHASE1,digestive_system_disease
745,Gastric Cancer|Gastroesophageal Junction Adenocarcinoma|Solid Tumor,Infigratinib,CCN1CCN(CC1)C2=CC=C(C=C2)NC3=CC(=NC=N3)N(C)C(=O)NC4=C(C(=CC(=C4Cl)OC)OC)Cl,PHASE2,digestive_system_disease
746,Cystic Fibrosis|Pseudomonas Aeruginosa,Colistin,CCC(C)CCCC(=O)NC(CCN)C(=O)NC(C(C)O)C(=O)NC(CCN)C(=O)NC1CCNC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC1=O)CCN)CC(C)C)CC(C)C)CCN)CCN)C(C)O,PHASE2,digestive_system_disease
747,Ann Arbor Stage III B-Cell Non-Hodgkin Lymphoma|Ann Arbor Stage IV B-Cell Non-Hodgkin Lymphoma|Metastatic Malignant Solid Neoplasm|Stage III Hepatocellular Carcinoma AJCC v7|Stage IIIA Hepatocellular Carcinoma AJCC v7|Stage IIIB Hepatocellular Carcinoma AJCC v7|Stage IIIC Hepatocellular Carcinoma AJCC v7|Stage IV Hepatocellular Carcinoma AJCC v7|Stage IVA Hepatocellular Carcinoma AJCC v7|Stage IVB Hepatocellular Carcinoma AJCC v7|Unresectable Solid Neoplasm,Tazemetostat,CCN(C1CCOCC1)C2=CC(=CC(=C2C)C(=O)NCC3=C(C=C(NC3=O)C)C)C4=CC=C(C=C4)CN5CCOCC5,PHASE1,digestive_system_disease
748,Advanced Malignant Solid Neoplasm|Bladder Carcinoma|Breast Carcinoma|Cervical Carcinoma|Colon Carcinoma|Colorectal Carcinoma|Endometrial Carcinoma|Esophageal Carcinoma|Gastric Carcinoma|Glioma|Head and Neck Carcinoma|Kidney Carcinoma|Liver and Intrahepatic Bile Duct Carcinoma|Lung Carcinoma|Lymphoma|Malignant Uterine Neoplasm|Melanoma|Multiple Myeloma|Ovarian Carcinoma|Pancreatic Carcinoma|Prostate Carcinoma|Rectal Carcinoma|Recurrent Bladder Carcinoma|Recurrent Breast Carcinoma|Recurrent Cervical Carcinoma|Recurrent Colon Carcinoma|Recurrent Colorectal Carcinoma|Recurrent Esophageal Carcinoma|Recurrent Gastric Carcinoma|Recurrent Glioma|Recurrent Head and Neck Carcinoma|Recurrent Liver Carcinoma|Recurrent Lung Carcinoma|Recurrent Lymphoma|Recurrent Malignant Solid Neoplasm|Recurrent Melanoma|Recurrent Multiple Myeloma|Recurrent Ovarian Carcinoma|Recurrent Pancreatic Carcinoma|Recurrent Prostate Carcinoma|Recurrent Rectal Carcinoma|Recurrent Skin Carcinoma|Recurrent Thyroid Gland Carcinoma|Recurrent Uterine Corpus Cancer|Refractory Lymphoma|Refractory Malignant Solid Neoplasm|Refractory Multiple Myeloma|Skin Carcinoma|Thyroid Gland Carcinoma|Uterine Corpus Cancer,Capivasertib,C1CN(CCC1(C(=O)NC(CCO)C2=CC=C(C=C2)Cl)N)C3=NC=NC4=C3C=CN4,PHASE2,digestive_system_disease
749,Advanced Malignant Solid Neoplasm|Bladder Carcinoma|Breast Carcinoma|Cervical Carcinoma|Colon Carcinoma|Colorectal Carcinoma|Endometrial Carcinoma|Esophageal Carcinoma|Gastric Carcinoma|Glioma|Head and Neck Carcinoma|Kidney Carcinoma|Liver and Intrahepatic Bile Duct Carcinoma|Lung Carcinoma|Lymphoma|Malignant Uterine Neoplasm|Melanoma|Multiple Myeloma|Ovarian Carcinoma|Pancreatic Carcinoma|Prostate Carcinoma|Rectal Carcinoma|Recurrent Bladder Carcinoma|Recurrent Breast Carcinoma|Recurrent Cervical Carcinoma|Recurrent Colon Carcinoma|Recurrent Colorectal Carcinoma|Recurrent Esophageal Carcinoma|Recurrent Gastric Carcinoma|Recurrent Glioma|Recurrent Head and Neck Carcinoma|Recurrent Liver Carcinoma|Recurrent Lung Carcinoma|Recurrent Lymphoma|Recurrent Malignant Solid Neoplasm|Recurrent Melanoma|Recurrent Multiple Myeloma|Recurrent Ovarian Carcinoma|Recurrent Pancreatic Carcinoma|Recurrent Prostate Carcinoma|Recurrent Rectal Carcinoma|Recurrent Skin Carcinoma|Recurrent Thyroid Gland Carcinoma|Recurrent Uterine Corpus Cancer|Refractory Lymphoma|Refractory Malignant Solid Neoplasm|Refractory Multiple Myeloma|Skin Carcinoma|Thyroid Gland Carcinoma|Uterine Corpus Cancer,Taselisib,CC1=NN(C(=N1)C2=CN3CCOC4=C(C3=N2)C=CC(=C4)C5=CN(N=C5)C(C)(C)C(=O)N)C(C)C,PHASE2,digestive_system_disease
750,"Neurologically Impaired|Irritable Mood|Signs and Symptoms, Digestive|Sleeplessness|Chronic Pain",Gabapentin,C1CCC(CC1)(CC(=O)O)CN,PHASE2,digestive_system_disease
751,Ulcerative Colitis,Hydroxocobalamin,CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)([O-])OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.O.[Co+2],PHASE2,digestive_system_disease
752,Severe Hepatic Impairment,Dacomitinib,COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)NC(=O)C=CCN4CCCCC4,PHASE1,digestive_system_disease
753,Hepatitis B,Carbamazepine,C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N,PHASE1,digestive_system_disease
754,Metastatic Pancreatic Cancer,Aldoxorubicin,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=NNC(=O)CCCCCN6C(=O)C=CC6=O)CO)O)N)O,PHASE2,digestive_system_disease
755,Recurrent and Metastatic Gastric Cancer,Fluzoparib,C1CN2C(=NC(=N2)C(F)(F)F)CN1C(=O)C3=C(C=CC(=C3)CC4=NNC(=O)C5=CC=CC=C54)F,PHASE1,digestive_system_disease
756,Irritable Bowel Syndrome,Dextofisopam,CCC1C(=NN=C(C2=CC(=C(C=C12)OC)OC)C3=CC(=C(C=C3)OC)OC)C,PHASE2,digestive_system_disease
757,HIV-1-infection|Hepatic Impairment,Dolutegravir,CC1CCOC2N1C(=O)C3=C(C(=O)C(=CN3C2)C(=O)NCC4=C(C=C(C=C4)F)F)O,PHASE1,digestive_system_disease
758,Liver Dysfunction,Nemonoxacin,CC1CC(CN(C1)C2=C(C3=C(C=C2)C(=O)C(=CN3C4CC4)C(=O)O)OC)N,PHASE1,digestive_system_disease
759,Metastatic Pancreatic Adenocarcinoma|Metastatic Pancreatic Cancer,Indoximod,CN1C=C(C2=CC=CC=C21)CC(C(=O)O)N,PHASE1|PHASE2,digestive_system_disease
760,Radiation Esophagitis,Sucralfate,C(C1C(C(C(C(O1)OC2(C(C(C(O2)COS(=O)(=O)O[Al])OS(=O)(=O)O[Al])OS(=O)(=O)O[Al])COS(=O)(=O)O[Al])OS(=O)(=O)O[Al])OS(=O)(=O)O[Al])OS(=O)(=O)O[Al])OS(=O)(=O)O[Al].O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.[Al],PHASE2,digestive_system_disease
761,Primary Sclerosing Cholangitis,Vidofludimus,COC1=CC=CC(=C1)C2=CC(=C(C=C2)NC(=O)C3=C(CCC3)C(=O)O)F,PHASE2,digestive_system_disease
762,Hepatic Impairment,Vorasidenib,CC(C(F)(F)F)NC1=NC(=NC(=N1)C2=NC(=CC=C2)Cl)NC(C)C(F)(F)F,PHASE1,digestive_system_disease
763,GIST - Gastrointestinal Stromal Tumor,Repaglinide,CCOC1=C(C=CC(=C1)CC(=O)NC(CC(C)C)C2=CC=CC=C2N3CCCCC3)C(=O)O,PHASE1,digestive_system_disease
764,Stomach Cancer,Vinflunine,CCC12C=CCN3C1C4(CC3)C(C(C2OC(=O)C)(C(=O)OC)O)N(C5=CC(=C(C=C45)C6(CC7CC(CN(C7)CC8=C6NC9=CC=CC=C89)C(C)(F)F)C(=O)OC)OC)C,PHASE2|PHASE3,digestive_system_disease
765,Acute Pancreatitis,Ketorolac,C1CN2C(=CC=C2C(=O)C3=CC=CC=C3)C1C(=O)O,PHASE2,digestive_system_disease
766,Hepatic Impairment,Apalutamide,CNC(=O)C1=C(C=C(C=C1)N2C(=S)N(C(=O)C23CCC3)C4=CC(=C(N=C4)C#N)C(F)(F)F)F,PHASE1,digestive_system_disease
767,Gastroparesis,Ketoconazole,CC(=O)N1CCN(CC1)C2=CC=C(C=C2)OCC3COC(O3)(CN4C=CN=C4)C5=C(C=C(C=C5)Cl)Cl,PHASE1,digestive_system_disease
768,Gastric Adenocarcinoma|Stage II Gastric Cancer|Stage III Gastric Cancer|Stage IV Gastric Cancer,Fludeoxyglucose,C(C(C(C(C(C=O)F)O)O)O)O,PHASE2,digestive_system_disease
769,Ulcerative Colitis,Cobitolimod,CC1=CN(C(=O)NC1=O)C2CC(C(O2)COP(=O)(O)OC3CC(OC3COP(=O)(O)OC4CC(OC4COP(=O)(O)OC5CC(OC5COP(=O)(O)OC6CC(OC6COP(=O)(O)OC7CC(OC7COP(=S)(O)OC8CC(OC8COP(=S)(O)OC9CC(OC9COP(=S)(O)OC1CC(OC1CO)N1C=NC2=C1N=C(NC2=O)N)N1C=NC2=C1N=C(NC2=O)N)N1C=NC2=C(N=CN=C21)N)N1C=NC2=C(N=CN=C21)N)N1C=CC(=NC1=O)N)N1C=NC2=C(N=CN=C21)N)N1C=NC2=C1N=C(NC2=O)N)N1C=C(C(=O)NC1=O)C)OP(=O)(O)OCC1C(CC(O1)N1C=CC(=NC1=O)N)OP(=O)(O)OCC1C(CC(O1)N1C=NC2=C1N=C(NC2=O)N)OP(=O)(O)OCC1C(CC(O1)N1C=C(C(=O)NC1=O)C)OP(=O)(O)OCC1C(CC(O1)N1C=CC(=NC1=O)N)OP(=O)(O)OCC1C(CC(O1)N1C=CC(=NC1=O)N)OP(=O)(O)OCC1C(CC(O1)N1C=NC2=C(N=CN=C21)N)OP(=O)(O)OCC1C(CC(O1)N1C=C(C(=O)NC1=O)C)OP(=S)(O)OCC1C(CC(O1)N1C=NC2=C1N=C(NC2=O)N)OP(=S)(O)OCC1C(CC(O1)N1C=NC2=C1N=C(NC2=O)N)OP(=S)(O)OCC1C(CC(O1)N1C=CC(=NC1=O)N)O,PHASE1,digestive_system_disease
770,Crohn's Disease,Calcitriol,CC(CCCC(C)(C)O)C1CCC2C1(CCCC2=CC=C3CC(CC(C3=C)O)O)C,PHASE1|PHASE2,digestive_system_disease
771,Pancreatic Cancer,Bosutinib,CN1CCN(CC1)CCCOC2=C(C=C3C(=C2)N=CC(=C3NC4=CC(=C(C=C4Cl)Cl)OC)C#N)OC,PHASE1,digestive_system_disease
772,Irritable Colon,Alosetron,CC1=C(N=CN1)CN2CCC3=C(C2=O)C4=CC=CC=C4N3C,PHASE2,digestive_system_disease
773,Obesity,Quinine,COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O,PHASE1,digestive_system_disease
774,Metastatic Pancreatic Cancer,Anamorelin,CC(C)(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)N3CCCC(C3)(CC4=CC=CC=C4)C(=O)N(C)N(C)C)N,PHASE2,digestive_system_disease
775,Malignant Neoplasm of Breast|CNS Malignancy|Malignant Neoplasm of Gastrointestinal Tract|Genitourinary Neoplasms Malignancy and Gender Unspecified|Head and Neck Neoplasms|Melanoma|Malignant Neoplasm of Thorax,Alisertib,COC1=C(C(=CC=C1)F)C2=NCC3=CN=C(N=C3C4=C2C=C(C=C4)Cl)NC5=CC(=C(C=C5)C(=O)O)OC,PHASE1,digestive_system_disease
776,Ileus,Ipamorelin,CC(C)(C(=O)NC(CC1=CN=CN1)C(=O)NC(CC2=CC3=CC=CC=C3C=C2)C(=O)NC(CC4=CC=CC=C4)C(=O)NC(CCCCN)C(=O)N)N,PHASE2,digestive_system_disease
777,"Hepatitis C, Chronic",Ethinylestradiol,CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O,PHASE1,digestive_system_disease
778,Irritable Bowel Syndrome,Trimebutine,CCC(COC(=O)C1=CC(=C(C(=C1)OC)OC)OC)(C2=CC=CC=C2)N(C)C,PHASE2|PHASE3,digestive_system_disease
779,Moderate Hepatic Impairment|Normal Hepatic Function,Rivipansel,CC1C(C(C(C(O1)OC2C(CC(CC2OC3C(C(C(C(O3)CO)O)OC(CC4CCCCC4)C(=O)O)OC(=O)C5=CC=CC=C5)C(=O)NCCNC(=O)COCCOCC(=O)NC6=C7C(=CC(=C6)S(=O)(=O)O)C=C(C=C7S(=O)(=O)O)S(=O)(=O)O)NC(=O)C8=CC(=O)NC(=O)N8)O)O)O,PHASE1,digestive_system_disease
780,Neoplasm Metastasis,Combretastatin,COC1=C(C=C(C=C1)CC(C2=CC(=C(C(=C2)OC)OC)OC)O)O,PHASE1,digestive_system_disease
781,Erythropoietic Protoporphyria,Afamelanotide,CCCCC(C(=O)NC(CCC(=O)O)C(=O)NC(CC1=CN=CN1)C(=O)NC(CC2=CC=CC=C2)C(=O)NC(CCCNC(=N)N)C(=O)NC(CC3=CNC4=CC=CC=C43)C(=O)NCC(=O)NC(CCCCN)C(=O)N5CCCC5C(=O)NC(C(C)C)C(=O)N)NC(=O)C(CO)NC(=O)C(CC6=CC=C(C=C6)O)NC(=O)C(CO)NC(=O)C,PHASE2,digestive_system_disease
782,Oral Mucositis,Benzydamine,CN(C)CCCOC1=NN(C2=CC=CC=C21)CC3=CC=CC=C3,PHASE1|PHASE2,digestive_system_disease
783,Colorectal Neoplasms,Levocetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,PHASE2,digestive_system_disease
784,Cholecystitis,Cefotetan,CN1C(=NN=N1)SCC2=C(N3C(C(C3=O)(NC(=O)C4SC(=C(C(=O)N)C(=O)O)S4)OC)SC2)C(=O)O,PHASE1,digestive_system_disease
785,Intestinal Obstruction,Sulfasalazine,C1=CC=NC(=C1)NS(=O)(=O)C2=CC=C(C=C2)N=NC3=CC(=C(C=C3)O)C(=O)O,PHASE1,digestive_system_disease
786,"Myeloma, Plasma-Cell|Lymphoma, Malignant",Aprepitant,CC(C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)OC2C(N(CCO2)CC3=NNC(=O)N3)C4=CC=C(C=C4)F,PHASE2,digestive_system_disease
787,Advanced Bile Duct Carcinoma|Stage II Esophageal Cancer AJCC v7|Stage II Pancreatic Cancer AJCC v6 and v7|Stage IIA Esophageal Cancer AJCC v7|Stage IIA Pancreatic Cancer AJCC v6 and v7|Stage IIB Esophageal Cancer AJCC v7|Stage IIB Pancreatic Cancer AJCC v6 and v7|Stage III Colon Cancer AJCC v7|Stage III Esophageal Cancer AJCC v7|Stage III Gastric Cancer AJCC v7|Stage III Liver Cancer|Stage III Pancreatic Cancer AJCC v6 and v7|Stage III Rectal Cancer AJCC v7|Stage III Small Intestinal Cancer AJCC v7|Stage IIIA Colon Cancer AJCC v7|Stage IIIA Esophageal Cancer AJCC v7|Stage IIIA Gastric Cancer AJCC v7|Stage IIIA Rectal Cancer AJCC v7|Stage IIIA Small Intestinal Cancer AJCC v7|Stage IIIB Colon Cancer AJCC v7|Stage IIIB Esophageal Cancer AJCC v7|Stage IIIB Gastric Cancer AJCC v7|Stage IIIB Rectal Cancer AJCC v7|Stage IIIB Small Intestinal Cancer AJCC v7|Stage IIIC Colon Cancer AJCC v7|Stage IIIC Esophageal Cancer AJCC v7|Stage IIIC Gastric Cancer AJCC v7|Stage IIIC Rectal Cancer AJCC v7|Stage IV Colon Cancer AJCC v7|Stage IV Esophageal Cancer AJCC v7|Stage IV Gastric Cancer AJCC v7|Stage IV Liver Cancer|Stage IV Pancreatic Cancer AJCC v6 and v7|Stage IV Rectal Cancer AJCC v7|Stage IV Small Intestinal Cancer AJCC v7|Stage IVA Colon Cancer AJCC v7|Stage IVA Liver Cancer|Stage IVA Rectal Cancer AJCC v7|Stage IVB Colon Cancer AJCC v7|Stage IVB Liver Cancer|Stage IVB Rectal Cancer AJCC v7,Ropidoxuridine,C1C(C(OC1N2C=C(C=NC2=O)I)CO)O,PHASE1,digestive_system_disease
788,"Gastroesophageal Reflux Disease|Reflux, Gastroesophageal",Lavoltidine,CN1C(=NC(=N1)CO)NCCCOC2=CC=CC(=C2)CN3CCCCC3,PHASE1,digestive_system_disease
789,Fontan Operation|Protein-Losing Enteropathy|Camostat Mesylate,Camostat,CN(C)C(=O)COC(=O)CC1=CC=C(C=C1)OC(=O)C2=CC=C(C=C2)N=C(N)N,PHASE2,digestive_system_disease
790,Hepatic Impairment,Orelabrutinib,C=CC(=O)N1CCC(CC1)C2=NC(=C(C=C2)C(=O)N)C3=CC=C(C=C3)OC4=CC=CC=C4,PHASE1,digestive_system_disease
791,Hepatic Impairment,Cenobamate,C1=CC=C(C(=C1)C(CN2N=CN=N2)OC(=O)N)Cl,PHASE1,digestive_system_disease
792,Primary Biliary Cholangitis|Liver Stiffness,Setanaxib,CN1C(=O)C=C2C(=C1C3=CC(=CC=C3)N(C)C)C(=O)N(N2)C4=CC=CC=C4Cl,PHASE2|PHASE3,digestive_system_disease
793,Pancreas Cancer|Biliary Tract Cancer|Psychological Distress,Psilocybin,CN(C)CCC1=CNC2=C1C(=CC=C2)OP(=O)(O)O,PHASE1,digestive_system_disease
794,Hepatic Impairment|Healthy,Bardoxolone,CC1(CCC2(CCC3(C(C2C1)C(=O)C=C4C3(CCC5C4(C=C(C(=O)C5(C)C)C#N)C)C)C)C(=O)O)C,PHASE1,digestive_system_disease
795,Advanced HCC,Ningetinib,CC1=C(C(=O)N(N1C)C2=CC=CC=C2)C(=O)NC3=CC(=C(C=C3)OC4=C5C=CC(=CC5=NC=C4)OCC(C)(C)O)F,PHASE1|PHASE2,digestive_system_disease
796,Morbid Obesity|Postoperative Pain|Postoperative Bowel Function|Postoperative Ambulation,Levobupivacaine,CCCCN1CCCCC1C(=O)NC2=C(C=CC=C2C)C,PHASE2|PHASE3,digestive_system_disease
797,NASH - Nonalcoholic Steatohepatitis,Namodenoson,CNC(=O)C1C(C(C(O1)N2C=NC3=C(N=C(N=C32)Cl)NCC4=CC(=CC=C4)I)O)O,PHASE2,digestive_system_disease
798,Non-alcoholic Steatohepatitis,Carnitine,C[N+](C)(C)CC(CC(=O)[O-])O,PHASE2,digestive_system_disease
799,Non-alcoholic Steatohepatitis,Levocarnitine,C[N+](C)(C)CC(CC(=O)[O-])O,PHASE2,digestive_system_disease
800,Cirrhosis|Ascites|Nosocomial Spontaneous Bacterial Peritonitis,Daptomycin,CCCCCCCCCC(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(CC(=O)N)C(=O)NC(CC(=O)O)C(=O)NC3C(OC(=O)C(NC(=O)C(NC(=O)C(NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)CNC3=O)CCCN)CC(=O)O)C)CC(=O)O)CO)C(C)CC(=O)O)CC(=O)C4=CC=CC=C4N)C,PHASE2|PHASE3,digestive_system_disease
801,Hepatopathy,Hetrombopag,CC1=C(C(=O)N(N1)C2=CC3=C(CCCC3)C=C2)N=NC4=CC=CC(=C4O)C5=CC=C(O5)C(=O)O,PHASE2,digestive_system_disease
802,Migraine|Pain|Nausea|Vomiting|Aura,Sumatriptan,CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C,PHASE2,digestive_system_disease
803,Non Small Cell Lung Cancer (NSCLC),Alclometasone,CC1CC2C3C(CC4=CC(=O)C=CC4(C3C(CC2(C1(C(=O)CO)O)C)O)C)Cl,PHASE2,digestive_system_disease
804,Primary Biliary Cirrhosis,Moexipril,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CC3=CC(=C(C=C3CC2C(=O)O)OC)OC,PHASE2,digestive_system_disease
805,Ulcerative Colitis,Terbinafine,CC(C)(C)C#CC=CCN(C)CC1=CC=CC2=CC=CC=C21,PHASE2,digestive_system_disease
806,Colorectal Neoplasm,Modufolin,C1C2CN(CN2C3=C(N1)N=C(NC3=O)N)C4=CC=C(C=C4)C(=O)NC(CCC(=O)O)C(=O)O,PHASE1|PHASE2,digestive_system_disease
807,Gastroesophageal Reflux Disease,Pumosetrag,C1CN2CCC1C(C2)NC(=O)C3=CNC4=C(C3=O)SC=C4,PHASE2,digestive_system_disease
808,Ovarian Cancer|Fallopian Tube Cancer|Peritoneal Cancer,Letrozole,C1=CC(=CC=C1C#N)C(C2=CC=C(C=C2)C#N)N3C=NC=N3,PHASE2,digestive_system_disease
809,Thromboembolism of Vein VTE in Colorectal Cancer|Thromboembolism of Vein in Pancreatic Cancer|Thromboembolism of Vein in Non-small Cell Lung Cancer,Isoquercetin,C1=CC(=C(C=C1C2=C(C(=O)C3=C(C=C(C=C3O2)O)O)OC4C(C(C(C(O4)CO)O)O)O)O)O,PHASE2|PHASE3,digestive_system_disease
810,Hepatic Impairment,Siremadlin,CC(C)N1C2=C(C(=O)N(C2C3=CC=C(C=C3)Cl)C4=CC(=CN(C4=O)C)Cl)N=C1C5=CN=C(N=C5OC)OC,PHASE1,digestive_system_disease
811,Cryptosporidiosis|HIV Infections,Letrazuril,C1=CC(=CC=C1C(C#N)C2=C(C=C(C=C2Cl)N3C(=O)NC(=O)C=N3)Cl)F,PHASE1,digestive_system_disease
812,HIV Infections|Anus Neoplasms,Isotretinoin,CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CC(=O)O)C)C,PHASE1,digestive_system_disease
813,Hepatic Impairment|Moderate Impaired Hepatic Function,Quizartinib,CC(C)(C)C1=CC(=NO1)NC(=O)NC2=CC=C(C=C2)C3=CN4C5=C(C=C(C=C5)OCCN6CCOCC6)SC4=N3,PHASE1,digestive_system_disease
814,Acute Pain|Post Operative Pain|Anorectal Disorder|Analgesia,Hydromorphone,CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(=O)CC4,PHASE2,digestive_system_disease
815,Hepatic Insufficiency,Alitretinoin,CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CC(=O)O)C)C,PHASE1|PHASE2,digestive_system_disease
816,Non Alcoholic Steatohepatitis,Idebenone,CC1=C(C(=O)C(=C(C1=O)OC)OC)CCCCCCCCCCO,PHASE1|PHASE2,digestive_system_disease
817,Hepatic Impairment|Healthy Volunteers,Bocidelpar,CC1=CN=C(N1CC2=CC=CC=C2OCCCC(C)CC(=O)O)C3=CC=C(C=C3)C(F)(F)F,PHASE1,digestive_system_disease
818,Bowel Disease|Liver Diseases|Pancreas Disease|Anesthesia; Functional,Sufentanil,CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCC3=CC=CS3)COC,PHASE2|PHASE3,digestive_system_disease
819,Hepatitis C Virus Infection,Mifepristone,CC#CC1(CCC2C1(CC(C3=C4CCC(=O)C=C4CCC23)C5=CC=C(C=C5)N(C)C)C)O,PHASE2,digestive_system_disease
820,Ulcerative Colitis,Dersalazine,CC1=NC2=C(N1CC3CCN(CC3)C(=O)C=C(C4=CC=CC=C4)C5=CC=C(C=C5)N=NC6=CC(=C(C=C6)O)C(=O)O)C=CN=C2,PHASE2,digestive_system_disease
821,Resectable Pancreatic Ductal Adenocarcinoma|Stage 0 Pancreatic Cancer AJCC v8|Stage I Pancreatic Cancer AJCC v8|Stage IA Pancreatic Cancer AJCC v8|Stage IB Pancreatic Cancer AJCC v8|Stage II Pancreatic Cancer AJCC v8|Stage IIA Pancreatic Cancer AJCC v8|Stage IIB Pancreatic Cancer AJCC v8,Pyrvinium,CC1=CC(=C(N1C2=CC=CC=C2)C)C=CC3=[N+](C4=C(C=C3)C=C(C=C4)N(C)C)C,PHASE1,digestive_system_disease
822,Eosinophilic Esophagitis,Beclomethasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)Cl)C,PHASE1,digestive_system_disease
823,Chronic Pain|Chronic Pain Syndrome|Chronic Pancreatitis|Hyperalgesia|Opioid Use Disorder|Opioid-Related Disorders|Opioid Dependence|Chronic Abdominal Pain|ERCP|Pancreatic Surgery,Lacosamide,CC(=O)NC(COC)C(=O)NCC1=CC=CC=C1,PHASE1,digestive_system_disease
824,Short Bowel Syndrome,Cholestyramine,CCC(C)C.CCC(CC(C)C1=CC=CC=C1)C2=CC=C(C=C2)C[N+](C)(C)C.N.[Cl-],PHASE2,digestive_system_disease
825,Short Bowel Syndrome|Vitamin E Deficiency,Tocofersolan,CC1=C(C(=C(C2=C1OC(CC2)(C)CCCC(C)CCCC(C)CCCC(C)C)C)OC(=O)CCC(=O)OCCO)C,PHASE2,digestive_system_disease
826,Head and Neck Squamous Cell Carcinoma,Tramadol,CN(C)CC1CCCCC1(C2=CC(=CC=C2)OC)O,PHASE2,digestive_system_disease
827,Cystic Fibrosis,Fenretinide,CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CC(=O)NC2=CC=C(C=C2)O)C)C,PHASE1,digestive_system_disease
828,Inflammatory Bowel Diseases,Nifuroxazide,C1=CC(=CC=C1C(=O)NN=CC2=CC=C(O2)[N+](=O)[O-])O,PHASE2|PHASE3,digestive_system_disease
829,Hepatic Impairment,Omaveloxolone,CC1(CCC2(CCC3(C(C2C1)C(=O)C=C4C3(CCC5C4(C=C(C(=O)C5(C)C)C#N)C)C)C)NC(=O)C(C)(F)F)C,PHASE1,digestive_system_disease
830,Erythropoietic Protoporphyria|X-linked Protoporphyria,Cimetidine,CC1=C(N=CN1)CSCCNC(=NC)NC#N,PHASE2,digestive_system_disease
831,Recurrent Breast Carcinoma|Recurrent Fallopian Tube Carcinoma|Recurrent Ovarian Carcinoma|Recurrent Primary Peritoneal Carcinoma|Stage IIA Breast Cancer|Stage IIA Fallopian Tube Cancer|Stage IIA Ovarian Cancer|Stage IIB Breast Cancer|Stage IIB Fallopian Tube Cancer|Stage IIB Ovarian Cancer|Stage IIC Fallopian Tube Cancer|Stage IIC Ovarian Cancer|Stage IIIA Breast Cancer|Stage IIIA Fallopian Tube Cancer|Stage IIIA Ovarian Cancer|Stage IIIA Primary Peritoneal Cancer|Stage IIIB Breast Cancer|Stage IIIB Fallopian Tube Cancer|Stage IIIB Ovarian Cancer|Stage IIIB Primary Peritoneal Cancer|Stage IIIC Breast Cancer|Stage IIIC Fallopian Tube Cancer|Stage IIIC Ovarian Cancer|Stage IIIC Primary Peritoneal Cancer|Stage IV Fallopian Tube Cancer|Stage IV Ovarian Cancer|Stage IV Primary Peritoneal Cancer,Folate,C1=CC(=CC=C1C(=O)NC(CCC(=O)O)C(=O)O)NCC2=CN=C3C(=N2)C(=O)NC(=N3)N,PHASE1,digestive_system_disease
832,Cystic Fibrosis,Vardenafil,CCCC1=NC(=C2N1N=C(NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)CC)OCC)C,PHASE2,digestive_system_disease
833,Non Alcoholic Steatohepatitis (NASH),Licogliflozin,CCC1=C(C=C(C=C1)C2C(C(C(C(O2)CO)O)O)O)CC3=CC4=C(C=C3)OCCO4,PHASE2,digestive_system_disease
834,Hepatitis C|HIV,Abacavir,C1CC1NC2=C3C(=NC(=N2)N)N(C=N3)C4CC(C=C4)CO,PHASE1,digestive_system_disease
835,Liver Failure,Lofexidine,CC(C1=NCCN1)OC2=C(C=CC=C2Cl)Cl,PHASE1,digestive_system_disease
836,Metastatic Colorectal Cancer,Valproate,CCCC(CCC)C(=O)O,PHASE2,digestive_system_disease
837,Alcohol-Related Disorders,Dihydromyricetin,C1=C(C=C(C(=C1O)O)O)C2C(C(=O)C3=C(C=C(C=C3O2)O)O)O,PHASE1,digestive_system_disease
838,Colorectal Cancer,Pyridoxine,CC1=NC=C(C(=C1O)CO)CO,PHASE2,digestive_system_disease
839,Neoplasms,Streptozocin,CN(C(=O)NC1C(C(C(OC1O)CO)O)O)N=O,PHASE2,digestive_system_disease
840,Hepatic Impairment,Olorofim,CC1=CC(=C(N1C)C(=O)C(=O)NC2=CC=C(C=C2)N3CCN(CC3)C4=NC=C(C=N4)F)C5=CC=CC=C5,PHASE1,digestive_system_disease
841,Moderate Hepatic Impairment,Mitapivat,C1CC1CN2CCN(CC2)C(=O)C3=CC=C(C=C3)NS(=O)(=O)C4=CC=CC5=C4N=CC=C5,PHASE1,digestive_system_disease
842,Anus Neoplasms,Indigo,C1=CC=C2C(=C1)C(=C(N2)C3=NC4=CC=CC=C4C3=O)O,PHASE2,digestive_system_disease
843,Advanced Malignant Solid Neoplasm|ALK Positive|Metastatic Pancreatic Adenocarcinoma|Stage III Pancreatic Cancer|Stage IV Pancreatic Cancer,Ceritinib,CC1=CC(=C(C=C1C2CCNCC2)OC(C)C)NC3=NC=C(C(=N3)NC4=CC=CC=C4S(=O)(=O)C(C)C)Cl,PHASE1,digestive_system_disease
844,Rectal Cancer,Hydralazine,C1=CC=C2C(=C1)C=NN=C2NN,PHASE1|PHASE2,digestive_system_disease
845,Healthy|Hepatic Impairment,Favipiravir,C1=C(N=C(C(=O)N1)C(=O)N)F,PHASE1,digestive_system_disease
846,Cystic Fibrosis,Ataluren,C1=CC=C(C(=C1)C2=NC(=NO2)C3=CC(=CC=C3)C(=O)O)F,PHASE2,digestive_system_disease
847,Pancreatic Cancer,Chlorphenesin,C1=CC(=CC=C1OCC(CO)O)Cl,PHASE1,digestive_system_disease
848,Hepatic Impairment,Iptacopan,CCOC1CCN(C(C1)C2=CC=C(C=C2)C(=O)O)CC3=C(C=C(C4=C3C=CN4)C)OC,PHASE1,digestive_system_disease
849,Cryptosporidiosis|HIV Infections,Spiramycin,CC1CC=CC=CC(C(CC(C(C(C(CC(=O)O1)O)OC)OC2C(C(C(C(O2)C)OC3CC(C(C(O3)C)O)(C)O)N(C)C)O)CC=O)C)OC4CCC(C(O4)C)N(C)C,PHASE1,digestive_system_disease
850,Cystic Fibrosis|Aspergillosis,Posaconazole,CCC(C(C)O)N1C(=O)N(C=N1)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(C=C4)OCC5CC(OC5)(CN6C=NC=N6)C7=C(C=C(C=C7)F)F,PHASE2|PHASE3,digestive_system_disease
851,Hepatocellular Carcinoma,Tefinostat,C1CCC(C1)OC(=O)C(C2=CC=CC=C2)NCC3=CC=C(C=C3)NC(=O)CCCCCCC(=O)NO,PHASE1|PHASE2,digestive_system_disease
852,Liver Dysfunction,Mivacurium,C[N+]1(CCC2=CC(=C(C=C2C1CC3=CC(=C(C(=C3)OC)OC)OC)OC)OC)CCCOC(=O)CCC=CCCC(=O)OCCC[N+]4(CCC5=CC(=C(C=C5C4CC6=CC(=C(C(=C6)OC)OC)OC)OC)OC)C,PHASE2,digestive_system_disease
853,Cirrhosis|Hepatitis B Infection|Hepatitis C Infection|Metastatic Malignant Solid Neoplasm|Recurrent Hepatocellular Carcinoma|Recurrent Malignant Solid Neoplasm|Refractory Malignant Neoplasm|Stage IV Hepatocellular Carcinoma AJCC v7|Unresectable Solid Neoplasm,Navitoclax,CC1(CCC(=C(C1)CN2CCN(CC2)C3=CC=C(C=C3)C(=O)NS(=O)(=O)C4=CC(=C(C=C4)NC(CCN5CCOCC5)CSC6=CC=CC=C6)S(=O)(=O)C(F)(F)F)C7=CC=C(C=C7)Cl)C,PHASE1,digestive_system_disease
854,Chemotherapy-Induced Nausea and Vomiting|Ovarian Cancer,Ramosetron,CN1C=C(C2=CC=CC=C21)C(=O)C3CCC4=C(C3)NC=N4,PHASE2,digestive_system_disease
855,Falciparum Malaria,Artemether,CC1CCC2C(C(OC3C24C1CCC(O3)(OO4)C)OC)C,PHASE2,digestive_system_disease
856,Advanced Lymphoma|Advanced Malignant Solid Neoplasm|Ann Arbor Stage III B-Cell Non-Hodgkin Lymphoma|Ann Arbor Stage III T-Cell Non-Hodgkin Lymphoma|Ann Arbor Stage IV B-Cell Non-Hodgkin Lymphoma|Ann Arbor Stage IV T-Cell Non-Hodgkin Lymphoma|Refractory B-Cell Non-Hodgkin Lymphoma|Refractory Lymphoma|Refractory Malignant Solid Neoplasm|Refractory Pancreatic Carcinoma|Refractory T-Cell Non-Hodgkin Lymphoma|Stage II Pancreatic Cancer AJCC v8|Stage IIA Pancreatic Cancer AJCC v8|Stage IIB Pancreatic Cancer AJCC v8|Stage III Pancreatic Cancer AJCC v8|Stage IV Pancreatic Cancer AJCC v8|Unresectable Pancreatic Carcinoma,Molibresib,CCNC(=O)CC1C2=NN=C(N2C3=C(C=C(C=C3)OC)C(=N1)C4=CC=C(C=C4)Cl)C,PHASE1,digestive_system_disease
857,Cystic Fibrosis,Teicoplanin,CCCCCCCCCC(=O)NC1C(C(C(OC1OC2=C3C=C4C=C2OC5=C(C=C(C=C5)C(C6C(=O)NC(C7=C(C(=CC(=C7)O)OC8C(C(C(C(O8)CO)O)O)O)C9=C(C=CC(=C9)C(C(=O)N6)NC(=O)C4NC(=O)C1C2=CC(=CC(=C2)OC2=C(C=CC(=C2)C(C(=O)NC(CC2=CC(=C(O3)C=C2)Cl)C(=O)N1)N)O)O)O)C(=O)O)OC1C(C(C(C(O1)CO)O)O)NC(=O)C)Cl)CO)O)O,PHASE1,digestive_system_disease
858,Cystic Fibrosis,Gentamicin,CC(C1CCC(C(O1)OC2C(CC(C(C2O)OC3C(C(C(CO3)(C)O)NC)O)N)N)N)NC,PHASE2,digestive_system_disease
859,Non Alcoholic Steatohepatitis|Hyperuricemia,Febuxostat,CC1=C(SC(=N1)C2=CC(=C(C=C2)OCC(C)C)C#N)C(=O)O,PHASE2,digestive_system_disease
860,"Carcinoma, Non-Small-Cell Lung|Lung Cancer|Non-Small Cell Lung Cancer|Carcinoma, Esophageal|Malignant Pleural Mesotheliomas",Tetrahydrouridine,C1CN(C(=O)NC1O)C2C(C(C(O2)CO)O)O,PHASE1|PHASE2,digestive_system_disease
861,Breast Cancer|Colon Cancer,Eniluracil,C#CC1=CNC(=O)NC1=O,PHASE1,digestive_system_disease
862,Stage III Pancreatic Cancer AJCC v8|Stage IV Pancreatic Cancer AJCC v8|Unresectable Pancreatic Carcinoma,Bosentan,CC(C)(C)C1=CC=C(C=C1)S(=O)(=O)NC2=C(C(=NC(=N2)C3=NC=CC=N3)OCCO)OC4=CC=CC=C4OC,PHASE1,digestive_system_disease
863,Colorectal Cancer,Sevoflurane,C(OC(C(F)(F)F)C(F)(F)F)F,PHASE1,digestive_system_disease
864,MALT Lymphoma,Chlorambucil,C1=CC(=CC=C1CCCC(=O)O)N(CCCl)CCCl,PHASE2,digestive_system_disease
865,Colorectal Carcinoma,Dolcanatide,CC1C(=O)NC2CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(NC(=O)CNC(=O)C(NC2=O)C(C)O)C(=O)NC(CC(C)C)C(=O)O)C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)C(C)C)CC(=O)N)C(C)C)CC(C)C)CCC(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(CC(=O)O)NC(=O)C(CC(=O)N)N,PHASE1,digestive_system_disease
866,Hepatic Impairment,Ivosidenib,C1CC(=O)N(C1C(=O)N(C2=CC(=CN=C2)F)C(C3=CC=CC=C3Cl)C(=O)NC4CC(C4)(F)F)C5=NC=CC(=C5)C#N,PHASE1,digestive_system_disease
867,Hepatic Impairment,Tozadenant,CC1(CCN(CC1)C(=O)NC2=NC3=C(C=CC(=C3S2)N4CCOCC4)OC)O,PHASE1,digestive_system_disease
868,Gastroparesis,Naronapride,COC1CN(CCC1NC(=O)C2=CC(=C(C=C2OC)N)Cl)CCCCCC(=O)OC3CN4CCC3CC4,PHASE2,digestive_system_disease
869,Cannabinoid|Tetrahydrocannabinol|Chronic Pancreatitis|Abdominal Pain,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,PHASE2,digestive_system_disease
870,Non-small Cell Lung Cancer,Almonertinib,CN(C)CCN(C)C1=CC(=C(C=C1NC(=O)C=C)NC2=NC=CC(=N2)C3=CN(C4=CC=CC=C43)C5CC5)OC,PHASE2,digestive_system_disease
871,Gastroparesis,Granisetron,CN1C2CCCC1CC(C2)NC(=O)C3=NN(C4=CC=CC=C43)C,PHASE2,digestive_system_disease
872,Cancer Stem Cell,Fursultiamine,CC1=NC=C(C(=N1)N)CN(C=O)C(=C(CCO)SSCC2CCCO2)C,PHASE2,digestive_system_disease
873,Anti-Psychotic|Management of Manifestations of Psychotic Disorders|Treatment of Schizophrenia|Control Nausea and Vomiting|Relief of Restlessness and Apprehension Before Surgery|Acute Intermittent Porphyria|Adjunct in the Treatment of Tetanus|Control Manifestations of the Manic Type of Mani-depressive Illness|Relief of Intractable Hiccups,Chlorpromazine,CN(C)CCCN1C2=CC=CC=C2SC3=C1C=C(C=C3)Cl,PHASE1,digestive_system_disease
874,Hepatitis C,Norethisterone,CC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34,PHASE1,digestive_system_disease
875,Hepatitis C,Norethindrone,CC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34,PHASE1,digestive_system_disease
876,Anal Fissure,Isosorbide,C1C(C2C(O1)C(CO2)O)O,PHASE1,digestive_system_disease
877,Hepatitis B,Resiquimod,CCOCC1=NC2=C(N1CC(C)(C)O)C3=CC=CC=C3N=C2N,PHASE1|PHASE2,digestive_system_disease
878,Hepatitis C Infection|Depression,Paroxetine,C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4,PHASE2,digestive_system_disease
879,"Carcinoma, Small Cell|Carcinoma, Non-Small-Cell Lung|Esophageal Neoplasms|Mesothelioma",Alvocidib,CN1CCC(C(C1)O)C2=C(C=C(C3=C2OC(=CC3=O)C4=CC=CC=C4Cl)O)O,PHASE1,digestive_system_disease
880,"Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Anatomic Stage IV Breast Cancer AJCC v8|Anemia|Ann Arbor Stage III Hodgkin Lymphoma|Ann Arbor Stage III Non-Hodgkin Lymphoma|Ann Arbor Stage IV Hodgkin Lymphoma|Ann Arbor Stage IV Non-Hodgkin Lymphoma|Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative|Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Castration-Resistant Prostate Carcinoma|Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Hematopoietic and Lymphoid System Neoplasm|Locally Advanced Pancreatic Adenocarcinoma|Metastatic Breast Carcinoma|Metastatic Malignant Solid Neoplasm|Metastatic Pancreatic Adenocarcinoma|Myelodysplastic/Myeloproliferative Neoplasm With Ring Sideroblasts and Thrombocytosis|Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable|Primary Myelofibrosis|Recurrent Acute Lymphoblastic Leukemia|Recurrent Acute Myeloid Leukemia|Recurrent Chronic Lymphocytic Leukemia|Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Recurrent Hematologic Malignancy|Recurrent Hodgkin Lymphoma|Recurrent Myelodysplastic Syndrome|Recurrent Myelodysplastic/Myeloproliferative Neoplasm|Recurrent Myeloproliferative Neoplasm|Recurrent Non-Hodgkin Lymphoma|Recurrent Plasma Cell Myeloma|Recurrent Small Lymphocytic Lymphoma|Refractory Acute Lymphoblastic Leukemia|Refractory Acute Myeloid Leukemia|Refractory Chronic Lymphocytic Leukemia|Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Refractory Chronic Myelomonocytic Leukemia|Refractory Hematologic Malignancy|Refractory Hodgkin Lymphoma|Refractory Malignant Solid Neoplasm|Refractory Myelodysplastic Syndrome|Refractory Myelodysplastic/Myeloproliferative Neoplasm|Refractory Non-Hodgkin Lymphoma|Refractory Plasma Cell Myeloma|Refractory Primary Myelofibrosis|Refractory Small Lymphocytic Lymphoma|Stage II Pancreatic Cancer AJCC v8|Stage III Pancreatic Cancer AJCC v8|Stage IV Pancreatic Cancer AJCC v8|Stage IV Prostate Cancer AJCC v8|Unresectable Pancreatic Adenocarcinoma",Darolutamide,CC(CN1C=CC(=N1)C2=CC(=C(C=C2)C#N)Cl)NC(=O)C3=NNC(=C3)C(C)O,PHASE1,digestive_system_disease
881,"Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Anatomic Stage IV Breast Cancer AJCC v8|Anemia|Ann Arbor Stage III Hodgkin Lymphoma|Ann Arbor Stage III Non-Hodgkin Lymphoma|Ann Arbor Stage IV Hodgkin Lymphoma|Ann Arbor Stage IV Non-Hodgkin Lymphoma|Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative|Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Castration-Resistant Prostate Carcinoma|Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Hematopoietic and Lymphoid System Neoplasm|Locally Advanced Pancreatic Adenocarcinoma|Metastatic Breast Carcinoma|Metastatic Malignant Solid Neoplasm|Metastatic Pancreatic Adenocarcinoma|Myelodysplastic/Myeloproliferative Neoplasm With Ring Sideroblasts and Thrombocytosis|Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable|Primary Myelofibrosis|Recurrent Acute Lymphoblastic Leukemia|Recurrent Acute Myeloid Leukemia|Recurrent Chronic Lymphocytic Leukemia|Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Recurrent Hematologic Malignancy|Recurrent Hodgkin Lymphoma|Recurrent Myelodysplastic Syndrome|Recurrent Myelodysplastic/Myeloproliferative Neoplasm|Recurrent Myeloproliferative Neoplasm|Recurrent Non-Hodgkin Lymphoma|Recurrent Plasma Cell Myeloma|Recurrent Small Lymphocytic Lymphoma|Refractory Acute Lymphoblastic Leukemia|Refractory Acute Myeloid Leukemia|Refractory Chronic Lymphocytic Leukemia|Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Refractory Chronic Myelomonocytic Leukemia|Refractory Hematologic Malignancy|Refractory Hodgkin Lymphoma|Refractory Malignant Solid Neoplasm|Refractory Myelodysplastic Syndrome|Refractory Myelodysplastic/Myeloproliferative Neoplasm|Refractory Non-Hodgkin Lymphoma|Refractory Plasma Cell Myeloma|Refractory Primary Myelofibrosis|Refractory Small Lymphocytic Lymphoma|Stage II Pancreatic Cancer AJCC v8|Stage III Pancreatic Cancer AJCC v8|Stage IV Pancreatic Cancer AJCC v8|Stage IV Prostate Cancer AJCC v8|Unresectable Pancreatic Adenocarcinoma",Tretinoin,CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CC(=O)O)C)C,PHASE1,digestive_system_disease
882,Hepatic Impairment,Lemborexant,CC1=NC(=NC=C1OCC2(CC2C(=O)NC3=NC=C(C=C3)F)C4=CC(=CC=C4)F)C,PHASE1,digestive_system_disease
883,Gastric Adenocarcinoma or Gastroesophageal Junction Adenocarcinoma or Esophageal Carcinoma,Linagliptin,CC#CCN1C2=C(N=C1N3CCCC(C3)N)N(C(=O)N(C2=O)CC4=NC5=CC=CC=C5C(=N4)C)C,PHASE1|PHASE2,digestive_system_disease
884,Head and Neck Neoplasms|Mucositis,Brilacidin,C1CNCC1OC2=C(C=C(C=C2NC(=O)C3=CC(=NC=N3)C(=O)NC4=CC(=CC(=C4OC5CCNC5)NC(=O)CCCCN=C(N)N)C(F)(F)F)C(F)(F)F)NC(=O)CCCCN=C(N)N,PHASE2,digestive_system_disease
885,Ulcerative Colitis (UC),Upadacitinib,CCC1CN(CC1C2=CN=C3N2C4=C(NC=C4)N=C3)C(=O)NCC(F)(F)F,PHASE2|PHASE3,digestive_system_disease
886,Glioma|Hematopoietic and Lymphoid Cell Neoplasm|Lymphoma|Metastatic Malignant Solid Neoplasm|Neuroendocrine Neoplasm|Recurrent Adult Soft Tissue Sarcoma|Recurrent Bladder Carcinoma|Recurrent Breast Carcinoma|Recurrent Chronic Lymphocytic Leukemia|Recurrent Colorectal Carcinoma|Recurrent Head and Neck Carcinoma|Recurrent Lung Carcinoma|Recurrent Malignant Solid Neoplasm|Recurrent Melanoma|Recurrent Pancreatic Carcinoma|Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma|Recurrent Prostate Carcinoma|Recurrent Renal Cell Carcinoma|Recurrent Thyroid Gland Carcinoma|Refractory Chronic Lymphocytic Leukemia|Refractory Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma|Refractory Primary Cutaneous T-Cell Non-Hodgkin Lymphoma|Stage III Breast Cancer AJCC v7|Stage III Colorectal Cancer AJCC v7|Stage III Cutaneous Melanoma AJCC v7|Stage III Lung Cancer AJCC v7|Stage III Pancreatic Cancer AJCC v6 and v7|Stage III Prostate Cancer AJCC v7|Stage III Renal Cell Cancer AJCC v7|Stage III Soft Tissue Sarcoma AJCC v7|Stage IIIA Breast Cancer AJCC v7|Stage IIIA Colorectal Cancer AJCC v7|Stage IIIA Cutaneous Melanoma AJCC v7|Stage IIIB Breast Cancer AJCC v7|Stage IIIB Colorectal Cancer AJCC v7|Stage IIIB Cutaneous Melanoma AJCC v7|Stage IIIC Breast Cancer AJCC v7|Stage IIIC Colorectal Cancer AJCC v7|Stage IIIC Cutaneous Melanoma AJCC v7|Stage IV Breast Cancer AJCC v6 and v7|Stage IV Colorectal Cancer AJCC v7|Stage IV Cutaneous Melanoma AJCC v6 and v7|Stage IV Lung Cancer AJCC v7|Stage IV Pancreatic Cancer AJCC v6 and v7|Stage IV Prostate Cancer AJCC v7|Stage IV Renal Cell Cancer AJCC v7|Stage IV Soft Tissue Sarcoma AJCC v7|Stage IVA Colorectal Cancer AJCC v7|Stage IVB Colorectal Cancer AJCC v7|Unresectable Solid Neoplasm,Ciclosporin,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,PHASE1,skin_and_connective_tissue_disease
887,Glioma|Hematopoietic and Lymphoid Cell Neoplasm|Lymphoma|Metastatic Malignant Solid Neoplasm|Neuroendocrine Neoplasm|Recurrent Adult Soft Tissue Sarcoma|Recurrent Bladder Carcinoma|Recurrent Breast Carcinoma|Recurrent Chronic Lymphocytic Leukemia|Recurrent Colorectal Carcinoma|Recurrent Head and Neck Carcinoma|Recurrent Lung Carcinoma|Recurrent Malignant Solid Neoplasm|Recurrent Melanoma|Recurrent Pancreatic Carcinoma|Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma|Recurrent Prostate Carcinoma|Recurrent Renal Cell Carcinoma|Recurrent Thyroid Gland Carcinoma|Refractory Chronic Lymphocytic Leukemia|Refractory Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma|Refractory Primary Cutaneous T-Cell Non-Hodgkin Lymphoma|Stage III Breast Cancer AJCC v7|Stage III Colorectal Cancer AJCC v7|Stage III Cutaneous Melanoma AJCC v7|Stage III Lung Cancer AJCC v7|Stage III Pancreatic Cancer AJCC v6 and v7|Stage III Prostate Cancer AJCC v7|Stage III Renal Cell Cancer AJCC v7|Stage III Soft Tissue Sarcoma AJCC v7|Stage IIIA Breast Cancer AJCC v7|Stage IIIA Colorectal Cancer AJCC v7|Stage IIIA Cutaneous Melanoma AJCC v7|Stage IIIB Breast Cancer AJCC v7|Stage IIIB Colorectal Cancer AJCC v7|Stage IIIB Cutaneous Melanoma AJCC v7|Stage IIIC Breast Cancer AJCC v7|Stage IIIC Colorectal Cancer AJCC v7|Stage IIIC Cutaneous Melanoma AJCC v7|Stage IV Breast Cancer AJCC v6 and v7|Stage IV Colorectal Cancer AJCC v7|Stage IV Cutaneous Melanoma AJCC v6 and v7|Stage IV Lung Cancer AJCC v7|Stage IV Pancreatic Cancer AJCC v6 and v7|Stage IV Prostate Cancer AJCC v7|Stage IV Renal Cell Cancer AJCC v7|Stage IV Soft Tissue Sarcoma AJCC v7|Stage IVA Colorectal Cancer AJCC v7|Stage IVB Colorectal Cancer AJCC v7|Unresectable Solid Neoplasm,Chloroquine,CCN(CC)CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl,PHASE1,skin_and_connective_tissue_disease
888,Glioma|Hematopoietic and Lymphoid Cell Neoplasm|Lymphoma|Metastatic Malignant Solid Neoplasm|Neuroendocrine Neoplasm|Recurrent Adult Soft Tissue Sarcoma|Recurrent Bladder Carcinoma|Recurrent Breast Carcinoma|Recurrent Chronic Lymphocytic Leukemia|Recurrent Colorectal Carcinoma|Recurrent Head and Neck Carcinoma|Recurrent Lung Carcinoma|Recurrent Malignant Solid Neoplasm|Recurrent Melanoma|Recurrent Pancreatic Carcinoma|Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma|Recurrent Prostate Carcinoma|Recurrent Renal Cell Carcinoma|Recurrent Thyroid Gland Carcinoma|Refractory Chronic Lymphocytic Leukemia|Refractory Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma|Refractory Primary Cutaneous T-Cell Non-Hodgkin Lymphoma|Stage III Breast Cancer AJCC v7|Stage III Colorectal Cancer AJCC v7|Stage III Cutaneous Melanoma AJCC v7|Stage III Lung Cancer AJCC v7|Stage III Pancreatic Cancer AJCC v6 and v7|Stage III Prostate Cancer AJCC v7|Stage III Renal Cell Cancer AJCC v7|Stage III Soft Tissue Sarcoma AJCC v7|Stage IIIA Breast Cancer AJCC v7|Stage IIIA Colorectal Cancer AJCC v7|Stage IIIA Cutaneous Melanoma AJCC v7|Stage IIIB Breast Cancer AJCC v7|Stage IIIB Colorectal Cancer AJCC v7|Stage IIIB Cutaneous Melanoma AJCC v7|Stage IIIC Breast Cancer AJCC v7|Stage IIIC Colorectal Cancer AJCC v7|Stage IIIC Cutaneous Melanoma AJCC v7|Stage IV Breast Cancer AJCC v6 and v7|Stage IV Colorectal Cancer AJCC v7|Stage IV Cutaneous Melanoma AJCC v6 and v7|Stage IV Lung Cancer AJCC v7|Stage IV Pancreatic Cancer AJCC v6 and v7|Stage IV Prostate Cancer AJCC v7|Stage IV Renal Cell Cancer AJCC v7|Stage IV Soft Tissue Sarcoma AJCC v7|Stage IVA Colorectal Cancer AJCC v7|Stage IVB Colorectal Cancer AJCC v7|Unresectable Solid Neoplasm,Romidepsin,CC=C1C(=O)NC(C(=O)OC2CC(=O)NC(C(=O)NC(CSSCCC=C2)C(=O)N1)C(C)C)C(C)C,PHASE1,skin_and_connective_tissue_disease
889,"Lung Diseases, Interstitial|Systemic Sclerosis|Scleroderma",Bortezomib,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O,PHASE2,skin_and_connective_tissue_disease
890,"Lung Diseases, Interstitial|Systemic Sclerosis|Scleroderma",Mycophenolate,CC1=C2COC(=O)C2=C(C(=C1OC)CC=C(C)CCC(=O)O)O,PHASE2,skin_and_connective_tissue_disease
891,Giant Cell Arteritis,Methotrexate,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,PHASE2,skin_and_connective_tissue_disease
892,Small-cell Lung Cancer|Soft Tissue Sarcoma|Triple-negative Breast Cancer|Ovarian Cancer|Endometrial Cancer,Tinostamustine,CN1C2=C(C=C(C=C2)N(CCCl)CCCl)N=C1CCCCCCC(=O)NO,PHASE1|PHASE2,skin_and_connective_tissue_disease
893,Pulmonary Vascular Disorder|Primary Pulmonary Hypertension|Systemic Sclerosis|Other Systemic Involvement of Connective Tissue,Riociguat,CN(C1=C(N=C(N=C1N)C2=NN(C3=C2C=CC=N3)CC4=CC=CC=C4F)N)C(=O)OC,PHASE2,skin_and_connective_tissue_disease
894,"Sarcoma, Kaposi|HIV Infections",Nelfinavir,CC1=C(C=CC=C1O)C(=O)NC(CSC2=CC=CC=C2)C(CN3CC4CCCCC4CC3C(=O)NC(C)(C)C)O,PHASE2,skin_and_connective_tissue_disease
895,Skin Infection|Bacterial Infection,Daptomycin,CCCCCCCCCC(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(CC(=O)N)C(=O)NC(CC(=O)O)C(=O)NC3C(OC(=O)C(NC(=O)C(NC(=O)C(NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)CNC3=O)CCCN)CC(=O)O)C)CC(=O)O)CO)C(C)CC(=O)O)CC(=O)C4=CC=CC=C4N)C,PHASE2,skin_and_connective_tissue_disease
896,Skin Infection|Bacterial Infection,Brilacidin,C1CNCC1OC2=C(C=C(C=C2NC(=O)C3=CC(=NC=N3)C(=O)NC4=CC(=CC(=C4OC5CCNC5)NC(=O)CCCCN=C(N)N)C(F)(F)F)C(F)(F)F)NC(=O)CCCCN=C(N)N,PHASE2,skin_and_connective_tissue_disease
897,Polymyalgia Rheumatica|Inflammatory Diseases,Prednisone,CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C,PHASE2,skin_and_connective_tissue_disease
898,Giant Cell Arteritis,Prednisolone,CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O,PHASE2,skin_and_connective_tissue_disease
899,Menkes Disease|Occipital Horn Syndrome,Droxidopa,C1=CC(=C(C=C1C(C(C(=O)O)N)O)O)O,PHASE1|PHASE2,skin_and_connective_tissue_disease
900,Mastocytosis,Hydroxychloroquine,CCN(CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl)CCO,PHASE2|PHASE3,skin_and_connective_tissue_disease
901,Advanced Cancer|Malignant Neoplasm of Breast|Malignant Neoplasms of Bone and Articular Cartilage|Malignant Neoplasms of Digestive Organs|Malignant Neoplasms of Eye Brain and Other Parts of Central Nervous System|Malignant Neoplasms of Female Genital Organs|Malignant Neoplasms of Ill-defined Secondary and Unspecified Sites|Malignant Neoplasms of Independent (Primary) Multiple Sites|Malignant Neoplasms of Lip Oral Cavity and Pharynx|Malignant Neoplasms of Male Genital Organs|Malignant Neoplasms of Mesothelial and Soft Tissue|Malignant Neoplasms of Respiratory and Intrathoracic Organs|Malignant Neoplasms of Thyroid and Other Endocrine Glands|Malignant Neoplasms of Urinary Tract,Lenvatinib,COC1=CC2=NC=CC(=C2C=C1C(=O)N)OC3=CC(=C(C=C3)NC(=O)NC4CC4)Cl,PHASE1,skin_and_connective_tissue_disease
902,Advanced Cancer|Malignant Neoplasm of Breast|Malignant Neoplasms of Bone and Articular Cartilage|Malignant Neoplasms of Digestive Organs|Malignant Neoplasms of Eye Brain and Other Parts of Central Nervous System|Malignant Neoplasms of Female Genital Organs|Malignant Neoplasms of Ill-defined Secondary and Unspecified Sites|Malignant Neoplasms of Independent (Primary) Multiple Sites|Malignant Neoplasms of Lip Oral Cavity and Pharynx|Malignant Neoplasms of Male Genital Organs|Malignant Neoplasms of Mesothelial and Soft Tissue|Malignant Neoplasms of Respiratory and Intrathoracic Organs|Malignant Neoplasms of Thyroid and Other Endocrine Glands|Malignant Neoplasms of Urinary Tract,Capecitabine,CCCCCOC(=O)NC1=NC(=O)N(C=C1F)C2C(C(C(O2)C)O)O,PHASE1,skin_and_connective_tissue_disease
903,Polymyalgia Rheumatica|Effect of Drug|Safety Issues,Tofacitinib,CC1CCN(CC1N(C)C2=NC=NC3=C2C=CN3)C(=O)CC#N,PHASE2,skin_and_connective_tissue_disease
904,"Systemic Sclerosis|Scleroderma|Diffuse Systemic Sclerosis|Diffuse Scleroderma|Diffuse Cutaneous Systemic Sclerosis|Diffuse Cutaneous Scleroderma|Progressive Systemic Sclerosis|Progressive Scleroderma|Scleroderma, Systemic|Scleroderma, Diffuse|Scleroderma;Progressive|Systemic Sclerosis, Diffuse|Systemic; Sclerosis, Progressive|Scleroderma of Lung|Scleroderma With Pulmonary Involvement|Systemic Sclerosis Pulmonary|Systemic Sclerosis With Lung Involvement|Interstitial Lung Disease|Pulmonary Fibrosis Interstitial",Ixazomib,B(C(CC(C)C)NC(=O)CNC(=O)C1=C(C=CC(=C1)Cl)Cl)(O)O,PHASE2,skin_and_connective_tissue_disease
905,Staphylococcal Skin Infections|Streptococcal Infections,Ceftobiprole,C1CNCC1N2CCC(=CC3=C(N4C(C(C4=O)NC(=O)C(=NO)C5=NSC(=N5)N)SC3)C(=O)O)C2=O,PHASE1,skin_and_connective_tissue_disease
906,Breast Carcinoma|Endometrial Clear Cell Adenocarcinoma|Endometrial Serous Adenocarcinoma|Uterine Corpus Cancer|Uterine Corpus Carcinosarcoma,Metformin,CN(C)C(=N)N=C(N)N,PHASE2,skin_and_connective_tissue_disease
907,Breast Carcinoma|Endometrial Clear Cell Adenocarcinoma|Endometrial Serous Adenocarcinoma|Uterine Corpus Cancer|Uterine Corpus Carcinosarcoma,Doxycycline,CC1C2C(C3C(C(=O)C(=C(C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O,PHASE2,skin_and_connective_tissue_disease
908,"Arthritis, Rheumatoid",Cantharidin,CC12C3CCC(C1(C(=O)OC2=O)C)O3,PHASE1,skin_and_connective_tissue_disease
909,Raynaud's Phenomenon Secondary to Systemic Sclerosis,Alprostadil,CCCCCC(C=CC1C(CC(=O)C1CCCCCCC(=O)O)O)O,PHASE2,skin_and_connective_tissue_disease
910,Solid Tumors|Soft-tissue Sarcoma|Breast Cancer,Cyclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,PHASE1|PHASE2,skin_and_connective_tissue_disease
911,Systemic Sclerosis,Itacitinib,C1CN(CCC1N2CC(C2)(CC#N)N3C=C(C=N3)C4=C5C=CNC5=NC=N4)C(=O)C6=C(C(=NC=C6)C(F)(F)F)F,PHASE2,skin_and_connective_tissue_disease
912,Skin Infections (Acne),Isotretinoin,CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CC(=O)O)C)C,PHASE1,skin_and_connective_tissue_disease
913,Digital Ulcer of Scleroderma,Diltiazem,CC(=O)OC1C(SC2=CC=CC=C2N(C1=O)CCN(C)C)C3=CC=C(C=C3)OC,PHASE2,skin_and_connective_tissue_disease
914,Liposarcoma|CRC|Prostate Cancer|Breast Neoplasms|Adenocarcinoma of Lung|Solid Tumors,Letrozole,C1=CC(=CC=C1C#N)C(C2=CC=C(C=C2)C#N)N3C=NC=N3,PHASE1|PHASE2,skin_and_connective_tissue_disease
915,Liposarcoma|CRC|Prostate Cancer|Breast Neoplasms|Adenocarcinoma of Lung|Solid Tumors,Fulvestrant,CC12CCC3C(C1CCC2O)C(CC4=C3C=CC(=C4)O)CCCCCCCCCS(=O)CCCC(C(F)(F)F)(F)F,PHASE1|PHASE2,skin_and_connective_tissue_disease
916,Liposarcoma|CRC|Prostate Cancer|Breast Neoplasms|Adenocarcinoma of Lung|Solid Tumors,Midazolam,CC1=NC=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4F,PHASE1|PHASE2,skin_and_connective_tissue_disease
917,Liposarcoma|CRC|Prostate Cancer|Breast Neoplasms|Adenocarcinoma of Lung|Solid Tumors,Enzalutamide,CC1(C(=O)N(C(=S)N1C2=CC(=C(C=C2)C(=O)NC)F)C3=CC(=C(C=C3)C#N)C(F)(F)F)C,PHASE1|PHASE2,skin_and_connective_tissue_disease
918,"Osteoarthritis|Arthritis, Rheumatoid|Arthritis, Psoriatic",Naltrexone,C1CC1CN2CCC34C5C(=O)CCC3(C2CC6=C4C(=C(C=C6)O)O5)O,PHASE2,skin_and_connective_tissue_disease
919,Breast Neoplasms|Breast Cancer|Breast Tumors|Angiosarcoma|TNBC - Triple-Negative Breast Cancer|HER2-positive Breast Cancer|HER2-negative Breast Cancer|Hormone Receptor Positive Tumor|Hormone Receptor Negative Tumor|Early-stage Breast Cancer|Locally Advanced Breast Cancer,Ganetespib,CC(C)C1=C(C=C(C(=C1)C2=NNC(=O)N2C3=CC4=C(C=C3)N(C=C4)C)O)O,PHASE2,skin_and_connective_tissue_disease
920,Breast Neoplasms|Breast Cancer|Breast Tumors|Angiosarcoma|TNBC - Triple-Negative Breast Cancer|HER2-positive Breast Cancer|HER2-negative Breast Cancer|Hormone Receptor Positive Tumor|Hormone Receptor Negative Tumor|Early-stage Breast Cancer|Locally Advanced Breast Cancer,Neratinib,CCOC1=C(C=C2C(=C1)N=CC(=C2NC3=CC(=C(C=C3)OCC4=CC=CC=N4)Cl)C#N)NC(=O)C=CCN(C)C,PHASE2,skin_and_connective_tissue_disease
921,Breast Neoplasms|Breast Cancer|Breast Tumors|Angiosarcoma|TNBC - Triple-Negative Breast Cancer|HER2-positive Breast Cancer|HER2-negative Breast Cancer|Hormone Receptor Positive Tumor|Hormone Receptor Negative Tumor|Early-stage Breast Cancer|Locally Advanced Breast Cancer,Talazoparib,CN1C(=NC=N1)C2C(NC3=CC(=CC4=C3C2=NNC4=O)F)C5=CC=C(C=C5)F,PHASE2,skin_and_connective_tissue_disease
922,Breast Neoplasms|Breast Cancer|Breast Tumors|Angiosarcoma|TNBC - Triple-Negative Breast Cancer|HER2-positive Breast Cancer|HER2-negative Breast Cancer|Hormone Receptor Positive Tumor|Hormone Receptor Negative Tumor|Early-stage Breast Cancer|Locally Advanced Breast Cancer,Irinotecan,CCC1=C2CN3C(=CC4=C(C3=O)COC(=O)C4(CC)O)C2=NC5=C1C=C(C=C5)OC(=O)N6CCC(CC6)N7CCCCC7,PHASE2,skin_and_connective_tissue_disease
923,Breast Neoplasms|Breast Cancer|Breast Tumors|Angiosarcoma|TNBC - Triple-Negative Breast Cancer|HER2-positive Breast Cancer|HER2-negative Breast Cancer|Hormone Receptor Positive Tumor|Hormone Receptor Negative Tumor|Early-stage Breast Cancer|Locally Advanced Breast Cancer,Olaparib,C1CC1C(=O)N2CCN(CC2)C(=O)C3=C(C=CC(=C3)CC4=NNC(=O)C5=CC=CC=C54)F,PHASE2,skin_and_connective_tissue_disease
924,Breast Neoplasms|Breast Cancer|Breast Tumors|Angiosarcoma|TNBC - Triple-Negative Breast Cancer|HER2-positive Breast Cancer|HER2-negative Breast Cancer|Hormone Receptor Positive Tumor|Hormone Receptor Negative Tumor|Early-stage Breast Cancer|Locally Advanced Breast Cancer,Tucatinib,CC1=C(C=CC(=C1)NC2=NC=NC3=C2C=C(C=C3)NC4=NC(CO4)(C)C)OC5=CC6=NC=NN6C=C5,PHASE2,skin_and_connective_tissue_disease
925,Breast Neoplasms|Breast Cancer|Breast Tumors|Angiosarcoma|TNBC - Triple-Negative Breast Cancer|HER2-positive Breast Cancer|HER2-negative Breast Cancer|Hormone Receptor Positive Tumor|Hormone Receptor Negative Tumor|Early-stage Breast Cancer|Locally Advanced Breast Cancer,Trilaciclib,CN1CCN(CC1)C2=CN=C(C=C2)NC3=NC=C4C=C5C(=O)NCC6(N5C4=N3)CCCCC6,PHASE2,skin_and_connective_tissue_disease
926,Breast Neoplasms|Breast Cancer|Breast Tumors|Angiosarcoma|TNBC - Triple-Negative Breast Cancer|HER2-positive Breast Cancer|HER2-negative Breast Cancer|Hormone Receptor Positive Tumor|Hormone Receptor Negative Tumor|Early-stage Breast Cancer|Locally Advanced Breast Cancer,Paclitaxel,CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C,PHASE2,skin_and_connective_tissue_disease
927,Breast Neoplasms|Breast Cancer|Breast Tumors|Angiosarcoma|TNBC - Triple-Negative Breast Cancer|HER2-positive Breast Cancer|HER2-negative Breast Cancer|Hormone Receptor Positive Tumor|Hormone Receptor Negative Tumor|Early-stage Breast Cancer|Locally Advanced Breast Cancer,Carboplatin,C1CC(C1)(C(=O)O)C(=O)O.[NH2-].[NH2-].[Pt+2],PHASE2,skin_and_connective_tissue_disease
928,Breast Neoplasms|Breast Cancer|Breast Tumors|Angiosarcoma|TNBC - Triple-Negative Breast Cancer|HER2-positive Breast Cancer|HER2-negative Breast Cancer|Hormone Receptor Positive Tumor|Hormone Receptor Negative Tumor|Early-stage Breast Cancer|Locally Advanced Breast Cancer,Abemaciclib,CCN1CCN(CC1)CC2=CN=C(C=C2)NC3=NC=C(C(=N3)C4=CC5=C(C(=C4)F)N=C(N5C(C)C)C)F,PHASE2,skin_and_connective_tissue_disease
929,Breast Neoplasms|Breast Cancer|Breast Tumors|Angiosarcoma|TNBC - Triple-Negative Breast Cancer|HER2-positive Breast Cancer|HER2-negative Breast Cancer|Hormone Receptor Positive Tumor|Hormone Receptor Negative Tumor|Early-stage Breast Cancer|Locally Advanced Breast Cancer,Lasofoxifene,C1CCN(C1)CCOC2=CC=C(C=C2)C3C(CCC4=C3C=CC(=C4)O)C5=CC=CC=C5,PHASE2,skin_and_connective_tissue_disease
930,Scleroderma|Scleroderma Renal Crisis|Chronic Kidney Disease,Zibotentan,CC1=CN=C(C(=N1)OC)NS(=O)(=O)C2=C(N=CC=C2)C3=CC=C(C=C3)C4=NN=CO4,PHASE2,skin_and_connective_tissue_disease
931,Human Immunodeficiency Virus 1 Positive|Skin Kaposi Sarcoma,Pomalidomide,C1CC(=O)NC(=O)C1N2C(=O)C3=C(C2=O)C(=CC=C3)N,PHASE2,skin_and_connective_tissue_disease
932,Bone Sarcoma|Dedifferentiated Chondrosarcoma|Giant Cell Tumor of Bone|Malignancy in Giant Cell Tumor of Bone|Malignant Solid Neoplasm|Ovarian Carcinosarcoma|Platinum-Resistant Ovarian Carcinoma|Poorly Differentiated Thyroid Gland Carcinoma|Recurrent Osteosarcoma|Recurrent Ovarian Carcinoma|Refractory Osteosarcoma|Soft Tissue Sarcoma|Thyroid Gland Anaplastic Carcinoma|Thyroid Gland Squamous Cell Carcinoma|Undifferentiated High Grade Pleomorphic Sarcoma of Bone|Triple Negative Breast Cancer,Fludarabine,C1=NC2=C(N=C(N=C2N1C3C(C(C(O3)CO)O)O)F)N,PHASE2,skin_and_connective_tissue_disease
933,Scleroderma,Clobetasol,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CCl)O)C)O)F)C,PHASE1,skin_and_connective_tissue_disease
934,Scleroderma,Calcipotriol,CC(C=CC(C1CC1)O)C2CCC3C2(CCCC3=CC=C4CC(CC(C4=C)O)O)C,PHASE1,skin_and_connective_tissue_disease
935,Scleroderma,Calcipotriene,CC(C=CC(C1CC1)O)C2CCC3C2(CCCC3=CC=C4CC(CC(C4=C)O)O)C,PHASE1,skin_and_connective_tissue_disease
936,Scleroderma,Tacrolimus,CC1CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC(=O)C(C=C(C1)C)CC=C)O)C)C(=CC4CCC(C(C4)OC)O)C)O)C)OC)OC,PHASE1,skin_and_connective_tissue_disease
937,Systemic Sclerosis,Nilotinib,CC1=C(C=C(C=C1)C(=O)NC2=CC(=CC(=C2)C(F)(F)F)N3C=C(N=C3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,PHASE2,skin_and_connective_tissue_disease
938,Advanced Malignant Solid Neoplasm|C-KIT Tyrosine Kinase Protein Overexpression|Clinical Stage IV Cutaneous Melanoma AJCC v8|Metastatic Gastrointestinal Stromal Tumor|Metastatic Malignant Solid Neoplasm|Metastatic Melanoma|Pathologic Stage IV Cutaneous Melanoma AJCC v8|Unresectable Melanoma|Unresectable Solid Neoplasm,Imatinib,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,PHASE1,skin_and_connective_tissue_disease
939,Community Acquired Pneumonia|Staphylococcal Skin Infections,Friulimicin B,CC1C(C(=O)N2CCCCC2C(=O)NC(C(=O)NC(C(=O)NCC(=O)NC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)N3CCCC3C(=O)N1)C(C)C)C(C)N)CC(=O)O)CC(=O)O)C(C)C(=O)O)NC(=O)C(CC(=O)N)NC(=O)CC=CCCCCCCCC(C)C,PHASE1,skin_and_connective_tissue_disease
940,Skin and Connective Tissue Diseases,Betamethasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,PHASE1,skin_and_connective_tissue_disease
941,"Lupus Erythematosus, Cutaneous",Alitretinoin,CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CC(=O)O)C)C,PHASE2,skin_and_connective_tissue_disease
942,Advanced Solid Tumors|HR+ Breast Cancer|CCNE1 Amplification|HER2-negative Breast Cancer|Ovarian Cancer|Endometrial Cancer|Gastric Cancer|Esophageal Adenocarcinoma|Carcinosarcoma,Ribociclib,CN(C)C(=O)C1=CC2=CN=C(N=C2N1C3CCCC3)NC4=NC=C(C=C4)N5CCNCC5,PHASE1|PHASE2,skin_and_connective_tissue_disease
943,Anatomic Stage IV Breast Cancer AJCC v8|Clinical Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8|Clinical Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8|Clinical Stage IVB Gastroesophageal Junction Adenocarcinoma AJCC v8|Locally Advanced Malignant Solid Neoplasm|Locally Advanced Melanoma|Locally Advanced Primary Malignant Central Nervous System Neoplasm|Locally Advanced Sarcoma|Metastatic Malignant Solid Neoplasm|Metastatic Melanoma|Metastatic Primary Malignant Central Nervous System Neoplasm|Metastatic Sarcoma|Pathologic Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8|Pathologic Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8|Pathologic Stage IVB Gastroesophageal Junction Adenocarcinoma AJCC v8|Postneoadjuvant Therapy Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8|Postneoadjuvant Therapy Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8|Postneoadjuvant Therapy Stage IVB Gastroesophageal Junction Adenocarcinoma AJCC v8|Prognostic Stage IIIC Breast Cancer AJCC v8|Prognostic Stage IV Breast Cancer AJCC v8|Stage IIIC Colorectal Cancer AJCC v8|Stage IIIC Lung Cancer AJCC v8|Stage IV Colorectal Cancer AJCC v8|Stage IV Lung Cancer AJCC v8|Stage IVA Colorectal Cancer AJCC v8|Stage IVA Lung Cancer AJCC v8|Stage IVB Colorectal Cancer AJCC v8|Stage IVB Lung Cancer AJCC v8|Stage IVC Colorectal Cancer AJCC v8,Avapritinib,CC(C1=CC=C(C=C1)F)(C2=CN=C(N=C2)N3CCN(CC3)C4=NC=NN5C4=CC(=C5)C6=CN(N=C6)C)N,PHASE2,skin_and_connective_tissue_disease
944,"Skin Infections, Bacterial",Retapamulin,CC1CCC23CCC(=O)C2C1(C(CC(C(C3C)O)(C)C=C)OC(=O)CSC4CC5CCC(C4)N5C)C,PHASE1,skin_and_connective_tissue_disease
945,Dermatomyositis,Baricitinib,CCS(=O)(=O)N1CC(C1)(CC#N)N2C=C(C=N2)C3=C4C=CNC4=NC=N3,PHASE2,skin_and_connective_tissue_disease
946,Recurrent Cutaneous Melanoma|Recurrent Lip and Oral Cavity Carcinoma|Recurrent Malignant Endocrine Neoplasm|Recurrent Malignant Female Reproductive System Neoplasm|Recurrent Malignant Male Reproductive System Neoplasm|Recurrent Malignant Mesothelioma|Recurrent Malignant Neoplasm of Multiple Primary Sites|Recurrent Malignant Oral Neoplasm|Recurrent Malignant Pharyngeal Neoplasm|Recurrent Malignant Skin Neoplasm|Recurrent Malignant Soft Tissue Neoplasm|Recurrent Malignant Solid Neoplasm|Recurrent Malignant Thyroid Gland Neoplasm|Recurrent Malignant Urinary System Neoplasm|Refractory Cutaneous Melanoma|Refractory Malignant Bone Neoplasm|Refractory Malignant Endocrine Neoplasm|Refractory Malignant Female Reproductive System Neoplasm|Refractory Malignant Male Reproductive System Neoplasm|Refractory Malignant Mesothelioma|Refractory Malignant Neoplasm of Multiple Primary Sites|Refractory Malignant Oral Neoplasm|Refractory Malignant Pharyngeal Neoplasm|Refractory Malignant Skin Neoplasm|Refractory Malignant Soft Tissue Neoplasm|Refractory Malignant Solid Neoplasm|Refractory Malignant Thyroid Gland Neoplasm|Refractory Malignant Urinary System Neoplasm,Etoposide,CC1OCC2C(O1)C(C(C(O2)OC3C4COC(=O)C4C(C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)O)OC)O)O,PHASE1,skin_and_connective_tissue_disease
947,Advanced Malignant Solid Neoplasm|Ann Arbor Stage III Non-Hodgkin Lymphoma|Ann Arbor Stage IV Non-Hodgkin Lymphoma|Histiocytic Sarcoma|Juvenile Xanthogranuloma|Langerhans Cell Histiocytosis|Malignant Glioma|Recurrent Childhood Rhabdomyosarcoma|Recurrent Ependymoma|Recurrent Ewing Sarcoma|Recurrent Glioma|Recurrent Hepatoblastoma|Recurrent Langerhans Cell Histiocytosis|Recurrent Malignant Germ Cell Tumor|Recurrent Malignant Solid Neoplasm|Recurrent Medulloblastoma|Recurrent Neuroblastoma|Recurrent Non-Hodgkin Lymphoma|Recurrent Osteosarcoma|Recurrent Peripheral Primitive Neuroectodermal Tumor|Recurrent Primary Central Nervous System Neoplasm|Recurrent Rhabdoid Tumor|Recurrent Soft Tissue Sarcoma|Refractory Ewing Sarcoma|Refractory Glioma|Refractory Hepatoblastoma|Refractory Langerhans Cell Histiocytosis|Refractory Malignant Germ Cell Tumor|Refractory Malignant Solid Neoplasm|Refractory Medulloblastoma|Refractory Neuroblastoma|Refractory Non-Hodgkin Lymphoma|Refractory Osteosarcoma|Refractory Peripheral Primitive Neuroectodermal Tumor|Refractory Primary Central Nervous System Neoplasm|Refractory Rhabdoid Tumor|Refractory Rhabdomyosarcoma|Rhabdoid Tumor|Stage III Osteosarcoma AJCC v7|Stage III Soft Tissue Sarcoma AJCC v7|Stage IV Osteosarcoma AJCC v7|Stage IV Soft Tissue Sarcoma AJCC v7|Stage IVA Osteosarcoma AJCC v7|Stage IVB Osteosarcoma AJCC v7|Wilms Tumor,Ensartinib,CC1CN(CC(N1)C)C(=O)C2=CC=C(C=C2)NC(=O)C3=NN=C(C(=C3)OC(C)C4=C(C=CC(=C4Cl)F)Cl)N,PHASE2,skin_and_connective_tissue_disease
948,Advanced Malignant Solid Neoplasm|Ann Arbor Stage III Non-Hodgkin Lymphoma|Ann Arbor Stage IV Non-Hodgkin Lymphoma|Histiocytic Sarcoma|Juvenile Xanthogranuloma|Langerhans Cell Histiocytosis|Malignant Glioma|Recurrent Childhood Rhabdomyosarcoma|Recurrent Ependymoma|Recurrent Ewing Sarcoma|Recurrent Glioma|Recurrent Hepatoblastoma|Recurrent Langerhans Cell Histiocytosis|Recurrent Malignant Germ Cell Tumor|Recurrent Malignant Solid Neoplasm|Recurrent Medulloblastoma|Recurrent Neuroblastoma|Recurrent Non-Hodgkin Lymphoma|Recurrent Osteosarcoma|Recurrent Peripheral Primitive Neuroectodermal Tumor|Recurrent Primary Central Nervous System Neoplasm|Recurrent Rhabdoid Tumor|Recurrent Soft Tissue Sarcoma|Refractory Ewing Sarcoma|Refractory Glioma|Refractory Hepatoblastoma|Refractory Langerhans Cell Histiocytosis|Refractory Malignant Germ Cell Tumor|Refractory Malignant Solid Neoplasm|Refractory Medulloblastoma|Refractory Neuroblastoma|Refractory Non-Hodgkin Lymphoma|Refractory Osteosarcoma|Refractory Peripheral Primitive Neuroectodermal Tumor|Refractory Primary Central Nervous System Neoplasm|Refractory Rhabdoid Tumor|Refractory Rhabdomyosarcoma|Rhabdoid Tumor|Stage III Osteosarcoma AJCC v7|Stage III Soft Tissue Sarcoma AJCC v7|Stage IV Osteosarcoma AJCC v7|Stage IV Soft Tissue Sarcoma AJCC v7|Stage IVA Osteosarcoma AJCC v7|Stage IVB Osteosarcoma AJCC v7|Wilms Tumor,Erdafitinib,CC(C)NCCN(C1=CC2=NC(=CN=C2C=C1)C3=CN(N=C3)C)C4=CC(=CC(=C4)OC)OC,PHASE2,skin_and_connective_tissue_disease
949,Advanced Malignant Solid Neoplasm|Ann Arbor Stage III Non-Hodgkin Lymphoma|Ann Arbor Stage IV Non-Hodgkin Lymphoma|Histiocytic Sarcoma|Juvenile Xanthogranuloma|Langerhans Cell Histiocytosis|Malignant Glioma|Recurrent Childhood Rhabdomyosarcoma|Recurrent Ependymoma|Recurrent Ewing Sarcoma|Recurrent Glioma|Recurrent Hepatoblastoma|Recurrent Langerhans Cell Histiocytosis|Recurrent Malignant Germ Cell Tumor|Recurrent Malignant Solid Neoplasm|Recurrent Medulloblastoma|Recurrent Neuroblastoma|Recurrent Non-Hodgkin Lymphoma|Recurrent Osteosarcoma|Recurrent Peripheral Primitive Neuroectodermal Tumor|Recurrent Primary Central Nervous System Neoplasm|Recurrent Rhabdoid Tumor|Recurrent Soft Tissue Sarcoma|Refractory Ewing Sarcoma|Refractory Glioma|Refractory Hepatoblastoma|Refractory Langerhans Cell Histiocytosis|Refractory Malignant Germ Cell Tumor|Refractory Malignant Solid Neoplasm|Refractory Medulloblastoma|Refractory Neuroblastoma|Refractory Non-Hodgkin Lymphoma|Refractory Osteosarcoma|Refractory Peripheral Primitive Neuroectodermal Tumor|Refractory Primary Central Nervous System Neoplasm|Refractory Rhabdoid Tumor|Refractory Rhabdomyosarcoma|Rhabdoid Tumor|Stage III Osteosarcoma AJCC v7|Stage III Soft Tissue Sarcoma AJCC v7|Stage IV Osteosarcoma AJCC v7|Stage IV Soft Tissue Sarcoma AJCC v7|Stage IVA Osteosarcoma AJCC v7|Stage IVB Osteosarcoma AJCC v7|Wilms Tumor,Larotrectinib,C1CC(N(C1)C2=NC3=C(C=NN3C=C2)NC(=O)N4CCC(C4)O)C5=C(C=CC(=C5)F)F,PHASE2,skin_and_connective_tissue_disease
950,Advanced Malignant Solid Neoplasm|Ann Arbor Stage III Non-Hodgkin Lymphoma|Ann Arbor Stage IV Non-Hodgkin Lymphoma|Histiocytic Sarcoma|Juvenile Xanthogranuloma|Langerhans Cell Histiocytosis|Malignant Glioma|Recurrent Childhood Rhabdomyosarcoma|Recurrent Ependymoma|Recurrent Ewing Sarcoma|Recurrent Glioma|Recurrent Hepatoblastoma|Recurrent Langerhans Cell Histiocytosis|Recurrent Malignant Germ Cell Tumor|Recurrent Malignant Solid Neoplasm|Recurrent Medulloblastoma|Recurrent Neuroblastoma|Recurrent Non-Hodgkin Lymphoma|Recurrent Osteosarcoma|Recurrent Peripheral Primitive Neuroectodermal Tumor|Recurrent Primary Central Nervous System Neoplasm|Recurrent Rhabdoid Tumor|Recurrent Soft Tissue Sarcoma|Refractory Ewing Sarcoma|Refractory Glioma|Refractory Hepatoblastoma|Refractory Langerhans Cell Histiocytosis|Refractory Malignant Germ Cell Tumor|Refractory Malignant Solid Neoplasm|Refractory Medulloblastoma|Refractory Neuroblastoma|Refractory Non-Hodgkin Lymphoma|Refractory Osteosarcoma|Refractory Peripheral Primitive Neuroectodermal Tumor|Refractory Primary Central Nervous System Neoplasm|Refractory Rhabdoid Tumor|Refractory Rhabdomyosarcoma|Rhabdoid Tumor|Stage III Osteosarcoma AJCC v7|Stage III Soft Tissue Sarcoma AJCC v7|Stage IV Osteosarcoma AJCC v7|Stage IV Soft Tissue Sarcoma AJCC v7|Stage IVA Osteosarcoma AJCC v7|Stage IVB Osteosarcoma AJCC v7|Wilms Tumor,Palbociclib,CC1=C(C(=O)N(C2=NC(=NC=C12)NC3=NC=C(C=C3)N4CCNCC4)C5CCCC5)C(=O)C,PHASE2,skin_and_connective_tissue_disease
951,Advanced Malignant Solid Neoplasm|Ann Arbor Stage III Non-Hodgkin Lymphoma|Ann Arbor Stage IV Non-Hodgkin Lymphoma|Histiocytic Sarcoma|Juvenile Xanthogranuloma|Langerhans Cell Histiocytosis|Malignant Glioma|Recurrent Childhood Rhabdomyosarcoma|Recurrent Ependymoma|Recurrent Ewing Sarcoma|Recurrent Glioma|Recurrent Hepatoblastoma|Recurrent Langerhans Cell Histiocytosis|Recurrent Malignant Germ Cell Tumor|Recurrent Malignant Solid Neoplasm|Recurrent Medulloblastoma|Recurrent Neuroblastoma|Recurrent Non-Hodgkin Lymphoma|Recurrent Osteosarcoma|Recurrent Peripheral Primitive Neuroectodermal Tumor|Recurrent Primary Central Nervous System Neoplasm|Recurrent Rhabdoid Tumor|Recurrent Soft Tissue Sarcoma|Refractory Ewing Sarcoma|Refractory Glioma|Refractory Hepatoblastoma|Refractory Langerhans Cell Histiocytosis|Refractory Malignant Germ Cell Tumor|Refractory Malignant Solid Neoplasm|Refractory Medulloblastoma|Refractory Neuroblastoma|Refractory Non-Hodgkin Lymphoma|Refractory Osteosarcoma|Refractory Peripheral Primitive Neuroectodermal Tumor|Refractory Primary Central Nervous System Neoplasm|Refractory Rhabdoid Tumor|Refractory Rhabdomyosarcoma|Rhabdoid Tumor|Stage III Osteosarcoma AJCC v7|Stage III Soft Tissue Sarcoma AJCC v7|Stage IV Osteosarcoma AJCC v7|Stage IV Soft Tissue Sarcoma AJCC v7|Stage IVA Osteosarcoma AJCC v7|Stage IVB Osteosarcoma AJCC v7|Wilms Tumor,Selpercatinib,CC(C)(COC1=CN2C(=C(C=N2)C#N)C(=C1)C3=CN=C(C=C3)N4CC5CC(C4)N5CC6=CN=C(C=C6)OC)O,PHASE2,skin_and_connective_tissue_disease
952,Advanced Malignant Solid Neoplasm|Ann Arbor Stage III Non-Hodgkin Lymphoma|Ann Arbor Stage IV Non-Hodgkin Lymphoma|Histiocytic Sarcoma|Juvenile Xanthogranuloma|Langerhans Cell Histiocytosis|Malignant Glioma|Recurrent Childhood Rhabdomyosarcoma|Recurrent Ependymoma|Recurrent Ewing Sarcoma|Recurrent Glioma|Recurrent Hepatoblastoma|Recurrent Langerhans Cell Histiocytosis|Recurrent Malignant Germ Cell Tumor|Recurrent Malignant Solid Neoplasm|Recurrent Medulloblastoma|Recurrent Neuroblastoma|Recurrent Non-Hodgkin Lymphoma|Recurrent Osteosarcoma|Recurrent Peripheral Primitive Neuroectodermal Tumor|Recurrent Primary Central Nervous System Neoplasm|Recurrent Rhabdoid Tumor|Recurrent Soft Tissue Sarcoma|Refractory Ewing Sarcoma|Refractory Glioma|Refractory Hepatoblastoma|Refractory Langerhans Cell Histiocytosis|Refractory Malignant Germ Cell Tumor|Refractory Malignant Solid Neoplasm|Refractory Medulloblastoma|Refractory Neuroblastoma|Refractory Non-Hodgkin Lymphoma|Refractory Osteosarcoma|Refractory Peripheral Primitive Neuroectodermal Tumor|Refractory Primary Central Nervous System Neoplasm|Refractory Rhabdoid Tumor|Refractory Rhabdomyosarcoma|Rhabdoid Tumor|Stage III Osteosarcoma AJCC v7|Stage III Soft Tissue Sarcoma AJCC v7|Stage IV Osteosarcoma AJCC v7|Stage IV Soft Tissue Sarcoma AJCC v7|Stage IVA Osteosarcoma AJCC v7|Stage IVB Osteosarcoma AJCC v7|Wilms Tumor,Selumetinib,CN1C=NC2=C1C=C(C(=C2F)NC3=C(C=C(C=C3)Br)Cl)C(=O)NOCCO,PHASE2,skin_and_connective_tissue_disease
953,Advanced Malignant Solid Neoplasm|Ann Arbor Stage III Non-Hodgkin Lymphoma|Ann Arbor Stage IV Non-Hodgkin Lymphoma|Histiocytic Sarcoma|Juvenile Xanthogranuloma|Langerhans Cell Histiocytosis|Malignant Glioma|Recurrent Childhood Rhabdomyosarcoma|Recurrent Ependymoma|Recurrent Ewing Sarcoma|Recurrent Glioma|Recurrent Hepatoblastoma|Recurrent Langerhans Cell Histiocytosis|Recurrent Malignant Germ Cell Tumor|Recurrent Malignant Solid Neoplasm|Recurrent Medulloblastoma|Recurrent Neuroblastoma|Recurrent Non-Hodgkin Lymphoma|Recurrent Osteosarcoma|Recurrent Peripheral Primitive Neuroectodermal Tumor|Recurrent Primary Central Nervous System Neoplasm|Recurrent Rhabdoid Tumor|Recurrent Soft Tissue Sarcoma|Refractory Ewing Sarcoma|Refractory Glioma|Refractory Hepatoblastoma|Refractory Langerhans Cell Histiocytosis|Refractory Malignant Germ Cell Tumor|Refractory Malignant Solid Neoplasm|Refractory Medulloblastoma|Refractory Neuroblastoma|Refractory Non-Hodgkin Lymphoma|Refractory Osteosarcoma|Refractory Peripheral Primitive Neuroectodermal Tumor|Refractory Primary Central Nervous System Neoplasm|Refractory Rhabdoid Tumor|Refractory Rhabdomyosarcoma|Rhabdoid Tumor|Stage III Osteosarcoma AJCC v7|Stage III Soft Tissue Sarcoma AJCC v7|Stage IV Osteosarcoma AJCC v7|Stage IV Soft Tissue Sarcoma AJCC v7|Stage IVA Osteosarcoma AJCC v7|Stage IVB Osteosarcoma AJCC v7|Wilms Tumor,Tazemetostat,CCN(C1CCOCC1)C2=CC(=CC(=C2C)C(=O)NCC3=C(C=C(NC3=O)C)C)C4=CC=C(C=C4)CN5CCOCC5,PHASE2,skin_and_connective_tissue_disease
954,Advanced Malignant Solid Neoplasm|Ann Arbor Stage III Non-Hodgkin Lymphoma|Ann Arbor Stage IV Non-Hodgkin Lymphoma|Histiocytic Sarcoma|Juvenile Xanthogranuloma|Langerhans Cell Histiocytosis|Malignant Glioma|Recurrent Childhood Rhabdomyosarcoma|Recurrent Ependymoma|Recurrent Ewing Sarcoma|Recurrent Glioma|Recurrent Hepatoblastoma|Recurrent Langerhans Cell Histiocytosis|Recurrent Malignant Germ Cell Tumor|Recurrent Malignant Solid Neoplasm|Recurrent Medulloblastoma|Recurrent Neuroblastoma|Recurrent Non-Hodgkin Lymphoma|Recurrent Osteosarcoma|Recurrent Peripheral Primitive Neuroectodermal Tumor|Recurrent Primary Central Nervous System Neoplasm|Recurrent Rhabdoid Tumor|Recurrent Soft Tissue Sarcoma|Refractory Ewing Sarcoma|Refractory Glioma|Refractory Hepatoblastoma|Refractory Langerhans Cell Histiocytosis|Refractory Malignant Germ Cell Tumor|Refractory Malignant Solid Neoplasm|Refractory Medulloblastoma|Refractory Neuroblastoma|Refractory Non-Hodgkin Lymphoma|Refractory Osteosarcoma|Refractory Peripheral Primitive Neuroectodermal Tumor|Refractory Primary Central Nervous System Neoplasm|Refractory Rhabdoid Tumor|Refractory Rhabdomyosarcoma|Rhabdoid Tumor|Stage III Osteosarcoma AJCC v7|Stage III Soft Tissue Sarcoma AJCC v7|Stage IV Osteosarcoma AJCC v7|Stage IV Soft Tissue Sarcoma AJCC v7|Stage IVA Osteosarcoma AJCC v7|Stage IVB Osteosarcoma AJCC v7|Wilms Tumor,Tipifarnib,CN1C=NC=C1C(C2=CC=C(C=C2)Cl)(C3=CC4=C(C=C3)N(C(=O)C=C4C5=CC(=CC=C5)Cl)C)N,PHASE2,skin_and_connective_tissue_disease
955,Advanced Malignant Solid Neoplasm|Ann Arbor Stage III Non-Hodgkin Lymphoma|Ann Arbor Stage IV Non-Hodgkin Lymphoma|Histiocytic Sarcoma|Juvenile Xanthogranuloma|Langerhans Cell Histiocytosis|Malignant Glioma|Recurrent Childhood Rhabdomyosarcoma|Recurrent Ependymoma|Recurrent Ewing Sarcoma|Recurrent Glioma|Recurrent Hepatoblastoma|Recurrent Langerhans Cell Histiocytosis|Recurrent Malignant Germ Cell Tumor|Recurrent Malignant Solid Neoplasm|Recurrent Medulloblastoma|Recurrent Neuroblastoma|Recurrent Non-Hodgkin Lymphoma|Recurrent Osteosarcoma|Recurrent Peripheral Primitive Neuroectodermal Tumor|Recurrent Primary Central Nervous System Neoplasm|Recurrent Rhabdoid Tumor|Recurrent Soft Tissue Sarcoma|Refractory Ewing Sarcoma|Refractory Glioma|Refractory Hepatoblastoma|Refractory Langerhans Cell Histiocytosis|Refractory Malignant Germ Cell Tumor|Refractory Malignant Solid Neoplasm|Refractory Medulloblastoma|Refractory Neuroblastoma|Refractory Non-Hodgkin Lymphoma|Refractory Osteosarcoma|Refractory Peripheral Primitive Neuroectodermal Tumor|Refractory Primary Central Nervous System Neoplasm|Refractory Rhabdoid Tumor|Refractory Rhabdomyosarcoma|Rhabdoid Tumor|Stage III Osteosarcoma AJCC v7|Stage III Soft Tissue Sarcoma AJCC v7|Stage IV Osteosarcoma AJCC v7|Stage IV Soft Tissue Sarcoma AJCC v7|Stage IVA Osteosarcoma AJCC v7|Stage IVB Osteosarcoma AJCC v7|Wilms Tumor,Ulixertinib,CC(C)NC1=NC=C(C(=C1)C2=CNC(=C2)C(=O)NC(CO)C3=CC(=CC=C3)Cl)Cl,PHASE2,skin_and_connective_tissue_disease
956,Advanced Malignant Solid Neoplasm|Ann Arbor Stage III Non-Hodgkin Lymphoma|Ann Arbor Stage IV Non-Hodgkin Lymphoma|Histiocytic Sarcoma|Juvenile Xanthogranuloma|Langerhans Cell Histiocytosis|Malignant Glioma|Recurrent Childhood Rhabdomyosarcoma|Recurrent Ependymoma|Recurrent Ewing Sarcoma|Recurrent Glioma|Recurrent Hepatoblastoma|Recurrent Langerhans Cell Histiocytosis|Recurrent Malignant Germ Cell Tumor|Recurrent Malignant Solid Neoplasm|Recurrent Medulloblastoma|Recurrent Neuroblastoma|Recurrent Non-Hodgkin Lymphoma|Recurrent Osteosarcoma|Recurrent Peripheral Primitive Neuroectodermal Tumor|Recurrent Primary Central Nervous System Neoplasm|Recurrent Rhabdoid Tumor|Recurrent Soft Tissue Sarcoma|Refractory Ewing Sarcoma|Refractory Glioma|Refractory Hepatoblastoma|Refractory Langerhans Cell Histiocytosis|Refractory Malignant Germ Cell Tumor|Refractory Malignant Solid Neoplasm|Refractory Medulloblastoma|Refractory Neuroblastoma|Refractory Non-Hodgkin Lymphoma|Refractory Osteosarcoma|Refractory Peripheral Primitive Neuroectodermal Tumor|Refractory Primary Central Nervous System Neoplasm|Refractory Rhabdoid Tumor|Refractory Rhabdomyosarcoma|Rhabdoid Tumor|Stage III Osteosarcoma AJCC v7|Stage III Soft Tissue Sarcoma AJCC v7|Stage IV Osteosarcoma AJCC v7|Stage IV Soft Tissue Sarcoma AJCC v7|Stage IVA Osteosarcoma AJCC v7|Stage IVB Osteosarcoma AJCC v7|Wilms Tumor,Vemurafenib,CCCS(=O)(=O)NC1=C(C(=C(C=C1)F)C(=O)C2=CNC3=C2C=C(C=N3)C4=CC=C(C=C4)Cl)F,PHASE2,skin_and_connective_tissue_disease
957,Hematological Neoplasms|Non-Hodgkin's Lymphoma|Hodgkin's Lymphoma|Lymphoma|Multiple Myeloma|Acute Myeloid Leukemia|Leukemia|Myelodysplastic Syndromes|Neoplasms|Melanoma|Breast Cancer|Metastatic Breast Cancer|Non-Small Cell Lung Cancer|Small Cell Lung Cancer|Renal Cell Carcinoma|Glioblastoma Multiforme|Osteosarcoma|Sarcoma|Thyroid Cancer|Genitourinary,Azacitidine,C1=NC(=NC(=O)N1C2C(C(C(O2)CO)O)O)N,PHASE1,skin_and_connective_tissue_disease
958,"Breast Cancer|Ovarian Epithelial Cancer Recurrent|Sarcoma|Non-small Cell Lung Cancer|Carcinoma, Transitional Cell|Prostate Cancer|Prostatic Neoplasms",Mifepristone,CC#CC1(CCC2C1(CC(C3=C4CCC(=O)C=C4CCC23)C5=CC=C(C=C5)N(C)C)C)O,PHASE1,skin_and_connective_tissue_disease
959,"Breast Cancer|Ovarian Epithelial Cancer Recurrent|Sarcoma|Non-small Cell Lung Cancer|Carcinoma, Transitional Cell|Prostate Cancer|Prostatic Neoplasms",Eribulin,CC1CC2CCC3C(=C)CC(O3)CCC45CC6C(O4)C7C(O6)C(O5)C8C(O7)CCC(O8)CC(=O)CC9C(CC(C1=C)O2)OC(C9OC)CC(CN)O,PHASE1,skin_and_connective_tissue_disease
960,Carney Complex|Chondrosarcoma|Gastrointestinal Stromal Tumor|Paraganglioma,Linsitinib,CC1(CC(C1)C2=NC(=C3N2C=CN=C3N)C4=CC5=C(C=C4)C=CC(=N5)C6=CC=CC=C6)O,PHASE2,skin_and_connective_tissue_disease
961,Alveolar Soft Part Sarcoma|Angiomatoid Fibrous Histiocytoma|Atypical Fibroxanthoma|Clear Cell Sarcoma of Soft Tissue|Epithelioid Malignant Peripheral Nerve Sheath Tumor|Epithelioid Sarcoma|Extraskeletal Myxoid Chondrosarcoma|Extraskeletal Osteosarcoma|Fibrohistiocytic Neoplasm|Fibrosarcoma|Inflammatory Myofibroblastic Tumor|Intimal Sarcoma|Leiomyosarcoma|Liposarcoma|Liver Embryonal Sarcoma|Low Grade Fibromyxoid Sarcoma|Low Grade Myofibroblastic Sarcoma|Malignant Cutaneous Granular Cell Tumor|Malignant Peripheral Nerve Sheath Tumor|Malignant Triton Tumor|Mesenchymal Chondrosarcoma|Myxofibrosarcoma|Myxoid Chondrosarcoma|Myxoinflammatory Fibroblastic Sarcoma|Nerve Sheath Neoplasm|PEComa|Pericytic Neoplasm|Plexiform Fibrohistiocytic Tumor|Sclerosing Epithelioid Fibrosarcoma|Skin Glomus Tumor|Stage IB Soft Tissue Sarcoma AJCC v7|Stage IIB Soft Tissue Sarcoma AJCC v7|Stage III Soft Tissue Sarcoma AJCC v7|Stage IV Soft Tissue Sarcoma AJCC v7|Synovial Sarcoma|Undifferentiated High Grade Pleomorphic Sarcoma of Bone,Doxorubicin,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)N)O,PHASE2|PHASE3,skin_and_connective_tissue_disease
962,Alveolar Soft Part Sarcoma|Angiomatoid Fibrous Histiocytoma|Atypical Fibroxanthoma|Clear Cell Sarcoma of Soft Tissue|Epithelioid Malignant Peripheral Nerve Sheath Tumor|Epithelioid Sarcoma|Extraskeletal Myxoid Chondrosarcoma|Extraskeletal Osteosarcoma|Fibrohistiocytic Neoplasm|Fibrosarcoma|Inflammatory Myofibroblastic Tumor|Intimal Sarcoma|Leiomyosarcoma|Liposarcoma|Liver Embryonal Sarcoma|Low Grade Fibromyxoid Sarcoma|Low Grade Myofibroblastic Sarcoma|Malignant Cutaneous Granular Cell Tumor|Malignant Peripheral Nerve Sheath Tumor|Malignant Triton Tumor|Mesenchymal Chondrosarcoma|Myxofibrosarcoma|Myxoid Chondrosarcoma|Myxoinflammatory Fibroblastic Sarcoma|Nerve Sheath Neoplasm|PEComa|Pericytic Neoplasm|Plexiform Fibrohistiocytic Tumor|Sclerosing Epithelioid Fibrosarcoma|Skin Glomus Tumor|Stage IB Soft Tissue Sarcoma AJCC v7|Stage IIB Soft Tissue Sarcoma AJCC v7|Stage III Soft Tissue Sarcoma AJCC v7|Stage IV Soft Tissue Sarcoma AJCC v7|Synovial Sarcoma|Undifferentiated High Grade Pleomorphic Sarcoma of Bone,Ifosfamide,C1CN(P(=O)(OC1)NCCCl)CCCl,PHASE2|PHASE3,skin_and_connective_tissue_disease
963,Alveolar Soft Part Sarcoma|Angiomatoid Fibrous Histiocytoma|Atypical Fibroxanthoma|Clear Cell Sarcoma of Soft Tissue|Epithelioid Malignant Peripheral Nerve Sheath Tumor|Epithelioid Sarcoma|Extraskeletal Myxoid Chondrosarcoma|Extraskeletal Osteosarcoma|Fibrohistiocytic Neoplasm|Fibrosarcoma|Inflammatory Myofibroblastic Tumor|Intimal Sarcoma|Leiomyosarcoma|Liposarcoma|Liver Embryonal Sarcoma|Low Grade Fibromyxoid Sarcoma|Low Grade Myofibroblastic Sarcoma|Malignant Cutaneous Granular Cell Tumor|Malignant Peripheral Nerve Sheath Tumor|Malignant Triton Tumor|Mesenchymal Chondrosarcoma|Myxofibrosarcoma|Myxoid Chondrosarcoma|Myxoinflammatory Fibroblastic Sarcoma|Nerve Sheath Neoplasm|PEComa|Pericytic Neoplasm|Plexiform Fibrohistiocytic Tumor|Sclerosing Epithelioid Fibrosarcoma|Skin Glomus Tumor|Stage IB Soft Tissue Sarcoma AJCC v7|Stage IIB Soft Tissue Sarcoma AJCC v7|Stage III Soft Tissue Sarcoma AJCC v7|Stage IV Soft Tissue Sarcoma AJCC v7|Synovial Sarcoma|Undifferentiated High Grade Pleomorphic Sarcoma of Bone,Pazopanib,CC1=C(C=C(C=C1)NC2=NC=CC(=N2)N(C)C3=CC4=NN(C(=C4C=C3)C)C)S(=O)(=O)N,PHASE2|PHASE3,skin_and_connective_tissue_disease
964,"Sarcoma, Kaposi|HIV Infections",Ritonavir,CC(C)C1=NC(=CS1)CN(C)C(=O)NC(C(C)C)C(=O)NC(CC2=CC=CC=C2)CC(C(CC3=CC=CC=C3)NC(=O)OCC4=CN=CS4)O,PHASE2,skin_and_connective_tissue_disease
965,Scleroderma,Lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C,PHASE2|PHASE3,skin_and_connective_tissue_disease
966,Solid Tumors|Colorectal Cancer|Breast Cancer|Ovarian Cancer|Colon Cancer|Rectal Cancer|Neoplasms|Endometrial Cancer|Soft Tissue Sarcoma|Triple Negative Breast Cancer|Pancreas Cancer|Pancreatic Cancer,Gemcitabine,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)(F)F,PHASE1|PHASE2,skin_and_connective_tissue_disease
967,Cutaneous Lupus Erythematosus,Lanraplenib,C1CN(CCN1C2COC2)C3=CC=C(C=C3)NC4=NC(=CN5C4=NC=C5)C6=CN=CC(=N6)N,PHASE2,skin_and_connective_tissue_disease
968,Cutaneous Lupus Erythematosus,Filgotinib,C1CC1C(=O)NC2=NN3C(=N2)C=CC=C3C4=CC=C(C=C4)CN5CCS(=O)(=O)CC5,PHASE2,skin_and_connective_tissue_disease
969,Systemic Lupus Erythematosus|Systemic Sclerosis,Busulfan,CS(=O)(=O)OCCCCOS(=O)(=O)C,PHASE1,skin_and_connective_tissue_disease
970,Discoid Lupus Erythematosus,Delgocitinib,CC1CN(C12CCN(C2)C3=NC=NC4=C3C=CN4)C(=O)CC#N,PHASE2,skin_and_connective_tissue_disease
971,Systemic Scleroderma,Plerixafor,C1CNCCNCCCN(CCNC1)CC2=CC=C(C=C2)CN3CCCNCCNCCCNCC3,PHASE2,skin_and_connective_tissue_disease
972,Epidermolysis Bullosa (EB)|Epidermolysis Bullosa Simplex|Dystrophic Epidermolysis Bullosa|Junctional Epidermolysis Bullosa,Diacerein,CC(=O)OC1=CC=CC2=C1C(=O)C3=C(C2=O)C=C(C=C3OC(=O)C)C(=O)O,PHASE1,skin_and_connective_tissue_disease
973,Systemic Sclerosis|Gastroesophageal Reflux|Proton Pubm Inhibitor,Omeprazole,CC1=CN=C(C(=C1OC)C)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC,PHASE1,skin_and_connective_tissue_disease
974,HLRCC|Sporadic Papillary Renal Cell Cancer,Erlotinib,COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC,PHASE2,skin_and_connective_tissue_disease
975,Breast Cancer|Soft Tissue Sarcoma,Temozolomide,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N,PHASE2,skin_and_connective_tissue_disease
976,Systemic Sclerosis,Tadalafil,CN1CC(=O)N2C(C1=O)CC3=C(C2C4=CC5=C(C=C4)OCO5)NC6=CC=CC=C36,PHASE2,skin_and_connective_tissue_disease
977,Epidermolysis Bullosa Dystrophica|Squamous Cell Carcinoma,Rigosertib,COC1=C(C=C(C=C1)CS(=O)(=O)C=CC2=C(C=C(C=C2OC)OC)OC)NCC(=O)O,PHASE1|PHASE2,skin_and_connective_tissue_disease
978,"Infections, Gram-Positive Bacterial|Abscess|Burns|Cellulitis|Ulcer|Wound Infections",Telavancin,CCCCCCCCCCNCCNC1(CC(OC(C1O)C)OC2C(C(C(OC2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)C(C(C(=O)NC(C(=O)NC5C(=O)NC7C8=CC(=C(C=C8)O)C9=C(C(=C(C=C9C(NC(=O)C(C(C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)O)CNCP(=O)(O)O)O)CC(=O)N)NC(=O)C(CC(C)C)NC)O)Cl)CO)O)O)C,PHASE2,skin_and_connective_tissue_disease
979,"Infections, Gram-Positive Bacterial|Abscess|Burns|Cellulitis|Ulcer|Wound Infections",Vancomycin,CC1C(C(CC(O1)OC2C(C(C(OC2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)C(C(C(=O)NC(C(=O)NC5C(=O)NC7C8=CC(=C(C=C8)O)C9=C(C=C(C=C9O)O)C(NC(=O)C(C(C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)CC(=O)N)NC(=O)C(CC(C)C)NC)O)Cl)CO)O)O)(C)N)O,PHASE2,skin_and_connective_tissue_disease
980,"Infections, Gram-Positive Bacterial|Abscess|Burns|Cellulitis|Ulcer|Wound Infections",Phenoxymethylpenicillin,CC1(C(N2C(S1)C(C2=O)NC(=O)COC3=CC=CC=C3)C(=O)O)C,PHASE2,skin_and_connective_tissue_disease
981,"Infections, Gram-Positive Bacterial|Abscess|Burns|Cellulitis|Ulcer|Wound Infections",Penicillin,CC1(C(N2C(S1)C(C2=O)NC(=O)CC3=CC=CC=C3)C(=O)O)C,PHASE2,skin_and_connective_tissue_disease
982,Focal Segmental Glomerulosclerosis|Minimal Change Disease|Immunoglobulin A Nephropathy|IgA Vasculitis|Alport Syndrome,Sparsentan,CCCCC1=NC2(CCCC2)C(=O)N1CC3=CC(=C(C=C3)C4=CC=CC=C4S(=O)(=O)NC5=NOC(=C5C)C)COCC,PHASE2,skin_and_connective_tissue_disease
983,Advanced Fallopian Tube Carcinoma|Advanced Malignant Solid Neoplasm|Advanced Melanoma|Advanced Ovarian Carcinoma|Advanced Primary Peritoneal Carcinoma|Advanced Synovial Sarcoma|Clinical Stage III Cutaneous Melanoma AJCC v8|Clinical Stage IV Cutaneous Melanoma AJCC v8|Metastatic Fallopian Tube Carcinoma|Metastatic Melanoma|Metastatic Ovarian Carcinoma|Metastatic Primary Peritoneal Carcinoma|Metastatic Synovial Sarcoma|Pathologic Stage III Cutaneous Melanoma AJCC v8|Pathologic Stage IIIA Cutaneous Melanoma AJCC v8|Pathologic Stage IIIB Cutaneous Melanoma AJCC v8|Pathologic Stage IIIC Cutaneous Melanoma AJCC v8|Pathologic Stage IIID Cutaneous Melanoma AJCC v8|Pathologic Stage IV Cutaneous Melanoma AJCC v8|Platinum-Resistant Fallopian Tube Carcinoma|Platinum-Resistant Ovarian Carcinoma|Platinum-Resistant Primary Peritoneal Carcinoma|Stage III Fallopian Tube Cancer AJCC v8|Stage III Ovarian Cancer AJCC v8|Stage III Primary Peritoneal Cancer AJCC v8|Stage IIIA Fallopian Tube Cancer AJCC v8|Stage IIIA Ovarian Cancer AJCC v8|Stage IIIA Primary Peritoneal Cancer AJCC v8|Stage IIIA1 Fallopian Tube Cancer AJCC v8|Stage IIIA1 Ovarian Cancer AJCC v8|Stage IIIA2 Fallopian Tube Cancer AJCC v8|Stage IIIA2 Ovarian Cancer AJCC v8|Stage IIIB Fallopian Tube Cancer AJCC v8|Stage IIIB Ovarian Cancer AJCC v8|Stage IIIB Primary Peritoneal Cancer AJCC v8|Stage IIIC Fallopian Tube Cancer AJCC v8|Stage IIIC Ovarian Cancer AJCC v8|Stage IIIC Primary Peritoneal Cancer AJCC v8|Stage IV Fallopian Tube Cancer AJCC v8|Stage IV Ovarian Cancer AJCC v8|Stage IV Primary Peritoneal Cancer AJCC v8|Stage IVA Fallopian Tube Cancer AJCC v8|Stage IVA Ovarian Cancer AJCC v8|Stage IVA Primary Peritoneal Cancer AJCC v8|Stage IVB Fallopian Tube Cancer AJCC v8|Stage IVB Ovarian Cancer AJCC v8|Stage IVB Primary Peritoneal Cancer AJCC v8|Unresectable Melanoma|Unresectable Ovarian Carcinoma|Unresectable Synovial Sarcoma,Decitabine,C1C(C(OC1N2C=NC(=NC2=O)N)CO)O,PHASE1|PHASE2,skin_and_connective_tissue_disease
984,Raynaud Phenomenon Secondary to Systemic Sclerosis,Iloprost,CC#CCC(C)C(C=CC1C(CC2C1CC(=CCCCC(=O)O)C2)O)O,PHASE2,skin_and_connective_tissue_disease
985,"Pulmonary Fibrosis|Scleroderma, Systemic",Bosentan,CC(C)(C)C1=CC=C(C=C1)S(=O)(=O)NC2=C(C(=NC(=N2)C3=NC=CC=N3)OCCO)OC4=CC=CC=C4OC,PHASE2|PHASE3,skin_and_connective_tissue_disease
986,Diffuse Cutaneous Systemic Sclerosis,Belumosudil,CC(C)NC(=O)COC1=CC=CC(=C1)C2=NC3=CC=CC=C3C(=N2)NC4=CC5=C(C=C4)NN=C5,PHASE2,skin_and_connective_tissue_disease
987,"Colorectal Cancer Not MSI-H or MMR-deficient|GIST|Oesophageal or Gastric Carcinoma|Biliary Tract Cancer|Hepatocellular Carcinoma|Soft-tissue Sarcoma|Thyroid Cancer|Gastro-enteropancreatic Neuroendocrine Tumor|Non-small Cell Lung Cancer|Solid Tumor, Adult|Urothelial Carcinoma|HPV-Related Carcinoma|Triple Negative Breast Cancer|Renal Carcinoma|Mesotheliomas Pleural",Regorafenib,CNC(=O)C1=NC=CC(=C1)OC2=CC(=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F)F,PHASE1|PHASE2,skin_and_connective_tissue_disease
988,"Scleroderma, Systemic",Nintedanib,CN1CCN(CC1)CC(=O)N(C)C2=CC=C(C=C2)N=C(C3=CC=CC=C3)C4=C(NC5=C4C=CC(=C5)C(=O)OC)O,PHASE1,skin_and_connective_tissue_disease
989,"Anaplastic Large Cell Lymphoma|Nodal Peripheral T-Cell Lymphoma With TFH Phenotype|Recurrent Anaplastic Large Cell Lymphoma|Recurrent Angioimmunoblastic T-Cell Lymphoma|Recurrent Enteropathy-Associated T-Cell Lymphoma|Recurrent Follicular Lymphoma|Recurrent Hepatosplenic T-Cell Lymphoma|Recurrent Mature T- Cell and NK-Cell Non-Hodgkin Lymphoma|Recurrent Monomorphic Epitheliotropic Intestinal T-cell Lymphoma|Recurrent Mycosis Fungoides|Recurrent Peripheral T-Cell Lymphoma, Not Otherwise Specified|Refractory Anaplastic Large Cell Lymphoma|Refractory Angioimmunoblastic T-Cell Lymphoma|Refractory Enteropathy-Associated T-Cell Lymphoma|Refractory Follicular Lymphoma|Refractory Hepatosplenic T-Cell Lymphoma|Refractory Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma|Refractory Mycosis Fungoides|Refractory Peripheral T-Cell Lymphoma, Not Otherwise Specified|Subcutaneous Panniculitis-Like T-Cell Lymphoma",Pralatrexate,C#CCC(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,PHASE1|PHASE2,skin_and_connective_tissue_disease
990,Interstitial Lung Disease|Scleroderma|Pulmonary Hypertension,Macitentan,CCCNS(=O)(=O)NC1=C(C(=NC=N1)OCCOC2=NC=C(C=N2)Br)C3=CC=C(C=C3)Br,PHASE2|PHASE3,skin_and_connective_tissue_disease
991,Systemic Sclerosis|Scleroderma,Mesna,C(CS(=O)(=O)[O-])S.[Na+],PHASE2|PHASE3,skin_and_connective_tissue_disease
992,Systemic Sclerosis|Scleroderma,Methylprednisolone,CC1CC2C3CCC(C3(CC(C2C4(C1=CC(=O)C=C4)C)O)C)(C(=O)CO)O,PHASE2|PHASE3,skin_and_connective_tissue_disease
993,Skin Infection,Linezolid,CC(=O)NCC1CN(C(=O)O1)C2=CC(=C(C=C2)N3CCOCC3)F,PHASE2,skin_and_connective_tissue_disease
994,Advanced Differentiated Thyroid Gland Carcinoma|Advanced Head and Neck Carcinoma|Advanced Hepatocellular Carcinoma|Advanced Kaposi Sarcoma|Advanced Lung Non-Small Cell Carcinoma|Advanced Lung Small Cell Carcinoma|Advanced Malignant Solid Neoplasm|Advanced Melanoma|Advanced Ovarian Carcinoma|Advanced Prostate Carcinoma|Advanced Renal Cell Carcinoma|Advanced Thyroid Gland Medullary Carcinoma|Advanced Triple-Negative Breast Carcinoma|Advanced Urothelial Carcinoma|Anatomic Stage III Breast Cancer AJCC v8|Anatomic Stage IV Breast Cancer AJCC v8|Castration-Resistant Prostate Carcinoma|Clinical Stage III Cutaneous Melanoma AJCC v8|Clinical Stage IV Cutaneous Melanoma AJCC v8|HIV Infection|Metastatic Differentiated Thyroid Gland Carcinoma|Metastatic Head and Neck Carcinoma|Metastatic Hepatocellular Carcinoma|Metastatic Kaposi Sarcoma|Metastatic Lung Non-Small Cell Carcinoma|Metastatic Lung Small Cell Carcinoma|Metastatic Malignant Solid Neoplasm|Metastatic Melanoma|Metastatic Ovarian Carcinoma|Metastatic Prostate Carcinoma|Metastatic Renal Cell Carcinoma|Metastatic Thyroid Gland Medullary Carcinoma|Metastatic Triple-Negative Breast Carcinoma|Metastatic Urothelial Carcinoma|Recurrent Differentiated Thyroid Gland Carcinoma|Recurrent Head and Neck Carcinoma|Recurrent Hepatocellular Carcinoma|Recurrent Kaposi Sarcoma|Recurrent Lung Non-Small Cell Carcinoma|Recurrent Lung Small Cell Carcinoma|Recurrent Malignant Solid Neoplasm|Recurrent Melanoma|Recurrent Ovarian Carcinoma|Recurrent Prostate Carcinoma|Recurrent Renal Cell Carcinoma|Recurrent Thyroid Gland Medullary Carcinoma|Recurrent Triple-Negative Breast Carcinoma|Recurrent Urothelial Carcinoma|Refractory Differentiated Thyroid Gland Carcinoma|Stage III Differentiated Thyroid Gland Carcinoma AJCC v8|Stage III Hepatocellular Carcinoma AJCC v8|Stage III Lung Cancer AJCC v8|Stage III Ovarian Cancer AJCC v8|Stage III Prostate Cancer AJCC v8|Stage III Renal Cell Cancer AJCC v8|Stage III Thyroid Gland Medullary Carcinoma AJCC v8|Stage IV Differentiated Thyroid Gland Carcinoma AJCC v8|Stage IV Hepatocellular Carcinoma AJCC v8|Stage IV Lung Cancer AJCC v8|Stage IV Ovarian Cancer AJCC v8|Stage IV Prostate Cancer AJCC v8|Stage IV Renal Cell Cancer AJCC v8|Stage IV Thyroid Gland Medullary Carcinoma AJCC v8,Cabozantinib,COC1=CC2=C(C=CN=C2C=C1OC)OC3=CC=C(C=C3)NC(=O)C4(CC4)C(=O)NC5=CC=C(C=C5)F,PHASE1,skin_and_connective_tissue_disease
995,Infectious Skin Diseases|Bacterial Skin Diseases|Staphylococcal Skin Infections|Streptococcal Infections|Abscess,Radezolid,CC(=O)NCC1CN(C(=O)O1)C2=CC(=C(C=C2)C3=CC=C(C=C3)CNCC4=NNN=C4)F,PHASE2,skin_and_connective_tissue_disease
996,Advanced Malignant Neoplasm|Castleman Disease|Digestive System Carcinoma|Erdheim-Chester Disease|Lip and Oral Cavity Carcinoma|Lymphangioleiomyomatosis|Malignant Endocrine Neoplasm|Malignant Female Reproductive System Neoplasm|Malignant Male Reproductive System Neoplasm|Malignant Neoplasm|Malignant Respiratory Tract Neoplasm|Malignant Thoracic Neoplasm|Malignant Urinary System Neoplasm|Mesothelial Neoplasm|Metastatic Malignant Neoplasm|Metastatic Urothelial Carcinoma|Neurofibromatosis Type 2|Recurrent Adult Soft Tissue Sarcoma|Recurrent Breast Carcinoma|Recurrent Childhood Soft Tissue Sarcoma|Recurrent Digestive System Carcinoma|Recurrent Female Reproductive System Carcinoma|Recurrent Male Reproductive System Carcinoma|Recurrent Malignant Neoplasm|Recurrent Pharyngeal Carcinoma|Recurrent Thyroid Gland Carcinoma|Refractory Malignant Neoplasm|Soft Tissue Neoplasm|Stage III Breast Cancer AJCC v7|Stage III Pharyngeal Cancer|Stage IIIA Breast Cancer AJCC v7|Stage IIIB Breast Cancer AJCC v7|Stage IIIC Breast Cancer AJCC v7|Stage IV Breast Cancer AJCC v6 and v7|Stage IV Pharyngeal Cancer|Stage IVA Pharyngeal Cancer|Stage IVB Pharyngeal Cancer|Stage IVC Pharyngeal Cancer|Thyroid Gland Neoplasm,Temsirolimus,CC1CCC2CC(C(=CC=CC=CC(CC(C(=O)C(C(C(=CC(C(=O)CC(OC(=O)C3CCCCN3C(=O)C(=O)C1(O2)O)C(C)CC4CCC(C(C4)OC)OC(=O)C(C)(CO)CO)C)C)O)OC)C)C)C)OC,PHASE1,skin_and_connective_tissue_disease
997,Systemic Sclerosis,Pirfenidone,CC1=CN(C(=O)C=C1)C2=CC=CC=C2,PHASE2,skin_and_connective_tissue_disease
998,Raynaud's Phenomenon Secondary to Systemic Sclerosis,Selexipag,CC(C)N(CCCCOCC(=O)NS(=O)(=O)C)C1=CN=C(C(=N1)C2=CC=CC=C2)C3=CC=CC=C3,PHASE2,skin_and_connective_tissue_disease
999,"Lupus Erythematosus, Discoid|Lupus Erythematosus, Subacute Cutaneous",Deucravacitinib,CNC(=O)C1=NN=C(C=C1NC2=CC=CC(=C2OC)C3=NN(C=N3)C)NC(=O)C4CC4,PHASE2,skin_and_connective_tissue_disease
1000,"Scleroderma, Diffuse|Scleroderma, Systemic|Scleroderma, Limited|Sclerosis, Progressive Systemic|Skin Diseases|Connective Tissue Diseases|Pathologic Processes|Autoimmune Diseases",Ifetroban,CCCCCNC(=O)C1=COC(=N1)C2C3CCC(C2CC4=CC=CC=C4CCC(=O)O)O3,PHASE2,skin_and_connective_tissue_disease
1001,T-Cell Peripheral Lymphoma|Gamma Delta Hepatosplenic T-Cell Lymphoma|Subcutaneous Panniculitis-Like T-Cell Lymphoma|NK T-Cell Lymphoma,Vincristine,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O,PHASE1,skin_and_connective_tissue_disease
1002,Chronic Heart Failure With Preserved Ejection Fraction,Vericiguat,COC(=O)NC1=C(N=C(N=C1N)C2=NN(C3=C2C=C(C=N3)F)CC4=CC=CC=C4F)N,PHASE2,cardiovascular_disease
1003,Breast Carcinoma|Hematopoietic and Lymphoid Cell Neoplasm|Lymphoma|Sarcoma,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,PHASE2,cardiovascular_disease
1004,Breast Carcinoma|Hematopoietic and Lymphoid Cell Neoplasm|Lymphoma|Sarcoma,Lisinopril,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,PHASE2,cardiovascular_disease
1005,Breast Carcinoma|Hematopoietic and Lymphoid Cell Neoplasm|Lymphoma|Sarcoma,Pravastatin,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O,PHASE2,cardiovascular_disease
1006,Breast Carcinoma|Hematopoietic and Lymphoid Cell Neoplasm|Lymphoma|Sarcoma,Spironolactone,CC(=O)SC1CC2=CC(=O)CCC2(C3C1C4CCC5(C4(CC3)C)CCC(=O)O5)C,PHASE2,cardiovascular_disease
1007,Deep Venous Thrombosis,Enoxaparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,PHASE1|PHASE2,cardiovascular_disease
1008,Ocular Hypertension|Open-angle Glaucoma,Travoprost,CC(C)OC(=O)CCCC=CCC1C(CC(C1C=CC(COC2=CC=CC(=C2)C(F)(F)F)O)O)O,PHASE2,cardiovascular_disease
1009,Hypertension,Telmisartan,CCCC1=NC2=C(N1CC3=CC=C(C=C3)C4=CC=CC=C4C(=O)O)C=C(C=C2C)C5=NC6=CC=CC=C6N5C,PHASE1,cardiovascular_disease
1010,Intracranial Aneurysm|Inflammation Vascular,Atorvastatin,CC(C)C1=C(C(=C(N1CCC(CC(CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4,PHASE2,cardiovascular_disease
1011,"Coronary Artery Disease|Exercise Addiction|Complication, Cardio-respiratory",Ciclosporin,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,PHASE2,cardiovascular_disease
1012,"Coronary Artery Disease|Exercise Addiction|Complication, Cardio-respiratory",Chloroquine,CCN(CC)CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl,PHASE2,cardiovascular_disease
1013,Atrial Fibrillation (AF)|Stroke,Rivaroxaban,C1COCC(=O)N1C2=CC=C(C=C2)N3CC(OC3=O)CNC(=O)C4=CC=C(S4)Cl,PHASE2,cardiovascular_disease
1014,Lymphoma|Multiple Myeloma|Acute Myeloid Leukemia|Diffuse Large B-Cell Lymphoma,Azacitidine,C1=NC(=NC(=O)N1C2C(C(C(O2)CO)O)O)N,PHASE1,cardiovascular_disease
1015,Lymphoma|Multiple Myeloma|Acute Myeloid Leukemia|Diffuse Large B-Cell Lymphoma,Venetoclax,CC1(CCC(=C(C1)C2=CC=C(C=C2)Cl)CN3CCN(CC3)C4=CC(=C(C=C4)C(=O)NS(=O)(=O)C5=CC(=C(C=C5)NCC6CCOCC6)[N+](=O)[O-])OC7=CN=C8C(=C7)C=CN8)C,PHASE1,cardiovascular_disease
1016,Lymphoma|Multiple Myeloma|Acute Myeloid Leukemia|Diffuse Large B-Cell Lymphoma,Carfilzomib,CC(C)CC(C(=O)C1(CO1)C)NC(=O)C(CC2=CC=CC=C2)NC(=O)C(CC(C)C)NC(=O)C(CCC3=CC=CC=C3)NC(=O)CN4CCOCC4,PHASE1,cardiovascular_disease
1017,Lymphoma|Multiple Myeloma|Acute Myeloid Leukemia|Diffuse Large B-Cell Lymphoma,Dexamethasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,PHASE1,cardiovascular_disease
1018,Multiple Myeloma,Palbociclib,CC1=C(C(=O)N(C2=NC(=NC=C12)NC3=NC=C(C=C3)N4CCNCC4)C5CCCC5)C(=O)C,PHASE1,cardiovascular_disease
1019,Multiple Myeloma,Lenalidomide,C1CC(=O)NC(=O)C1N2CC3=C(C2=O)C=CC=C3N,PHASE1,cardiovascular_disease
1020,Multiple Myeloma,Pomalidomide,C1CC(=O)NC(=O)C1N2C(=O)C3=C(C2=O)C(=CC=C3)N,PHASE2,cardiovascular_disease
1021,Multiple Myeloma,Bortezomib,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O,PHASE2,cardiovascular_disease
1022,Portal Hypertension,Alverine,CCN(CCCC1=CC=CC=C1)CCCC2=CC=CC=C2,PHASE2,cardiovascular_disease
1023,Atrial Fibrillation or Atrial Flutter|Thrombosis of Left Atrial Appendage,Dabigatran,CN1C2=C(C=C(C=C2)C(=O)N(CCC(=O)O)C3=CC=CC=N3)N=C1CNC4=CC=C(C=C4)C(=N)N,PHASE2,cardiovascular_disease
1024,Atrial Fibrillation or Atrial Flutter|Thrombosis of Left Atrial Appendage,Phenprocoumon,CCC(C1=CC=CC=C1)C2=C(C3=CC=CC=C3OC2=O)O,PHASE2,cardiovascular_disease
1025,Coronary Artery Disease|Type 2 Diabetes Mellitus,Pioglitazone,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3,PHASE2|PHASE3,cardiovascular_disease
1026,Hemorrhoids,Iferanserin,CN1CCCCC1CCC2=CC=CC=C2NC(=O)C=CC3=CC=CC=C3,PHASE2,cardiovascular_disease
1027,Multiple Myeloma,Panobinostat,CC1=C(C2=CC=CC=C2N1)CCNCC3=CC=C(C=C3)C=CC(=O)NO,PHASE1,cardiovascular_disease
1028,"Stroke, Acute|Vessels; Occlusion|Blood Pressure|Endovascular Thrombectomy|Mechanical Thrombectomy",Labetalol,CC(CCC1=CC=CC=C1)NCC(C2=CC(=C(C=C2)O)C(=O)N)O,PHASE2,cardiovascular_disease
1029,"Stroke, Acute|Vessels; Occlusion|Blood Pressure|Endovascular Thrombectomy|Mechanical Thrombectomy",Hydralazine,C1=CC=C2C(=C1)C=NN=C2NN,PHASE2,cardiovascular_disease
1030,"Stroke, Acute|Vessels; Occlusion|Blood Pressure|Endovascular Thrombectomy|Mechanical Thrombectomy",Enalapril,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O,PHASE2,cardiovascular_disease
1031,Multiple Myeloma,Tucidinostat,C1=CC(=CN=C1)C=CC(=O)NCC2=CC=C(C=C2)C(=O)NC3=C(C=C(C=C3)F)N,PHASE1|PHASE2,cardiovascular_disease
1032,"Cavernous Malformations,Cerebral and/or Spinal",Propranolol,CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O,PHASE1,cardiovascular_disease
1033,Hypertension,Nebivolol,C1CC2=C(C=CC(=C2)F)OC1C(CNCC(C3CCC4=C(O3)C=CC(=C4)F)O)O,PHASE2,cardiovascular_disease
1034,"Subarachnoid Hemorrhage|Intracerebral Hemorrhage|Ventriculitis, Cerebral|Hydrocephalus",Nafcillin,CCOC1=C(C2=CC=CC=C2C=C1)C(=O)NC3C4N(C3=O)C(C(S4)(C)C)C(=O)O,PHASE1,cardiovascular_disease
1035,"Subarachnoid Hemorrhage|Intracerebral Hemorrhage|Ventriculitis, Cerebral|Hydrocephalus",Doxycycline,CC1C2C(C3C(C(=O)C(=C(C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O,PHASE1,cardiovascular_disease
1036,Pulmonary Arterial Hypertension,Imatinib,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,PHASE2,cardiovascular_disease
1037,Waldenstrom's Macroglobulinemia,Valaciclovir,CC(C)C(C(=O)OCCOCN1C=NC2=C1N=C(NC2=O)N)N,PHASE2,cardiovascular_disease
1038,Waldenstrom's Macroglobulinemia,Valacyclovir,CC(C)C(C(=O)OCCOCN1C=NC2=C1N=C(NC2=O)N)N,PHASE2,cardiovascular_disease
1039,Tuberculous Pericarditis|HIV Status,Rifampin,CC1C=CC=C(C(=O)NC2=C(C(=C3C(=C2O)C(=C(C4=C3C(=O)C(O4)(OC=CC(C(C(C(C(C(C1O)C)O)C)OC(=O)C)C)OC)C)C)O)O)C=NN5CCN(CC5)C)C,PHASE2,cardiovascular_disease
1040,Tuberculous Pericarditis|HIV Status,Rifampicin,CC1C=CC=C(C(=O)NC2=C(C(=C3C(=C2O)C(=C(C4=C3C(=O)C(O4)(OC=CC(C(C(C(C(C(C1O)C)O)C)OC(=O)C)C)OC)C)C)O)O)C=NN5CCN(CC5)C)C,PHASE2,cardiovascular_disease
1041,Obstructive Sleep Apnea|Sleep-Disordered Breathing|Blood Pressure|Hypertension,Acetazolamide,CC(=O)NC1=NN=C(S1)S(=O)(=O)N,PHASE2,cardiovascular_disease
1042,Multiple Myeloma,Bendamustine,CN1C2=C(C=C(C=C2)N(CCCl)CCCl)N=C1CCCC(=O)O,PHASE1|PHASE2,cardiovascular_disease
1043,Multiple Myeloma,Prednisone,CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C,PHASE1|PHASE2,cardiovascular_disease
1044,Plasma Cell Leukemia|Plasmacytoma|Recurrent Plasma Cell Myeloma|Refractory Plasma Cell Myeloma,Busulfan,CS(=O)(=O)OCCCCOS(=O)(=O)C,PHASE2,cardiovascular_disease
1045,Plasma Cell Leukemia|Plasmacytoma|Recurrent Plasma Cell Myeloma|Refractory Plasma Cell Myeloma,Gemcitabine,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)(F)F,PHASE2,cardiovascular_disease
1046,Plasma Cell Leukemia|Plasmacytoma|Recurrent Plasma Cell Myeloma|Refractory Plasma Cell Myeloma,Melphalan,C1=CC(=CC=C1CC(C(=O)O)N)N(CCCl)CCCl,PHASE2,cardiovascular_disease
1047,Multiple Myeloma in Relapse,Vorinostat,C1=CC=C(C=C1)NC(=O)CCCCCCC(=O)NO,PHASE1|PHASE2,cardiovascular_disease
1048,Multiple Myeloma in Relapse,Doxorubicin,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)N)O,PHASE1|PHASE2,cardiovascular_disease
1049,Multiple Myeloma,Nirogacestat,CCCC(C(=O)NC1=CN(C=N1)C(C)(C)CNCC(C)(C)C)NC2CCC3=C(C2)C(=CC(=C3)F)F,PHASE1,cardiovascular_disease
1050,HIV|Cardiovascular Diseases|Inflammation,Aspirin,CC(=O)OC1=CC=CC=C1C(=O)O,PHASE2,cardiovascular_disease
1051,HIV|Cardiovascular Diseases|Inflammation,Clopidogrel,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,PHASE2,cardiovascular_disease
1052,Follicular Lymphoma|Small Lymphocytic Lymphoma|Marginal Zone Lymphoma|Lymphoplasmacytic Lymphoma|Diffuse Large B Cell Lymphoma|Mantle Cell Lymphoma|Burkitt's Lymphoma,Imexon,C1C2N1C(=O)N=C2N,PHASE2,cardiovascular_disease
1053,Persistent Pulmonary Hypertension of Newborn,Sildenafil,CCCC1=NN(C2=C1N=C(NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C,PHASE1|PHASE2,cardiovascular_disease
1054,Venous Thromboembolism,Apixaban,COC1=CC=C(C=C1)N2C3=C(CCN(C3=O)C4=CC=C(C=C4)N5CCCCC5=O)C(=N2)C(=O)N,PHASE2,cardiovascular_disease
1055,Pulmonary Arterial Hypertension,Apabetalone,CC1=CC(=CC(=C1OCCO)C)C2=NC3=C(C(=CC(=C3)OC)OC)C(=O)N2,PHASE2,cardiovascular_disease
1056,Stroke|Inflammation,Fingolimod,CCCCCCCCC1=CC=C(C=C1)CCC(CO)(CO)N,PHASE2,cardiovascular_disease
1057,Coronary Artery Disease,Sirolimus,CC1CCC2CC(C(=CC=CC=CC(CC(C(=O)C(C(C(=CC(C(=O)CC(OC(=O)C3CCCCN3C(=O)C(=O)C1(O2)O)C(C)CC4CCC(C(C4)OC)O)C)C)O)OC)C)C)C)OC,PHASE1|PHASE2,cardiovascular_disease
1058,Chronic Kidney Diseases|Heart Failure With Preserved Ejection Fraction|Kidney Diseases|Heart Failure,Dapagliflozin,CCOC1=CC=C(C=C1)CC2=C(C=CC(=C2)C3C(C(C(C(O3)CO)O)O)O)Cl,PHASE1|PHASE2,cardiovascular_disease
1059,"Cardiomyopathy, Hypertrophic|Cardiomyopathy, Hypertrophic, Familial",Perhexiline,C1CCC(CC1)C(CC2CCCCN2)C3CCCCC3,PHASE2,cardiovascular_disease
1060,Renal Artery Obstruction|Stents|Lipids|Glomerular Filtration Rate|Blood Pressure,Rosuvastatin,CC(C)C1=NC(=NC(=C1C=CC(CC(CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C,PHASE2|PHASE3,cardiovascular_disease
1061,Multiple Myeloma,Cyclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,PHASE2|PHASE3,cardiovascular_disease
1062,Multiple Myeloma,Thalidomide,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O,PHASE2|PHASE3,cardiovascular_disease
1063,Hypertension,Atenolol,CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O,PHASE1,cardiovascular_disease
1064,Hypertension,Moxifloxacin,COC1=C2C(=CC(=C1N3CC4CCCNC4C3)F)C(=O)C(=CN2C5CC5)C(=O)O,PHASE1,cardiovascular_disease
1065,Subarachnoid Hemorrhage|Delayed Vasospasm,Simvastatin,CCC(C)(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,PHASE1|PHASE2,cardiovascular_disease
1066,Hypotension|Valve Surgery,Phenylephrine,CNCC(C1=CC(=CC=C1)O)O,PHASE2,cardiovascular_disease
1067,Non-Hodgkin's Lymphoma|Hodgkin's Lymphoma|Multiple Myeloma|Chronic Lymphocytic Leukemia|Acute Myelogenous Leukemia,Fludarabine,C1=NC2=C(N=C(N=C2N1C3C(C(C(O3)CO)O)O)F)N,PHASE2,cardiovascular_disease
1068,Pulmonary Hypertension|Interstitial Lung Disease|Combined Pulmonary Fibrosis and Emphysema,Treprostinil,CCCCCC(CCC1C(CC2C1CC3=C(C2)C(=CC=C3)OCC(=O)O)O)O,PHASE2|PHASE3,cardiovascular_disease
1069,Stroke,Urokinase,CC(C)OC(=O)NC1=CC2=C(C=C1)N=C(N2)C3=CSC=N3,PHASE2,cardiovascular_disease
1070,Autonomic Failure|Pure Autonomic Failure|Multiple System Atrophy|Parkinson Disease|Orthostatic Hypotension,Droxidopa,C1=CC(=C(C=C1C(C(C(=O)O)N)O)O)O,PHASE1,cardiovascular_disease
1071,Autonomic Failure|Pure Autonomic Failure|Multiple System Atrophy|Parkinson Disease|Orthostatic Hypotension,Midodrine,COC1=CC(=C(C=C1)OC)C(CNC(=O)CN)O,PHASE1,cardiovascular_disease
1072,Multiple Myeloma in Relapse,Selinexor,C1=CN=C(C=N1)NNC(=O)C=CN2C=NC(=N2)C3=CC(=CC(=C3)C(F)(F)F)C(F)(F)F,PHASE2,cardiovascular_disease
1073,Cerebral Hemorrhage|Atrial Fibrillation,Dipyridamole,C1CCN(CC1)C2=NC(=NC3=C2N=C(N=C3N4CCCCC4)N(CCO)CCO)N(CCO)CCO,PHASE2,cardiovascular_disease
1074,Glaucoma|Open Angle or Ocular Hypertension,Brinzolamide,CCNC1CN(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)CCCOC,PHASE1|PHASE2,cardiovascular_disease
1075,Heart Failure Preserved Ejection Fraction|Resistant Hypertension,Allopurinol,C1=NNC2=C1C(=O)NC=N2,PHASE2,cardiovascular_disease
1076,Essential Hypertension,Digoxin,CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,PHASE1,cardiovascular_disease
1077,Essential Hypertension,Fimasartan,CCCCC1=NC(=C(C(=O)N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CC(=S)N(C)C)C,PHASE1,cardiovascular_disease
1078,Multiple Myeloma|High Risk Smoldering Multiple Myeloma,Ixazomib,B(C(CC(C)C)NC(=O)CNC(=O)C1=C(C=CC(=C1)Cl)Cl)(O)O,PHASE1,cardiovascular_disease
1079,Essential Hypertension,Rostafuroxin,CC12CCC(CC1CCC3C2CCC4(C3(CCC4(C5=COC=C5)O)O)C)O,PHASE2,cardiovascular_disease
1080,Essential Hypertension,Losartan,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl,PHASE2,cardiovascular_disease
1081,Arterial Occlusive Disease,Paclitaxel,CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C,PHASE2|PHASE3,cardiovascular_disease
1082,Inflammation|Hypertension,Ramipril,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCC3CC2C(=O)O,PHASE2,cardiovascular_disease
1083,Hypoplastic Left Heart|Congenital Heart Disease,Oxandrolone,CC12CCC3C(C1CCC2(C)O)CCC4C3(COC(=O)C4)C,PHASE1|PHASE2,cardiovascular_disease
1084,"Glaucoma, Open-Angle|Hypertension, Ocular",Latanoprost,CC(C)OC(=O)CCCC=CCC1C(CC(C1CCC(CCC2=CC=CC=C2)O)O)O,PHASE2,cardiovascular_disease
1085,Retinal Neovascularization,Squalamine,CC(C)C(CCC(C)C1CCC2C1(CCC3C2C(CC4C3(CCC(C4)NCCCNCCCCN)C)O)C)OS(=O)(=O)O,PHASE2,cardiovascular_disease
1086,Heart Failure,Midazolam,CC1=NC=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4F,PHASE1,cardiovascular_disease
1087,Primary Open-Angle Glaucoma (POAG)|Ocular Hypertension (OHT),Trabodenoson,C1CCC(C1)NC2=C3C(=NC=N2)N(C=N3)C4C(C(C(O4)CO[N+](=O)[O-])O)O,PHASE2,cardiovascular_disease
1088,Primary Open-Angle Glaucoma (POAG)|Ocular Hypertension (OHT),Timolol,CC(C)(C)NCC(COC1=NSN=C1N2CCOCC2)O,PHASE2,cardiovascular_disease
1089,Heart Failure With Reduced Ejection Fraction,Melatonin,CC(=O)NCCC1=CNC2=C1C=C(C=C2)OC,PHASE2,cardiovascular_disease
1090,Barth Syndrome,Elamipretide,CC1=CC(=CC(=C1CC(C(=O)NC(CCCCN)C(=O)NC(CC2=CC=CC=C2)C(=O)N)NC(=O)C(CCCN=C(N)N)N)C)O,PHASE2|PHASE3,cardiovascular_disease
1091,Multiple Myeloma,Mesna,C(CS(=O)(=O)[O-])S.[Na+],PHASE2|PHASE3,cardiovascular_disease
1092,Diabetic Retinopathy|Macular Edema,Ketorolac,C1CN2C(=CC=C2C(=O)C3=CC=CC=C3)C1C(=O)O,PHASE2,cardiovascular_disease
1093,Diabetic Retinopathy|Macular Edema,Nepafenac,C1=CC=C(C=C1)C(=O)C2=CC=CC(=C2N)CC(=O)N,PHASE2,cardiovascular_disease
1094,Precapillary Pulmonary Hypertension,Trimetazidine,COC1=C(C(=C(C=C1)CN2CCNCC2)OC)OC,PHASE2|PHASE3,cardiovascular_disease
1095,"Hypertension, Pulmonary",Iloprost,CC#CCC(C)C(C=CC1C(CC2C1CC(=CCCCC(=O)O)C2)O)O,PHASE2,cardiovascular_disease
1096,Obesity|Hypoandrogenism,Clomifene,CCN(CC)CCOC1=CC=C(C=C1)C(=C(C2=CC=CC=C2)Cl)C3=CC=CC=C3,PHASE2,cardiovascular_disease
1097,Obesity|Hypoandrogenism,Clomiphene,CCN(CC)CCOC1=CC=C(C=C1)C(=C(C2=CC=CC=C2)Cl)C3=CC=CC=C3,PHASE2,cardiovascular_disease
1098,Coronary Artery Disease,Bradykinin,C1CC(N(C1)C(=O)C2CCCN2C(=O)C(CCCN=C(N)N)N)C(=O)NCC(=O)NC(CC3=CC=CC=C3)C(=O)NC(CO)C(=O)N4CCCC4C(=O)NC(CC5=CC=CC=C5)C(=O)NC(CCCN=C(N)N)C(=O)O,PHASE1,cardiovascular_disease
1099,Multiple Myeloma,Dextromethorphan,CN1CCC23CCCCC2C1CC4=C3C=C(C=C4)OC,PHASE2,cardiovascular_disease
1100,Acute Coronary Syndrome,Ticagrelor,CCCSC1=NC(=C2C(=N1)N(N=N2)C3CC(C(C3O)O)OCCO)NC4CC4C5=CC(=C(C=C5)F)F,PHASE2,cardiovascular_disease
1101,Hypertension,Daglutril,CCOC(=O)C(CCC1=CC=CC=C1)CC2(CCCC2)C(=O)NC3CCC4=CC=CC=C4N(C3=O)CC(=O)O,PHASE2,cardiovascular_disease
1102,Chronic Thromboembolic Pulmonary Hypertension,Macitentan,CCCNS(=O)(=O)NC1=C(C(=NC=N1)OCCOC2=NC=C(C=N2)Br)C3=CC=C(C=C3)Br,PHASE2,cardiovascular_disease
1103,Advanced Multiple Myeloma,Filanesib,CN(C(=O)N1C(SC(=N1)C2=C(C=CC(=C2)F)F)(CCCN)C3=CC=CC=C3)OC,PHASE2,cardiovascular_disease
1104,Hemorrhoids|Liver Cirrhosis,Polidocanol,CCCCCCCCCCCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO,PHASE2|PHASE3,cardiovascular_disease
1105,ICAD - Intracranial Atherosclerotic Disease,Colchicine,CC(=O)NC1CCC2=CC(=C(C(=C2C3=CC=C(C(=O)C=C13)OC)OC)OC)OC,PHASE2,cardiovascular_disease
1106,Marginal Zone Lymphoma|Waldenstrom Macroglobulinemia|Non Follicular Indolent Non-Hodgkin Lymphoma,Umbralisib,CC(C)OC1=C(C=C(C=C1)C2=NN(C3=NC=NC(=C23)N)C(C)C4=C(C(=O)C5=C(O4)C=CC(=C5)F)C6=CC(=CC=C6)F)F,PHASE2,cardiovascular_disease
1107,Head Trauma|Subarachnoid Hemorrhage|Close Head Injury,Morphine,CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O,PHASE1|PHASE2,cardiovascular_disease
1108,Ischemic Stroke,Meglumine,CNCC(C(C(C(CO)O)O)O)O,PHASE2|PHASE3,cardiovascular_disease
1109,Pulmonary Embolism,Diclofenac,C1=CC=C(C(=C1)CC(=O)O)NC2=C(C=CC=C2Cl)Cl,PHASE2|PHASE3,cardiovascular_disease
1110,Multiple Myeloma,Clarithromycin,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)O)(C)O,PHASE1|PHASE2,cardiovascular_disease
1111,Hypotension,Ivabradine,CN(CCCN1CCC2=CC(=C(C=C2CC1=O)OC)OC)CC3CC4=CC(=C(C=C34)OC)OC,PHASE2,cardiovascular_disease
1112,Postmenopause|Hypertension|Pre-Hypertension,Drospirenone,CC12CCC(=O)C=C1C3CC3C4C2CCC5(C4C6CC6C57CCC(=O)O7)C,PHASE2,cardiovascular_disease
1113,Postmenopause|Hypertension|Pre-Hypertension,Medroxyprogesterone,CC1CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C,PHASE2,cardiovascular_disease
1114,"Follicular Lymphoma|Marginal Zone Lymphoma|Mantle Cell Lymphoma|Small Lymphocytic Lymphoma|Lymphoplasmacytic Lymphoma|Low Grade B-cell Lymphoma, Not Otherwise Specified|Diffuse Large B-cell Lymphoma|Peripheral T-cell Lymphoma|Angioimmunoblastic T-cell Lymphoma|Anaplastic Large-cell Lymphoma",Clofarabine,C1=NC2=C(N=C(N=C2N1C3C(C(C(O3)CO)O)F)Cl)N,PHASE1|PHASE2,cardiovascular_disease
1115,Primary Open Angle Glaucoma|Ocular Hypertension,Epigallocatechin,C1C(C(OC2=CC(=CC(=C21)O)O)C3=CC(=C(C(=C3)O)O)O)O,PHASE1|PHASE2,cardiovascular_disease
1116,"Non-Alcoholic Fatty Liver Disease|Obesity|Obesity, Abdominal|Liver Fat|Fatty Liver",Tesamorelin,CCC=CCC(=O)NC(CC1=CC=C(C=C1)O)C(=O)NC(C)C(=O)NC(CC(=O)O)C(=O)NC(C)C(=O)NC(C(C)CC)C(=O)NC(CC2=CC=CC=C2)C(=O)NC(C(C)O)C(=O)NC(CC(=O)N)C(=O)NC(CO)C(=O)NC(CC3=CC=C(C=C3)O)C(=O)NC(CCCNC(=N)N)C(=O)NC(CCCCN)C(=O)NC(C(C)C)C(=O)NC(CC(C)C)C(=O)NCC(=O)NC(CCC(=O)N)C(=O)NC(CC(C)C)C(=O)NC(CO)C(=O)NC(C)C(=O)NC(CCCNC(=N)N)C(=O)NC(CCCCN)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(CCC(=O)N)C(=O)NC(CC(=O)O)C(=O)NC(C(C)CC)C(=O)NC(CCSC)C(=O)NC(CO)C(=O)NC(CCCNC(=N)N)C(=O)NC(CCC(=O)N)C(=O)NC(CCC(=O)N)C(=O)NCC(=O)NC(CCC(=O)O)C(=O)NC(CO)C(=O)NC(CC(=O)N)C(=O)NC(CCC(=O)N)C(=O)NC(CCC(=O)O)C(=O)NC(CCCNC(=N)N)C(=O)NCC(=O)NC(C)C(=O)NC(CCCNC(=N)N)C(=O)NC(C)C(=O)NC(CCCNC(=N)N)C(=O)NC(CC(C)C)C(=O)N,PHASE2,cardiovascular_disease
1117,Cardiovascular Diseases|Cardiovascular Risk Factor|Vasodilation,Tempol,CC1(CC(CC(N1[O])(C)C)O)C,PHASE1,cardiovascular_disease
1118,Cardiovascular Diseases|Cardiovascular Risk Factor|Vasodilation,Apocynin,CC(=O)C1=CC(=C(C=C1)O)OC,PHASE1,cardiovascular_disease
1119,Thrombosis,Itraconazole,CCC(C)N1C(=O)N(C=N1)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(C=C4)OCC5COC(O5)(CN6C=NC=N6)C7=C(C=C(C=C7)Cl)Cl,PHASE1,cardiovascular_disease
1120,Age Related Macular Degeneration|Diabetic Retinopathy,Brimonidine,C1CN=C(N1)NC2=C(C3=NC=CN=C3C=C2)Br,PHASE2,cardiovascular_disease
1121,Waldenstrom's Macroglobulinemia,Ibrutinib,C=CC(=O)N1CCCC(C1)N2C3=NC=NC(=C3C(=N2)C4=CC=C(C=C4)OC5=CC=CC=C5)N,PHASE1,cardiovascular_disease
1122,Myocardial Bridging,Diltiazem,CC(=O)OC1C(SC2=CC=CC=C2N(C1=O)CCN(C)C)C3=CC=C(C=C3)OC,PHASE2,cardiovascular_disease
1123,Non-Hodgkin's Lymphoma|Multiple Myeloma,Plerixafor,C1CNCCNCCCN(CCNC1)CC2=CC=C(C=C2)CN3CCCNCCNCCCNCC3,PHASE2,cardiovascular_disease
1124,Refractory Hypertension,Reserpine,COC1C(CC2CN3CCC4=C(C3CC2C1C(=O)OC)NC5=C4C=CC(=C5)OC)OC(=O)C6=CC(=C(C(=C6)OC)OC)OC,PHASE2,cardiovascular_disease
1125,Acute Coronary Syndrome,Prasugrel,CC(=O)OC1=CC2=C(S1)CCN(C2)C(C3=CC=CC=C3F)C(=O)C4CC4,PHASE2,cardiovascular_disease
1126,Atrial Fibrillation,Eplerenone,CC12CCC(=O)C=C1CC(C3C24C(O4)CC5(C3CCC56CCC(=O)O6)C)C(=O)OC,PHASE2,cardiovascular_disease
1127,Ischemic Stroke,Donepezil,COC1=C(C=C2C(=C1)CC(C2=O)CC3CCN(CC3)CC4=CC=CC=C4)OC,PHASE2,cardiovascular_disease
1128,Essential Hypertension,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,PHASE2,cardiovascular_disease
1129,"Hypertension, Pulmonary",Riociguat,CN(C1=C(N=C(N=C1N)C2=NN(C3=C2C=CC=N3)CC4=CC=CC=C4F)N)C(=O)OC,PHASE2,cardiovascular_disease
1130,Acute Coronary Syndrome,Losmapimod,CC1=C(C=C(C=C1F)C(=O)NC2CC2)C3=NC=C(C=C3)C(=O)NCC(C)(C)C,PHASE1,cardiovascular_disease
1131,Advanced Lymphoma|Advanced Malignant Solid Neoplasm|Hematopoietic and Lymphoid Cell Neoplasm|Refractory Lymphoma|Refractory Malignant Solid Neoplasm|Refractory Multiple Myeloma,Dabrafenib,CC(C)(C)C1=NC(=C(S1)C2=NC(=NC=C2)N)C3=C(C(=CC=C3)NS(=O)(=O)C4=C(C=CC=C4F)F)F,PHASE2,cardiovascular_disease
1132,Advanced Lymphoma|Advanced Malignant Solid Neoplasm|Hematopoietic and Lymphoid Cell Neoplasm|Refractory Lymphoma|Refractory Malignant Solid Neoplasm|Refractory Multiple Myeloma,Trametinib,CC1=C2C(=C(N(C1=O)C)NC3=C(C=C(C=C3)I)F)C(=O)N(C(=O)N2C4=CC=CC(=C4)NC(=O)C)C5CC5,PHASE2,cardiovascular_disease
1133,Recurrent Follicular Lymphoma|Recurrent Mantle Cell Lymphoma|Recurrent Marginal Zone Lymphoma|Recurrent Non-Hodgkin Lymphoma|Recurrent Small Lymphocytic Lymphoma|Recurrent Waldenstrom Macroglobulinemia|Refractory Follicular Lymphoma|Refractory Mantle Cell Lymphoma|Refractory Marginal Zone Lymphoma|Refractory Non-Hodgkin Lymphoma|Refractory Small Lymphocytic Lymphoma,Temsirolimus,CC1CCC2CC(C(=CC=CC=CC(CC(C(=O)C(C(C(=CC(C(=O)CC(OC(=O)C3CCCCN3C(=O)C(=O)C1(O2)O)C(C)CC4CCC(C(C4)OC)OC(=O)C(C)(CO)CO)C)C)O)OC)C)C)C)OC,PHASE1|PHASE2,cardiovascular_disease
1134,Multiple Trauma|Cardiovascular Diseases|Aged,Esmolol,CC(C)NCC(COC1=CC=C(C=C1)CCC(=O)OC)O,PHASE2,cardiovascular_disease
1135,Multiple Trauma|Cardiovascular Diseases|Aged,Metoprolol,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O,PHASE2,cardiovascular_disease
1136,Ischemia-reperfusion Injury.,Vardenafil,CCCC1=NC(=C2N1N=C(NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)CC)OCC)C,PHASE1,cardiovascular_disease
1137,Atherosclerosis,Methylprednisolone,CC1CC2C3CCC(C3(CC(C2C4(C1=CC(=O)C=C4)C)O)C)(C(=O)CO)O,PHASE1|PHASE2,cardiovascular_disease
1138,Multiple Myeloma,Vactosertib,CC1=NC(=CC=C1)C2=C(N=C(N2)CNC3=CC=CC=C3F)C4=CN5C(=NC=N5)C=C4,PHASE1,cardiovascular_disease
1139,"Leukemia|Lymphoma|Hodgkin's Disease|Hematologic Neoplasms|Multiple Myeloma|Carcinoma, Renal Cell",Pentostatin,C1C(C(OC1N2C=NC3=C2NC=NCC3O)CO)O,PHASE2,cardiovascular_disease
1140,"Kidney Failure, Chronic|Diabetic Nephropathies|Glomerulonephritis, IGA|Hypertension, Renal",Mycophenolate,CC1=C2COC(=O)C2=C(C(=C1OC)CC=C(C)CCC(=O)O)O,PHASE2,cardiovascular_disease
1141,Abdominal Aortic Aneurysm,Metformin,CN(C)C(=N)N=C(N)N,PHASE2,cardiovascular_disease
1142,Intracerebral Hemorrhage,Deferoxamine,CC(=O)N(CCCCCNC(=O)CCC(=O)N(CCCCCNC(=O)CCC(=O)N(CCCCCN)O)O)O,PHASE2,cardiovascular_disease
1143,Giant Cell Arteritis,Methotrexate,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,PHASE2,cardiovascular_disease
1144,"Claudication, Intermittent|Peripheral Artery Disease|Peripheral Vascular Diseases",Sapropterin,CC(C(C1CNC2=C(N1)C(=O)NC(=N2)N)O)O,PHASE1,cardiovascular_disease
1145,"Claudication, Intermittent|Peripheral Artery Disease|Peripheral Vascular Diseases",Tetrahydrobiopterin,CC(C(C1CNC2=C(N1)C(=O)NC(=N2)N)O)O,PHASE1,cardiovascular_disease
1146,Multiple Myeloma,Iberdomide,C1CC(=O)NC(=O)C1N2CC3=C(C2=O)C=CC=C3OCC4=CC=C(C=C4)CN5CCOCC5,PHASE1|PHASE2,cardiovascular_disease
1147,Leukemia|Lymphoma|Multiple Myeloma and Plasma Cell Neoplasm|Myelodysplastic Syndromes,Thiotepa,C1CN1P(=S)(N2CC2)N3CC3,PHASE1,cardiovascular_disease
1148,Hypertension,Azilsartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NOC(=O)N5)C(=O)O,PHASE2,cardiovascular_disease
1149,Hypertension,Olmesartan,CCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)C(=O)O)C(C)(C)O,PHASE2,cardiovascular_disease
1150,Coronary Artery Disease|Cerebrovascular Disease|Peripheral Vascular Disease,Rifalazil,CC1C=CC=C(C(=O)NC2=C3C(=C4C(=C(C(=C5C4=C(C(O5)(OC=CC(C(C(C(C(C(C1O)C)O)C)OC(=O)C)C)OC)C)O)C)O)C2=O)N=C6C(=CC(=CC6=O)N7CCN(CC7)CC(C)C)O3)C,PHASE2,cardiovascular_disease
1151,Hypertension|Chronic Kidney Disease|Nephrotic Syndrome,Valsartan,CCCCC(=O)N(CC1=CC=C(C=C1)C2=CC=CC=C2C3=NNN=N3)C(C(C)C)C(=O)O,PHASE1,cardiovascular_disease
1152,Heart Diseases,Dexmedetomidine,CC1=C(C(=CC=C1)C(C)C2=CN=CN2)C,PHASE1,cardiovascular_disease
1153,Heart Diseases,Sevoflurane,C(OC(C(F)(F)F)C(F)(F)F)F,PHASE1,cardiovascular_disease
1154,Heart Diseases,Isoflurane,C(C(F)(F)F)(OC(F)F)Cl,PHASE1,cardiovascular_disease
1155,Hypertension,Minocycline,CN(C)C1C2CC3CC4=C(C=CC(=C4C(=C3C(=O)C2(C(=C(C1=O)C(=O)N)O)O)O)O)N(C)C,PHASE1|PHASE2,cardiovascular_disease
1156,"Diabetes Mellitus, Type 2|Acute Heart Failure",Empagliflozin,C1COCC1OC2=CC=C(C=C2)CC3=C(C=CC(=C3)C4C(C(C(C(O4)CO)O)O)O)Cl,PHASE2,cardiovascular_disease
1157,"Cardiomyopathy, Hypertrophic|Heart Hypertrophy",Cyclosporine,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,PHASE2,cardiovascular_disease
1158,Essential Hypertension,Candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,PHASE2,cardiovascular_disease
1159,Myocardial Ischemia,Ranolazine,CC1=C(C(=CC=C1)C)NC(=O)CN2CCN(CC2)CC(COC3=CC=CC=C3OC)O,PHASE2,cardiovascular_disease
1160,Cerebral Vasospasm,Milrinone,CC1=C(C=C(C(=O)N1)C#N)C2=CC=NC=C2,PHASE2,cardiovascular_disease
1161,Atherosclerosis|Inflammation,Sitagliptin,C1CN2C(=NN=C2C(F)(F)F)CN1C(=O)CC(CC3=CC(=C(C=C3F)F)F)N,PHASE2,cardiovascular_disease
1162,Acute Ischemic Stroke,Tromethamine,C(C(CO)(CO)N)O,PHASE1,cardiovascular_disease
1163,HIV Infections|Non-Alcoholic Fatty Liver Disease,Semaglutide,CCC(C)C(C(=O)NC(C)C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(CC(C)C)C(=O)NC(C(C)C)C(=O)NC(CCCNC(=N)N)C(=O)NCC(=O)NC(CCCNC(=N)N)C(=O)NCC(=O)O)NC(=O)C(CC3=CC=CC=C3)NC(=O)C(CCC(=O)O)NC(=O)C(CCCCNC(=O)COCCOCCNC(=O)COCCOCCNC(=O)CCC(C(=O)O)NC(=O)CCCCCCCCCCCCCCCCC(=O)O)NC(=O)C(C)NC(=O)C(C)NC(=O)C(CCC(=O)N)NC(=O)CNC(=O)C(CCC(=O)O)NC(=O)C(CC(C)C)NC(=O)C(CC4=CC=C(C=C4)O)NC(=O)C(CO)NC(=O)C(CO)NC(=O)C(C(C)C)NC(=O)C(CC(=O)O)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C(CC5=CC=CC=C5)NC(=O)C(C(C)O)NC(=O)CNC(=O)C(CCC(=O)O)NC(=O)C(C)(C)NC(=O)C(CC6=CN=CN6)N,PHASE2,cardiovascular_disease
1164,Turner Syndrome|Short Stature,Vosoritide,CCC(C)C1C(=O)NCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)NCC(=O)NC(C(=O)NCC(=O)NC(CSSCC(C(=O)NC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCNC(=N)N)CC(=O)O)CC(C)C)CCCCN)CC(C)C)CC2=CC=CC=C2)NC(=O)CNC(=O)C(CCCCN)NC(=O)C(CO)NC(=O)C(CC(C)C)NC(=O)CNC(=O)C(CCCCN)NC(=O)C(CCCCN)NC(=O)C(CC(=O)N)NC(=O)C(C)NC(=O)CNC(=O)C(CCCCN)NC(=O)C(CC3=CC=C(C=C3)O)NC(=O)C(CCCCN)NC(=O)C(CCCNC(=N)N)NC(=O)C(C)NC(=O)C(CC(=O)N)NC(=O)C4CCCN4C(=O)C(CC5=CN=CN5)NC(=O)C(CCC(=O)O)NC(=O)C(CCC(=O)N)NC(=O)CNC(=O)C6CCCN6)C(=O)O)CC(C)C)CO)CCSC)CO,PHASE2,cardiovascular_disease
1165,Thromboembolism|Hemodialysis,Dalteparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,PHASE2|PHASE3,cardiovascular_disease
1166,Thromboembolism|Hemodialysis,Tinzaparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,PHASE2|PHASE3,cardiovascular_disease
1167,Cardiovascular Disease,Evacetrapib,CC1=CC(=C2C(=C1)C(CCCN2CC3CCC(CC3)C(=O)O)N(CC4=CC(=CC(=C4)C(F)(F)F)C(F)(F)F)C5=NN(N=N5)C)C,PHASE1,cardiovascular_disease
1168,Ischemic Stroke,Argatroban,CC1CCN(C(C1)C(=O)O)C(=O)C(CCCN=C(N)N)NS(=O)(=O)C2=CC=CC3=C2NCC(C3)C,PHASE2,cardiovascular_disease
1169,Deep Vein Thrombosis|Pulmonary Embolism,Nadroparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,PHASE2|PHASE3,cardiovascular_disease
1170,Deep Vein Thrombosis|Pulmonary Embolism,Fondaparinux,COC1C(C(C(C(O1)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)COS(=O)(=O)O)OC4C(C(C(C(O4)C(=O)O)OC5C(C(C(C(O5)COS(=O)(=O)O)O)O)NS(=O)(=O)O)O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O)NS(=O)(=O)O,PHASE2|PHASE3,cardiovascular_disease
1171,Heart Failure,Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,PHASE2,cardiovascular_disease
1172,Hypertension|Vitamin D Deficiency,Cholecalciferol,CC(C)CCCC(C)C1CCC2C1(CCCC2=CC=C3CC(CCC3=C)O)C,PHASE2,cardiovascular_disease
1173,Pulmonary Hypertension,Bosentan,CC(C)(C)C1=CC=C(C=C1)S(=O)(=O)NC2=C(C(=NC(=N2)C3=NC=CC=N3)OCCO)OC4=CC=CC=C4OC,PHASE2|PHASE3,cardiovascular_disease
1174,Pulmonary Hypertension,Ambrisentan,CC1=CC(=NC(=N1)OC(C(=O)O)C(C2=CC=CC=C2)(C3=CC=CC=C3)OC)C,PHASE2|PHASE3,cardiovascular_disease
1175,Atherosclerosis,Darapladib,CCN(CC)CCN(CC1=CC=C(C=C1)C2=CC=C(C=C2)C(F)(F)F)C(=O)CN3C4=C(CCC4)C(=O)N=C3SCC5=CC=C(C=C5)F,PHASE1,cardiovascular_disease
1176,Cardiovascular Diseases|Heart Diseases|Hypertension,Fosinopril,CCC(=O)OC(C(C)C)OP(=O)(CCCCC1=CC=CC=C1)CC(=O)N2CC(CC2C(=O)O)C3CCCCC3,PHASE2,cardiovascular_disease
1177,Multiple Myeloma,Etoposide,CC1OCC2C(O1)C(C(C(O2)OC3C4COC(=O)C4C(C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)O)OC)O)O,PHASE2,cardiovascular_disease
1178,Heart Failure,Cannabidiol,CCCCCC1=CC(=C(C(=C1)O)C2C=C(CCC2C(=C)C)C)O,PHASE1,cardiovascular_disease
1179,Stroke,Exenatide,CCC(C)C(C(=O)NC(CCC(=O)O)C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(CC(C)C)C(=O)NC(CCCCN)C(=O)NC(CC(=O)N)C(=O)NCC(=O)NCC(=O)N3CCCC3C(=O)NC(CO)C(=O)NC(CO)C(=O)NCC(=O)NC(C)C(=O)N4CCCC4C(=O)N5CCCC5C(=O)N6CCCC6C(=O)NC(CO)C(=O)N)NC(=O)C(CC7=CC=CC=C7)NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(C(C)C)NC(=O)C(C)NC(=O)C(CCC(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(CCSC)NC(=O)C(CCC(=O)N)NC(=O)C(CCCCN)NC(=O)C(CO)NC(=O)C(CC(C)C)NC(=O)C(CC(=O)O)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C(CC8=CC=CC=C8)NC(=O)C(C(C)O)NC(=O)CNC(=O)C(CCC(=O)O)NC(=O)CNC(=O)C(CC9=CNC=N9)N,PHASE2,cardiovascular_disease
1180,Giant Cell Arteritis,Prednisolone,CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O,PHASE2,cardiovascular_disease
1181,VHL - Von Hippel-Lindau Syndrome|VHL Gene Mutation|VHL Syndrome|VHL Gene Inactivation|VHL-Associated Renal Cell Carcinoma|VHL-Associated Clear Cell Renal Cell Carcinoma,Belzutifan,CS(=O)(=O)C1=C2C(C(C(C2=C(C=C1)OC3=CC(=CC(=C3)C#N)F)F)F)O,PHASE2,cardiovascular_disease
1182,Anemia|Cardiovascular Disease,Ferumoxytol,O[Fe]=O.O[Fe]=O.[Fe],PHASE1|PHASE2,cardiovascular_disease
1183,Atherosclerosis|Heterozygous Familial Hypercholesterolemia,Pactimibe,CCCCCCCCN1CCC2=C(C(=C(C(=C21)NC(=O)C(C)(C)C)C)CC(=O)O)C,PHASE2|PHASE3,cardiovascular_disease
1184,Heart Failure,Finerenone,CCOC1=NC=C(C2=C1C(C(=C(N2)C)C(=O)N)C3=C(C=C(C=C3)C#N)OC)C,PHASE2,cardiovascular_disease
1185,Postoperative Cardiac Complication,Celiprolol,CCN(CC)C(=O)NC1=CC(=C(C=C1)OCC(CNC(C)(C)C)O)C(=O)C,PHASE2,cardiovascular_disease
1186,"Kidney Failure, Chronic|Prediabetic State",Liraglutide,CCCCCCCCCCCCCCCC(=O)NC(CCC(=O)NCCCCC(C(=O)NC(CCC(=O)O)C(=O)NC(CC1=CC=CC=C1)C(=O)NC(C(C)CC)C(=O)NC(C)C(=O)NC(CC2=CNC3=CC=CC=C32)C(=O)NC(CC(C)C)C(=O)NC(C(C)C)C(=O)NC(CCCNC(=N)N)C(=O)NCC(=O)NC(CCCNC(=N)N)C(=O)NCC(=O)O)NC(=O)C(C)NC(=O)C(C)NC(=O)C(CCC(=O)N)NC(=O)CNC(=O)C(CCC(=O)O)NC(=O)C(CC(C)C)NC(=O)C(CC4=CC=C(C=C4)O)NC(=O)C(CO)NC(=O)C(CO)NC(=O)C(C(C)C)NC(=O)C(CC(=O)O)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C(CC5=CC=CC=C5)NC(=O)C(C(C)O)NC(=O)CNC(=O)C(CCC(=O)O)NC(=O)C(C)NC(=O)C(CC6=CN=CN6)N)C(=O)O,PHASE2,cardiovascular_disease
1187,Stroke,Enecadin,CC1=NC(=CC(=N1)OCCCCCN2CCCCC2)C3=CC=C(C=C3)F,PHASE2,cardiovascular_disease
1188,Advanced Lymphoma|Advanced Malignant Solid Neoplasm|Hematopoietic and Lymphoid Cell Neoplasm|Refractory Lymphoma|Refractory Malignant Solid Neoplasm|Refractory Multiple Myeloma,Defactinib,CNC(=O)C1=CC=C(C=C1)NC2=NC=C(C(=N2)NCC3=NC=CN=C3N(C)S(=O)(=O)C)C(F)(F)F,PHASE2,cardiovascular_disease
1189,Chronic Myeloid Leukemia (CML),Ponatinib,CC1=C(C=C(C=C1)C(=O)NC2=CC(=C(C=C2)CN3CCN(CC3)C)C(F)(F)F)C#CC4=CN=C5N4N=CC=C5,PHASE2,cardiovascular_disease
1190,Grade I or II Essential Hypertension,Hydrochlorothiazide,C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl,PHASE2|PHASE3,cardiovascular_disease
1191,Acute Myocardial Infarction Type 1,Deferiprone,CC1=C(C(=O)C=CN1C)O,PHASE1,cardiovascular_disease
1192,Arterial Hypertension|Diabetes|Hypokalemia|Hyponatremia,Cicletanine,CC1=NC=C2C(OCC2=C1O)C3=CC=C(C=C3)Cl,PHASE1|PHASE2,cardiovascular_disease
1193,Hereditary Hemorrhagic Telangiectasia|Epistaxis,Pazopanib,CC1=C(C=C(C=C1)NC2=NC=CC(=N2)N(C)C3=CC4=NN(C(=C4C=C3)C)C)S(=O)(=O)N,PHASE1|PHASE2,cardiovascular_disease
1194,Multiple Myeloma,Cobimetinib,C1CCNC(C1)C2(CN(C2)C(=O)C3=C(C(=C(C=C3)F)F)NC4=C(C=C(C=C4)I)F)O,PHASE1|PHASE2,cardiovascular_disease
1195,Congestive Heart Failure,Nesiritide,CCC(C)C1C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NCC(=O)NC(C(=O)NCC(=O)NC(CSSCC(C(=O)NC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCNC(=N)N)CC(=O)O)CCSC)CCCCN)CCCNC(=N)N)CC2=CC=CC=C2)NC(=O)CNC(=O)C(CO)NC(=O)CNC(=O)C(CCC(=O)N)NC(=O)C(C(C)C)NC(=O)C(CCSC)NC(=O)C(CCCCN)NC(=O)C3CCCN3C(=O)C(CO)N)C(=O)NC(CCCCN)C(=O)NC(C(C)C)C(=O)NC(CC(C)C)C(=O)NC(CCCNC(=N)N)C(=O)NC(CCCNC(=N)N)C(=O)NC(CC4=CN=CN4)C(=O)O)CC(C)C)CO)CO)CO)CO,PHASE1|PHASE2,cardiovascular_disease
1196,Infectious Endocarditis,Ceftriaxone,CN1C(=NC(=O)C(=O)N1)SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)O,PHASE2,cardiovascular_disease
1197,Stroke,Warfarin,CC(=O)CC(C1=CC=CC=C1)C2=C(C3=CC=CC=C3OC2=O)O,PHASE1,cardiovascular_disease
1198,Stroke,Edaravone,CC1=NN(C(=O)C1)C2=CC=CC=C2,PHASE1,cardiovascular_disease
1199,Myelodysplastic Syndrome|Chronic Myelomonocytic Leukemia|Small Lymphocytic Lymphoma|Chronic Lymphocytic Leukemia|Prolymphocytic Leukemia|Chronic Myeloid Leukemia|Chronic Myeloproliferative Disorders|Multiple Myeloma|Plasma Cell Neoplasm|Plasma Cell Dyscrasia|Myelofibrosis|Polycythemia Vera|Essential Thrombocythemia|Plasma Cell Leukemia,Tacrolimus,CC1CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC(=O)C(C=C(C1)C)CC=C)O)C)C(=CC4CCC(C(C4)OC)O)C)O)C)OC)OC,PHASE2,cardiovascular_disease
1200,Intermittent Claudication,Cilostazol,C1CCC(CC1)N2C(=NN=N2)CCCCOC3=CC4=C(C=C3)NC(=O)CC4,PHASE1,cardiovascular_disease
1201,Chronic Stable Angina,Capadenoson,C1=CC(=CC=C1C2=C(C(=NC(=C2C#N)SCC3=CSC(=N3)C4=CC=C(C=C4)Cl)N)C#N)OCCO,PHASE2,cardiovascular_disease
1202,Non Hodgkin Lymphoma|Follicular Lymphoma|Indolent Lymphoma|B-cell Lymphoma|Transformed Lymphoma|Marginal Zone Lymphoma|Waldenstrom Macroglobulinemia|Small Lymphocytic Lymphoma|Lymphoplasmacytic Lymphoma,Idelalisib,CCC(C1=NC2=C(C(=CC=C2)F)C(=O)N1C3=CC=CC=C3)NC4=NC=NC5=C4NC=N5,PHASE2,cardiovascular_disease
1203,Acute Stroke|Visual Field Loss,Fluoxetine,CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F,PHASE2,cardiovascular_disease
1204,Subarachnoid Hemorrhage|Cerebral Vasospasm,Dantrolene,C1C(=O)NC(=O)N1N=CC2=CC=C(O2)C3=CC=C(C=C3)[N+](=O)[O-],PHASE1|PHASE2,cardiovascular_disease
1205,Type 1 Diabetes|Diabetic Kidney Disease|Cardiovascular Diseases|Endothelial Dysfunction|Insulin Sensitivity,Iohexol,CC(=O)N(CC(CO)O)C1=C(C(=C(C(=C1I)C(=O)NCC(CO)O)I)C(=O)NCC(CO)O)I,PHASE1,cardiovascular_disease
1206,Polymyalgia Rheumatica|Effect of Drug|Safety Issues,Tofacitinib,CC1CCN(CC1N(C)C2=NC=NC3=C2C=CN3)C(=O)CC#N,PHASE2,cardiovascular_disease
1207,Hypertension,Chlorthalidone,C1=CC=C2C(=C1)C(=O)NC2(C3=CC(=C(C=C3)Cl)S(=O)(=O)N)O,PHASE1,cardiovascular_disease
1208,Stroke|Cerebrovascular Accident,Citrulline,C(CC(C(=O)O)N)CNC(=O)N,PHASE2,cardiovascular_disease
1209,"Fibrillation, Atrial|Atrial Fibrillation",Odiparcil,CC1=CC(=O)OC2=C1C=CC(=C2)OC3C(C(C(CS3)O)O)O,PHASE1,cardiovascular_disease
1210,Deep Vein Thrombosis|Venous Thromboembolism,Edoxaban,CN1CCC2=C(C1)SC(=N2)C(=O)NC3CC(CCC3NC(=O)C(=O)NC4=NC=C(C=C4)Cl)C(=O)N(C)C,PHASE1,cardiovascular_disease
1211,Cyanotic Congenital Heart Disease,Topiramate,CC1(OC2COC3(C(C2O1)OC(O3)(C)C)COS(=O)(=O)N)C,PHASE1,cardiovascular_disease
1212,Phlebitis,Clobetasol,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CCl)O)C)O)F)C,PHASE1|PHASE2,cardiovascular_disease
1213,Pulmonary Arterial Hypertension,Tadalafil,CN1CC(=O)N2C(C1=O)CC3=C(C2C4=CC5=C(C=C4)OCO5)NC6=CC=CC=C36,PHASE1|PHASE2,cardiovascular_disease
1214,High Altitude Pulmonary Hypertension,Bambuterol,CC(C)(C)NCC(C1=CC(=CC(=C1)OC(=O)N(C)C)OC(=O)N(C)C)O,PHASE1,cardiovascular_disease
1215,Out-Of-Hospital Cardiac Arrest|Postcardiac Arrest Syndrome,Hydrocortisone,CC12CCC(=O)C=C1CCC3C2C(CC4(C3CCC4(C(=O)CO)O)C)O,PHASE2,cardiovascular_disease
1216,Metabolic Syndrome x,Fenofibrate,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl,PHASE2,cardiovascular_disease
1217,Aneurysmal Subarachnoid Hemorrhage,Tiopronin,CC(C(=O)NCC(=O)O)S,PHASE2,cardiovascular_disease
1218,Central Retinal Vein Occlusion,Triamcinolone,CC12CC(C3(C(C1CC(C2(C(=O)CO)O)O)CCC4=CC(=O)C=CC43C)F)O,PHASE2|PHASE3,cardiovascular_disease
1219,Mitral Valve Insufficiency|Aortic Valve Insufficiency|Cardiac Disease,Propofol,CC(C)C1=C(C(=CC=C1)C(C)C)O,PHASE1,cardiovascular_disease
1220,Cardiogenic Shock,Istaroxime,CC12CCC(=NOCCN)CC1C(=O)CC3C2CCC4(C3CCC4=O)C,PHASE1|PHASE2,cardiovascular_disease
1221,Plasmacytoma|Recurrent Multiple Myeloma|Refractory Multiple Myeloma,Navtemadlin,CC(C)C(CS(=O)(=O)C(C)C)N1C(C(CC(C1=O)(C)CC(=O)O)C2=CC(=CC=C2)Cl)C3=CC=C(C=C3)Cl,PHASE1,cardiovascular_disease
1222,Multiple Myeloma,Imetelstat,CCCCCCCCCCCCCCCC(=O)NCC(COP(=S)(O)OCC1C(CC(O1)N2C=C(C(=O)NC2=O)C)NP(=S)(O)OCC3C(CC(O3)N4C=NC5=C(N=CN=C54)N)NP(=S)(O)OCC6C(CC(O6)N7C=NC8=C7N=C(NC8=O)N)NP(=S)(O)OCC9C(CC(O9)N1C=NC2=C1N=C(NC2=O)N)NP(=S)(O)OCC1C(CC(O1)N1C=NC2=C1N=C(NC2=O)N)NP(=S)(O)OCC1C(CC(O1)N1C=C(C(=O)NC1=O)C)NP(=S)(O)OCC1C(CC(O1)N1C=C(C(=O)NC1=O)C)NP(=S)(O)OCC1C(CC(O1)N1C=NC2=C(N=CN=C21)N)NP(=S)(O)OCC1C(CC(O1)N1C=NC2=C1N=C(NC2=O)N)NP(=S)(O)OCC1C(CC(O1)N1C=NC2=C(N=CN=C21)N)NP(=S)(O)OCC1C(CC(O1)N1C=CC(=NC1=O)N)NP(=S)(O)OCC1C(CC(O1)N1C=NC2=C(N=CN=C21)N)NP(=O)(OCC1C(CC(O1)N1C=NC2=C(N=CN=C21)N)N)S)O,PHASE2,cardiovascular_disease
1223,Coronary Artery Disease,Gefarnate,CC(=CCCC(=CCCC(=CCCC(=O)OCC=C(C)CCC=C(C)C)C)C)C,PHASE2|PHASE3,cardiovascular_disease
1224,Heart Failure,Pyridostigmine,C[N+]1=CC=CC(=C1)OC(=O)N(C)C,PHASE2,cardiovascular_disease
1225,"Stroke, Acute",Desmopressin,C1CC(N(C1)C(=O)C2CSSCCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N2)CC(=O)N)CCC(=O)N)CC3=CC=CC=C3)CC4=CC=C(C=C4)O)C(=O)NC(CCCN=C(N)N)C(=O)NCC(=O)N,PHASE2,cardiovascular_disease
1226,Atrial Fibrillation,Vernakalant,COC1=C(C=C(C=C1)CCOC2CCCCC2N3CCC(C3)O)OC,PHASE2,cardiovascular_disease
1227,"Hypertension|Hypertension, Essential",Trimethaphan,C1CC2C3C(C[S+]2C1)N(C(=O)N3CC4=CC=CC=C4)CC5=CC=CC=C5,PHASE1,cardiovascular_disease
1228,Descending Aortic Dissection|Postoperative Pain|Thoracoabdominal Aortic Aneurysm,Ketamine,CNC1(CCCCC1=O)C2=CC=CC=C2Cl,PHASE2,cardiovascular_disease
1229,Smoldering Multiple Myeloma,Hiltonol,C1=CN(C(=O)N=C1N)C2C(C(C(O2)COP(=O)(O)O)O)O.C1=NC2=C(C(=O)N1)N=CN2C3C(C(C(O3)COP(=O)(O)O)O)O.C(CCNC(=O)O)CN.C(C(=O)O)O,PHASE1,cardiovascular_disease
1230,Smoldering Multiple Myeloma,Citarinostat,C1=CC=C(C=C1)N(C2=CC=CC=C2Cl)C3=NC=C(C=N3)C(=O)NCCCCCCC(=O)NO,PHASE1,cardiovascular_disease
1231,Intracerebral Hemorrhage,Celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,PHASE2,cardiovascular_disease
1232,Multiple Myeloma,Oprozomib,CC1=NC=C(S1)C(=O)NC(COC)C(=O)NC(COC)C(=O)NC(CC2=CC=CC=C2)C(=O)C3(CO3)C,PHASE1|PHASE2,cardiovascular_disease
1233,Hypertension,Aliskiren,CC(C)C(CC1=CC(=C(C=C1)OC)OCCCOC)CC(C(CC(C(C)C)C(=O)NCC(C)(C)C(=O)N)O)N,PHASE2,cardiovascular_disease
1234,Multiple Myeloma,Ibritumomab,CC(CN(CC(CC1=CC=C(C=C1)NC(=O)NC)N(CC(=O)O)CC(=O)O)CC(=O)O)N(CC(=O)O)CC(=O)O,PHASE2,cardiovascular_disease
1235,Atrial Fibrillation,Isoproterenol,CC(C)NCC(C1=CC(=C(C=C1)O)O)O,PHASE2,cardiovascular_disease
1236,Atrial Fibrillation,Isoprenaline,CC(C)NCC(C1=CC(=C(C=C1)O)O)O,PHASE2,cardiovascular_disease
1237,Arrhythmia,Quinidine,COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O,PHASE2|PHASE3,cardiovascular_disease
1238,Multiple Myeloma,Fludeoxyglucose,C(C(C(C(C(C=O)F)O)O)O)O,PHASE2,cardiovascular_disease
1239,Pregnancy|Severe Pre-eclampsia,Remifentanil,CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCC(=O)OC)C(=O)OC,PHASE2,cardiovascular_disease
1240,Coronary Heart Disease,Amiloride,C1(=C(N=C(C(=N1)Cl)N)N)C(=O)N=C(N)N,PHASE2|PHASE3,cardiovascular_disease
1241,Essential Hypertension,Ketoconazole,CC(=O)N1CCN(CC1)C2=CC=C(C=C2)OCC3COC(O3)(CN4C=CN=C4)C5=C(C=C(C=C5)Cl)Cl,PHASE1,cardiovascular_disease
1242,Ischemic Optic Neuropathy,Alprostadil,CCCCCC(C=CC1C(CC(=O)C1CCCCCCC(=O)O)O)O,PHASE2,cardiovascular_disease
1243,Atrial Fibrillation|Atrial Flutter,Celivarone,CCCCC1=C(C2=C(O1)C=CC(=C2)C(=O)OC(C)C)C(=O)C3=CC=C(C=C3)CCCN(CCCC)CCCC,PHASE2,cardiovascular_disease
1244,Smoldering Plasma Cell Myeloma,Cholestyramine,CCC(C)C.CCC(CC(C)C1=CC=CC=C1)C2=CC=C(C=C2)C[N+](C)(C)C.N.[Cl-],PHASE2,cardiovascular_disease
1245,Smoldering Plasma Cell Myeloma,Leflunomide,CC1=C(C=NO1)C(=O)NC2=CC=C(C=C2)C(F)(F)F,PHASE2,cardiovascular_disease
1246,Lymphoma,Vincristine,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O,PHASE2,cardiovascular_disease
1247,Congestive Heart Failure,Piboserod,CCCCN1CCC(CC1)CNC(=O)C2=C3N(CCCO3)C4=CC=CC=C42,PHASE2,cardiovascular_disease
1248,Hypertension Pulmonary Secondary Heart Failure|Right Sided Heart Failure With Normal Ejection Fraction|Heart Failure With Normal Ejection Fraction,Levosimendan,CC1CC(=O)NN=C1C2=CC=C(C=C2)NN=C(C#N)C#N,PHASE2,cardiovascular_disease
1249,Hypertension Pulmonary Secondary Heart Failure|Right Sided Heart Failure With Normal Ejection Fraction|Heart Failure With Normal Ejection Fraction,Simendan,CC1CC(=O)NN=C1C2=CC=C(C=C2)NN=C(C#N)C#N,PHASE2,cardiovascular_disease
1250,Waldenstrm's Macroglobulinemia,Perifosine,CCCCCCCCCCCCCCCCCCOP(=O)([O-])OC1CC[N+](CC1)(C)C,PHASE2,cardiovascular_disease
1251,Liver Transplant With Clinically Significant Portal Hypertension,Somatostatin,CC(C1C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=CC=C4)CC5=CC=CC=C5)CC(=O)N)CCCCN)NC(=O)CNC(=O)C(C)N)C(=O)O)CO)C(C)O)CC6=CC=CC=C6)O,PHASE1,cardiovascular_disease
1252,MELAS Syndrome,Idebenone,CC1=C(C(=O)C(=C(C1=O)OC)OC)CCCCCCCCCCO,PHASE2,cardiovascular_disease
1253,Obesity|Prehypertension|Hypertension,Clonidine,C1CN=C(N1)NC2=C(C=CC=C2Cl)Cl,PHASE2,cardiovascular_disease
1254,B-Cell Prolymphocytic Leukemia|Hypodiploidy|Loss of Chromosome 17p|Plasma Cell Leukemia|Progression of Multiple Myeloma or Plasma Cell Leukemia|Recurrent Adult Hodgkin Lymphoma|Recurrent Adult Non-Hodgkin Lymphoma|Recurrent Childhood Hodgkin Lymphoma|Recurrent Childhood Non-Hodgkin Lymphoma|Recurrent Chronic Lymphocytic Leukemia|Recurrent Plasma Cell Myeloma|Recurrent Small Lymphocytic Lymphoma|Refractory Childhood Hodgkin Lymphoma|Refractory Chronic Lymphocytic Leukemia|Refractory Non-Hodgkin Lymphoma|Refractory Plasma Cell Myeloma|Refractory Small Lymphocytic Lymphoma|t(14;16)|t(4;14)|T-Cell Prolymphocytic Leukemia|Waldenstrom Macroglobulinemia,Carmustine,C(CCl)NC(=O)N(CCCl)N=O,PHASE2,cardiovascular_disease
1255,B-Cell Prolymphocytic Leukemia|Hypodiploidy|Loss of Chromosome 17p|Plasma Cell Leukemia|Progression of Multiple Myeloma or Plasma Cell Leukemia|Recurrent Adult Hodgkin Lymphoma|Recurrent Adult Non-Hodgkin Lymphoma|Recurrent Childhood Hodgkin Lymphoma|Recurrent Childhood Non-Hodgkin Lymphoma|Recurrent Chronic Lymphocytic Leukemia|Recurrent Plasma Cell Myeloma|Recurrent Small Lymphocytic Lymphoma|Refractory Childhood Hodgkin Lymphoma|Refractory Chronic Lymphocytic Leukemia|Refractory Non-Hodgkin Lymphoma|Refractory Plasma Cell Myeloma|Refractory Small Lymphocytic Lymphoma|t(14;16)|t(4;14)|T-Cell Prolymphocytic Leukemia|Waldenstrom Macroglobulinemia,Cytarabine,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,PHASE2,cardiovascular_disease
1256,Wet Macular Degeneration|Age-related Macular Degeneration|Diabetic Macular Edema|Retinal Vein Occlusion,Dorzolamide,CCNC1CC(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)C,PHASE2,cardiovascular_disease
1257,Transfusional Iron Overload|Transfusional Hemosiderosis,Deferasirox,C1=CC=C(C(=C1)C2=NN(C(=N2)C3=CC=CC=C3O)C4=CC=C(C=C4)C(=O)O)O,PHASE2,cardiovascular_disease
1258,Acute Myocardial Infarction|Cardiogenic Shock,Dobutamine,CC(CCC1=CC=C(C=C1)O)NCCC2=CC(=C(C=C2)O)O,PHASE2,cardiovascular_disease
1259,Congenital Heart Disease,Phenoxybenzamine,CC(COC1=CC=CC=C1)N(CCCl)CC2=CC=CC=C2,PHASE2,cardiovascular_disease
1260,"Hypertension,Essential",Captopril,CC(CS)C(=O)N1CCCC1C(=O)O,PHASE1|PHASE2,cardiovascular_disease
1261,Multiple Myeloma,Dasatinib,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=CC(=NC(=N3)C)N4CCN(CC4)CCO,PHASE1,cardiovascular_disease
1262,Leukemia|Multiple Myeloma|Myelodysplastic Syndrome|Non-Hodgkin's Lymphoma,Leuprorelin,CCNC(=O)C1CCCN1C(=O)C(CCCN=C(N)N)NC(=O)C(CC(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC2=CC=C(C=C2)O)NC(=O)C(CO)NC(=O)C(CC3=CNC4=CC=CC=C43)NC(=O)C(CC5=CN=CN5)NC(=O)C6CCC(=O)N6,PHASE2,cardiovascular_disease
1263,Leukemia|Multiple Myeloma|Myelodysplastic Syndrome|Non-Hodgkin's Lymphoma,Leuprolide,CCNC(=O)C1CCCN1C(=O)C(CCCN=C(N)N)NC(=O)C(CC(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC2=CC=C(C=C2)O)NC(=O)C(CO)NC(=O)C(CC3=CNC4=CC=CC=C43)NC(=O)C(CC5=CN=CN5)NC(=O)C6CCC(=O)N6,PHASE2,cardiovascular_disease
1264,Leukemia|Multiple Myeloma|Myelodysplastic Syndrome|Non-Hodgkin's Lymphoma,Degarelix,CC(C)CC(C(=O)NC(CCCCNC(C)C)C(=O)N1CCCC1C(=O)NC(C)C(=O)N)NC(=O)C(CC2=CC=C(C=C2)NC(=O)N)NC(=O)C(CC3=CC=C(C=C3)NC(=O)C4CC(=O)NC(=O)N4)NC(=O)C(CO)NC(=O)C(CC5=CN=CC=C5)NC(=O)C(CC6=CC=C(C=C6)Cl)NC(=O)C(CC7=CC8=CC=CC=C8C=C7)NC(=O)C,PHASE2,cardiovascular_disease
1265,Schizophrenia|Schizoaffective Disorder,Paliperidone,CC1=C(C(=O)N2CCCC(C2=N1)O)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F,PHASE1,cardiovascular_disease
1266,Multiple Myeloma,Uproleselan,CCC1CC(CC(C1OC2C(C(C(C(O2)C)O)O)O)OC3C(C(C(C(O3)CO)O)OC(CC4CCCCC4)C(=O)O)NC(=O)C)C(=O)NCCNC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC,PHASE2,cardiovascular_disease
1267,Acute Stroke,Glyburide,COC1=C(C=C(C=C1)Cl)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCCCC3,PHASE2|PHASE3,cardiovascular_disease
1268,Hypertension,Doxazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4COC5=CC=CC=C5O4)N)OC,PHASE2|PHASE3,cardiovascular_disease
1269,Hypertension,Nifedipine,CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC,PHASE2|PHASE3,cardiovascular_disease
1270,Pulmonary Arterial Hypertension,Beraprost,CC#CCC(C)C(C=CC1C(CC2C1C3=CC=CC(=C3O2)CCCC(=O)O)O)O,PHASE2,cardiovascular_disease
1271,"Multiple Myeloma|Multiple Myeloma in Relapse|Multiple Myeloma, Refractory",Marizomib,CC12C(C(=O)NC1(C(=O)O2)C(C3CCCC=C3)O)CCCl,PHASE2,cardiovascular_disease
1272,Heart Disease,Regadenoson,CNC(=O)C1=CN(N=C1)C2=NC(=C3C(=N2)N(C=N3)C4C(C(C(O4)CO)O)O)N,PHASE1,cardiovascular_disease
1273,Open-Angle Glaucoma|Ocular Hypertension,Bimatoprost,CCNC(=O)CCCC=CCC1C(CC(C1C=CC(CCC2=CC=CC=C2)O)O)O,PHASE1|PHASE2,cardiovascular_disease
1274,Hereditary Hemorrhagic Telangiectasia|Gastrointestinal Hemorrhage|Anemia,Octreotide,CC(C1C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=CC=C4)NC(=O)C(CC5=CC=CC=C5)N)C(=O)NC(CO)C(C)O)O,PHASE2,cardiovascular_disease
1275,"Hypertension, Pulmonary|Pulmonary Arterial Hypertension",Esomeprazole,CC1=CN=C(C(=C1OC)C)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC,PHASE1,cardiovascular_disease
1276,Open-angle Glaucoma|Oular Hypertension,Anecortave,CC12CCC(=O)C=C1CCC3C2=CCC4(C3CCC4(C(=O)CO)O)C,PHASE2|PHASE3,cardiovascular_disease
1277,Thrombosis Prophylaxis (Risk of Thrombosis Due to Central Venous Line (CVL),Semuloparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,PHASE2,cardiovascular_disease
1278,Stroke,Maraviroc,CC1=NN=C(N1C2CC3CCC(C2)N3CCC(C4=CC=CC=C4)NC(=O)C5CCC(CC5)(F)F)C(C)C,PHASE2|PHASE3,cardiovascular_disease
1279,Multiple Myeloma,Rimiducid,CCC(C1=CC(=C(C(=C1)OC)OC)OC)C(=O)N2CCCCC2C(=O)OC(CCC3=CC(=C(C=C3)OC)OC)C4=CC(=CC=C4)OCC(=O)NCCNC(=O)COC5=CC=CC(=C5)C(CCC6=CC(=C(C=C6)OC)OC)OC(=O)C7CCCCN7C(=O)C(CC)C8=CC(=C(C(=C8)OC)OC)OC,PHASE1,cardiovascular_disease
1280,"Subarachnoid Hemorrhage, Aneurysmal",Tirofiban,CCCCS(=O)(=O)NC(CC1=CC=C(C=C1)OCCCCC2CCNCC2)C(=O)O,PHASE1|PHASE2,cardiovascular_disease
1281,Healthy Participants,Mavacamten,CC(C)N1C(=O)C=C(NC1=O)NC(C)C2=CC=CC=C2,PHASE1,cardiovascular_disease
1282,Cardiovascular Diseases|Nephropathy,Tolvaptan,CC1=CC=CC=C1C(=O)NC2=CC(=C(C=C2)C(=O)N3CCCC(C4=C3C=CC(=C4)Cl)O)C,PHASE2,cardiovascular_disease
1283,Symptomatic Neurogenic Orthostatic Hypotension (NOH)|Parkinson's Disease|Multiple System Atrophy,Fipamezole,CCC1(CC2=C(C1)C=C(C=C2)F)C3=CN=CN3,PHASE2,cardiovascular_disease
1284,Multiple System Atrophy,Safinamide,CC(C(=O)N)NCC1=CC=C(C=C1)OCC2=CC(=CC=C2)F,PHASE2,cardiovascular_disease
1285,Congestive Heart Failure,Cinaciguat,C1=CC=C(C=C1)CCC2=CC=C(C=C2)COC3=CC=CC=C3CCN(CCCCC(=O)O)CC4=CC=C(C=C4)C(=O)O,PHASE2,cardiovascular_disease
1286,Cerebrovascular Accident,Isoxaflutole,CS(=O)(=O)C1=C(C=CC(=C1)C(F)(F)F)C(=O)C2=C(ON=C2)C3CC3,PHASE1,cardiovascular_disease
1287,Chronic Obstructive Pulmonary Disease,Indacaterol,CCC1=C(C=C2CC(CC2=C1)NCC(C3=C4C=CC(=O)NC4=C(C=C3)O)O)CC,PHASE2,cardiovascular_disease
1288,Chronic Obstructive Pulmonary Disease,Salmeterol,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O,PHASE2,cardiovascular_disease
1289,Acute Ischemic Stroke,Balovaptan,CN1CC2=C(C=CC(=C2)Cl)N3C(=NN=C3C4CCC(CC4)OC5=CC=CC=N5)C1,PHASE2,cardiovascular_disease
1290,"Cerebral Stroke|Cerebrovascular Accident, Acute|Cerebrovascular Stroke|Stroke, Acute|Stroke",Dapsone,C1=CC(=CC=C1N)S(=O)(=O)C2=CC=C(C=C2)N,PHASE2|PHASE3,cardiovascular_disease
1291,Stroke|Acute Ischemic Stroke,Repinotan,C1CC2=CC=CC=C2OC1CNCCCCN3C(=O)C4=CC=CC=C4S3(=O)=O,PHASE2,cardiovascular_disease
1292,Multiple Myeloma|Refractory Multiple Myeloma|Relapsed/Refractory Multiple Myeloma,Cabozantinib,COC1=CC2=C(C=CN=C2C=C1OC)OC3=CC=C(C=C3)NC(=O)C4(CC4)C(=O)NC5=CC=C(C=C5)F,PHASE1|PHASE2,cardiovascular_disease
1293,"Kidney Failure, Chronic|Cardiovascular Disease|Arteriosclerosis",Hydroxychloroquine,CCN(CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl)CCO,PHASE2,cardiovascular_disease
1294,Coagulopathy|Cardiovascular Complication|COVID-19,Camostat,CN(C)C(=O)COC(=O)CC1=CC=C(C=C1)OC(=O)C2=CC=C(C=C2)N=C(N)N,PHASE1|PHASE2,cardiovascular_disease
1295,"Cardiac Valve Disease|Coronary Artery Disease|Organ Failure, Multiple",Valproate,CCCC(CCC)C(=O)O,PHASE1|PHASE2,cardiovascular_disease
1296,HIV Infections,Cenicriviroc,CCCCOCCOC1=CC=C(C=C1)C2=CC3=C(C=C2)N(CCCC(=C3)C(=O)NC4=CC=C(C=C4)S(=O)CC5=CN=CN5CCC)CC(C)C,PHASE2,cardiovascular_disease
1297,Cerebral Infarction,Vorapaxar,CCOC(=O)NC1CCC2C(C1)CC3C(C2C=CC4=NC=C(C=C4)C5=CC(=CC=C5)F)C(OC3=O)C,PHASE2,cardiovascular_disease
1298,Hypertension,Cilnidipine,CC1=C(C(C(=C(N1)C)C(=O)OCC=CC2=CC=CC=C2)C3=CC(=CC=C3)[N+](=O)[O-])C(=O)OCCOC,PHASE1,cardiovascular_disease
1299,B-Cell Prolymphocytic Leukemia|Recurrent Chronic Lymphocytic Leukemia|Recurrent Diffuse Large B-Cell Lymphoma|Recurrent Follicular Lymphoma|Recurrent Lymphoplasmacytic Lymphoma|Recurrent Mantle Cell Lymphoma|Recurrent Marginal Zone Lymphoma|Recurrent Non-Hodgkin Lymphoma|Recurrent Small Lymphocytic Lymphoma|Refractory Chronic Lymphocytic Leukemia|Refractory Diffuse Large B-Cell Lymphoma|Refractory Follicular Lymphoma|Refractory Lymphoplasmacytic Lymphoma|Refractory Mantle Cell Lymphoma|Refractory Marginal Zone Lymphoma|Refractory Non-Hodgkin Lymphoma|Refractory Small Lymphocytic Lymphoma|Richter Syndrome,Pevonedistat,C1CC2=CC=CC=C2C1NC3=C4C=CN(C4=NC=N3)C5CC(C(C5)O)COS(=O)(=O)N,PHASE1,cardiovascular_disease
1300,Medical Oncology,Copanlisib,COC1=C(C=CC2=C3NCCN3C(=NC(=O)C4=CN=C(N=C4)N)N=C21)OCCCN5CCOCC5,PHASE1,cardiovascular_disease
1301,Patent Ductus Arteriosus After Premature Birth,Acetaminophen,CC(=O)NC1=CC=C(C=C1)O,PHASE2,cardiovascular_disease
1302,Patent Ductus Arteriosus After Premature Birth,Ibuprofen,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O,PHASE2,cardiovascular_disease
1303,Myocardial Stunning,Diazoxide,CC1=NS(=O)(=O)C2=C(N1)C=CC(=C2)Cl,PHASE1,cardiovascular_disease
1304,Venous Thromboembolism|Anticoagulant-induced Bleeding|Venous Thromboses|Pulmonary Embolism,Acenocoumarol,CC(=O)CC(C1=CC=C(C=C1)[N+](=O)[O-])C2=C(C3=CC=CC=C3OC2=O)O,PHASE2|PHASE3,cardiovascular_disease
1305,Renal Cell Carcinoma|Metastatic Renal Cell Carcinoma|Non-metastatic Renal Cell Carcinoma,Axitinib,CNC(=O)C1=CC=CC=C1SC2=CC3=C(C=C2)C(=NN3)C=CC4=CC=CC=N4,PHASE2,cardiovascular_disease
1306,Macular Edema|Central Retinal Vein Occlusion,Ecallantide,CCC(C)C1C(=O)NC(C(=O)NCC(=O)NCC(=O)NC2CSSCC3C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N4CCCC4C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NCC(=O)N5CCCC5C(=O)N3)CC(=O)O)CC(=O)O)C)CCCCN)CC6=CC=CC=C6)C)NC(=O)C(CC7=CC=CC=C7)NC(=O)C(CO)NC(=O)C(CC8=CN=CN8)NC(=O)C(CCSC)NC(=O)C(C)NC(=O)C(CCC(=O)O)N)C(=O)NC(C(C)O)C(=O)NC(CCCNC(=N)N)C(=O)NC(CC(=O)O)C(=O)O)CCSC)CCCCN)CCCCN)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)CNC(=O)C(NC2=O)CCC(=O)O)CC(=O)N)CCC(=O)N)CC(=O)N)CCCNC(=N)N)CC9=CC=CC=C9)CCC(=O)O)CO)CC(C)C)CCC(=O)O)CCC(=O)O)C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CC1=CC=CC=C1)CCC(=O)O)CCC(=O)O)CCC(=O)N)CCCNC(=N)N)C(C)O)CC1=CC=CC=C1)C(C)CC)CC(=O)N)CC1=CC=CC=C1)CC1=CC=CC=C1)CC1=CNC2=CC=CC=C21)CCCNC(=N)N)CC1=CN=CN1)C)C)CCCNC(=N)N)CC1=CC=C(C=C1)O,PHASE1,cardiovascular_disease
1307,Alagille Syndrome,Maralixibat,CCCCC1(CS(=O)(=O)C2=C(C=C(C=C2)N(C)C)C(C1O)C3=CC=C(C=C3)OCC4=CC=C(C=C4)C[N+]56CCN(CC5)CC6)CCCC,PHASE2,cardiovascular_disease
1308,Heart Disease,Pentobarbital,CCCC(C)C1(C(=O)NC(=O)NC1=O)CC,PHASE1,cardiovascular_disease
1309,Multiple Myeloma,Pamidronate,C(CN)C(O)(P(=O)(O)O)P(=O)(O)O,PHASE2,cardiovascular_disease
1310,Arrhythmia Prophylaxis|Ventricular Arrhythmia,Amiodarone,CCCCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)I)OCCN(CC)CC)I,PHASE2,cardiovascular_disease
1311,Anemia,Erythropoietin,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NN=N[N-]4)CO)Cl.[K+],PHASE2,cardiovascular_disease
1312,HIV|Vascular Diseases|Cardiovascular Diseases|Atherosclerosis|HIV Infections,Pentoxifylline,CC(=O)CCCCN1C(=O)C2=C(N=CN2C)N(C1=O)C,PHASE2,cardiovascular_disease
1313,Renal Cell Carcinoma,Lenvatinib,COC1=CC2=NC=CC(=C2C=C1C(=O)N)OC3=CC(=C(C=C3)NC(=O)NC4CC4)Cl,PHASE2,cardiovascular_disease
1314,Rheumatic Heart Disease,Phenoxymethylpenicillin,CC1(C(N2C(S1)C(C2=O)NC(=O)COC3=CC=CC=C3)C(=O)O)C,PHASE2,cardiovascular_disease
1315,Rheumatic Heart Disease,Penicillin,CC1(C(N2C(S1)C(C2=O)NC(=O)CC3=CC=CC=C3)C(=O)O)C,PHASE2,cardiovascular_disease
1316,Hyperemia Eye,Naphazoline,C1CN=C(N1)CC2=CC=CC3=CC=CC=C32,PHASE1,cardiovascular_disease
1317,Hyperemia Eye,Hypromellose,CC(COCC1C(C(C(C(O1)OC)OCC(C)O)OCC(C)O)OC2C(C(C(C(O2)COC)OC3C(C(C(C(O3)CO)OC)O)O)OC)OC)O,PHASE1,cardiovascular_disease
1318,Atrial Fibrillation,Dronedarone,CCCCC1=C(C2=C(O1)C=CC(=C2)NS(=O)(=O)C)C(=O)C3=CC=C(C=C3)OCCCN(CCCC)CCCC,PHASE2,cardiovascular_disease
1319,Patent Ductus Arteriosus,Indomethacin,CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)Cl)C=CC(=C2)OC)CC(=O)O,PHASE2,cardiovascular_disease
1320,Hypertension,Irbesartan,CCCCC1=NC2(CCCC2)C(=O)N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5,PHASE2|PHASE3,cardiovascular_disease
1321,Cushing Syndrome|Endocrine Disease,Pentetreotide,CC(C1C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=CC=C4)NC(=O)C(CC5=CC=CC=C5)NC(=O)CN(CCN(CCN(CC(=O)O)CC(=O)O)CC(=O)O)CC(=O)O)C(=O)NC(CO)C(C)O)O,PHASE2,cardiovascular_disease
1322,Multiple Myeloma,Amrubicin,CC(=O)C1(CC(C2=C(C1)C(=C3C(=C2O)C(=O)C4=CC=CC=C4C3=O)O)OC5CC(C(CO5)O)O)N,PHASE1|PHASE2,cardiovascular_disease
1323,Multiple Myeloma,Pegfilgrastim,CC(C(C(=O)O)N)OC1C(C(C(C(O1)COC2(CC(C(C(O2)C(C(CO)O)O)NC(=O)CNC(=O)OCCOC)O)C(=O)O)O)O)NC(=O)C,PHASE1|PHASE2,cardiovascular_disease
1324,Heart Failure With Preserved Ejection Fraction,Carnitine,C[N+](C)(C)CC(CC(=O)[O-])O,PHASE2,cardiovascular_disease
1325,Heart Failure With Preserved Ejection Fraction,Levocarnitine,C[N+](C)(C)CC(CC(=O)[O-])O,PHASE2,cardiovascular_disease
1326,Atrial Fibrillation,Etripamil,CC(C)C(CCCN(C)CCC1=CC(=CC=C1)C(=O)OC)(C#N)C2=CC(=C(C=C2)OC)OC,PHASE2,cardiovascular_disease
1327,Arrhythmogenic Right Ventricular Cardiomyopathy,Flecainide,C1CCNC(C1)CNC(=O)C2=C(C=CC(=C2)OCC(F)(F)F)OCC(F)(F)F,PHASE2,cardiovascular_disease
1328,Recurrent Plasma Cell Myeloma|Refractory Plasma Cell Myeloma,Sonidegib,CC1CN(CC(O1)C)C2=NC=C(C=C2)NC(=O)C3=CC=CC(=C3C)C4=CC=C(C=C4)OC(F)(F)F,PHASE2,cardiovascular_disease
1329,Pulmonary Hypertension|Sickle Cell Disease|Thalassemia,Glutamine,C(CC(=O)N)C(C(=O)O)N,PHASE2,cardiovascular_disease
1330,Obesity|Cardiovascular Diseases|Hypertension|Nocturnal Blood Pressure|Natriuretic Peptides|Renin-Angiotensin-Aldosterone System,Sacubitril,CCOC(=O)C(C)CC(CC1=CC=C(C=C1)C2=CC=CC=C2)NC(=O)CCC(=O)O,PHASE2|PHASE3,cardiovascular_disease
1331,Prevention of Subclinical Atherosclerosis Progression|Prevention of Cognitive Decline,Nattokinase,B1(OC(=O)CC(O1)(CC(=O)O)C(=O)O)C(CC(C)C)NC(=O)CNC(=O)C2=C(C=CC(=C2)Cl)Cl,PHASE2,cardiovascular_disease
1332,Acute Myeloid Leukemia|Diffuse Large B-cell Lymphoma|Acute Lymphoblastic Leukemia|Multiple Myeloma,Birabresib,CC1=C(SC2=C1C(=NC(C3=NN=C(N32)C)CC(=O)NC4=CC=C(C=C4)O)C5=CC=C(C=C5)Cl)C,PHASE1,cardiovascular_disease
1333,"Stroke, Ischemic",Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,PHASE2,cardiovascular_disease
1334,"Heart Defects, Congenital",Dexrazoxane,CC(CN1CC(=O)NC(=O)C1)N2CC(=O)NC(=O)C2,PHASE1,cardiovascular_disease
1335,Autonomic Failure|Orthostatic Hypotension,Atomoxetine,CC1=CC=CC=C1OC(CCNC)C2=CC=CC=C2,PHASE1,cardiovascular_disease
1336,Autonomic Failure|Orthostatic Hypotension,Acarbose,CC1C(C(C(C(O1)OC2C(OC(C(C2O)O)OC3C(OC(C(C3O)O)O)CO)CO)O)O)NC4C=C(C(C(C4O)O)O)CO,PHASE1,cardiovascular_disease
1337,Autonomic Failure|Orthostatic Hypotension,Yohimbine,COC(=O)C1C(CCC2C1CC3C4=C(CCN3C2)C5=CC=CC=C5N4)O,PHASE1,cardiovascular_disease
1338,Autonomic Failure|Orthostatic Hypotension,Modafinil,C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N,PHASE1,cardiovascular_disease
1339,Autonomic Failure|Orthostatic Hypotension,Diphenhydramine,CN(C)CCOC(C1=CC=CC=C1)C2=CC=CC=C2,PHASE1,cardiovascular_disease
1340,Autonomic Failure|Orthostatic Hypotension,Ranitidine,CNC(=C[N+](=O)[O-])NCCSCC1=CC=C(O1)CN(C)C,PHASE1,cardiovascular_disease
1341,Autonomic Failure|Orthostatic Hypotension,Tranylcypromine,C1C(C1N)C2=CC=CC=C2,PHASE1,cardiovascular_disease
1342,Autonomic Failure|Orthostatic Hypotension,Methylphenidate,COC(=O)C(C1CCCCN1)C2=CC=CC=C2,PHASE1,cardiovascular_disease
1343,Autonomic Failure|Orthostatic Hypotension,Oxymetazoline,CC1=CC(=C(C(=C1CC2=NCCN2)C)O)C(C)(C)C,PHASE1,cardiovascular_disease
1344,Autonomic Failure|Orthostatic Hypotension,Rivastigmine,CCN(C)C(=O)OC1=CC=CC(=C1)C(C)N(C)C,PHASE1,cardiovascular_disease
1345,Autonomic Failure|Orthostatic Hypotension,Carbidopa,CC(CC1=CC(=C(C=C1)O)O)(C(=O)O)NN,PHASE1,cardiovascular_disease
1346,Diabetic Retinopathy,Runcaciguat,CC(C(C1=CC=C(C=C1)Cl)C(=O)NC2=C(C=CC(=C2)C(CC(=O)O)C3CC3)Cl)C(F)(F)F,PHASE2,cardiovascular_disease
1347,Multiple Myeloma,Fosaprepitant,CC(C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)OC2C(N(CCO2)CC3=NN(C(=O)N3)P(=O)(O)O)C4=CC=C(C=C4)F,PHASE1|PHASE2,cardiovascular_disease
1348,"Lymphoma, Non-Hodgkin|Multiple Myeloma|Advanced Solid Tumors",Olaparib,C1CC1C(=O)N2CCN(CC2)C(=O)C3=C(C=CC(=C3)CC4=NNC(=O)C5=CC=CC=C54)F,PHASE2,cardiovascular_disease
1349,"Lymphoma, Non-Hodgkin|Multiple Myeloma|Advanced Solid Tumors",Bosutinib,CN1CCN(CC1)CCCOC2=C(C=C3C(=C2)N=CC(=C3NC4=CC(=C(C=C4Cl)Cl)OC)C#N)OC,PHASE2,cardiovascular_disease
1350,"Lymphoma, Non-Hodgkin|Multiple Myeloma|Advanced Solid Tumors",Crizotinib,CC(C1=C(C=CC(=C1Cl)F)Cl)OC2=C(N=CC(=C2)C3=CN(N=C3)C4CCNCC4)N,PHASE2,cardiovascular_disease
1351,"Lymphoma, Non-Hodgkin|Multiple Myeloma|Advanced Solid Tumors",Sunitinib,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C,PHASE2,cardiovascular_disease
1352,"Lymphoma, Non-Hodgkin|Multiple Myeloma|Advanced Solid Tumors",Erlotinib,COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC,PHASE2,cardiovascular_disease
1353,"Lymphoma, Non-Hodgkin|Multiple Myeloma|Advanced Solid Tumors",Vemurafenib,CCCS(=O)(=O)NC1=C(C(=C(C=C1)F)C(=O)C2=CNC3=C2C=C(C=N3)C4=CC=C(C=C4)Cl)F,PHASE2,cardiovascular_disease
1354,"Lymphoma, Non-Hodgkin|Multiple Myeloma|Advanced Solid Tumors",Vismodegib,CS(=O)(=O)C1=CC(=C(C=C1)C(=O)NC2=CC(=C(C=C2)Cl)C3=CC=CC=N3)Cl,PHASE2,cardiovascular_disease
1355,"Lymphoma, Non-Hodgkin|Multiple Myeloma|Advanced Solid Tumors",Tucatinib,CC1=C(C=CC(=C1)NC2=NC=NC3=C2C=C(C=C3)NC4=NC(CO4)(C)C)OC5=CC6=NC=NN6C=C5,PHASE2,cardiovascular_disease
1356,Waldenstrom Macroglobulinemia,Acalabrutinib,CC#CC(=O)N1CCCC1C2=NC(=C3N2C=CN=C3N)C4=CC=C(C=C4)C(=O)NC5=CC=CC=N5,PHASE2,cardiovascular_disease
1357,Multiple System Atrophy,Inosine,C1=NC2=C(C(=O)N1)N=CN2C3C(C(C(O3)CO)O)O,PHASE2,cardiovascular_disease
1358,LQT2 Syndrome,Eleclazine,C1COC2=C(C=C(C=C2)C3=CC=C(C=C3)OC(F)(F)F)C(=O)N1CC4=NC=CC=N4,PHASE1,cardiovascular_disease
1359,Adult B Acute Lymphoblastic Leukemia|Adult T Acute Lymphoblastic Leukemia|Anaplastic Large Cell Lymphoma|Angioimmunoblastic T-Cell Lymphoma|Chronic Lymphocytic Leukemia|Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue|Hepatosplenic T-Cell Lymphoma|Intraocular Lymphoma|Lymphomatous Involvement of Non-Cutaneous Extranodal Site|Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma|Nodal Marginal Zone Lymphoma|Primary Cutaneous B-Cell Non-Hodgkin Lymphoma|Recurrent Adult Acute Lymphoblastic Leukemia|Recurrent Adult Burkitt Lymphoma|Recurrent Adult Grade III Lymphomatoid Granulomatosis|Recurrent Adult Hodgkin Lymphoma|Recurrent Adult Immunoblastic Lymphoma|Recurrent Adult Lymphoblastic Lymphoma|Recurrent Adult T-Cell Leukemia/Lymphoma|Recurrent Grade 1 Follicular Lymphoma|Recurrent Grade 2 Follicular Lymphoma|Recurrent Grade 3 Follicular Lymphoma|Recurrent Mantle Cell Lymphoma|Recurrent Marginal Zone Lymphoma|Recurrent Mycosis Fungoides and Sezary Syndrome|Recurrent Non-Hodgkin Lymphoma|Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma|Recurrent Small Lymphocytic Lymphoma|Refractory Chronic Lymphocytic Leukemia|Refractory Hairy Cell Leukemia|Small Intestinal Lymphoma|Splenic Marginal Zone Lymphoma|T-Cell Large Granular Lymphocyte Leukemia|Testicular Lymphoma|Waldenstrom Macroglobulinemia,Alisertib,COC1=C(C(=CC=C1)F)C2=NCC3=CN=C(N=C3C4=C2C=C(C=C4)Cl)NC5=CC(=C(C=C5)C(=O)O)OC,PHASE1,cardiovascular_disease
1360,Atrial Fibrillation Paroxysmal,Riluzole,C1=CC2=C(C=C1OC(F)(F)F)SC(=N2)N,PHASE2,cardiovascular_disease
1361,Thromboembolism,Betrixaban,CN(C)C(=N)C1=CC=C(C=C1)C(=O)NC2=C(C=C(C=C2)OC)C(=O)NC3=NC=C(C=C3)Cl,PHASE2,cardiovascular_disease
1362,Ischemic Stroke,Verapamil,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,PHASE1,cardiovascular_disease
1363,Ischemic Stroke,Citicoline,C[N+](C)(C)CCOP(=O)([O-])OP(=O)(O)OCC1C(C(C(O1)N2C=CC(=NC2=O)N)O)O,PHASE1,cardiovascular_disease
1364,Hypertension,Nicardipine,CC1=C(C(C(=C(N1)C)C(=O)OCCN(C)CC2=CC=CC=C2)C3=CC(=CC=C3)[N+](=O)[O-])C(=O)OC,PHASE2,cardiovascular_disease
1365,Myocardial Infarction|Acute Coronary Syndromes|Unstable Angina,Eptifibatide,C1CC2C(=O)NC(CSSCCC(=O)NC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)N2C1)CC3=CNC4=CC=CC=C43)CC(=O)O)CCCCN=C(N)N)C(=O)N,PHASE2,cardiovascular_disease
1366,Depression|Coronary Artery Disease (CAD)|Acute Coronary Syndrome (ACS),Sertraline,CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl,PHASE1,cardiovascular_disease
1367,Clinically Significant Portal Hypertension,Sorafenib,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,PHASE2,cardiovascular_disease
1368,Orthostatic Hypertension,Norepinephrine,C1=CC(=C(C=C1C(CN)O)O)O,PHASE1|PHASE2,cardiovascular_disease
1369,Coronary Heart Disease,Bivalirudin,CCC(C)C(C(=O)N1CCCC1C(=O)NC(CCC(=O)O)C(=O)NC(CCC(=O)O)C(=O)NC(CC2=CC=C(C=C2)O)C(=O)NC(CC(C)C)C(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(CC3=CC=CC=C3)NC(=O)C(CC(=O)O)NC(=O)CNC(=O)C(CC(=O)N)NC(=O)CNC(=O)CNC(=O)CNC(=O)CNC(=O)C4CCCN4C(=O)C(CCCNC(=N)N)NC(=O)C5CCCN5C(=O)C(CC6=CC=CC=C6)N,PHASE2,cardiovascular_disease
1370,Obesity-Associated Insulin Resistance,Moxonidine,CC1=NC(=C(C(=N1)Cl)NC2=NCCN2)OC,PHASE1,cardiovascular_disease
1371,"Arteritis, Giant Cell",Baricitinib,CCS(=O)(=O)N1CC(C1)(CC#N)N2C=C(C=N2)C3=C4C=CNC4=NC=N3,PHASE2,cardiovascular_disease
1372,"IgA Monoclonal Gammopathy|IgG Monoclonal Gammopathy|IgM Monoclonal Gammopathy|Light Chain Deposition Disease|Monoclonal Gammopathy|Smoldering Waldenstrom Macroglobulinemia|Waldenstrom Macroglobulinemia|Gammopathy, Monoclonal|Gammopathy Igg",Rifaximin,CC1C=CC=C(C(=O)NC2=C(C3=C(C4=C(C(=C3O)C)OC(C4=O)(OC=CC(C(C(C(C(C(C1O)C)O)C)OC(=O)C)C)OC)C)C5=C2N6C=CC(=CC6=N5)C)O)C,PHASE1,cardiovascular_disease
1373,Mantle Cell Lymphoma|B Cell Lymphoma|Multiple Myeloma,Canfosfamide,C1=CC=C(C=C1)C(C(=O)O)NC(=O)C(CS(=O)(=O)CCOP(=O)(N(CCCl)CCCl)N(CCCl)CCCl)NC(=O)CCC(C(=O)O)N,PHASE2,cardiovascular_disease
1374,Essential Hypertension,Aprocitentan,C1=CC(=CC=C1C2=C(N=CN=C2OCCOC3=NC=C(C=N3)Br)NS(=O)(=O)N)Br,PHASE2,cardiovascular_disease
1375,Solid Tumours|Multiple Myeloma|Lung Cancer|Ovarian Cancer,Everolimus,CC1CCC2CC(C(=CC=CC=CC(CC(C(=O)C(C(C(=CC(C(=O)CC(OC(=O)C3CCCCN3C(=O)C(=O)C1(O2)O)C(C)CC4CCC(C(C4)OC)OCCO)C)C)O)OC)C)C)C)OC,PHASE1,cardiovascular_disease
1376,Acute Coronary Syndrome,Bisoprolol,CC(C)NCC(COC1=CC=C(C=C1)COCCOC(C)C)O,PHASE2,cardiovascular_disease
1377,"Leukemia, Acute|Myelodysplastic Syndromes|Myelomonocytic Leukemia, Chronic|T-cell Prolymphocytic Leukemia|CML|Myeloproliferative Disorders|Multiple Myeloma|Plasma Cell Leukemia",Itacitinib,C1CN(CCC1N2CC(C2)(CC#N)N3C=C(C=N3)C4=C5C=CNC5=NC=N4)C(=O)C6=C(C(=NC=C6)C(F)(F)F)F,PHASE1,cardiovascular_disease
1378,Henoch-Schnlein Purpura Nephritis,Benazepril,CCOC(=O)C(CCC1=CC=CC=C1)NC2CCC3=CC=CC=C3N(C2=O)CC(=O)O,PHASE1|PHASE2,cardiovascular_disease
1379,Multiple Myeloma,Montelukast,CC(C)(C1=CC=CC=C1CCC(C2=CC=CC(=C2)C=CC3=NC4=C(C=CC(=C4)Cl)C=C3)SCC5(CC5)CC(=O)O)O,PHASE1,cardiovascular_disease
1380,Blood High Pressure|Aortic Dissection Type B,Urapidil,CN1C(=CC(=O)N(C1=O)C)NCCCN2CCN(CC2)C3=CC=CC=C3OC,PHASE1,cardiovascular_disease
1381,Pulmonary Hypertension|Mirabegron|Heart Failure|Pulmonary Vascular Resistance Abnormality,Mirabegron,C1=CC=C(C=C1)C(CNCCC2=CC=C(C=C2)NC(=O)CC3=CSC(=N3)N)O,PHASE2,cardiovascular_disease
1382,Marijuana Dependence,Dronabinol,CCCCCC1=CC(=C2C3C=C(CCC3C(OC2=C1)(C)C)C)O,PHASE1,cardiovascular_disease
1383,Relapsed or Refractory Lymphoproliferative Malignancies|Hodgkin's Lymphoma|Peripheral T-cell Lymphoma|B-cell Lymphoma|Waldenstrom's Macroglobulinemia,Pralatrexate,C#CCC(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,PHASE1|PHASE2,cardiovascular_disease
1384,Heart Failure,Glucagon,CC(C)CC(C(=O)NC(CCSC)C(=O)NC(CC(=O)N)C(=O)NC(C(C)O)C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)NC(=O)C(CCC(=O)N)NC(=O)C(C(C)C)NC(=O)C(CC3=CC=CC=C3)NC(=O)C(CC(=O)O)NC(=O)C(CCC(=O)N)NC(=O)C(C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C(CC(=O)O)NC(=O)C(CC(C)C)NC(=O)C(CC4=CC=C(C=C4)O)NC(=O)C(CCCCN)NC(=O)C(CO)NC(=O)C(CC5=CC=C(C=C5)O)NC(=O)C(CC(=O)O)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C(CC6=CC=CC=C6)NC(=O)C(C(C)O)NC(=O)CNC(=O)C(CCC(=O)N)NC(=O)C(CO)NC(=O)C(CC7=CN=CN7)N,PHASE1,cardiovascular_disease
1385,Pulmonary Arterial Hypertension|Right Heart Failure,Famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,PHASE2,cardiovascular_disease
1386,Coronary Artery Disease,Varespladib,CCC1=C(C2=C(N1CC3=CC=CC=C3)C=CC=C2OCC(=O)O)C(=O)C(=O)N,PHASE2,cardiovascular_disease
1387,Fabry Disease,Migalastat,C1C(C(C(C(N1)CO)O)O)O,PHASE2,cardiovascular_disease
1388,"Kidney, Polycystic, Autosomal Dominant",Imidapril,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C(CN(C2=O)C)C(=O)O,PHASE2,cardiovascular_disease
1389,Congestive Heart Failure Chronic,Resveratrol,C1=CC(=CC=C1C=CC2=CC(=CC(=C2)O)O)O,PHASE2,cardiovascular_disease
1390,Heart Arrest,Epinephrine,CNCC(C1=CC(=C(C=C1)O)O)O,PHASE2,cardiovascular_disease
1391,Stroke,Dextroamphetamine,CC(CC1=CC=CC=C1)N,PHASE2,cardiovascular_disease
1392,Patent Ductus Arteriosus,Paracetamol,CC(=O)NC1=CC=C(C=C1)O,PHASE2|PHASE3,cardiovascular_disease
1393,"Cerebral Small Vessel Diseases|Stroke, Lacunar",Isosorbide,C1C(C2C(O1)C(CO2)O)O,PHASE2|PHASE3,cardiovascular_disease
1394,"Paroxysmal Nocturnal Hemoglobinuria|Hemoglobinuria|Hemoglobinuria, Paroxysmal|Proteinuria|Urination Disorders|Thrombosis|Bone Marrow Failure|Aplastic Anemia,|Anemia, Hemolytic",Levamisole,C1CSC2=NC(CN21)C3=CC=CC=C3,PHASE2,cardiovascular_disease
1395,Vascular Anomalies,Marimastat,CC(C)CC(C(C(=O)NO)O)C(=O)NC(C(=O)NC)C(C)(C)C,PHASE1,cardiovascular_disease
1396,Eosinophilic Granulomatosis With Polyangiitis (EGPA)|Churg-Strauss Syndrome (CSS)|Giant Cell Arteritis|Granulomatosis With Polyangiitis|Microscopic Polyangiitis|Polyarteritis Nodosa|Takayasu Arteritis,Naltrexone,C1CC1CN2CCC34C5C(=O)CCC3(C2CC6=C4C(=C(C=C6)O)O5)O,PHASE2,cardiovascular_disease
1397,Valve Heart Disease|Elective Cesarean Delivery,Lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C,PHASE2,cardiovascular_disease
1398,Vasoplegic Syndrome,Hydroxocobalamin,CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)([O-])OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.O.[Co+2],PHASE2,cardiovascular_disease
1399,High Blood Pressure|Migraine Headaches|Chest Pain,Nadolol,CC(C)(C)NCC(COC1=CC=CC2=C1CC(C(C2)O)O)O,PHASE1,cardiovascular_disease
1400,Coronary Artery Disease (CAD),Cangrelor,CSCCNC1=C2C(=NC(=N1)SCCC(F)(F)F)N(C=N2)C3C(C(C(O3)COP(=O)(O)OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O)O,PHASE2,cardiovascular_disease
1401,Subarachnoid Hemorrhage|Subdural Hematoma|Traumatic Brain Injury|Ischemic Stroke|Fever|Intracerebral Hemorrhage,Bromocriptine,CC(C)CC1C(=O)N2CCCC2C3(N1C(=O)C(O3)(C(C)C)NC(=O)C4CN(C5CC6=C(NC7=CC=CC(=C67)C5=C4)Br)C)O,PHASE1|PHASE2,cardiovascular_disease
1402,Coronary Artery Bypass Graft Surgery|Myocardial Ischemia|Reperfusion Injury|Myocardial Revascularization,Pyridoxal,CC1=NC=C(C(=C1O)C=O)CO,PHASE2,cardiovascular_disease
1403,Renal Insufficiency|Heart Failure,Tonapofylline,CCCN1C2=C(C(=O)N(C1=O)CCC)NC(=N2)C34CCC(CC3)(CC4)CCC(=O)O,PHASE2,cardiovascular_disease
1404,Open Angle Glaucoma|Ocular Hypertension,Netarsudil,CC1=CC(=C(C=C1)C(=O)OCC2=CC=C(C=C2)C(CN)C(=O)NC3=CC4=C(C=C3)C=NC=C4)C,PHASE2,cardiovascular_disease
1405,Cardiovascular Diseases,Ziprasidone,C1CN(CCN1CCC2=C(C=C3C(=C2)CC(=O)N3)Cl)C4=NSC5=CC=CC=C54,PHASE1,cardiovascular_disease
1406,Cardiovascular Diseases,Lorcaserin,CC1CNCCC2=C1C=C(C=C2)Cl,PHASE1,cardiovascular_disease
1407,Acute Myocardial Infarction,Selatogrel,CCCCOC(=O)N1CCN(CC1)C(=O)C(CP(=O)(O)O)NC(=O)C2=CC(=NC(=N2)C3=CC=CC=C3)N4CCC(C4)OC,PHASE2,cardiovascular_disease
1408,Cirrhosis|Portal Hypertension|Non-alcoholic Steatohepatitis,Emricasan,CC(C(=O)NC(CC(=O)O)C(=O)COC1=C(C(=CC(=C1F)F)F)F)NC(=O)C(=O)NC2=CC=CC=C2C(C)(C)C,PHASE2,cardiovascular_disease
1409,Heart Failure,Cenderitide,CCC(C)C(C(=O)NCC(=O)NC(CO)C(=O)NC(CCSC)C(=O)NC(CO)C(=O)NCC(=O)NC(CC(C)C)C(=O)NCC(=O)NC(CS)C(=O)N1CCCC1C(=O)NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CCCN=C(N)N)C(=O)NC(CC(=O)O)C(=O)N2CCCC2C(=O)NC(CCCN=C(N)N)C(=O)N3CCCC3C(=O)NC(CC(=O)O)C(=O)NC(C)C(=O)N4CCCC4C(=O)NC(CO)C(=O)NC(C(C)O)C(=O)NC(CO)C(=O)NC(C)C(=O)O)NC(=O)C(CCCN=C(N)N)NC(=O)C(CC(=O)O)NC(=O)C(CC(C)C)NC(=O)C(CCCCN)NC(=O)C(CC(C)C)NC(=O)CNC(=O)C(CC5=CC=CC=C5)NC(=O)C(CS)NC(=O)CNC(=O)C(CCCCN)NC(=O)C(CO)NC(=O)C(CC(C)C)NC(=O)CN,PHASE2,cardiovascular_disease
1410,HepatoCellular Carcinoma|Portal Vein Tumor Thrombosis,Lipotecan,CCC1(C2=C(COC1=O)C(=O)N3CC4=CC5=C(C=CC(=C5CN(C)C)O)N=C4C3=C2)OC(=O)C(C)ON=C6C7=C(C(=CC(=C7)[N+](=O)[O-])[N+](=O)[O-])C8=C6C=C(C=C8[N+](=O)[O-])[N+](=O)[O-],PHASE1|PHASE2,cardiovascular_disease
1411,Hodgkin's Lymphoma|Mature T-cell Lymphoma|Multiple Myeloma,Romidepsin,CC=C1C(=O)NC(C(=O)OC2CC(=O)NC(C(=O)NC(CSSCCC=C2)C(=O)N1)C(C)C)C(C)C,PHASE1,cardiovascular_disease
1412,"Neoplasms, Haematologic",Afuresertib,CN1C(=C(C=N1)Cl)C2=C(SC(=C2)C(=O)NC(CC3=CC(=CC=C3)F)CN)Cl,PHASE1,cardiovascular_disease
1413,"Telangiectasia, Hereditary Hemorrhagic|Rendu Osler Disease",Nintedanib,CN1CCN(CC1)CC(=O)N(C)C2=CC=C(C=C2)N=C(C3=CC=CC=C3)C4=C(NC5=C4C=CC(=C5)C(=O)OC)O,PHASE2,cardiovascular_disease
1414,Pulmonary Hypertension|Heart Failure With Normal Ejection Fraction|Pulmonary Heart Disease and Diseases of Pulmonary Circulation,Chlorhexidine,C1=CC(=CC=C1NC(=NC(=NCCCCCCN=C(N)N=C(N)NC2=CC=C(C=C2)Cl)N)N)Cl,PHASE1,cardiovascular_disease
1415,Coronary Heart Disease|Chlamydophila Pneumoniae Infections,Azithromycin,CCC1C(C(C(N(CC(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)C)O)(C)O,PHASE2,cardiovascular_disease
1416,Coronary Heart Disease|Chlamydophila Pneumoniae Infections,Rifabutin,CC1C=CC=C(C(=O)NC2=C(C3=C(C4=C(C(=C3O)C)OC(C4=O)(OC=CC(C(C(C(C(C(C1O)C)O)C)OC(=O)C)C)OC)C)C5=NC6(CCN(CC6)CC(C)C)N=C25)O)C,PHASE2,cardiovascular_disease
1417,Long QT Syndrome,Lumacaftor,CC1=C(N=C(C=C1)NC(=O)C2(CC2)C3=CC4=C(C=C3)OC(O4)(F)F)C5=CC(=CC=C5)C(=O)O,PHASE2,cardiovascular_disease
1418,Long QT Syndrome,Ivacaftor,CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C,PHASE2,cardiovascular_disease
1419,Myocardial Infarction,Mangafodipir,[H+].[H+].[H+].[H+].CC1=NC=C(C(=C1O)CN(CCN(CC2=C(C(=NC=C2COP(=O)([O-])[O-])C)O)CC(=O)[O-])CC(=O)[O-])COP(=O)([O-])[O-].[Mn+2],PHASE2,cardiovascular_disease
1420,Conscious Sedation,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,PHASE2,cardiovascular_disease
1421,Multiple Myeloma,Opaganib,C1C2CC3(CC1CC(C2)(C3)C(=O)NCC4=CC=NC=C4)C5=CC=C(C=C5)Cl,PHASE1|PHASE2,cardiovascular_disease
1422,"Subarachnoid Hemorrhage, Aneurysmal",Nimodipine,CC1=C(C(C(=C(N1)C)C(=O)OC(C)C)C2=CC(=CC=C2)[N+](=O)[O-])C(=O)OCCOC,PHASE1,cardiovascular_disease
1423,Recurrent Plasma Cell Myeloma|Refractory Plasma Cell Myeloma,Nelfinavir,CC1=C(C=CC=C1O)C(=O)NC(CSC2=CC=CC=C2)C(CN3CC4CCCCC4CC3C(=O)NC(C)(C)C)O,PHASE1,cardiovascular_disease
1424,"Infant, Newborn|Infant, Low Birth Weight|Infant, Small for Gestational Age|Infant, Premature|Hypotension|Blood Pressure",Dopamine,C1=CC(=C(C=C1CCN)O)O,PHASE1,cardiovascular_disease
1425,Pulmonary Arterial Hypertension,Ralinepag,C1CC(CCC1COCC(=O)O)COC(=O)N(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,PHASE2,cardiovascular_disease
1426,Peripheral Artery Disease,Lenomorelin,CCCCCCCC(=O)OCC(C(=O)NC(CO)C(=O)NC(CC1=CC=CC=C1)C(=O)NC(CC(C)C)C(=O)NC(CO)C(=O)N2CCCC2C(=O)NC(CCC(=O)O)C(=O)NC(CC3=CNC=N3)C(=O)NC(CCC(=O)N)C(=O)NC(CCCNC(=N)N)C(=O)NC(C(C)C)C(=O)NC(CCC(=O)N)C(=O)NC(CCC(=O)N)C(=O)NC(CCCNC(=N)N)C(=O)NC(CCCCN)C(=O)NC(CCC(=O)O)C(=O)NC(CO)C(=O)NC(CCCCN)C(=O)NC(CCCCN)C(=O)N4CCCC4C(=O)N5CCCC5C(=O)NC(C)C(=O)NC(CCCCN)C(=O)NC(CC(C)C)C(=O)NC(CCC(=O)N)C(=O)N6CCCC6C(=O)NC(CCCNC(=N)N)C(=O)O)NC(=O)CN,PHASE2,cardiovascular_disease
1427,Stroke,Basmisanil,CC1=C(C(=NO1)C2=CC=C(C=C2)F)COC3=NC=C(C=C3)C(=O)N4CCS(=O)(=O)CC4,PHASE2,cardiovascular_disease
1428,Cardiorenal Syndrome,Chlortalidone,C1=CC=C2C(=C1)C(=O)NC2(C3=CC(=C(C=C3)Cl)S(=O)(=O)N)O,PHASE2,cardiovascular_disease
1429,Coagulation Defect; Bleeding,Atropine,CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3,PHASE2,cardiovascular_disease
1430,Angiodysplasia,Pasireotide,C1C(CN2C1C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C2=O)CC3=CC=CC=C3)CC4=CC=C(C=C4)OCC5=CC=CC=C5)CCCCN)CC6=CNC7=CC=CC=C76)C8=CC=CC=C8)OC(=O)NCCN,PHASE2,cardiovascular_disease
1431,Multiple Myeloma,Plinabulin,CC(C)(C)C1=C(N=CN1)C=C2C(=O)NC(=CC3=CC=CC=C3)C(=O)N2,PHASE2,cardiovascular_disease
1432,Congestive Heart Failure,Rosiglitazone,CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3,PHASE2,cardiovascular_disease
1433,Atherosclerosis,Flutemetamol,CNC1=C(C=C(C=C1)C2=NC3=C(S2)C=C(C=C3)O)F,PHASE2|PHASE3,cardiovascular_disease
1434,Cardiac Remodeling|Myocardial Infarction,Paroxetine,C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4,PHASE2,cardiovascular_disease
1435,"Aortic Aneurysm, Thoracic",Pimonidazole,C1CCN(CC1)CC(CN2C=CN=C2[N+](=O)[O-])O,PHASE1,cardiovascular_disease
1436,Relapsed/Refractory Multiple Myeloma,Mitoxantrone,C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO,PHASE1|PHASE2,cardiovascular_disease
1437,Hypertension,Felodipine,CCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C,PHASE1,cardiovascular_disease
1438,Pulmonary Arterial Hypertension,Nilotinib,CC1=C(C=C(C=C1)C(=O)NC2=CC(=CC(=C2)C(F)(F)F)N3C=C(N=C3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,PHASE2,cardiovascular_disease
1439,"Acute Leukemia|Acute Lymphoblastic Leukemia|Acute Myeloid Leukemia|Adult Diffuse Large Cell Lymphoma|Anaplastic Large Cell Lymphoma|Burkitt Lymphoma|Chronic Myeloid Leukemia, BCR-ABL1 Positive|Chronic Myelomonocytic Leukemia|Hodgkin Lymphoma|Lymphoblastic Lymphoma|Lymphoplasmacytic Lymphoma|Mantle Cell Lymphoma|Mixed Phenotype Acute Leukemia|Myelodysplastic Syndrome|Prolymphocytic Leukemia|Refractory Chronic Lymphocytic Leukemia|Refractory Follicular Lymphoma|Refractory Marginal Zone Lymphoma|Refractory Small Lymphocytic Lymphoma",Treosulfan,CS(=O)(=O)OCC(C(COS(=O)(=O)C)O)O,PHASE2,cardiovascular_disease
1440,Deep Venous Thrombosis,Desirudin,CCC(C)C1C(=O)NC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(CSSCC2C(=O)NCC(=O)NC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)N2)C(C)C)CC(=O)N)CO)CCC(=O)O)NC(=O)C(CC(C)C)NC(=O)C3CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)N3)CC(C)C)CC(=O)N)CCC(=O)N)CO)CCC(=O)O)C(C)O)NC(=O)C(CC(=O)O)NC(=O)C(C(C)O)NC(=O)C(CC4=CC=C(C=C4)O)NC(=O)C(C(C)C)NC(=O)C(C(C)C)N)C(=O)N1)CCCCN)CC(=O)N)CCC(=O)N)C(=O)NC(C(C)C)C(=O)NC(C(C)O)C(=O)NCC(=O)NC(CCC(=O)O)C(=O)NCC(=O)NC(C(C)O)C(=O)N5CCCC5C(=O)NC(CCCCN)C(=O)N6CCCC6C(=O)NC(CCC(=O)N)C(=O)NC(CO)C(=O)NC(CC7=CN=CN7)C(=O)NC(CC(=O)N)C(=O)NC(CC(=O)O)C(=O)NCC(=O)NC(CC(=O)O)C(=O)NC(CC8=CC=CC=C8)C(=O)NC(CCC(=O)O)C(=O)NC(CCC(=O)O)C(=O)NC(C(C)CC)C(=O)N9CCCC9C(=O)NC(CCC(=O)O)C(=O)NC(CCC(=O)O)C(=O)NC(CC1=CC=C(C=C1)O)C(=O)NC(CC(C)C)C(=O)NC(CCC(=O)N)C(=O)O)CCC(=O)N)CC(=O)N)CCCCN)CCC(=O)O)CC(=O)O)CO)CC(C)C,PHASE2|PHASE3,cardiovascular_disease
1441,Coronary Disease,Otamixaban,CC(C(CC1=CC(=CC=C1)C(=N)N)C(=O)OC)NC(=O)C2=CC=C(C=C2)C3=CC=[N+](C=C3)[O-],PHASE2,cardiovascular_disease
1442,Subarachnoid Hemorrhage,Prostacyclin,CCCCCC(C=CC1C(CC2C1CC(=CCCCC(=O)O)O2)O)O,PHASE2,cardiovascular_disease
1443,Subarachnoid Hemorrhage,Epoprostenol,CCCCCC(C=CC1C(CC2C1CC(=CCCCC(=O)O)O2)O)O,PHASE2,cardiovascular_disease
1444,Cardiovascular Disease Risk Factors,Puerarin,C1=CC(=CC=C1C2=COC3=C(C2=O)C=CC(=C3C4C(C(C(C(O4)CO)O)O)O)O)O,PHASE2,cardiovascular_disease
1445,Cigarette Smoking Toxicity|Nicotine|Acute Cardiovascular Disease,Prazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4=CC=CO4)N)OC,PHASE1,cardiovascular_disease
1446,Granulomatosis With Polyangiitis|Wegener Granulomatosis,Trimethoprim,COC1=CC(=CC(=C1OC)OC)CC2=CN=C(N=C2N)N,PHASE1|PHASE2,cardiovascular_disease
1447,Granulomatosis With Polyangiitis|Wegener Granulomatosis,Sulfamethoxazole,CC1=CC(=NO1)NS(=O)(=O)C2=CC=C(C=C2)N,PHASE1|PHASE2,cardiovascular_disease
1448,Carney Complex|Chondrosarcoma|Gastrointestinal Stromal Tumor|Paraganglioma,Linsitinib,CC1(CC(C1)C2=NC(=C3N2C=CN=C3N)C4=CC5=C(C=C4)C=CC(=N5)C6=CC=CC=C6)O,PHASE2,cardiovascular_disease
1449,Intraluminal Pulmonary Vein Stenosis,Vinblastine,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O,PHASE2,cardiovascular_disease
1450,Coronary Heart Disease,Dalcetrapib,CCC(CC)CC1(CCCCC1)C(=O)NC2=CC=CC=C2SC(=O)C(C)C,PHASE2,cardiovascular_disease
1451,Acute Leukemia|Chronic Myeloproliferative Disease|Chronic Lymphoproliferative Disease|Multiple Myeloma|Lymphoma|Poor-risk Myelodysplasia (MDS),Darinaparsin,C[As](C)SCC(C(=O)NCC(=O)O)NC(=O)CCC(C(=O)O)N,PHASE1,cardiovascular_disease
1452,Angina,Febuxostat,CC1=C(SC(=N1)C2=CC(=C(C=C2)OCC(C)C)C#N)C(=O)O,PHASE2,cardiovascular_disease
1453,Hypertension|Diabetes,Linagliptin,CC#CCN1C2=C(N=C1N3CCCC(C3)N)N(C(=O)N(C2=O)CC4=NC5=CC=CC=C5C(=N4)C)C,PHASE1,cardiovascular_disease
1454,Lumbar Spine Surgery|Thoracic Spine Surgery,Ropivacaine,CCCN1CCCCC1C(=O)NC2=C(C=CC=C2C)C,PHASE2|PHASE3,cardiovascular_disease
1455,Single Ventricle Heart Disease After Fontan Surgery,Udenafil,CCCC1=NN(C2=C1N=C(NC2=O)C3=C(C=CC(=C3)S(=O)(=O)NCCC4CCCN4C)OCCC)C,PHASE1|PHASE2,cardiovascular_disease
1456,Hypertension,Perindopril,CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O,PHASE2,cardiovascular_disease
1457,Stroke,Serotonin,C1=CC2=C(C=C1O)C(=CN2)CCN,PHASE2,cardiovascular_disease
1458,Chronic Obstructive Pulmonary Disease|Pulmonary Artery Hypertension|Heart Failure|Hypertension,Fexofenadine,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,PHASE1,cardiovascular_disease
1459,Chronic Obstructive Pulmonary Disease|Pulmonary Artery Hypertension|Heart Failure|Hypertension,Phentolamine,CC1=CC=C(C=C1)N(CC2=NCCN2)C3=CC(=CC=C3)O,PHASE1,cardiovascular_disease
1460,Right Hemisphere Stroke|Hemispatial Neglect|Motor Deficit,Rotigotine,CCCN(CCC1=CC=CS1)C2CCC3=C(C2)C=CC=C3O,PHASE2,cardiovascular_disease
1461,Ischemic Mitral Regurgitation,Cyproheptadine,CN1CCC(=C2C3=CC=CC=C3C=CC4=CC=CC=C42)CC1,PHASE2,cardiovascular_disease
1462,"Post-COVID-19 Syndrome|Long COVID|Long Covid19|COVID-19|POTS - Postural Orthostatic Tachycardia Syndrome|Post COVID-19 Condition|Post-COVID Syndrome|Post COVID-19 Condition, Unspecified|Postinfectious Inflammation|Postinfectious Disorder",Nirmatrelvir,CC1(C2C1C(N(C2)C(=O)C(C(C)(C)C)NC(=O)C(F)(F)F)C(=O)NC(CC3CCNC3=O)C#N)C,PHASE2,cardiovascular_disease
1463,Congestive Heart Failure,Azimilide,CN1CCN(CC1)CCCCN2C(=O)CN(C2=O)N=CC3=CC=C(O3)C4=CC=C(C=C4)Cl,PHASE2,cardiovascular_disease
1464,"Duchenne Muscular Dystrophy Cardiomyopathy|Cardiomyopathy, Dilated",Ifetroban,CCCCCNC(=O)C1=COC(=N1)C2C3CCC(C2CC4=CC=CC=C4CCC(=O)O)O3,PHASE2,cardiovascular_disease
1465,Compartment Syndrome of Leg|Healthy,Mepivacaine,CC1=C(C(=CC=C1)C)NC(=O)C2CCCCN2C,PHASE1,cardiovascular_disease
1466,Cerebral Hemorrhage|Cerebral Edema|Intracerebral Hemorrhage|Stroke,Conivaptan,CC1=NC2=C(N1)CCN(C3=CC=CC=C32)C(=O)C4=CC=C(C=C4)NC(=O)C5=CC=CC=C5C6=CC=CC=C6,PHASE1,cardiovascular_disease
1467,Diabetic Foot Ulcer,Levofloxacin,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O,PHASE2,cardiovascular_disease
1468,Coronary Artery Disease,Ezetimibe,C1=CC(=CC=C1C2C(C(=O)N2C3=CC=C(C=C3)F)CCC(C4=CC=C(C=C4)F)O)O,PHASE2|PHASE3,cardiovascular_disease
1469,"Diabetes Mellitus, Type 2|Hypertension",Ertugliflozin,CCOC1=CC=C(C=C1)CC2=C(C=CC(=C2)C34C(C(C(C(O3)(CO4)CO)O)O)O)Cl,PHASE2,cardiovascular_disease
1470,Multiple Myeloma,Tasquinimod,CN1C2=C(C(=CC=C2)OC)C(=C(C1=O)C(=O)N(C)C3=CC=C(C=C3)C(F)(F)F)O,PHASE1,cardiovascular_disease
1471,Coronary Artery Stenosis,Alendronate,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,PHASE2,cardiovascular_disease
1472,Multiple Myeloma,Acetylcarnitine,CC(=O)OC(CC(=O)[O-])C[N+](C)(C)C,PHASE2,cardiovascular_disease
1473,Pulmonary Arterial Hypertension,Catechin,C1C(C(OC2=CC(=CC(=C21)O)O)C3=CC(=C(C=C3)O)O)O,PHASE1,cardiovascular_disease
1474,Pulmonary Arterial Hypertension,Epicatechin,C1C(C(OC2=CC(=CC(=C21)O)O)C3=CC(=C(C=C3)O)O)O,PHASE1,cardiovascular_disease
1475,"Stroke, Ischemic|Stroke Hemorrhagic",Amantadine,C1C2CC3CC1CC(C2)(C3)N,PHASE2,cardiovascular_disease
1476,Retinal Vein Occlusion,Fasudil,C1CNCCN(C1)S(=O)(=O)C2=CC=CC3=C2C=CN=C3,PHASE2|PHASE3,cardiovascular_disease
1477,Congestive Heart Failure,Oxypurinol,C1=NNC2=C1C(=O)NC(=O)N2,PHASE2|PHASE3,cardiovascular_disease
1478,Multiple Myeloma,Ruxolitinib,C1CCC(C1)C(CC#N)N2C=C(C=N2)C3=C4C=CNC4=NC=N3,PHASE1,cardiovascular_disease
1479,Multiple Myeloma,Cisplatin,N.N.Cl[Pt]Cl,PHASE2,cardiovascular_disease
1480,Coronary Artery Disease,Iopamidol,CC(C(=O)NC1=C(C(=C(C(=C1I)C(=O)NC(CO)CO)I)C(=O)NC(CO)CO)I)O,PHASE2,cardiovascular_disease
1481,Myeloma,Topotecan,CCC1(C2=C(COC1=O)C(=O)N3CC4=CC5=C(C=CC(=C5CN(C)C)O)N=C4C3=C2)O,PHASE2,cardiovascular_disease
1482,Myocardial Infarction,Fulacimstat,CN1C2=C(C=C(C=C2)N3C=C(C(=O)N(C3=O)C4CCC5=C4C=CC=C5C(F)(F)F)C(=O)O)OC1=O,PHASE2,cardiovascular_disease
1483,Essential Hypertension,Lercanidipine,CC1=C(C(C(=C(N1)C)C(=O)OC(C)(C)CN(C)CCC(C2=CC=CC=C2)C3=CC=CC=C3)C4=CC(=CC=C4)[N+](=O)[O-])C(=O)OC,PHASE2,cardiovascular_disease
1484,Acute Heart Failure,Serelaxin,CCC(C)C1C(=O)NC(CSSCC(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C2CSSCC(C(=O)NC(CSSCC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)C)C(C)CC)CCC(=O)N)C)CCCNC(=N)N)C(C)C)CC(C)C)CCC(=O)O)CCCNC(=N)N)NC(=O)C(CC(C)C)NC(=O)C(CCCCN)NC(=O)C(C(C)CC)NC(=O)C(C(C)C)NC(=O)C(CCC(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(CCSC)NC(=O)C(CC3=CNC4=CC=CC=C43)NC(=O)C(CO)NC(=O)C(CC(=O)O)N)C(=O)NC(C(=O)NC(C(=O)NCC(=O)N2)C(C)C)CC5=CN=CN5)NC(=O)C(CCCCN)NC(=O)C(CC(=O)N)NC(=O)C(C)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CO)NC(=O)C(CC6=CC=C(C=C6)O)NC(=O)C(CC(C)C)NC(=O)C7CCC(=O)N7)C(C)O)CCCCN)CCCNC(=N)N)CO)CC(C)C)C)CCCNC(=N)N)CC8=CC=CC=C8)C(=O)O)C(=O)NCC(=O)NC(CCSC)C(=O)NC(CO)C(=O)NC(C(C)O)C(=O)NC(CC9=CNC1=CC=CC=C19)C(=O)NC(CO)C(=O)O,PHASE2,cardiovascular_disease
1485,Angina Pectoris,Lacidipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2C=CC(=O)OC(C)(C)C)C(=O)OCC)C)C,PHASE2,cardiovascular_disease
1486,Heart Failure,Bumetanide,CCCCNC1=C(C(=CC(=C1)C(=O)O)S(=O)(=O)N)OC2=CC=CC=C2,PHASE1,cardiovascular_disease
1487,Heart Failure,Chlorothiazide,C1=C2C(=CC(=C1Cl)S(=O)(=O)N)S(=O)(=O)N=CN2,PHASE1,cardiovascular_disease
1488,Prolonged QT Interval in EKG and Sudden Death,Ibutilide,CCCCCCCN(CC)CCCC(C1=CC=C(C=C1)NS(=O)(=O)C)O,PHASE2,cardiovascular_disease
1489,Cerebral Arteriovenous Malformation,Lovastatin,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,PHASE2,cardiovascular_disease
1490,Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma|Mantle Cell Lymphoma|Marginal Zone Lymphoma|Waldenstrom Macroglobulinemia,Zanubrutinib,C=CC(=O)N1CCC(CC1)C2CCNC3=C(C(=NN23)C4=CC=C(C=C4)OC5=CC=CC=C5)C(=O)N,PHASE2,cardiovascular_disease
1491,Fabry Disease|Neuropathic Pain,Gabapentin,C1CCC(CC1)(CC(=O)O)CN,PHASE2,cardiovascular_disease
1492,Chronic Myeloproliferative Disorders|Leukemia|Lymphoma|Multiple Myeloma and Plasma Cell Neoplasm|Myelodysplastic Syndromes|Myelodysplastic/Myeloproliferative Neoplasms|Precancerous Condition,Phenytoin,C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=CC=C3,PHASE1|PHASE2,cardiovascular_disease
1493,Microvascular Angina,Zibotentan,CC1=CN=C(C(=N1)OC)NS(=O)(=O)C2=C(N=CC=C2)C3=CC=C(C=C3)C4=NN=CO4,PHASE2,cardiovascular_disease
1494,Atherosclerosis|Cardiovascular Disease|Inflammation|Insulin Resistance|Noninsulin-dependent Diabetes Mellitus,Salsalate,C1=CC=C(C(=C1)C(=O)OC2=CC=CC=C2C(=O)O)O,PHASE2|PHASE3,cardiovascular_disease
1495,Gastrointestinal Cancer|Cancer of Unknown Primary Site|Pancreatic Cancer|Bile Duct Neoplasms,Gimeracil,C1=C(C(=CNC1=O)Cl)O,PHASE2,cardiovascular_disease
1496,Gastrointestinal Cancer|Cancer of Unknown Primary Site|Pancreatic Cancer|Bile Duct Neoplasms,Capecitabine,CCCCCOC(=O)NC1=NC(=O)N(C=C1F)C2C(C(C(O2)C)O)O,PHASE2,cardiovascular_disease
1497,Atrial Fibrillation,Sotalol,CC(C)NCC(C1=CC=C(C=C1)NS(=O)(=O)C)O,PHASE1,cardiovascular_disease
1498,Tobacco Use Disorder,Varenicline,C1C2CNCC1C3=CC4=NC=CN=C4C=C23,PHASE2|PHASE3,cardiovascular_disease
1499,Multiple Myeloma in Relapse|Multiple Myeloma Progression|Multiple Myeloma With Failed Remission,Tinostamustine,CN1C2=C(C=C(C=C2)N(CCCl)CCCl)N=C1CCCCCCC(=O)NO,PHASE1|PHASE2,cardiovascular_disease
1500,Cardiac Catheterization|Blood Pressure|Heart Ventricles|Echocardiography|Heart Failure,Perflubutane,C(C(C(F)(F)F)(F)F)(C(F)(F)F)(F)F,PHASE2,cardiovascular_disease
1501,Multiple Myeloma,Colesevelam,CCCCCCCCCCNCC=C.C[N+](C)(C)CCCCCCNCC=C.C=CCN.C1C(O1)CCl.Cl.[Cl-],PHASE2,cardiovascular_disease
1502,Fabry Disease,Lucerastat,CCCCN1CC(C(C(C1CO)O)O)O,PHASE1,cardiovascular_disease
1503,Myocardial Fibrosis,Pirfenidone,CC1=CN(C(=O)C=C1)C2=CC=CC=C2,PHASE2,cardiovascular_disease
1504,Type 2 Diabetes|Hypertension,Aprepitant,CC(C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)OC2C(N(CCO2)CC3=NNC(=O)N3)C4=CC=C(C=C4)F,PHASE2,cardiovascular_disease
1505,Multiple Myeloma,Tipifarnib,CN1C=NC=C1C(C2=CC=C(C=C2)Cl)(C3=CC4=C(C=C3)N(C(=O)C=C4C5=CC(=CC=C5)Cl)C)N,PHASE1,cardiovascular_disease
1506,Acute Cerebrovascular Accident|Cerebral Edema,Pantoprazole,COC1=C(C(=NC=C1)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC(F)F)OC,PHASE2,cardiovascular_disease
1507,ANCA Associated Vasculitis|Cardiovascular Diseases|Kidney Diseases,Sparsentan,CCCCC1=NC2(CCCC2)C(=O)N1CC3=CC(=C(C=C3)C4=CC=CC=C4S(=O)(=O)NC5=NOC(=C5C)C)COCC,PHASE2,cardiovascular_disease
1508,Postural Tachycardia Syndrome,Galantamine,CN1CCC23C=CC(CC2OC4=C(C=CC(=C34)C1)OC)O,PHASE1,cardiovascular_disease
1509,Erythromelalgia,Amitriptyline,CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31,PHASE2,cardiovascular_disease
1510,Congestive Heart Failure,Lixivaptan,CC1=C(C=C(C=C1)F)C(=O)NC2=CC(=C(C=C2)C(=O)N3CC4=CC=CN4CC5=CC=CC=C53)Cl,PHASE2,cardiovascular_disease
1511,Cardiovascular Disease|Sudden Cardiac Death,Alfacalcidol,CC(C)CCCC(C)C1CCC2C1(CCCC2=CC=C3CC(CC(C3=C)O)O)C,PHASE2,cardiovascular_disease
1512,Cardiovascular Disease|Sudden Cardiac Death,Ergocalciferol,CC(C)C(C)C=CC(C)C1CCC2C1(CCCC2=CC=C3CC(CCC3=C)O)C,PHASE2,cardiovascular_disease
1513,Cardiac Arrest,Ubiquinol,CC1=C(C(=C(C(=C1O)OC)OC)O)CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C,PHASE2,cardiovascular_disease
1514,Neonatal Seizure|Neonatal Encephalopathy|Hypoxic-Ischemic Encephalopathy|Seizure Newborn,Levetiracetam,CCC(C(=O)N)N1CCCC1=O,PHASE2,cardiovascular_disease
1515,Neonatal Seizure|Neonatal Encephalopathy|Hypoxic-Ischemic Encephalopathy|Seizure Newborn,Phenobarbital,CCC1(C(=O)NC(=O)NC1=O)C2=CC=CC=C2,PHASE2,cardiovascular_disease
1516,"Arrhythmia, Cardiac",Propafenone,CCCNCC(COC1=CC=CC=C1C(=O)CCC2=CC=CC=C2)O,PHASE1,cardiovascular_disease
1517,Refractory Multiple Myeloma,Tivantinib,C1CC2=C3C(=CC=C2)C(=CN3C1)C4C(C(=O)NC4=O)C5=CNC6=CC=CC=C65,PHASE2,cardiovascular_disease
1518,Autonomic Failure|Pure Autonomic Failure|Parkinson Disease|Multiple System Atrophy|Dementia With Lewy Bodies,Entacapone,CCN(CC)C(=O)C(=CC1=CC(=C(C(=C1)O)O)[N+](=O)[O-])C#N,PHASE1,cardiovascular_disease
1519,Neuroendocrine Tumors|Von Hippel-Lindau Syndrome|Hippel-Lindau Disease,Dotatate,CC(C1C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=C(C=C4)O)NC(=O)C(CC5=CC=CC=C5)NC(=O)CN6CCN(CCN(CCN(CC6)CC(=O)O)CC(=O)O)CC(=O)O)C(=O)NC(C(C)O)C(=O)O)O,PHASE2,cardiovascular_disease
1520,Recurrent Plasma Cell Myeloma|Refractory Plasma Cell Myeloma,Selumetinib,CN1C=NC2=C1C=C(C(=C2F)NC3=C(C=C(C=C3)Br)Cl)C(=O)NOCCO,PHASE2,cardiovascular_disease
1521,Non-hodgkins Lymphoma|Hodgkins Lymphoma|Multiple Myeloma,Pegaspargase,CC1=CC(=C(C=C1)C(=O)C(=C)CN(C)C)C,PHASE2,cardiovascular_disease
1522,Thrombocytopenia|Multiple Myeloma,Eltrombopag,CC1=C(C=C(C=C1)N2C(=O)C(=C(N2)C)N=NC3=CC=CC(=C3O)C4=CC(=CC=C4)C(=O)O)C,PHASE2,cardiovascular_disease
1523,STEMI,Acetylcysteine,CC(=O)NC(CS)C(=O)O,PHASE2,cardiovascular_disease
1524,"Lymphoma, T-Cell, Cutaneous|Lymphoma, T-Cell, Peripheral|Chronic Lymphocytic Leukemia|Lymphoproliferative Disorders|Waldenstrom Macroglobulinemia|Lymphoplasmacytic Lymphoma|Mantle Cell Lymphoma",Pacritinib,C1CCN(C1)CCOC2=C3COCC=CCOCC4=CC(=CC=C4)C5=NC(=NC=C5)NC(=C3)C=C2,PHASE1,cardiovascular_disease
1525,Systolic Heart Failure,Probenecid,CCCN(CCC)S(=O)(=O)C1=CC=C(C=C1)C(=O)O,PHASE2,cardiovascular_disease
1526,Waldenstrom's Macroglobulinemia|Multiple Myeloma,Enzastaurin,CN1C=C(C2=CC=CC=C21)C3=C(C(=O)NC3=O)C4=CN(C5=CC=CC=C54)C6CCN(CC6)CC7=CC=CC=N7,PHASE2,cardiovascular_disease
1527,Hereditary Hemorrhagic Telangiectasia,Tamoxifen,CCC(=C(C1=CC=CC=C1)C2=CC=C(C=C2)OCCN(C)C)C3=CC=CC=C3,PHASE2,cardiovascular_disease
1528,Cirrhosis|Ascites,Terlipressin,C1CC(N(C1)C(=O)C2CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N2)CC(=O)N)CCC(=O)N)CC3=CC=CC=C3)CC4=CC=C(C=C4)O)NC(=O)CNC(=O)CNC(=O)CN)C(=O)NC(CCCCN)C(=O)NCC(=O)N,PHASE2|PHASE3,cardiovascular_disease
1529,Brugada Syndrome|Sudden Death,Ajmaline,CCC1C2CC3C4C5(CC(C2C5O)N3C1O)C6=CC=CC=C6N4C,PHASE2,cardiovascular_disease
1530,Williams Beuren Syndrome,Minoxidil,C1CCN(CC1)C2=NC(=N)N(C(=C2)N)O,PHASE2,cardiovascular_disease
1531,Idiopathic Pulmonary Arterial Hypertension.,Albuterol,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,PHASE2,cardiovascular_disease
1532,Idiopathic Pulmonary Arterial Hypertension.,Salbutamol,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,PHASE2,cardiovascular_disease
1533,Subclinical Hypothyroidism,Levothyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,PHASE2|PHASE3,cardiovascular_disease
1534,Atrial Fibrillation,Triiodothyronine,C1=CC(=C(C=C1OC2=C(C=C(C=C2I)CC(C(=O)O)N)I)I)O,PHASE1,cardiovascular_disease
1535,Atrial Fibrillation,Liothyronine,C1=CC(=C(C=C1OC2=C(C=C(C=C2I)CC(C(=O)O)N)I)I)O,PHASE1,cardiovascular_disease
1536,Thrombosis,Lepirudin,CCC(C)C1C(=O)NC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(CSSCC2C(=O)NCC(=O)NC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)N2)C(C)C)CC(=O)N)CO)CCC(=O)O)NC(=O)C(CC(C)C)NC(=O)C3CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)N3)CC(C)C)CC(=O)N)CCC(=O)N)CO)CCC(=O)O)C(C)O)NC(=O)C(CC(=O)O)NC(=O)C(C(C)O)NC(=O)C(CC4=CC=C(C=C4)O)NC(=O)C(C(C)O)NC(=O)C(CC(C)C)N)C(=O)N1)CCCCN)CC(=O)N)CCC(=O)N)C(=O)NC(C(C)C)C(=O)NC(C(C)O)C(=O)NCC(=O)NC(CCC(=O)O)C(=O)NCC(=O)NC(C(C)O)C(=O)N5CCCC5C(=O)NC(CCCCN)C(=O)N6CCCC6C(=O)NC(CCC(=O)N)C(=O)NC(CO)C(=O)NC(CC7=CNC=N7)C(=O)NC(CC(=O)N)C(=O)NC(CC(=O)O)C(=O)NCC(=O)NC(CC(=O)O)C(=O)NC(CC8=CC=CC=C8)C(=O)NC(CCC(=O)O)C(=O)NC(CCC(=O)O)C(=O)NC(C(C)CC)C(=O)N9CCCC9C(=O)NC(CCC(=O)O)C(=O)NC(CCC(=O)O)C(=O)NC(CC1=CC=C(C=C1)O)C(=O)NC(CC(C)C)C(=O)NC(CCC(=O)N)C(=O)O)CCC(=O)N)CC(=O)N)CCCCN)CCC(=O)O)CC(=O)O)CO)CC(C)C,PHASE2,cardiovascular_disease
1537,Preeclampsia,Torsemide,CC1=CC(=CC=C1)NC2=C(C=NC=C2)S(=O)(=O)NC(=O)NC(C)C,PHASE2,cardiovascular_disease
1538,Preeclampsia,Torasemide,CC1=CC(=CC=C1)NC2=C(C=NC=C2)S(=O)(=O)NC(=O)NC(C)C,PHASE2,cardiovascular_disease
1539,Hepatic Veno-Occlusive Disease,Defibrotide,CC(C)C1=C(C=C(C(=C1)C2=NNC(=O)N2C3=CC4=C(C=C3)N(C=C4)C)O)OP(=O)(O)O,PHASE2|PHASE3,cardiovascular_disease
1540,Multiple Myeloma,Budesonide,CCCC1OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C,PHASE2,cardiovascular_disease
1541,Ischemic Stroke|Post-stroke Cognitive Impairment,Cromolyn,C1=CC2=C(C(=C1)OCC(COC3=CC=CC4=C3C(=O)C=C(O4)C(=O)O)O)C(=O)C=C(O2)C(=O)O,PHASE2,cardiovascular_disease
1542,Subarachnoid Hemorrhage|Hypertension,Clevidipine,CCCC(=O)OCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C,PHASE2,cardiovascular_disease
1543,Multiple Myeloma,Tecemotide,CCCCCCCCCCCCCCCC(=O)NCCCCC(C(=O)NCC(=O)O)NC(=O)C1CCCN1C(=O)C2CCCN2C(=O)C(C)NC(=O)C(C(C)O)NC(=O)C(CO)NC(=O)CNC(=O)C3CCCN3C(=O)C(C)NC(=O)C4CCCN4C(=O)C(CCCNC(=N)N)NC(=O)C(C(C)O)NC(=O)C(CC(=O)O)NC(=O)C5CCCN5C(=O)C(C)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C(C(C)C)NC(=O)CNC(=O)C(CC6=CN=CN6)NC(=O)C(C)NC(=O)C7CCCN7C(=O)C8CCCN8C(=O)C(C)NC(=O)C(C(C)O)NC(=O)C(CO)N,PHASE2,cardiovascular_disease
1544,Lung Cancer|Solid Tumor|Gastric Cancer|Urothelial Cancer|Endometrial Cancer|Multiple Myeloma|Myeloproliferative Neoplasms|Breast Cancer|Cholangiocarcinoma|UC|MPN,Pemigatinib,CCN1C2=C3C=C(NC3=NC=C2CN(C1=O)C4=C(C(=CC(=C4F)OC)OC)F)CN5CCOCC5,PHASE1|PHASE2,cardiovascular_disease
1545,Lung Cancer|Solid Tumor|Gastric Cancer|Urothelial Cancer|Endometrial Cancer|Multiple Myeloma|Myeloproliferative Neoplasms|Breast Cancer|Cholangiocarcinoma|UC|MPN,Docetaxel,CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O,PHASE1|PHASE2,cardiovascular_disease
1546,Drug-induced QT Prolongation|Pharmacokinetics|Pharmacodynamics,Dofetilide,CN(CCC1=CC=C(C=C1)NS(=O)(=O)C)CCOC2=CC=C(C=C2)NS(=O)(=O)C,PHASE1,cardiovascular_disease
1547,Drug-induced QT Prolongation|Pharmacokinetics|Pharmacodynamics,Mexiletine,CC1=C(C(=CC=C1)C)OCC(C)N,PHASE1,cardiovascular_disease
1548,Congestive Heart Failure|Non-ischemic Cardiomyopathy,Triheptanoin,CCCCCCC(=O)OCC(COC(=O)CCCCCC)OC(=O)CCCCCC,PHASE1|PHASE2,cardiovascular_disease
1549,Aneurysmal Subarachnoid Hemorrhage,Clazosentan,CC1=CN=C(C=C1)S(=O)(=O)NC2=C(C(=NC(=N2)C3=CC(=NC=C3)C4=NNN=N4)OCCO)OC5=CC=CC=C5OC,PHASE2,cardiovascular_disease
1550,Anemia|Fatigue|Fever|Lymphadenopathy|Lymphocytosis|Night Sweats|Recurrent Chronic Lymphocytic Leukemia|Recurrent Plasma Cell Myeloma|Refractory Chronic Lymphocytic Leukemia|Refractory Plasma Cell Myeloma|Splenomegaly|Thrombocytopenia|Weight Loss,Ritonavir,CC(C)C1=NC(=CS1)CN(C)C(=O)NC(C(C)C)C(=O)NC(CC2=CC=CC=C2)CC(C(CC3=CC=CC=C3)NC(=O)OCC4=CN=CS4)O,PHASE1,cardiovascular_disease
1551,Ataxia Telangiectasia,Betamethasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,PHASE1,cardiovascular_disease
1552,Aortic Valve Stenosis,Ataciguat,C1COCCN1S(=O)(=O)C2=CC=C(C=C2)NC(=O)C3=C(C=CC(=C3)Cl)NS(=O)(=O)C4=CC=C(S4)Cl,PHASE1,cardiovascular_disease
1553,Parkinson's Disease|Multiple System Atrophy|Orthostatic Hypotension,Fludrocortisone,CC12CCC(=O)C=C1CCC3C2(C(CC4(C3CCC4(C(=O)CO)O)C)O)F,PHASE1,cardiovascular_disease
1554,Parkinson's Disease|Multiple System Atrophy|Orthostatic Hypotension,Domperidone,C1CN(CCC1N2C3=C(C=C(C=C3)Cl)NC2=O)CCCN4C5=CC=CC=C5NC4=O,PHASE1,cardiovascular_disease
1555,Hyperinsulinism|Insulin Resistance|Insulin Sensitivity|Glucose Intolerance|Hypertension,Vigabatrin,C=CC(CCC(=O)O)N,PHASE2,cardiovascular_disease
1556,Congestive Heart Failure|Renal Impairment,Pecavaptan,CC(C1=NC(=NN1C2=CC(=CC=C2)Cl)CN3C(=O)N(C(=N3)C4=CC=C(C=C4)Cl)CC(C(F)(F)F)O)O,PHASE1,cardiovascular_disease
1557,Behcet Syndrome,Apremilast,CCOC1=C(C=CC(=C1)C(CS(=O)(=O)C)N2C(=O)C3=C(C2=O)C(=CC=C3)NC(=O)C)OC,PHASE2,cardiovascular_disease
1558,Drug-induced QT Prolongation|Pharmacokinetics|Pharmacodynamics,Pimozide,C1CN(CCC1N2C3=CC=CC=C3NC2=O)CCCC(C4=CC=C(C=C4)F)C5=CC=C(C=C5)F,PHASE1,cardiovascular_disease
1559,Drug-induced QT Prolongation|Pharmacokinetics|Pharmacodynamics,Cobicistat,CC(C)C1=NC(=CS1)CN(C)C(=O)NC(CCN2CCOCC2)C(=O)NC(CCC(CC3=CC=CC=C3)NC(=O)OCC4=CN=CS4)CC5=CC=CC=C5,PHASE1,cardiovascular_disease
1560,Megalencephaly-capillary Malformation Polymicrogyria Syndrome (MCAP),Alpelisib,CC1=C(SC(=N1)NC(=O)N2CCCC2C(=O)N)C3=CC(=NC=C3)C(C)(C)C(F)(F)F,PHASE2,cardiovascular_disease
1561,Multiple Myeloma,Tazemetostat,CCN(C1CCOCC1)C2=CC(=CC(=C2C)C(=O)NCC3=C(C=C(NC3=O)C)C)C4=CC=C(C=C4)CN5CCOCC5,PHASE1|PHASE2,cardiovascular_disease
1562,Heart Failure,Bendroflumethiazide,C1=CC=C(C=C1)CC2NC3=C(C=C(C(=C3)C(F)(F)F)S(=O)(=O)N)S(=O)(=O)N2,PHASE1,cardiovascular_disease
1563,Cerebrovascular Accident|Hemiparesis,Ropinirole,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1,PHASE2,cardiovascular_disease
1564,Solid Tumors|Lymphoma|Multiple Myeloma,Bexarotene,CC1=CC2=C(C=C1C(=C)C3=CC=C(C=C3)C(=O)O)C(CCC2(C)C)(C)C,PHASE1,cardiovascular_disease
1565,Atrial Fibrillation,Bupivacaine,CCCCN1CCCCC1C(=O)NC2=C(C=CC=C2C)C,PHASE2|PHASE3,cardiovascular_disease
1566,Subacute/Chronic Myocardial Infarction,Gadobutrol,C1CN(CCN(CCN(CCN1CC(=O)[O-])CC(=O)[O-])C(CO)C(CO)O)CC(=O)[O-].[Gd+3],PHASE2,cardiovascular_disease
1567,Arterial Ischemic Stroke,Afamelanotide,CCCCC(C(=O)NC(CCC(=O)O)C(=O)NC(CC1=CN=CN1)C(=O)NC(CC2=CC=CC=C2)C(=O)NC(CCCNC(=N)N)C(=O)NC(CC3=CNC4=CC=CC=C43)C(=O)NCC(=O)NC(CCCCN)C(=O)N5CCCC5C(=O)NC(C(C)C)C(=O)N)NC(=O)C(CO)NC(=O)C(CC6=CC=C(C=C6)O)NC(=O)C(CO)NC(=O)C,PHASE2,cardiovascular_disease
1568,Diastolic Dysfunction|Systolic Dysfunction|Diastolic Heart Failure,Sulforaphane,CS(=O)CCCCN=C=S,PHASE1|PHASE2,cardiovascular_disease
1569,Myeloma,Vinorelbine,CCC1=CC2CC(C3=C(CN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC,PHASE2,cardiovascular_disease
1570,Pulmonary Arterial Hypertension,Tezosentan,CC(C)C1=CN=C(C=C1)S(=O)(=O)NC2=C(C(=NC(=N2)C3=CC(=NC=C3)C4=NNN=N4)OCCO)OC5=CC=CC=C5OC,PHASE2,cardiovascular_disease
1571,"Cancer of Pancreas|Cancer of Liver|Cancer of Rectum|Cancer of Colon|Cancer, Gall Bladder|Myeloma Multiple|Glioblastoma Multiforme",Leucovorin,C1C(N(C2=C(N1)N=C(NC2=O)N)C=O)CNC3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,PHASE1|PHASE2,cardiovascular_disease
1572,"Cancer of Pancreas|Cancer of Liver|Cancer of Rectum|Cancer of Colon|Cancer, Gall Bladder|Myeloma Multiple|Glioblastoma Multiforme",Oxaliplatin,C1CCC(C(C1)[NH-])[NH-].C(=O)(C(=O)O)O.[Pt+2],PHASE1|PHASE2,cardiovascular_disease
1573,"Cancer of Pancreas|Cancer of Liver|Cancer of Rectum|Cancer of Colon|Cancer, Gall Bladder|Myeloma Multiple|Glioblastoma Multiforme",Irinotecan,CCC1=C2CN3C(=CC4=C(C3=O)COC(=O)C4(CC)O)C2=NC5=C1C=C(C=C5)OC(=O)N6CCC(CC6)N7CCCCC7,PHASE1|PHASE2,cardiovascular_disease
1574,"Cancer of Pancreas|Cancer of Liver|Cancer of Rectum|Cancer of Colon|Cancer, Gall Bladder|Myeloma Multiple|Glioblastoma Multiforme",Temozolomide,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N,PHASE1|PHASE2,cardiovascular_disease
1575,Pulmonary Arterial Hypertension,Zamicastat,C1C(COC2=C1C=C(C=C2F)F)N3C(=CNC3=S)CCNCC4=CC=CC=C4,PHASE2,cardiovascular_disease
1576,HIV Infections|Cardiovascular Diseases|Hypertension,Indinavir,CC(C)(C)NC(=O)C1CN(CCN1CC(CC(CC2=CC=CC=C2)C(=O)NC3C(CC4=CC=CC=C34)O)O)CC5=CN=CC=C5,PHASE1,cardiovascular_disease
1577,Wegener's Granulomatosis,Gusperimus,C(CCCN=C(N)N)CCC(=O)NC(C(=O)NCCCCNCCCN)O,PHASE2,cardiovascular_disease
1578,Loss of Chromosome 17p|Recurrent Plasma Cell Myeloma,Idasanutlin,CC(C)(C)CC1C(C(C(N1)C(=O)NC2=C(C=C(C=C2)C(=O)O)OC)C3=C(C(=CC=C3)Cl)F)(C#N)C4=C(C=C(C=C4)Cl)F,PHASE1|PHASE2,cardiovascular_disease
1579,Multiple Myeloma,Atiprimod,CCCC1(CCC2(CC1)CCN(C2)CCCN(CC)CC)CCC,PHASE1|PHASE2,cardiovascular_disease
1580,Pulmonary Hypertension|Schistosomiasis,Selexipag,CC(C)N(CCCCOCC(=O)NS(=O)(=O)C)C1=CN=C(C(=N1)C2=CC=CC=C2)C3=CC=CC=C3,PHASE2,cardiovascular_disease
1581,Pulmonary Arterial Hypertension,Sulfasalazine,C1=CC=NC(=C1)NS(=O)(=O)C2=CC=C(C=C2)N=NC3=CC(=C(C=C3)O)C(=O)O,PHASE1|PHASE2,cardiovascular_disease
1582,Endocarditis|Bacteremia,Dalbavancin,CC(C)CCCCCCCCC(=O)NC1C(C(C(OC1OC2=C3C=C4C=C2OC5=C(C=C(C=C5)C(C6C(=O)NC(C7=C(C(=CC(=C7)O)OC8C(C(C(C(O8)CO)O)O)O)C9=C(C=CC(=C9)C(C(=O)N6)NC(=O)C4NC(=O)C1C2=C(C(=CC(=C2)OC2=C(C=CC(=C2)C(C(=O)NC(CC2=CC=C(O3)C=C2)C(=O)N1)NC)O)O)Cl)O)C(=O)NCCCN(C)C)O)Cl)C(=O)O)O)O,PHASE2,cardiovascular_disease
1583,Velo-cardio-facial Syndrome|Psychosis,Metyrosine,CC(CC1=CC=C(C=C1)O)(C(=O)O)N,PHASE2,cardiovascular_disease
1584,Hypertension,Levamlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,PHASE1,cardiovascular_disease
1585,"Slow-Flow Vascular Malformation|Fast-Flow Vascular Malformation|Vascular Malformations|Venous Malformation|Lymphatic Malformation, Low Flow|Lymphatic Malformation|Lymphangioma|Arteriovenous Malformations|Venous Malformation, Low Flow|Cystic Hygroma|Vascular Anomaly|Vascular Anomalies|PI3K Gene Mutation|MAP2K1 Gene Mutation|PIK3CA-related Overgrowth Spectrum|Arteriovenous Malformation (AVM)|KRAS G12C|KRAS G12D",Mirdametinib,C1=CC(=C(C=C1I)F)NC2=C(C=CC(=C2F)F)C(=O)NOCC(CO)O,PHASE2,cardiovascular_disease
1586,Advanced Lymphoma|Advanced Malignant Solid Neoplasm|Hematopoietic and Lymphoid Cell Neoplasm|Refractory Lymphoma|Refractory Malignant Solid Neoplasm|Refractory Multiple Myeloma,Taselisib,CC1=NN(C(=N1)C2=CN3CCOC4=C(C3=N2)C=CC(=C4)C5=CN(N=C5)C(C)(C)C(=O)N)C(C)C,PHASE2,cardiovascular_disease
1587,Relapsed Refractory Multiple Myeloma,Abemaciclib,CCN1CCN(CC1)CC2=CN=C(C=C2)NC3=NC=C(C(=N3)C4=CC5=C(C(=C4)F)N=C(N5C(C)C)C)F,PHASE1|PHASE2,cardiovascular_disease
1588,Relapsed Refractory Multiple Myeloma,Enasidenib,CC(C)(CNC1=NC(=NC(=N1)C2=NC(=CC=C2)C(F)(F)F)NC3=CC(=NC=C3)C(F)(F)F)O,PHASE1|PHASE2,cardiovascular_disease
1589,Relapsed Refractory Multiple Myeloma,Erdafitinib,CC(C)NCCN(C1=CC2=NC(=CN=C2C=C1)C3=CN(N=C3)C)C4=CC(=CC(=C4)OC)OC,PHASE1|PHASE2,cardiovascular_disease
1590,Chronic Obstructive Pulmonary Disease,Formoterol,CC(CC1=CC=C(C=C1)OC)NCC(C2=CC(=C(C=C2)O)NC=O)O,PHASE2,cardiovascular_disease
1591,Multiple Myeloma,Plitidepsin,CCC(C)C1C(CC(=O)OC(C(=O)C(C(=O)NC(C(=O)N2CCCC2C(=O)N(C(C(=O)OC(C(C(=O)N1)NC(=O)C(CC(C)C)N(C)C(=O)C3CCCN3C(=O)C(=O)C)C)CC4=CC=C(C=C4)OC)C)CC(C)C)C)C(C)C)O,PHASE2,cardiovascular_disease
1592,Wegener's Granulomatosis|Renal Limited Vasculitis|Microscopic Polyangiitis,Azathioprine,CN1C=NC(=C1SC2=NC=NC3=C2NC=N3)[N+](=O)[O-],PHASE2,cardiovascular_disease
1593,"Acute Myeloid Leukemia|Acute Lymphocytic Leukemia|Chronic Lymphocytic Leukemia|Myelodysplasia|Lymphoma, Non-Hodgkin|Hodgkin's Lymphoma|Multiple Myeloma",Clioquinol,C1=CC2=C(C(=C(C=C2Cl)I)O)N=C1,PHASE1,cardiovascular_disease
1594,Multiple Myeloma,Dovitinib,CN1CCN(CC1)C2=CC3=C(C=C2)N=C(N3)C4=C(C5=C(C=CC=C5F)NC4=O)N,PHASE1,cardiovascular_disease
1595,Hypertension Secondary to Kidney Transplant,Isradipine,CC1=C(C(C(=C(N1)C)C(=O)OC(C)C)C2=CC=CC3=NON=C32)C(=O)OC,PHASE2|PHASE3,cardiovascular_disease
1596,Diabetic Foot Ulcer,Ketanserin,C1CN(CCC1C(=O)C2=CC=C(C=C2)F)CCN3C(=O)C4=CC=CC=C4NC3=O,PHASE1|PHASE2,cardiovascular_disease
1597,Atherosclerotic Cardiovascular Disease|Symptomatic Atherosclerosis|Type2 Diabetes|Familial Hypercholesterolemia,Inclisiran,CC(=O)NC1C(C(C(OC1OCCCCC(=O)NCCCNC(=O)CCOCC(COCCC(=O)NCCCNC(=O)CCCCOC2C(C(C(C(O2)CO)O)O)NC(=O)C)(COCCC(=O)NCCCNC(=O)CCCCOC3C(C(C(C(O3)CO)O)O)NC(=O)C)NC(=O)CCCCCCCCCCC(=O)N4CC(CC4COP(=O)(O)O)O)CO)O)O,PHASE2,cardiovascular_disease
1598,Carotid Artery Stenosis,Terazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4CCCO4)N)OC,PHASE2,cardiovascular_disease
1599,Stroke|Hemispatial Neglect,Guanfacine,C1=CC(=C(C(=C1)Cl)CC(=O)N=C(N)N)Cl,PHASE2,cardiovascular_disease
1600,Relapsed or Refractory Multiple Myeloma|Patients With BRAFV600 E or BRAFV600K Mutation,Encorafenib,CC(C)N1C=C(C(=N1)C2=C(C(=CC(=C2)Cl)NS(=O)(=O)C)F)C3=NC(=NC=C3)NCC(C)NC(=O)OC,PHASE2,cardiovascular_disease
1601,Relapsed or Refractory Multiple Myeloma|Patients With BRAFV600 E or BRAFV600K Mutation,Binimetinib,CN1C=NC2=C1C=C(C(=C2F)NC3=C(C=C(C=C3)Br)F)C(=O)NOCCO,PHASE2,cardiovascular_disease
1602,Hypertrophic Cardiomyopathy,Triethylenetetramine,C(CNCCNCCN)N,PHASE2,cardiovascular_disease
1603,Hypertrophic Cardiomyopathy,Trientine,C(CNCCNCCN)N,PHASE2,cardiovascular_disease
1604,Myeloma,Pyridoxine,CC1=NC=C(C(=C1O)CO)CO,PHASE2,cardiovascular_disease
1605,Arterial Calcification|CD73 Deficiency,Etidronate,CC(O)(P(=O)(O)O)P(=O)(O)O,PHASE2,cardiovascular_disease
1606,Patent Ductus Arteriosus (PDA)|Acute Kidney Injury (AKI),Fenoldopam,C1CNCC(C2=CC(=C(C(=C21)Cl)O)O)C3=CC=C(C=C3)O,PHASE2|PHASE3,cardiovascular_disease
1607,Out-of-hospital Cardiac Arrest,Rocuronium,CC(=O)OC1C(CC2C1(CCC3C2CCC4C3(CC(C(C4)O)N5CCOCC5)C)C)[N+]6(CCCC6)CC=C,PHASE2,cardiovascular_disease
1608,High Altitude Pulmonary Hypertension,Aminophylline,CN1C2=C(C(=O)N(C1=O)C)NC=N2.CN1C2=C(C(=O)N(C1=O)C)NC=N2.C(CN)N,PHASE1,cardiovascular_disease
1609,"Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable|Leukemia|Lymphoma|Multiple Myeloma|MDS|Myelodysplastic/Myeloproliferative Diseases",Ganciclovir,C1=NC2=C(N1COC(CO)CO)N=C(NC2=O)N,PHASE2,cardiovascular_disease
1610,Portal Hypertension,Cobiprostone,CCC(C)CC(C1(CCC2C(O1)CC(=O)C2CCCCCCC(=O)O)O)(F)F,PHASE2,cardiovascular_disease
1611,Coronary Artery Disease,Quercetin,C1=CC(=C(C=C1C2=C(C(=O)C3=C(C=C(C=C3O2)O)O)O)O)O,PHASE2,cardiovascular_disease
1612,Cardiac Failure Aggravated,Sotagliflozin,CCOC1=CC=C(C=C1)CC2=C(C=CC(=C2)C3C(C(C(C(O3)SC)O)O)O)Cl,PHASE2,cardiovascular_disease
1613,Advanced Malignant Solid Neoplasm|Bladder Carcinoma|Breast Carcinoma|Cervical Carcinoma|Colon Carcinoma|Colorectal Carcinoma|Endometrial Carcinoma|Esophageal Carcinoma|Gastric Carcinoma|Glioma|Head and Neck Carcinoma|Kidney Carcinoma|Liver and Intrahepatic Bile Duct Carcinoma|Lung Carcinoma|Lymphoma|Malignant Uterine Neoplasm|Melanoma|Multiple Myeloma|Ovarian Carcinoma|Pancreatic Carcinoma|Prostate Carcinoma|Rectal Carcinoma|Recurrent Bladder Carcinoma|Recurrent Breast Carcinoma|Recurrent Cervical Carcinoma|Recurrent Colon Carcinoma|Recurrent Colorectal Carcinoma|Recurrent Esophageal Carcinoma|Recurrent Gastric Carcinoma|Recurrent Glioma|Recurrent Head and Neck Carcinoma|Recurrent Liver Carcinoma|Recurrent Lung Carcinoma|Recurrent Lymphoma|Recurrent Malignant Solid Neoplasm|Recurrent Melanoma|Recurrent Multiple Myeloma|Recurrent Ovarian Carcinoma|Recurrent Pancreatic Carcinoma|Recurrent Prostate Carcinoma|Recurrent Rectal Carcinoma|Recurrent Skin Carcinoma|Recurrent Thyroid Gland Carcinoma|Recurrent Uterine Corpus Cancer|Refractory Lymphoma|Refractory Malignant Solid Neoplasm|Refractory Multiple Myeloma|Skin Carcinoma|Thyroid Gland Carcinoma|Uterine Corpus Cancer,Afatinib,CN(C)CC=CC(=O)NC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC(=C(C=C3)F)Cl)OC4CCOC4,PHASE2,cardiovascular_disease
1614,Advanced Malignant Solid Neoplasm|Bladder Carcinoma|Breast Carcinoma|Cervical Carcinoma|Colon Carcinoma|Colorectal Carcinoma|Endometrial Carcinoma|Esophageal Carcinoma|Gastric Carcinoma|Glioma|Head and Neck Carcinoma|Kidney Carcinoma|Liver and Intrahepatic Bile Duct Carcinoma|Lung Carcinoma|Lymphoma|Malignant Uterine Neoplasm|Melanoma|Multiple Myeloma|Ovarian Carcinoma|Pancreatic Carcinoma|Prostate Carcinoma|Rectal Carcinoma|Recurrent Bladder Carcinoma|Recurrent Breast Carcinoma|Recurrent Cervical Carcinoma|Recurrent Colon Carcinoma|Recurrent Colorectal Carcinoma|Recurrent Esophageal Carcinoma|Recurrent Gastric Carcinoma|Recurrent Glioma|Recurrent Head and Neck Carcinoma|Recurrent Liver Carcinoma|Recurrent Lung Carcinoma|Recurrent Lymphoma|Recurrent Malignant Solid Neoplasm|Recurrent Melanoma|Recurrent Multiple Myeloma|Recurrent Ovarian Carcinoma|Recurrent Pancreatic Carcinoma|Recurrent Prostate Carcinoma|Recurrent Rectal Carcinoma|Recurrent Skin Carcinoma|Recurrent Thyroid Gland Carcinoma|Recurrent Uterine Corpus Cancer|Refractory Lymphoma|Refractory Malignant Solid Neoplasm|Refractory Multiple Myeloma|Skin Carcinoma|Thyroid Gland Carcinoma|Uterine Corpus Cancer,Capivasertib,C1CN(CCC1(C(=O)NC(CCO)C2=CC=C(C=C2)Cl)N)C3=NC=NC4=C3C=CN4,PHASE2,cardiovascular_disease
1615,Advanced Malignant Solid Neoplasm|Bladder Carcinoma|Breast Carcinoma|Cervical Carcinoma|Colon Carcinoma|Colorectal Carcinoma|Endometrial Carcinoma|Esophageal Carcinoma|Gastric Carcinoma|Glioma|Head and Neck Carcinoma|Kidney Carcinoma|Liver and Intrahepatic Bile Duct Carcinoma|Lung Carcinoma|Lymphoma|Malignant Uterine Neoplasm|Melanoma|Multiple Myeloma|Ovarian Carcinoma|Pancreatic Carcinoma|Prostate Carcinoma|Rectal Carcinoma|Recurrent Bladder Carcinoma|Recurrent Breast Carcinoma|Recurrent Cervical Carcinoma|Recurrent Colon Carcinoma|Recurrent Colorectal Carcinoma|Recurrent Esophageal Carcinoma|Recurrent Gastric Carcinoma|Recurrent Glioma|Recurrent Head and Neck Carcinoma|Recurrent Liver Carcinoma|Recurrent Lung Carcinoma|Recurrent Lymphoma|Recurrent Malignant Solid Neoplasm|Recurrent Melanoma|Recurrent Multiple Myeloma|Recurrent Ovarian Carcinoma|Recurrent Pancreatic Carcinoma|Recurrent Prostate Carcinoma|Recurrent Rectal Carcinoma|Recurrent Skin Carcinoma|Recurrent Thyroid Gland Carcinoma|Recurrent Uterine Corpus Cancer|Refractory Lymphoma|Refractory Malignant Solid Neoplasm|Refractory Multiple Myeloma|Skin Carcinoma|Thyroid Gland Carcinoma|Uterine Corpus Cancer,Ipatasertib,CC1CC(C2=C1C(=NC=N2)N3CCN(CC3)C(=O)C(CNC(C)C)C4=CC=C(C=C4)Cl)O,PHASE2,cardiovascular_disease
1616,Advanced Malignant Solid Neoplasm|Bladder Carcinoma|Breast Carcinoma|Cervical Carcinoma|Colon Carcinoma|Colorectal Carcinoma|Endometrial Carcinoma|Esophageal Carcinoma|Gastric Carcinoma|Glioma|Head and Neck Carcinoma|Kidney Carcinoma|Liver and Intrahepatic Bile Duct Carcinoma|Lung Carcinoma|Lymphoma|Malignant Uterine Neoplasm|Melanoma|Multiple Myeloma|Ovarian Carcinoma|Pancreatic Carcinoma|Prostate Carcinoma|Rectal Carcinoma|Recurrent Bladder Carcinoma|Recurrent Breast Carcinoma|Recurrent Cervical Carcinoma|Recurrent Colon Carcinoma|Recurrent Colorectal Carcinoma|Recurrent Esophageal Carcinoma|Recurrent Gastric Carcinoma|Recurrent Glioma|Recurrent Head and Neck Carcinoma|Recurrent Liver Carcinoma|Recurrent Lung Carcinoma|Recurrent Lymphoma|Recurrent Malignant Solid Neoplasm|Recurrent Melanoma|Recurrent Multiple Myeloma|Recurrent Ovarian Carcinoma|Recurrent Pancreatic Carcinoma|Recurrent Prostate Carcinoma|Recurrent Rectal Carcinoma|Recurrent Skin Carcinoma|Recurrent Thyroid Gland Carcinoma|Recurrent Uterine Corpus Cancer|Refractory Lymphoma|Refractory Malignant Solid Neoplasm|Refractory Multiple Myeloma|Skin Carcinoma|Thyroid Gland Carcinoma|Uterine Corpus Cancer,Larotrectinib,C1CC(N(C1)C2=NC3=C(C=NN3C=C2)NC(=O)N4CCC(C4)O)C5=C(C=CC(=C5)F)F,PHASE2,cardiovascular_disease
1617,Advanced Malignant Solid Neoplasm|Bladder Carcinoma|Breast Carcinoma|Cervical Carcinoma|Colon Carcinoma|Colorectal Carcinoma|Endometrial Carcinoma|Esophageal Carcinoma|Gastric Carcinoma|Glioma|Head and Neck Carcinoma|Kidney Carcinoma|Liver and Intrahepatic Bile Duct Carcinoma|Lung Carcinoma|Lymphoma|Malignant Uterine Neoplasm|Melanoma|Multiple Myeloma|Ovarian Carcinoma|Pancreatic Carcinoma|Prostate Carcinoma|Rectal Carcinoma|Recurrent Bladder Carcinoma|Recurrent Breast Carcinoma|Recurrent Cervical Carcinoma|Recurrent Colon Carcinoma|Recurrent Colorectal Carcinoma|Recurrent Esophageal Carcinoma|Recurrent Gastric Carcinoma|Recurrent Glioma|Recurrent Head and Neck Carcinoma|Recurrent Liver Carcinoma|Recurrent Lung Carcinoma|Recurrent Lymphoma|Recurrent Malignant Solid Neoplasm|Recurrent Melanoma|Recurrent Multiple Myeloma|Recurrent Ovarian Carcinoma|Recurrent Pancreatic Carcinoma|Recurrent Prostate Carcinoma|Recurrent Rectal Carcinoma|Recurrent Skin Carcinoma|Recurrent Thyroid Gland Carcinoma|Recurrent Uterine Corpus Cancer|Refractory Lymphoma|Refractory Malignant Solid Neoplasm|Refractory Multiple Myeloma|Skin Carcinoma|Thyroid Gland Carcinoma|Uterine Corpus Cancer,Osimertinib,CN1C=C(C2=CC=CC=C21)C3=NC(=NC=C3)NC4=C(C=C(C(=C4)NC(=O)C=C)N(C)CCN(C)C)OC,PHASE2,cardiovascular_disease
1618,Advanced Malignant Solid Neoplasm|Bladder Carcinoma|Breast Carcinoma|Cervical Carcinoma|Colon Carcinoma|Colorectal Carcinoma|Endometrial Carcinoma|Esophageal Carcinoma|Gastric Carcinoma|Glioma|Head and Neck Carcinoma|Kidney Carcinoma|Liver and Intrahepatic Bile Duct Carcinoma|Lung Carcinoma|Lymphoma|Malignant Uterine Neoplasm|Melanoma|Multiple Myeloma|Ovarian Carcinoma|Pancreatic Carcinoma|Prostate Carcinoma|Rectal Carcinoma|Recurrent Bladder Carcinoma|Recurrent Breast Carcinoma|Recurrent Cervical Carcinoma|Recurrent Colon Carcinoma|Recurrent Colorectal Carcinoma|Recurrent Esophageal Carcinoma|Recurrent Gastric Carcinoma|Recurrent Glioma|Recurrent Head and Neck Carcinoma|Recurrent Liver Carcinoma|Recurrent Lung Carcinoma|Recurrent Lymphoma|Recurrent Malignant Solid Neoplasm|Recurrent Melanoma|Recurrent Multiple Myeloma|Recurrent Ovarian Carcinoma|Recurrent Pancreatic Carcinoma|Recurrent Prostate Carcinoma|Recurrent Rectal Carcinoma|Recurrent Skin Carcinoma|Recurrent Thyroid Gland Carcinoma|Recurrent Uterine Corpus Cancer|Refractory Lymphoma|Refractory Malignant Solid Neoplasm|Refractory Multiple Myeloma|Skin Carcinoma|Thyroid Gland Carcinoma|Uterine Corpus Cancer,Sapanisertib,CC(C)N1C2=NC=NC(=C2C(=N1)C3=CC4=C(C=C3)OC(=N4)N)N,PHASE2,cardiovascular_disease
1619,Advanced Malignant Solid Neoplasm|Bladder Carcinoma|Breast Carcinoma|Cervical Carcinoma|Colon Carcinoma|Colorectal Carcinoma|Endometrial Carcinoma|Esophageal Carcinoma|Gastric Carcinoma|Glioma|Head and Neck Carcinoma|Kidney Carcinoma|Liver and Intrahepatic Bile Duct Carcinoma|Lung Carcinoma|Lymphoma|Malignant Uterine Neoplasm|Melanoma|Multiple Myeloma|Ovarian Carcinoma|Pancreatic Carcinoma|Prostate Carcinoma|Rectal Carcinoma|Recurrent Bladder Carcinoma|Recurrent Breast Carcinoma|Recurrent Cervical Carcinoma|Recurrent Colon Carcinoma|Recurrent Colorectal Carcinoma|Recurrent Esophageal Carcinoma|Recurrent Gastric Carcinoma|Recurrent Glioma|Recurrent Head and Neck Carcinoma|Recurrent Liver Carcinoma|Recurrent Lung Carcinoma|Recurrent Lymphoma|Recurrent Malignant Solid Neoplasm|Recurrent Melanoma|Recurrent Multiple Myeloma|Recurrent Ovarian Carcinoma|Recurrent Pancreatic Carcinoma|Recurrent Prostate Carcinoma|Recurrent Rectal Carcinoma|Recurrent Skin Carcinoma|Recurrent Thyroid Gland Carcinoma|Recurrent Uterine Corpus Cancer|Refractory Lymphoma|Refractory Malignant Solid Neoplasm|Refractory Multiple Myeloma|Skin Carcinoma|Thyroid Gland Carcinoma|Uterine Corpus Cancer,Ulixertinib,CC(C)NC1=NC=C(C(=C1)C2=CNC(=C2)C(=O)NC(CO)C3=CC(=CC=C3)Cl)Cl,PHASE2,cardiovascular_disease
1620,Pulmonary Hypertension,Hymecromone,CC1=CC(=O)OC2=C1C=CC(=C2)O,PHASE2,cardiovascular_disease
1621,"Central Retinal Vein Occlusion, Non-Ischemic",Hydroxyurea,C(=O)(N)NO,PHASE2,cardiovascular_disease
1622,Obesity|Metabolic Syndrome X,Orlistat,CCCCCCCCCCCC(CC1C(C(=O)O1)CCCCCC)OC(=O)C(CC(C)C)NC=O,PHASE2,cardiovascular_disease
1623,Hemorrhoid Pain|Hemorrhoids,Metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-],PHASE2|PHASE3,cardiovascular_disease
1624,Systemic Lupus Erythematosus,Dehydroepiandrosterone,CC12CCC3C(C1CCC2=O)CC=C4C3(CCC(C4)O)C,PHASE2|PHASE3,cardiovascular_disease
1625,Systemic Lupus Erythematosus,Prasterone,CC12CCC3C(C1CCC2=O)CC=C4C3(CCC(C4)O)C,PHASE2|PHASE3,cardiovascular_disease
1626,Healthy Subjects|Atherosclerosis,Rilapladib,COCCN1CCC(CC1)N(CC2=CC=C(C=C2)C3=CC=C(C=C3)C(F)(F)F)C(=O)CN4C5=CC=CC=C5C(=O)C=C4SCC6=C(C(=CC=C6)F)F,PHASE1,cardiovascular_disease
1627,"Von-Hippel Lindau|Kidney Disease, Chronic",Perflutren,C(C(F)(F)F)(C(F)(F)F)(F)F,PHASE2,cardiovascular_disease
1628,Chronic Hepatitis B|Chronic Hepatitis D|Glomerulonephritis|Polyarteritis Nodosa,Lamivudine,C1C(OC(S1)CO)N2C=CC(=NC2=O)N,PHASE2,cardiovascular_disease
1629,Lung Adenocarcinoma|Lung Adenosquamous Carcinoma|Malignant Pericardial Effusion|Malignant Pleural Effusion|Minimally Invasive Lung Adenocarcinoma|Stage IIIB Lung Non-Small Cell Cancer AJCC v7|Stage IV Lung Non-Small Cell Cancer AJCC v7,Carboplatin,C1CC(C1)(C(=O)O)C(=O)O.[NH2-].[NH2-].[Pt+2],PHASE2,cardiovascular_disease
1630,Diabetic Foot Infections,Nemonoxacin,CC1CC(CN(C1)C2=C(C3=C(C=C2)C(=O)C(=CN3C4CC4)C(=O)O)OC)N,PHASE2,cardiovascular_disease
1631,Coronary Artery Disease,Nicorandil,C1=CC(=CN=C1)C(=O)NCCO[N+](=O)[O-],PHASE2,cardiovascular_disease
1632,"Kidney Failure, Chronic|Cardiovascular Diseases",Sevelamer,C=CCN.C1C(O1)CCl,PHASE2,cardiovascular_disease
1633,Diabetic Retinopathy,Pimagedine,C(=NN)(N)N,PHASE1,cardiovascular_disease
1634,Human Immunodeficiency Virus 1,Darunavir,CC(C)CN(CC(C(CC1=CC=CC=C1)NC(=O)OC2COC3C2CCO3)O)S(=O)(=O)C4=CC=C(C=C4)N,PHASE2,cardiovascular_disease
1635,Drug-induced QT Prolongation|Pharmacokinetics|Pharmacodynamics,Lopinavir,CC1=C(C(=CC=C1)C)OCC(=O)NC(CC2=CC=CC=C2)C(CC(CC3=CC=CC=C3)NC(=O)C(C(C)C)N4CCCNC4=O)O,PHASE1,cardiovascular_disease
1636,Major Depression|Cancer|Diabetes|Cardiovascular Diseases,Desvenlafaxine,CN(C)CC(C1=CC=C(C=C1)O)C2(CCCCC2)O,PHASE2|PHASE3,cardiovascular_disease
1637,Ischemia-reperfusion Injury in Liver Transplant|Early Allograft Dysfunction,Reparixin,CC(C)CC1=CC=C(C=C1)C(C)C(=O)NS(=O)(=O)C,PHASE2,cardiovascular_disease
1638,Hypotension,Metaraminol,CC(C(C1=CC(=CC=C1)O)O)N,PHASE2,cardiovascular_disease
1639,"Hypertension, Pulmonary",Terbogrel,CC(C)(C)N=C(NC#N)NC1=CC=CC(=C1)C(=CCCCC(=O)O)C2=CN=CC=C2,PHASE2,cardiovascular_disease
1640,Glaucoma|Ocular Hypertension,Benzalkonium,CCCCCCCCCCCCC[N+](C)(C)CC1=CC=CC=C1,PHASE2,cardiovascular_disease
1641,High Blood Pressure,Calcitriol,CC(CCCC(C)(C)O)C1CCC2C1(CCCC2=CC=C3CC(CC(C3=C)O)O)C,PHASE2,cardiovascular_disease
1642,Congenital Heart Disease,Tryptophan,C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)N,PHASE2,cardiovascular_disease
1643,Iris Neovascularization|Diabetic Retinopathy,Pegaptanib,COCCOC(=O)NCCCCC(C(=O)NCCCCCCCOP(=O)(C)O)NC(=O)OCCOC,PHASE1,cardiovascular_disease
1644,"Myeloma, Plasma-Cell|Lymphoma, Malignant",Palonosetron,C1CC2CN(C(=O)C3=CC=CC(=C23)C1)C4CN5CCC4CC5,PHASE2,cardiovascular_disease
1645,"Ischemic Stroke, Acute",Sarecycline,CN(C)C1C2CC3CC4=C(C=CC(=C4C(=C3C(=O)C2(C(=C(C1=O)C(=O)N)O)O)O)O)CN(C)OC,PHASE2,cardiovascular_disease
1646,Symptomatic Neurogenic Orthostatic Hypertension|nOH,Ampreloxetine,C1CNCCC1C2=CC=CC=C2COC3=C(C=C(C=C3F)F)F,PHASE1,cardiovascular_disease
1647,Multiple Myeloma,Anlotinib,CC1=CC2=C(N1)C=CC(=C2F)OC3=C4C=C(C(=CC4=NC=C3)OCC5(CC5)N)OC,PHASE1,cardiovascular_disease
1648,Multiple Myeloma,Osalmid,C1=CC=C(C(=C1)C(=O)NC2=CC=C(C=C2)O)O,PHASE1|PHASE2,cardiovascular_disease
1649,Angioedema,Icatibant,C1CCC2C(C1)CC(N2C(=O)C3CC4=CC=CC=C4CN3C(=O)C(CO)NC(=O)C(CC5=CC=CS5)NC(=O)CNC(=O)C6CC(CN6C(=O)C7CCCN7C(=O)C(CCCN=C(N)N)NC(=O)C(CCCN=C(N)N)N)O)C(=O)NC(CCCN=C(N)N)C(=O)O,PHASE2,cardiovascular_disease
1650,Angioedema,Cortisone,CC12CCC(=O)C=C1CCC3C2C(=O)CC4(C3CCC4(C(=O)CO)O)C,PHASE2,cardiovascular_disease
1651,"Solid Tumors|Lymphoma, Non-Hodgkin|Multiple Myeloma",Ondansetron,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C,PHASE1,cardiovascular_disease
1652,"Ischemic Stroke, Acute",Propylthiouracil,CCCC1=CC(=O)NC(=S)N1,PHASE2,cardiovascular_disease
1653,"Ischemic Stroke, Acute",Perphenazine,C1CN(CCN1CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl)CCO,PHASE2,cardiovascular_disease
1654,Cardiopulmonary Arrest|Fungal Infection,Fluconazole,C1=CC(=C(C=C1F)F)C(CN2C=NC=N2)(CN3C=NC=N3)O,PHASE1,cardiovascular_disease
1655,Ectopic Pregnancy,Letrozole,C1=CC(=CC=C1C#N)C(C2=CC=C(C=C2)C#N)N3C=NC=N3,PHASE1|PHASE2,cardiovascular_disease
1656,Recurrent Multiple Myeloma|Refractory Multiple Myeloma,Telaglenastat,C1=CC=NC(=C1)CC(=O)NC2=NN=C(S2)CCCCC3=NN=C(C=C3)NC(=O)CC4=CC(=CC=C4)OC(F)(F)F,PHASE1,cardiovascular_disease
1657,Adult B Acute Lymphoblastic Leukemia|Adult Nasal Type Extranodal NK/T-Cell Lymphoma|Adult Solid Neoplasm|Anaplastic Large Cell Lymphoma|Angioimmunoblastic T-Cell Lymphoma|Chronic Lymphocytic Leukemia|Cutaneous B-Cell Non-Hodgkin Lymphoma|Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue|Hepatosplenic T-Cell Lymphoma|Intraocular Lymphoma|Lymphomatous Involvement of Non-Cutaneous Extranodal Site|Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma|Nodal Marginal Zone Lymphoma|Recurrent Adult Acute Lymphoblastic Leukemia|Recurrent Adult Burkitt Lymphoma|Recurrent Adult Diffuse Large Cell Lymphoma|Recurrent Adult Diffuse Mixed Cell Lymphoma|Recurrent Adult Diffuse Small Cleaved Cell Lymphoma|Recurrent Adult Grade III Lymphomatoid Granulomatosis|Recurrent Adult Hodgkin Lymphoma|Recurrent Adult Immunoblastic Lymphoma|Recurrent Adult Lymphoblastic Lymphoma|Recurrent Adult T-Cell Leukemia/Lymphoma|Recurrent Cutaneous T-Cell Non-Hodgkin Lymphoma|Recurrent Grade 1 Follicular Lymphoma|Recurrent Grade 2 Follicular Lymphoma|Recurrent Grade 3 Follicular Lymphoma|Recurrent Mantle Cell Lymphoma|Recurrent Marginal Zone Lymphoma|Recurrent Mycosis Fungoides and Sezary Syndrome|Recurrent Small Lymphocytic Lymphoma|Refractory Chronic Lymphocytic Leukemia|Refractory Hairy Cell Leukemia|Refractory Plasma Cell Myeloma|Small Intestinal Lymphoma|Splenic Marginal Zone Lymphoma|Testicular Lymphoma|Waldenstrom Macroglobulinemia,Veliparib,CC1(CCCN1)C2=NC3=C(C=CC=C3N2)C(=O)N,PHASE1|PHASE2,cardiovascular_disease
1658,Multiple Myeloma|Non-Hodgkin's Lymphoma,Meloxicam,CC1=CN=C(S1)NC(=O)C2=C(C3=CC=CC=C3S(=O)(=O)N2C)O,PHASE2,cardiovascular_disease
1659,Hypertension,Norfloxacin,CCN1C=C(C(=O)C2=CC(=C(C=C21)N3CCNCC3)F)C(=O)O,PHASE1,cardiovascular_disease
1660,Hypertension,Indapamide,CC1CC2=CC=CC=C2N1NC(=O)C3=CC(=C(C=C3)Cl)S(=O)(=O)N,PHASE2,cardiovascular_disease
1661,Thromboembolism of Vein VTE in Colorectal Cancer|Thromboembolism of Vein in Pancreatic Cancer|Thromboembolism of Vein in Non-small Cell Lung Cancer,Isoquercetin,C1=CC(=C(C=C1C2=C(C(=O)C3=C(C=C(C=C3O2)O)O)OC4C(C(C(C(O4)CO)O)O)O)O)O,PHASE2|PHASE3,cardiovascular_disease
1662,ST Elevation Myocardial Infarction,Roxadustat,CC1=C2C=C(C=CC2=C(C(=N1)C(=O)NCC(=O)O)O)OC3=CC=CC=C3,PHASE2,cardiovascular_disease
1663,Immune Thrombocytopenia|Blood Coagulation Disorders|Thrombocytopenia|Physiological Effects of Drugs,Danazol,CC12CCC3C(C1CCC2(C#C)O)CCC4=CC5=C(CC34C)C=NO5,PHASE2,cardiovascular_disease
1664,Heart Rate|Blood Pressure|Arrhythmias,Dimethindene,CC(C1=CC=CC=N1)C2=C(CC3=CC=CC=C32)CCN(C)C,PHASE1|PHASE2,cardiovascular_disease
1665,Heart Rate|Blood Pressure|Arrhythmias,Dimetindene,CC(C1=CC=CC=N1)C2=C(CC3=CC=CC=C32)CCN(C)C,PHASE1|PHASE2,cardiovascular_disease
1666,Anemia|B-Cell Prolymphocytic Leukemia|Grade 1 Follicular Lymphoma|Grade 2 Follicular Lymphoma|Grade 3a Follicular Lymphoma|Hairy Cell Leukemia|Lymphoplasmacytic Lymphoma|Mantle Cell Lymphoma|Marginal Zone Lymphoma|Recurrent Chronic Lymphocytic Leukemia|Recurrent Small Lymphocytic Lymphoma|Refractory Chronic Lymphocytic Leukemia|Refractory Small Lymphocytic Lymphoma|Richter Syndrome,Entospletinib,C1COCCN1C2=CC=C(C=C2)NC3=NC(=CN4C3=NC=C4)C5=CC6=C(C=C5)C=NN6,PHASE1|PHASE2,cardiovascular_disease
1667,Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue|Nodal Marginal Zone Lymphoma|Recurrent Adult Diffuse Large Cell Lymphoma|Recurrent Adult Diffuse Mixed Cell Lymphoma|Recurrent Adult Diffuse Small Cleaved Cell Lymphoma|Recurrent Grade 1 Follicular Lymphoma|Recurrent Grade 2 Follicular Lymphoma|Recurrent Grade 3 Follicular Lymphoma|Recurrent Mantle Cell Lymphoma|Recurrent Marginal Zone Lymphoma|Refractory Plasma Cell Myeloma|Splenic Marginal Zone Lymphoma|Waldenstrom Macroglobulinemia,Alvocidib,CN1CCC(C(C1)O)C2=C(C=C(C3=C2OC(=CC3=O)C4=CC=CC=C4Cl)O)O,PHASE1,cardiovascular_disease
1668,Diabetes Type 2|Coronary Artery Disease,Canagliflozin,CC1=C(C=C(C=C1)C2C(C(C(C(O2)CO)O)O)O)CC3=CC=C(S3)C4=CC=C(C=C4)F,PHASE2|PHASE3,cardiovascular_disease
1669,Calcific Aortic Valve Disease,Evogliptin,CC(C)(C)OCC1C(=O)NCCN1C(=O)CC(CC2=CC(=C(C=C2F)F)F)N,PHASE2|PHASE3,cardiovascular_disease
1670,Amyloidosis,Inotersen,CC1=CN(C(=O)NC1=O)C2CC(C(O2)COP(=S)(O)OC3CC(OC3COP(=S)(O)OC4CC(OC4COP(=S)(O)OC5C(OC(C5OCCOC)N6C=NC7=C6N=C(NC7=O)N)COP(=S)(O)OC8C(OC(C8OCCOC)N9C=C(C(=O)NC9=O)C)COP(=S)(O)OC1C(OC(C1OCCOC)N1C=C(C(=O)NC1=O)C)COP(=O)(OC1C(OC(C1OCCOC)N1C=C(C(=NC1=O)N)C)COP(=S)(O)OC1C(OC(C1OCCOC)N1C=C(C(=O)NC1=O)C)CO)S)N1C=NC2=C1N=C(NC2=O)N)N1C=C(C(=O)NC1=O)C)OP(=S)(O)OCC1C(CC(O1)N1C=NC2=C(N=CN=C21)N)OP(=S)(O)OCC1C(CC(O1)N1C=C(C(=NC1=O)N)C)OP(=S)(O)OCC1C(CC(O1)N1C=NC2=C(N=CN=C21)N)OP(=S)(O)OCC1C(CC(O1)N1C=C(C(=O)NC1=O)C)OP(=S)(O)OCC1C(CC(O1)N1C=NC2=C1N=C(NC2=O)N)OP(=S)(O)OCC1C(CC(O1)N1C=NC2=C(N=CN=C21)N)OP(=S)(O)OCC1C(CC(O1)N1C=NC2=C(N=CN=C21)N)OP(=S)(O)OCC1C(C(C(O1)N1C=NC2=C(N=CN=C21)N)OCCOC)OP(=S)(O)OCC1C(C(C(O1)N1C=C(C(=O)NC1=O)C)OCCOC)OP(=S)(O)OCC1C(C(C(O1)N1C=C(C(=NC1=O)N)C)OCCOC)OP(=S)(O)OCC1C(C(C(O1)N1C=C(C(=NC1=O)N)C)OCCOC)OP(=S)(O)OCC1C(C(C(O1)N1C=C(C(=NC1=O)N)C)OCCOC)O,PHASE2,cardiovascular_disease
1671,Acute Decompensated Heart Failure,Metolazone,CC1NC2=CC(=C(C=C2C(=O)N1C3=CC=CC=C3C)S(=O)(=O)N)Cl,PHASE2,cardiovascular_disease
1672,Multiple Myeloma|Hodgkin Lymphoma|Non-Hodgkin Lymphoma|HDT-AHCT,Romiplostim,CC1=CC(=C(N1)C=C2C3=CC=CC=C3NC2=O)C,PHASE2,cardiovascular_disease
1673,Diabetic Foot Ulcers,Gentamicin,CC(C1CCC(C(O1)OC2C(CC(C(C2O)OC3C(C(C(CO3)(C)O)NC)O)N)N)N)NC,PHASE1|PHASE2,cardiovascular_disease
1674,Diabetic Foot Ulcers,Ciprofloxacin,C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O,PHASE1|PHASE2,cardiovascular_disease
1675,Stroke|Cerebrovascular Accident|Hemiparesis,Armodafinil,C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N,PHASE2,cardiovascular_disease
1676,"Lymphoma, Non-Hodgkin|Multiple Myeloma|Advanced Solid Tumors",Regorafenib,CNC(=O)C1=NC=CC(=C1)OC2=CC(=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F)F,PHASE2,cardiovascular_disease
1677,"Lymphoma, Non-Hodgkin|Multiple Myeloma|Advanced Solid Tumors",Talazoparib,CN1C(=NC=N1)C2C(NC3=CC(=CC4=C3C2=NNC4=O)F)C5=CC=C(C=C5)F,PHASE2,cardiovascular_disease
1678,"Lymphoma, Non-Hodgkin|Multiple Myeloma|Advanced Solid Tumors",Entrectinib,CN1CCN(CC1)C2=CC(=C(C=C2)C(=O)NC3=NNC4=C3C=C(C=C4)CC5=CC(=CC(=C5)F)F)NC6CCOCC6,PHASE2,cardiovascular_disease
1679,"Lymphoma, Non-Hodgkin|Multiple Myeloma|Advanced Solid Tumors",Futibatinib,COC1=CC(=CC(=C1)C#CC2=NN(C3=NC=NC(=C23)N)C4CCN(C4)C(=O)C=C)OC,PHASE2,cardiovascular_disease
1680,Coronary Artery Disease|Percutaneous Coronary Intervention|Platelet Aggregation Inhibitors,Vicagrel,CC(=O)OC1=CC2=C(S1)CCN(C2)C(C3=CC=CC=C3Cl)C(=O)OC,PHASE2,cardiovascular_disease
1681,Staphylococcus Aureus Bacteremia|Staphylococcus Aureus Septicemia|Staphylococcal Sepsis|Staphylococcus Aureus Endocarditis,Ertapenem,CC1C2C(C(=O)N2C(=C1SC3CC(NC3)C(=O)NC4=CC=CC(=C4)C(=O)O)C(=O)O)C(C)O,PHASE2,cardiovascular_disease
1682,Renal Transplantation,Fluvastatin,CC(C)N1C2=CC=CC=C2C(=C1C=CC(CC(CC(=O)O)O)O)C3=CC=C(C=C3)F,PHASE2|PHASE3,cardiovascular_disease
1683,Congestive Heart Failure,Icodextrin,C1=CC(=C(C(=C1)Cl)C=NN=C(N)N)Cl,PHASE2,cardiovascular_disease
1684,Multiple Myeloma,Ciforadenant,CC1=CC=C(O1)C2=C3C(=NC(=N2)N)N(N=N3)CC4=NC(=CC=C4)COC5CCOC5,PHASE1,cardiovascular_disease
1685,Acute Pancreatitis|Intra-abdominal Hypertension,Neostigmine,CN(C)C(=O)OC1=CC=CC(=C1)[N+](C)(C)C,PHASE2,cardiovascular_disease
1686,Methamphetamine Use Disorder|Drug Interaction|Cardiovascular Abnormalities,Mirtazapine,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4,PHASE1,cardiovascular_disease
1687,Methamphetamine Use Disorder|Drug Interaction|Cardiovascular Abnormalities,Metamfetamine,CC(CC1=CC=CC=C1)NC,PHASE1,cardiovascular_disease
1688,Methamphetamine Use Disorder|Drug Interaction|Cardiovascular Abnormalities,Methamphetamine,CC(CC1=CC=CC=C1)NC,PHASE1,cardiovascular_disease
1689,Multiple Myeloma,Roneparstat,CC(=O)NC1C(C(C(OC1OC2C(C(C(OC2C(=O)O)OC3C(OC(C(C3O)NC(=O)C)OC(CO)C(C(=O)O)OC(CO)O)CO)OS(=O)(=O)O)O)CO)O)O,PHASE1,cardiovascular_disease
1690,Pulmonary Arterial Hypertension,Selonsertib,CC1=CC(=C(C=C1N2C=C(N=C2)C3CC3)C(=O)NC4=CC=CC(=N4)C5=NN=CN5C(C)C)F,PHASE2,cardiovascular_disease
1691,Atrial Fibrillation,Tecadenoson,C1COCC1NC2=C3C(=NC=N2)N(C=N3)C4C(C(C(O4)CO)O)O,PHASE2,cardiovascular_disease
1692,Recurrent Plasma Cell Myeloma,Dinaciclib,CCC1=C2N=C(C=C(N2N=C1)NCC3=C[N+](=CC=C3)[O-])N4CCCCC4CCO,PHASE1,cardiovascular_disease
1693,Peripheral Artery Disease,Probucol,CC(C)(C)C1=CC(=CC(=C1O)C(C)(C)C)SC(C)(C)SC2=CC(=C(C(=C2)C(C)(C)C)O)C(C)(C)C,PHASE2,cardiovascular_disease
1694,Recurrent Plasma Cell Myeloma|Refractory Plasma Cell Myeloma,Uprosertib,CN1C(=C(C=N1)Cl)C2=C(OC(=C2)C(=O)NC(CC3=CC(=C(C=C3)F)F)CN)Cl,PHASE2,cardiovascular_disease
1695,Multiple Myeloma,Ricolinostat,C1=CC=C(C=C1)N(C2=CC=CC=C2)C3=NC=C(C=N3)C(=O)NCCCCCCC(=O)NO,PHASE1|PHASE2,cardiovascular_disease
1696,Granisetron,Granisetron,CN1C2CCCC1CC(C2)NC(=O)C3=NN(C4=CC=CC=C43)C,PHASE2|PHASE3,cardiovascular_disease
1697,Heart Failure With Preserved Ejection Fraction (HFpEF),Verinurad,CC(C)(C(=O)O)SC1=C(C=NC=C1)C2=CC=C(C3=CC=CC=C32)C#N,PHASE2,cardiovascular_disease
1698,Adult Non-Hodgkin Lymphoma|Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue|Nodal Marginal Zone Lymphoma|Recurrent Adult Diffuse Large Cell Lymphoma|Recurrent Grade 1 Follicular Lymphoma|Recurrent Grade 2 Follicular Lymphoma|Recurrent Grade 3 Follicular Lymphoma|Recurrent Mantle Cell Lymphoma|Recurrent Marginal Zone Lymphoma|Recurrent Small Lymphocytic Lymphoma|Splenic Marginal Zone Lymphoma|Waldenstrom Macroglobulinemia,Agatolimod,CC1=CN(C(=O)NC1=O)C2CC(C(O2)COP(=S)(O)OC3CC(OC3COP(=S)(O)OC4CC(OC4COP(=S)(O)OC5CC(OC5COP(=S)(O)OC6CC(OC6COP(=S)(O)OC7CC(OC7COP(=S)(O)OC8CC(OC8COP(=S)(O)OC9CC(OC9COP(=S)(O)OC1CC(OC1COP(=S)(O)OC1CC(OC1COP(=S)(O)OC1CC(OC1COP(=S)(O)OC1CC(OC1COP(=S)(O)OC1CC(OC1COP(=S)(O)OC1CC(OC1COP(=S)(O)OC1CC(OC1COP(=S)(O)OC1CC(OC1COP(=S)(O)OC1CC(OC1COP(=S)(O)OC1CC(OC1COP(=S)(O)OC1CC(OC1COP(=S)(O)OC1CC(OC1COP(=S)(O)OC1CC(OC1COP(=S)(O)OC1CC(OC1COP(=S)(O)OC1CC(OC1COP(=S)(O)OC1CC(OC1CO)N1C=C(C(=O)NC1=O)C)N1C=CC(=NC1=O)N)N1C=NC2=C1N=C(NC2=O)N)N1C=C(C(=O)NC1=O)C)N1C=CC(=NC1=O)N)N1C=NC(=C1C)C(=O)NC(=C)N)N1C=C(C(=NC1=O)N)C)N1C=C(C(=NC1=O)N)C)N1C=C(C(=O)NC1=O)C)N1C=C(C(=O)NC1=O)C)N1C=NC2=C1N=C(NC2=O)N)N1C=C(C(=O)NC1=O)C)N1C=CC(=NC1=O)N)N1C=NC2=C1N=C(NC2=O)N)N1C=C(C(=NC1=O)N)C)N1C=C(C(=NC1=O)N)C)N1C=C(C(=NC1=O)N)C)N1C=C(C(=NC1=O)N)C)N1C=NC2=C1N=C(NC2=O)N)N1C=C(C(=O)NC1=O)C)N1C=CC(=NC1=O)N)N1C=NC2=C1N=C(NC2=O)N)N1C=C(C(=O)NC1=O)C)O,PHASE1|PHASE2,cardiovascular_disease
1699,Cushing's Syndrome,Mifepristone,CC#CC1(CCC2C1(CC(C3=C4CCC(=O)C=C4CCC23)C5=CC=C(C=C5)N(C)C)C)O,PHASE2,cardiovascular_disease
1700,Multiple Myeloma,Fluphenazine,C1CN(CCN1CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)C(F)(F)F)CCO,PHASE1,cardiovascular_disease
1701,Heart Failure With Preserved Ejection Fraction,Teprenone,CC(=CCCC(=CCCC(=CCCC(=CCCC(=O)C)C)C)C)C,PHASE2,cardiovascular_disease
1702,Essential Hypertension,Bexagliflozin,C1CC1OCCOC2=CC=C(C=C2)CC3=C(C=CC(=C3)C4C(C(C(C(O4)CO)O)O)O)Cl,PHASE2|PHASE3,cardiovascular_disease
1703,Pulmonary Arterial Hypertension,Anastrozole,CC(C)(C#N)C1=CC(=CC(=C1)CN2C=NC=N2)C(C)(C)C#N,PHASE2,cardiovascular_disease
1704,Diastolic Heart Failure,Alagebrium,CC1=C(SC=[N+]1CC(=O)C2=CC=CC=C2)C,PHASE2,cardiovascular_disease
1705,Acute Myocardial Infarction|Acute Myocardial Ischemia|STEMI - ST Elevation Myocardial Infarction,Dutogliptin,B(C1CCCN1C(=O)CNC2CCNC2)(O)O,PHASE2,cardiovascular_disease
1706,"Abnormalities, Cardiovascular",Volanesorsen,CC1=CN(C(=O)NC1=O)C2CC(C(O2)COP(=S)(O)OC3CC(OC3COP(=S)(O)OC4CC(OC4COP(=S)(O)OC5C(OC(C5OCCOC)N6C=C(C(=O)NC6=O)C)COP(=S)(O)OC7C(OC(C7OCCOC)N8C=C(C(=O)NC8=O)C)COP(=S)(O)OC9C(OC(C9OCCOC)N1C=C(C(=NC1=O)N)C)COP(=S)(O)OC1C(OC(C1OCCOC)N1C=NC2=C1N=C(NC2=O)N)COP(=S)(O)OC1C(OC(C1OCCOC)N1C=NC2=C(N=CN=C21)N)CO)N1C=C(C(=NC1=O)N)C)N1C=C(C(=O)NC1=O)C)OP(=S)(O)OCC1C(CC(O1)N1C=NC2=C1N=C(NC2=O)N)OP(=S)(O)OCC1C(CC(O1)N1C=C(C(=O)NC1=O)C)OP(=S)(O)OCC1C(CC(O1)N1C=C(C(=NC1=O)N)C)OP(=S)(O)OCC1C(CC(O1)N1C=C(C(=NC1=O)N)C)OP(=S)(O)OCC1C(CC(O1)N1C=NC2=C(N=CN=C21)N)OP(=S)(O)OCC1C(CC(O1)N1C=NC2=C1N=C(NC2=O)N)OP(=S)(O)OCC1C(CC(O1)N1C=C(C(=NC1=O)N)C)OP(=S)(O)OCC1C(C(C(O1)N1C=C(C(=O)NC1=O)C)OCCOC)OP(=S)(O)OCC1C(C(C(O1)N1C=C(C(=O)NC1=O)C)OCCOC)OP(=S)(O)OCC1C(C(C(O1)N1C=C(C(=O)NC1=O)C)OCCOC)OP(=S)(O)OCC1C(C(C(O1)N1C=NC2=C(N=CN=C21)N)OCCOC)OP(=S)(O)OCC1C(C(C(O1)N1C=C(C(=O)NC1=O)C)OCCOC)O,PHASE1,cardiovascular_disease
1707,Pulmonary Arterial Hypertension,Fulvestrant,CC12CCC3C(C1CCC2O)C(CC4=C3C=CC(=C4)O)CCCCCCCCCS(=O)CCCC(C(F)(F)F)(F)F,PHASE2,cardiovascular_disease
1708,Refractory Multiple Myeloma,Noscapine,CN1CCC2=CC3=C(C(=C2C1C4C5=C(C(=C(C=C5)OC)OC)C(=O)O4)OC)OCO3,PHASE1,cardiovascular_disease
1709,Multiple Myeloma,Disulfiram,CCN(CC)C(=S)SSC(=S)N(CC)CC,PHASE1,cardiovascular_disease
1710,Macular Edema|Retinal Vein Occlusion,Fluocinolone,CC12CC(C3(C(C1CC(C2(C(=O)CO)O)O)CC(C4=CC(=O)C=CC43C)F)F)O,PHASE2,cardiovascular_disease
1711,Pulmonary Arterial Hypertension|Pulmonary Hypertension|Interstitial Lung Disease|Idiopathic Interstitial Pneumonia|Idiopathic Pulmonary Fibrosis|Sarcoidosis|Respiratory Bronchiolitis Associated Interstitial Lung Disease|Desquamative Interstitial Pneumonia|Cryptogenic Organizing Pneumonia|Acute Interstitial Pneumonitis|Idiopathic Lymphoid Interstitial Pneumonia|Idiopathic Pleuroparenchymal Fibroelastosis,Bardoxolone,CC1(CCC2(CCC3(C(C2C1)C(=O)C=C4C3(CCC5C4(C=C(C(=O)C5(C)C)C#N)C)C)C)C(=O)O)C,PHASE2,cardiovascular_disease
1712,"Heart Failure, Congestive",Ularitide,CCC(C)C1C(=O)NCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)NCC(=O)NC(C(=O)NCC(=O)NC(CSSCC(C(=O)NC(C(=O)NCC(=O)NCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCNC(=N)N)CC(=O)O)CCSC)CCCNC(=N)N)CC2=CC=CC=C2)NC(=O)C(CO)NC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC(=O)C(CCCNC(=N)N)NC(=O)C(CC(C)C)NC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC(=O)C3CCCN3C(=O)C(C)NC(=O)C(C(C)O)N)C(=O)NC(CC(=O)N)C(=O)NC(CO)C(=O)NC(CC4=CC=CC=C4)C(=O)NC(CCCNC(=N)N)C(=O)NC(CC5=CC=C(C=C5)O)C(=O)O)CC(C)C)CO)CCC(=O)N)C,PHASE1,cardiovascular_disease
1713,Renal Cancer|Von Hippel Lindau,Vandetanib,CN1CCC(CC1)COC2=C(C=C3C(=C2)N=CN=C3NC4=C(C=C(C=C4)Br)F)OC,PHASE2,cardiovascular_disease
1714,Heart Failure,Ruboxistaurin,CN(C)CC1CCN2C=C(C3=CC=CC=C32)C4=C(C5=CN(CCO1)C6=CC=CC=C65)C(=O)NC4=O,PHASE1|PHASE2,cardiovascular_disease
1715,Tachycardia|Chronic Orthostatic Intolerance,Mecamylamine,CC1(C2CCC(C2)C1(C)NC)C,PHASE1|PHASE2,cardiovascular_disease
1716,TTR Cardiomyopathy,Tafamidis,C1=CC2=C(C=C1C(=O)O)OC(=N2)C3=CC(=CC(=C3)Cl)Cl,PHASE1,cardiovascular_disease
1717,Multiple Myeloma,Etodolac,CCC1=C2C(=CC=C1)C3=C(N2)C(OCC3)(CC)CC(=O)O,PHASE2,cardiovascular_disease
1718,Acute Coronary Syndrome|Myocardial Infarction|ST Elevation Myocardial Infarction|Heart Diseases|Anxiety,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,PHASE1|PHASE2,cardiovascular_disease
1719,Cerebrovascular Disorders|Memory|Functional Recovery|Drug Intervention,Roflumilast,C1CC1COC2=C(C=CC(=C2)C(=O)NC3=C(C=NC=C3Cl)Cl)OC(F)F,PHASE2,cardiovascular_disease
1720,Hypertension|Peripheral Artery Disease,Sarpogrelate,CN(C)CC(COC1=CC=CC=C1CCC2=CC(=CC=C2)OC)OC(=O)CCC(=O)O,PHASE1,cardiovascular_disease
1721,Symptomatic Atrial Fibrillation|Atrial Flutter,Vanoxerine,C1CN(CCN1CCCC2=CC=CC=C2)CCOC(C3=CC=C(C=C3)F)C4=CC=C(C=C4)F,PHASE2,cardiovascular_disease
1722,Chagas Disease,Nifurtimox,CC1CS(=O)(=O)CCN1N=CC2=CC=C(O2)[N+](=O)[O-],PHASE2|PHASE3,cardiovascular_disease
1723,Chagas Disease,Benznidazole,C1=CC=C(C=C1)CNC(=O)CN2C=CN=C2[N+](=O)[O-],PHASE2|PHASE3,cardiovascular_disease
1724,Vascular Dementia,Ergoloid,CCC(C)C1C(=O)N2CCCC2C3(N1C(=O)C(O3)(C(C)C)NC(=O)C4CC5C(CC6=CNC7=CC=CC5=C67)N(C4)C)O.CC(C)CC1C(=O)N2CCCC2C3(N1C(=O)C(O3)(C(C)C)NC(=O)C4CC5C(CC6=CNC7=CC=CC5=C67)N(C4)C)O.CC(C)C1C(=O)N2CCCC2C3(N1C(=O)C(O3)(C(C)C)NC(=O)C4CC5C(CC6=CNC7=CC=CC5=C67)N(C4)C)O.CC(C)C1(C(=O)N2C(C(=O)N3CCCC3C2(O1)O)CC4=CC=CC=C4)NC(=O)C5CC6C(CC7=CNC8=CC=CC6=C78)N(C5)C,PHASE2,cardiovascular_disease
1725,Cardiac Arrest,Landiolol,CC1(OCC(O1)COC(=O)CCC2=CC=C(C=C2)OCC(CNCCNC(=O)N3CCOCC3)O)C,PHASE1|PHASE2,cardiovascular_disease
1726,"Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Anatomic Stage IV Breast Cancer AJCC v8|Anemia|Ann Arbor Stage III Hodgkin Lymphoma|Ann Arbor Stage III Non-Hodgkin Lymphoma|Ann Arbor Stage IV Hodgkin Lymphoma|Ann Arbor Stage IV Non-Hodgkin Lymphoma|Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative|Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Castration-Resistant Prostate Carcinoma|Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Hematopoietic and Lymphoid System Neoplasm|Locally Advanced Pancreatic Adenocarcinoma|Metastatic Breast Carcinoma|Metastatic Malignant Solid Neoplasm|Metastatic Pancreatic Adenocarcinoma|Myelodysplastic/Myeloproliferative Neoplasm With Ring Sideroblasts and Thrombocytosis|Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable|Primary Myelofibrosis|Recurrent Acute Lymphoblastic Leukemia|Recurrent Acute Myeloid Leukemia|Recurrent Chronic Lymphocytic Leukemia|Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Recurrent Hematologic Malignancy|Recurrent Hodgkin Lymphoma|Recurrent Myelodysplastic Syndrome|Recurrent Myelodysplastic/Myeloproliferative Neoplasm|Recurrent Myeloproliferative Neoplasm|Recurrent Non-Hodgkin Lymphoma|Recurrent Plasma Cell Myeloma|Recurrent Small Lymphocytic Lymphoma|Refractory Acute Lymphoblastic Leukemia|Refractory Acute Myeloid Leukemia|Refractory Chronic Lymphocytic Leukemia|Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Refractory Chronic Myelomonocytic Leukemia|Refractory Hematologic Malignancy|Refractory Hodgkin Lymphoma|Refractory Malignant Solid Neoplasm|Refractory Myelodysplastic Syndrome|Refractory Myelodysplastic/Myeloproliferative Neoplasm|Refractory Non-Hodgkin Lymphoma|Refractory Plasma Cell Myeloma|Refractory Primary Myelofibrosis|Refractory Small Lymphocytic Lymphoma|Stage II Pancreatic Cancer AJCC v8|Stage III Pancreatic Cancer AJCC v8|Stage IV Pancreatic Cancer AJCC v8|Stage IV Prostate Cancer AJCC v8|Unresectable Pancreatic Adenocarcinoma",Abiraterone,CC12CCC(CC1=CCC3C2CCC4(C3CC=C4C5=CN=CC=C5)C)O,PHASE1,cardiovascular_disease
1727,"Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Anatomic Stage IV Breast Cancer AJCC v8|Anemia|Ann Arbor Stage III Hodgkin Lymphoma|Ann Arbor Stage III Non-Hodgkin Lymphoma|Ann Arbor Stage IV Hodgkin Lymphoma|Ann Arbor Stage IV Non-Hodgkin Lymphoma|Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative|Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Castration-Resistant Prostate Carcinoma|Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Hematopoietic and Lymphoid System Neoplasm|Locally Advanced Pancreatic Adenocarcinoma|Metastatic Breast Carcinoma|Metastatic Malignant Solid Neoplasm|Metastatic Pancreatic Adenocarcinoma|Myelodysplastic/Myeloproliferative Neoplasm With Ring Sideroblasts and Thrombocytosis|Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable|Primary Myelofibrosis|Recurrent Acute Lymphoblastic Leukemia|Recurrent Acute Myeloid Leukemia|Recurrent Chronic Lymphocytic Leukemia|Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Recurrent Hematologic Malignancy|Recurrent Hodgkin Lymphoma|Recurrent Myelodysplastic Syndrome|Recurrent Myelodysplastic/Myeloproliferative Neoplasm|Recurrent Myeloproliferative Neoplasm|Recurrent Non-Hodgkin Lymphoma|Recurrent Plasma Cell Myeloma|Recurrent Small Lymphocytic Lymphoma|Refractory Acute Lymphoblastic Leukemia|Refractory Acute Myeloid Leukemia|Refractory Chronic Lymphocytic Leukemia|Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Refractory Chronic Myelomonocytic Leukemia|Refractory Hematologic Malignancy|Refractory Hodgkin Lymphoma|Refractory Malignant Solid Neoplasm|Refractory Myelodysplastic Syndrome|Refractory Myelodysplastic/Myeloproliferative Neoplasm|Refractory Non-Hodgkin Lymphoma|Refractory Plasma Cell Myeloma|Refractory Primary Myelofibrosis|Refractory Small Lymphocytic Lymphoma|Stage II Pancreatic Cancer AJCC v8|Stage III Pancreatic Cancer AJCC v8|Stage IV Pancreatic Cancer AJCC v8|Stage IV Prostate Cancer AJCC v8|Unresectable Pancreatic Adenocarcinoma",Bicalutamide,CC(CS(=O)(=O)C1=CC=C(C=C1)F)(C(=O)NC2=CC(=C(C=C2)C#N)C(F)(F)F)O,PHASE1,cardiovascular_disease
1728,"Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Anatomic Stage IV Breast Cancer AJCC v8|Anemia|Ann Arbor Stage III Hodgkin Lymphoma|Ann Arbor Stage III Non-Hodgkin Lymphoma|Ann Arbor Stage IV Hodgkin Lymphoma|Ann Arbor Stage IV Non-Hodgkin Lymphoma|Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative|Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Castration-Resistant Prostate Carcinoma|Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Hematopoietic and Lymphoid System Neoplasm|Locally Advanced Pancreatic Adenocarcinoma|Metastatic Breast Carcinoma|Metastatic Malignant Solid Neoplasm|Metastatic Pancreatic Adenocarcinoma|Myelodysplastic/Myeloproliferative Neoplasm With Ring Sideroblasts and Thrombocytosis|Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable|Primary Myelofibrosis|Recurrent Acute Lymphoblastic Leukemia|Recurrent Acute Myeloid Leukemia|Recurrent Chronic Lymphocytic Leukemia|Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Recurrent Hematologic Malignancy|Recurrent Hodgkin Lymphoma|Recurrent Myelodysplastic Syndrome|Recurrent Myelodysplastic/Myeloproliferative Neoplasm|Recurrent Myeloproliferative Neoplasm|Recurrent Non-Hodgkin Lymphoma|Recurrent Plasma Cell Myeloma|Recurrent Small Lymphocytic Lymphoma|Refractory Acute Lymphoblastic Leukemia|Refractory Acute Myeloid Leukemia|Refractory Chronic Lymphocytic Leukemia|Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Refractory Chronic Myelomonocytic Leukemia|Refractory Hematologic Malignancy|Refractory Hodgkin Lymphoma|Refractory Malignant Solid Neoplasm|Refractory Myelodysplastic Syndrome|Refractory Myelodysplastic/Myeloproliferative Neoplasm|Refractory Non-Hodgkin Lymphoma|Refractory Plasma Cell Myeloma|Refractory Primary Myelofibrosis|Refractory Small Lymphocytic Lymphoma|Stage II Pancreatic Cancer AJCC v8|Stage III Pancreatic Cancer AJCC v8|Stage IV Pancreatic Cancer AJCC v8|Stage IV Prostate Cancer AJCC v8|Unresectable Pancreatic Adenocarcinoma",Cabazitaxel,CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)OC)C)OC,PHASE1,cardiovascular_disease
1729,"Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Anatomic Stage IV Breast Cancer AJCC v8|Anemia|Ann Arbor Stage III Hodgkin Lymphoma|Ann Arbor Stage III Non-Hodgkin Lymphoma|Ann Arbor Stage IV Hodgkin Lymphoma|Ann Arbor Stage IV Non-Hodgkin Lymphoma|Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative|Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Castration-Resistant Prostate Carcinoma|Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Hematopoietic and Lymphoid System Neoplasm|Locally Advanced Pancreatic Adenocarcinoma|Metastatic Breast Carcinoma|Metastatic Malignant Solid Neoplasm|Metastatic Pancreatic Adenocarcinoma|Myelodysplastic/Myeloproliferative Neoplasm With Ring Sideroblasts and Thrombocytosis|Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable|Primary Myelofibrosis|Recurrent Acute Lymphoblastic Leukemia|Recurrent Acute Myeloid Leukemia|Recurrent Chronic Lymphocytic Leukemia|Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Recurrent Hematologic Malignancy|Recurrent Hodgkin Lymphoma|Recurrent Myelodysplastic Syndrome|Recurrent Myelodysplastic/Myeloproliferative Neoplasm|Recurrent Myeloproliferative Neoplasm|Recurrent Non-Hodgkin Lymphoma|Recurrent Plasma Cell Myeloma|Recurrent Small Lymphocytic Lymphoma|Refractory Acute Lymphoblastic Leukemia|Refractory Acute Myeloid Leukemia|Refractory Chronic Lymphocytic Leukemia|Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Refractory Chronic Myelomonocytic Leukemia|Refractory Hematologic Malignancy|Refractory Hodgkin Lymphoma|Refractory Malignant Solid Neoplasm|Refractory Myelodysplastic Syndrome|Refractory Myelodysplastic/Myeloproliferative Neoplasm|Refractory Non-Hodgkin Lymphoma|Refractory Plasma Cell Myeloma|Refractory Primary Myelofibrosis|Refractory Small Lymphocytic Lymphoma|Stage II Pancreatic Cancer AJCC v8|Stage III Pancreatic Cancer AJCC v8|Stage IV Pancreatic Cancer AJCC v8|Stage IV Prostate Cancer AJCC v8|Unresectable Pancreatic Adenocarcinoma",Dacomitinib,COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)NC(=O)C=CCN4CCCCC4,PHASE1,cardiovascular_disease
1730,"Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Anatomic Stage IV Breast Cancer AJCC v8|Anemia|Ann Arbor Stage III Hodgkin Lymphoma|Ann Arbor Stage III Non-Hodgkin Lymphoma|Ann Arbor Stage IV Hodgkin Lymphoma|Ann Arbor Stage IV Non-Hodgkin Lymphoma|Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative|Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Castration-Resistant Prostate Carcinoma|Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Hematopoietic and Lymphoid System Neoplasm|Locally Advanced Pancreatic Adenocarcinoma|Metastatic Breast Carcinoma|Metastatic Malignant Solid Neoplasm|Metastatic Pancreatic Adenocarcinoma|Myelodysplastic/Myeloproliferative Neoplasm With Ring Sideroblasts and Thrombocytosis|Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable|Primary Myelofibrosis|Recurrent Acute Lymphoblastic Leukemia|Recurrent Acute Myeloid Leukemia|Recurrent Chronic Lymphocytic Leukemia|Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Recurrent Hematologic Malignancy|Recurrent Hodgkin Lymphoma|Recurrent Myelodysplastic Syndrome|Recurrent Myelodysplastic/Myeloproliferative Neoplasm|Recurrent Myeloproliferative Neoplasm|Recurrent Non-Hodgkin Lymphoma|Recurrent Plasma Cell Myeloma|Recurrent Small Lymphocytic Lymphoma|Refractory Acute Lymphoblastic Leukemia|Refractory Acute Myeloid Leukemia|Refractory Chronic Lymphocytic Leukemia|Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Refractory Chronic Myelomonocytic Leukemia|Refractory Hematologic Malignancy|Refractory Hodgkin Lymphoma|Refractory Malignant Solid Neoplasm|Refractory Myelodysplastic Syndrome|Refractory Myelodysplastic/Myeloproliferative Neoplasm|Refractory Non-Hodgkin Lymphoma|Refractory Plasma Cell Myeloma|Refractory Primary Myelofibrosis|Refractory Small Lymphocytic Lymphoma|Stage II Pancreatic Cancer AJCC v8|Stage III Pancreatic Cancer AJCC v8|Stage IV Pancreatic Cancer AJCC v8|Stage IV Prostate Cancer AJCC v8|Unresectable Pancreatic Adenocarcinoma",Darolutamide,CC(CN1C=CC(=N1)C2=CC(=C(C=C2)C#N)Cl)NC(=O)C3=NNC(=C3)C(C)O,PHASE1,cardiovascular_disease
1731,"Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Anatomic Stage IV Breast Cancer AJCC v8|Anemia|Ann Arbor Stage III Hodgkin Lymphoma|Ann Arbor Stage III Non-Hodgkin Lymphoma|Ann Arbor Stage IV Hodgkin Lymphoma|Ann Arbor Stage IV Non-Hodgkin Lymphoma|Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative|Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Castration-Resistant Prostate Carcinoma|Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Hematopoietic and Lymphoid System Neoplasm|Locally Advanced Pancreatic Adenocarcinoma|Metastatic Breast Carcinoma|Metastatic Malignant Solid Neoplasm|Metastatic Pancreatic Adenocarcinoma|Myelodysplastic/Myeloproliferative Neoplasm With Ring Sideroblasts and Thrombocytosis|Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable|Primary Myelofibrosis|Recurrent Acute Lymphoblastic Leukemia|Recurrent Acute Myeloid Leukemia|Recurrent Chronic Lymphocytic Leukemia|Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Recurrent Hematologic Malignancy|Recurrent Hodgkin Lymphoma|Recurrent Myelodysplastic Syndrome|Recurrent Myelodysplastic/Myeloproliferative Neoplasm|Recurrent Myeloproliferative Neoplasm|Recurrent Non-Hodgkin Lymphoma|Recurrent Plasma Cell Myeloma|Recurrent Small Lymphocytic Lymphoma|Refractory Acute Lymphoblastic Leukemia|Refractory Acute Myeloid Leukemia|Refractory Chronic Lymphocytic Leukemia|Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Refractory Chronic Myelomonocytic Leukemia|Refractory Hematologic Malignancy|Refractory Hodgkin Lymphoma|Refractory Malignant Solid Neoplasm|Refractory Myelodysplastic Syndrome|Refractory Myelodysplastic/Myeloproliferative Neoplasm|Refractory Non-Hodgkin Lymphoma|Refractory Plasma Cell Myeloma|Refractory Primary Myelofibrosis|Refractory Small Lymphocytic Lymphoma|Stage II Pancreatic Cancer AJCC v8|Stage III Pancreatic Cancer AJCC v8|Stage IV Pancreatic Cancer AJCC v8|Stage IV Prostate Cancer AJCC v8|Unresectable Pancreatic Adenocarcinoma",Enzalutamide,CC1(C(=O)N(C(=S)N1C2=CC(=C(C=C2)C(=O)NC)F)C3=CC(=C(C=C3)C#N)C(F)(F)F)C,PHASE1,cardiovascular_disease
1732,"Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Anatomic Stage IV Breast Cancer AJCC v8|Anemia|Ann Arbor Stage III Hodgkin Lymphoma|Ann Arbor Stage III Non-Hodgkin Lymphoma|Ann Arbor Stage IV Hodgkin Lymphoma|Ann Arbor Stage IV Non-Hodgkin Lymphoma|Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative|Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Castration-Resistant Prostate Carcinoma|Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Hematopoietic and Lymphoid System Neoplasm|Locally Advanced Pancreatic Adenocarcinoma|Metastatic Breast Carcinoma|Metastatic Malignant Solid Neoplasm|Metastatic Pancreatic Adenocarcinoma|Myelodysplastic/Myeloproliferative Neoplasm With Ring Sideroblasts and Thrombocytosis|Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable|Primary Myelofibrosis|Recurrent Acute Lymphoblastic Leukemia|Recurrent Acute Myeloid Leukemia|Recurrent Chronic Lymphocytic Leukemia|Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Recurrent Hematologic Malignancy|Recurrent Hodgkin Lymphoma|Recurrent Myelodysplastic Syndrome|Recurrent Myelodysplastic/Myeloproliferative Neoplasm|Recurrent Myeloproliferative Neoplasm|Recurrent Non-Hodgkin Lymphoma|Recurrent Plasma Cell Myeloma|Recurrent Small Lymphocytic Lymphoma|Refractory Acute Lymphoblastic Leukemia|Refractory Acute Myeloid Leukemia|Refractory Chronic Lymphocytic Leukemia|Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Refractory Chronic Myelomonocytic Leukemia|Refractory Hematologic Malignancy|Refractory Hodgkin Lymphoma|Refractory Malignant Solid Neoplasm|Refractory Myelodysplastic Syndrome|Refractory Myelodysplastic/Myeloproliferative Neoplasm|Refractory Non-Hodgkin Lymphoma|Refractory Plasma Cell Myeloma|Refractory Primary Myelofibrosis|Refractory Small Lymphocytic Lymphoma|Stage II Pancreatic Cancer AJCC v8|Stage III Pancreatic Cancer AJCC v8|Stage IV Pancreatic Cancer AJCC v8|Stage IV Prostate Cancer AJCC v8|Unresectable Pancreatic Adenocarcinoma",Fluorouracil,C1=C(C(=O)NC(=O)N1)F,PHASE1,cardiovascular_disease
1733,"Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Anatomic Stage IV Breast Cancer AJCC v8|Anemia|Ann Arbor Stage III Hodgkin Lymphoma|Ann Arbor Stage III Non-Hodgkin Lymphoma|Ann Arbor Stage IV Hodgkin Lymphoma|Ann Arbor Stage IV Non-Hodgkin Lymphoma|Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative|Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Castration-Resistant Prostate Carcinoma|Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Hematopoietic and Lymphoid System Neoplasm|Locally Advanced Pancreatic Adenocarcinoma|Metastatic Breast Carcinoma|Metastatic Malignant Solid Neoplasm|Metastatic Pancreatic Adenocarcinoma|Myelodysplastic/Myeloproliferative Neoplasm With Ring Sideroblasts and Thrombocytosis|Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable|Primary Myelofibrosis|Recurrent Acute Lymphoblastic Leukemia|Recurrent Acute Myeloid Leukemia|Recurrent Chronic Lymphocytic Leukemia|Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Recurrent Hematologic Malignancy|Recurrent Hodgkin Lymphoma|Recurrent Myelodysplastic Syndrome|Recurrent Myelodysplastic/Myeloproliferative Neoplasm|Recurrent Myeloproliferative Neoplasm|Recurrent Non-Hodgkin Lymphoma|Recurrent Plasma Cell Myeloma|Recurrent Small Lymphocytic Lymphoma|Refractory Acute Lymphoblastic Leukemia|Refractory Acute Myeloid Leukemia|Refractory Chronic Lymphocytic Leukemia|Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Refractory Chronic Myelomonocytic Leukemia|Refractory Hematologic Malignancy|Refractory Hodgkin Lymphoma|Refractory Malignant Solid Neoplasm|Refractory Myelodysplastic Syndrome|Refractory Myelodysplastic/Myeloproliferative Neoplasm|Refractory Non-Hodgkin Lymphoma|Refractory Plasma Cell Myeloma|Refractory Primary Myelofibrosis|Refractory Small Lymphocytic Lymphoma|Stage II Pancreatic Cancer AJCC v8|Stage III Pancreatic Cancer AJCC v8|Stage IV Pancreatic Cancer AJCC v8|Stage IV Prostate Cancer AJCC v8|Unresectable Pancreatic Adenocarcinoma",Lorlatinib,CC1C2=C(C=CC(=C2)F)C(=O)N(CC3=NN(C(=C3C4=CC(=C(N=C4)N)O1)C#N)C)C,PHASE1,cardiovascular_disease
1734,"Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Anatomic Stage IV Breast Cancer AJCC v8|Anemia|Ann Arbor Stage III Hodgkin Lymphoma|Ann Arbor Stage III Non-Hodgkin Lymphoma|Ann Arbor Stage IV Hodgkin Lymphoma|Ann Arbor Stage IV Non-Hodgkin Lymphoma|Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative|Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Castration-Resistant Prostate Carcinoma|Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Hematopoietic and Lymphoid System Neoplasm|Locally Advanced Pancreatic Adenocarcinoma|Metastatic Breast Carcinoma|Metastatic Malignant Solid Neoplasm|Metastatic Pancreatic Adenocarcinoma|Myelodysplastic/Myeloproliferative Neoplasm With Ring Sideroblasts and Thrombocytosis|Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable|Primary Myelofibrosis|Recurrent Acute Lymphoblastic Leukemia|Recurrent Acute Myeloid Leukemia|Recurrent Chronic Lymphocytic Leukemia|Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Recurrent Hematologic Malignancy|Recurrent Hodgkin Lymphoma|Recurrent Myelodysplastic Syndrome|Recurrent Myelodysplastic/Myeloproliferative Neoplasm|Recurrent Myeloproliferative Neoplasm|Recurrent Non-Hodgkin Lymphoma|Recurrent Plasma Cell Myeloma|Recurrent Small Lymphocytic Lymphoma|Refractory Acute Lymphoblastic Leukemia|Refractory Acute Myeloid Leukemia|Refractory Chronic Lymphocytic Leukemia|Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Refractory Chronic Myelomonocytic Leukemia|Refractory Hematologic Malignancy|Refractory Hodgkin Lymphoma|Refractory Malignant Solid Neoplasm|Refractory Myelodysplastic Syndrome|Refractory Myelodysplastic/Myeloproliferative Neoplasm|Refractory Non-Hodgkin Lymphoma|Refractory Plasma Cell Myeloma|Refractory Primary Myelofibrosis|Refractory Small Lymphocytic Lymphoma|Stage II Pancreatic Cancer AJCC v8|Stage III Pancreatic Cancer AJCC v8|Stage IV Pancreatic Cancer AJCC v8|Stage IV Prostate Cancer AJCC v8|Unresectable Pancreatic Adenocarcinoma",Neratinib,CCOC1=C(C=C2C(=C1)N=CC(=C2NC3=CC(=C(C=C3)OCC4=CC=CC=N4)Cl)C#N)NC(=O)C=CCN(C)C,PHASE1,cardiovascular_disease
1735,"Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Anatomic Stage IV Breast Cancer AJCC v8|Anemia|Ann Arbor Stage III Hodgkin Lymphoma|Ann Arbor Stage III Non-Hodgkin Lymphoma|Ann Arbor Stage IV Hodgkin Lymphoma|Ann Arbor Stage IV Non-Hodgkin Lymphoma|Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative|Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Castration-Resistant Prostate Carcinoma|Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Hematopoietic and Lymphoid System Neoplasm|Locally Advanced Pancreatic Adenocarcinoma|Metastatic Breast Carcinoma|Metastatic Malignant Solid Neoplasm|Metastatic Pancreatic Adenocarcinoma|Myelodysplastic/Myeloproliferative Neoplasm With Ring Sideroblasts and Thrombocytosis|Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable|Primary Myelofibrosis|Recurrent Acute Lymphoblastic Leukemia|Recurrent Acute Myeloid Leukemia|Recurrent Chronic Lymphocytic Leukemia|Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Recurrent Hematologic Malignancy|Recurrent Hodgkin Lymphoma|Recurrent Myelodysplastic Syndrome|Recurrent Myelodysplastic/Myeloproliferative Neoplasm|Recurrent Myeloproliferative Neoplasm|Recurrent Non-Hodgkin Lymphoma|Recurrent Plasma Cell Myeloma|Recurrent Small Lymphocytic Lymphoma|Refractory Acute Lymphoblastic Leukemia|Refractory Acute Myeloid Leukemia|Refractory Chronic Lymphocytic Leukemia|Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Refractory Chronic Myelomonocytic Leukemia|Refractory Hematologic Malignancy|Refractory Hodgkin Lymphoma|Refractory Malignant Solid Neoplasm|Refractory Myelodysplastic Syndrome|Refractory Myelodysplastic/Myeloproliferative Neoplasm|Refractory Non-Hodgkin Lymphoma|Refractory Plasma Cell Myeloma|Refractory Primary Myelofibrosis|Refractory Small Lymphocytic Lymphoma|Stage II Pancreatic Cancer AJCC v8|Stage III Pancreatic Cancer AJCC v8|Stage IV Pancreatic Cancer AJCC v8|Stage IV Prostate Cancer AJCC v8|Unresectable Pancreatic Adenocarcinoma",Tretinoin,CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CC(=O)O)C)C,PHASE1,cardiovascular_disease
1736,Congestive Heart Failure,Fenoterol,CC(CC1=CC=C(C=C1)O)NCC(C2=CC(=CC(=C2)O)O)O,PHASE1,cardiovascular_disease
1737,Multiple Myeloma,Ganetespib,CC(C)C1=C(C=C(C(=C1)C2=NNC(=O)N2C3=CC4=C(C=C3)N(C=C4)C)O)O,PHASE1,cardiovascular_disease
1738,Lymphoma,Fludarabine,C1=NC2=C(N=C(N=C2N1C3C(C(C(O3)CO)O)O)F)N,PHASE2,immune_system_disease
1739,HIV Infections,Ribavirin,C1=NC(=NN1C2C(C(C(O2)CO)O)O)C(=O)N,PHASE1,immune_system_disease
1740,"Rhinitis, Allergic, Perennial and Seasonal",Levocetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,PHASE1,immune_system_disease
1741,"Rhinitis, Allergic, Perennial and Seasonal",Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,PHASE1,immune_system_disease
1742,"Lymphoblastic Leukemia, Acute, Childhood",Clofarabine,C1=NC2=C(N=C(N=C2N1C3C(C(C(O3)CO)O)F)Cl)N,PHASE1,immune_system_disease
1743,Non-Hodgkin Lymphoma,Entospletinib,C1COCCN1C2=CC=C(C=C2)NC3=NC(=CN4C3=NC=C4)C5=CC6=C(C=C5)C=NN6,PHASE1|PHASE2,immune_system_disease
1744,Non-Hodgkin Lymphoma,Vincristine,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O,PHASE1|PHASE2,immune_system_disease
1745,"Cancer|Pancreatic Cancer|Sarcoma|Renal Cancer|Refractory Cancer|Refractory Neoplasm|Refractory Non-Hodgkin Lymphoma|Pancreatic Adenocarcinoma|Resistant Cancer|Neoplasm Metastasis|Neoplasm of Bone|Neoplasm, Breast|Neoplasm of Lung|Neoplasms,Colorectal|Neoplasms Pancreatic|Malignant Glioma|Malignancies|Malignancies Multiple|Bone Metastases|Bone Neoplasm|Bone Cancer|Pancreas Cancer|Pancreatic Neoplasms|Breast Neoplasms|Acute T Cell Leukemia Lymphoma",Gemcitabine,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)(F)F,PHASE2,immune_system_disease
1746,"Cancer|Pancreatic Cancer|Sarcoma|Renal Cancer|Refractory Cancer|Refractory Neoplasm|Refractory Non-Hodgkin Lymphoma|Pancreatic Adenocarcinoma|Resistant Cancer|Neoplasm Metastasis|Neoplasm of Bone|Neoplasm, Breast|Neoplasm of Lung|Neoplasms,Colorectal|Neoplasms Pancreatic|Malignant Glioma|Malignancies|Malignancies Multiple|Bone Metastases|Bone Neoplasm|Bone Cancer|Pancreas Cancer|Pancreatic Neoplasms|Breast Neoplasms|Acute T Cell Leukemia Lymphoma",Doxorubicin,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)N)O,PHASE2,immune_system_disease
1747,"Cancer|Pancreatic Cancer|Sarcoma|Renal Cancer|Refractory Cancer|Refractory Neoplasm|Refractory Non-Hodgkin Lymphoma|Pancreatic Adenocarcinoma|Resistant Cancer|Neoplasm Metastasis|Neoplasm of Bone|Neoplasm, Breast|Neoplasm of Lung|Neoplasms,Colorectal|Neoplasms Pancreatic|Malignant Glioma|Malignancies|Malignancies Multiple|Bone Metastases|Bone Neoplasm|Bone Cancer|Pancreas Cancer|Pancreatic Neoplasms|Breast Neoplasms|Acute T Cell Leukemia Lymphoma",Lomustine,C1CCC(CC1)NC(=O)N(CCCl)N=O,PHASE2,immune_system_disease
1748,"Cancer|Pancreatic Cancer|Sarcoma|Renal Cancer|Refractory Cancer|Refractory Neoplasm|Refractory Non-Hodgkin Lymphoma|Pancreatic Adenocarcinoma|Resistant Cancer|Neoplasm Metastasis|Neoplasm of Bone|Neoplasm, Breast|Neoplasm of Lung|Neoplasms,Colorectal|Neoplasms Pancreatic|Malignant Glioma|Malignancies|Malignancies Multiple|Bone Metastases|Bone Neoplasm|Bone Cancer|Pancreas Cancer|Pancreatic Neoplasms|Breast Neoplasms|Acute T Cell Leukemia Lymphoma",Carboplatin,C1CC(C1)(C(=O)O)C(=O)O.[NH2-].[NH2-].[Pt+2],PHASE2,immune_system_disease
1749,"Cancer|Pancreatic Cancer|Sarcoma|Renal Cancer|Refractory Cancer|Refractory Neoplasm|Refractory Non-Hodgkin Lymphoma|Pancreatic Adenocarcinoma|Resistant Cancer|Neoplasm Metastasis|Neoplasm of Bone|Neoplasm, Breast|Neoplasm of Lung|Neoplasms,Colorectal|Neoplasms Pancreatic|Malignant Glioma|Malignancies|Malignancies Multiple|Bone Metastases|Bone Neoplasm|Bone Cancer|Pancreas Cancer|Pancreatic Neoplasms|Breast Neoplasms|Acute T Cell Leukemia Lymphoma",Paclitaxel,CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C,PHASE2,immune_system_disease
1750,"Cancer|Pancreatic Cancer|Sarcoma|Renal Cancer|Refractory Cancer|Refractory Neoplasm|Refractory Non-Hodgkin Lymphoma|Pancreatic Adenocarcinoma|Resistant Cancer|Neoplasm Metastasis|Neoplasm of Bone|Neoplasm, Breast|Neoplasm of Lung|Neoplasms,Colorectal|Neoplasms Pancreatic|Malignant Glioma|Malignancies|Malignancies Multiple|Bone Metastases|Bone Neoplasm|Bone Cancer|Pancreas Cancer|Pancreatic Neoplasms|Breast Neoplasms|Acute T Cell Leukemia Lymphoma",Irinotecan,CCC1=C2CN3C(=CC4=C(C3=O)COC(=O)C4(CC)O)C2=NC5=C1C=C(C=C5)OC(=O)N6CCC(CC6)N7CCCCC7,PHASE2,immune_system_disease
1751,"Diabetes Mellitus, Type 1|Hypoglycemia|Hypoglycemia Unawareness",Dapagliflozin,CCOC1=CC=C(C=C1)CC2=C(C=CC(=C2)C3C(C(C(C(O3)CO)O)O)O)Cl,PHASE2,immune_system_disease
1752,Non-Hodgkin's Lymphoma,Cyclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,PHASE2,immune_system_disease
1753,Non-Hodgkin's Lymphoma,Methotrexate,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,PHASE2,immune_system_disease
1754,Non-Hodgkin's Lymphoma,Daunorubicin,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)C)O)N)O,PHASE2,immune_system_disease
1755,HIV Infections,Indinavir,CC(C)(C)NC(=O)C1CN(CCN1CC(CC(CC2=CC=CC=C2)C(=O)NC3C(CC4=CC=CC=C34)O)O)CC5=CN=CC=C5,PHASE1,immune_system_disease
1756,HIV Infections,Ritonavir,CC(C)C1=NC(=CS1)CN(C)C(=O)NC(C(C)C)C(=O)NC(CC2=CC=CC=C2)CC(C(CC3=CC=CC=C3)NC(=O)OCC4=CN=CS4)O,PHASE1,immune_system_disease
1757,Methemoglobinemia|Linear IgA Bullous Dermatosis,Dapsone,C1=CC(=CC=C1N)S(=O)(=O)C2=CC=C(C=C2)N,PHASE1,immune_system_disease
1758,Lymphoma|Multiple Myeloma|Acute Myeloid Leukemia|Diffuse Large B-Cell Lymphoma,Azacitidine,C1=NC(=NC(=O)N1C2C(C(C(O2)CO)O)O)N,PHASE1,immune_system_disease
1759,Lymphoma|Multiple Myeloma|Acute Myeloid Leukemia|Diffuse Large B-Cell Lymphoma,Venetoclax,CC1(CCC(=C(C1)C2=CC=C(C=C2)Cl)CN3CCN(CC3)C4=CC(=C(C=C4)C(=O)NS(=O)(=O)C5=CC(=C(C=C5)NCC6CCOCC6)[N+](=O)[O-])OC7=CN=C8C(=C7)C=CN8)C,PHASE1,immune_system_disease
1760,Lymphoma|Multiple Myeloma|Acute Myeloid Leukemia|Diffuse Large B-Cell Lymphoma,Carfilzomib,CC(C)CC(C(=O)C1(CO1)C)NC(=O)C(CC2=CC=CC=C2)NC(=O)C(CC(C)C)NC(=O)C(CCC3=CC=CC=C3)NC(=O)CN4CCOCC4,PHASE1,immune_system_disease
1761,Lymphoma|Multiple Myeloma|Acute Myeloid Leukemia|Diffuse Large B-Cell Lymphoma,Dexamethasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,PHASE1,immune_system_disease
1762,Multiple Myeloma,Palbociclib,CC1=C(C(=O)N(C2=NC(=NC=C12)NC3=NC=C(C=C3)N4CCNCC4)C5CCCC5)C(=O)C,PHASE1,immune_system_disease
1763,Multiple Myeloma,Lenalidomide,C1CC(=O)NC(=O)C1N2CC3=C(C2=O)C=CC=C3N,PHASE1,immune_system_disease
1764,Leukemia|Myelodysplastic Syndrome|Non-Hodgkin's Lymphoma|Allogeneic Marrow Transplant,Busulfan,CS(=O)(=O)OCCCCOS(=O)(=O)C,PHASE2,immune_system_disease
1765,Leukemia|Myelodysplastic Syndrome|Non-Hodgkin's Lymphoma|Allogeneic Marrow Transplant,Melphalan,C1=CC(=CC=C1CC(C(=O)O)N)N(CCCl)CCCl,PHASE2,immune_system_disease
1766,Multiple Myeloma,Pomalidomide,C1CC(=O)NC(=O)C1N2C(=O)C3=C(C2=O)C(=CC=C3)N,PHASE2,immune_system_disease
1767,Multiple Myeloma,Bortezomib,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O,PHASE2,immune_system_disease
1768,Acute Lymphoblastic Leukemia|Adult B Acute Lymphoblastic Leukemia|Childhood B Acute Lymphoblastic Leukemia,Cytarabine,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,PHASE1,immune_system_disease
1769,Acute Lymphoblastic Leukemia|Adult B Acute Lymphoblastic Leukemia|Childhood B Acute Lymphoblastic Leukemia,Ciclosporin,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,PHASE1,immune_system_disease
1770,Acute Lymphoblastic Leukemia|Adult B Acute Lymphoblastic Leukemia|Childhood B Acute Lymphoblastic Leukemia,Chloroquine,CCN(CC)CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl,PHASE1,immune_system_disease
1771,Acute Lymphoblastic Leukemia|Adult B Acute Lymphoblastic Leukemia|Childhood B Acute Lymphoblastic Leukemia,Mercaptopurine,C1=NC2=C(N1)C(=S)N=CN2,PHASE1,immune_system_disease
1772,Acute Lymphoblastic Leukemia|Adult B Acute Lymphoblastic Leukemia|Childhood B Acute Lymphoblastic Leukemia,Pegaspargase,CC1=CC(=C(C=C1)C(=O)C(=C)CN(C)C)C,PHASE1,immune_system_disease
1773,Acute Lymphoblastic Leukemia|Adult B Acute Lymphoblastic Leukemia|Childhood B Acute Lymphoblastic Leukemia,Prednisone,CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C,PHASE1,immune_system_disease
1774,Acute Lymphoblastic Leukemia|Adult B Acute Lymphoblastic Leukemia|Childhood B Acute Lymphoblastic Leukemia,Tioguanine,C1=NC2=C(N1)C(=S)N=C(N2)N,PHASE1,immune_system_disease
1775,Acute Lymphoblastic Leukemia|Adult B Acute Lymphoblastic Leukemia|Childhood B Acute Lymphoblastic Leukemia,Thioguanine,C1=NC2=C(N1)C(=S)N=C(N2)N,PHASE1,immune_system_disease
1776,HIV Infections,Abacavir,C1CC1NC2=C3C(=NC(=N2)N)N(C=N3)C4CC(C=C4)CO,PHASE1,immune_system_disease
1777,HIV Infections,Amprenavir,CC(C)CN(CC(C(CC1=CC=CC=C1)NC(=O)OC2CCOC2)O)S(=O)(=O)C3=CC=C(C=C3)N,PHASE1,immune_system_disease
1778,HIV Infections,Lamivudine,C1C(OC(S1)CO)N2C=CC(=NC2=O)N,PHASE1,immune_system_disease
1779,HIV Infections,Zidovudine,CC1=CN(C(=O)NC1=O)C2CC(C(O2)CO)N=[N+]=[N-],PHASE1,immune_system_disease
1780,Chronic GVHD,Sirolimus,CC1CCC2CC(C(=CC=CC=CC(CC(C(=O)C(C(C(=CC(C(=O)CC(OC(=O)C3CCCCN3C(=O)C(=O)C1(O2)O)C(C)CC4CCC(C(C4)OC)O)C)C)O)OC)C)C)C)OC,PHASE2|PHASE3,immune_system_disease
1781,Glioma|Hematopoietic and Lymphoid Cell Neoplasm|Lymphoma|Metastatic Malignant Solid Neoplasm|Neuroendocrine Neoplasm|Recurrent Adult Soft Tissue Sarcoma|Recurrent Bladder Carcinoma|Recurrent Breast Carcinoma|Recurrent Chronic Lymphocytic Leukemia|Recurrent Colorectal Carcinoma|Recurrent Head and Neck Carcinoma|Recurrent Lung Carcinoma|Recurrent Malignant Solid Neoplasm|Recurrent Melanoma|Recurrent Pancreatic Carcinoma|Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma|Recurrent Prostate Carcinoma|Recurrent Renal Cell Carcinoma|Recurrent Thyroid Gland Carcinoma|Refractory Chronic Lymphocytic Leukemia|Refractory Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma|Refractory Primary Cutaneous T-Cell Non-Hodgkin Lymphoma|Stage III Breast Cancer AJCC v7|Stage III Colorectal Cancer AJCC v7|Stage III Cutaneous Melanoma AJCC v7|Stage III Lung Cancer AJCC v7|Stage III Pancreatic Cancer AJCC v6 and v7|Stage III Prostate Cancer AJCC v7|Stage III Renal Cell Cancer AJCC v7|Stage III Soft Tissue Sarcoma AJCC v7|Stage IIIA Breast Cancer AJCC v7|Stage IIIA Colorectal Cancer AJCC v7|Stage IIIA Cutaneous Melanoma AJCC v7|Stage IIIB Breast Cancer AJCC v7|Stage IIIB Colorectal Cancer AJCC v7|Stage IIIB Cutaneous Melanoma AJCC v7|Stage IIIC Breast Cancer AJCC v7|Stage IIIC Colorectal Cancer AJCC v7|Stage IIIC Cutaneous Melanoma AJCC v7|Stage IV Breast Cancer AJCC v6 and v7|Stage IV Colorectal Cancer AJCC v7|Stage IV Cutaneous Melanoma AJCC v6 and v7|Stage IV Lung Cancer AJCC v7|Stage IV Pancreatic Cancer AJCC v6 and v7|Stage IV Prostate Cancer AJCC v7|Stage IV Renal Cell Cancer AJCC v7|Stage IV Soft Tissue Sarcoma AJCC v7|Stage IVA Colorectal Cancer AJCC v7|Stage IVB Colorectal Cancer AJCC v7|Unresectable Solid Neoplasm,Romidepsin,CC=C1C(=O)NC(C(=O)OC2CC(=O)NC(C(=O)NC(CSSCCC=C2)C(=O)N1)C(C)C)C(C)C,PHASE1,immune_system_disease
1782,Atopic Dermatitis,Hydrocortisone,CC12CCC(=O)C=C1CCC3C2C(CC4(C3CCC4(C(=O)CO)O)C)O,PHASE2,immune_system_disease
1783,"Ultraviolet Rays|Immunosuppression|Hypersensitivity, Delayed|Immune Tolerance/Drug Effects",Diphencyprone,C1=CC=C(C=C1)C2=C(C2=O)C3=CC=CC=C3,PHASE1,immune_system_disease
1784,"Acute Lymphoblastic Leukemia, Adult",Ponatinib,CC1=C(C=C(C=C1)C(=O)NC2=CC(=C(C=C2)CN3CCN(CC3)C)C(F)(F)F)C#CC4=CN=C5N4N=CC=C5,PHASE2,immune_system_disease
1785,"Acute Lymphoblastic Leukemia, Adult",Imatinib,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,PHASE2,immune_system_disease
1786,Chronic Lymphocytic Leukemia|Small Lymphocytic Lymphoma,Bendamustine,CN1C2=C(C=C(C=C2)N(CCCl)CCCl)N=C1CCCC(=O)O,PHASE2,immune_system_disease
1787,Advanced Solid Tumors|Lymphoma,Ixazomib,B(C(CC(C)C)NC(=O)CNC(=O)C1=C(C=CC(=C1)Cl)Cl)(O)O,PHASE1,immune_system_disease
1788,Graft Vs Host Disease,Cyclosporine,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,PHASE1,immune_system_disease
1789,Multiple Myeloma,Panobinostat,CC1=C(C2=CC=CC=C2N1)CCNCC3=CC=C(C=C3)C=CC(=O)NO,PHASE1,immune_system_disease
1790,Peanut Allergies in Children,Ketotifen,CN1CCC(=C2C3=C(C(=O)CC4=CC=CC=C42)SC=C3)CC1,PHASE2,immune_system_disease
1791,Immune Thrombocytopenia,Danazol,CC12CCC3C(C1CCC2(C#C)O)CCC4=CC5=C(CC34C)C=NO5,PHASE2,immune_system_disease
1792,Extranodal NK/T-cell Lymphoma,Etoposide,CC1OCC2C(O1)C(C(C(O2)OC3C4COC(=O)C4C(C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)O)OC)O)O,PHASE2,immune_system_disease
1793,HIV Infections,Dolutegravir,CC1CCOC2N1C(=O)C3=C(C(=O)C(=CN3C2)C(=O)NCC4=C(C=C(C=C4)F)F)O,PHASE2|PHASE3,immune_system_disease
1794,Acute Biphenotypic Leukemia|Acute Myeloid Leukemia|de Novo Myelodysplastic Syndrome|Myelodysplastic Syndrome|Myeloproliferative Neoplasm,Cladribine,C1C(C(OC1N2C=NC3=C(N=C(N=C32)Cl)N)CO)O,PHASE1|PHASE2,immune_system_disease
1795,Acute Biphenotypic Leukemia|Acute Myeloid Leukemia|de Novo Myelodysplastic Syndrome|Myelodysplastic Syndrome|Myeloproliferative Neoplasm,Mitoxantrone,C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO,PHASE1|PHASE2,immune_system_disease
1796,Acute Biphenotypic Leukemia|Acute Myeloid Leukemia|de Novo Myelodysplastic Syndrome|Myelodysplastic Syndrome|Myeloproliferative Neoplasm,Sorafenib,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,PHASE1|PHASE2,immune_system_disease
1797,Acute Lymphoblastic Leukemia (ALL)|Acute Myeloid Leukemia (AML)|Myeloid Sarcoma|Chronic Myeloid Leukemia (CML)|Juvenile Myelomonocytic Leukemia (JMML)|Myelodysplastic Syndrome (MDS)|Non-Hodgkin Lymphoma (NHL),Mesna,C(CS(=O)(=O)[O-])S.[Na+],PHASE2,immune_system_disease
1798,Acute Lymphoblastic Leukemia (ALL)|Acute Myeloid Leukemia (AML)|Myeloid Sarcoma|Chronic Myeloid Leukemia (CML)|Juvenile Myelomonocytic Leukemia (JMML)|Myelodysplastic Syndrome (MDS)|Non-Hodgkin Lymphoma (NHL),Tacrolimus,CC1CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC(=O)C(C=C(C1)C)CC=C)O)C)C(=CC4CCC(C(C4)OC)O)C)O)C)OC)OC,PHASE2,immune_system_disease
1799,Acute Lymphoblastic Leukemia (ALL)|Acute Myeloid Leukemia (AML)|Myeloid Sarcoma|Chronic Myeloid Leukemia (CML)|Juvenile Myelomonocytic Leukemia (JMML)|Myelodysplastic Syndrome (MDS)|Non-Hodgkin Lymphoma (NHL),Thiotepa,C1CN1P(=S)(N2CC2)N3CC3,PHASE2,immune_system_disease
1800,Type 1 Diabetes|Hypoglycemia,Pitolisant,C1CCN(CC1)CCCOCCCC2=CC=C(C=C2)Cl,PHASE1,immune_system_disease
1801,Multiple Myeloma,Tucidinostat,C1=CC(=CN=C1)C=CC(=O)NCC2=CC=C(C=C2)C(=O)NC3=C(C=C(C=C3)F)N,PHASE1|PHASE2,immune_system_disease
1802,Non-Hodgkin's Lymphoma,Ibritumomab,CC(CN(CC(CC1=CC=C(C=C1)NC(=O)NC)N(CC(=O)O)CC(=O)O)CC(=O)O)N(CC(=O)O)CC(=O)O,PHASE2,immune_system_disease
1803,Non-Hodgkin's Lymphoma,Tricyclazole,CC1=C2C(=CC=C1)SC3=NN=CN23,PHASE2,immune_system_disease
1804,Cardiopulmonary Bypass,Nelfinavir,CC1=C(C=CC=C1O)C(=O)NC(CSC2=CC=CC=C2)C(CN3CC4CCCCC4CC3C(=O)NC(C)(C)C)O,PHASE1,immune_system_disease
1805,Adenosine Deaminase Deficiency|Autosomal Recessive Disorder|Immune System Disorder|Purine-Nucleoside Phosphorylase Deficiency|Severe Combined Immunodeficiency|Severe Combined Immunodeficiency With Absence of T and B Cells|X-Linked Severe Combined Immunodeficiency,Mycophenolate,CC1=C2COC(=O)C2=C(C(=C1OC)CC=C(C)CCC(=O)O)O,PHASE1,immune_system_disease
1806,Waldenstrom's Macroglobulinemia,Valaciclovir,CC(C)C(C(=O)OCCOCN1C=NC2=C1N=C(NC2=O)N)N,PHASE2,immune_system_disease
1807,Waldenstrom's Macroglobulinemia,Valacyclovir,CC(C)C(C(=O)OCCOCN1C=NC2=C1N=C(NC2=O)N)N,PHASE2,immune_system_disease
1808,Non-Hodgkin's Lymphoma|Chronic Lymphocytic Leukemia,Noscapine,CN1CCC2=CC3=C(C(=C2C1C4C5=C(C(=C(C=C5)OC)OC)C(=O)O4)OC)OCO3,PHASE1|PHASE2,immune_system_disease
1809,Autoimmune Diseases,Azithromycin,CCC1C(C(C(N(CC(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)C)O)(C)O,PHASE1,immune_system_disease
1810,Relapsed/Refractory Peripheral T-cell Lymphoma,Decitabine,C1C(C(OC1N2C=NC(=NC2=O)N)CO)O,PHASE1|PHASE2,immune_system_disease
1811,Relapsed/Refractory Peripheral T-cell Lymphoma,Cedazuridine,C1CN(C(=O)NC1O)C2C(C(C(O2)CO)O)(F)F,PHASE1|PHASE2,immune_system_disease
1812,Thyroid Associated Orbitopathy,Triamcinolone,CC12CC(C3(C(C1CC(C2(C(=O)CO)O)O)CCC4=CC(=O)C=CC43C)F)O,PHASE2,immune_system_disease
1813,Persistent Asthma,Fluticasone,CC1CC2C3CC(C4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)SCF)O)C)O)F)C)F,PHASE2,immune_system_disease
1814,Mantle-Cell Lymphoma,Obatoclax,CC1=CC(=C(N1)C=C2C(=CC(=C3C=C4C=CC=CC4=N3)N2)OC)C,PHASE1|PHASE2,immune_system_disease
1815,Graft Vs Host Disease|GVHD,Pacritinib,C1CCN(C1)CCOC2=C3COCC=CCOCC4=CC(=CC=C4)C5=NC(=NC=C5)NC(=C3)C=C2,PHASE1|PHASE2,immune_system_disease
1816,Non-Hodgkin's Lymphoma|Cancer,Allopurinol,C1=NNC2=C1C(=O)NC=N2,PHASE2,immune_system_disease
1817,Diffuse Large B-Cell Lymphoma,Fostamatinib,CC1(C(=O)N(C2=C(O1)C=CC(=N2)NC3=NC(=NC=C3F)NC4=CC(=C(C(=C4)OC)OC)OC)COP(=O)(O)O)C,PHASE2,immune_system_disease
1818,Chronic Lymphocytic Leukemia,Dasatinib,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=CC(=NC(=N3)C)N4CCN(CC4)CCO,PHASE2,immune_system_disease
1819,Multiple Myeloma in Relapse,Vorinostat,C1=CC=C(C=C1)NC(=O)CCCCCCC(=O)NO,PHASE1|PHASE2,immune_system_disease
1820,Thyroid-Associated Ophthalmopathy,Methylprednisolone,CC1CC2C3CCC(C3(CC(C2C4(C1=CC(=O)C=C4)C)O)C)(C(=O)CO)O,PHASE2,immune_system_disease
1821,Multiple Myeloma,Nirogacestat,CCCC(C(=O)NC1=CN(C=N1)C(C)(C)CNCC(C)(C)C)NC2CCC3=C(C2)C(=CC(=C3)F)F,PHASE1,immune_system_disease
1822,Follicular Lymphoma|Small Lymphocytic Lymphoma|Marginal Zone Lymphoma|Lymphoplasmacytic Lymphoma|Diffuse Large B Cell Lymphoma|Mantle Cell Lymphoma|Burkitt's Lymphoma,Imexon,C1C2N1C(=O)N=C2N,PHASE2,immune_system_disease
1823,Venous Thromboembolism,Apixaban,COC1=CC=C(C=C1)N2C3=C(CCN(C3=O)C4=CC=C(C=C4)N5CCCCC5=O)C(=N2)C(=O)N,PHASE2,immune_system_disease
1824,Type 1 Diabetes,Exenatide,CCC(C)C(C(=O)NC(CCC(=O)O)C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(CC(C)C)C(=O)NC(CCCCN)C(=O)NC(CC(=O)N)C(=O)NCC(=O)NCC(=O)N3CCCC3C(=O)NC(CO)C(=O)NC(CO)C(=O)NCC(=O)NC(C)C(=O)N4CCCC4C(=O)N5CCCC5C(=O)N6CCCC6C(=O)NC(CO)C(=O)N)NC(=O)C(CC7=CC=CC=C7)NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(C(C)C)NC(=O)C(C)NC(=O)C(CCC(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(CCSC)NC(=O)C(CCC(=O)N)NC(=O)C(CCCCN)NC(=O)C(CO)NC(=O)C(CC(C)C)NC(=O)C(CC(=O)O)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C(CC8=CC=CC=C8)NC(=O)C(C(C)O)NC(=O)CNC(=O)C(CCC(=O)O)NC(=O)CNC(=O)C(CC9=CNC=N9)N,PHASE2,immune_system_disease
1825,Stroke|Inflammation,Fingolimod,CCCCCCCCC1=CC=C(C=C1)CCC(CO)(CO)N,PHASE2,immune_system_disease
1826,Acute Myelogenous Leukemia|Acute Lymphocytic Leukemia|Myelodysplastic Syndromes|Non-Hodgkin Lymphoma|Hodgkin Disease,Itacitinib,C1CN(CCC1N2CC(C2)(CC#N)N3C=C(C=N3)C4=C5C=CNC5=NC=N4)C(=O)C6=C(C(=NC=C6)C(F)(F)F)F,PHASE1,immune_system_disease
1827,Rheumatoid Arthritis,Tofacitinib,CC1CCN(CC1N(C)C2=NC=NC3=C2C=CN3)C(=O)CC#N,PHASE2,immune_system_disease
1828,"Infection, Human Immunodeficiency Virus",Darunavir,CC(C)CN(CC(C(CC1=CC=CC=C1)NC(=O)OC2COC3C2CCO3)O)S(=O)(=O)C4=CC=C(C=C4)N,PHASE1,immune_system_disease
1829,"Infection, Human Immunodeficiency Virus",Cobicistat,CC(C)C1=NC(=CS1)CN(C)C(=O)NC(CCN2CCOCC2)C(=O)NC(CCC(CC3=CC=CC=C3)NC(=O)OCC4=CN=CS4)CC5=CC=CC=C5,PHASE1,immune_system_disease
1830,Multiple Sclerosis,Methylphenidate,COC(=O)C(C1CCCCN1)C2=CC=CC=C2,PHASE2|PHASE3,immune_system_disease
1831,Lymphoma,Ifosfamide,C1CN(P(=O)(OC1)NCCCl)CCCl,PHASE2,immune_system_disease
1832,Primary Central Nervous Lymphoma|Intraocular Lymphoma,Ibrutinib,C=CC(=O)N1CCCC(C1)N2C3=NC=NC(=C3C(=N2)C4=CC=C(C=C4)OC5=CC=CC=C5)N,PHASE2,immune_system_disease
1833,T Cell Lymphoma,Tenalisib,CCC(C1=C(C(=O)C2=CC=CC=C2O1)C3=CC(=CC=C3)F)NC4=NC=NC5=C4NC=N5,PHASE1|PHASE2,immune_system_disease
1834,Seasonal Allergic Rhinitis,Azelastine,CN1CCCC(CC1)N2C(=O)C3=CC=CC=C3C(=N2)CC4=CC=C(C=C4)Cl,PHASE2,immune_system_disease
1835,Multiple Myeloma,Thalidomide,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O,PHASE2|PHASE3,immune_system_disease
1836,"Infection, Human Immunodeficiency Virus",Raltegravir,CC1=NN=C(O1)C(=O)NC(C)(C)C2=NC(=C(C(=O)N2C)O)C(=O)NCC3=CC=C(C=C3)F,PHASE1,immune_system_disease
1837,"Lymphoma, B-Cell",Cisplatin,N.N.Cl[Pt]Cl,PHASE1|PHASE2,immune_system_disease
1838,"Infections, Human Immunodeficiency Virus and Tuberculosis",Iohexol,CC(=O)N(CC(CO)O)C1=C(C(=C(C(=C1I)C(=O)NCC(CO)O)I)C(=O)NCC(CO)O)I,PHASE1,immune_system_disease
1839,"Pneumonia, Pneumocystis Carinii|HIV Infections",Sitamaquine,CCN(CC)CCCCCCNC1=CC(=CC2=C(C=CN=C12)C)OC,PHASE2,immune_system_disease
1840,HIV Infections,Efavirenz,C1CC1C#CC2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F,PHASE1|PHASE2,immune_system_disease
1841,HIV Infections,Didanosine,C1CC(OC1CO)N2C=NC3=C2N=CNC3=O,PHASE1|PHASE2,immune_system_disease
1842,HIV Infections,Emtricitabine,C1C(OC(S1)CO)N2C=C(C(=NC2=O)N)F,PHASE1|PHASE2,immune_system_disease
1843,B-Cell Lymphoma Originating in the CNS,Temozolomide,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N,PHASE2,immune_system_disease
1844,"Arthritis, Rheumatoid",Prednisolone,CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O,PHASE2,immune_system_disease
1845,Diffuse Large B Cell Lymphoma|Relapsed Diffuse Large B-Cell Lymphoma|Refractory Diffuse Large B-Cell Lymphoma,Copanlisib,COC1=C(C=CC2=C3NCCN3C(=NC(=O)C4=CN=C(N=C4)N)N=C21)OCCCN5CCOCC5,PHASE1|PHASE2,immune_system_disease
1846,Multiple Myeloma in Relapse,Selinexor,C1=CN=C(C=N1)NNC(=O)C=CN2C=NC(=N2)C3=CC(=CC(=C3)C(F)(F)F)C(F)(F)F,PHASE2,immune_system_disease
1847,Optic Neuritis|Multiple Sclerosis,Phenytoin,C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=CC=C3,PHASE2,immune_system_disease
1848,Systemic Lupus Erythematosus,Artenimol,CC1CCC2C(C(OC3C24C1CCC(O3)(OO4)C)O)C,PHASE2,immune_system_disease
1849,HIV Infections,Dapivirine,CC1=CC(=C(C(=C1)C)NC2=NC(=NC=C2)NC3=CC=C(C=C3)C#N)C,PHASE1,immune_system_disease
1850,Graft Versus Host Disease|Leukemia|Myelodysplastic Syndromes,Idarubicin,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=CC=CC=C5C4=O)O)(C(=O)C)O)N)O,PHASE2,immune_system_disease
1851,Chronic Lymphocytic Leukemia|Small Lymphocytic Lymphoma|Relapsed Chronic Lymphocytic Leukemia|Refractory Chronic Lymphocytic Leukemia,Acalabrutinib,CC#CC(=O)N1CCCC1C2=NC(=C3N2C=CN=C3N)C4=CC=C(C=C4)C(=O)NC5=CC=CC=N5,PHASE2,immune_system_disease
1852,Chronic Lymphocytic Leukemia|Small Lymphocytic Lymphoma|Relapsed Chronic Lymphocytic Leukemia|Refractory Chronic Lymphocytic Leukemia,Umbralisib,CC(C)OC1=C(C=C(C=C1)C2=NN(C3=NC=NC(=C23)N)C(C)C4=C(C(=O)C5=C(O4)C=CC(=C5)F)C6=CC(=CC=C6)F)F,PHASE2,immune_system_disease
1853,Non-Hodgkin's Lymphoma,Oxaliplatin,C1CCC(C(C1)[NH-])[NH-].C(=O)(C(=O)O)O.[Pt+2],PHASE2,immune_system_disease
1854,Allergic Asthma,Roflumilast,C1CC1COC2=C(C=CC(=C2)C(=O)NC3=C(C=NC=C3Cl)Cl)OC(F)F,PHASE2,immune_system_disease
1855,Asthma,Budesonide,CCCC1OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C,PHASE1|PHASE2,immune_system_disease
1856,Atopic Dermatitis|Pruritus|Dermatitis,Naltrexone,C1CC1CN2CCC34C5C(=O)CCC3(C2CC6=C4C(=C(C=C6)O)O5)O,PHASE2,immune_system_disease
1857,Primary Immune Thrombocytopenia (ITP),Eltrombopag,CC1=C(C=C(C=C1)N2C(=O)C(=C(N2)C)N=NC3=CC=CC(=C3O)C4=CC(=CC=C4)C(=O)O)C,PHASE2,immune_system_disease
1858,Seasonal Allergic Conjunctivitis,Olopatadine,CN(C)CCC=C1C2=CC=CC=C2COC3=C1C=C(C=C3)CC(=O)O,PHASE2,immune_system_disease
1859,"Arthritis, Rheumatoid",Ramipril,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCC3CC2C(=O)O,PHASE2|PHASE3,immune_system_disease
1860,Asthma,Nedocromil,CCCC1=C2C(=CC3=C1OC(=CC3=O)C(=O)O)C(=O)C=C(N2CC)C(=O)O,PHASE1,immune_system_disease
1861,Asthma,Montelukast,CC(C)(C1=CC=CC=C1CCC(C2=CC=CC(=C2)C=CC3=NC4=C(C=CC(=C4)Cl)C=C3)SCC5(CC5)CC(=O)O)O,PHASE1,immune_system_disease
1862,Asthma,Mometasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CCl)O)C)O)Cl)C,PHASE1,immune_system_disease
1863,"Lymphoma, Including Chronic Lymphocytic Leukemia|Solid Tumors",Rifampin,CC1C=CC=C(C(=O)NC2=C(C(=C3C(=C2O)C(=C(C4=C3C(=O)C(O4)(OC=CC(C(C(C(C(C(C1O)C)O)C)OC(=O)C)C)OC)C)C)O)O)C=NN5CCN(CC5)C)C,PHASE1,immune_system_disease
1864,"Lymphoma, Including Chronic Lymphocytic Leukemia|Solid Tumors",Rifampicin,CC1C=CC=C(C(=O)NC2=C(C(=C3C(=C2O)C(=C(C4=C3C(=O)C(O4)(OC=CC(C(C(C(C(C(C1O)C)O)C)OC(=O)C)C)OC)C)C)O)O)C=NN5CCN(CC5)C)C,PHASE1,immune_system_disease
1865,Peripheral T-cell Lymphoma,Belinostat,C1=CC=C(C=C1)NS(=O)(=O)C2=CC=CC(=C2)C=CC(=O)NO,PHASE1,immune_system_disease
1866,Diffuse Large B-Cell Lymphoma,Metformin,CN(C)C(=N)N=C(N)N,PHASE2,immune_system_disease
1867,"Lymphoblastic Leukemia, Acute, Childhood|Lymphoblastic Lymphoma|Peripheral T-cell Lymphoma",Temsirolimus,CC1CCC2CC(C(=CC=CC=CC(CC(C(=O)C(C(C(=CC(C(=O)CC(OC(=O)C3CCCCN3C(=O)C(=O)C1(O2)O)C(C)CC4CCC(C(C4)OC)OC(=O)C(C)(CO)CO)C)C)O)OC)C)C)C)OC,PHASE1,immune_system_disease
1868,Newly Diagnosed Peripheral T-cell Lymphoma,Duvelisib,CC(C1=CC2=C(C(=CC=C2)Cl)C(=O)N1C3=CC=CC=C3)NC4=NC=NC5=C4NC=N5,PHASE2,immune_system_disease
1869,Rheumatoid Arthritis,Cilostazol,C1CCC(CC1)N2C(=NN=N2)CCCCOC3=CC4=C(C=C3)NC(=O)CC4,PHASE2|PHASE3,immune_system_disease
1870,Chronic Graft Versus Host Disease|Fasciitis,Glasdegib,CN1CCC(CC1C2=NC3=CC=CC=C3N2)NC(=O)NC4=CC=C(C=C4)C#N,PHASE1|PHASE2,immune_system_disease
1871,Diffuse Large B-Cell Lymphoma|Grade 3b Follicular Lymphoma|High Grade B-Cell Lymphoma,Fludeoxyglucose,C(C(C(C(C(C=O)F)O)O)O)O,PHASE1|PHASE2,immune_system_disease
1872,Diffuse Large B-cell Lymphoma (DLBCL),Zanubrutinib,C=CC(=O)N1CCC(CC1)C2CCNC3=C(C(=NN23)C4=CC=C(C=C4)OC5=CC=CC=C5)C(=O)N,PHASE2,immune_system_disease
1873,Antiphospholipid Syndrome,Fluvastatin,CC(C)N1C2=CC=CC=C2C(=C1C=CC(CC(CC(=O)O)O)O)C3=CC=C(C=C3)F,PHASE2,immune_system_disease
1874,Asthma,Tofimilast,CCC1=NN(C2=C1CCN3C2=NN=C3C4=CC=CS4)C5CCCC5,PHASE2,immune_system_disease
1875,HIV Infections,Nevirapine,CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4,PHASE2,immune_system_disease
1876,HIV Infections,Stavudine,CC1=CN(C(=O)NC1=O)C2C=CC(O2)CO,PHASE2,immune_system_disease
1877,Pompe Disease,Diphenhydramine,CN(C)CCOC(C1=CC=CC=C1)C2=CC=CC=C2,PHASE1,immune_system_disease
1878,Pompe Disease,Acetaminophen,CC(=O)NC1=CC=C(C=C1)O,PHASE1,immune_system_disease
1879,Pompe Disease,Lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C,PHASE1,immune_system_disease
1880,"High-grade B-cell Lymphoma|Burkitt Lymphoma|Lymphoma, B-Cell|Lymphoma, Large B-Cell, Diffuse|Lymphatic Diseases|Lymphoma, High-Grade|C-MYC/BCL2 Double-Hit High-Grade B-Cell Lymphoma|C-MYC/BCL6 Double-Hit High-Grade B-Cell Lymphoma|C-Myc Gene Rearrangement",Sepantronium,CC1=[N+](C2=C(N1CCOC)C(=O)C3=CC=CC=C3C2=O)CC4=NC=CN=C4,PHASE2,immune_system_disease
1881,"Rhinitis, Allergic",Chlorpheniramine,CN(C)CCC(C1=CC=C(C=C1)Cl)C2=CC=CC=N2,PHASE2,immune_system_disease
1882,Hematologic Diseases|Acute-graft-versus-host Disease|Leukemia|Non-Hodgkin Lymphoma (NHL)|Hodgkin Lymphoma,Carmustine,C(CCl)NC(=O)N(CCCl)N=O,PHASE2,immune_system_disease
1883,Granulomatous and Lymphocytic Interstitial Lung Disease,Azathioprine,CN1C=NC(=C1SC2=NC=NC3=C2NC=N3)[N+](=O)[O-],PHASE2,immune_system_disease
1884,Acute Lymphocytic Leukemia,Ozogamicin,CCN(C1COC(CC1OC)OC2C(C(C(OC2OC3C#CC=CC#CC4(CC(=O)C(=C3C4=CCSSC(C)(C)CC(=O)NN=C(C)C5=CC=C(C=C5)OCCCC(=O)N)NC(=O)OC)O)C)NOC6CC(C(C(O6)C)SC(=O)C7=C(C(=C(C(=C7OC)OC)OC8C(C(C(C(O8)C)O)OC)O)I)C)O)O)C(=O)C,PHASE2,immune_system_disease
1885,Diffuse Large B-Cell Lymphoma|Drug Toxicity,Glucarpidase,[Zn+2].[Zn+2].[Zn+2].[Zn+2],PHASE2,immune_system_disease
1886,Cognitive Fatigue,Dalfampridine,C1=CN=CC=C1N,PHASE2|PHASE3,immune_system_disease
1887,Immunocytoma/Morbus Waldenstrm|B-Cell Non-Hodgkin's Lymphoma|B-Cell Chronic Lymphocytic Leukemia,Pentostatin,C1C(C(OC1N2C=NC3=C2NC=NCC3O)CO)O,PHASE2,immune_system_disease
1888,HIV Infections,Nystatin,CC1C=CC=CCCC=CC=CC=CC=CC(CC2C(C(CC(O2)(CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)O)C(=O)O)OC3C(C(C(C(O3)C)O)N)O,PHASE1,immune_system_disease
1889,B-cell Lymphoma,Parsaclisib,CCOC1=C(C(=C(C=C1C(C)N2C3=NC=NC(=C3C(=N2)C)N)Cl)F)C4CC(=O)NC4,PHASE1,immune_system_disease
1890,Cold Contact Urticaria,Rupatadine,CC1=CC(=CN=C1)CN2CCC(=C3C4=C(CCC5=C3N=CC=C5)C=C(C=C4)Cl)CC2,PHASE2,immune_system_disease
1891,Fibromyalgia,Melatonin,CC(=O)NCCC1=CNC2=C1C=C(C=C2)OC,PHASE2|PHASE3,immune_system_disease
1892,Fibromyalgia,Amitriptyline,CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31,PHASE2|PHASE3,immune_system_disease
1893,HIV Infections,Lopinavir,CC1=C(C(=CC=C1)C)OCC(=O)NC(CC2=CC=CC=C2)C(CC(CC3=CC=CC=C3)NC(=O)C(C(C)C)N4CCCNC4=O)O,PHASE2,immune_system_disease
1894,Asthma,Voriconazole,CC(C1=NC=NC=C1F)C(CN2C=NC=N2)(C3=C(C=C(C=C3)F)F)O,PHASE1,immune_system_disease
1895,Multiple Myeloma,Dextromethorphan,CN1CCC23CCCCC2C1CC4=C3C=C(C=C4)OC,PHASE2,immune_system_disease
1896,"Hepatitis C, Chronic|HIV Infection",Telaprevir,CCCC(C(=O)C(=O)NC1CC1)NC(=O)C2C3CCCC3CN2C(=O)C(C(C)(C)C)NC(=O)C(C4CCCCC4)NC(=O)C5=NC=CN=C5,PHASE2,immune_system_disease
1897,Asthma,Epinephrine,CNCC(C1=CC(=C(C=C1)O)O)O,PHASE1|PHASE2,immune_system_disease
1898,Advanced Cancer|Gastric Cancer|Breast Cancer|Pancreatic Cancer|Prostate Cancer Metastatic|Colo-rectal Cancer|Solid Tumor|Solid Carcinoma|Solid Carcinoma of Stomach|Cancer of Stomach|Lymphoma|Sarcoma|Cutaneous T Cell Lymphoma|Head and Neck Squamous Cell Carcinoma|Basal Cell Carcinoma|Cutaneous T-cell Lymphoma|Cutaneous Squamous Cell Carcinoma,Capecitabine,CCCCCOC(=O)NC1=NC(=O)N(C=C1F)C2C(C(C(O2)C)O)O,PHASE1,immune_system_disease
1899,Indolent B-cell Lymphoma|Hepatitis C,Ledipasvir,CC(C)C(C(=O)N1CC2(CC2)CC1C3=NC=C(N3)C4=CC5=C(C=C4)C6=C(C5(F)F)C=C(C=C6)C7=CC8=C(C=C7)N=C(N8)C9C1CCC(C1)N9C(=O)C(C(C)C)NC(=O)OC)NC(=O)OC,PHASE2,immune_system_disease
1900,Indolent B-cell Lymphoma|Hepatitis C,Sofosbuvir,CC(C)OC(=O)C(C)NP(=O)(OCC1C(C(C(O1)N2C=CC(=O)NC2=O)(C)F)O)OC3=CC=CC=C3,PHASE2,immune_system_disease
1901,Indolent B-cell Lymphoma|Hepatitis C,Velpatasvir,CC1CCC(N1C(=O)C(C(C)C)NC(=O)OC)C2=NC3=C(N2)C=CC4=CC5=C(C=C43)OCC6=C5C=CC(=C6)C7=CN=C(N7)C8CC(CN8C(=O)C(C9=CC=CC=C9)NC(=O)OC)COC,PHASE2,immune_system_disease
1902,Advanced Multiple Myeloma,Filanesib,CN(C(=O)N1C(SC(=N1)C2=C(C=CC(=C2)F)F)(CCCN)C3=CC=CC=C3)OC,PHASE2,immune_system_disease
1903,HIV Infections,Zalcitabine,C1CC(OC1CO)N2C=CC(=NC2=O)N,PHASE2,immune_system_disease
1904,Mantle Cell Lymphoma,Pegfilgrastim,CC(C(C(=O)O)N)OC1C(C(C(C(O1)COC2(CC(C(C(O2)C(C(CO)O)O)NC(=O)CNC(=O)OCCOC)O)C(=O)O)O)O)NC(=O)C,PHASE1,immune_system_disease
1905,"Infections, Human Immunodeficiency Virus and Hepatitis",Levonorgestrel,CCC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34,PHASE1,immune_system_disease
1906,Asthma,Cavosonstat,C1=CC(=C(C=C1C(=O)O)Cl)C2=NC3=C(C=C2)C=C(C=C3)O,PHASE2,immune_system_disease
1907,Ovarian Cancer|Peritoneal Cancer|Fallopian Tube Cancer,Pemetrexed,C1=CC(=CC=C1CCC2=CNC3=C2C(=O)NC(=N3)N)C(=O)NC(CCC(=O)O)C(=O)O,PHASE2,immune_system_disease
1908,Diffuse Large B-cell Lymphoma (DLBCL)|Relapsed Diffuse Large B-cell Lymphoma (DLBCL)|Refractory Diffuse Large B-cell Lymphoma (DLBCL),Plerixafor,C1CNCCNCCCN(CCNC1)CC2=CC=C(C=C2)CN3CCCNCCNCCCNCC3,PHASE2,immune_system_disease
1909,Multiple Myeloma,Clarithromycin,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)O)(C)O,PHASE1|PHASE2,immune_system_disease
1910,HIV Infection|HIV Infections,Losartan,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl,PHASE2,immune_system_disease
1911,Atopic Dermatitis|Allergic Contact Dermatitis,Apremilast,CCOC1=C(C=CC(=C1)C(CS(=O)(=O)C)N2C(=O)C3=C(C2=O)C(=CC=C3)NC(=O)C)OC,PHASE2,immune_system_disease
1912,Acute-graft-versus-host Disease|Chronic Graft-versus-host-disease|Solid Organ Transplant,Ruxolitinib,C1CCC(C1)C(CC#N)N2C=C(C=N2)C3=C4C=CNC4=NC=N3,PHASE1,immune_system_disease
1913,Acute Myeloid Leukemia (AML)|Acute Lymphoblastic Leukemia (ALL)|Neuroblastoma|Solid Tumors,Idasanutlin,CC(C)(C)CC1C(C(C(N1)C(=O)NC2=C(C=C(C=C2)C(=O)O)OC)C3=C(C(=CC=C3)Cl)F)(C#N)C4=C(C=C(C=C4)Cl)F,PHASE1|PHASE2,immune_system_disease
1914,Acute Myeloid Leukemia (AML)|Acute Lymphoblastic Leukemia (ALL)|Neuroblastoma|Solid Tumors,Topotecan,CCC1(C2=C(COC1=O)C(=O)N3CC4=CC5=C(C=CC(=C5CN(C)C)O)N=C4C3=C2)O,PHASE1|PHASE2,immune_system_disease
1915,Atopic Dermatitis,Indigo,C1=CC=C2C(=C1)C(=C(N2)C3=NC4=CC=CC=C4C3=O)O,PHASE2,immune_system_disease
1916,HIV/AIDS|HIV Infections,Etravirine,CC1=CC(=CC(=C1OC2=NC(=NC(=C2Br)N)NC3=CC=C(C=C3)C#N)C)C#N,PHASE1,immune_system_disease
1917,Human Immunodeficiency Virus|HIV,Islatravir,C#CC1(C(CC(O1)N2C=NC3=C(N=C(N=C32)F)N)O)CO,PHASE2,immune_system_disease
1918,Hodgkin Disease,Vinblastine,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O,PHASE2,immune_system_disease
1919,Hodgkin Disease,Dacarbazine,CN(C)N=NC1=C(NC=N1)C(=O)N,PHASE2,immune_system_disease
1920,HIV Infections|AIDS,Cholecalciferol,CC(C)CCCC(C)C1CCC2C1(CCCC2=CC=C3CC(CCC3=C)O)C,PHASE2,immune_system_disease
1921,"Natural Killer/T-Cell Lymphoma, Nasal and Nasal-Type",Anlotinib,CC1=CC2=C(N1)C=CC(=C2F)OC3=C4C=C(C(=CC4=NC=C3)OCC5(CC5)N)OC,PHASE2,immune_system_disease
1922,Graft-versus-host-disease|Graft Vs Host Disease,Baricitinib,CCS(=O)(=O)N1CC(C1)(CC#N)N2C=C(C=N2)C3=C4C=CNC4=NC=N3,PHASE1,immune_system_disease
1923,Human Immunodeficiency Virus,Aspirin,CC(=O)OC1=CC=CC=C1C(=O)O,PHASE2,immune_system_disease
1924,Human Immunodeficiency Virus,Atorvastatin,CC(C)C1=C(C(=C(N1CCC(CC(CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4,PHASE2,immune_system_disease
1925,Follicular Lymphoma|B-Cell Lymphoma|Mantle Cell Lymphoma|Diffuse Large B Cell Lymphoma,Tazemetostat,CCN(C1CCOCC1)C2=CC(=CC(=C2C)C(=O)NCC3=C(C=C(NC3=O)C)C)C4=CC=C(C=C4)CN5CCOCC5,PHASE1,immune_system_disease
1926,HIV Infections,Saquinavir,CC(C)(C)NC(=O)C1CC2CCCCC2CN1CC(C(CC3=CC=CC=C3)NC(=O)C(CC(=O)N)NC(=O)C4=NC5=CC=CC=C5C=C4)O,PHASE2,immune_system_disease
1927,IgA Nephropathy|Immunoglobulin A Nephropathy,Atrasentan,CCCCN(CCCC)C(=O)CN1CC(C(C1C2=CC=C(C=C2)OC)C(=O)O)C3=CC4=C(C=C3)OCO4,PHASE2,immune_system_disease
1928,"Dermatitis, Atopic",Branebrutinib,CC#CC(=O)NC1CCCN(C1)C2=C(C=C(C3=C2C(=C(N3)C)C)C(=O)N)F,PHASE2,immune_system_disease
1929,Idiopathic Thrombocytopenic Purpura,Romiplostim,CC1=CC(=C(N1)C=C2C3=CC=CC=C3NC2=O)C,PHASE2,immune_system_disease
1930,Rheumatoid Arthritis,Upadacitinib,CCC1CN(CC1C2=CN=C3N2C4=C(NC=C4)N=C3)C(=O)NCC(F)(F)F,PHASE2,immune_system_disease
1931,Myasthenia Gravis,Albuterol,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,PHASE2|PHASE3,immune_system_disease
1932,Myasthenia Gravis,Salbutamol,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,PHASE2|PHASE3,immune_system_disease
1933,HIV Infections|Cachexia|Anorexia|AIDS Wasting Syndrome|HIV Wasting Syndrome,Megestrol,CC1=CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C,PHASE2,immune_system_disease
1934,Multiple Sclerosis,Duloxetine,CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32,PHASE2|PHASE3,immune_system_disease
1935,Sjogren's Syndrome,Iguratimod,CS(=O)(=O)NC1=C(C=C2C(=C1)OC=C(C2=O)NC=O)OC3=CC=CC=C3,PHASE1|PHASE2,immune_system_disease
1936,HIV Infections,Miglustat,CCCCN1CC(C(C(C1CO)O)O)O,PHASE1,immune_system_disease
1937,Advanced Lymphoma|Advanced Malignant Solid Neoplasm|Hematopoietic and Lymphoid Cell Neoplasm|Refractory Lymphoma|Refractory Malignant Solid Neoplasm|Refractory Multiple Myeloma,Dabrafenib,CC(C)(C)C1=NC(=C(S1)C2=NC(=NC=C2)N)C3=C(C(=CC=C3)NS(=O)(=O)C4=C(C=CC=C4F)F)F,PHASE2,immune_system_disease
1938,Advanced Lymphoma|Advanced Malignant Solid Neoplasm|Hematopoietic and Lymphoid Cell Neoplasm|Refractory Lymphoma|Refractory Malignant Solid Neoplasm|Refractory Multiple Myeloma,Trametinib,CC1=C2C(=C(N(C1=O)C)NC3=C(C=C(C=C3)I)F)C(=O)N(C(=O)N2C4=CC=CC(=C4)NC(=O)C)C5CC5,PHASE2,immune_system_disease
1939,"Diabetes Mellitus, Type 1",Vildagliptin,C1CC(N(C1)C(=O)CNC23CC4CC(C2)CC(C4)(C3)O)C#N,PHASE2,immune_system_disease
1940,Solid Tumor|Colorectal Cancer|Non Hodgkin Lymphoma|Sarcoma|Chondrosarcoma|Small Lymphocytic Lymphoma|Chronic Lymphocytic Leukemia|Acute Myeloid Leukemia,Birinapant,CCC(C(=O)N1CC(CC1CC2=C(NC3=C2C=CC(=C3)F)C4=C(C5=C(N4)C=C(C=C5)F)CC6CC(CN6C(=O)C(CC)NC(=O)C(C)NC)O)O)NC(=O)C(C)NC,PHASE1,immune_system_disease
1941,Solid Tumor|Colorectal Cancer|Non Hodgkin Lymphoma|Sarcoma|Chondrosarcoma|Small Lymphocytic Lymphoma|Chronic Lymphocytic Leukemia|Acute Myeloid Leukemia,Docetaxel,CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O,PHASE1,immune_system_disease
1942,Asthma,Formoterol,CC(CC1=CC=C(C=C1)OC)NCC(C2=CC(=C(C=C2)O)NC=O)O,PHASE2,immune_system_disease
1943,Asthma,Beclomethasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)Cl)C,PHASE2,immune_system_disease
1944,Atopic Dermatitis,Warfarin,CC(=O)CC(C1=CC=CC=C1)C2=C(C3=CC=CC=C3OC2=O)O,PHASE1,immune_system_disease
1945,Atopic Dermatitis,Omeprazole,CC1=CN=C(C(=C1OC)C)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC,PHASE1,immune_system_disease
1946,Atopic Dermatitis,Metoprolol,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O,PHASE1,immune_system_disease
1947,Atopic Dermatitis,Midazolam,CC1=NC=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4F,PHASE1,immune_system_disease
1948,Primary Progressive Multiple Sclerosis,Idebenone,CC1=C(C(=O)C(=C(C1=O)OC)OC)CCCCCCCCCCO,PHASE1|PHASE2,immune_system_disease
1949,Multiple Myeloma,Vactosertib,CC1=NC(=CC=C1)C2=C(N=C(N2)CNC3=CC=CC=C3F)C4=CN5C(=NC=N5)C=C4,PHASE1,immune_system_disease
1950,Atopic Dermatitis,Halobetasol,CC1CC2C3CC(C4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CCl)O)C)O)F)C)F,PHASE2,immune_system_disease
1951,Atopic Dermatitis,Ulobetasol,CC1CC2C3CC(C4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CCl)O)C)O)F)C)F,PHASE2,immune_system_disease
1952,"Infection, Human Immunodeficiency Virus|HIV Infections",Cabotegravir,CC1COC2N1C(=O)C3=C(C(=O)C(=CN3C2)C(=O)NCC4=C(C=C(C=C4)F)F)O,PHASE1,immune_system_disease
1953,"Infection, Human Immunodeficiency Virus|HIV Infections",Rifabutin,CC1C=CC=C(C(=O)NC2=C(C3=C(C4=C(C(=C3O)C)OC(C4=O)(OC=CC(C(C(C(C(C(C1O)C)O)C)OC(=O)C)C)OC)C)C5=NC6(CCN(CC6)CC(C)C)N=C25)O)C,PHASE1,immune_system_disease
1954,HIV Infections|Histoplasmosis,Itraconazole,CCC(C)N1C(=O)N(C=N1)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(C=C4)OCC5COC(O5)(CN6C=NC=N6)C7=C(C=C(C=C7)Cl)Cl,PHASE1,immune_system_disease
1955,Diffuse Large B-Cell Lymphoma|Transformed Follicular Lymphoma|Mantle Cell Lymphoma|Burkitt's Lymphoma,Alisertib,COC1=C(C(=CC=C1)F)C2=NCC3=CN=C(N=C3C4=C2C=C(C=C4)Cl)NC5=CC(=C(C=C5)C(=O)O)OC,PHASE1|PHASE2,immune_system_disease
1956,Lymphoma,Ciprofloxacin,C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O,PHASE1,immune_system_disease
1957,Lymphoma,Fluconazole,C1=CC(=C(C=C1F)F)C(CN2C=NC=N2)(CN3C=NC=N3)O,PHASE1,immune_system_disease
1958,Multiple Myeloma,Iberdomide,C1CC(=O)NC(=O)C1N2CC3=C(C2=O)C=CC=C3OCC4=CC=C(C=C4)CN5CCOCC5,PHASE1|PHASE2,immune_system_disease
1959,Asthma,Rosiglitazone,CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3,PHASE1,immune_system_disease
1960,Philadelphia Chromsome Positive Acute Lymphoblastic Leukemia,Nilotinib,CC1=C(C=C(C=C1)C(=O)NC2=CC(=CC(=C2)C(F)(F)F)N3C=C(N=C3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,PHASE2,immune_system_disease
1961,HIV Infections,Maraviroc,CC1=NN=C(N1C2CC3CCC(C2)N3CCC(C4=CC=CC=C4)NC(=O)C5CCC(CC5)(F)F)C(C)C,PHASE2|PHASE3,immune_system_disease
1962,Memory Disorders|Multiple Sclerosis,Atomoxetine,CC1=CC=CC=C1OC(CCNC)C2=CC=CC=C2,PHASE2,immune_system_disease
1963,Myasthenia Gravis|Ocular Myasthenia Gravis,Apraclonidine,C1CN=C(N1)NC2=C(C=C(C=C2Cl)N)Cl,PHASE2,immune_system_disease
1964,"Asthma, Exercise-Induced",Reproterol,CN1C2=C(C(=O)N(C1=O)C)N(C=N2)CCCNCC(C3=CC(=CC(=C3)O)O)O,PHASE2,immune_system_disease
1965,Breast Cancer,Epirubicin,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)N)O,PHASE2,immune_system_disease
1966,Breast Cancer,Triptorelin,CC(C)CC(C(=O)NC(CCCN=C(N)N)C(=O)N1CCCC1C(=O)NCC(=O)N)NC(=O)C(CC2=CNC3=CC=CC=C32)NC(=O)C(CC4=CC=C(C=C4)O)NC(=O)C(CO)NC(=O)C(CC5=CNC6=CC=CC=C65)NC(=O)C(CC7=CN=CN7)NC(=O)C8CCC(=O)N8,PHASE2,immune_system_disease
1967,Breast Cancer,Exemestane,CC12CCC3C(C1CCC2=O)CC(=C)C4=CC(=O)C=CC34C,PHASE2,immune_system_disease
1968,Multiple Sclerosis,Famciclovir,CC(=O)OCC(CCN1C=NC2=CN=C(N=C21)N)COC(=O)C,PHASE2,immune_system_disease
1969,"Diabetes Mellitus, Type 1",Verapamil,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,PHASE2,immune_system_disease
1970,HIV Infections|Acquired Immunodeficiency Syndrome,Atazanavir,CC(C)(C)C(C(=O)NC(CC1=CC=CC=C1)C(CN(CC2=CC=C(C=C2)C3=CC=CC=N3)NC(=O)C(C(C)(C)C)NC(=O)OC)O)NC(=O)OC,PHASE2,immune_system_disease
1971,HIV Infections|Acquired Immunodeficiency Syndrome,Tenofovir,CC(CN1C=NC2=C(N=CN=C21)N)OCP(=O)(O)O,PHASE2,immune_system_disease
1972,Hormone-sensitive Metastatic Breast Cancer,Erlotinib,COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC,PHASE2,immune_system_disease
1973,Hormone-sensitive Metastatic Breast Cancer,Letrozole,C1=CC(=CC=C1C#N)C(C2=CC=C(C=C2)C#N)N3C=NC=N3,PHASE2,immune_system_disease
1974,Hormone-sensitive Metastatic Breast Cancer,Goserelin,CC(C)CC(C(=O)NC(CCCN=C(N)N)C(=O)N1CCCC1C(=O)NNC(=O)N)NC(=O)C(COC(C)(C)C)NC(=O)C(CC2=CC=C(C=C2)O)NC(=O)C(CO)NC(=O)C(CC3=CNC4=CC=CC=C43)NC(=O)C(CC5=CN=CN5)NC(=O)C6CCC(=O)N6,PHASE2,immune_system_disease
1975,HIV Infections,Capravirine,CC(C)C1=C(N(C(=N1)COC(=O)N)CC2=CC=NC=C2)SC3=CC(=CC(=C3)Cl)Cl,PHASE2,immune_system_disease
1976,Hematopoietic and Lymphoid System Neoplasm|Recurrent Ependymoma|Recurrent Ewing Sarcoma|Recurrent Hepatoblastoma|Recurrent Histiocytic and Dendritic Cell Neoplasm|Recurrent Langerhans Cell Histiocytosis|Recurrent Lymphoma|Recurrent Malignant Germ Cell Tumor|Recurrent Malignant Glioma|Recurrent Malignant Solid Neoplasm|Recurrent Medulloblastoma|Recurrent Neuroblastoma|Recurrent Non-Hodgkin Lymphoma|Recurrent Osteosarcoma|Recurrent Peripheral Primitive Neuroectodermal Tumor|Recurrent Rhabdoid Tumor|Recurrent Rhabdomyosarcoma|Recurrent Soft Tissue Sarcoma|Recurrent WHO Grade 2 Glioma|Refractory Ependymoma|Refractory Ewing Sarcoma|Refractory Hepatoblastoma|Refractory Histiocytic and Dendritic Cell Neoplasm|Refractory Langerhans Cell Histiocytosis|Refractory Lymphoma|Refractory Malignant Germ Cell Tumor|Refractory Malignant Glioma|Refractory Malignant Solid Neoplasm|Refractory Medulloblastoma|Refractory Neuroblastoma|Refractory Non-Hodgkin Lymphoma|Refractory Osteosarcoma|Refractory Peripheral Primitive Neuroectodermal Tumor|Refractory Rhabdoid Tumor|Refractory Rhabdomyosarcoma|Refractory Soft Tissue Sarcoma|Refractory WHO Grade 2 Glioma|Wilms Tumor,Selpercatinib,CC(C)(COC1=CN2C(=C(C=N2)C#N)C(=C1)C3=CN=C(C=C3)N4CC5CC(C4)N5CC6=CN=C(C=C6)OC)O,PHASE2,immune_system_disease
1977,Optic Neuritis|Multiple Sclerosis,Amiloride,C1(=C(N=C(C(=N1)Cl)N)N)C(=O)N=C(N)N,PHASE2,immune_system_disease
1978,Type 1 Diabetes,Glucagon,CC(C)CC(C(=O)NC(CCSC)C(=O)NC(CC(=O)N)C(=O)NC(C(C)O)C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)NC(=O)C(CCC(=O)N)NC(=O)C(C(C)C)NC(=O)C(CC3=CC=CC=C3)NC(=O)C(CC(=O)O)NC(=O)C(CCC(=O)N)NC(=O)C(C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C(CC(=O)O)NC(=O)C(CC(C)C)NC(=O)C(CC4=CC=C(C=C4)O)NC(=O)C(CCCCN)NC(=O)C(CO)NC(=O)C(CC5=CC=C(C=C5)O)NC(=O)C(CC(=O)O)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C(CC6=CC=CC=C6)NC(=O)C(C(C)O)NC(=O)CNC(=O)C(CCC(=O)N)NC(=O)C(CO)NC(=O)C(CC7=CN=CN7)N,PHASE2,immune_system_disease
1979,Relapsing Multiple Sclerosis,Glatiramer,CC(C(=O)O)N.C1=CC(=CC=C1CC(C(=O)O)N)O.C(CCN)CC(C(=O)O)N.C(CC(=O)O)C(C(=O)O)N,PHASE2,immune_system_disease
1980,Refractory Acute Lymphoblastic Leukemia|Relapsed Acute Lymphoblastic Leukemia,Navitoclax,CC1(CCC(=C(C1)CN2CCN(CC2)C3=CC=C(C=C3)C(=O)NS(=O)(=O)C4=CC(=C(C=C4)NC(CCN5CCOCC5)CSC6=CC=CC=C6)S(=O)(=O)C(F)(F)F)C7=CC=C(C=C7)Cl)C,PHASE1|PHASE2,immune_system_disease
1981,Refractory Acute Lymphoblastic Leukemia|Relapsed Acute Lymphoblastic Leukemia,Leucovorin,C1C(N(C2=C(N1)N=C(NC2=O)N)C=O)CNC3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,PHASE1|PHASE2,immune_system_disease
1982,Multiple Sclerosis,Pioglitazone,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3,PHASE1|PHASE2,immune_system_disease
1983,Multiple Sclerosis,Dantrolene,C1C(=O)NC(=O)N1N=CC2=CC=C(O2)C3=CC=C(C=C3)[N+](=O)[O-],PHASE1|PHASE2,immune_system_disease
1984,Multiple Sclerosis,Pirfenidone,CC1=CN(C(=O)C=C1)C2=CC=CC=C2,PHASE1|PHASE2,immune_system_disease
1985,"Healthy Subjects|Infection, Human Immunodeficiency Virus",Flurbiprofen,CC(C1=CC(=C(C=C1)C2=CC=CC=C2)F)C(=O)O,PHASE1,immune_system_disease
1986,Follicular Lymphoma,Idelalisib,CCC(C1=NC2=C(C(=CC=C2)F)C(=O)N1C3=CC=CC=C3)NC4=NC=NC5=C4NC=N5,PHASE2,immune_system_disease
1987,HIV Infection,Aprepitant,CC(C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)OC2C(N(CCO2)CC3=NNC(=O)N3)C4=CC=C(C=C4)F,PHASE1,immune_system_disease
1988,Mantle Cell Lymphoma,Chlorambucil,C1=CC(=CC=C1CCCC(=O)O)N(CCCl)CCCl,PHASE2,immune_system_disease
1989,Advanced Solid Neoplasm|Aggressive Non-Hodgkin Lymphoma|Recurrent Solid Neoplasm|Refractory Mantle Cell Lymphoma|T-Cell Non-Hodgkin Lymphoma|Unresectable Solid Neoplasm,Veliparib,CC1(CCCN1)C2=NC3=C(C=CC=C3N2)C(=O)N,PHASE1,immune_system_disease
1990,Asthma,Zileuton,CC(C1=CC2=CC=CC=C2S1)N(C(=O)N)O,PHASE1|PHASE2,immune_system_disease
1991,Chronic Graft-versus-host-disease,Belumosudil,CC(C)NC(=O)COC1=CC=CC(=C1)C2=NC3=CC=CC=C3C(=N2)NC4=CC5=C(C=C4)NN=C5,PHASE2,immune_system_disease
1992,Multiple Sclerosis,Carbidopa,CC(CC1=CC(=C(C=C1)O)O)(C(=O)O)NN,PHASE1,immune_system_disease
1993,HIV Infections,Bupivacaine,CCCCN1CCCCC1C(=O)NC2=C(C=CC=C2C)C,PHASE1,immune_system_disease
1994,Multiple Sclerosis|Fatigue,Ketamine,CNC1(CCCCC1=O)C2=CC=CC=C2Cl,PHASE1|PHASE2,immune_system_disease
1995,Skin Inflammation|Allergic Contact Dermatitis,Betamethasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,PHASE2|PHASE3,immune_system_disease
1996,Multiple Sclerosis,Dexrazoxane,CC(CN1CC(=O)NC(=O)C1)N2CC(=O)NC(=O)C2,PHASE2,immune_system_disease
1997,Asthma,Methacholine,CC(C[N+](C)(C)C)OC(=O)C,PHASE2,immune_system_disease
1998,Gastric Cancer|Gastroesophageal Junction Adenocarcinoma,Fluorouracil,C1=C(C(=O)NC(=O)N1)F,PHASE2,immune_system_disease
1999,Aggressive Systemic Mastocytosis|Systemic Mastocytosis-associated Hematologic Non-mast Cell Disease|Mast Cell Leukemia|Relapsed or Refractory Myeloid Malignancies,Avapritinib,CC(C1=CC=C(C=C1)F)(C2=CN=C(N=C2)N3CCN(CC3)C4=NC=NN5C4=CC(=C5)C6=CN(N=C6)C)N,PHASE1,immune_system_disease
2000,Type 1 Diabetes,Eflornithine,C(CC(C(F)F)(C(=O)O)N)CN,PHASE1,immune_system_disease
2001,Neoplasms Malignant,Crizotinib,CC(C1=C(C=CC(=C1Cl)F)Cl)OC2=C(N=CC(=C2)C3=CN(N=C3)C4CCNCC4)N,PHASE1,immune_system_disease
2002,Hypersensitivity,Sugammadex,C(CSCC1C2C(C(C(O1)OC3C(OC(C(C3O)O)OC4C(OC(C(C4O)O)OC5C(OC(C(C5O)O)OC6C(OC(C(C6O)O)OC7C(OC(C(C7O)O)OC8C(OC(C(C8O)O)OC9C(OC(O2)C(C9O)O)CSCCC(=O)O)CSCCC(=O)O)CSCCC(=O)O)CSCCC(=O)O)CSCCC(=O)O)CSCCC(=O)O)CSCCC(=O)O)O)O)C(=O)O,PHASE1,immune_system_disease
2003,Immune Thrombocytopenia|Bruton's Tyrosine Kinase,Orelabrutinib,C=CC(=O)N1CCC(CC1)C2=NC(=C(C=C2)C(=O)N)C3=CC=C(C=C3)OC4=CC=CC=C4,PHASE2,immune_system_disease
2004,Type 1 Diabetes,Bromocriptine,CC(C)CC1C(=O)N2CCCC2C3(N1C(=O)C(O3)(C(C)C)NC(=O)C4CN(C5CC6=C(NC7=CC=CC(=C67)C5=C4)Br)C)O,PHASE2,immune_system_disease
2005,Type1 Diabetes Mellitus|Autoimmune Diabetes,Liraglutide,CCCCCCCCCCCCCCCC(=O)NC(CCC(=O)NCCCCC(C(=O)NC(CCC(=O)O)C(=O)NC(CC1=CC=CC=C1)C(=O)NC(C(C)CC)C(=O)NC(C)C(=O)NC(CC2=CNC3=CC=CC=C32)C(=O)NC(CC(C)C)C(=O)NC(C(C)C)C(=O)NC(CCCNC(=N)N)C(=O)NCC(=O)NC(CCCNC(=N)N)C(=O)NCC(=O)O)NC(=O)C(C)NC(=O)C(C)NC(=O)C(CCC(=O)N)NC(=O)CNC(=O)C(CCC(=O)O)NC(=O)C(CC(C)C)NC(=O)C(CC4=CC=C(C=C4)O)NC(=O)C(CO)NC(=O)C(CO)NC(=O)C(C(C)C)NC(=O)C(CC(=O)O)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C(CC5=CC=CC=C5)NC(=O)C(C(C)O)NC(=O)CNC(=O)C(CCC(=O)O)NC(=O)C(C)NC(=O)C(CC6=CN=CN6)N)C(=O)O,PHASE1|PHASE2,immune_system_disease
2006,Advanced Lymphoma|Advanced Malignant Solid Neoplasm|Hematopoietic and Lymphoid Cell Neoplasm|Refractory Lymphoma|Refractory Malignant Solid Neoplasm|Refractory Multiple Myeloma,Defactinib,CNC(=O)C1=CC=C(C=C1)NC2=NC=C(C(=N2)NCC3=NC=CN=C3N(C)S(=O)(=O)C)C(F)(F)F,PHASE2,immune_system_disease
2007,Sjogren's Syndrome,Lanraplenib,C1CN(CCN1C2COC2)C3=CC=C(C=C3)NC4=NC(=CN5C4=NC=C5)C6=CN=CC(=N6)N,PHASE2,immune_system_disease
2008,Sjogren's Syndrome,Filgotinib,C1CC1C(=O)NC2=NN3C(=N2)C=CC=C3C4=CC=C(C=C4)CN5CCS(=O)(=O)CC5,PHASE2,immune_system_disease
2009,Sjogren's Syndrome,Tirabrutinib,CC#CC(=O)N1CCC(C1)N2C3=NC=NC(=C3N(C2=O)C4=CC=C(C=C4)OC5=CC=CC=C5)N,PHASE2,immune_system_disease
2010,Systemic Lupus Erythematosus,Fulvestrant,CC12CCC3C(C1CCC2O)C(CC4=C3C=CC(=C4)O)CCCCCCCCCS(=O)CCCC(C(F)(F)F)(F)F,PHASE2,immune_system_disease
2011,Multiple Myeloma,Cobimetinib,C1CCNC(C1)C2(CN(C2)C(=O)C3=C(C(=C(C=C3)F)F)NC4=C(C=C(C=C4)I)F)O,PHASE1|PHASE2,immune_system_disease
2012,Type 1 Diabetes Mellitus,Lisofylline,CC(CCCCN1C(=O)C2=C(N=CN2C)N(C1=O)C)O,PHASE1|PHASE2,immune_system_disease
2013,Castration-Sensitive Prostate Carcinoma|Metastatic Prostate Adenocarcinoma|Stage IV Prostate Cancer AJCC v8|Stage IVA Prostate Cancer AJCC v8|Stage IVB Prostate Cancer AJCC v8,Abiraterone,CC12CCC(CC1=CCC3C2CCC4(C3CC=C4C5=CN=CC=C5)C)O,PHASE2,immune_system_disease
2014,Castration-Sensitive Prostate Carcinoma|Metastatic Prostate Adenocarcinoma|Stage IV Prostate Cancer AJCC v8|Stage IVA Prostate Cancer AJCC v8|Stage IVB Prostate Cancer AJCC v8,Bicalutamide,CC(CS(=O)(=O)C1=CC=C(C=C1)F)(C(=O)NC2=CC(=C(C=C2)C#N)C(F)(F)F)O,PHASE2,immune_system_disease
2015,Castration-Sensitive Prostate Carcinoma|Metastatic Prostate Adenocarcinoma|Stage IV Prostate Cancer AJCC v8|Stage IVA Prostate Cancer AJCC v8|Stage IVB Prostate Cancer AJCC v8,Degarelix,CC(C)CC(C(=O)NC(CCCCNC(C)C)C(=O)N1CCCC1C(=O)NC(C)C(=O)N)NC(=O)C(CC2=CC=C(C=C2)NC(=O)N)NC(=O)C(CC3=CC=C(C=C3)NC(=O)C4CC(=O)NC(=O)N4)NC(=O)C(CO)NC(=O)C(CC5=CN=CC=C5)NC(=O)C(CC6=CC=C(C=C6)Cl)NC(=O)C(CC7=CC8=CC=CC=C8C=C7)NC(=O)C,PHASE2,immune_system_disease
2016,Castration-Sensitive Prostate Carcinoma|Metastatic Prostate Adenocarcinoma|Stage IV Prostate Cancer AJCC v8|Stage IVA Prostate Cancer AJCC v8|Stage IVB Prostate Cancer AJCC v8,Leuprolide,CCNC(=O)C1CCCN1C(=O)C(CCCN=C(N)N)NC(=O)C(CC(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC2=CC=C(C=C2)O)NC(=O)C(CO)NC(=O)C(CC3=CNC4=CC=CC=C43)NC(=O)C(CC5=CN=CN5)NC(=O)C6CCC(=O)N6,PHASE2,immune_system_disease
2017,Castration-Sensitive Prostate Carcinoma|Metastatic Prostate Adenocarcinoma|Stage IV Prostate Cancer AJCC v8|Stage IVA Prostate Cancer AJCC v8|Stage IVB Prostate Cancer AJCC v8,Talazoparib,CN1C(=NC=N1)C2C(NC3=CC(=CC4=C3C2=NNC4=O)F)C5=CC=C(C=C5)F,PHASE2,immune_system_disease
2018,Rheumatoid Arthritis,Enalapril,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O,PHASE2,immune_system_disease
2019,Lymphoma|Relapsed|Refractory,Entinostat,C1=CC=C(C(=C1)N)NC(=O)C2=CC=C(C=C2)CNC(=O)OCC3=CN=CC=C3,PHASE2,immune_system_disease
2020,"Leukemia, Lymphocytic, Acute|Leukemia, Nonlymphocytic, Acute|Leukemia, Myeloid, Chronic|Myelodysplastic Syndromes",Vosaroxin,CNC1CN(CC1OC)C2=NC3=C(C=C2)C(=O)C(=CN3C4=NC=CS4)C(=O)O,PHASE1,immune_system_disease
2021,Mastocytosis,Hydroxychloroquine,CCN(CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl)CCO,PHASE2|PHASE3,immune_system_disease
2022,Atopic Dermatitis|Eczema,Mapracorat,CC1=NC2=C(C=C1)C(=CC=C2)NCC(CC(C)(C)C3=CC(=CC4=C3OCC4)F)(C(F)(F)F)O,PHASE2,immune_system_disease
2023,Patients With Advanced Ovarian Cancer Sensitive to Platinum-based Chemotherapy,Zibotentan,CC1=CN=C(C(=N1)OC)NS(=O)(=O)C2=C(N=CC=C2)C3=CC=C(C=C3)C4=NN=CO4,PHASE2,immune_system_disease
2024,HIV Infections,Cysteamine,C(CS)N,PHASE2,immune_system_disease
2025,HIV Infection|LTBI,Isoniazid,C1=CN=CC=C1C(=O)NN,PHASE2,immune_system_disease
2026,HIV Infection|LTBI,Rifapentine,CC1C=CC=C(C(=O)NC2=C(C(=C3C(=C2O)C(=C(C4=C3C(=O)C(O4)(OC=CC(C(C(C(C(C(C1O)C)O)C)OC(=O)C)C)OC)C)C)O)O)C=NN5CCN(CC5)C6CCCC6)C,PHASE2,immune_system_disease
2027,HIV Infection|LTBI,Pyridoxine,CC1=NC=C(C(=C1O)CO)CO,PHASE2,immune_system_disease
2028,"Peripheral T Cell Lymphoma Unspecified|Anaplastic Large Cell Lymphoma, ALK-negative|Angioimmunoblastic T Cell Lymphoma|Cutaneous T Cell Lymphoma",Everolimus,CC1CCC2CC(C(=CC=CC=CC(CC(C(=O)C(C(C(=CC(C(=O)CC(OC(=O)C3CCCCN3C(=O)C(=O)C1(O2)O)C(C)CC4CCC(C(C4)OC)OCCO)C)C)O)OC)C)C)C)OC,PHASE1|PHASE2,immune_system_disease
2029,Food Allergy,Abrocitinib,CCCS(=O)(=O)NC1CC(C1)N(C)C2=NC=NC3=C2C=CN3,PHASE1,immune_system_disease
2030,Lupus Nephritis,Iptacopan,CCOC1CCN(C(C1)C2=CC=C(C=C2)C(=O)O)CC3=C(C=C(C4=C3C=CN4)C)OC,PHASE2,immune_system_disease
2031,HCV-HIV Co-Infection,Asunaprevir,CC(C)(C)C(C(=O)N1CC(CC1C(=O)NC2(CC2C=C)C(=O)NS(=O)(=O)C3CC3)OC4=NC=C(C5=C4C=C(C=C5)Cl)OC)NC(=O)OC(C)(C)C,PHASE2,immune_system_disease
2032,HCV-HIV Co-Infection,Daclatasvir,CC(C)C(C(=O)N1CCCC1C2=NC=C(N2)C3=CC=C(C=C3)C4=CC=C(C=C4)C5=CN=C(N5)C6CCCN6C(=O)C(C(C)C)NC(=O)OC)NC(=O)OC,PHASE2,immune_system_disease
2033,Waldenstrom's Macroglobulinemia,Simvastatin,CCC(C)(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,PHASE2,immune_system_disease
2034,Atopic Dermatitis,Fexofenadine,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,PHASE2|PHASE3,immune_system_disease
2035,Human Immunodeficiency Virus Type 1,Enfuvirtide,CCC(C)C(C(=O)NC(CCC(=O)O)C(=O)NC(CCC(=O)O)C(=O)NC(CO)C(=O)NC(CCC(=O)N)C(=O)NC(CC(=O)N)C(=O)NC(CCC(=O)N)C(=O)NC(CCC(=O)N)C(=O)NC(CCC(=O)O)C(=O)NC(CCCCN)C(=O)NC(CC(=O)N)C(=O)NC(CCC(=O)O)C(=O)NC(CCC(=O)N)C(=O)NC(CCC(=O)O)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(CCC(=O)O)C(=O)NC(CC(C)C)C(=O)NC(CC(=O)O)C(=O)NC(CCCCN)C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(C)C(=O)NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC3=CNC4=CC=CC=C43)C(=O)NC(CC(=O)N)C(=O)NC(CC5=CNC6=CC=CC=C65)C(=O)NC(CC7=CC=CC=C7)C(=O)N)NC(=O)C(CC(C)C)NC(=O)C(CO)NC(=O)C(CC8=CN=CN8)NC(=O)C(C(C)CC)NC(=O)C(CC(C)C)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C(CC9=CC=C(C=C9)O)NC(=O)C,PHASE2,immune_system_disease
2036,Anemia|Chronic Lymphocytic Leukemia|Prolymphocytic Leukemia|Recurrent Small Lymphocytic Lymphoma|Refractory Chronic Lymphocytic Leukemia|Thrombocytopenia,Alvocidib,CN1CCC(C(C1)O)C2=C(C=C(C3=C2OC(=CC3=O)C4=CC=CC=C4Cl)O)O,PHASE1,immune_system_disease
2037,"Tuberculosis, Pulmonary|Tuberculosis, Multidrug-Resistant|Tuberculosis, MDR|Tuberculosis|Drug-Resistant Tuberculosis",Pretomanid,C1C(COC2=NC(=CN21)[N+](=O)[O-])OCC3=CC=C(C=C3)OC(F)(F)F,PHASE2|PHASE3,immune_system_disease
2038,"Tuberculosis, Pulmonary|Tuberculosis, Multidrug-Resistant|Tuberculosis, MDR|Tuberculosis|Drug-Resistant Tuberculosis",Bedaquiline,CN(C)CCC(C1=CC=CC2=CC=CC=C21)(C(C3=CC=CC=C3)C4=C(N=C5C=CC(=CC5=C4)Br)OC)O,PHASE2|PHASE3,immune_system_disease
2039,"Tuberculosis, Pulmonary|Tuberculosis, Multidrug-Resistant|Tuberculosis, MDR|Tuberculosis|Drug-Resistant Tuberculosis",Moxifloxacin,COC1=C2C(=CC(=C1N3CC4CCCNC4C3)F)C(=O)C(=CN2C5CC5)C(=O)O,PHASE2|PHASE3,immune_system_disease
2040,"Tuberculosis, Pulmonary|Tuberculosis, Multidrug-Resistant|Tuberculosis, MDR|Tuberculosis|Drug-Resistant Tuberculosis",Pyrazinamide,C1=CN=C(C=N1)C(=O)N,PHASE2|PHASE3,immune_system_disease
2041,Plasmacytoma|Recurrent Multiple Myeloma|Refractory Multiple Myeloma,Navtemadlin,CC(C)C(CS(=O)(=O)C(C)C)N1C(C(CC(C1=O)(C)CC(=O)O)C2=CC(=CC=C2)Cl)C3=CC=C(C=C3)Cl,PHASE1,immune_system_disease
2042,Multiple Myeloma,Imetelstat,CCCCCCCCCCCCCCCC(=O)NCC(COP(=S)(O)OCC1C(CC(O1)N2C=C(C(=O)NC2=O)C)NP(=S)(O)OCC3C(CC(O3)N4C=NC5=C(N=CN=C54)N)NP(=S)(O)OCC6C(CC(O6)N7C=NC8=C7N=C(NC8=O)N)NP(=S)(O)OCC9C(CC(O9)N1C=NC2=C1N=C(NC2=O)N)NP(=S)(O)OCC1C(CC(O1)N1C=NC2=C1N=C(NC2=O)N)NP(=S)(O)OCC1C(CC(O1)N1C=C(C(=O)NC1=O)C)NP(=S)(O)OCC1C(CC(O1)N1C=C(C(=O)NC1=O)C)NP(=S)(O)OCC1C(CC(O1)N1C=NC2=C(N=CN=C21)N)NP(=S)(O)OCC1C(CC(O1)N1C=NC2=C1N=C(NC2=O)N)NP(=S)(O)OCC1C(CC(O1)N1C=NC2=C(N=CN=C21)N)NP(=S)(O)OCC1C(CC(O1)N1C=CC(=NC1=O)N)NP(=S)(O)OCC1C(CC(O1)N1C=NC2=C(N=CN=C21)N)NP(=O)(OCC1C(CC(O1)N1C=NC2=C(N=CN=C21)N)N)S)O,PHASE2,immune_system_disease
2043,Acute Myeloid Leukemia|Acute Lymphoid Leukemia,Deferasirox,C1=CC=C(C(=C1)C2=NN(C(=N2)C3=CC=CC=C3O)C4=CC=C(C=C4)C(=O)O)O,PHASE1,immune_system_disease
2044,HIV Infections|Acquired Immunodeficiency Syndrome,Vicriviroc,CC1CN(CCN1C(COC)C2=CC=C(C=C2)C(F)(F)F)C3(CCN(CC3)C(=O)C4=C(N=CN=C4C)C)C,PHASE2,immune_system_disease
2045,Rheumatoid Arthritis,Rosuvastatin,CC(C)C1=NC(=NC(=C1C=CC(CC(CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C,PHASE1,immune_system_disease
2046,HIV Infections,Tipranavir,CCCC1(CC(=C(C(=O)O1)C(CC)C2=CC(=CC=C2)NS(=O)(=O)C3=NC=C(C=C3)C(F)(F)F)O)CCC4=CC=CC=C4,PHASE2,immune_system_disease
2047,HIV Infections,Delavirdine,CC(C)NC1=C(N=CC=C1)N2CCN(CC2)C(=O)C3=CC4=C(N3)C=CC(=C4)NS(=O)(=O)C,PHASE2,immune_system_disease
2048,Peripheral T-cell Lymphoma,Vindesine,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C)(C(=O)N)O)O)CC)OC)C(=O)OC)O,PHASE2,immune_system_disease
2049,Peripheral T-cell Lymphoma,Bleomycin,CC1=C(N=C(N=C1N)C(CC(=O)N)NCC(C(=O)N)N)C(=O)NC(C(C2=CN=CN2)OC3C(C(C(C(O3)CO)O)O)OC4C(C(C(C(O4)CO)O)OC(=O)N)O)C(=O)NC(C)C(C(C)C(=O)NC(C(C)O)C(=O)NCCC5=NC(=CS5)C6=NC(=CS6)C(=O)NCCC[S+](C)C)O,PHASE2,immune_system_disease
2050,Smoldering Multiple Myeloma,Hiltonol,C1=CN(C(=O)N=C1N)C2C(C(C(O2)COP(=O)(O)O)O)O.C1=NC2=C(C(=O)N1)N=CN2C3C(C(C(O3)COP(=O)(O)O)O)O.C(CCNC(=O)O)CN.C(C(=O)O)O,PHASE1,immune_system_disease
2051,Smoldering Multiple Myeloma,Citarinostat,C1=CC=C(C=C1)N(C2=CC=CC=C2Cl)C3=NC=C(C=N3)C(=O)NCCCCCCC(=O)NO,PHASE1,immune_system_disease
2052,Multiple Myeloma,Oprozomib,CC1=NC=C(S1)C(=O)NC(COC)C(=O)NC(COC)C(=O)NC(CC2=CC=CC=C2)C(=O)C3(CO3)C,PHASE1|PHASE2,immune_system_disease
2053,Mycobacterium Avium-intracellulare Infection,Streptomycin,CC1C(C(C(O1)OC2C(C(C(C(C2O)O)N=C(N)N)O)N=C(N)N)OC3C(C(C(C(O3)CO)O)O)NC)(C=O)O,PHASE2,immune_system_disease
2054,"Arthritis, Rheumatoid",Cantharidin,CC12C3CCC(C1(C(=O)OC2=O)C)O3,PHASE1,immune_system_disease
2055,HIV Infections,Rilpivirine,CC1=CC(=CC(=C1NC2=NC(=NC=C2)NC3=CC=C(C=C3)C#N)C)C=CC#N,PHASE1,immune_system_disease
2056,Multiple Sclerosis,Teriflunomide,CC(=C(C#N)C(=O)NC1=CC=C(C=C1)C(F)(F)F)O,PHASE2,immune_system_disease
2057,Atopic Dermatitis,Clobetasol,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CCl)O)C)O)F)C,PHASE1|PHASE2,immune_system_disease
2058,Autoimmune Hepatitis,Cannabidiol,CCCCCC1=CC(=C(C(=C1)O)C2C=C(CCC2C(=C)C)C)O,PHASE2,immune_system_disease
2059,B-cell Chronic Lymphocytic Leukemia,Forodesine,C1=C(C2=C(N1)C(=O)NC=N2)C3C(C(C(N3)CO)O)O,PHASE1,immune_system_disease
2060,Hematologic Malignancy|Malignant Lymphoma,Ketoconazole,CC(=O)N1CCN(CC1)C2=CC=C(C=C2)OCC3COC(O3)(CN4C=CN=C4)C5=C(C=C(C=C5)Cl)Cl,PHASE1,immune_system_disease
2061,Acute Myelogenous Leukemia|Acute Lymphoblastic Leukemia|Non-Hodgkin's Lymphoma,Fenretinide,CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CC(=O)NC2=CC=C(C=C2)O)C)C,PHASE1,immune_system_disease
2062,Smoldering Plasma Cell Myeloma,Cholestyramine,CCC(C)C.CCC(CC(C)C1=CC=CC=C1)C2=CC=C(C=C2)C[N+](C)(C)C.N.[Cl-],PHASE2,immune_system_disease
2063,Smoldering Plasma Cell Myeloma,Leflunomide,CC1=C(C=NO1)C(=O)NC2=CC=C(C=C2)C(F)(F)F,PHASE2,immune_system_disease
2064,Acute HIV Infection|HIV Infections,Telmisartan,CCCC1=NC2=C(N1CC3=CC=C(C=C3)C4=CC=CC=C4C(=O)O)C=C(C=C2C)C5=NC6=CC=CC=C6N5C,PHASE1,immune_system_disease
2065,Asthma,Ambrisentan,CC1=CC(=NC(=N1)OC(C(=O)O)C(C2=CC=CC=C2)(C3=CC=CC=C3)OC)C,PHASE2,immune_system_disease
2066,Asthma,Bosentan,CC(C)(C)C1=CC=C(C=C1)S(=O)(=O)NC2=C(C(=NC(=N2)C3=NC=CC=N3)OCCO)OC4=CC=CC=C4OC,PHASE2,immune_system_disease
2067,Waldenstrm's Macroglobulinemia,Perifosine,CCCCCCCCCCCCCCCCCCOP(=O)([O-])OC1CC[N+](CC1)(C)C,PHASE2,immune_system_disease
2068,Chemotherapeutic Agent Toxicity|Cognitive/Functional Effects|Lymphoma|Neurotoxicity|Radiation Toxicity,Procarbazine,CC(C)NC(=O)C1=CC=C(C=C1)CNNC,PHASE2,immune_system_disease
2069,Post-nasal Drip|Seasonal Allergic Rhinitis|Rhinorrhea,Desloratadine,C1CC2=C(C=CC(=C2)Cl)C(=C3CCNCC3)C4=C1C=CC=N4,PHASE2,immune_system_disease
2070,Post-nasal Drip|Seasonal Allergic Rhinitis|Rhinorrhea,Oxybutynin,CCN(CC)CC#CCOC(=O)C(C1CCCCC1)(C2=CC=CC=C2)O,PHASE2,immune_system_disease
2071,Recurrent B Acute Lymphoblastic Leukemia|Recurrent T Acute Lymphoblastic Leukemia|Refractory B Acute Lymphoblastic Leukemia|Refractory T Acute Lymphoblastic Leukemia,Nelarabine,COC1=NC(=NC2=C1N=CN2C3C(C(C(O3)CO)O)O)N,PHASE1|PHASE2,immune_system_disease
2072,HIV Infections,Raluridine,C1C(C(OC1N2C=C(C(=O)NC2=O)Cl)CO)F,PHASE1,immune_system_disease
2073,Peripheral T-cell Lymphoma,Pralatrexate,C#CCC(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,PHASE1|PHASE2,immune_system_disease
2074,Acute Myeloid Leukemia|Acute Lymphoblastic Leukemia,Aspacytarabine,C1=CN(C(=O)N=C1NC(=O)CC(C(=O)O)N)C2C(C(C(O2)CO)O)O,PHASE1|PHASE2,immune_system_disease
2075,Relapsing-remitting Multiple Sclerosis,Evobrutinib,C=CC(=O)N1CCC(CC1)CNC2=NC=NC(=C2C3=CC=C(C=C3)OC4=CC=CC=C4)N,PHASE2,immune_system_disease
2076,Leukemia|Multiple Myeloma|Myelodysplastic Syndrome|Non-Hodgkin's Lymphoma,Leuprorelin,CCNC(=O)C1CCCN1C(=O)C(CCCN=C(N)N)NC(=O)C(CC(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC2=CC=C(C=C2)O)NC(=O)C(CO)NC(=O)C(CC3=CNC4=CC=CC=C43)NC(=O)C(CC5=CN=CN5)NC(=O)C6CCC(=O)N6,PHASE2,immune_system_disease
2077,Hematopoietic and Lymphoid Cell Neoplasm|Recurrent Acute Lymphoblastic Leukemia|Recurrent Acute Myeloid Leukemia|Recurrent Chronic Myelomonocytic Leukemia|Recurrent Myelodysplastic Syndrome|Refractory Acute Lymphoblastic Leukemia|Refractory Acute Myeloid Leukemia|Refractory Chronic Myelomonocytic Leukemia|Refractory Myelodysplastic Syndrome,Posaconazole,CCC(C(C)O)N1C(=O)N(C=N1)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(C=C4)OCC5CC(OC5)(CN6C=NC=N6)C7=C(C=C(C=C7)F)F,PHASE1|PHASE2,immune_system_disease
2078,Mild to Moderate Atopic Dermatitis,Crisaborole,B1(C2=C(CO1)C=C(C=C2)OC3=CC=C(C=C3)C#N)O,PHASE1,immune_system_disease
2079,Multiple Myeloma,Uproleselan,CCC1CC(CC(C1OC2C(C(C(C(O2)C)O)O)O)OC3C(C(C(C(O3)CO)O)OC(CC4CCCCC4)C(=O)O)NC(=O)C)C(=O)NCCNC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC,PHASE2,immune_system_disease
2080,Atopic Dermatitis,Pimecrolimus,CCC1C=C(CC(CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC1=O)O)C)C(=CC4CCC(C(C4)OC)Cl)C)O)C)OC)OC)C)C,PHASE1,immune_system_disease
2081,"Recurrent Acute Leukemia|Recurrent B Acute Lymphoblastic Leukemia|Recurrent Blastic Plasmacytoid Dendritic Cell Neoplasm|Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Recurrent Hairy Cell Leukemia|Recurrent Hematologic Malignancy|Recurrent Hodgkin Lymphoma|Recurrent T Acute Lymphoblastic Leukemia|Refractory Acute Leukemia|Refractory B Acute Lymphoblastic Leukemia|Refractory Blastic Plasmacytoid Dendritic Cell Neoplasm|Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Refractory Hairy Cell Leukemia|Refractory Hematologic Malignancy|Refractory Hodgkin Lymphoma|Refractory T Acute Lymphoblastic Leukemia|Systemic Mastocytosis",Ibuprofen,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O,PHASE1,immune_system_disease
2082,"Recurrent Acute Leukemia|Recurrent B Acute Lymphoblastic Leukemia|Recurrent Blastic Plasmacytoid Dendritic Cell Neoplasm|Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Recurrent Hairy Cell Leukemia|Recurrent Hematologic Malignancy|Recurrent Hodgkin Lymphoma|Recurrent T Acute Lymphoblastic Leukemia|Refractory Acute Leukemia|Refractory B Acute Lymphoblastic Leukemia|Refractory Blastic Plasmacytoid Dendritic Cell Neoplasm|Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Refractory Hairy Cell Leukemia|Refractory Hematologic Malignancy|Refractory Hodgkin Lymphoma|Refractory T Acute Lymphoblastic Leukemia|Systemic Mastocytosis",Ranitidine,CNC(=C[N+](=O)[O-])NCCSCC1=CC=C(O1)CN(C)C,PHASE1,immune_system_disease
2083,"Multiple Sclerosis, Relapsing-Remitting",Firategrast,CCOCC1=CC(=C(C(=C1)OC)C2=CC=C(C=C2)CC(C(=O)O)NC(=O)C3=C(C=CC=C3F)F)OC,PHASE1,immune_system_disease
2084,Allergic Conjunctivitis,Loteprednol,CC12CC(C3C(C1CCC2(C(=O)OCCl)O)CCC4=CC(=O)C=CC34C)O,PHASE2,immune_system_disease
2085,"Acute Lymphoblastic Leukemia|Leukemia, Acute Myeloid (AML), Child|Lymphoma, Non-Hodgkin|Myelodysplastic Syndromes|Primary Immunodeficiency|Anemia, Aplastic|Hemoglobinopathies|Cytopenia|Fanconi Anemia|Diamond Blackfan Anemia|Thalassemia|Anemia, Sickle Cell",Rimiducid,CCC(C1=CC(=C(C(=C1)OC)OC)OC)C(=O)N2CCCCC2C(=O)OC(CCC3=CC(=C(C=C3)OC)OC)C4=CC(=CC=C4)OCC(=O)NCCNC(=O)COC5=CC=CC(=C5)C(CCC6=CC(=C(C=C6)OC)OC)OC(=O)C7CCCCN7C(=O)C(CC)C8=CC(=C(C(=C8)OC)OC)OC,PHASE1|PHASE2,immune_system_disease
2086,HIV Infections,Levofloxacin,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O,PHASE1,immune_system_disease
2087,Chronic Urticaria,Miltefosine,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,PHASE2,immune_system_disease
2088,"Multiple Myeloma|Multiple Myeloma in Relapse|Multiple Myeloma, Refractory",Marizomib,CC12C(C(=O)NC1(C(=O)O2)C(C3CCCC=C3)O)CCCl,PHASE2,immune_system_disease
2089,"Multiple Sclerosis, Relapsing-Remitting",Domperidone,C1CN(CCC1N2C3=C(C=C(C=C3)Cl)NC2=O)CCCN4C5=CC=CC=C5NC4=O,PHASE2,immune_system_disease
2090,Vincristine Induced Neurotoxicity|Acute Lymphoblastic Leukaemia,Mecobalamin,[CH3-].CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)([O-])OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=C(C7=NC(=CC8=NC(=C(C4=N5)C)C(C8(C)C)CCC(=O)N)C(C7(C)CC(=O)N)CCC(=O)N)C)[N-]6)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[Co+3],PHASE2|PHASE3,immune_system_disease
2091,HIV Infections,Pravastatin,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O,PHASE1,immune_system_disease
2092,HIV Infections,Doravirine,CN1C(=NNC1=O)CN2C=CC(=C(C2=O)OC3=CC(=CC(=C3)C#N)Cl)C(F)(F)F,PHASE2,immune_system_disease
2093,Rheumatoid Arthritis,Rebamipide,C1=CC=C2C(=C1)C(=CC(=O)N2)CC(C(=O)O)NC(=O)C3=CC=C(C=C3)Cl,PHASE1|PHASE2,immune_system_disease
2094,Chronic Graft Versus Host Disease,Vismodegib,CS(=O)(=O)C1=CC(=C(C=C1)C(=O)NC2=CC(=C(C=C2)Cl)C3=CC=CC=N3)Cl,PHASE2,immune_system_disease
2095,Dense Deposit Disease,Sulodexide,CNC1=C2C(=NC=N1)N(C=N2)C3C(C(C(O3)CO)O)OC,PHASE1,immune_system_disease
2096,BRCA Wild Type Platinum Sensitive Recurrent Ovarian Cancer,Olaparib,C1CC1C(=O)N2CCN(CC2)C(=O)C3=C(C=CC(=C3)CC4=NNC(=O)C5=CC=CC=C54)F,PHASE2,immune_system_disease
2097,"Multiple Sclerosis, Relapsing-Remitting",Inosine,C1=NC2=C(C(=O)N1)N=CN2C3C(C(C(O3)CO)O)O,PHASE2,immune_system_disease
2098,HIV Infections,Hydroxyurea,C(=O)(N)NO,PHASE1,immune_system_disease
2099,HIV Infections,Methoxsalen,COC1=C2C(=CC3=C1OC=C3)C=CC(=O)O2,PHASE1,immune_system_disease
2100,Rhinitis|Seasonal Rhinitis,Phenylephrine,CNCC(C1=CC(=CC=C1)O)O,PHASE2,immune_system_disease
2101,Rhinitis|Seasonal Rhinitis,Loratadine,CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1,PHASE2,immune_system_disease
2102,"Nasal Polyps|Asthma, Aspirin-Induced|Aspirin-exacerbated Respiratory Disease|Aspirin-Sensitive Asthma With Nasal Polyps",Ifetroban,CCCCCNC(=O)C1=COC(=N1)C2C3CCC(C2CC4=CC=CC=C4CCC(=O)O)O3,PHASE2,immune_system_disease
2103,Acute Lymphocytic Leukemia,Annamycin,CC1C(C(C(C(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=CC=CC=C5C4=O)O)(C(=O)CO)O)I)O)O,PHASE1|PHASE2,immune_system_disease
2104,Asthma,Salmeterol,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O,PHASE1,immune_system_disease
2105,Atopic Dermatitis,Antroquinonol,CC1C(C(C(=C(C1=O)OC)OC)O)CC=C(C)CCC=C(C)CCC=C(C)C,PHASE2,immune_system_disease
2106,Hodgkin Disease|Hodgkin's Lymphoma|Lymphoma,Vinorelbine,CCC1=CC2CC(C3=C(CN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC,PHASE2,immune_system_disease
2107,Allergic Conjunctivitis,Brimonidine,C1CN=C(N1)NC2=C(C3=NC=CN=C3C=C2)Br,PHASE2,immune_system_disease
2108,Allergic Conjunctivitis,Oxymetazoline,CC1=CC(=C(C(=C1CC2=NCCN2)C)O)C(C)(C)C,PHASE2,immune_system_disease
2109,"Multiple Sclerosis, Secondary Progressive",Indapamide,CC1CC2=CC=CC=C2N1NC(=O)C3=CC(=C(C=C3)Cl)S(=O)(=O)N,PHASE2,immune_system_disease
2110,HIV Seropositivity,Lovastatin,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,PHASE2,immune_system_disease
2111,Atopic Dermatitis,Tapinarof,CC(C)C1=C(C=C(C=C1O)C=CC2=CC=CC=C2)O,PHASE2,immune_system_disease
2112,Head and Neck Cancer|Oral Mucositis,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,PHASE1,immune_system_disease
2113,Recurrent Adult Diffuse Large Cell Lymphoma,Selumetinib,CN1C=NC2=C1C=C(C(=C2F)NC3=C(C=C(C=C3)Br)Cl)C(=O)NOCCO,PHASE2,immune_system_disease
2114,"Acute Biphenotypic Leukemia|Acute Lymphoblastic Leukemia in Remission|Acute Myeloid Leukemia in Remission|Blasts Under 5 Percent of Bone Marrow Nucleated Cells|Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Myelodysplastic Syndrome (MDS)",Treosulfan,CS(=O)(=O)OCC(C(COS(=O)(=O)C)O)O,PHASE2,immune_system_disease
2115,Allergic Rhinitis,Ketorolac,C1CN2C(=CC=C2C(=O)C3=CC=CC=C3)C1C(=O)O,PHASE1,immune_system_disease
2116,Allergic Rhinitis,Tromethamine,C(C(CO)(CO)N)O,PHASE1,immune_system_disease
2117,"Diabetes Mellitus, Type 1",Deoxyspergualin,C(CCCN=C(N)N)CCC(=O)NC(C(=O)NCCCCNCCCN)O,PHASE2,immune_system_disease
2118,HIV Infections,Celgosivir,CCCC(=O)OC1CN2CCC(C2C(C1O)O)O,PHASE2,immune_system_disease
2119,Relapsing Remitting Multiple Sclerosis,Laquinimod,CCN(C1=CC=CC=C1)C(=O)C2=C(C3=C(C=CC=C3Cl)N(C2=O)C)O,PHASE2,immune_system_disease
2120,HIV,Glutamine,C(CC(=O)N)C(C(=O)O)N,PHASE1|PHASE2,immune_system_disease
2121,"C3 Glomerulonephritis|Dense Deposit Disease|C3 Glomerulopathy|Immune Complex Mediated Membranoproliferative Glomerulonephritis|Membranoproliferative Glomerulonephritis Types I, II, and III",Danicopan,CC1=NC=C(C=N1)C2=CC3=C(C=C2)N(N=C3C(=O)C)CC(=O)N4CC(CC4C(=O)NC5=NC(=CC=C5)Br)F,PHASE2,immune_system_disease
2122,Atopic Dermatitis,Ivermectin,CCC(C)C1C(CCC2(O1)CC3CC(O2)CC=C(C(C(C=CC=C4COC5C4(C(C=C(C5O)C)C(=O)O3)O)C)OC6CC(C(C(O6)C)OC7CC(C(C(O7)C)O)OC)OC)C)C,PHASE2,immune_system_disease
2123,Allergic Rhinitis|Upper Respiratory Infection,Doxylamine,CC(C1=CC=CC=C1)(C2=CC=CC=N2)OCCN(C)C,PHASE1,immune_system_disease
2124,"Neoplasms|Colorectal Neoplasms|Melanoma|Pancreatic Neoplasms|Sarcoma|Ovarian Neoplasms|Brain Neoplasms|Thyroid Neoplasms|Neuroendocrine Tumors|Cholangiocarcinoma|Salivary Gland Neoplasms|Head and Neck Neoplasms|Thyroid Cancer, Papillary|Lymphoma, Large-Cell, Anaplastic|Neoplasms by Site|Respiratory Tract Neoplasms|Thoracic Neoplasms|Respiratory Tract Diseases|Carcinoma, Bronchogenic|Bronchial Neoplasms|Intestinal Neoplasms|Gastrointestinal Neoplasms|Digestive System Neoplasms|Digestive System Diseases|Gastrointestinal Diseases|Colonic Diseases|Intestinal Diseases|Central Nervous System",Alectinib,CCC1=CC2=C(C=C1N3CCC(CC3)N4CCOCC4)C(C5=C(C2=O)C6=C(N5)C=C(C=C6)C#N)(C)C,PHASE2,immune_system_disease
2125,Insulin Sensitivity,Gemcabene,CC(C)(CCCCOCCCCC(C)(C)C(=O)O)C(=O)O,PHASE2,immune_system_disease
2126,Asthma,Olodaterol,CC(C)(CC1=CC=C(C=C1)OC)NCC(C2=C3C(=CC(=C2)O)NC(=O)CO3)O,PHASE2,immune_system_disease
2127,Multiple Myeloma|Refractory Multiple Myeloma|Relapsed/Refractory Multiple Myeloma,Cabozantinib,COC1=CC2=C(C=CN=C2C=C1OC)OC3=CC=C(C=C3)NC(=O)C4(CC4)C(=O)NC5=CC=C(C=C5)F,PHASE1|PHASE2,immune_system_disease
2128,Type I Diabetes,Ladarixin,CC(C1=CC=C(C=C1)OS(=O)(=O)C(F)(F)F)C(=O)NS(=O)(=O)C,PHASE2,immune_system_disease
2129,Multiple Sclerosis,Mangafodipir,[H+].[H+].[H+].[H+].CC1=NC=C(C(=C1O)CN(CCN(CC2=C(C(=NC=C2COP(=O)([O-])[O-])C)O)CC(=O)[O-])CC(=O)[O-])COP(=O)([O-])[O-].[Mn+2],PHASE1,immune_system_disease
2130,Asthma,Tiotropium,C[N+]1(C2CC(CC1C3C2O3)OC(=O)C(C4=CC=CS4)(C5=CC=CS5)O)C,PHASE2,immune_system_disease
2131,B-Cell Prolymphocytic Leukemia|Recurrent Chronic Lymphocytic Leukemia|Recurrent Diffuse Large B-Cell Lymphoma|Recurrent Follicular Lymphoma|Recurrent Lymphoplasmacytic Lymphoma|Recurrent Mantle Cell Lymphoma|Recurrent Marginal Zone Lymphoma|Recurrent Non-Hodgkin Lymphoma|Recurrent Small Lymphocytic Lymphoma|Refractory Chronic Lymphocytic Leukemia|Refractory Diffuse Large B-Cell Lymphoma|Refractory Follicular Lymphoma|Refractory Lymphoplasmacytic Lymphoma|Refractory Mantle Cell Lymphoma|Refractory Marginal Zone Lymphoma|Refractory Non-Hodgkin Lymphoma|Refractory Small Lymphocytic Lymphoma|Richter Syndrome,Pevonedistat,C1CC2=CC=CC=C2C1NC3=C4C=CN(C4=NC=N3)C5CC(C(C5)O)COS(=O)(=O)N,PHASE1,immune_system_disease
2132,Asthma,Setipiprant,C1CN(CC2=C1N(C3=C2C=C(C=C3)F)CC(=O)O)C(=O)C4=CC=CC5=CC=CC=C54,PHASE2,immune_system_disease
2133,Diffuse Large B-cell Lymphoma|Mantle Cell Lymphoma,Abexinostat,CN(C)CC1=C(OC2=CC=CC=C21)C(=O)NCCOC3=CC=C(C=C3)C(=O)NO,PHASE1,immune_system_disease
2134,Immune Thrombocytopenia,Terbutaline,CC(C)(C)NCC(C1=CC(=CC(=C1)O)O)O,PHASE2,immune_system_disease
2135,Lymphoma,Amoxicillin,CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=C(C=C3)O)N)C(=O)O)C,PHASE2,immune_system_disease
2136,Lymphoma,Metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-],PHASE2,immune_system_disease
2137,Lymphoma,Tetracycline,CC1(C2CC3C(C(=O)C(=C(C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O,PHASE2,immune_system_disease
2138,"Graves Ophthalmopathy|Graves Disease|Thyroid-associated Ophthalmopathy|Thyroid Diseases|Endocrine System Diseases|Eye Diseases, Hereditary|Hyperthyroidism|Autoimmune Diseases|Immune System Diseases",Doxycycline,CC1C2C(C3C(C(=O)C(=C(C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O,PHASE2,immune_system_disease
2139,Seasonal Allergic Rhinitis,Bilastine,CCOCCN1C2=CC=CC=C2N=C1C3CCN(CC3)CCC4=CC=C(C=C4)C(C)(C)C(=O)O,PHASE2,immune_system_disease
2140,Multiple Myeloma,Pamidronate,C(CN)C(O)(P(=O)(O)O)P(=O)(O)O,PHASE2,immune_system_disease
2141,HIV Infections,Adefovir,C1=NC(=C2C(=N1)N(C=N2)CCOCP(=O)(O)O)N,PHASE1,immune_system_disease
2142,Type1 Diabetes Mellitus|Enterovirus,Pleconaril,CC1=CC(=CC(=C1OCCCC2=CC(=NO2)C)C)C3=NOC(=N3)C(F)(F)F,PHASE2,immune_system_disease
2143,Lymphoma,Mechlorethamine,CN(CCCl)CCCl,PHASE2,immune_system_disease
2144,HIV-1-infection,Lenacapavir,CC(C)(C#CC1=NC(=C(C=C1)C2=C3C(=C(C=C2)Cl)C(=NN3CC(F)(F)F)NS(=O)(=O)C)C(CC4=CC(=CC(=C4)F)F)NC(=O)CN5C6=C(C7CC7C6(F)F)C(=N5)C(F)(F)F)S(=O)(=O)C,PHASE2|PHASE3,immune_system_disease
2145,Thyroiditis Autoimmune,Selenomethionine,C[Se]CCC(C(=O)O)N,PHASE2,immune_system_disease
2146,Sjgren Syndrome,Remibrutinib,CC1=C(C=C(C=C1NC(=O)C2=C(C=C(C=C2)C3CC3)F)F)C4=C(C(=NC=N4)N)OCCN(C)C(=O)C=C,PHASE2,immune_system_disease
2147,Type 1 Diabetes|Hypoglycemia,Dasiglucagon,CC(C)CC(C(=O)NC(CCC(=O)O)C(=O)NC(CO)C(=O)NC(C(C)O)C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)NC(=O)C(CCCCN)NC(=O)C(C(C)C)NC(=O)C(CC3=CC=CC=C3)NC(=O)C(CCC(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(C)NC(=O)C(CCCNC(=N)N)NC(=O)C(C)NC(=O)C(C)(C)NC(=O)C(CC(=O)O)NC(=O)C(CC(C)C)NC(=O)C(CC4=CC=C(C=C4)O)NC(=O)C(CCCCN)NC(=O)C(CO)NC(=O)C(CC5=CC=C(C=C5)O)NC(=O)C(CC(=O)O)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C(CC6=CC=CC=C6)NC(=O)C(C(C)O)NC(=O)CNC(=O)C(CCC(=O)N)NC(=O)C(CO)NC(=O)C(CC7=CNC=N7)N,PHASE2,immune_system_disease
2148,"Acute Myeloid Leukemia|Chronic Lymphocytic Leukemia|AML, Adult|CLL|CLL, Relapsed|CLL, Refractory",Pitavastatin,C1CC1C2=NC3=CC=CC=C3C(=C2C=CC(CC(CC(=O)O)O)O)C4=CC=C(C=C4)F,PHASE1,immune_system_disease
2149,Eosinophilic Esophagitis,Mesalazine,C1=CC(=C(C=C1N)C(=O)O)O,PHASE2,immune_system_disease
2150,Eosinophilic Esophagitis,Mesalamine,C1=CC(=C(C=C1N)C(=O)O)O,PHASE2,immune_system_disease
2151,Multiple Myeloma,Amrubicin,CC(=O)C1(CC(C2=C(C1)C(=C3C(=C2O)C(=O)C4=CC=CC=C4C3=O)O)OC5CC(C(CO5)O)O)N,PHASE1|PHASE2,immune_system_disease
2152,Type 1 Diabetes Mellitus|Type 2 Diabetes Mellitus,Ruboxistaurin,CN(C)CC1CCN2C=C(C3=CC=CC=C32)C4=C(C5=CN(CCO1)C6=CC=CC=C65)C(=O)NC4=O,PHASE2|PHASE3,immune_system_disease
2153,Recurrent Plasma Cell Myeloma|Refractory Plasma Cell Myeloma,Sonidegib,CC1CN(CC(O1)C)C2=NC=C(C=C2)NC(=O)C3=CC=CC(=C3C)C4=CC=C(C=C4)OC(F)(F)F,PHASE2,immune_system_disease
2154,Cutaneous T-Cell Lymphoma/Mycosis Fungoides,Cobomarsen,CC1=CN(C(=O)NC1=O)C2C3C(C(O2)(CO3)COP(=S)(O)OC4C5C(OC4(CO5)COP(=S)(O)OC6CC(OC6COP(=S)(O)OC7CC(OC7COP(=S)(O)OC8C9C(OC8(CO9)COP(=S)(O)OC1CC(OC1COP(=S)(O)OC1C2C(OC1(CO2)CO)N1C=C(C(=NC1=O)N)C)N1C=NC2=C(N=CN=C21)N)N1C=C(C(=NC1=O)N)C)N1C=NC2=C1N=C(NC2=O)N)N1C=NC2=C(N=CN=C21)N)N1C=C(C(=O)NC1=O)C)OP(=S)(O)OCC1C(CC(O1)N1C=NC2=C(N=CN=C21)N)OP(=S)(O)OCC12COC(C1OP(=S)(O)OCC1C(CC(O1)N1C=CC(=NC1=O)N)OP(=S)(O)OCC13COC(C1OP(=S)(O)OCC14COC(C1OP(=S)(O)OCC15COC(C1OP(=S)(O)OCC16COC(C1O)C(O6)N1C=NC6=C(N=CN=C61)N)C(O5)N1C=C(C(=O)NC1=O)C)C(O4)N1C=C(C(=O)NC1=O)C)C(O3)N1C=NC3=C(N=CN=C31)N)C(O2)N1C=NC2=C1N=C(NC2=O)N,PHASE2,immune_system_disease
2155,Acute Myeloid Leukemia|Diffuse Large B-cell Lymphoma|Acute Lymphoblastic Leukemia|Multiple Myeloma,Birabresib,CC1=C(SC2=C1C(=NC(C3=NN=C(N32)C)CC(=O)NC4=CC=C(C=C4)O)C5=CC=C(C=C5)Cl)C,PHASE1,immune_system_disease
2156,Follicular Lymphoma (FL/Indolent NHL)|Aggressive NHL (a NHL)|Chronic Lymphocytic Leukemia (CLL) / Small Lymphocytic Lymphoma (SLL)|T-cell Lymphoma (PTCL and CTCL)|B-cell Non Hodgkin Lymphoma (NHL),Cerdulatinib,CCS(=O)(=O)N1CCN(CC1)C2=CC=C(C=C2)NC3=NC=C(C(=N3)NC4CC4)C(=O)N,PHASE1|PHASE2,immune_system_disease
2157,Peripheral T Cell Lymphoma,Linperlisib,CC(C)(C1CCN(CC1)CC2=C3C(=CC(=C2)F)C(=NC(=N3)N4CCOCC4)C5=CC(=C(N=C5)OC)NS(=O)(=O)C)O,PHASE1|PHASE2,immune_system_disease
2158,Peripheral T Cell Lymphoma,Rivoceranib,C1CCC(C1)(C#N)C2=CC=C(C=C2)NC(=O)C3=C(N=CC=C3)NCC4=CC=NC=C4,PHASE1|PHASE2,immune_system_disease
2159,Graft-versus-host Disease Prevention,Piperacillin,CCN1CCN(C(=O)C1=O)C(=O)NC(C2=CC=CC=C2)C(=O)NC3C4N(C3=O)C(C(S4)(C)C)C(=O)O,PHASE2,immune_system_disease
2160,Graft-versus-host Disease Prevention,Tazobactam,CC1(C(N2C(S1(=O)=O)CC2=O)C(=O)O)CN3C=CN=N3,PHASE2,immune_system_disease
2161,Multiple Myeloma,Fosaprepitant,CC(C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)OC2C(N(CCO2)CC3=NN(C(=O)N3)P(=O)(O)O)C4=CC=C(C=C4)F,PHASE1|PHASE2,immune_system_disease
2162,Asthma,Ciclesonide,CC(C)C(=O)OCC(=O)C12C(CC3C1(CC(C4C3CCC5=CC(=O)C=CC45C)O)C)OC(O2)C6CCCCC6,PHASE2,immune_system_disease
2163,Rheumatoid Arthritis,Methylprednisone,CC1CC2C3CCC4=CC(=O)C=CC4(C3C(=O)CC2(C1(C(=O)CO)O)C)C,PHASE2,immune_system_disease
2164,"Lymphoma, Non-Hodgkin|Multiple Myeloma|Advanced Solid Tumors",Axitinib,CNC(=O)C1=CC=CC=C1SC2=CC3=C(C=C2)C(=NN3)C=CC4=CC=CC=N4,PHASE2,immune_system_disease
2165,"Lymphoma, Non-Hodgkin|Multiple Myeloma|Advanced Solid Tumors",Bosutinib,CN1CCN(CC1)CCCOC2=C(C=C3C(=C2)N=CC(=C3NC4=CC(=C(C=C4Cl)Cl)OC)C#N)OC,PHASE2,immune_system_disease
2166,"Lymphoma, Non-Hodgkin|Multiple Myeloma|Advanced Solid Tumors",Sunitinib,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C,PHASE2,immune_system_disease
2167,"Lymphoma, Non-Hodgkin|Multiple Myeloma|Advanced Solid Tumors",Vemurafenib,CCCS(=O)(=O)NC1=C(C(=C(C=C1)F)C(=O)C2=CNC3=C2C=C(C=N3)C4=CC=C(C=C4)Cl)F,PHASE2,immune_system_disease
2168,"Lymphoma, Non-Hodgkin|Multiple Myeloma|Advanced Solid Tumors",Tucatinib,CC1=C(C=CC(=C1)NC2=NC=NC3=C2C=C(C=C3)NC4=NC(CO4)(C)C)OC5=CC6=NC=NN6C=C5,PHASE2,immune_system_disease
2169,HIV-1 Infection,Clopidogrel,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,PHASE2,immune_system_disease
2170,Type 1 Diabetes,Sitagliptin,C1CN2C(=NN=C2C(F)(F)F)CN1C(=O)CC(CC3=CC(=C(C=C3F)F)F)N,PHASE2|PHASE3,immune_system_disease
2171,HIV Infections,Telinavir,CC(C)CN(CC(C(CC1=CC=CC=C1)NC(=O)C(CC(=O)N)NC(=O)C2=NC3=CC=CC=C3C=C2)O)C(=O)NC(C)(C)C,PHASE1,immune_system_disease
2172,Epstein-Barr Virus Associated Lymphoma|Lymphoproliferative Disorders,Valganciclovir,CC(C)C(C(=O)OCC(CO)OCN1C=NC2=C1N=C(NC2=O)N)N,PHASE1|PHASE2,immune_system_disease
2173,Invasive Pulmonary Aspergillosis|Lymphoblastic Leukaemia|Myeloblastic Leukaemia|Lymphoblastic Leukemia|Myeloblastic Leukemia,Amphotericin B,CC1C=CC=CC=CC=CC=CC=CC=CC(CC2C(C(CC(O2)(CC(CC(C(CCC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)O)C(=O)O)OC3C(C(C(C(O3)C)O)N)O,PHASE2,immune_system_disease
2174,Pruritus|Atopic Dermatitis,Serlopitant,CC(C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)OC2CCC3CN(CC3C2C4=CC=C(C=C4)F)C5=CC(=O)CC5,PHASE2,immune_system_disease
2175,Rheumatoid Arthritis,Tranilast,COC1=C(C=C(C=C1)C=CC(=O)NC2=CC=CC=C2C(=O)O)OC,PHASE1,immune_system_disease
2176,Lymphangioleiomyomatosis|Lymphangiomyomas|Pleural Effusions|Ascites,Octreotide,CC(C1C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=CC=C4)NC(=O)C(CC5=CC=CC=C5)N)C(=O)NC(CO)C(C)O)O,PHASE2,immune_system_disease
2177,Type 1 Diabetes,Ergocalciferol,CC(C)C(C)C=CC(C)C1CCC2C1(CCCC2=CC=C3CC(CCC3=C)O)C,PHASE2|PHASE3,immune_system_disease
2178,Cytomegalovirus Retinitis|HIV Infections,Foscarnet,C(=O)(O)P(=O)(O)O,PHASE1,immune_system_disease
2179,Asthma,Abediterol,C1=CC=C(C=C1)C(COCCCCCCNCC(C2=C3C=CC(=O)NC3=C(C=C2)O)O)(F)F,PHASE1,immune_system_disease
2180,"Immunoglobulin A Nephropathy|Kidney Diseases|Glomerulonephritis, IGA|Glomerulonephritis|Autoimmune Diseases|Immune System Diseases",Sparsentan,CCCCC1=NC2(CCCC2)C(=O)N1CC3=CC(=C(C=C3)C4=CC=CC=C4S(=O)(=O)NC5=NOC(=C5C)C)COCC,PHASE2,immune_system_disease
2181,"Eczema|Dermatitis|Skin Diseases, Genetic|Dermatitis, Atopic|Skin Diseases",Trimethoprim,COC1=CC(=CC(=C1OC)OC)CC2=CN=C(N=C2N)N,PHASE2,immune_system_disease
2182,"Eczema|Dermatitis|Skin Diseases, Genetic|Dermatitis, Atopic|Skin Diseases",Cephalexin,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O,PHASE2,immune_system_disease
2183,Sarcoidosis|Precapillary Pulmonary Hypertension|Interstitial Lung Disease,Treprostinil,CCCCCC(CCC1C(CC2C1CC3=C(C2)C(=CC=C3)OCC(=O)O)O)O,PHASE2,immune_system_disease
2184,Hypersensitivity,Paricalcitol,CC(C=CC(C)C(C)(C)O)C1CCC2C1(CCCC2=CC=C3CC(CC(C3)O)O)C,PHASE2,immune_system_disease
2185,Chronic Lymphocytic Leukemia|Small Lymphocytic Lymphoma,Dinaciclib,CCC1=C2N=C(C=C(N2N=C1)NCC3=C[N+](=CC=C3)[O-])N4CCCCC4CCO,PHASE1,immune_system_disease
2186,Asthma,Levalbuterol,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,PHASE2,immune_system_disease
2187,Asthma,Levosalbutamol,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,PHASE2,immune_system_disease
2188,"Arthritis, Rheumatoid",Gadobutrol,C1CN(CCN(CCN(CCN1CC(=O)[O-])CC(=O)[O-])C(CO)C(CO)O)CC(=O)[O-].[Gd+3],PHASE1,immune_system_disease
2189,HIV Infections,Tucaresol,C1=CC(=C(C(=C1)OCC2=CC=C(C=C2)C(=O)O)C=O)O,PHASE1,immune_system_disease
2190,HIV Infections,Methadone,CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2,PHASE1,immune_system_disease
2191,Type 1 Diabetes Mellitus,Sotagliflozin,CCOC1=CC=C(C=C1)CC2=C(C=CC(=C2)C3C(C(C(C(O3)SC)O)O)O)Cl,PHASE2,immune_system_disease
2192,Hematologic Malignancy|Acute Leukemia|Remission|Acute Myeloid Leukemia|Acute Lymphoblastic Leukemia|AML|TP53|Intrachromosomal Amplification of Chromosome 21|Cytogenetic Abnormality|CNS Leukemia|Minimal Residual Disease|Myelodysplasia|Juvenile Myelomonocytic Leukemia|Somatic Mutation|PTPN11 Gene Mutation|N-RAS Gene Amplification|Neurofibromatosis 1|NF1 Mutation|CBL Gene Mutation|Monosomy 7|Chromosome Abnormality|Fetal Hemoglobin,Levetiracetam,CCC(C(=O)N)N1CCCC1=O,PHASE2,immune_system_disease
2193,Rheumatoid Arthritis,Loxoprofen,CC(C1=CC=C(C=C1)CC2CCCC2=O)C(=O)O,PHASE2,immune_system_disease
2194,Multiple Myeloma,Tadalafil,CN1CC(=O)N2C(C1=O)CC3=C(C2C4=CC5=C(C=C4)OCO5)NC6=CC=CC=C36,PHASE2,immune_system_disease
2195,Cutaneous T-cell Lymphoma,Bexarotene,CC1=CC2=C(C=C1C(=C)C3=CC=C(C=C3)C(=O)O)C(CCC2(C)C)(C)C,PHASE1,immune_system_disease
2196,"IgA Monoclonal Gammopathy|IgG Monoclonal Gammopathy|IgM Monoclonal Gammopathy|Light Chain Deposition Disease|Monoclonal Gammopathy|Smoldering Waldenstrom Macroglobulinemia|Waldenstrom Macroglobulinemia|Gammopathy, Monoclonal|Gammopathy Igg",Rifaximin,CC1C=CC=C(C(=O)NC2=C(C3=C(C4=C(C(=C3O)C)OC(C4=O)(OC=CC(C(C(C(C(C(C1O)C)O)C)OC(=O)C)C)OC)C)C5=C2N6C=CC(=CC6=N5)C)O)C,PHASE1,immune_system_disease
2197,HIV Infections|Condyloma Acuminata,Cidofovir,C1=CN(C(=O)N=C1N)CC(CO)OCP(=O)(O)O,PHASE1,immune_system_disease
2198,Seasonal Allergic Rhinitis,Epinastine,C1C2C3=CC=CC=C3CC4=CC=CC=C4N2C(=N1)N,PHASE2,immune_system_disease
2199,Indolent Systemic Mastocytosis,Midostaurin,CC12C(C(CC(O1)N3C4=CC=CC=C4C5=C6C(=C7C8=CC=CC=C8N2C7=C53)CNC6=O)N(C)C(=O)C9=CC=CC=C9)OC,PHASE2,immune_system_disease
2200,"Diabetes Mellitus, Type 1|Insulin-dependent Diabetes Mellitus",Pramlintide,CCC(C)C(C(=O)NC(CC(C)C)C(=O)N1CCCC1C(=O)N2CCCC2C(=O)NC(C(C)O)C(=O)NC(CC(=O)N)C(=O)NC(C(C)C)C(=O)NCC(=O)NC(CO)C(=O)NC(CC(=O)N)C(=O)NC(C(C)O)C(=O)NC(CC3=CC=C(C=C3)O)C(=O)N)NC(=O)C4CCCN4C(=O)CNC(=O)C(CC5=CC=CC=C5)NC(=O)C(CC(=O)N)NC(=O)C(CC(=O)N)NC(=O)C(CO)NC(=O)C(CO)NC(=O)C(CC6=CNC=N6)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC7=CC=CC=C7)NC(=O)C(CC(=O)N)NC(=O)C(C)NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CCC(=O)N)NC(=O)C(C(C)O)NC(=O)C(C)NC(=O)C8CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N8)C(C)O)C)C(C)O)CC(=O)N)NC(=O)C(CCCCN)N,PHASE2,immune_system_disease
2201,Mantle Cell Lymphoma,Abemaciclib,CCN1CCN(CC1)CC2=CN=C(C=C2)NC3=NC=C(C(=N3)C4=CC5=C(C(=C4)F)N=C(N5C(C)C)C)F,PHASE2,immune_system_disease
2202,Anaplastic Lymphoma Kinase Positive (ALK +) Anaplastic Large Cell Lymphoma|Inflammatory Myofibroblastic Tumors|Solid Tumors,Brigatinib,CN1CCN(CC1)C2CCN(CC2)C3=CC(=C(C=C3)NC4=NC=C(C(=N4)NC5=CC=CC=C5P(=O)(C)C)Cl)OC,PHASE1|PHASE2,immune_system_disease
2203,Diabetic Kidney Disease|Type 1 Diabetes,Semaglutide,CCC(C)C(C(=O)NC(C)C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(CC(C)C)C(=O)NC(C(C)C)C(=O)NC(CCCNC(=N)N)C(=O)NCC(=O)NC(CCCNC(=N)N)C(=O)NCC(=O)O)NC(=O)C(CC3=CC=CC=C3)NC(=O)C(CCC(=O)O)NC(=O)C(CCCCNC(=O)COCCOCCNC(=O)COCCOCCNC(=O)CCC(C(=O)O)NC(=O)CCCCCCCCCCCCCCCCC(=O)O)NC(=O)C(C)NC(=O)C(C)NC(=O)C(CCC(=O)N)NC(=O)CNC(=O)C(CCC(=O)O)NC(=O)C(CC(C)C)NC(=O)C(CC4=CC=C(C=C4)O)NC(=O)C(CO)NC(=O)C(CO)NC(=O)C(C(C)C)NC(=O)C(CC(=O)O)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C(CC5=CC=CC=C5)NC(=O)C(C(C)O)NC(=O)CNC(=O)C(CCC(=O)O)NC(=O)C(C)(C)NC(=O)C(CC6=CN=CN6)N,PHASE2,immune_system_disease
2204,Septic Shock,Dexmedetomidine,CC1=C(C(=CC=C1)C(C)C2=CN=CN2)C,PHASE2,immune_system_disease
2205,Mantle Cell Lymphoma|B Cell Lymphoma|Multiple Myeloma,Canfosfamide,C1=CC=C(C=C1)C(C(=O)O)NC(=O)C(CS(=O)(=O)CCOP(=O)(N(CCCl)CCCl)N(CCCl)CCCl)NC(=O)CCC(C(=O)O)N,PHASE2,immune_system_disease
2206,Recurrent Chronic Lymphocytic Leukemia|Recurrent Small Lymphocytic Lymphoma|Refractory Chronic Lymphocytic Leukemia|Refractory Small Lymphocytic Lymphoma,Buparlisib,C1COCCN1C2=NC(=NC(=C2)C3=CN=C(C=C3C(F)(F)F)N)N4CCOCC4,PHASE1,immune_system_disease
2207,"Diabetes Mellitus, Type 1",Albiglutide,CCC(C)C(C(=O)NC(C)C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(CC(C)C)C(=O)NC(C(C)C)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCNC(=N)N)C(=O)N)NC(=O)C(CC3=CC=CC=C3)NC(=O)C(CCC(=O)O)NC(=O)C(CCCCN)NC(=O)C(C)NC(=O)C(C)NC(=O)C(CCC(=O)N)NC(=O)CNC(=O)C(CCC(=O)O)NC(=O)C(CC(C)C)NC(=O)C(CC4=CC=C(C=C4)O)NC(=O)C(CO)NC(=O)C(CO)NC(=O)C(C(C)C)NC(=O)C(CC(=O)O)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C(CC5=CC=CC=C5)NC(=O)C(C(C)O)NC(=O)CNC(=O)C(CCC(=O)O)NC(=O)CNC(=O)C(CC6=CN=CN6)N,PHASE2,immune_system_disease
2208,Advanced Solid Tumors|Lymphomas,Camptothecin,CCC1(C2=C(COC1=O)C(=O)N3CC4=CC5=CC=CC=C5N=C4C3=C2)O,PHASE1,immune_system_disease
2209,Henoch-Schnlein Purpura Nephritis,Benazepril,CCOC(=O)C(CCC1=CC=CC=C1)NC2CCC3=CC=CC=C3N(C2=O)CC(=O)O,PHASE1|PHASE2,immune_system_disease
2210,Henoch-Schnlein Purpura Nephritis,Dipyridamole,C1CCN(CC1)C2=NC(=NC3=C2N=C(N=C3N4CCCCC4)N(CCO)CCO)N(CCO)CCO,PHASE1|PHASE2,immune_system_disease
2211,Type 1 Diabetes Mellitus|Type 2 Diabetes Mellitus,Ebselen,C1=CC=C(C=C1)N2C(=O)C3=CC=CC=C3[Se]2,PHASE2|PHASE3,immune_system_disease
2212,Hodgkins Lymphoma,Erythropoietin,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NN=N[N-]4)CO)Cl.[K+],PHASE2,immune_system_disease
2213,Rectal Hypersensitivity|Irritable Bowel Syndrome-Constipation,Escitalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,PHASE2,immune_system_disease
2214,Acute Lymphoblastic Leukemia|Acute Myeloid Leukemia|Myelodysplastic Syndromes,Biotin,C1C2C(C(S1)CCCCC(=O)O)NC(=O)N2,PHASE2,immune_system_disease
2215,Seasonal Allergic Rhinitis,Bepotastine,C1CN(CCC1OC(C2=CC=C(C=C2)Cl)C3=CC=CC=N3)CCCC(=O)O,PHASE2,immune_system_disease
2216,Asthma,Indacaterol,CCC1=C(C=C2CC(CC2=C1)NCC(C3=C4C=CC(=O)NC4=C(C=C3)O)O)CC,PHASE2,immune_system_disease
2217,"Cardiovascular Diseases|Arthritis, Rheumatoid",Colchicine,CC(=O)NC1CCC2=CC(=C(C(=C2C3=CC=C(C(=O)C=C13)OC)OC)OC)OC,PHASE2,immune_system_disease
2218,Rheumatoid Arthritis,Paroxetine,C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4,PHASE1|PHASE2,immune_system_disease
2219,Multiple Sclerosis,Amphetamine,CC(CC1=CC=CC=C1)N,PHASE2|PHASE3,immune_system_disease
2220,HIV|Human Immunodeficiency Virus,Disulfiram,CCN(CC)C(=S)SSC(=S)N(CC)CC,PHASE1|PHASE2,immune_system_disease
2221,Diffuse Large B-cell Lymphoma,Valproate,CCCC(CCC)C(=O)O,PHASE1|PHASE2,immune_system_disease
2222,Solid Tumor|Glioma|Angioimmunoblastic T-cell Lymphoma|Intrahepatic Cholangiocarcinoma|Chondrosarcoma,Enasidenib,CC(C)(CNC1=NC(=NC(=N1)C2=NC(=CC=C2)C(F)(F)F)NC3=CC(=NC=C3)C(F)(F)F)O,PHASE1|PHASE2,immune_system_disease
2223,HIV Infections,Famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,PHASE1,immune_system_disease
2224,Eosinophilic Asthma|Asthma,Pramipexole,CCCNC1CCC2=C(C1)SC(=N2)N,PHASE2,immune_system_disease
2225,Eosinophilic Asthma|Asthma,Dexpramipexole,CCCNC1CCC2=C(C1)SC(=N2)N,PHASE2,immune_system_disease
2226,Eosinophilic Esophagitis,Etrasimod,C1CCC(C1)C2=C(C=C(C=C2)COC3=CC4=C(C=C3)NC5=C4CCC5CC(=O)O)C(F)(F)F,PHASE2,immune_system_disease
2227,HIV Infections,Carnitine,C[N+](C)(C)CC(CC(=O)[O-])O,PHASE2,immune_system_disease
2228,HIV Infections,Levocarnitine,C[N+](C)(C)CC(CC(=O)[O-])O,PHASE2,immune_system_disease
2229,Lymphoma,Acetylcysteine,CC(=O)NC(CS)C(=O)O,PHASE1,immune_system_disease
2230,HIV Infections,Racivir,C1C(OC(S1)CO)N2C=C(C(=NC2=O)N)F,PHASE2,immune_system_disease
2231,Cutaneous T-Cell Lymphoma,Enzastaurin,CN1C=C(C2=CC=CC=C21)C3=C(C(=O)NC3=O)C4=CN(C5=CC=CC=C54)C6CCN(CC6)CC7=CC=CC=N7,PHASE2,immune_system_disease
2232,HIV/AIDS|Albuminuria|Kidney Diseases|Genetic Predisposition,Lisinopril,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,PHASE2,immune_system_disease
2233,"Lupus Erythematosus, Cutaneous",Alitretinoin,CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CC(=O)O)C)C,PHASE2,immune_system_disease
2234,Diabetic Nephropathies,Fenofibrate,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl,PHASE2,immune_system_disease
2235,HIV Infections,Glycovir,CCCCN1CC(C(C(C1COC(=O)CCC)OC(=O)CCC)OC(=O)CCC)OC(=O)CCC,PHASE2,immune_system_disease
2236,"Dermatitis, Atopic",Fluvoxamine,COCCCCC(=NOCCN)C1=CC=C(C=C1)C(F)(F)F,PHASE1,immune_system_disease
2237,HIV Infections,Loperamide,CN(C)C(=O)C(CCN1CCC(CC1)(C2=CC=C(C=C2)Cl)O)(C3=CC=CC=C3)C4=CC=CC=C4,PHASE1,immune_system_disease
2238,HIV Infections,Simethicone,CO[Si](C)(C)O[Si](C)(C)C.O=[Si]=O,PHASE1,immune_system_disease
2239,HIV Infections,Mifepristone,CC#CC1(CCC2C1(CC(C3=C4CCC(=O)C=C4CCC23)C5=CC=C(C=C5)N(C)C)C)O,PHASE1|PHASE2,immune_system_disease
2240,Multiple Sclerosis|Cognition Disorders,Memantine,CC12CC3CC(C1)(CC(C3)(C2)N)C,PHASE2|PHASE3,immune_system_disease
2241,Colorectal Neoplasms|Breast Neoplasms,Cediranib,CC1=CC2=C(N1)C=CC(=C2F)OC3=NC=NC4=CC(=C(C=C43)OC)OCCCN5CCCC5,PHASE1|PHASE2,immune_system_disease
2242,"Multiple Sclerosis, Relapsing-Remitting",Minocycline,CN(C)C1C2CC3CC4=C(C=CC(=C4C(=C3C(=O)C2(C(=C(C1=O)C(=O)N)O)O)O)O)N(C)C,PHASE2,immune_system_disease
2243,Type 1 Diabetes Mellitus|Dyslipidemia,Ezetimibe,C1=CC(=CC=C1C2C(C(=O)N2C3=CC=C(C=C3)F)CCC(C4=CC=C(C=C4)F)O)O,PHASE2,immune_system_disease
2244,Advanced Malignant Solid Neoplasm|Recurrent Ependymoma|Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor|Recurrent Glioma|Recurrent Hepatoblastoma|Recurrent Kidney Wilms Tumor|Recurrent Langerhans Cell Histiocytosis|Recurrent Malignant Germ Cell Tumor|Recurrent Malignant Glioma|Recurrent Malignant Solid Neoplasm|Recurrent Medulloblastoma|Recurrent Neuroblastoma|Recurrent Non-Hodgkin Lymphoma|Recurrent Osteosarcoma|Recurrent Rhabdoid Tumor|Recurrent Rhabdomyosarcoma|Recurrent Soft Tissue Sarcoma|Refractory Ependymoma|Refractory Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor|Refractory Glioma|Refractory Hepatoblastoma|Refractory Langerhans Cell Histiocytosis|Refractory Malignant Germ Cell Tumor|Refractory Malignant Glioma|Refractory Malignant Solid Neoplasm|Refractory Medulloblastoma|Refractory Neuroblastoma|Refractory Non-Hodgkin Lymphoma|Refractory Osteosarcoma|Refractory Primary Central Nervous System Neoplasm|Refractory Rhabdoid Tumor|Refractory Rhabdomyosarcoma|Refractory Soft Tissue Sarcoma,Larotrectinib,C1CC(N(C1)C2=NC3=C(C=NN3C=C2)NC(=O)N4CCC(C4)O)C5=C(C=CC(=C5)F)F,PHASE2,immune_system_disease
2245,"NMO Spectrum Disorder|Spasticity, Muscle",Nabiximols,CCCCCC1=CC(=C(C(=C1)O)C2C=C(CCC2C(=C)C)C)O.CCCCCC1=CC(=C2C3C=C(CCC3C(OC2=C1)(C)C)C)O,PHASE2,immune_system_disease
2246,HIV Infections,Calanolide A,CCCC1=CC(=O)OC2=C1C3=C(C=CC(O3)(C)C)C4=C2C(C(C(O4)C)C)O,PHASE1,immune_system_disease
2247,"Neoplasms, Haematologic",Afuresertib,CN1C(=C(C=N1)Cl)C2=C(SC(=C2)C(=O)NC(CC3=CC(=CC=C3)F)CN)Cl,PHASE1,immune_system_disease
2248,Advanced Malignant Solid Neoplasm|Malignant Solid Neoplasm|Recurrent Ependymoma|Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor|Recurrent Hepatoblastoma|Recurrent Langerhans Cell Histiocytosis|Recurrent Malignant Germ Cell Tumor|Recurrent Malignant Glioma|Recurrent Malignant Solid Neoplasm|Recurrent Medulloblastoma|Recurrent Neuroblastoma|Recurrent Non-Hodgkin Lymphoma|Recurrent Osteosarcoma|Recurrent Primary Central Nervous System Neoplasm|Recurrent Rhabdoid Tumor|Recurrent Rhabdomyosarcoma|Recurrent Soft Tissue Sarcoma|Refractory Ependymoma|Refractory Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor|Refractory Hepatoblastoma|Refractory Langerhans Cell Histiocytosis|Refractory Malignant Germ Cell Tumor|Refractory Malignant Glioma|Refractory Malignant Solid Neoplasm|Refractory Medulloblastoma|Refractory Neuroblastoma|Refractory Non-Hodgkin Lymphoma|Refractory Osteosarcoma|Refractory Primary Central Nervous System Neoplasm|Refractory Rhabdoid Tumor|Refractory Rhabdomyosarcoma|Refractory Soft Tissue Sarcoma|Wilms Tumor,Ensartinib,CC1CN(CC(N1)C)C(=O)C2=CC=C(C=C2)NC(=O)C3=NN=C(C(=C3)OC(C)C4=C(C=CC(=C4Cl)F)Cl)N,PHASE2,immune_system_disease
2249,EBV Lymphomas|Lympho-proliferative Diseases,Ganciclovir,C1=NC2=C(N1COC(CO)CO)N=C(NC2=O)N,PHASE2,immune_system_disease
2250,Advanced Solid Tumors|Lymphomas,Darinaparsin,C[As](C)SCC(C(=O)NCC(=O)O)NC(=O)CCC(C(=O)O)N,PHASE1,immune_system_disease
2251,Thyroid Eye Disease|Graves Orbitopathy|Endocrine System Diseases|Eye Diseases|Thyroid Associated Ophthalmopathy|Graves Ophthalmopathy|Thyroid Diseases|Orbital Diseases|Proptosis|IGF1R|Exophthalmos|Hashimoto,Linsitinib,CC1(CC(C1)C2=NC(=C3N2C=CN=C3N)C4=CC5=C(C=C4)C=CC(=N5)C6=CC=CC=C6)O,PHASE2|PHASE3,immune_system_disease
2252,Multiple Sclerosis,Ponesimod,CCCN=C1N(C(=O)C(=CC2=CC(=C(C=C2)OCC(CO)O)Cl)S1)C3=CC=CC=C3C,PHASE2,immune_system_disease
2253,Multiple Myeloma,Opaganib,C1C2CC3(CC1CC(C2)(C3)C(=O)NCC4=CC=NC=C4)C5=CC=C(C=C5)Cl,PHASE1|PHASE2,immune_system_disease
2254,"Diabetes Mellitus, Type 1",Benfotiamine,CC1=NC=C(C(=N1)N)CN(C=O)C(=C(CCOP(=O)(O)O)SC(=O)C2=CC=CC=C2)C,PHASE1|PHASE2,immune_system_disease
2255,Recurrent Ovarian Cancer|Recurrent Epithelial Cancer of Ovary|Recurrent Epithelial Ovarian Cancer|Recurrent Fallopian Tube Cancer|Peritoneal Cancer|Recurrent Carcinoma of Ovary|Adenocarcinoma of Ovary,Niraparib,C1CC(CNC1)C2=CC=C(C=C2)N3C=C4C=CC=C(C4=N3)C(=O)N,PHASE2,immune_system_disease
2256,Advanced Malignant Solid Neoplasm|Ann Arbor Stage III Non-Hodgkin Lymphoma|Ann Arbor Stage IV Non-Hodgkin Lymphoma|Histiocytic Sarcoma|Juvenile Xanthogranuloma|Langerhans Cell Histiocytosis|Malignant Glioma|Recurrent Childhood Rhabdomyosarcoma|Recurrent Ependymoma|Recurrent Ewing Sarcoma|Recurrent Glioma|Recurrent Hepatoblastoma|Recurrent Langerhans Cell Histiocytosis|Recurrent Malignant Germ Cell Tumor|Recurrent Malignant Solid Neoplasm|Recurrent Medulloblastoma|Recurrent Neuroblastoma|Recurrent Non-Hodgkin Lymphoma|Recurrent Osteosarcoma|Recurrent Peripheral Primitive Neuroectodermal Tumor|Recurrent Primary Central Nervous System Neoplasm|Recurrent Rhabdoid Tumor|Recurrent Soft Tissue Sarcoma|Refractory Ewing Sarcoma|Refractory Glioma|Refractory Hepatoblastoma|Refractory Langerhans Cell Histiocytosis|Refractory Malignant Germ Cell Tumor|Refractory Malignant Solid Neoplasm|Refractory Medulloblastoma|Refractory Neuroblastoma|Refractory Non-Hodgkin Lymphoma|Refractory Osteosarcoma|Refractory Peripheral Primitive Neuroectodermal Tumor|Refractory Primary Central Nervous System Neoplasm|Refractory Rhabdoid Tumor|Refractory Rhabdomyosarcoma|Rhabdoid Tumor|Stage III Osteosarcoma AJCC v7|Stage III Soft Tissue Sarcoma AJCC v7|Stage IV Osteosarcoma AJCC v7|Stage IV Soft Tissue Sarcoma AJCC v7|Stage IVA Osteosarcoma AJCC v7|Stage IVB Osteosarcoma AJCC v7|Wilms Tumor,Erdafitinib,CC(C)NCCN(C1=CC2=NC(=CN=C2C=C1)C3=CN(N=C3)C)C4=CC(=CC(=C4)OC)OC,PHASE2,immune_system_disease
2257,Advanced Malignant Solid Neoplasm|Ann Arbor Stage III Non-Hodgkin Lymphoma|Ann Arbor Stage IV Non-Hodgkin Lymphoma|Histiocytic Sarcoma|Juvenile Xanthogranuloma|Langerhans Cell Histiocytosis|Malignant Glioma|Recurrent Childhood Rhabdomyosarcoma|Recurrent Ependymoma|Recurrent Ewing Sarcoma|Recurrent Glioma|Recurrent Hepatoblastoma|Recurrent Langerhans Cell Histiocytosis|Recurrent Malignant Germ Cell Tumor|Recurrent Malignant Solid Neoplasm|Recurrent Medulloblastoma|Recurrent Neuroblastoma|Recurrent Non-Hodgkin Lymphoma|Recurrent Osteosarcoma|Recurrent Peripheral Primitive Neuroectodermal Tumor|Recurrent Primary Central Nervous System Neoplasm|Recurrent Rhabdoid Tumor|Recurrent Soft Tissue Sarcoma|Refractory Ewing Sarcoma|Refractory Glioma|Refractory Hepatoblastoma|Refractory Langerhans Cell Histiocytosis|Refractory Malignant Germ Cell Tumor|Refractory Malignant Solid Neoplasm|Refractory Medulloblastoma|Refractory Neuroblastoma|Refractory Non-Hodgkin Lymphoma|Refractory Osteosarcoma|Refractory Peripheral Primitive Neuroectodermal Tumor|Refractory Primary Central Nervous System Neoplasm|Refractory Rhabdoid Tumor|Refractory Rhabdomyosarcoma|Rhabdoid Tumor|Stage III Osteosarcoma AJCC v7|Stage III Soft Tissue Sarcoma AJCC v7|Stage IV Osteosarcoma AJCC v7|Stage IV Soft Tissue Sarcoma AJCC v7|Stage IVA Osteosarcoma AJCC v7|Stage IVB Osteosarcoma AJCC v7|Wilms Tumor,Tipifarnib,CN1C=NC=C1C(C2=CC=C(C=C2)Cl)(C3=CC4=C(C=C3)N(C(=O)C=C4C5=CC(=CC=C5)Cl)C)N,PHASE2,immune_system_disease
2258,Advanced Malignant Solid Neoplasm|Ann Arbor Stage III Non-Hodgkin Lymphoma|Ann Arbor Stage IV Non-Hodgkin Lymphoma|Histiocytic Sarcoma|Juvenile Xanthogranuloma|Langerhans Cell Histiocytosis|Malignant Glioma|Recurrent Childhood Rhabdomyosarcoma|Recurrent Ependymoma|Recurrent Ewing Sarcoma|Recurrent Glioma|Recurrent Hepatoblastoma|Recurrent Langerhans Cell Histiocytosis|Recurrent Malignant Germ Cell Tumor|Recurrent Malignant Solid Neoplasm|Recurrent Medulloblastoma|Recurrent Neuroblastoma|Recurrent Non-Hodgkin Lymphoma|Recurrent Osteosarcoma|Recurrent Peripheral Primitive Neuroectodermal Tumor|Recurrent Primary Central Nervous System Neoplasm|Recurrent Rhabdoid Tumor|Recurrent Soft Tissue Sarcoma|Refractory Ewing Sarcoma|Refractory Glioma|Refractory Hepatoblastoma|Refractory Langerhans Cell Histiocytosis|Refractory Malignant Germ Cell Tumor|Refractory Malignant Solid Neoplasm|Refractory Medulloblastoma|Refractory Neuroblastoma|Refractory Non-Hodgkin Lymphoma|Refractory Osteosarcoma|Refractory Peripheral Primitive Neuroectodermal Tumor|Refractory Primary Central Nervous System Neoplasm|Refractory Rhabdoid Tumor|Refractory Rhabdomyosarcoma|Rhabdoid Tumor|Stage III Osteosarcoma AJCC v7|Stage III Soft Tissue Sarcoma AJCC v7|Stage IV Osteosarcoma AJCC v7|Stage IV Soft Tissue Sarcoma AJCC v7|Stage IVA Osteosarcoma AJCC v7|Stage IVB Osteosarcoma AJCC v7|Wilms Tumor,Ulixertinib,CC(C)NC1=NC=C(C(=C1)C2=CNC(=C2)C(=O)NC(CO)C3=CC(=CC=C3)Cl)Cl,PHASE2,immune_system_disease
2259,HIV Infections|Peripheral Nervous System Disease,Mexiletine,CC1=C(C(=CC=C1)C)OCC(C)N,PHASE2,immune_system_disease
2260,HIV Infections|Peripheral Nervous System Disease,Benztropine,CN1C2CCC1CC(C2)OC(C3=CC=CC=C3)C4=CC=CC=C4,PHASE2,immune_system_disease
2261,HIV Infections|Peripheral Nervous System Disease,Benzatropine,CN1C2CCC1CC(C2)OC(C3=CC=CC=C3)C4=CC=CC=C4,PHASE2,immune_system_disease
2262,Advanced Solid Tumors|Lymphomas,Lenvatinib,COC1=CC2=NC=CC(=C2C=C1C(=O)N)OC3=CC(=C(C=C3)NC(=O)NC4CC4)Cl,PHASE1,immune_system_disease
2263,Lymphoma,Enoxaparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,PHASE1|PHASE2,immune_system_disease
2264,Atopic Dermatitis,Omiganan,CCC(C)C(C(=O)NC(CC(C)C)C(=O)NC(CCCNC(=N)N)C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)N3CCCC3C(=O)NC(CC4=CNC5=CC=CC=C54)C(=O)NC(CC6=CNC7=CC=CC=C76)C(=O)N8CCCC8C(=O)NC(CC9=CNC1=CC=CC=C19)C(=O)NC(CCCNC(=N)N)C(=O)NC(CCCNC(=N)N)C(=O)NC(CCCCN)C(=O)N)N,PHASE2,immune_system_disease
2265,Insulin Sensitivity,Eritoran,CCCCCCCCCCCC(=O)CC(=O)NC1C(C(C(OC1OP(=O)(O)O)COC2C(C(C(C(O2)COC)OP(=O)(O)O)OCCC(CCCCCCC)OC)NC(=O)CCCCCCCCCC=CCCCCCC)O)OCCCCCCCCCC,PHASE2,immune_system_disease
2266,Pruritus|Atopic Dermatitis,Orvepitant,CC1=C(C=CC(=C1)F)C2CC(CCN2C(=O)N(C)C(C)C3=CC(=CC(=C3)C(F)(F)F)C(F)(F)F)N4CCN5C(C4)CCC5=O,PHASE2,immune_system_disease
2267,Asthma,Sulforaphane,CS(=O)CCCCN=C=S,PHASE1,immune_system_disease
2268,Hepatitis B,Alendronate,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,PHASE1,immune_system_disease
2269,Relapsing Multiple Sclerosis,Ozanimod,CC(C)OC1=C(C=C(C=C1)C2=NC(=NO2)C3=C4CCC(C4=CC=C3)NCCO)C#N,PHASE2|PHASE3,immune_system_disease
2270,HIV Infections,Gemfibrozil,CC1=CC(=C(C=C1)C)OCCCC(C)(C)C(=O)O,PHASE1,immune_system_disease
2271,Hodgkin Lymphoma|Refractory Hodgkin Lymphoma,Pentamidine,C1=CC(=CC=C1C(=N)N)OCCCCCOC2=CC=C(C=C2)C(=N)N,PHASE1,immune_system_disease
2272,Primary Central Nervous System Lymphoma,Isavuconazole,CC(C1=NC(=CS1)C2=CC=C(C=C2)C#N)C(CN3C=NC=N3)(C4=C(C=CC(=C4)F)F)O,PHASE1,immune_system_disease
2273,Multiple Myeloma,Plinabulin,CC(C)(C)C1=C(N=CN1)C=C2C(=O)NC(=CC3=CC=CC=C3)C(=O)N2,PHASE2,immune_system_disease
2274,Pediatric Cancer|Solid Tumors|Lymphoma,Eribulin,CC1CC2CCC3C(=C)CC(O3)CCC45CC6C(O4)C7C(O6)C(O5)C8C(O7)CCC(O8)CC(=O)CC9C(CC(C1=C)O2)OC(C9OC)CC(CN)O,PHASE1,immune_system_disease
2275,Rheumatoid Arthritis,Repaglinide,CCOC1=C(C=CC(=C1)CC(=O)NC(CC(C)C)C2=CC=CC=C2N3CCCCC3)C(=O)O,PHASE1,immune_system_disease
2276,"Neurofibroma, Plexiform|Precursor Cell Lymphoblastic Leukemia-Lymphoma|Leukemia, Promyelocytic, Acute|Sarcoma",Pexidartinib,C1=CC(=NC=C1CC2=CNC3=C2C=C(C=N3)Cl)NCC4=CN=C(C=C4)C(F)(F)F,PHASE1,immune_system_disease
2277,Muscle Spasticity,Tizanidine,C1CN=C(N1)NC2=C(C=CC3=NSN=C32)Cl,PHASE1|PHASE2,immune_system_disease
2278,HIV Infections,Emivirine,CCOCN1C(=C(C(=O)NC1=O)C(C)C)CC2=CC=CC=C2,PHASE2,immune_system_disease
2279,Type 1 Diabetes Mellitus,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,PHASE1|PHASE2,immune_system_disease
2280,Atopic Dermatitis|Eczema|Chronic Pruritus,Tradipitant,C1=CC=C(C(=C1)C(=O)C2=C(N=CC=C2)C3=C(N(N=N3)CC4=CC(=CC(=C4)C(F)(F)F)C(F)(F)F)C5=CC=NC=C5)Cl,PHASE2,immune_system_disease
2281,Prostate Cancer Metastatic,Enzalutamide,CC1(C(=O)N(C(=S)N1C2=CC(=C(C=C2)C(=O)NC)F)C3=CC(=C(C=C3)C#N)C(F)(F)F)C,PHASE2,immune_system_disease
2282,Advanced NSCLC With EGFR Mutation,Gefitinib,COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4,PHASE2,immune_system_disease
2283,Prostate Cancer Metastatic,Rucaparib,CNCC1=CC=C(C=C1)C2=C3CCNC(=O)C4=C3C(=CC(=C4)F)N2,PHASE2,immune_system_disease
2284,"Healthy Volunteers (Intended Indication: Metastatic Patients With Triple Negative or HR+ Breast Cancer, or Hormone Sensitive Prostate Cancer)",Capivasertib,C1CN(CCC1(C(=O)NC(CCO)C2=CC=C(C=C2)Cl)N)C3=NC=NC4=C3C=CN4,PHASE1,immune_system_disease
2285,Hereditary Angioedema Types I and II,Ecallantide,CCC(C)C1C(=O)NC(C(=O)NCC(=O)NCC(=O)NC2CSSCC3C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N4CCCC4C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NCC(=O)N5CCCC5C(=O)N3)CC(=O)O)CC(=O)O)C)CCCCN)CC6=CC=CC=C6)C)NC(=O)C(CC7=CC=CC=C7)NC(=O)C(CO)NC(=O)C(CC8=CN=CN8)NC(=O)C(CCSC)NC(=O)C(C)NC(=O)C(CCC(=O)O)N)C(=O)NC(C(C)O)C(=O)NC(CCCNC(=N)N)C(=O)NC(CC(=O)O)C(=O)O)CCSC)CCCCN)CCCCN)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)CNC(=O)C(NC2=O)CCC(=O)O)CC(=O)N)CCC(=O)N)CC(=O)N)CCCNC(=N)N)CC9=CC=CC=C9)CCC(=O)O)CO)CC(C)C)CCC(=O)O)CCC(=O)O)C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CC1=CC=CC=C1)CCC(=O)O)CCC(=O)O)CCC(=O)N)CCCNC(=N)N)C(C)O)CC1=CC=CC=C1)C(C)CC)CC(=O)N)CC1=CC=CC=C1)CC1=CC=CC=C1)CC1=CNC2=CC=CC=C21)CCCNC(=N)N)CC1=CN=CN1)C)C)CCCNC(=N)N)CC1=CC=C(C=C1)O,PHASE2,immune_system_disease
2286,Drug-drug Interaction|Autoimmune Diseases|Fibrotic Disease,Rabeprazole,CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCCCOC,PHASE1,immune_system_disease
2287,"Acute Biphenotypic Leukemia|Acute Myeloid Leukemia|Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Blasts 10 Percent or More of Bone Marrow Nucleated Cells|Blasts 10 Percent or More of Peripheral Blood White Cells|de Novo Myelodysplastic Syndrome|Myelodysplastic Syndrome|Previously Treated Myelodysplastic Syndrome|Recurrent Acute Myeloid Leukemia|Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Refractory Acute Myeloid Leukemia|Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Secondary Acute Myeloid Leukemia|Untreated Adult Acute Myeloid Leukemia",Gilteritinib,CCC1=C(N=C(C(=N1)C(=O)N)NC2=CC(=C(C=C2)N3CCC(CC3)N4CCN(CC4)C)OC)NC5CCOCC5,PHASE2,immune_system_disease
2288,Resolved Hepatitis B|CD20 Positive B-cell Lymphoma,Entecavir,C=C1C(CC(C1CO)O)N2C=NC3=C2N=C(NC3=O)N,PHASE2,immune_system_disease
2289,Granulomatosis With Polyangiitis|Wegener Granulomatosis,Sulfamethoxazole,CC1=CC(=NO1)NS(=O)(=O)C2=CC=C(C=C2)N,PHASE1|PHASE2,immune_system_disease
2290,Leukemia,Sapacitabine,CCCCCCCCCCCCCCCC(=O)NC1=NC(=O)N(C=C1)C2C(C(C(O2)CO)O)C#N,PHASE2,immune_system_disease
2291,Rheumatoid Arthritis,Digoxin,CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,PHASE1,immune_system_disease
2292,Lupus Nephritis,Voclosporin,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC=C)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,PHASE2,immune_system_disease
2293,Healthy,Tretinoin,CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CC(=O)O)C)C,PHASE1,immune_system_disease
2294,Hematopoietic and Lymphoid Cell Neoplasm|Recurrent Acute Biphenotypic Leukemia|Recurrent Acute Myeloid Leukemia|Recurrent Myelodysplastic Syndrome|Refractory Acute Biphenotypic Leukemia|Refractory Acute Myeloid Leukemia|Refractory Myelodysplastic Syndrome,Omacetaxine,COC1=CC23CCCN2CCC4=CC5=C(C=C4C3C1O)OCO5,PHASE1|PHASE2,immune_system_disease
2295,Progressive Multiple Sclerosis,Acyclovir,C1=NC2=C(N1COCCO)N=C(NC2=O)N,PHASE1,immune_system_disease
2296,Progressive Multiple Sclerosis,Paracetamol,CC(=O)NC1=CC=C(C=C1)O,PHASE1,immune_system_disease
2297,Progressive Multiple Sclerosis,Dexchlorpheniramine,CN(C)CCC(C1=CC=C(C=C1)Cl)C2=CC=CC=N2,PHASE1,immune_system_disease
2298,"Infections, Human Immunodeficiency Virus and Herpesviridae",Fosamprenavir,CC(C)CN(CC(C(CC1=CC=CC=C1)NC(=O)OC2CCOC2)OP(=O)(O)O)S(=O)(=O)C3=CC=C(C=C3)N,PHASE1,immune_system_disease
2299,Metastatic Pancreatic Cancer,Rintatolimod,C1=CN(C(=O)N=C1N)C2C(C(C(O2)COP(=O)(O)O)O)O.C1=CN(C(=O)NC1=O)C2C(C(C(O2)COP(=O)(O)O)O)O.C1=NC2=C(C(=O)N1)N=CN2C3C(C(C(O3)COP(=O)(O)O)O)O,PHASE1|PHASE2,immune_system_disease
2300,"Nystagmus, Congenital|Nystagmus, Acquired|Multiple Sclerosis",Neramexane,CC1(CC(CC(C1)(C)N)(C)C)C,PHASE2,immune_system_disease
2301,HIV Infections,Atevirdine,CCNC1=C(N=CC=C1)N2CCN(CC2)C(=O)C3=CC4=C(N3)C=CC(=C4)OC,PHASE1,immune_system_disease
2302,AIDS Dementia Complex|HIV Infections,Nimodipine,CC1=C(C(C(=C(N1)C)C(=O)OC(C)C)C2=CC(=CC=C2)[N+](=O)[O-])C(=O)OCCOC,PHASE1,immune_system_disease
2303,Multiple Sclerosis|Overactive Detrusor,Darifenacin,C1CN(CC1C(C2=CC=CC=C2)(C3=CC=CC=C3)C(=O)N)CCC4=CC5=C(C=C4)OCC5,PHASE2,immune_system_disease
2304,Type 1 Diabetes,Empagliflozin,C1COCC1OC2=CC=C(C=C2)CC3=C(C=CC(=C3)C4C(C(C(C(O4)CO)O)O)O)Cl,PHASE1,immune_system_disease
2305,Multiple Sclerosis,Topiramate,CC1(OC2COC3(C(C2O1)OC(O3)(C)C)COS(=O)(=O)N)C,PHASE2,immune_system_disease
2306,Ependymoma|Medulloblastoma|Glioblastoma|Primary Brain Tumor,Indoximod,CN1C=C(C2=CC=CC=C21)CC(C(=O)O)N,PHASE1,immune_system_disease
2307,Cutaneous T-Cell Lymphoma,Tazarotene,CCOC(=O)C1=CN=C(C=C1)C#CC2=CC3=C(C=C2)SCCC3(C)C,PHASE1|PHASE2,immune_system_disease
2308,Peripheral Neuropathy|Type 1 Diabetes,Salsalate,C1=CC=C(C(=C1)C(=O)OC2=CC=CC=C2C(=O)O)O,PHASE2,immune_system_disease
2309,AIDS Dementia Complex,Ferumoxytol,O[Fe]=O.O[Fe]=O.[Fe],PHASE2,immune_system_disease
2310,Atopic Dermatitis,Calcipotriol,CC(C=CC(C1CC1)O)C2CCC3C2(CCCC3=CC=C4CC(CC(C4=C)O)O)C,PHASE2,immune_system_disease
2311,Solid Tumors|Lymphoma,Esomeprazole,CC1=CN=C(C(=C1OC)C)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC,PHASE1,immune_system_disease
2312,Stem Cell Transplantation|Graft vs Host Disease,Micafungin,CCCCCOC1=CC=C(C=C1)C2=CC(=NO2)C3=CC=C(C=C3)C(=O)NC4CC(C(NC(=O)C5C(C(CN5C(=O)C(NC(=O)C(NC(=O)C6CC(CN6C(=O)C(NC4=O)C(C)O)O)C(C(C7=CC(=C(C=C7)O)OS(=O)(=O)O)O)O)C(CC(=O)N)O)C)O)O)O,PHASE1,immune_system_disease
2313,Atopic Dermatitis,Gentamicin,CC(C1CCC(C(O1)OC2C(CC(C(C2O)OC3C(C(C(CO3)(C)O)NC)O)N)N)N)NC,PHASE1,immune_system_disease
2314,"Breast Cancer|Cholangiocarcinoma|Colorectal Cancer|Head and Neck Neoplasms|Lymphoma, Large-Cell, Anaplastic|Melanoma|Neuroendocrine Tumors|Non-Small Cell Lung Cancer|Ovarian Cancer|Pancreatic Cancer|Papillary Thyroid Cancer|Primary Brain Tumors|Renal Cell Carcinoma|Sarcomas|Salivary Gland Cancers|Adult Solid Tumor",Entrectinib,CN1CCN(CC1)C2=CC(=C(C=C2)C(=O)NC3=NNC4=C3C=C(C=C4)CC5=CC(=CC(=C5)F)F)NC6CCOCC6,PHASE2,immune_system_disease
2315,Multiple Sclerosis,Isoxsuprine,CC(COC1=CC=CC=C1)NC(C)C(C2=CC=C(C=C2)O)O,PHASE1|PHASE2,immune_system_disease
2316,"Leukemia, Chronic Lymphatic",Imiquimod,CC(C)CN1C=NC2=C1C3=CC=CC=C3N=C2N,PHASE2,immune_system_disease
2317,Bronchial Asthma,Apocynin,CC(=O)C1=CC(=C(C=C1)O)OC,PHASE1,immune_system_disease
2318,Multiple Myeloma,Tasquinimod,CN1C2=C(C(=CC=C2)OC)C(=C(C1=O)C(=O)N(C)C3=CC=C(C=C3)C(F)(F)F)O,PHASE1,immune_system_disease
2319,Methamphetamine Dependence|HIV Infection,Ibudilast,CC(C)C1=NN2C=CC=CC2=C1C(=O)C(C)C,PHASE2,immune_system_disease
2320,Multiple Myeloma,Acetylcarnitine,CC(=O)OC(CC(=O)[O-])C[N+](C)(C)C,PHASE2,immune_system_disease
2321,Infectious Mononucleosis,Valomaciclovir,CC(C)C(C(=O)OCCC(CN1C=NC2=C1N=C(NC2=O)N)CO)N,PHASE1|PHASE2,immune_system_disease
2322,Multiple Sclerosis|Fatigue,Mitoquinone,CC1=C(C(=O)C(=C(C1=O)OC)OC)CCCCCCCCCC[P+](C2=CC=CC=C2)(C3=CC=CC=C3)C4=CC=CC=C4,PHASE1|PHASE2,immune_system_disease
2323,Multiple Sclerosis|Bladder Dysfunction,Alfuzosin,CN(CCCNC(=O)C1CCCO1)C2=NC3=CC(=C(C=C3C(=N2)N)OC)OC,PHASE2|PHASE3,immune_system_disease
2324,Pruritus|Atopic Dermatitis,Asimadoline,CN(C(CN1CCC(C1)O)C2=CC=CC=C2)C(=O)C(C3=CC=CC=C3)C4=CC=CC=C4,PHASE2,immune_system_disease
2325,Asthma|Electrophilic Fatty Acids,Indomethacin,CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)Cl)C=CC(=C2)OC)CC(=O)O,PHASE1,immune_system_disease
2326,Asthma,Vilanterol,C1=CC(=C(C(=C1)Cl)COCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O)Cl,PHASE2,immune_system_disease
2327,"Attention Deficit Disorder With Hyperactivity|Diabetes Mellitus, Type 1",Lisdexamfetamine,CC(CC1=CC=CC=C1)NC(=O)C(CCCCN)N,PHASE2,immune_system_disease
2328,HIV|Contraception|HIV Infections,Medroxyprogesterone,CC1CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C,PHASE2,immune_system_disease
2329,Discoid Lupus Erythematosus,Delgocitinib,CC1CN(C12CCN(C2)C3=NC=NC4=C3C=CN4)C(=O)CC#N,PHASE2,immune_system_disease
2330,"B Acute Lymphoblastic Leukemia|B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1|B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative|Recurrent Adult Acute Lymphoblastic Leukemia|Refractory Adult Acute Lymphoblastic Leukemia|T Acute Lymphoblastic Leukemia",Sapanisertib,CC(C)N1C2=NC=NC(=C2C(=N1)C3=CC4=C(C=C3)OC(=N4)N)N,PHASE2,immune_system_disease
2331,"Conjunctivitis, Allergic",Reproxalap,CC(C)(C1=C(C=C2C=C(C=CC2=N1)Cl)N)O,PHASE1|PHASE2,immune_system_disease
2332,Advanced Solid Tumor|Lymphoma,Milademetan,CC1(CCC2(CC1)C3(C(C(N2)C(=O)NC4CCC(OC4)C(=O)N)C5=C(C(=NC=C5)Cl)F)C6=C(C=C(C=C6)Cl)NC3=O)C,PHASE1,immune_system_disease
2333,Follicular Lymphoma,Allicin,C=CCSS(=O)CC=C,PHASE2,immune_system_disease
2334,Follicular Lymphoma,Quercetin,C1=CC(=C(C=C1C2=C(C(=O)C3=C(C=C(C=C3O2)O)O)O)O)O,PHASE2,immune_system_disease
2335,HIV Infections,Dinitrochlorobenzene,C1=CC(=C(C=C1[N+](=O)[O-])[N+](=O)[O-])Cl,PHASE1,immune_system_disease
2336,"Leukemia, Lymphocytic, Chronic, B-Cell",Ethinylestradiol,CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O,PHASE1,immune_system_disease
2337,"Leukemia, Lymphocytic, Chronic, B-Cell",Bupropion,CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C,PHASE1,immune_system_disease
2338,"Diabetes Mellitus, Type 1",Canagliflozin,CC1=C(C=C(C=C1)C2C(C(C(C(O2)CO)O)O)O)CC3=CC=C(S3)C4=CC=C(C=C4)F,PHASE2,immune_system_disease
2339,Exercise-Induced Asthma,Oglemilast,CS(=O)(=O)NC1=CC2=C(C=C1)OC3=C(C=CC(=C23)C(=O)NC4=C(C=NC=C4Cl)Cl)OC(F)F,PHASE2,immune_system_disease
2340,Multiple Sclerosis,Riluzole,C1=CC2=C(C=C1OC(F)(F)F)SC(=N2)N,PHASE2,immune_system_disease
2341,Lymphoma,Amifostine,C(CN)CNCCSP(=O)(O)O,PHASE2,immune_system_disease
2342,HIV Infections,Vesnarinone,COC1=C(C=C(C=C1)C(=O)N2CCN(CC2)C3=CC4=C(C=C3)NC(=O)CC4)OC,PHASE1,immune_system_disease
2343,Allergic Asthma,Pemirolast,CC1=CC=CN2C1=NC=C(C2=O)C3=NNN=N3,PHASE2,immune_system_disease
2344,IgA Nephropathy|CKD Associated With Type 1 Diabetes|Focal Segmental Glomerulosclerosis|Autosomal Dominant Polycystic Kidney,Bardoxolone,CC1(CCC2(CCC3(C(C2C1)C(=O)C=C4C3(CCC5C4(C=C(C(=O)C5(C)C)C#N)C)C)C)C(=O)O)C,PHASE2,immune_system_disease
2345,Type 1 Diabetes Mellitus|Hypercalciuria,Chlorthalidone,C1=CC=C2C(=C1)C(=O)NC2(C3=CC(=C(C=C3)Cl)S(=O)(=O)N)O,PHASE2,immune_system_disease
2346,Ebola|HIV/AIDS,Remdesivir,CCC(CC)COC(=O)C(C)NP(=O)(OCC1C(C(C(O1)(C#N)C2=CC=C3N2N=CN=C3N)O)O)OC4=CC=CC=C4,PHASE2,immune_system_disease
2347,HIV/AIDS,Albuvirtide,CCC(C)C(C(=O)NC(CC(=O)N)C(=O)NC(CC(=O)N)C(=O)NC(CC1=CC=C(C=C1)O)C(=O)NC(C(C)O)C(=O)NC(CCCCNC(=O)COCCOCCNC(=O)CCN2C(=O)C=CC2=O)C(=O)NC(CC(C)C)C(=O)NC(C(C)CC)C(=O)NC(CC3=CNC=N3)C(=O)NC(CCC(=O)O)C(=O)NC(CC(C)C)C(=O)NC(C(C)CC)C(=O)NC(CCC(=O)O)C(=O)NC(CCC(=O)O)C(=O)NC(CO)C(=O)NC(CCC(=O)N)C(=O)NC(CC(=O)N)C(=O)NC(CCC(=O)N)C(=O)NC(CCC(=O)N)C(=O)NC(CCC(=O)O)C(=O)NC(CCCCN)C(=O)NC(CC(=O)N)C(=O)NC(CCC(=O)O)C(=O)NC(CCC(=O)N)C(=O)NC(CCC(=O)O)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)N)NC(=O)C(CCC(=O)O)NC(=O)C(CCCNC(=N)N)NC(=O)C(CC(=O)O)NC(=O)C(CC4=CNC5=CC=CC=C54)NC(=O)C(CCC(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(CC6=CNC7=CC=CC=C76)NC(=O)C,PHASE1,immune_system_disease
2348,"Diabetes Mellitus, Type 1",Calcitriol,CC(CCCC(C)(C)O)C1CCC2C1(CCCC2=CC=C3CC(CC(C3=C)O)O)C,PHASE2,immune_system_disease
2349,Metabolic Syndrome X,Resveratrol,C1=CC(=CC=C1C=CC2=CC(=CC(=C2)O)O)O,PHASE2,immune_system_disease
2350,Non-Hodgkin's Lymphoma,Chiauranib,COC1=CC2=NC=CC(=C2C=C1)OC3=CC4=C(C=C3)C(=CC=C4)C(=O)NC5=CC=CC=C5N,PHASE1,immune_system_disease
2351,Secondary Progressive Multiple Sclerosis,Lamotrigine,C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N,PHASE2,immune_system_disease
2352,Hairy Cell Leukemia,Encorafenib,CC(C)N1C=C(C(=N1)C2=C(C(=CC(=C2)Cl)NS(=O)(=O)C)F)C3=NC(=NC=C3)NCC(C)NC(=O)OC,PHASE2,immune_system_disease
2353,Tumor Lysis Syndrome,Febuxostat,CC1=C(SC(=N1)C2=CC(=C(C=C2)OCC(C)C)C#N)C(=O)O,PHASE1|PHASE2,immune_system_disease
2354,Recurrent Ependymoma|Recurrent Ewing Sarcoma|Recurrent Hepatoblastoma|Recurrent Langerhans Cell Histiocytosis|Recurrent Malignant Germ Cell Tumor|Recurrent Malignant Glioma|Recurrent Malignant Solid Neoplasm|Recurrent Medulloblastoma|Recurrent Neuroblastoma|Recurrent Non-Hodgkin Lymphoma|Recurrent Osteosarcoma|Recurrent Peripheral Primitive Neuroectodermal Tumor|Recurrent Rhabdoid Tumor|Recurrent Rhabdomyosarcoma|Recurrent Soft Tissue Sarcoma|Recurrent WHO Grade 2 Glioma|Refractory Ependymoma|Refractory Ewing Sarcoma|Refractory Hepatoblastoma|Refractory Langerhans Cell Histiocytosis|Refractory Malignant Germ Cell Tumor|Refractory Malignant Glioma|Refractory Malignant Solid Neoplasm|Refractory Medulloblastoma|Refractory Neuroblastoma|Refractory Non-Hodgkin Lymphoma|Refractory Osteosarcoma|Refractory Peripheral Primitive Neuroectodermal Tumor|Refractory Rhabdoid Tumor|Refractory Rhabdomyosarcoma|Refractory Soft Tissue Sarcoma|Refractory WHO Grade 2 Glioma|Wilms Tumor,Ivosidenib,C1CC(=O)N(C1C(=O)N(C2=CC(=CN=C2)F)C(C3=CC=CC=C3Cl)C(=O)NC4CC(C4)(F)F)C5=NC=CC(=C5)C#N,PHASE2,immune_system_disease
2355,Rheumatoid Arthritis,Puerarin,C1=CC(=CC=C1C2=COC3=C(C2=O)C=CC(=C3C4C(C(C(C(O4)CO)O)O)O)O)O,PHASE2,immune_system_disease
2356,Multiple Myeloma in Relapse|Multiple Myeloma Progression|Multiple Myeloma With Failed Remission,Tinostamustine,CN1C2=C(C=C(C=C2)N(CCCl)CCCl)N=C1CCCCCCC(=O)NO,PHASE1|PHASE2,immune_system_disease
2357,Advanced Solid Tumors|Lymphoma,Quarfloxin,CN1CCCC1CCNC(=O)C2=CN3C4=CC5=CC=CC=C5C=C4OC6=C3C(=CC(=C6N7CCC(C7)C8=NC=CN=C8)F)C2=O,PHASE1,immune_system_disease
2358,Locally Advanced Rectal Cancer,Fruquintinib,CC1=C(C2=C(O1)C=C(C=C2)OC3=NC=NC4=CC(=C(C=C43)OC)OC)C(=O)NC,PHASE2,immune_system_disease
2359,Pulmonary Lymphangioleiomyomatosis,Saracatinib,CN1CCN(CC1)CCOC2=CC3=C(C(=C2)OC4CCOCC4)C(=NC=N3)NC5=C(C=CC6=C5OCO6)Cl,PHASE1,immune_system_disease
2360,Multiple Myeloma,Colesevelam,CCCCCCCCCCNCC=C.C[N+](C)(C)CCCCCCNCC=C.C=CCN.C1C(O1)CCl.Cl.[Cl-],PHASE2,immune_system_disease
2361,Hepatocellular Carcinoma,Regorafenib,CNC(=O)C1=NC=CC(=C1)OC2=CC(=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F)F,PHASE2,immune_system_disease
2362,Sarcoidosis; Antimycobacterial Therapy,Ethambutol,CCC(CO)NCCNC(CC)CO,PHASE2,immune_system_disease
2363,Multiple Sclerosis|Optic Nerve|Neuritis,Nerispirdine,CCCN(C1=C(C=NC=C1)F)N2C=C(C3=CC=CC=C32)C,PHASE2,immune_system_disease
2364,Allergic Conjunctivitis,Lifitegrast,CS(=O)(=O)C1=CC=CC(=C1)CC(C(=O)O)NC(=O)C2=C(C=C3CN(CCC3=C2Cl)C(=O)C4=CC5=C(C=C4)C=CO5)Cl,PHASE2,immune_system_disease
2365,Hematologic Malignancy|Acute Lymphocytic Leukemia|Chronic Lymphocytic Leukemia|Myelodysplasia|Acute Myeloid Leukemia|Chronic Myelogenous Leukemia|Hodgkin's Disease,Ciclopirox,CC1=CC(=O)N(C(=C1)C2CCCCC2)O,PHASE1,immune_system_disease
2366,Lymphoblastic Leukemia,Ziftomenib,CC1=C(C=CC2=C1C=C(N2CC(C)N3CCN(CC3)S(=O)(=O)C)C#N)CN4CCC(CC4)NC5=C6C=C(SC6=NC(=N5)NC)CC(F)(F)F,PHASE1|PHASE2,immune_system_disease
2367,Refractory Multiple Myeloma,Tivantinib,C1CC2=C3C(=CC=C2)C(=CN3C1)C4C(C(=O)NC4=O)C5=CNC6=CC=CC=C65,PHASE2,immune_system_disease
2368,Eosinophilic Esophagitis (EoE),Bethanechol,CC(C[N+](C)(C)C)OC(=O)N,PHASE2,immune_system_disease
2369,HIV Infections,Peldesine,C1=CC(=CN=C1)CC2=CNC3=C2N=C(NC3=O)N,PHASE1,immune_system_disease
2370,Sickle Cell Disease|Graft Versus Host Disease,Meperidine,CCOC(=O)C1(CCN(CC1)C)C2=CC=CC=C2,PHASE1,immune_system_disease
2371,Relapsing-remitting Multiple Sclerosis|Secondary-progressive Multiple Sclerosis|Primary-progressive Multiple Sclerosis,Norethisterone,CC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34,PHASE2,immune_system_disease
2372,Relapsing-remitting Multiple Sclerosis|Secondary-progressive Multiple Sclerosis|Primary-progressive Multiple Sclerosis,Norethindrone,CC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34,PHASE2,immune_system_disease
2373,Lung Cancer|Anaplastic Lymphoma Kinase Gene Translocation|ROS1 Rearrangement|Relapsed Cancer|MET Amplification|Resistant Cancer|NSCLC,Lorlatinib,CC1C2=C(C=CC(=C2)F)C(=O)N(CC3=NN(C(=C3C4=CC(=C(N=C4)N)O1)C#N)C)C,PHASE1|PHASE2,immune_system_disease
2374,Lung Cancer|Anaplastic Lymphoma Kinase Gene Translocation|ROS1 Rearrangement|Relapsed Cancer|MET Amplification|Resistant Cancer|NSCLC,Binimetinib,CN1C=NC2=C1C=C(C(=C2F)NC3=C(C=C(C=C3)Br)F)C(=O)NOCCO,PHASE1|PHASE2,immune_system_disease
2375,ALK-activated Tumors,Ceritinib,CC1=CC(=C(C=C1C2CCNCC2)OC(C)C)NC3=NC=C(C(=N3)NC4=CC=CC=C4S(=O)(=O)C(C)C)Cl,PHASE1,immune_system_disease
2376,"Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)|Coronavirus Disease 2019 (COVID-19)|Immunocompromised|Hospitalization|Child, Hospitalized",Nirmatrelvir,CC1(C2C1C(N(C2)C(=O)C(C(C)(C)C)NC(=O)C(F)(F)F)C(=O)NC(CC3CCNC3=O)C#N)C,PHASE2,immune_system_disease
2377,Lupus Nephritis,Tamibarotene,CC1(CCC(C2=C1C=CC(=C2)NC(=O)C3=CC=C(C=C3)C(=O)O)(C)C)C,PHASE2,immune_system_disease
2378,"Recurrent Diffuse Large B-Cell Lymphoma Activated B-Cell Type|Recurrent Diffuse Large B-Cell Lymphoma Germinal Center B-Cell Type|Recurrent High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements|Recurrent High Grade B-Cell Lymphoma With MYC, BCL2, and BCL6 Rearrangements|Refractory Diffuse Large B-Cell Lymphoma Activated B-Cell Type|Refractory Diffuse Large B-Cell Lymphoma Germinal Center B-Cell Type|Refractory High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements|Refractory High Grade B-Cell Lymphoma With MYC, BCL2, and BCL6 Rearrangements|Transformed Indolent B-Cell Non-Hodgkin Lymphoma to Diffuse Large B-Cell Lymphoma",Tegavivint,CC1CC(CN(C1)S(=O)(=O)C2=CC3=C(C=C2)C(=C4C=CC(=CC4=C3N=O)S(=O)(=O)N5CC(CC(C5)C)C)NO)C,PHASE1,immune_system_disease
2379,Sarcoidosis|Fatigue|Sleepiness,Modafinil,C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N,PHASE2|PHASE3,immune_system_disease
2380,Sarcoidosis|Fatigue|Sleepiness,Armodafinil,C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N,PHASE2|PHASE3,immune_system_disease
2381,Cachexia|HIV Infections|HIV Wasting Syndrome,Dronabinol,CCCCCC1=CC(=C2C3C=C(CCC3C(OC2=C1)(C)C)C)O,PHASE1,immune_system_disease
2382,Asthma,Fevipiprant,CC1=C(C2=C(N1CC3=C(C=C(C=C3)S(=O)(=O)C)C(F)(F)F)N=CC=C2)CC(=O)O,PHASE2,immune_system_disease
2383,Systemic Lupus Erythematosus,Cenerimod,CCC1=C(C(=CC(=C1)C2=NOC(=N2)C3=CC(=NC(=C3)OC)C4CCCC4)C)OCC(CO)O,PHASE2,immune_system_disease
2384,Lymphoma|Multiple Myeloma,Tinzaparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,PHASE2,immune_system_disease
2385,"Lymphoma, Non-Hodgkin|Advanced Stage Diffuse Large B-Cell Non-Hodgkin's Lymphoma",Ondansetron,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C,PHASE2,immune_system_disease
2386,Lymphangioleiomyomatosis,Nintedanib,CN1CCN(CC1)CC(=O)N(C)C2=CC=C(C=C2)N=C(C3=CC=CC=C3)C4=C(NC5=C4C=CC(=C5)C(=O)OC)O,PHASE2,immune_system_disease
2387,Atopic Dermatitis,Fluocinonide,CC(=O)OCC(=O)C12C(CC3C1(CC(C4(C3CC(C5=CC(=O)C=CC54C)F)F)O)C)OC(O2)(C)C,PHASE2,immune_system_disease
2388,Immune Thrombocytopenia (ITP),Lusutrombopag,CCCCCCOC(C)C1=CC=CC(=C1OC)C2=CSC(=N2)NC(=O)C3=CC(=C(C(=C3)Cl)C=C(C)C(=O)O)Cl,PHASE2,immune_system_disease
2389,HIV Infections,Acitretin,CC1=CC(=C(C(=C1C=CC(=CC=CC(=CC(=O)O)C)C)C)C)OC,PHASE1,immune_system_disease
2390,Multiple Myeloma,Propranolol,CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O,PHASE2,immune_system_disease
2391,Multiple Sclerosis,Pantoprazole,COC1=C(C(=NC=C1)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC(F)F)OC,PHASE1,immune_system_disease
2392,Lymphoma|Advanced Cancer,Tolbutamide,CCCCNC(=O)NS(=O)(=O)C1=CC=C(C=C1)C,PHASE1,immune_system_disease
2393,Lymphoma|Advanced Cancer,Tasisulam,C1=CC(=C(C=C1Cl)Cl)C(=O)NS(=O)(=O)C2=CC=C(S2)Br,PHASE1,immune_system_disease
2394,"Rhinitis, Allergic, Perennial and Seasonal",Levocabastine,CC1CN(CCC1(C2=CC=CC=C2)C(=O)O)C3CCC(CC3)(C#N)C4=CC=C(C=C4)F,PHASE2,immune_system_disease
2395,Thyroid-Associated Ophthalmopathy,Lanreotide,CC(C)C1C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=C(C=C4)O)NC(=O)C(CC5=CC6=CC=CC=C6C=C5)N)C(=O)NC(C(C)O)C(=O)N,PHASE2,immune_system_disease
2396,Peripheral T-cell Lymphomas,Endostar,CN(CC(=O)C1=CC=CC=C1)N=O,PHASE2,immune_system_disease
2397,Impaired Glucose Tolerance|Insulin Sensitivity|Glucose Metabolism Disorders,Linagliptin,CC#CCN1C2=C(N=C1N3CCCC(C3)N)N(C(=O)N(C2=O)CC4=NC5=CC=CC=C5C(=N4)C)C,PHASE2,immune_system_disease
2398,Multiple Myeloma,Tecemotide,CCCCCCCCCCCCCCCC(=O)NCCCCC(C(=O)NCC(=O)O)NC(=O)C1CCCN1C(=O)C2CCCN2C(=O)C(C)NC(=O)C(C(C)O)NC(=O)C(CO)NC(=O)CNC(=O)C3CCCN3C(=O)C(C)NC(=O)C4CCCN4C(=O)C(CCCNC(=N)N)NC(=O)C(C(C)O)NC(=O)C(CC(=O)O)NC(=O)C5CCCN5C(=O)C(C)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C(C(C)C)NC(=O)CNC(=O)C(CC6=CN=CN6)NC(=O)C(C)NC(=O)C7CCCN7C(=O)C8CCCN8C(=O)C(C)NC(=O)C(C(C)O)NC(=O)C(CO)N,PHASE2,immune_system_disease
2399,"Lymphoma, Non-Hodgkin|HIV Infections",Mitoguazone,CC(=NN=C(N)N)C=NN=C(N)N,PHASE2,immune_system_disease
2400,Cutaneous Nerves CNS Itch,Clonidine,C1CN=C(N1)NC2=C(C=CC=C2Cl)Cl,PHASE1,immune_system_disease
2401,"IgA Nephropathy (IgAN)|Berger Disease|Glomerulonephritis, IgA",Cemdisiran,CC(=O)NC1C(C(C(OC1OCCCCC(=O)NCCCNC(=O)CCOCC(COCCC(=O)NCCCNC(=O)CCCCOC2C(C(C(C(O2)CO)O)O)NC(=O)C)(COCCC(=O)NCCCNC(=O)CCCCOC3C(C(C(C(O3)CO)O)O)NC(=O)C)NC(=O)CCCCCCCCCCC(=O)N4CC(CC4COP(=O)(O)O)O)CO)O)O,PHASE2,immune_system_disease
2402,Lung Cancer|Solid Tumor|Gastric Cancer|Urothelial Cancer|Endometrial Cancer|Multiple Myeloma|Myeloproliferative Neoplasms|Breast Cancer|Cholangiocarcinoma|UC|MPN,Pemigatinib,CCN1C2=C3C=C(NC3=NC=C2CN(C1=O)C4=C(C(=CC(=C4F)OC)OC)F)CN5CCOCC5,PHASE1|PHASE2,immune_system_disease
2403,Allergic Bronchopulmonary Aspergillosis,Deflazacort,CC1=NC2(C(O1)CC3C2(CC(C4C3CCC5=CC(=O)C=CC45C)O)C)C(=O)COC(=O)C,PHASE2|PHASE3,immune_system_disease
2404,Rheumatoid Arthritis,Revamilast,C1=CC(=C2C(=C1C(=O)N=C3C(=CN(C=C3Cl)O)Cl)C4=C(O2)C=CN=C4)OC(F)F,PHASE2,immune_system_disease
2405,"Multiple Sclerosis, Relapsing-Remitting|Multiple Sclerosis",Guanabenz,C1=CC(=C(C(=C1)Cl)C=NN=C(N)N)Cl,PHASE1,immune_system_disease
2406,Constipation|Fecal Incontinence|Multiple Sclerosis,Bisacodyl,CC(=O)OC1=CC=C(C=C1)C(C2=CC=C(C=C2)OC(=O)C)C3=CC=CC=N3,PHASE2,immune_system_disease
2407,Relapsing Remitting Multiple Sclerosis,Flupirtine,CCOC(=O)NC1=C(N=C(C=C1)NCC2=CC=C(C=C2)F)N,PHASE2,immune_system_disease
2408,HIV Infections,Bevirimat,CC(=C)C1CCC2(C1C3CCC4C5(CCC(C(C5CCC4(C3(CC2)C)C)(C)C)OC(=O)CC(C)(C)C(=O)O)C)C(=O)O,PHASE2,immune_system_disease
2409,"Lymphoma, Non-Hodgkin",Pixantrone,C1=CC(=C2C(=C1NCCN)C(=O)C3=C(C2=O)C=NC=C3)NCCN,PHASE2,immune_system_disease
2410,Multiple Sclerosis,Liothyronine,C1=CC(=C(C=C1OC2=C(C=C(C=C2I)CC(C(=O)O)N)I)I)O,PHASE1,immune_system_disease
2411,Spasticity|Multiple Sclerosis,Baclofen,C1=CC(=CC=C1C(CC(=O)O)CN)Cl,PHASE2,immune_system_disease
2412,Autoimmune Disease|Lymphatic Disease|Lymphoproliferative Disorder,Pyrimethamine,CCC1=C(C(=NC(=N1)N)N)C2=CC=C(C=C2)Cl,PHASE1,immune_system_disease
2413,HIV,Tesamorelin,CCC=CCC(=O)NC(CC1=CC=C(C=C1)O)C(=O)NC(C)C(=O)NC(CC(=O)O)C(=O)NC(C)C(=O)NC(C(C)CC)C(=O)NC(CC2=CC=CC=C2)C(=O)NC(C(C)O)C(=O)NC(CC(=O)N)C(=O)NC(CO)C(=O)NC(CC3=CC=C(C=C3)O)C(=O)NC(CCCNC(=N)N)C(=O)NC(CCCCN)C(=O)NC(C(C)C)C(=O)NC(CC(C)C)C(=O)NCC(=O)NC(CCC(=O)N)C(=O)NC(CC(C)C)C(=O)NC(CO)C(=O)NC(C)C(=O)NC(CCCNC(=N)N)C(=O)NC(CCCCN)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(CCC(=O)N)C(=O)NC(CC(=O)O)C(=O)NC(C(C)CC)C(=O)NC(CCSC)C(=O)NC(CO)C(=O)NC(CCCNC(=N)N)C(=O)NC(CCC(=O)N)C(=O)NC(CCC(=O)N)C(=O)NCC(=O)NC(CCC(=O)O)C(=O)NC(CO)C(=O)NC(CC(=O)N)C(=O)NC(CCC(=O)N)C(=O)NC(CCC(=O)O)C(=O)NC(CCCNC(=N)N)C(=O)NCC(=O)NC(C)C(=O)NC(CCCNC(=N)N)C(=O)NC(C)C(=O)NC(CCCNC(=N)N)C(=O)NC(CC(C)C)C(=O)N,PHASE1,immune_system_disease
2414,"Arthritis, Rheumatoid|Atherosclerosis",Sildenafil,CCCC1=NN(C2=C1N=C(NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C,PHASE2,immune_system_disease
2415,Pancreatic Islet Transplantation in Type 1 Diabetes Mellitus,Reparixin,CC(C)CC1=CC=C(C=C1)C(C)C(=O)NS(=O)(=O)C,PHASE2,immune_system_disease
2416,Mantle Cell Lymphoma|Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma,Elsamitrucin,CC1C(C(C(C(O1)OC2C(OC(C(C2(C)O)O)C)OC3=CC=CC4=C3C5=C6C7=C(C=CC(=C7C(=O)O5)C)OC(=O)C6=C4O)N)OC)O,PHASE2,immune_system_disease
2417,Status Asthmaticus,Ipratropium,CC(C)[N+]1(C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3)C,PHASE1,immune_system_disease
2418,Diabetes Mellitus Type 1|Autoimmune Diabetes,Lansoprazole,CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCC(F)(F)F,PHASE2,immune_system_disease
2419,Platinum-Sensitive Biliary Tract Cancer,Pamiparib,CC12CCCN1CC3=NNC(=O)C4=C5C3=C2NC5=CC(=C4)F,PHASE2,immune_system_disease
2420,HIV Infections,Chlorhexidine,C1=CC(=CC=C1NC(=NC(=NCCCCCCN=C(N)N=C(N)NC2=CC=C(C=C2)Cl)N)N)Cl,PHASE2,immune_system_disease
2421,Human Immunodeficiency Virus (HIV)-1 Infection,Elvucitabine,C1=CC(OC1CO)N2C=C(C(=NC2=O)N)F,PHASE2,immune_system_disease
2422,Acquired Immunodeficiency Syndrome,Dimiracetam,C1CC(=O)N2C1NC(=O)C2,PHASE2,immune_system_disease
2423,Acute Myeloid Leukemia (AML)|Acute Lymphoblastic Leukemia (ALL),Pyronaridine,COC1=NC2=C(C3=C(C=C(C=C3)Cl)N=C2C=C1)NC4=CC(=C(C(=C4)CN5CCCC5)O)CN6CCCC6,PHASE2,immune_system_disease
2424,"Chronic Idiopathic Thrombocytopenic Purpura|Purpura, Thrombocytopenic, Idiopathic",Avatrombopag,C1CCC(CC1)N2CCN(CC2)C3=C(N=C(S3)NC(=O)C4=CC(=C(N=C4)N5CCC(CC5)C(=O)O)Cl)C6=CC(=CS6)Cl,PHASE2,immune_system_disease
2425,"Asthma, Aspirin-Induced|Aspirin Exacerbated Asthma",Prasugrel,CC(=O)OC1=CC2=C(S1)CCN(C2)C(C3=CC=CC=C3F)C(=O)C4CC4,PHASE2,immune_system_disease
2426,Hodgkin Lymphoma,Mocetinostat,C1=CC=C(C(=C1)N)NC(=O)C2=CC=C(C=C2)CNC3=NC=CC(=N3)C4=CN=CC=C4,PHASE1|PHASE2,immune_system_disease
2427,Mitochondrial Diseases|Drug Resistant Epilepsy|Leigh Disease|Leigh Syndrome|Mitochondrial Encephalopathy (MELAS)|Pontocerebellar Hypoplasia Type 6 (PCH6)|Alpers Disease|Alpers Syndrome,Vatiquinone,CC1=C(C(=O)C(=C(C1=O)C)CCC(C)(CCC=C(C)CCC=C(C)CCC=C(C)C)O)C,PHASE2|PHASE3,immune_system_disease
2428,HIV Infections|HIV Wasting Syndrome,Nandrolone,CC12CCC3C(C1CCC2O)CCC4=CC(=O)CCC34,PHASE1,immune_system_disease
2429,Graft-versus-host Disease|Acute-graft-versus-host Disease,Defibrotide,CC(C)C1=C(C=C(C(=C1)C2=NNC(=O)N2C3=CC4=C(C=C3)N(C=C4)C)O)OP(=O)(O)O,PHASE2,immune_system_disease
2430,Metastatic Fallopian Tube Carcinoma|Metastatic Ovarian Carcinoma|Metastatic Primary Peritoneal Carcinoma|Ovarian Endometrioid Tumor|Ovarian High Grade Serous Adenocarcinoma|Platinum-Sensitive Ovarian Carcinoma|Recurrent Fallopian Tube Carcinoma|Recurrent Ovarian Carcinoma|Recurrent Primary Peritoneal Carcinoma|Stage IV Fallopian Tube Cancer AJCC v6 and v7|Stage IV Ovarian Cancer AJCC v6 and v7|Stage IV Primary Peritoneal Cancer AJCC v7,Berzosertib,CC(C)S(=O)(=O)C1=CC=C(C=C1)C2=CN=C(C(=N2)C3=CC(=NO3)C4=CC=C(C=C4)CNC)N,PHASE1,immune_system_disease
2431,Graft-versus-host-disease|CMV,Letermovir,COC1=C(C=C(C=C1)C(F)(F)F)N2C(C3=C(C(=CC=C3)F)N=C2N4CCN(CC4)C5=CC(=CC=C5)OC)CC(=O)O,PHASE2,immune_system_disease
2432,Asthma,Navarixin,CCC(C1=CC=C(O1)C)NC2=C(C(=O)C2=O)NC3=CC=CC(=C3O)C(=O)N(C)C,PHASE2,immune_system_disease
2433,Rheumatoid Arthritis,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,PHASE2,immune_system_disease
2434,Wegener's Granulomatosis,Gusperimus,C(CCCN=C(N)N)CCC(=O)NC(C(=O)NCCCCNCCCN)O,PHASE2,immune_system_disease
2435,Multiple Sclerosis|MS,Isoxaflutole,CS(=O)(=O)C1=C(C=CC(=C1)C(F)(F)F)C(=O)C2=C(ON=C2)C3CC3,PHASE1,immune_system_disease
2436,Multiple Myeloma,Atiprimod,CCCC1(CCC2(CC1)CCN(C2)CCCN(CC)CC)CCC,PHASE1|PHASE2,immune_system_disease
2437,Transgender Health|Gender Dysphoria|Transgender Women|Human Immunodeficiency Virus,Spironolactone,CC(=O)SC1CC2=CC(=O)CCC2(C3C1C4CCC5(C4(CC3)C)CCC(=O)O5)C,PHASE1,immune_system_disease
2438,HIV Infections,Pyridostigmine,C[N+]1=CC=CC(=C1)OC(=O)N(C)C,PHASE2,immune_system_disease
2439,Multiple Sclerosis,Rolipram,COC1=C(C=C(C=C1)C2CC(=O)NC2)OC3CCCC3,PHASE2,immune_system_disease
2440,"Drug/Agent Toxicity by Tissue/Organ|Lymphoma|Neutropenia|Small Intestine Cancer|Unspecified Adult Solid Tumor, Protocol Specific",Phenobarbital,CCC1(C(=O)NC(=O)NC1=O)C2=CC=CC=C2,PHASE1,immune_system_disease
2441,Secondary Progressive Multiple Sclerosis,Fluoxetine,CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F,PHASE2,immune_system_disease
2442,Advanced Lymphoma|Advanced Malignant Solid Neoplasm|Hematopoietic and Lymphoid Cell Neoplasm|Refractory Lymphoma|Refractory Malignant Solid Neoplasm|Refractory Multiple Myeloma,Taselisib,CC1=NN(C(=N1)C2=CN3CCOC4=C(C3=N2)C=CC(=C4)C5=CN(N=C5)C(C)(C)C(=O)N)C(C)C,PHASE2,immune_system_disease
2443,Chronic Lymphocytic Leukemia,Talabostat,B(C1CCCN1C(=O)C(C(C)C)N)(O)O,PHASE2,immune_system_disease
2444,Actinic Keratosis,Calcipotriene,CC(C=CC(C1CC1)O)C2CCC3C2(CCCC3=CC=C4CC(CC(C4=C)O)O)C,PHASE2,immune_system_disease
2445,Multiple Myeloma,Plitidepsin,CCC(C)C1C(CC(=O)OC(C(=O)C(C(=O)NC(C(=O)N2CCCC2C(=O)N(C(C(=O)OC(C(C(=O)N1)NC(=O)C(CC(C)C)N(C)C(=O)C3CCCN3C(=O)C(=O)C)C)CC4=CC=C(C=C4)OC)C)CC(C)C)C)C(C)C)O,PHASE2,immune_system_disease
2446,Infertility|Autoimmune Thyroiditis,Levothyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,PHASE2,immune_system_disease
2447,Infertility|Autoimmune Thyroiditis,Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,PHASE2,immune_system_disease
2448,Relapsed Multiple Myeloma,Celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,PHASE1,immune_system_disease
2449,HIV Infection,Lactoferrin,CCC(C)C(C(=NC(C(C)O)C(=NC(CS)C(=NC(C(C)C)C(=NC(CCCNC(=N)N)C(=NC(CCCNC(=N)N)C(=NC(C)C(=NC(CC1=CC=CC=C1)C(=O)O)O)O)O)O)O)O)O)N=C(C(CO)N=C(C2CCCN2C(=O)C(C)N=C(CN=C(C(CC(C)C)N=C(C(CCCCN)N=C(C(CCCCN)N=C(C(CCSC)N=C(C(CCCNC(=N)N)N=C(C(CC3=CNC4=CC=CC=C43)N=C(C(CCC(=N)O)N=C(C(CC5=CNC6=CC=CC=C65)N=C(C(CCCNC(=N)N)N=C(C(CCCNC(=N)N)N=C(C(CS)N=C(C(CCCCN)N=C(C(CC7=CC=CC=C7)N)O)O)O)O)O)O)O)O)O)O)O)O)O)O)O)O,PHASE2,immune_system_disease
2450,"Acute Myeloid Leukemia|Acute Lymphocytic Leukemia|Chronic Lymphocytic Leukemia|Myelodysplasia|Lymphoma, Non-Hodgkin|Hodgkin's Lymphoma|Multiple Myeloma",Clioquinol,C1=CC2=C(C(=C(C=C2Cl)I)O)N=C1,PHASE1,immune_system_disease
2451,Multiple Myeloma,Dovitinib,CN1CCN(CC1)C2=CC3=C(C=C2)N=C(N3)C4=C(C5=C(C=CC=C5F)NC4=O)N,PHASE1,immune_system_disease
2452,Hepatitis C|Human Immunodeficiency Virus,Boceprevir,CC1(C2C1C(N(C2)C(=O)C(C(C)(C)C)NC(=O)NC(C)(C)C)C(=O)NC(CC3CCC3)C(=O)C(=O)N)C,PHASE2,immune_system_disease
2453,Primary Central Nervous System Lymphoma|Non-Hodgkin Lymphoma of Extranodal Site,Paxalisib,CC1(C2=NC3=C(N2CCO1)N=C(N=C3N4CCOCC4)C5=CN=C(N=C5)N)C,PHASE2,immune_system_disease
2454,Systemic Lupus Erythematosus,Afimetoran,CC1=C(C2=NC=NN2C=C1C3=C(C4=C(N3)C=CC(=C4)C5CCN(CC5)CC(=O)N)C(C)C)C,PHASE2,immune_system_disease
2455,Multiple Sclerosis,Vancomycin,CC1C(C(CC(O1)OC2C(C(C(OC2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)C(C(C(=O)NC(C(=O)NC5C(=O)NC7C8=CC(=C(C=C8)O)C9=C(C=C(C=C9O)O)C(NC(=O)C(C(C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)CC(=O)N)NC(=O)C(CC(C)C)NC)O)Cl)CO)O)O)(C)N)O,PHASE1,immune_system_disease
2456,Pulmonary Sarcoidosis,Pentoxifylline,CC(=O)CCCCN1C(=O)C2=C(N=CN2C)N(C1=O)C,PHASE2,immune_system_disease
2457,Metastatic Castration-Resistant Prostate Cancer|Metastatic Castration-Sensitive Prostate Cancer|Non-Metastatic Castration-Resistant Prostate Cancer,Relugolix,CN(C)CC1=C(SC2=C1C(=O)N(C(=O)N2CC3=C(C=CC=C3F)F)C4=NN=C(C=C4)OC)C5=CC=C(C=C5)NC(=O)NOC,PHASE1,immune_system_disease
2458,Metastatic Castration-Resistant Prostate Cancer|Metastatic Castration-Sensitive Prostate Cancer|Non-Metastatic Castration-Resistant Prostate Cancer,Apalutamide,CNC(=O)C1=C(C=C(C=C1)N2C(=S)N(C(=O)C23CCC3)C4=CC(=C(N=C4)C#N)C(F)(F)F)F,PHASE1,immune_system_disease
2459,Colorectal Neoplasms|Neoplasm Metastasis|Colonic Neoplasms|Rectal Neoplasms,Levoleucovorin,C1C(N(C2=C(N1)N=C(NC2=O)N)C=O)CNC3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,PHASE2,immune_system_disease
2460,"Diabetes Mellitus, Type 1",Erythromycin,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)O)(C)O,PHASE1,immune_system_disease
2461,Chronic Lymphocytic Leukemia,Ceralasertib,CC1COCCN1C2=NC(=NC(=C2)C3(CC3)S(=N)(=O)C)C4=C5C=CNC5=NC=C4,PHASE1,immune_system_disease
2462,Asthma,Laninamivir,CC(=O)NC1C(C=C(OC1C(C(CO)O)OC)C(=O)O)N=C(N)N,PHASE1,immune_system_disease
2463,Cardiac Steatosis|Hepatic Steatosis,Eplerenone,CC12CCC(=O)C=C1CC(C3C24C(O4)CC5(C3CCC56CCC(=O)O6)C)C(=O)OC,PHASE2,immune_system_disease
2464,"Lymphoma, T-Cell, Cutaneous",Quisinostat,CN1C=C(C2=CC=CC=C21)CNCC3CCN(CC3)C4=NC=C(C=N4)C(=O)NO,PHASE2,immune_system_disease
2465,Asthma,Glycopyrrolate,C[N+]1(CCC(C1)OC(=O)C(C2CCCC2)(C3=CC=CC=C3)O)C.[Br-],PHASE2,immune_system_disease
2466,Asthma,Glycopyrronium,C[N+]1(CCC(C1)OC(=O)C(C2CCCC2)(C3=CC=CC=C3)O)C,PHASE2,immune_system_disease
2467,Leukemias|Acute Myeloid Leukemia (AML)|Acute Lymphocytic Leukemia (ALL)|Adult T Cell Leukemia (ATL)|Chronic Myeloid Leukemia (CML-BP)|Chronic Lymphocytic Leukemia (CLL)|Myelodysplastic Syndrome (MDS)|Chronic Myelomonocytic Leukemia (CMML),Terameprocol,CC(CC1=CC(=C(C=C1)OC)OC)C(C)CC2=CC(=C(C=C2)OC)OC,PHASE1,immune_system_disease
2468,Neoplasms,Daniquidone,C1C2=C(C=CC(=C2)N)N=C3N1C(=O)C4=CC=CC=C43,PHASE1,immune_system_disease
2469,Giant Cell Arteritis,Dotatate,CC(C1C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=C(C=C4)O)NC(=O)C(CC5=CC=CC=C5)NC(=O)CN6CCN(CCN(CCN(CC6)CC(=O)O)CC(=O)O)CC(=O)O)C(=O)NC(C(C)O)C(=O)O)O,PHASE2,immune_system_disease
2470,HIV Infections,Oxazepam,C1=CC=C(C=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O,PHASE1,immune_system_disease
2471,Non-Hodgkin's Lymphoma,Dulanermin,CS(=O)(=O)NC1=C(C=C(C=C1)[N+](=O)[O-])OC2=CC=CC=C2,PHASE1|PHASE2,immune_system_disease
2472,HIV Infections|Human Immunodeficiency Virus,Dexelvucitabine,C1=CC(OC1CO)N2C=C(C(=NC2=O)N)F,PHASE2,immune_system_disease
2473,Fibromyalgia|Chronic Fatigue Syndrome|Multiple Sclerosis|Healthy,Oxyquinoline,C1=CC2=C(C(=C1)O)N=CC=C2,PHASE1,immune_system_disease
2474,"Mild Persistent Asthma, Uncomplicated",Nadolol,CC(C)(C)NCC(COC1=CC=CC2=C1CC(C(C2)O)O)O,PHASE2,immune_system_disease
2475,Relapsed/Refractory Diffuse Large B Cell Lymphoma,Poseltinib,CN1CCN(CC1)C2=CC=C(C=C2)NC3=NC4=C(C(=N3)OC5=CC=CC(=C5)NC(=O)C=C)OC=C4,PHASE2,immune_system_disease
2476,Philadelphia Chromosome|Acute Myeloid Leukemia|Acute Lymphoblastic Leukemia|Chronic Myeloid Leukemia|Mixed Phenotype Acute Leukemia,Flumatinib,CC1=C(C=C(C=N1)NC(=O)C2=CC(=C(C=C2)CN3CCN(CC3)C)C(F)(F)F)NC4=NC=CC(=N4)C5=CN=CC=C5,PHASE2,immune_system_disease
2477,"Multiple Sclerosis (MS)|Multiple Sclerosis, Relapsing-Remitting|Multiple Sclerosis, Primary Progressive|Multiple Sclerosis, Chronic Progressive|Multiple Sclerosis Relapse|Multiple Sclerosis Brain Lesion|Multiple Sclerosis Benign",Clemastine,CC(C1=CC=CC=C1)(C2=CC=C(C=C2)Cl)OCCC3CCCN3C,PHASE1|PHASE2,immune_system_disease
2478,Advanced Malignant Solid Neoplasm|Bladder Carcinoma|Breast Carcinoma|Cervical Carcinoma|Colon Carcinoma|Colorectal Carcinoma|Endometrial Carcinoma|Esophageal Carcinoma|Gastric Carcinoma|Glioma|Head and Neck Carcinoma|Kidney Carcinoma|Liver and Intrahepatic Bile Duct Carcinoma|Lung Carcinoma|Lymphoma|Malignant Uterine Neoplasm|Melanoma|Multiple Myeloma|Ovarian Carcinoma|Pancreatic Carcinoma|Prostate Carcinoma|Rectal Carcinoma|Recurrent Bladder Carcinoma|Recurrent Breast Carcinoma|Recurrent Cervical Carcinoma|Recurrent Colon Carcinoma|Recurrent Colorectal Carcinoma|Recurrent Esophageal Carcinoma|Recurrent Gastric Carcinoma|Recurrent Glioma|Recurrent Head and Neck Carcinoma|Recurrent Liver Carcinoma|Recurrent Lung Carcinoma|Recurrent Lymphoma|Recurrent Malignant Solid Neoplasm|Recurrent Melanoma|Recurrent Multiple Myeloma|Recurrent Ovarian Carcinoma|Recurrent Pancreatic Carcinoma|Recurrent Prostate Carcinoma|Recurrent Rectal Carcinoma|Recurrent Skin Carcinoma|Recurrent Thyroid Gland Carcinoma|Recurrent Uterine Corpus Cancer|Refractory Lymphoma|Refractory Malignant Solid Neoplasm|Refractory Multiple Myeloma|Skin Carcinoma|Thyroid Gland Carcinoma|Uterine Corpus Cancer,Afatinib,CN(C)CC=CC(=O)NC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC(=C(C=C3)F)Cl)OC4CCOC4,PHASE2,immune_system_disease
2479,Advanced Malignant Solid Neoplasm|Bladder Carcinoma|Breast Carcinoma|Cervical Carcinoma|Colon Carcinoma|Colorectal Carcinoma|Endometrial Carcinoma|Esophageal Carcinoma|Gastric Carcinoma|Glioma|Head and Neck Carcinoma|Kidney Carcinoma|Liver and Intrahepatic Bile Duct Carcinoma|Lung Carcinoma|Lymphoma|Malignant Uterine Neoplasm|Melanoma|Multiple Myeloma|Ovarian Carcinoma|Pancreatic Carcinoma|Prostate Carcinoma|Rectal Carcinoma|Recurrent Bladder Carcinoma|Recurrent Breast Carcinoma|Recurrent Cervical Carcinoma|Recurrent Colon Carcinoma|Recurrent Colorectal Carcinoma|Recurrent Esophageal Carcinoma|Recurrent Gastric Carcinoma|Recurrent Glioma|Recurrent Head and Neck Carcinoma|Recurrent Liver Carcinoma|Recurrent Lung Carcinoma|Recurrent Lymphoma|Recurrent Malignant Solid Neoplasm|Recurrent Melanoma|Recurrent Multiple Myeloma|Recurrent Ovarian Carcinoma|Recurrent Pancreatic Carcinoma|Recurrent Prostate Carcinoma|Recurrent Rectal Carcinoma|Recurrent Skin Carcinoma|Recurrent Thyroid Gland Carcinoma|Recurrent Uterine Corpus Cancer|Refractory Lymphoma|Refractory Malignant Solid Neoplasm|Refractory Multiple Myeloma|Skin Carcinoma|Thyroid Gland Carcinoma|Uterine Corpus Cancer,Ipatasertib,CC1CC(C2=C1C(=NC=N2)N3CCN(CC3)C(=O)C(CNC(C)C)C4=CC=C(C=C4)Cl)O,PHASE2,immune_system_disease
2480,Advanced Malignant Solid Neoplasm|Bladder Carcinoma|Breast Carcinoma|Cervical Carcinoma|Colon Carcinoma|Colorectal Carcinoma|Endometrial Carcinoma|Esophageal Carcinoma|Gastric Carcinoma|Glioma|Head and Neck Carcinoma|Kidney Carcinoma|Liver and Intrahepatic Bile Duct Carcinoma|Lung Carcinoma|Lymphoma|Malignant Uterine Neoplasm|Melanoma|Multiple Myeloma|Ovarian Carcinoma|Pancreatic Carcinoma|Prostate Carcinoma|Rectal Carcinoma|Recurrent Bladder Carcinoma|Recurrent Breast Carcinoma|Recurrent Cervical Carcinoma|Recurrent Colon Carcinoma|Recurrent Colorectal Carcinoma|Recurrent Esophageal Carcinoma|Recurrent Gastric Carcinoma|Recurrent Glioma|Recurrent Head and Neck Carcinoma|Recurrent Liver Carcinoma|Recurrent Lung Carcinoma|Recurrent Lymphoma|Recurrent Malignant Solid Neoplasm|Recurrent Melanoma|Recurrent Multiple Myeloma|Recurrent Ovarian Carcinoma|Recurrent Pancreatic Carcinoma|Recurrent Prostate Carcinoma|Recurrent Rectal Carcinoma|Recurrent Skin Carcinoma|Recurrent Thyroid Gland Carcinoma|Recurrent Uterine Corpus Cancer|Refractory Lymphoma|Refractory Malignant Solid Neoplasm|Refractory Multiple Myeloma|Skin Carcinoma|Thyroid Gland Carcinoma|Uterine Corpus Cancer,Osimertinib,CN1C=C(C2=CC=CC=C21)C3=NC(=NC=C3)NC4=C(C=C(C(=C4)NC(=O)C=C)N(C)CCN(C)C)OC,PHASE2,immune_system_disease
2481,"Eczema, Atopic",Palmidrol,CCCCCCCCCCCCCCCC(=O)NCCO,PHASE2|PHASE3,immune_system_disease
2482,Diltiazem Skin Sensitivity.,Diltiazem,CC(=O)OC1C(SC2=CC=CC=C2N(C1=O)CCN(C)C)C3=CC=C(C=C3)OC,PHASE1,immune_system_disease
2483,HIV Infections,Amdoxovir,C1C(OC(O1)CO)N2C=NC3=C(N=C(N=C32)N)N,PHASE2,immune_system_disease
2484,Recurrent Anaplastic Large Cell Lymphoma|Recurrent Diffuse Large B-Cell Lymphoma|Recurrent Mantle Cell Lymphoma|Recurrent Transformed Non-Hodgkin Lymphoma|Refractory Anaplastic Large Cell Lymphoma|Refractory Diffuse Large B-Cell Lymphoma|Refractory Mantle Cell Lymphoma|Refractory Transformed Non-Hodgkin Lymphoma,Onalespib,CC(C)C1=CC(=C(C=C1O)O)C(=O)N2CC3=C(C2)C=C(C=C3)CN4CCN(CC4)C,PHASE2,immune_system_disease
2485,"Lymphoblastic Leukemia, Acute",Pirarubicin,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)N)OC6CCCCO6,PHASE2,immune_system_disease
2486,"Lupus Erythematosus, Systemic|Sjogren's Syndrome",Dehydroepiandrosterone,CC12CCC3C(C1CCC2=O)CC=C4C3(CCC(C4)O)C,PHASE2,immune_system_disease
2487,"Lupus Erythematosus, Systemic|Sjogren's Syndrome",Prasterone,CC12CCC3C(C1CCC2=O)CC=C4C3(CCC(C4)O)C,PHASE2,immune_system_disease
2488,"Leukemia, B-Cell, Chronic",Acadesine,C1=NC(=C(N1C2C(C(C(O2)CO)O)O)N)C(=O)N,PHASE1|PHASE2,immune_system_disease
2489,Recurrent Adult Acute Lymphoblastic Leukemia|Refractory Adult Acute Lymphoblastic Leukemia,Volasertib,CCC1C(=O)N(C2=CN=C(N=C2N1C(C)C)NC3=C(C=C(C=C3)C(=O)NC4CCC(CC4)N5CCN(CC5)CC6CC6)OC)C,PHASE1,immune_system_disease
2490,HIV Infection,Deferiprone,CC1=C(C(=O)C=CN1C)O,PHASE1,immune_system_disease
2491,"Lymphoma, T-Cell|Mycosis Fungoides|Hematologic Neoplasms",Isotretinoin,CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CC(=O)O)C)C,PHASE2,immune_system_disease
2492,HIV Infections,Lentinan,C(C1C(C(C(C(O1)OCC2C(C(C(C(O2)O)O)OC3C(C(C(C(O3)CO)O)OC4C(C(C(C(O4)CO)O)OC5C(C(C(C(O5)COC6C(C(C(C(O6)CO)O)O)O)O)OC7C(C(C(C(O7)CO)O)O)O)O)O)O)O)O)O)O)O,PHASE2,immune_system_disease
2493,Pain|Chronic Disease,Tropisetron,CN1C2CCC1CC(C2)OC(=O)C3=CNC4=CC=CC=C43,PHASE2,immune_system_disease
2494,Salt-sensitive Hypertension,Valsartan,CCCCC(=O)N(CC1=CC=C(C=C1)C2=CC=CC=C2C3=NNN=N3)C(C(C)C)C(=O)O,PHASE2,immune_system_disease
2495,Multiple Sclerosis,Acetazolamide,CC(=O)NC1=NN=C(S1)S(=O)(=O)N,PHASE2,immune_system_disease
2496,HIV Infections,Fostemsavir,CC1=NN(C=N1)C2=NC=C(C3=C2N(C=C3C(=O)C(=O)N4CCN(CC4)C(=O)C5=CC=CC=C5)COP(=O)(O)O)OC,PHASE1,immune_system_disease
2497,Solid Tumors and Lymphomas,Alobresib,CC1=C(C(=NO1)C)C2=CC(=C3C(=C2)NC(=N3)C4CC4)C(C5=CC=CC=N5)(C6=CC=CC=N6)O,PHASE1,immune_system_disease
2498,Skin Alterations Associated With Atopic Dermatitis,Sertaconazole,C1=CC2=C(C(=C1)Cl)SC=C2COC(CN3C=CN=C3)C4=C(C=C(C=C4)Cl)Cl,PHASE2,immune_system_disease
2499,"Bacterial Infections|Pneumonia, Pneumocystis Carinii|HIV Infections",Atovaquone,C1CC(CCC1C2=CC=C(C=C2)Cl)C3=C(C4=CC=CC=C4C(=O)C3=O)O,PHASE2,immune_system_disease
2500,Graves Disease|Thyroid Associated Ophthalmopathy,Methimazole,CN1C=CNC1=S,PHASE1|PHASE2,immune_system_disease
2501,Sarcoidosis-associated Pulmonary Hypertension,Selexipag,CC(C)N(CCCCOCC(=O)NS(=O)(=O)C)C1=CN=C(C(=N1)C2=CC=CC=C2)C3=CC=CC=C3,PHASE2,immune_system_disease
2502,Malignancies|B-Cell Lymphoma,Aroplatin,CC(C)(C)CCCCCC(=O)[O-].CC(C)(C)CCCCCC(=O)[O-].C1CCC(C(C1)N)N.[Pt+2],PHASE1,immune_system_disease
2503,Multiple Myeloma,Pasireotide,C1C(CN2C1C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C2=O)CC3=CC=CC=C3)CC4=CC=C(C=C4)OCC5=CC=CC=C5)CCCCN)CC6=CNC7=CC=CC=C76)C8=CC=CC=C8)OC(=O)NCCN,PHASE2,immune_system_disease
2504,HIV Infections,Alovudine,CC1=CN(C(=O)NC1=O)C2CC(C(O2)CO)F,PHASE2,immune_system_disease
2505,Systemic Lupus Erythematosus,Etonogestrel,CCC12CC(=C)C3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34,PHASE2|PHASE3,immune_system_disease
2506,HIV-infection/AIDS,Cenicriviroc,CCCCOCCOC1=CC=C(C=C1)C2=CC3=C(C=C2)N(CCCC(=C3)C(=O)NC4=CC=C(C=C4)S(=O)CC5=CN=CN5CCC)CC(C)C,PHASE1,immune_system_disease
2507,Type 1 Diabetes,Leptin,CC(C)CC(C(=NC(CCC(=N)O)C(=NCC(=NC(CO)C(=NC(CC(C)C)C(=NC(CCC(=N)O)C(=NC(CC(=O)O)C(=NC(CCSC)C(=NC(CC(C)C)C(=NC(CC1=CNC2=CC=CC=C21)C(=NC(CCC(=N)O)C(=NC(CC(C)C)C(=NC(CC(=O)O)C(=NC(CC(C)C)C(=NC(CO)C(=O)N3CCCC3C(=NCC(=NC(CS)C(=O)O)O)O)O)O)O)O)O)O)O)O)O)O)O)O)O)O)N,PHASE1,immune_system_disease
2508,"Myeloma, Plasma-Cell|Lymphoma, Malignant",Palonosetron,C1CC2CN(C(=O)C3=CC=CC(=C23)C1)C4CN5CCC4CC5,PHASE2,immune_system_disease
2509,Multiple Myeloma,Osalmid,C1=CC=C(C(=C1)C(=O)NC2=CC=C(C=C2)O)O,PHASE1|PHASE2,immune_system_disease
2510,Angioedema,Icatibant,C1CCC2C(C1)CC(N2C(=O)C3CC4=CC=CC=C4CN3C(=O)C(CO)NC(=O)C(CC5=CC=CS5)NC(=O)CNC(=O)C6CC(CN6C(=O)C7CCCN7C(=O)C(CCCN=C(N)N)NC(=O)C(CCCN=C(N)N)N)O)C(=O)NC(CCCN=C(N)N)C(=O)O,PHASE2,immune_system_disease
2511,Angioedema,Cortisone,CC12CCC(=O)C=C1CCC3C2C(=O)CC4(C3CCC4(C(=O)CO)O)C,PHASE2,immune_system_disease
2512,Refractory Chronic Lymphocytic Leukemia|Refractory Small Lymphocytic Lymphoma,Trabectedin,CC1=CC2=C(C3C4C5C6=C(C(=C7C(=C6C(N4C(C(C2)N3C)O)COC(=O)C8(CS5)C9=CC(=C(C=C9CCN8)O)OC)OCO7)C)OC(=O)C)C(=C1OC)O,PHASE1,immune_system_disease
2513,Chronic Idiopathic Thrombocytopenic Purpura,Hetrombopag,CC1=C(C(=O)N(N1)C2=CC3=C(CCCC3)C=C2)N=NC4=CC=CC(=C4O)C5=CC=C(O5)C(=O)O,PHASE1,immune_system_disease
2514,Ataxia Telangiectasia,Triheptanoin,CCCCCCC(=O)OCC(COC(=O)CCCCCC)OC(=O)CCCCCC,PHASE2,immune_system_disease
2515,HIV Infections,Thymopentin,CC(C)C(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)NC(=O)C(CC(=O)O)NC(=O)C(CCCCN)NC(=O)C(CCCN=C(N)N)N,PHASE2,immune_system_disease
2516,NSAID-induced Gastroduodenal Injury|Ulcers|Rheumatoid Arthritis|Osteoarthritis,Cobiprostone,CCC(C)CC(C1(CCC2C(O1)CC(=O)C2CCCCCCC(=O)O)O)(F)F,PHASE2,immune_system_disease
2517,Recurrent Multiple Myeloma|Refractory Multiple Myeloma,Telaglenastat,C1=CC=NC(=C1)CC(=O)NC2=NN=C(S2)CCCCC3=NN=C(C=C3)NC(=O)CC4=CC(=CC=C4)OC(F)(F)F,PHASE1,immune_system_disease
2518,Recurrent Mantle Cell Lymphoma|Refractory Mantle Cell Lymphoma,Eprenetapopt,COCC1(C(=O)C2CCN1CC2)CO,PHASE2,immune_system_disease
2519,"Diabetes Mellitus, Type 1|Diabetic Nephropathy",Alagebrium,CC1=C(SC=[N+]1CC(=O)C2=CC=CC=C2)C,PHASE2,immune_system_disease
2520,Diffuse B-Cell Lymphoma,Avadomide,CC1=NC2=CC=CC(=C2C(=O)N1C3CCC(=O)NC3=O)N,PHASE1,immune_system_disease
2521,Multiple Myeloma|Non-Hodgkin's Lymphoma,Meloxicam,CC1=CN=C(S1)NC(=O)C2=C(C3=CC=CC=C3S(=O)(=O)N2C)O,PHASE2,immune_system_disease
2522,Rheumatoid Arthritis,Folate,C1=CC(=CC=C1C(=O)NC(CCC(=O)O)C(=O)O)NCC2=CN=C3C(=N2)C(=O)NC(=N3)N,PHASE2,immune_system_disease
2523,Multiple Myeloma in Relapse|Multiple Myeloma Progression|Multiple Myeloma Stage II|Multiple Myeloma Stage I|Multiple Myeloma With Failed Remission|Multiple Myeloma Stage III,Rivaroxaban,C1COCC(=O)N1C2=CC=C(C=C2)N3CC(OC3=O)CNC(=O)C4=CC=C(S4)Cl,PHASE2|PHASE3,immune_system_disease
2524,Multiple Sclerosis,Oxcarbazepine,C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N,PHASE2,immune_system_disease
2525,Type 1 Diabetes,Saxagliptin,C1C2CC2N(C1C#N)C(=O)C(C34CC5CC(C3)CC(C5)(C4)O)N,PHASE2,immune_system_disease
2526,Asthma|Distal Lung Inflammation,Flunisolide,CC1(OC2CC3C4CC(C5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C)F)C,PHASE1|PHASE2,immune_system_disease
2527,Asthma,Gefapixant,CC(C)C1=CC(=C(C=C1OC2=CN=C(N=C2N)N)S(=O)(=O)N)OC,PHASE2,immune_system_disease
2528,HIV Associated Cognitive Motor Complex,Galantamine,CN1CCC23C=CC(CC2OC4=C(C=CC(=C34)C1)OC)O,PHASE2,immune_system_disease
2529,Rheumatoid Arthritis,Cetrorelix,CC(C)CC(C(=O)NC(CCCN=C(N)N)C(=O)N1CCCC1C(=O)NC(C)C(=O)N)NC(=O)C(CCCNC(=O)N)NC(=O)C(CC2=CC=C(C=C2)O)NC(=O)C(CO)NC(=O)C(CC3=CN=CC=C3)NC(=O)C(CC4=CC=C(C=C4)Cl)NC(=O)C(CC5=CC6=CC=CC=C6C=C5)NC(=O)C,PHASE2,immune_system_disease
2530,Ovarian Cancer|Fallopian Tube Cancer|Peritoneal Carcinoma,Pazopanib,CC1=C(C=C(C=C1)NC2=NC=CC(=N2)N(C)C3=CC4=NN(C(=C4C=C3)C)C)S(=O)(=O)N,PHASE1|PHASE2,immune_system_disease
2531,Asthma,Gallopamil,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C(=C2)OC)OC)OC,PHASE2,immune_system_disease
2532,Type 1 Diabetes Mellitus,Lixisenatide,CCC(C)C(C(=O)NC(CCC(=O)O)C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(CC(C)C)C(=O)NC(CCCCN)C(=O)NC(CC(=O)N)C(=O)NCC(=O)NCC(=O)N3CCCC3C(=O)NC(CO)C(=O)NC(CO)C(=O)NCC(=O)NC(C)C(=O)N4CCCC4C(=O)N5CCCC5C(=O)NC(CO)C(=O)NC(CCCCN)C(=O)NC(CCCCN)C(=O)NC(CCCCN)C(=O)NC(CCCCN)C(=O)NC(CCCCN)C(=O)NC(CCCCN)C(=O)N)NC(=O)C(CC6=CC=CC=C6)NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(C(C)C)NC(=O)C(C)NC(=O)C(CCC(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(CCSC)NC(=O)C(CCC(=O)N)NC(=O)C(CCCCN)NC(=O)C(CO)NC(=O)C(CC(C)C)NC(=O)C(CC(=O)O)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C(CC7=CC=CC=C7)NC(=O)C(C(C)O)NC(=O)CNC(=O)C(CCC(=O)O)NC(=O)CNC(=O)C(CC8=CNC=N8)N,PHASE1,immune_system_disease
2533,Hodgkin's Lymphoma,Resminostat,CN(C)CC1=CC=C(C=C1)S(=O)(=O)N2C=CC(=C2)C=CC(=O)NO,PHASE2,immune_system_disease
2534,Asthma,Zavegepant,CC1=CC(=CC2=C1NN=C2)CC(C(=O)N3CCN(CC3)C4CCN(CC4)C)NC(=O)N5CCC(CC5)C6=CC7=CC=CC=C7NC6=O,PHASE1,immune_system_disease
2535,HIV Infections,Nitazoxanide,CC(=O)OC1=CC=CC=C1C(=O)NC2=NC=C(S2)[N+](=O)[O-],PHASE1,immune_system_disease
2536,"Lymphoma, Non-Hodgkin|Multiple Myeloma|Advanced Solid Tumors",Futibatinib,COC1=CC(=CC(=C1)C#CC2=NN(C3=NC=NC(=C23)N)C4CCN(C4)C(=O)C=C)OC,PHASE2,immune_system_disease
2537,"Leukemia, Mast-Cell|Mantle-cell Lymphoma",Granisetron,CN1C2CCCC1CC(C2)NC(=O)C3=NN(C4=CC=CC=C43)C,PHASE2,immune_system_disease
2538,Asthma,Procaterol,CCC(C(C1=C2C=CC(=O)NC2=C(C=C1)O)O)NC(C)C,PHASE2,immune_system_disease
2539,Multiple Myeloma,Ciforadenant,CC1=CC=C(O1)C2=C3C(=NC(=N2)N)N(N=N3)CC4=NC(=CC=C4)COC5CCOC5,PHASE1,immune_system_disease
2540,HIV Infections,Tamoxifen,CCC(=C(C1=CC=CC=C1)C2=CC=C(C=C2)OCCN(C)C)C3=CC=CC=C3,PHASE2,immune_system_disease
2541,Multiple Myeloma,Roneparstat,CC(=O)NC1C(C(C(OC1OC2C(C(C(OC2C(=O)O)OC3C(OC(C(C3O)NC(=O)C)OC(CO)C(C(=O)O)OC(CO)O)CO)OS(=O)(=O)O)O)CO)O)O,PHASE1,immune_system_disease
2542,Type1 Diabetes Mellitus,Methyldopa,CC(CC1=CC(=C(C=C1)O)O)(C(=O)O)N,PHASE2,immune_system_disease
2543,Acute Myeloid Leukemia|Blasts 20 Percent or More of Bone Marrow Nucleated Cells|High Risk Myelodysplastic Syndrome|Recurrent Acute Biphenotypic Leukemia|Recurrent Acute Myeloid Leukemia|Recurrent High Risk Myelodysplastic Syndrome|Refractory Acute Myeloid Leukemia|Refractory High Risk Myelodysplastic Syndrome,Quizartinib,CC(C)(C)C1=CC(=NO1)NC(=O)NC2=CC=C(C=C2)C3=CN4C5=C(C=C(C=C5)OCCN6CCOCC6)SC4=N3,PHASE1|PHASE2,immune_system_disease
2544,Allergic Rhinitis,Esketamine,CNC1(CCCCC1=O)C2=CC=CC=C2Cl,PHASE1,immune_system_disease
2545,Allergic Reactions,Brompheniramine,CN(C)CCC(C1=CC=C(C=C1)Br)C2=CC=CC=N2,PHASE1,immune_system_disease
2546,C3 Glomerulopathy|Membranoproliferative Glomerulonephritis|Complement Abnormality|Dense Deposit Disease|C3 Glomerulonephritis,Aliskiren,CC(C)C(CC1=CC(=C(C=C1)OC)OCCCOC)CC(C(CC(C(C)C)C(=O)NCC(C)(C)C(=O)N)O)N,PHASE2,immune_system_disease
2547,Stroke|Cerebrovascular Disorders|Ischemic Stroke|Brain Diseases|Central Nervous System Diseases|Nervous System Diseases|Cardiovascular Diseases|Propranolol|Beta Blocker|Molecular Mechanisms of Pharmacological Action|Immunologic Factors|Physiological Effects of Drugs,Ceftriaxone,CN1C(=NC(=O)C(=O)N1)SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)O,PHASE2,immune_system_disease
2548,Recurrent Plasma Cell Myeloma|Refractory Plasma Cell Myeloma,Uprosertib,CN1C(=C(C=N1)Cl)C2=C(OC(=C2)C(=O)NC(CC3=CC(=C(C=C3)F)F)CN)Cl,PHASE2,immune_system_disease
2549,Multiple Myeloma,Ricolinostat,C1=CC=C(C=C1)N(C2=CC=CC=C2)C3=NC=C(C=N3)C(=O)NCCCCCCC(=O)NO,PHASE1|PHASE2,immune_system_disease
2550,Secondary-progressive Multiple Sclerosis,Siponimod,CCC1=C(C=CC(=C1)C(=NOCC2=CC(=C(C=C2)C3CCCCC3)C(F)(F)F)C)CN4CC(C4)C(=O)O,PHASE2|PHASE3,immune_system_disease
2551,Polyarticular Course Juvenile Idiopathic Arthritis,Givinostat,CCN(CC)CC1=CC2=C(C=C1)C=C(C=C2)COC(=O)NC3=CC=C(C=C3)C(=O)NO,PHASE2,immune_system_disease
2552,Chronic Lymphocytic Leukemia,Oblimersen,CC1=CN(C(=O)NC1=O)C2CC(C(O2)COP(=S)([O-])OC3CC(OC3COP(=O)(OC4CC(OC4COP(=S)([O-])OC5CC(OC5COP(=S)([O-])OC6CC(OC6COP(=S)([O-])OC7CC(OC7COP(=S)([O-])OC8CC(OC8COP(=S)([O-])OC9CC(OC9COP(=S)([O-])OC1CC(OC1COP(=S)([O-])OC1CC(OC1COP(=S)([O-])OC1CC(OC1COP(=S)([O-])OC1CC(OC1COP(=S)([O-])OC1CC(OC1COP(=S)([O-])OC1CC(OC1COP(=S)([O-])OC1CC(OC1COP(=S)([O-])OC1CC(OC1COP(=S)([O-])OC1CC(OC1COP(=S)([O-])OC1CC(OC1CO)N1C=C(C(=O)NC1=O)C)N1C=CC(=NC1=O)N)N1C=C(C(=O)NC1=O)C)N1C=CC(=NC1=O)N)N1C=CC(=NC1=O)N)N1C=CC(=NC1=O)N)N1C=NC2=C(N=CN=C21)N)N1C=NC2=C1N=C(NC2=O)N)N1C=CC(=NC1=O)N)N1C=NC2=C1N=C(NC2=O)N)N1C=C(C(=O)NC1=O)C)N1C=NC2=C1N=C(NC2=O)N)N1C=CC(=NC1=O)N)N1C=NC2=C1N=C(NC2=O)N)N1C=CC(=NC1=O)N)N1C=CC(=NC1=O)N)[S-])N1C=NC2=C(N=CN=C21)N)O.[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+],PHASE1|PHASE2,immune_system_disease
2553,Adult Non-Hodgkin Lymphoma|Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue|Nodal Marginal Zone Lymphoma|Recurrent Adult Diffuse Large Cell Lymphoma|Recurrent Grade 1 Follicular Lymphoma|Recurrent Grade 2 Follicular Lymphoma|Recurrent Grade 3 Follicular Lymphoma|Recurrent Mantle Cell Lymphoma|Recurrent Marginal Zone Lymphoma|Recurrent Small Lymphocytic Lymphoma|Splenic Marginal Zone Lymphoma|Waldenstrom Macroglobulinemia,Agatolimod,CC1=CN(C(=O)NC1=O)C2CC(C(O2)COP(=S)(O)OC3CC(OC3COP(=S)(O)OC4CC(OC4COP(=S)(O)OC5CC(OC5COP(=S)(O)OC6CC(OC6COP(=S)(O)OC7CC(OC7COP(=S)(O)OC8CC(OC8COP(=S)(O)OC9CC(OC9COP(=S)(O)OC1CC(OC1COP(=S)(O)OC1CC(OC1COP(=S)(O)OC1CC(OC1COP(=S)(O)OC1CC(OC1COP(=S)(O)OC1CC(OC1COP(=S)(O)OC1CC(OC1COP(=S)(O)OC1CC(OC1COP(=S)(O)OC1CC(OC1COP(=S)(O)OC1CC(OC1COP(=S)(O)OC1CC(OC1COP(=S)(O)OC1CC(OC1COP(=S)(O)OC1CC(OC1COP(=S)(O)OC1CC(OC1COP(=S)(O)OC1CC(OC1COP(=S)(O)OC1CC(OC1COP(=S)(O)OC1CC(OC1CO)N1C=C(C(=O)NC1=O)C)N1C=CC(=NC1=O)N)N1C=NC2=C1N=C(NC2=O)N)N1C=C(C(=O)NC1=O)C)N1C=CC(=NC1=O)N)N1C=NC(=C1C)C(=O)NC(=C)N)N1C=C(C(=NC1=O)N)C)N1C=C(C(=NC1=O)N)C)N1C=C(C(=O)NC1=O)C)N1C=C(C(=O)NC1=O)C)N1C=NC2=C1N=C(NC2=O)N)N1C=C(C(=O)NC1=O)C)N1C=CC(=NC1=O)N)N1C=NC2=C1N=C(NC2=O)N)N1C=C(C(=NC1=O)N)C)N1C=C(C(=NC1=O)N)C)N1C=C(C(=NC1=O)N)C)N1C=C(C(=NC1=O)N)C)N1C=NC2=C1N=C(NC2=O)N)N1C=C(C(=O)NC1=O)C)N1C=CC(=NC1=O)N)N1C=NC2=C1N=C(NC2=O)N)N1C=C(C(=O)NC1=O)C)O,PHASE1|PHASE2,immune_system_disease
2554,"Infection, Human Immunodeficiency Virus",Buprenorphine,CC(C)(C)C(C)(C1CC23CCC1(C4C25CCN(C3CC6=C5C(=C(C=C6)O)O4)CC7CC7)OC)O,PHASE1,immune_system_disease
2555,Rheumatoid Arthritis (RA),Niclosamide,C1=CC(=C(C=C1[N+](=O)[O-])Cl)NC(=O)C2=C(C=CC(=C2)Cl)O,PHASE1|PHASE2,immune_system_disease
2556,Multiple Myeloma,Fluphenazine,C1CN(CCN1CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)C(F)(F)F)CCO,PHASE1,immune_system_disease
2557,"Multiple Sclerosis|Multiple Sclerosis, Relapsing-Remitting",Bazedoxifene,CC1=C(N(C2=C1C=C(C=C2)O)CC3=CC=C(C=C3)OCCN4CCCCCC4)C5=CC=C(C=C5)O,PHASE2,immune_system_disease
2558,Asthma,Benzocaine,CCOC(=O)C1=CC=C(C=C1)N,PHASE2,immune_system_disease
2559,"Lupus Erythematosus, Discoid|Lupus Erythematosus, Subacute Cutaneous",Deucravacitinib,CNC(=O)C1=NN=C(C=C1NC2=CC=CC(=C2OC)C3=NN(C=N3)C)NC(=O)C4CC4,PHASE2,immune_system_disease
2560,Diabetes Mellitus|Cardiovascular Diseases|Insulin Sensitivity/Resistance|Metabolic Disease|Natriuretic Peptides|Metabolism|Energy Expenditure,Sacubitril,CCOC(=O)C(C)CC(CC1=CC=C(C=C1)C2=CC=CC=C2)NC(=O)CCC(=O)O,PHASE2,immune_system_disease
2561,"Epstein-Barr Virus Associated Lymphoproliferative Disorder|EBV-Related PTLD|EBV Related Non-Hodgkin's Lymphoma|Extranodal NK/T-cell Lymphoma|EBV-Positive DLBCL, Nos|EBV Associated Lymphoma|EBV-Related Hodgkin Lymphoma|EBV Related PTCL, Nos",Nanatinostat,C1C2C(C2NCC3=NC4=C(C=C3)C=C(C=C4)F)CN1C5=NC=C(C=N5)C(=O)NO,PHASE2,immune_system_disease
2562,Non-GCB/ABC Diffuse Large B-Cell Lymphoma|With and Without MyD88 and/or CD79B Mutations,Mivavotinib,CN1C=C(C=N1)C2=NC(=C(C3=C2C(=O)NC3)F)NC4CCCCC4N,PHASE2,immune_system_disease
2563,Advanced Lymphoma|Advanced Malignant Solid Neoplasm|Ann Arbor Stage III B-Cell Non-Hodgkin Lymphoma|Ann Arbor Stage III T-Cell Non-Hodgkin Lymphoma|Ann Arbor Stage IV B-Cell Non-Hodgkin Lymphoma|Ann Arbor Stage IV T-Cell Non-Hodgkin Lymphoma|Refractory B-Cell Non-Hodgkin Lymphoma|Refractory Lymphoma|Refractory Malignant Solid Neoplasm|Refractory Pancreatic Carcinoma|Refractory T-Cell Non-Hodgkin Lymphoma|Stage II Pancreatic Cancer AJCC v8|Stage IIA Pancreatic Cancer AJCC v8|Stage IIB Pancreatic Cancer AJCC v8|Stage III Pancreatic Cancer AJCC v8|Stage IV Pancreatic Cancer AJCC v8|Unresectable Pancreatic Carcinoma,Molibresib,CCNC(=O)CC1C2=NN=C(N2C3=C(C=C(C=C3)OC)C(=N1)C4=CC=C(C=C4)Cl)C,PHASE1,immune_system_disease
2564,Metastatic Hormone-sensitive Prostate Cancer,Darolutamide,CC(CN1C=CC(=N1)C2=CC(=C(C=C2)C#N)Cl)NC(=O)C3=NNC(=C3)C(C)O,PHASE2,immune_system_disease
2565,Acute Lymphoblastic Leukemia ALL,Ribociclib,CN(C)C(=O)C1=CC2=CN=C(N=C2N1C3CCCC3)NC4=NC=C(C=C4)N5CCNCC5,PHASE1,immune_system_disease
2566,Vernal Keratoconjunctivitis|Cyclosporine 0.05% Eye Drops,Tobramycin,C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(CC(C(O3)CN)O)N)N,PHASE1,immune_system_disease
2567,"Carcinoma, Non-Small-Cell Lung|Lung Cancer|Non-Small Cell Lung Cancer|Carcinoma, Esophageal|Malignant Pleural Mesotheliomas",Tetrahydrouridine,C1CN(C(=O)NC1O)C2C(C(C(O2)CO)O)O,PHASE1|PHASE2,immune_system_disease
2568,Rheumatoid Arthritis,Diacerein,CC(=O)OC1=CC=CC2=C1C(=O)C3=C(C2=O)C=C(C=C3OC(=O)C)C(=O)O,PHASE2,immune_system_disease
2569,Multiple Myeloma,Etodolac,CCC1=C2C(=CC=C1)C3=C(N2)C(OCC3)(CC)CC(=O)O,PHASE2,immune_system_disease
2570,Hepatitis B,Resiquimod,CCOCC1=NC2=C(N1CC(C)(C)O)C3=CC=CC=C3N=C2N,PHASE1|PHASE2,immune_system_disease
2571,Advanced Cancer|Colorectal Cancer|Mantle Cell Lymphoma,Merestinib,CC1=CC=C(C(=O)N1C2=CC=C(C=C2)F)C(=O)NC3=CC(=C(C=C3)OC4=C(C=C5C(=C4)C=NN5C)C6=CNN=C6)F,PHASE1,immune_system_disease
2572,Human Immunodeficiency Virus Type 1 (HIV-1) Infection,Vesatolimod,CCCCOC1=NC(=C2C(=N1)N(CC(=O)N2)CC3=CC=CC(=C3)CN4CCCC4)N,PHASE1,immune_system_disease
2573,"Diabetes Mellitus, Type 1",Naloxone,C=CCN1CCC23C4C(=O)CCC2(C1CC5=C3C(=C(C=C5)O)O4)O,PHASE2,immune_system_disease
2574,"Carcinoma, Small Cell Lung",Glufosfamide,C(CCl)NP(=O)(NCCCl)OC1C(C(C(C(O1)CO)O)O)O,PHASE2,immune_system_disease
2575,"Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Anatomic Stage IV Breast Cancer AJCC v8|Anemia|Ann Arbor Stage III Hodgkin Lymphoma|Ann Arbor Stage III Non-Hodgkin Lymphoma|Ann Arbor Stage IV Hodgkin Lymphoma|Ann Arbor Stage IV Non-Hodgkin Lymphoma|Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative|Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Castration-Resistant Prostate Carcinoma|Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Hematopoietic and Lymphoid System Neoplasm|Locally Advanced Pancreatic Adenocarcinoma|Metastatic Breast Carcinoma|Metastatic Malignant Solid Neoplasm|Metastatic Pancreatic Adenocarcinoma|Myelodysplastic/Myeloproliferative Neoplasm With Ring Sideroblasts and Thrombocytosis|Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable|Primary Myelofibrosis|Recurrent Acute Lymphoblastic Leukemia|Recurrent Acute Myeloid Leukemia|Recurrent Chronic Lymphocytic Leukemia|Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Recurrent Hematologic Malignancy|Recurrent Hodgkin Lymphoma|Recurrent Myelodysplastic Syndrome|Recurrent Myelodysplastic/Myeloproliferative Neoplasm|Recurrent Myeloproliferative Neoplasm|Recurrent Non-Hodgkin Lymphoma|Recurrent Plasma Cell Myeloma|Recurrent Small Lymphocytic Lymphoma|Refractory Acute Lymphoblastic Leukemia|Refractory Acute Myeloid Leukemia|Refractory Chronic Lymphocytic Leukemia|Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Refractory Chronic Myelomonocytic Leukemia|Refractory Hematologic Malignancy|Refractory Hodgkin Lymphoma|Refractory Malignant Solid Neoplasm|Refractory Myelodysplastic Syndrome|Refractory Myelodysplastic/Myeloproliferative Neoplasm|Refractory Non-Hodgkin Lymphoma|Refractory Plasma Cell Myeloma|Refractory Primary Myelofibrosis|Refractory Small Lymphocytic Lymphoma|Stage II Pancreatic Cancer AJCC v8|Stage III Pancreatic Cancer AJCC v8|Stage IV Pancreatic Cancer AJCC v8|Stage IV Prostate Cancer AJCC v8|Unresectable Pancreatic Adenocarcinoma",Cabazitaxel,CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)OC)C)OC,PHASE1,immune_system_disease
2576,"Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Anatomic Stage IV Breast Cancer AJCC v8|Anemia|Ann Arbor Stage III Hodgkin Lymphoma|Ann Arbor Stage III Non-Hodgkin Lymphoma|Ann Arbor Stage IV Hodgkin Lymphoma|Ann Arbor Stage IV Non-Hodgkin Lymphoma|Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative|Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Castration-Resistant Prostate Carcinoma|Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Hematopoietic and Lymphoid System Neoplasm|Locally Advanced Pancreatic Adenocarcinoma|Metastatic Breast Carcinoma|Metastatic Malignant Solid Neoplasm|Metastatic Pancreatic Adenocarcinoma|Myelodysplastic/Myeloproliferative Neoplasm With Ring Sideroblasts and Thrombocytosis|Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable|Primary Myelofibrosis|Recurrent Acute Lymphoblastic Leukemia|Recurrent Acute Myeloid Leukemia|Recurrent Chronic Lymphocytic Leukemia|Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Recurrent Hematologic Malignancy|Recurrent Hodgkin Lymphoma|Recurrent Myelodysplastic Syndrome|Recurrent Myelodysplastic/Myeloproliferative Neoplasm|Recurrent Myeloproliferative Neoplasm|Recurrent Non-Hodgkin Lymphoma|Recurrent Plasma Cell Myeloma|Recurrent Small Lymphocytic Lymphoma|Refractory Acute Lymphoblastic Leukemia|Refractory Acute Myeloid Leukemia|Refractory Chronic Lymphocytic Leukemia|Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Refractory Chronic Myelomonocytic Leukemia|Refractory Hematologic Malignancy|Refractory Hodgkin Lymphoma|Refractory Malignant Solid Neoplasm|Refractory Myelodysplastic Syndrome|Refractory Myelodysplastic/Myeloproliferative Neoplasm|Refractory Non-Hodgkin Lymphoma|Refractory Plasma Cell Myeloma|Refractory Primary Myelofibrosis|Refractory Small Lymphocytic Lymphoma|Stage II Pancreatic Cancer AJCC v8|Stage III Pancreatic Cancer AJCC v8|Stage IV Pancreatic Cancer AJCC v8|Stage IV Prostate Cancer AJCC v8|Unresectable Pancreatic Adenocarcinoma",Dacomitinib,COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)NC(=O)C=CCN4CCCCC4,PHASE1,immune_system_disease
2577,"Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Anatomic Stage IV Breast Cancer AJCC v8|Anemia|Ann Arbor Stage III Hodgkin Lymphoma|Ann Arbor Stage III Non-Hodgkin Lymphoma|Ann Arbor Stage IV Hodgkin Lymphoma|Ann Arbor Stage IV Non-Hodgkin Lymphoma|Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative|Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Castration-Resistant Prostate Carcinoma|Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Hematopoietic and Lymphoid System Neoplasm|Locally Advanced Pancreatic Adenocarcinoma|Metastatic Breast Carcinoma|Metastatic Malignant Solid Neoplasm|Metastatic Pancreatic Adenocarcinoma|Myelodysplastic/Myeloproliferative Neoplasm With Ring Sideroblasts and Thrombocytosis|Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable|Primary Myelofibrosis|Recurrent Acute Lymphoblastic Leukemia|Recurrent Acute Myeloid Leukemia|Recurrent Chronic Lymphocytic Leukemia|Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Recurrent Hematologic Malignancy|Recurrent Hodgkin Lymphoma|Recurrent Myelodysplastic Syndrome|Recurrent Myelodysplastic/Myeloproliferative Neoplasm|Recurrent Myeloproliferative Neoplasm|Recurrent Non-Hodgkin Lymphoma|Recurrent Plasma Cell Myeloma|Recurrent Small Lymphocytic Lymphoma|Refractory Acute Lymphoblastic Leukemia|Refractory Acute Myeloid Leukemia|Refractory Chronic Lymphocytic Leukemia|Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Refractory Chronic Myelomonocytic Leukemia|Refractory Hematologic Malignancy|Refractory Hodgkin Lymphoma|Refractory Malignant Solid Neoplasm|Refractory Myelodysplastic Syndrome|Refractory Myelodysplastic/Myeloproliferative Neoplasm|Refractory Non-Hodgkin Lymphoma|Refractory Plasma Cell Myeloma|Refractory Primary Myelofibrosis|Refractory Small Lymphocytic Lymphoma|Stage II Pancreatic Cancer AJCC v8|Stage III Pancreatic Cancer AJCC v8|Stage IV Pancreatic Cancer AJCC v8|Stage IV Prostate Cancer AJCC v8|Unresectable Pancreatic Adenocarcinoma",Neratinib,CCOC1=C(C=C2C(=C1)N=CC(=C2NC3=CC(=C(C=C3)OCC4=CC=CC=N4)Cl)C#N)NC(=O)C=CCN(C)C,PHASE1,immune_system_disease
2578,Mast Cell Activation Syndrome,Masitinib,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC(=CS4)C5=CN=CC=C5,PHASE2,immune_system_disease
2579,Pendular Nystagmus Patients With Multiple Sclerosis,Gabapentin,C1CCC(CC1)(CC(=O)O)CN,PHASE2,immune_system_disease
2580,Relapsing Multiple Sclerosis,Fenebrutinib,CC1CN(CCN1C2=CN=C(C=C2)NC3=CC(=CN(C3=O)C)C4=C(C(=NC=C4)N5CCN6C7=C(CC(C7)(C)C)C=C6C5=O)CO)C8COC8,PHASE2,immune_system_disease
2581,Multiple Myeloma,Ganetespib,CC(C)C1=C(C=C(C(=C1)C2=NNC(=O)N2C3=CC4=C(C=C3)N(C=C4)C)O)O,PHASE1,immune_system_disease
2582,Alcoholism,Baclofen,C1=CC(=CC=C1C(CC(=O)O)CN)Cl,PHASE2,mental_and_behavioural_disorder
2583,Alcoholism,Cyproheptadine,CN1CCC(=C2C3=CC=CC=C3C=CC4=CC=CC=C42)CC1,PHASE2,mental_and_behavioural_disorder
2584,Insomnia Chronic,Zopiclone,CN1CCN(CC1)C(=O)OC2C3=NC=CN=C3C(=O)N2C4=NC=C(C=C4)Cl,PHASE2,mental_and_behavioural_disorder
2585,Bipolar Disorder|Depressive Disorder,Bupropion,CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C,PHASE2,mental_and_behavioural_disorder
2586,Bipolar Disorder|Depressive Disorder,Sertraline,CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl,PHASE2,mental_and_behavioural_disorder
2587,Bipolar Disorder|Depressive Disorder,Venlafaxine,CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O,PHASE2,mental_and_behavioural_disorder
2588,"Depressive Disorder, Major|Alcoholism",Vortioxetine,CC1=CC(=C(C=C1)SC2=CC=CC=C2N3CCNCC3)C,PHASE2,mental_and_behavioural_disorder
2589,"Depressive Disorder, Major|Alcoholism",Acamprosate,CC(=O)NCCCS(=O)(=O)O,PHASE2,mental_and_behavioural_disorder
2590,Gambling,Naltrexone,C1CC1CN2CCC34C5C(=O)CCC3(C2CC6=C4C(=C(C=C6)O)O5)O,PHASE1,mental_and_behavioural_disorder
2591,Cancer|Major Depressive Disorder,Psilocybin,CN(C)CCC1=CNC2=C1C(=CC=C2)OP(=O)(O)O,PHASE2,mental_and_behavioural_disorder
2592,Attention Deficit Hyperactivity Disorder,Atomoxetine,CC1=CC=CC=C1OC(CCNC)C2=CC=CC=C2,PHASE2,mental_and_behavioural_disorder
2593,Attention Deficit Disorder With Hyperactivity,Guanfacine,C1=CC(=C(C(=C1)Cl)CC(=O)N=C(N)N)Cl,PHASE2,mental_and_behavioural_disorder
2594,Post Partum Depression,Ketamine,CNC1(CCCCC1=O)C2=CC=CC=C2Cl,PHASE2,mental_and_behavioural_disorder
2595,Gambling,Topiramate,CC1(OC2COC3(C(C2O1)OC(O3)(C)C)COS(=O)(=O)N)C,PHASE2,mental_and_behavioural_disorder
2596,Bipolar Depression,Ciclosporin,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,PHASE2,mental_and_behavioural_disorder
2597,Bipolar Depression,Chloroquine,CCN(CC)CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl,PHASE2,mental_and_behavioural_disorder
2598,HIV|Depression|Anhedonia,Baricitinib,CCS(=O)(=O)N1CC(C1)(CC#N)N2C=C(C=N2)C3=C4C=CNC4=NC=N3,PHASE2,mental_and_behavioural_disorder
2599,Post Traumatic Stress Disorder|Alcohol Use Disorder,Pregnenolone,CC(=O)C1CCC2C1(CCC3C2CC=C4C3(CCC(C4)O)C)C,PHASE1,mental_and_behavioural_disorder
2600,Attention Deficit Hyperactivity Disorder,Melatonin,CC(=O)NCCC1=CNC2=C1C=C(C=C2)OC,PHASE1|PHASE2,mental_and_behavioural_disorder
2601,Drug Addiction,Varenicline,C1C2CNCC1C3=CC4=NC=CN=C4C=C23,PHASE1,mental_and_behavioural_disorder
2602,Attention Deficit Hyperactivity Disorder,Dasotraline,C1CC(C2=CC=CC=C2C1C3=CC(=C(C=C3)Cl)Cl)N,PHASE2|PHASE3,mental_and_behavioural_disorder
2603,Obsessive-Compulsive Disorder,Pramipexole,CCCNC1CCC2=C(C1)SC(=N2)N,PHASE1,mental_and_behavioural_disorder
2604,Obsessive-Compulsive Disorder,Amisulpride,CCN1CCCC1CNC(=O)C2=CC(=C(C=C2OC)N)S(=O)(=O)CC,PHASE1,mental_and_behavioural_disorder
2605,Depression|Major Depressive Disorder,Tibolone,CC1CC2=C(CCC(=O)C2)C3C1C4CCC(C4(CC3)C)(C#C)O,PHASE1,mental_and_behavioural_disorder
2606,Stress Urinary Incontinence|Fecal Incontinence,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,PHASE1,mental_and_behavioural_disorder
2607,Stress Urinary Incontinence|Fecal Incontinence,Reboxetine,CCOC1=CC=CC=C1OC(C2CNCCO2)C3=CC=CC=C3,PHASE1,mental_and_behavioural_disorder
2608,Attention Deficit Hyperactivity Disorder,Amphetamine,CC(CC1=CC=CC=C1)N,PHASE2,mental_and_behavioural_disorder
2609,"ADHD, Predominantly Inattentive Type",Metadoxine,CC1=NC=C(C(=C1O)CO)CO.C1CC(=O)NC1C(=O)O,PHASE2,mental_and_behavioural_disorder
2610,Major Depressive Disorder,Ketoprofen,CC(C1=CC(=CC=C1)C(=O)C2=CC=CC=C2)C(=O)O,PHASE1,mental_and_behavioural_disorder
2611,Insomnia|Alcohol Use Disorder,Suvorexant,CC1CCN(CCN1C(=O)C2=C(C=CC(=C2)C)N3N=CC=N3)C4=NC5=C(O4)C=CC(=C5)Cl,PHASE2,mental_and_behavioural_disorder
2612,Attention Deficit Hyperactivity Disorder,Methylphenidate,COC(=O)C(C1CCCCN1)C2=CC=CC=C2,PHASE2,mental_and_behavioural_disorder
2613,Major Depressive Episode|Unipolar Depression|Bipolar Depression,Midazolam,CC1=NC=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4F,PHASE1,mental_and_behavioural_disorder
2614,Unipolar Depression,Minocycline,CN(C)C1C2CC3CC4=C(C=CC(=C4C(=C3C(=O)C2(C(=C(C1=O)C(=O)N)O)O)O)O)N(C)C,PHASE1,mental_and_behavioural_disorder
2615,Substance-related Disorders|HIV Risk Behavior,Methadone,CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2,PHASE1,mental_and_behavioural_disorder
2616,Substance-related Disorders|HIV Risk Behavior,Buprenorphine,CC(C)(C)C(C)(C1CC23CCC1(C4C25CCN(C3CC6=C5C(=C(C=C6)O)O4)CC7CC7)OC)O,PHASE1,mental_and_behavioural_disorder
2617,Major Depressive Disorder,Pexacerfont,CCC(C)NC1=NC(=NC2=C(C(=NN21)C)C3=C(N=C(C=C3)OC)C)C,PHASE1|PHASE2,mental_and_behavioural_disorder
2618,Major Depressive Disorder,Escitalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,PHASE1|PHASE2,mental_and_behavioural_disorder
2619,Depression,Milnacipran,CCN(CC)C(=O)C1(CC1CN)C2=CC=CC=C2,PHASE2|PHASE3,mental_and_behavioural_disorder
2620,Alcohol Use Disorder,Cannabidiol,CCCCCC1=CC(=C(C(=C1)O)C2C=C(CCC2C(=C)C)C)O,PHASE2,mental_and_behavioural_disorder
2621,Major Depressive Disorder|Bipolar Disorder,Cycloserine,C1C(C(=O)NO1)N,PHASE2,mental_and_behavioural_disorder
2622,Cocaine Dependence,Modafinil,C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N,PHASE2,mental_and_behavioural_disorder
2623,"Bipolar Depression|Suicidal Ideas|Suicidal Ideation|Suicide, Attempted",Lurasidone,C1CCC(C(C1)CN2CCN(CC2)C3=NSC4=CC=CC=C43)CN5C(=O)C6C7CCC(C7)C6C5=O,PHASE2,mental_and_behavioural_disorder
2624,REM Sleep Behavior Disorder|Parkinson Disease|Synucleinopathies,Rasagiline,C#CCNC1CCC2=CC=CC=C12,PHASE2|PHASE3,mental_and_behavioural_disorder
2625,Pathological Gambling,Tolcapone,CC1=CC=C(C=C1)C(=O)C2=CC(=C(C(=C2)O)O)[N+](=O)[O-],PHASE2,mental_and_behavioural_disorder
2626,"Depression, Postpartum|Analgesia, Obstetrical|Anesthesia, Obstetrical",Meperidine,CCOC(=O)C1(CCN(CC1)C)C2=CC=CC=C2,PHASE2|PHASE3,mental_and_behavioural_disorder
2627,"Depression, Postpartum|Analgesia, Obstetrical|Anesthesia, Obstetrical",Remifentanil,CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCC(=O)OC)C(=O)OC,PHASE2|PHASE3,mental_and_behavioural_disorder
2628,"Depression, Postpartum|Analgesia, Obstetrical|Anesthesia, Obstetrical",Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,PHASE2|PHASE3,mental_and_behavioural_disorder
2629,"Depression, Postpartum|Analgesia, Obstetrical|Anesthesia, Obstetrical",Ropivacaine,CCCN1CCCCC1C(=O)NC2=C(C=CC=C2C)C,PHASE2|PHASE3,mental_and_behavioural_disorder
2630,Major Depressive Disorder,Amitriptyline,CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31,PHASE2,mental_and_behavioural_disorder
2631,Major Depressive Disorder,Levomilnacipran,CCN(CC)C(=O)C1(CC1CN)C2=CC=CC=C2,PHASE2,mental_and_behavioural_disorder
2632,Major Depressive Disorder,Paroxetine,C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4,PHASE2,mental_and_behavioural_disorder
2633,Major Depressive Disorder,Fluoxetine,CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F,PHASE2,mental_and_behavioural_disorder
2634,"Depressive Disorder, Major",Radafaxine,CC1C(OCC(N1)(C)C)(C2=CC(=CC=C2)Cl)O,PHASE2,mental_and_behavioural_disorder
2635,Depression|Inflammation,Tofacitinib,CC1CCN(CC1N(C)C2=NC=NC3=C2C=CN3)C(=O)CC#N,PHASE1|PHASE2,mental_and_behavioural_disorder
2636,Attention Deficit Hyperactivity Disorder,Centanafadine,C1C2C1(CNC2)C3=CC4=CC=CC=C4C=C3,PHASE2,mental_and_behavioural_disorder
2637,Postpartum Depression,Quetiapine,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42,PHASE1,mental_and_behavioural_disorder
2638,REM Sleep Behavior Disorder|Pre-motor Parkinson Disease|Symptomatic Parkinson Disease,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,PHASE2,mental_and_behavioural_disorder
2639,Attention Deficit Disorder With Hyperactivity,Tipepidine,CN1CCCC(=C(C2=CC=CS2)C3=CC=CS3)C1,PHASE2,mental_and_behavioural_disorder
2640,"Major Depressive Disorder, Healthy Volunteer",Basimglurant,CC1=C(N=C(N1C2=CC=C(C=C2)F)C)C#CC3=CC(=NC=C3)Cl,PHASE1,mental_and_behavioural_disorder
2641,Parkinson's Disease|Mpulse Control Disorders,Clonidine,C1CN=C(N1)NC2=C(C=CC=C2Cl)Cl,PHASE2,mental_and_behavioural_disorder
2642,Skin-Picking|Trichotillomania (Hair-Pulling Disorder),Memantine,CC12CC3CC(C1)(CC(C3)(C2)N)C,PHASE2|PHASE3,mental_and_behavioural_disorder
2643,Mood Disorders,Erythropoietin,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NN=N[N-]4)CO)Cl.[K+],PHASE2,mental_and_behavioural_disorder
2644,Depression|Depressive Disorder,Folate,C1=CC(=CC=C1C(=O)NC(CCC(=O)O)C(=O)O)NCC2=CN=C3C(=N2)C(=O)NC(=N3)N,PHASE2,mental_and_behavioural_disorder
2645,"Perinatal Depression|Post Partum Depression|Depression, Postpartum|Depression",Leuprolide,CCNC(=O)C1CCCN1C(=O)C(CCCN=C(N)N)NC(=O)C(CC(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC2=CC=C(C=C2)O)NC(=O)C(CO)NC(=O)C(CC3=CNC4=CC=CC=C43)NC(=O)C(CC5=CN=CN5)NC(=O)C6CCC(=O)N6,PHASE2,mental_and_behavioural_disorder
2646,Bipolar Disorder,Riluzole,C1=CC2=C(C=C1OC(F)(F)F)SC(=N2)N,PHASE2,mental_and_behavioural_disorder
2647,Idiopathic Overactive Bladder With Urinary Incontinence,Trospium,C1CC[N+]2(C1)C3CCC2CC(C3)OC(=O)C(C4=CC=CC=C4)(C5=CC=CC=C5)O,PHASE1,mental_and_behavioural_disorder
2648,Fragile X Syndrome,Lovastatin,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,PHASE2,mental_and_behavioural_disorder
2649,REM Sleep Behavior Disorder,Clonazepam,C1C(=O)NC2=C(C=C(C=C2)[N+](=O)[O-])C(=N1)C3=CC=CC=C3Cl,PHASE2,mental_and_behavioural_disorder
2650,Cocaine Dependence|Alcohol Dependence,Aprepitant,CC(C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)OC2C(N(CCO2)CC3=NNC(=O)N3)C4=CC=C(C=C4)F,PHASE2,mental_and_behavioural_disorder
2651,"Depressive Disorder, Major",Seltorexant,CC1=CC(=NC(=N1)N2CC3CN(CC3C2)C(=O)C4=C(C=CC=C4F)N5N=CC=N5)C,PHASE1,mental_and_behavioural_disorder
2652,Alcohol Use Disorders (AUD),Mifepristone,CC#CC1(CCC2C1(CC(C3=C4CCC(=O)C=C4CCC23)C5=CC=C(C=C5)N(C)C)C)O,PHASE1|PHASE2,mental_and_behavioural_disorder
2653,Urinary Stress Incontinence,Duloxetine,CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32,PHASE2,mental_and_behavioural_disorder
2654,REM Sleep Behavior Disorder|Pre-motor Parkinson's Disease|Symptomatic Parkinson Disease,Terazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4CCCO4)N)OC,PHASE2,mental_and_behavioural_disorder
2655,"Depressive Disorder, Major",Desvenlafaxine,CN(C)CC(C1=CC=C(C=C1)O)C2(CCCCC2)O,PHASE1,mental_and_behavioural_disorder
2656,Bipolar Depression,Esketamine,CNC1(CCCCC1=O)C2=CC=CC=C2Cl,PHASE2,mental_and_behavioural_disorder
2657,Post Traumatic Stress Disorder|Alcohol Use Disorder,Zonisamide,C1=CC=C2C(=C1)C(=NO2)CS(=O)(=O)N,PHASE2,mental_and_behavioural_disorder
2658,Bipolar Depression,Valproate,CCCC(CCC)C(=O)O,PHASE2,mental_and_behavioural_disorder
2659,Bipolar Depression,Cytidine,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,PHASE2,mental_and_behavioural_disorder
2660,Urinary Incontinence,Litoxetine,C1CNCCC1OCC2=CC3=CC=CC=C3C=C2,PHASE1|PHASE2,mental_and_behavioural_disorder
2661,Bipolar Disorder,Levothyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,PHASE2|PHASE3,mental_and_behavioural_disorder
2662,Bipolar Disorder,Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,PHASE2|PHASE3,mental_and_behavioural_disorder
2663,Treatment Resistant Depression,Liafensine,CN1CC(C2=C(C1)C=C(C=C2)C3=NN=C(C=C3)N)C4=CC5=CC=CC=C5C=C4,PHASE2,mental_and_behavioural_disorder
2664,"Stress Disorders, Post-Traumatic|Alcohol Use Disorder",Propranolol,CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O,PHASE2,mental_and_behavioural_disorder
2665,Trichotillomania (Hair-Pulling Disorder)|Dermatillomania,Aripiprazole,C1CC(=O)NC2=C1C=CC(=C2)OCCCCN3CCN(CC3)C4=C(C(=CC=C4)Cl)Cl,PHASE2,mental_and_behavioural_disorder
2666,Major Depressive Disorder,Brexpiprazole,C1CN(CCN1CCCCOC2=CC3=C(C=C2)C=CC(=O)N3)C4=C5C=CSC5=CC=C4,PHASE1,mental_and_behavioural_disorder
2667,Psychotic Disorders|Schizophrenia|Bipolar Disorder|Depressive Disorder,Olanzapine,CC1=CC2=C(S1)NC3=CC=CC=C3N=C2N4CCN(CC4)C,PHASE1,mental_and_behavioural_disorder
2668,Psychotic Disorders|Schizophrenia|Bipolar Disorder|Depressive Disorder,Paliperidone,CC1=C(C(=O)N2CCCC(C2=N1)O)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F,PHASE1,mental_and_behavioural_disorder
2669,Psychotic Disorders|Schizophrenia|Bipolar Disorder|Depressive Disorder,Risperidone,CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F,PHASE1,mental_and_behavioural_disorder
2670,Major Depressive Disorder|Depression|Depressive Symptoms|Cardiovascular Disease (CVD)|Coronary Artery Disease (CAD)|Heart Disease,Pentoxifylline,CC(=O)CCCCN1C(=O)C2=C(N=CN2C)N(C1=O)C,PHASE2,mental_and_behavioural_disorder
2671,Intellectual Disability|Developmental Disability|Aggression|Behavior Problem,Nabilone,CCCCCCC(C)(C)C1=CC(=C2C3CC(=O)CCC3C(OC2=C1)(C)C)O,PHASE1,mental_and_behavioural_disorder
2672,Alcohol Use Disorder,Nalmefene,C=C1CCC2(C3CC4=C5C2(C1OC5=C(C=C4)O)CCN3CC6CC6)O,PHASE2,mental_and_behavioural_disorder
2673,Behavioural Disturbances|Pain|Dementia|Alzheimer's Dementia|Vascular Dementia,Acetaminophen,CC(=O)NC1=CC=C(C=C1)O,PHASE2,mental_and_behavioural_disorder
2674,Attention Deficit Disorder With Hyperactivity,Buspirone,C1CCC2(C1)CC(=O)N(C(=O)C2)CCCCN3CCN(CC3)C4=NC=CC=N4,PHASE2,mental_and_behavioural_disorder
2675,"Depressive Disorder, Major",Serotonin,C1=CC2=C(C=C1O)C(=CN2)CCN,PHASE2,mental_and_behavioural_disorder
2676,"Depressive Disorder, Major",Norepinephrine,C1=CC(=C(C=C1C(CN)O)O)O,PHASE2,mental_and_behavioural_disorder
2677,"Frontotemporal Dementia|Dementia|Aphasia, Primary Progressive|Pick Disease of the Brain|Brain Diseases|Central Nervous System Diseases|Nervous System Diseases|Neurocognitive Disorders|Mental Disorders|Neurodegenerative Diseases|Frontotemporal Lobar Degeneration|TDP-43 Proteinopathies|Proteostasis Deficiencies|Metabolic Disease|Aphasia|Speech Disorders|Language Disorders|Communication Disorders|Neurobehavioral Manifestations|Neurologic Manifestations",Rotigotine,CCCN(CCC1=CC=CS1)C2CCC3=C(C2)C=CC=C3O,PHASE2,mental_and_behavioural_disorder
2678,Bipolar I Depression,Armodafinil,C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N,PHASE2,mental_and_behavioural_disorder
2679,Dementia|Pain|Agitation,Paracetamol,CC(=O)NC1=CC=C(C=C1)O,PHASE2|PHASE3,mental_and_behavioural_disorder
2680,Dementia|Pain|Agitation,Morphine,CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O,PHASE2|PHASE3,mental_and_behavioural_disorder
2681,Dementia|Pain|Agitation,Pregabalin,CC(C)CC(CC(=O)O)CN,PHASE2|PHASE3,mental_and_behavioural_disorder
2682,Trichotillomania|Hair Pulling,Acetylcysteine,CC(=O)NC(CS)C(=O)O,PHASE2,mental_and_behavioural_disorder
2683,Bipolar Disorder|Bipolar Depression|Depression,Ziprasidone,C1CN(CCN1CCC2=C(C=C3C(=C2)CC(=O)N3)Cl)C4=NSC5=CC=CC=C54,PHASE2,mental_and_behavioural_disorder
2684,"Schizophrenia|Treatment Resistant Depression|Aging, Premature",Dasatinib,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=CC(=NC(=N3)C)N4CCN(CC4)CCO,PHASE2,mental_and_behavioural_disorder
2685,"Schizophrenia|Treatment Resistant Depression|Aging, Premature",Quercetin,C1=CC(=C(C=C1C2=C(C(=O)C3=C(C=C(C=C3O2)O)O)O)O)O,PHASE2,mental_and_behavioural_disorder
2686,Gambling|Opioid|Naloxone|Spray,Naloxone,C=CCN1CCC23C4C(=O)CCC2(C1CC5=C3C(=C(C=C5)O)O4)O,PHASE2,mental_and_behavioural_disorder
2687,Marijuana Abuse,Yohimbine,COC(=O)C1C(CCC2C1CC3C4=C(CCN3C2)C5=CC=CC=C5N4)O,PHASE1,mental_and_behavioural_disorder
2688,Premenstrual Syndrome|PMS|Healthy|Depression,Dutasteride,CC12CCC3C(C1CCC2C(=O)NC4=C(C=CC(=C4)C(F)(F)F)C(F)(F)F)CCC5C3(C=CC(=O)N5)C,PHASE1,mental_and_behavioural_disorder
2689,Trichotillomania (Hair-Pulling Disorder),Valbenazine,CC(C)CC1CN2CCC3=CC(=C(C=C3C2CC1OC(=O)C(C(C)C)N)OC)OC,PHASE2,mental_and_behavioural_disorder
2690,Dementia,Roflumilast,C1CC1COC2=C(C=CC(=C2)C(=O)NC3=C(C=NC=C3Cl)Cl)OC(F)F,PHASE2,mental_and_behavioural_disorder
2691,Amphetamine Addiction|Pharmacotherapy,Dextromethorphan,CN1CCC23CCCCC2C1CC4=C3C=C(C=C4)OC,PHASE2|PHASE3,mental_and_behavioural_disorder
2692,"Depression, Bipolar",Cariprazine,CN(C)C(=O)NC1CCC(CC1)CCN2CCN(CC2)C3=C(C(=CC=C3)Cl)Cl,PHASE2,mental_and_behavioural_disorder
2693,Autism Spectrum Disorders,Arbaclofen,C1=CC(=CC=C1C(CC(=O)O)CN)Cl,PHASE2,mental_and_behavioural_disorder
2694,"Attention Deficit Disorder With Hyperactivity|Diabetes Mellitus, Type 1",Lisdexamfetamine,CC(CC1=CC=CC=C1)NC(=O)C(CCCCN)N,PHASE2,mental_and_behavioural_disorder
2695,Treatment of Depression in Adults With Parkinson's Disease (PD),Pimavanserin,CC(C)COC1=CC=C(C=C1)CNC(=O)N(CC2=CC=C(C=C2)F)C3CCN(CC3)C,PHASE2,mental_and_behavioural_disorder
2696,Alzheimer Disease|Mild Cognitive Impairment,Donepezil,COC1=C(C=C2C(=C1)CC(C2=O)CC3CCN(CC3)CC4=CC=CC=C4)OC,PHASE2,mental_and_behavioural_disorder
2697,Major Depression|Dysthymia|Depressive Disorder Not Otherwise Specified,Imipramine,CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31,PHASE1|PHASE2,mental_and_behavioural_disorder
2698,Spinal Cord Injuries|Urinary Incontinence,Sildenafil,CCCC1=NN(C2=C1N=C(NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C,PHASE2,mental_and_behavioural_disorder
2699,REM Sleep Behavior Disorder|Parkinson Disease,Idebenone,CC1=C(C(=O)C(=C(C1=O)OC)OC)CCCCCCCCCCO,PHASE2|PHASE3,mental_and_behavioural_disorder
2700,Major Depressive Disorder,Vilazodone,C1CN(CCN1CCCCC2=CNC3=C2C=C(C=C3)C#N)C4=CC5=C(C=C4)OC(=C5)C(=O)N,PHASE2,mental_and_behavioural_disorder
2701,Attention Deficit Hyperactivity Disorder,Droxidopa,C1=CC(=C(C=C1C(C(C(=O)O)N)O)O)O,PHASE2,mental_and_behavioural_disorder
2702,Attention Deficit Hyperactivity Disorder,Carbidopa,CC(CC1=CC(=C(C=C1)O)O)(C(=O)O)NN,PHASE2,mental_and_behavioural_disorder
2703,Bipolar Disorder,Isradipine,CC1=C(C(C(=C(N1)C)C(=O)OC(C)C)C2=CC=CC3=NON=C32)C(=O)OC,PHASE2,mental_and_behavioural_disorder
2704,Depressive Disorder|Major Depressive Disorder|Bipolar Disorder|Post Traumatic Stress Disorder|Suicidal Ideation,Perampanel,C1=CC=C(C=C1)N2C=C(C=C(C2=O)C3=CC=CC=C3C#N)C4=CC=CC=N4,PHASE2,mental_and_behavioural_disorder
2705,Major Depression,Cimicoxib,COC1=C(C=C(C=C1)C2=C(N=CN2C3=CC=C(C=C3)S(=O)(=O)N)Cl)F,PHASE2,mental_and_behavioural_disorder
2706,Bipolar Disorder|Manic Depression,Lamotrigine,C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N,PHASE1,mental_and_behavioural_disorder
2707,Alcohol Use Disorder|Posttraumatic Stress Disorder (PTSD),Prazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4=CC=CO4)N)OC,PHASE2,mental_and_behavioural_disorder
2708,Trichotillomania|Skin-Picking,Dronabinol,CCCCCC1=CC(=C2C3C=C(CCC3C(OC2=C1)(C)C)C)O,PHASE2|PHASE3,mental_and_behavioural_disorder
2709,Major Depressive Disorder,Gaboxadol,C1CNCC2=C1C(=O)NO2,PHASE2,mental_and_behavioural_disorder
2710,Attention Deficit Hyperactivity Disorder,Edivoxetine,COC1=C(C=C(C=C1)F)CC(C2CCOCC2)(C3CNCCO3)O,PHASE2|PHASE3,mental_and_behavioural_disorder
2711,Pathological Gambling,Haloperidol,C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F,PHASE2,mental_and_behavioural_disorder
2712,Pathological Gambling,Fluphenazine,C1CN(CCN1CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)C(F)(F)F)CCO,PHASE2,mental_and_behavioural_disorder
2713,Pathological Gambling,Dextroamphetamine,CC(CC1=CC=CC=C1)N,PHASE2,mental_and_behavioural_disorder
2714,Depression,Trazodone,C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl,PHASE2|PHASE3,mental_and_behavioural_disorder
2715,"Depressive Disorder|Depression|Depression, Postpartum|Behavioral Symptoms|Mood Disorders|Mental Disorder|Pregnancy Complications|Postpartum Blues|PPD|Postpartum Disorder",Ganaxolone,CC(=O)C1CCC2C1(CCC3C2CCC4C3(CCC(C4)(C)O)C)C,PHASE2,mental_and_behavioural_disorder
2716,Alcohol Use Disorder (AUD)|Post Traumatic Stress Disorder (PTSD),Dexmedetomidine,CC1=C(C(=CC=C1)C(C)C2=CN=CN2)C,PHASE1,mental_and_behavioural_disorder
2717,Dementia,Fasudil,C1CNCCN(C1)S(=O)(=O)C2=CC=CC3=C2C=CN=C3,PHASE2,mental_and_behavioural_disorder
2718,Attention Deficit Hyperactivity Disorder,Amantadine,C1C2CC3CC1CC(C2)(C3)N,PHASE2,mental_and_behavioural_disorder
2719,Alcohol Abuse|Alcohol Addiction|Alcohol Dependence|Alcohol Use Disorder,Semaglutide,CCC(C)C(C(=O)NC(C)C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(CC(C)C)C(=O)NC(C(C)C)C(=O)NC(CCCNC(=N)N)C(=O)NCC(=O)NC(CCCNC(=N)N)C(=O)NCC(=O)O)NC(=O)C(CC3=CC=CC=C3)NC(=O)C(CCC(=O)O)NC(=O)C(CCCCNC(=O)COCCOCCNC(=O)COCCOCCNC(=O)CCC(C(=O)O)NC(=O)CCCCCCCCCCCCCCCCC(=O)O)NC(=O)C(C)NC(=O)C(C)NC(=O)C(CCC(=O)N)NC(=O)CNC(=O)C(CCC(=O)O)NC(=O)C(CC(C)C)NC(=O)C(CC4=CC=C(C=C4)O)NC(=O)C(CO)NC(=O)C(CO)NC(=O)C(C(C)C)NC(=O)C(CC(=O)O)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C(CC5=CC=CC=C5)NC(=O)C(C(C)O)NC(=O)CNC(=O)C(CCC(=O)O)NC(=O)C(C)(C)NC(=O)C(CC6=CN=CN6)N,PHASE2,mental_and_behavioural_disorder
2720,Alcohol Use Disorder,Ibudilast,CC(C)C1=NN2C=CC=CC2=C1C(=O)C(C)C,PHASE2,mental_and_behavioural_disorder
2721,PTSD|Alcohol Use Disorder,Brexanolone,CC(=O)C1CCC2C1(CCC3C2CCC4C3(CCC(C4)O)C)C,PHASE1,mental_and_behavioural_disorder
2722,Bipolar Depression,Uridine,C1=CN(C(=O)NC1=O)C2C(C(C(O2)CO)O)O,PHASE2,mental_and_behavioural_disorder
2723,Sleep Initiation and Maintenance Disorders,Zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C,PHASE2,mental_and_behavioural_disorder
2724,"Stress Disorder, Post Traumatic",Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,PHASE2|PHASE3,mental_and_behavioural_disorder
2725,Drug Abuse,Ramelteon,CCC(=O)NCCC1CCC2=C1C3=C(C=C2)OCC3,PHASE2,mental_and_behavioural_disorder
2726,"Depressive Disorder, Major",Rapastinel,CC(C(C(=O)N1CCCC1C(=O)N2CCCC2C(=O)NC(C(C)O)C(=O)N)N)O,PHASE2,mental_and_behavioural_disorder
2727,Amphetamine-Related Disorders,Reserpine,COC1C(CC2CN3CCC4=C(C3CC2C1C(=O)OC)NC5=C4C=CC(=C5)OC)OC(=O)C6=CC(=C(C(=C6)OC)OC)OC,PHASE1,mental_and_behavioural_disorder
2728,Pathological Gambling,Ecopipam,CN1CCC2=CC(=C(C=C2C3C1CCC4=CC=CC=C34)O)Cl,PHASE2,mental_and_behavioural_disorder
2729,"Major Depressive Disorder, Recurrent",Filorexant,CC1CCC(CN1C(=O)C2=C(C=CC(=C2)C)C3=NC=CC=N3)COC4=NC=C(C=C4)F,PHASE2,mental_and_behavioural_disorder
2730,Attention Deficit Disorder With Hyperactivity,Betahistine,CNCCC1=CC=CC=N1,PHASE1,mental_and_behavioural_disorder
2731,Behavior and Mental Disorders|Methamphetamine Disorders,Metamfetamine,CC(CC1=CC=CC=C1)NC,PHASE1,mental_and_behavioural_disorder
2732,Behavior and Mental Disorders|Methamphetamine Disorders,Methamphetamine,CC(CC1=CC=CC=C1)NC,PHASE1,mental_and_behavioural_disorder
2733,Alcohol Use Disorder,Citicoline,C[N+](C)(C)CCOP(=O)([O-])OP(=O)(O)OCC1C(C(C(O1)N2C=CC(=NC2=O)N)O)O,PHASE2,mental_and_behavioural_disorder
2734,Depressive Disorder,Dapagliflozin,CCOC1=CC=C(C=C1)CC2=C(C=CC(=C2)C3C(C(C(C(O3)CO)O)O)O)Cl,PHASE2,mental_and_behavioural_disorder
2735,Depressive Disorder,Atorvastatin,CC(C)C1=C(C(=C(N1CCC(CC(CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4,PHASE2,mental_and_behavioural_disorder
2736,Alcohol Use Disorder,Lacosamide,CC(=O)NC(COC)C(=O)NCC1=CC=CC=C1,PHASE1,mental_and_behavioural_disorder
2737,"Carcinoma, Non-Small-Cell Lung|Depression",Mirtazapine,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4,PHASE2,mental_and_behavioural_disorder
2738,"Depressive Disorder, Treatment-Resistant",Ebselen,C1=CC=C(C=C1)N2C(=O)C3=CC=CC=C3[Se]2,PHASE1,mental_and_behavioural_disorder
2739,Unipolar Depression,Enoxolone,CC1(C2CCC3(C(C2(CCC1O)C)C(=O)C=C4C3(CCC5(C4CC(CC5)(C)C(=O)O)C)C)C)C,PHASE1|PHASE2,mental_and_behavioural_disorder
2740,Attention Deficit Hyperactivity Disorder,Solriamfetol,C1=CC=C(C=C1)CC(COC(=O)N)N,PHASE2|PHASE3,mental_and_behavioural_disorder
2741,Schizophrenia|Alcohol Use Disorder,Samidorphan,C1CC1CN2CCC34CC(=O)CCC3(C2CC5=C4C(=C(C=C5)C(=O)N)O)O,PHASE2,mental_and_behavioural_disorder
2742,Bipolar Disorder,Felbamate,C1=CC=C(C=C1)C(COC(=O)N)COC(=O)N,PHASE2,mental_and_behavioural_disorder
2743,Disorder of Consciousness,Apomorphine,CN1CCC2=C3C1CC4=C(C3=CC=C2)C(=C(C=C4)O)O,PHASE2,mental_and_behavioural_disorder
2744,"Depressive Disorder, Treatment-Resistant",Quinidine,COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O,PHASE2,mental_and_behavioural_disorder
2745,Bipolar Depression,Asenapine,CN1CC2C(C1)C3=C(C=CC(=C3)Cl)OC4=CC=CC=C24,PHASE2,mental_and_behavioural_disorder
2746,Stress Urinary Incontinence,Fesoterodine,CC(C)C(=O)OC1=C(C=C(C=C1)CO)C(CCN(C(C)C)C(C)C)C2=CC=CC=C2,PHASE2,mental_and_behavioural_disorder
2747,Cocaine-Related Disorders,Tryptophan,C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)N,PHASE2,mental_and_behavioural_disorder
2748,Major Depressive Disorder,Diphenhydramine,CN(C)CCOC(C1=CC=CC=C1)C2=CC=CC=C2,PHASE1,mental_and_behavioural_disorder
2749,Cocaine Addiction,Vigabatrin,C=CC(CCC(=O)O)N,PHASE1,mental_and_behavioural_disorder
2750,Overactive Bladder,Tolterodine,CC1=CC(=C(C=C1)O)C(CCN(C(C)C)C(C)C)C2=CC=CC=C2,PHASE2,mental_and_behavioural_disorder
2751,Cocaine Abuse,Disulfiram,CCN(CC)C(=S)SSC(=S)N(CC)CC,PHASE1,mental_and_behavioural_disorder
2752,Obsessive-Compulsive Disorder|Pediatric Psychiatric Disorder,Celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,PHASE2,mental_and_behavioural_disorder
2753,G6PD Normal|G6PD Deficient|Healthy,Primaquine,CC(CCCN)NC1=C2C(=CC(=C1)OC)C=CC=N2,PHASE1,metabolic_disease
2754,Minimal Hepatic Encephalopathy,Rifaximin,CC1C=CC=C(C(=O)NC2=C(C3=C(C4=C(C(=C3O)C)OC(C4=O)(OC=CC(C(C(C(C(C(C1O)C)O)C)OC(=O)C)C)OC)C)C5=C2N6C=CC(=CC6=N5)C)O)C,PHASE1|PHASE2,metabolic_disease
2755,"Diabetes Mellitus, Type 1|Hypoglycemia|Hypoglycemia Unawareness",Dapagliflozin,CCOC1=CC=C(C=C1)CC2=C(C=CC(=C2)C3C(C(C(C(O3)CO)O)O)O)Cl,PHASE2,metabolic_disease
2756,SIADH,Empagliflozin,C1COCC1OC2=CC=C(C=C2)CC3=C(C=CC(=C3)C4C(C(C(C(O4)CO)O)O)O)Cl,PHASE2|PHASE3,metabolic_disease
2757,SIADH,Ciclosporin,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,PHASE2|PHASE3,metabolic_disease
2758,SIADH,Chloroquine,CCN(CC)CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl,PHASE2|PHASE3,metabolic_disease
2759,Hyperlipidemia|Diabetes,Metformin,CN(C)C(=N)N=C(N)N,PHASE1,metabolic_disease
2760,Hyperlipidemia|Diabetes,Rosuvastatin,CC(C)C1=NC(=NC(=C1C=CC(CC(CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C,PHASE1,metabolic_disease
2761,Methemoglobinemia|Linear IgA Bullous Dermatosis,Dapsone,C1=CC(=CC=C1N)S(=O)(=O)C2=CC=C(C=C2)N,PHASE1,metabolic_disease
2762,"Ultraviolet Rays|Immunosuppression|Hypersensitivity, Delayed|Immune Tolerance/Drug Effects",Diphencyprone,C1=CC=C(C=C1)C2=C(C2=O)C3=CC=CC=C3,PHASE1,metabolic_disease
2763,Gout,Colchicine,CC(=O)NC1CCC2=CC(=C(C(=C2C3=CC=C(C(=O)C=C13)OC)OC)OC)OC,PHASE1,metabolic_disease
2764,Gout,Febuxostat,CC1=C(SC(=N1)C2=CC(=C(C=C2)OCC(C)C)C#N)C(=O)O,PHASE1,metabolic_disease
2765,Coronary Artery Disease|Type 2 Diabetes Mellitus,Pioglitazone,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3,PHASE2|PHASE3,metabolic_disease
2766,Hypercholesterolemia,Atorvastatin,CC(C)C1=C(C(=C(N1CCC(CC(CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4,PHASE2,metabolic_disease
2767,Advanced Solid Tumors|Lymphoma,Ixazomib,B(C(CC(C)C)NC(=O)CNC(=O)C1=C(C=CC(=C1)Cl)Cl)(O)O,PHASE1,metabolic_disease
2768,Neurodegenerative Disease|Iron Overload,Deferiprone,CC1=C(C(=O)C=CN1C)O,PHASE2,metabolic_disease
2769,Hypertriglyceridemia,Simvastatin,CCC(C)(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,PHASE1,metabolic_disease
2770,"Diabetes Mellitus, Type 2",Glimepiride,CCC1=C(CN(C1=O)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCC(CC3)C)C,PHASE1,metabolic_disease
2771,Amyotrophic Lateral Sclerosis|ALS,Ciprofloxacin,C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O,PHASE2,metabolic_disease
2772,Amyotrophic Lateral Sclerosis|ALS,Celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,PHASE2,metabolic_disease
2773,Type 2 Diabetes Mellitus,Liraglutide,CCCCCCCCCCCCCCCC(=O)NC(CCC(=O)NCCCCC(C(=O)NC(CCC(=O)O)C(=O)NC(CC1=CC=CC=C1)C(=O)NC(C(C)CC)C(=O)NC(C)C(=O)NC(CC2=CNC3=CC=CC=C32)C(=O)NC(CC(C)C)C(=O)NC(C(C)C)C(=O)NC(CCCNC(=N)N)C(=O)NCC(=O)NC(CCCNC(=N)N)C(=O)NCC(=O)O)NC(=O)C(C)NC(=O)C(C)NC(=O)C(CCC(=O)N)NC(=O)CNC(=O)C(CCC(=O)O)NC(=O)C(CC(C)C)NC(=O)C(CC4=CC=C(C=C4)O)NC(=O)C(CO)NC(=O)C(CO)NC(=O)C(C(C)C)NC(=O)C(CC(=O)O)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C(CC5=CC=CC=C5)NC(=O)C(C(C)O)NC(=O)CNC(=O)C(CCC(=O)O)NC(=O)C(C)NC(=O)C(CC6=CN=CN6)N)C(=O)O,PHASE1,metabolic_disease
2774,Cancers With DNA Repair-Deficiency,Olaparib,C1CC1C(=O)N2CCN(CC2)C(=O)C3=C(C=CC(=C3)CC4=NNC(=O)C5=CC=CC=C54)F,PHASE2,metabolic_disease
2775,Cancers With DNA Repair-Deficiency,Trabectedin,CC1=CC2=C(C3C4C5C6=C(C(=C7C(=C6C(N4C(C(C2)N3C)O)COC(=O)C8(CS5)C9=CC(=C(C=C9CCN8)O)OC)OCO7)C)OC(=O)C)C(=C1OC)O,PHASE2,metabolic_disease
2776,"Gaucher Disease, Type 1|Cerebroside Lipidosis Syndrome|Glucocerebrosidase Deficiency Disease|Glucosylceramide Beta-Glucosidase Deficiency Disease|Gaucher Disease, Non-Neuronopathic Form",Eliglustat,CCCCCCCC(=O)NC(CN1CCCC1)C(C2=CC3=C(C=C2)OCCO3)O,PHASE2,metabolic_disease
2777,Type 1 Diabetes|Hypoglycemia,Pitolisant,C1CCN(CC1)CCCOCCCC2=CC=C(C=C2)Cl,PHASE1,metabolic_disease
2778,"Gaucher Disease, Type 1",Ambroxol,C1CC(CCC1NCC2=C(C(=CC(=C2)Br)Br)N)O,PHASE2,metabolic_disease
2779,Euglycemia|Hypoglycemia|Hyperglycemia,Exenatide,CCC(C)C(C(=O)NC(CCC(=O)O)C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(CC(C)C)C(=O)NC(CCCCN)C(=O)NC(CC(=O)N)C(=O)NCC(=O)NCC(=O)N3CCCC3C(=O)NC(CO)C(=O)NC(CO)C(=O)NCC(=O)NC(C)C(=O)N4CCCC4C(=O)N5CCCC5C(=O)N6CCCC6C(=O)NC(CO)C(=O)N)NC(=O)C(CC7=CC=CC=C7)NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(C(C)C)NC(=O)C(C)NC(=O)C(CCC(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(CCSC)NC(=O)C(CCC(=O)N)NC(=O)C(CCCCN)NC(=O)C(CO)NC(=O)C(CC(C)C)NC(=O)C(CC(=O)O)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C(CC8=CC=CC=C8)NC(=O)C(C(C)O)NC(=O)CNC(=O)C(CCC(=O)O)NC(=O)CNC(=O)C(CC9=CNC=N9)N,PHASE1|PHASE2,metabolic_disease
2780,Adenosine Deaminase Deficiency|Autosomal Recessive Disorder|Immune System Disorder|Purine-Nucleoside Phosphorylase Deficiency|Severe Combined Immunodeficiency|Severe Combined Immunodeficiency With Absence of T and B Cells|X-Linked Severe Combined Immunodeficiency,Cyclosporine,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,PHASE1,metabolic_disease
2781,Adenosine Deaminase Deficiency|Autosomal Recessive Disorder|Immune System Disorder|Purine-Nucleoside Phosphorylase Deficiency|Severe Combined Immunodeficiency|Severe Combined Immunodeficiency With Absence of T and B Cells|X-Linked Severe Combined Immunodeficiency,Mycophenolate,CC1=C2COC(=O)C2=C(C(=C1OC)CC=C(C)CCC(=O)O)O,PHASE1,metabolic_disease
2782,Hyperlipidemia,Sitagliptin,C1CN2C(=NN=C2C(F)(F)F)CN1C(=O)CC(CC3=CC(=C(C=C3F)F)F)N,PHASE2|PHASE3,metabolic_disease
2783,Hypercholesterolemia,Ezetimibe,C1=CC(=CC=C1C2C(C(=O)N2C3=CC=C(C=C3)F)CCC(C4=CC=C(C=C4)F)O)O,PHASE2,metabolic_disease
2784,Type 1 Diabetes Mellitus,Tacrolimus,CC1CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC(=O)C(C=C(C1)C)CC=C)O)C)C(=CC4CCC(C(C4)OC)O)C)O)C)OC)OC,PHASE2,metabolic_disease
2785,Dyslipidemia,Evacetrapib,CC1=CC(=C2C(=C1)C(CCCN2CC3CCC(CC3)C(=O)O)N(CC4=CC(=CC(=C4)C(F)(F)F)C(F)(F)F)C5=NN(N=N5)C)C,PHASE1,metabolic_disease
2786,Hyperlipidemia|HIV,Pitavastatin,C1CC1C2=NC3=CC=CC=C3C(=C2C=CC(CC(CC(=O)O)O)O)C4=CC=C(C=C4)F,PHASE1,metabolic_disease
2787,Hyperlipidemia|HIV,Darunavir,CC(C)CN(CC(C(CC1=CC=CC=C1)NC(=O)OC2COC3C2CCO3)O)S(=O)(=O)C4=CC=C(C=C4)N,PHASE1,metabolic_disease
2788,Hyperlipidemia|HIV,Ritonavir,CC(C)C1=NC(=CS1)CN(C)C(=O)NC(C(C)C)C(=O)NC(CC2=CC=CC=C2)CC(C(CC3=CC=CC=C3)NC(=O)OCC4=CN=CS4)O,PHASE1,metabolic_disease
2789,Hyperlipidemia|HIV,Efavirenz,C1CC1C#CC2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F,PHASE1,metabolic_disease
2790,Type 2 Diabetes Mellitus,Bexagliflozin,C1CC1OCCOC2=CC=C(C=C2)CC3=C(C=CC(=C3)C4C(C(C(C(O4)CO)O)O)O)Cl,PHASE1,metabolic_disease
2791,Type 2 Diabetes Mellitus,Probenecid,CCCN(CCC)S(=O)(=O)C1=CC=C(C=C1)C(=O)O,PHASE1,metabolic_disease
2792,Type 2 Diabetes Mellitus,Rifampin,CC1C=CC=C(C(=O)NC2=C(C(=C3C(=C2O)C(=C(C4=C3C(=O)C(O4)(OC=CC(C(C(C(C(C(C1O)C)O)C)OC(=O)C)C)OC)C)C)O)O)C=NN5CCN(CC5)C)C,PHASE1,metabolic_disease
2793,Type 2 Diabetes Mellitus,Rifampicin,CC1C=CC=C(C(=O)NC2=C(C(=C3C(=C2O)C(=C(C4=C3C(=O)C(O4)(OC=CC(C(C(C(C(C(C1O)C)O)C)OC(=O)C)C)OC)C)C)O)O)C=NN5CCN(CC5)C)C,PHASE1,metabolic_disease
2794,Type 2 Diabetes Mellitus,Verapamil,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,PHASE1,metabolic_disease
2795,"Diabetes Mellitus, Type 2",Canagliflozin,CC1=C(C=C(C=C1)C2C(C(C(C(O2)CO)O)O)O)CC3=CC=C(S3)C4=CC=C(C=C4)F,PHASE1,metabolic_disease
2796,Non Familial Chylocmicronemia Syndrome (Non-FCS),Fenofibrate,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl,PHASE2,metabolic_disease
2797,Alkaptonuria,Nitisinone,C1CC(=O)C(C(=O)C1)C(=O)C2=C(C=C(C=C2)C(F)(F)F)[N+](=O)[O-],PHASE2,metabolic_disease
2798,"Gout|Arthritis, Gouty|Hyperuricemia|Gout Chronic",Allopurinol,C1=NNC2=C1C(=O)NC=N2,PHASE2,metabolic_disease
2799,Post-Bariatric Hypoglycemia,Pasireotide,C1C(CN2C1C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C2=O)CC3=CC=CC=C3)CC4=CC=C(C=C4)OCC5=CC=CC=C5)CCCCN)CC6=CNC7=CC=CC=C76)C8=CC=CC=C8)OC(=O)NCCN,PHASE2,metabolic_disease
2800,Pre-diabetes|Obesity,Salsalate,C1=CC=C(C(=C1)C(=O)OC2=CC=CC=C2C(=O)O)O,PHASE1,metabolic_disease
2801,"Diabetes Mellitus, Type 2",Vildagliptin,C1CC(N(C1)C(=O)CNC23CC4CC(C2)CC(C4)(C3)O)C#N,PHASE1|PHASE2,metabolic_disease
2802,Non-Insulin-Dependent Diabetes Mellitus|Obesity,Orlistat,CCCCCCCCCCCC(CC1C(C(=O)O1)CCCCCC)OC(=O)C(CC(C)C)NC=O,PHASE2,metabolic_disease
2803,Pompe Disease,Sirolimus,CC1CCC2CC(C(=CC=CC=CC(CC(C(=O)C(C(C(=CC(C(=O)CC(OC(=O)C3CCCCN3C(=O)C(=O)C1(O2)O)C(C)CC4CCC(C(C4)OC)O)C)C)O)OC)C)C)C)OC,PHASE1,metabolic_disease
2804,Pompe Disease,Diphenhydramine,CN(C)CCOC(C1=CC=CC=C1)C2=CC=CC=C2,PHASE1,metabolic_disease
2805,Pompe Disease,Acetaminophen,CC(=O)NC1=CC=C(C=C1)O,PHASE1,metabolic_disease
2806,Pompe Disease,Lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C,PHASE1,metabolic_disease
2807,Insulin Resistance|Diabetes Mellitus|Abnormal Glucose Metabolism,Liothyronine,C1=CC(=C(C=C1OC2=C(C=C(C=C2I)CC(C(=O)O)N)I)I)O,PHASE2,metabolic_disease
2808,Gout,Arhalofenate,CC(=O)NCCOC(=O)C(C1=CC=C(C=C1)Cl)OC2=CC=CC(=C2)C(F)(F)F,PHASE2,metabolic_disease
2809,Pompe Disease,Duvoglustat,C1C(C(C(C(N1)CO)O)O)O,PHASE2,metabolic_disease
2810,Barth Syndrome,Elamipretide,CC1=CC(=CC(=C1CC(C(=O)NC(CCCCN)C(=O)NC(CC2=CC=CC=C2)C(=O)N)NC(=O)C(CCCN=C(N)N)N)C)O,PHASE2|PHASE3,metabolic_disease
2811,Obesity,Propofol,CC(C)C1=C(C(=CC=C1)C(C)C)O,PHASE1,metabolic_disease
2812,Obesity,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,PHASE1,metabolic_disease
2813,Obesity|Hypoandrogenism,Clomifene,CCN(CC)CCOC1=CC=C(C=C1)C(=C(C2=CC=CC=C2)Cl)C3=CC=CC=C3,PHASE2,metabolic_disease
2814,Obesity|Hypoandrogenism,Clomiphene,CCN(CC)CCOC1=CC=C(C=C1)C(=C(C2=CC=CC=C2)Cl)C3=CC=CC=C3,PHASE2,metabolic_disease
2815,Hypoglycemia,Dasiglucagon,CC(C)CC(C(=O)NC(CCC(=O)O)C(=O)NC(CO)C(=O)NC(C(C)O)C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)NC(=O)C(CCCCN)NC(=O)C(C(C)C)NC(=O)C(CC3=CC=CC=C3)NC(=O)C(CCC(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(C)NC(=O)C(CCCNC(=N)N)NC(=O)C(C)NC(=O)C(C)(C)NC(=O)C(CC(=O)O)NC(=O)C(CC(C)C)NC(=O)C(CC4=CC=C(C=C4)O)NC(=O)C(CCCCN)NC(=O)C(CO)NC(=O)C(CC5=CC=C(C=C5)O)NC(=O)C(CC(=O)O)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C(CC6=CC=CC=C6)NC(=O)C(C(C)O)NC(=O)CNC(=O)C(CCC(=O)N)NC(=O)C(CO)NC(=O)C(CC7=CNC=N7)N,PHASE1,metabolic_disease
2816,Type 2 Diabetes Mellitus,Saxagliptin,C1C2CC2N(C1C#N)C(=O)C(C34CC5CC(C3)CC(C5)(C4)O)N,PHASE1,metabolic_disease
2817,"Diabetes Mellitus, Type 2",Midazolam,CC1=NC=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4F,PHASE1,metabolic_disease
2818,"Diabetes Mellitus, Type 2",Rosiglitazone,CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3,PHASE1,metabolic_disease
2819,"Diabetes Mellitus, Type 2",Flurbiprofen,CC(C1=CC(=C(C=C1)C2=CC=CC=C2)F)C(=O)O,PHASE1,metabolic_disease
2820,Frontotemporal Dementia,Methylprednisolone,CC1CC2C3CCC(C3(CC(C2C4(C1=CC(=O)C=C4)C)O)C)(C(=O)CO)O,PHASE1|PHASE2,metabolic_disease
2821,Frontotemporal Dementia,Prednisone,CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C,PHASE1|PHASE2,metabolic_disease
2822,Metastatic Colorectal Cancers|Metastatic Gastric Cancers|Metastatic Oesophageal Cancers|Metastatic Pancreatic Cancers|Metastatic Biliary Cancers|Metastatic Breast Cancers,Capecitabine,CCCCCOC(=O)NC1=NC(=O)N(C=C1F)C2C(C(C(O2)C)O)O,PHASE1,metabolic_disease
2823,Healthy Subjects,Lenomorelin,CCCCCCCC(=O)OCC(C(=O)NC(CO)C(=O)NC(CC1=CC=CC=C1)C(=O)NC(CC(C)C)C(=O)NC(CO)C(=O)N2CCCC2C(=O)NC(CCC(=O)O)C(=O)NC(CC3=CNC=N3)C(=O)NC(CCC(=O)N)C(=O)NC(CCCNC(=N)N)C(=O)NC(C(C)C)C(=O)NC(CCC(=O)N)C(=O)NC(CCC(=O)N)C(=O)NC(CCCNC(=N)N)C(=O)NC(CCCCN)C(=O)NC(CCC(=O)O)C(=O)NC(CO)C(=O)NC(CCCCN)C(=O)NC(CCCCN)C(=O)N4CCCC4C(=O)N5CCCC5C(=O)NC(C)C(=O)NC(CCCCN)C(=O)NC(CC(C)C)C(=O)NC(CCC(=O)N)C(=O)N6CCCC6C(=O)NC(CCCNC(=N)N)C(=O)O)NC(=O)CN,PHASE1,metabolic_disease
2824,Amyotrophic Lateral Sclerosis (ALS),Pimozide,C1CN(CCC1N2C3=CC=CC=C3NC2=O)CCCC(C4=CC=C(C=C4)F)C5=CC=C(C=C5)F,PHASE2,metabolic_disease
2825,"Diabetes Mellitus, Type 2",Linagliptin,CC#CCN1C2=C(N=C1N3CCCC(C3)N)N(C(=O)N(C2=O)CC4=NC5=CC=CC=C5C(=N4)C)C,PHASE2,metabolic_disease
2826,Glycogen Storage Disease Type V,Triheptanoin,CCCCCCC(=O)OCC(COC(=O)CCCCCC)OC(=O)CCCCCC,PHASE2,metabolic_disease
2827,"Niemann-Pick Disease, Type C",Adrabetadex,CC(COCC1C2CC(C(O1)OC3C(OC(C(C3O)OCC(C)O)OC4C(OC(C(C4O)O)OC5C(OC(C(C5O)O)OC6C(OC(C(C6O)O)OC7C(OC(C(C7O)O)OC8C(OC(O2)C(C8O)O)COCC(C)O)CO)COCC(C)O)CO)CO)CO)O)O,PHASE2|PHASE3,metabolic_disease
2828,Diabetes Mellitus Type 2,Roflumilast,C1CC1COC2=C(C=CC(=C2)C(=O)NC3=C(C=NC=C3Cl)Cl)OC(F)F,PHASE2,metabolic_disease
2829,Syndromic Ichthyoses|CHILD Syndrome|Smith Lemli Opitz Syndrome|Conradi Syndrome,Lovastatin,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,PHASE2,metabolic_disease
2830,Recurrent Malignant Glioma,Irinotecan,CCC1=C2CN3C(=CC4=C(C3=O)COC(=O)C4(CC)O)C2=NC5=C1C=C(C=C5)OC(=O)N6CCC(CC6)N7CCCCC7,PHASE2,metabolic_disease
2831,Thalassemia|Iron Overload|Hemochromatosis,Nifedipine,CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC,PHASE1,metabolic_disease
2832,Acute Myeloid Leukemia in Remission|de Novo Myelodysplastic Syndrome|Fanconi Anemia|Previously Treated Myelodysplastic Syndrome,Cyclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,PHASE2,metabolic_disease
2833,Acute Myeloid Leukemia in Remission|de Novo Myelodysplastic Syndrome|Fanconi Anemia|Previously Treated Myelodysplastic Syndrome,Fludarabine,C1=NC2=C(N=C(N=C2N1C3C(C(C(O3)CO)O)O)F)N,PHASE2,metabolic_disease
2834,Dyslipidemia,Muraglitazar,CC1=C(N=C(O1)C2=CC=CC=C2)CCOC3=CC=C(C=C3)CN(CC(=O)O)C(=O)OC4=CC=C(C=C4)OC,PHASE2|PHASE3,metabolic_disease
2835,"Diabetes Mellitus, Type 2",Metoprolol,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O,PHASE1,metabolic_disease
2836,"Diabetes Mellitus, Type 2",Lisinopril,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,PHASE1,metabolic_disease
2837,"Diabetes Mellitus, Type 2",Warfarin,CC(=O)CC(C1=CC=CC=C1)C2=C(C3=CC=CC=C3OC2=O)O,PHASE1,metabolic_disease
2838,"Diabetes Mellitus, Type 2",Lixisenatide,CCC(C)C(C(=O)NC(CCC(=O)O)C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(CC(C)C)C(=O)NC(CCCCN)C(=O)NC(CC(=O)N)C(=O)NCC(=O)NCC(=O)N3CCCC3C(=O)NC(CO)C(=O)NC(CO)C(=O)NCC(=O)NC(C)C(=O)N4CCCC4C(=O)N5CCCC5C(=O)NC(CO)C(=O)NC(CCCCN)C(=O)NC(CCCCN)C(=O)NC(CCCCN)C(=O)NC(CCCCN)C(=O)NC(CCCCN)C(=O)NC(CCCCN)C(=O)N)NC(=O)C(CC6=CC=CC=C6)NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(C(C)C)NC(=O)C(C)NC(=O)C(CCC(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(CCSC)NC(=O)C(CCC(=O)N)NC(=O)C(CCCCN)NC(=O)C(CO)NC(=O)C(CC(C)C)NC(=O)C(CC(=O)O)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C(CC7=CC=CC=C7)NC(=O)C(C(C)O)NC(=O)CNC(=O)C(CCC(=O)O)NC(=O)CNC(=O)C(CC8=CNC=N8)N,PHASE1,metabolic_disease
2839,"Diabetes Mellitus, Type 2",Donepezil,COC1=C(C=C2C(=C1)CC(C2=O)CC3CCN(CC3)CC4=CC=CC=C4)OC,PHASE2,metabolic_disease
2840,HIV Infections|Cachexia|Anorexia|AIDS Wasting Syndrome|HIV Wasting Syndrome,Megestrol,CC1=CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C,PHASE2,metabolic_disease
2841,Venous Thromboembolism|Deep Venous Thrombosis|Pulmonary Embolus|Reconstructive Surgery,Enoxaparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,PHASE2,metabolic_disease
2842,Restless Legs Syndrome,Ropinirole,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1,PHASE1,metabolic_disease
2843,End Stage Renal Disease,Cholecalciferol,CC(C)CCCC(C)C1CCC2C1(CCCC2=CC=C3CC(CCC3=C)O)C,PHASE2|PHASE3,metabolic_disease
2844,"Diabetes Mellitus, Type II",Lobeglitazone,CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC(=NC=N3)OC4=CC=C(C=C4)OC,PHASE1,metabolic_disease
2845,Glucocorticoid-Associated Osteopenia and Osteoporosis,Alendronate,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,PHASE2|PHASE3,metabolic_disease
2846,Chronic Diarrhea|Irritable Bowel Syndrome With Diarrhea|Bile Acid Malabsorption,Colesevelam,CCCCCCCCCCNCC=C.C[N+](C)(C)CCCCCCNCC=C.C=CCN.C1C(O1)CCl.Cl.[Cl-],PHASE2,metabolic_disease
2847,Type 2 Diabetes Mellitus|Healthy Subjects,Sotagliflozin,CCOC1=CC=C(C=C1)CC2=C(C=CC(=C2)C3C(C(C(C(O3)SC)O)O)O)Cl,PHASE1,metabolic_disease
2848,Hypercholesteremia,Gemcabene,CC(C)(CCCCOCCCCC(C)(C)C(=O)O)C(=O)O,PHASE2,metabolic_disease
2849,"Diabetes Mellitus, Type 2",Ertugliflozin,CCOC1=CC=C(C=C1)CC2=C(C=CC(=C2)C34C(C(C(C(O3)(CO4)CO)O)O)O)Cl,PHASE2,metabolic_disease
2850,Obesity|Overweight|Overnutrition,Betahistine,CNCCC1=CC=CC=N1,PHASE1,metabolic_disease
2851,"Adrenal Hyperplasia, Congenital",Hydrocortisone,CC12CCC(=O)C=C1CCC3C2C(CC4(C3CCC4(C(=O)CO)O)C)O,PHASE2,metabolic_disease
2852,Hypertension|Hyperlipidemia,Fimasartan,CCCCC1=NC(=C(C(=O)N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CC(=S)N(C)C)C,PHASE1,metabolic_disease
2853,Metabolic Syndrome,Psyllium,CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC(=O)O,PHASE2,metabolic_disease
2854,Metabolic Acidosis,Meglumine,CNCC(C(C(C(CO)O)O)O)O,PHASE2,metabolic_disease
2855,Diabetes,Nesiritide,CCC(C)C1C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NCC(=O)NC(C(=O)NCC(=O)NC(CSSCC(C(=O)NC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCNC(=N)N)CC(=O)O)CCSC)CCCCN)CCCNC(=N)N)CC2=CC=CC=C2)NC(=O)CNC(=O)C(CO)NC(=O)CNC(=O)C(CCC(=O)N)NC(=O)C(C(C)C)NC(=O)C(CCSC)NC(=O)C(CCCCN)NC(=O)C3CCCN3C(=O)C(CO)N)C(=O)NC(CCCCN)C(=O)NC(C(C)C)C(=O)NC(CC(C)C)C(=O)NC(CCCNC(=N)N)C(=O)NC(CCCNC(=N)N)C(=O)NC(CC4=CN=CN4)C(=O)O)CC(C)C)CO)CO)CO)CO,PHASE1,metabolic_disease
2856,Triple Negative Breast Cancer|TNBC - Triple-Negative Breast Cancer,Paclitaxel,CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C,PHASE2,metabolic_disease
2857,Phenylketonuria,Sapropterin,CC(C(C1CNC2=C(N1)C(=O)NC(=N2)N)O)O,PHASE2,metabolic_disease
2858,Phenylketonuria,Tetrahydrobiopterin,CC(C(C1CNC2=C(N1)C(=O)NC(=N2)N)O)O,PHASE2,metabolic_disease
2859,Adenocarcinoma of the Prostate|Recurrent Prostate Cancer|Stage III Prostate Cancer|Stage IV Prostate Cancer,Enzalutamide,CC1(C(=O)N(C(=S)N1C2=CC(=C(C=C2)C(=O)NC)F)C3=CC(=C(C=C3)C#N)C(F)(F)F)C,PHASE2,metabolic_disease
2860,Amyloidosis,Idelalisib,CCC(C1=NC2=C(C(=CC=C2)F)C(=O)N1C3=CC=CC=C3)NC4=NC=NC5=C4NC=N5,PHASE2,metabolic_disease
2861,Prematurity|Iron-deficiency|Iron Deficiency Anemia|Iron Malabsorption,Ferumoxytol,O[Fe]=O.O[Fe]=O.[Fe],PHASE2,metabolic_disease
2862,HIV Infections|Non-Alcoholic Fatty Liver Disease,Semaglutide,CCC(C)C(C(=O)NC(C)C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(CC(C)C)C(=O)NC(C(C)C)C(=O)NC(CCCNC(=N)N)C(=O)NCC(=O)NC(CCCNC(=N)N)C(=O)NCC(=O)O)NC(=O)C(CC3=CC=CC=C3)NC(=O)C(CCC(=O)O)NC(=O)C(CCCCNC(=O)COCCOCCNC(=O)COCCOCCNC(=O)CCC(C(=O)O)NC(=O)CCCCCCCCCCCCCCCCC(=O)O)NC(=O)C(C)NC(=O)C(C)NC(=O)C(CCC(=O)N)NC(=O)CNC(=O)C(CCC(=O)O)NC(=O)C(CC(C)C)NC(=O)C(CC4=CC=C(C=C4)O)NC(=O)C(CO)NC(=O)C(CO)NC(=O)C(C(C)C)NC(=O)C(CC(=O)O)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C(CC5=CC=CC=C5)NC(=O)C(C(C)O)NC(=O)CNC(=O)C(CCC(=O)O)NC(=O)C(C)(C)NC(=O)C(CC6=CN=CN6)N,PHASE2,metabolic_disease
2863,Type 1 Diabetes,Glucagon,CC(C)CC(C(=O)NC(CCSC)C(=O)NC(CC(=O)N)C(=O)NC(C(C)O)C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)NC(=O)C(CCC(=O)N)NC(=O)C(C(C)C)NC(=O)C(CC3=CC=CC=C3)NC(=O)C(CC(=O)O)NC(=O)C(CCC(=O)N)NC(=O)C(C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C(CC(=O)O)NC(=O)C(CC(C)C)NC(=O)C(CC4=CC=C(C=C4)O)NC(=O)C(CCCCN)NC(=O)C(CO)NC(=O)C(CC5=CC=C(C=C5)O)NC(=O)C(CC(=O)O)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C(CC6=CC=CC=C6)NC(=O)C(C(C)O)NC(=O)CNC(=O)C(CCC(=O)N)NC(=O)C(CO)NC(=O)C(CC7=CN=CN7)N,PHASE2,metabolic_disease
2864,Amyotrophic Lateral Sclerosis,Riluzole,C1=CC2=C(C=C1OC(F)(F)F)SC(=N2)N,PHASE2|PHASE3,metabolic_disease
2865,Obesity|Insulin Resistance,Telmisartan,CCCC1=NC2=C(N1CC3=CC=C(C=C3)C4=CC=CC=C4C(=O)O)C=C(C=C2C)C5=NC6=CC=CC=C6N5C,PHASE2,metabolic_disease
2866,Acquired Hypogonadotropic Hypogonadism|Obesity,Enclomiphene,CCN(CC)CCOC1=CC=C(C=C1)C(=C(C2=CC=CC=C2)Cl)C3=CC=CC=C3,PHASE2,metabolic_disease
2867,Friedreich Ataxia,Etravirine,CC1=CC(=CC(=C1OC2=NC(=NC(=C2Br)N)NC3=CC=C(C=C3)C#N)C)C#N,PHASE2,metabolic_disease
2868,Amyotrophic Lateral Sclerosis,Memantine,CC12CC3CC(C1)(CC(C3)(C2)N)C,PHASE2|PHASE3,metabolic_disease
2869,X-Linked Adrenoleukodystrophy,Sobetirome,CC1=CC(=CC(=C1CC2=CC(=C(C=C2)O)C(C)C)C)OCC(=O)O,PHASE1|PHASE2,metabolic_disease
2870,Glycogen Storage Disease Type V|McArdle Disease,Valproate,CCCC(CCC)C(=O)O,PHASE2,metabolic_disease
2871,Type 2 Diabetes,Tesaglitazar,CCOC(CC1=CC=C(C=C1)OCCC2=CC=C(C=C2)OS(=O)(=O)C)C(=O)O,PHASE2,metabolic_disease
2872,Type 1 Diabetes,Eflornithine,C(CC(C(F)F)(C(=O)O)N)CN,PHASE1,metabolic_disease
2873,"Diabetes Mellitus, Type 2",Tadalafil,CN1CC(=O)N2C(C1=O)CC3=C(C2C4=CC5=C(C=C4)OCO5)NC6=CC=CC=C36,PHASE2,metabolic_disease
2874,Menkes Disease|Occipital Horn Syndrome,Droxidopa,C1=CC(=C(C=C1C(C(C(=O)O)N)O)O)O,PHASE1|PHASE2,metabolic_disease
2875,Mucopolysaccharidosis I,Azathioprine,CN1C=NC(=C1SC2=NC=NC3=C2NC=N3)[N+](=O)[O-],PHASE1|PHASE2,metabolic_disease
2876,Atherosclerosis|Heterozygous Familial Hypercholesterolemia,Pactimibe,CCCCCCCCN1CCC2=C(C(=C(C(=C21)NC(=O)C(C)(C)C)C)CC(=O)O)C,PHASE2|PHASE3,metabolic_disease
2877,Chronic Kidney Disease|Type 2 Diabetes|Diabetic Nephropathy,Bardoxolone,CC1(CCC2(CCC3(C(C2C1)C(=O)C=C4C3(CCC5C4(C=C(C(=O)C5(C)C)C#N)C)C)C)C(=O)O)C,PHASE2,metabolic_disease
2878,Heart Failure,Finerenone,CCOC1=NC=C(C2=C1C(C(=C(N2)C)C(=O)N)C3=C(C=C(C=C3)C#N)OC)C,PHASE2,metabolic_disease
2879,Heart Failure,Eplerenone,CC12CCC(=O)C=C1CC(C3C24C(O4)CC5(C3CCC56CCC(=O)O6)C)C(=O)OC,PHASE2,metabolic_disease
2880,Metabolic Syndrome,Melatonin,CC(=O)NCCC1=CNC2=C1C=C(C=C2)OC,PHASE2,metabolic_disease
2881,Hyperlipoproteinemia,Coenzyme A,CC(C)(COP(=O)(O)OP(=O)(O)OCC1C(C(C(O1)N2C=NC3=C(N=CN=C32)N)O)OP(=O)(O)O)C(C(=O)NCCC(=O)NCCS)O,PHASE2|PHASE3,metabolic_disease
2882,"Diabetes Mellitus, Type 2",Dorzagliatin,CC(C)CC(C(=O)NC1=NN(C=C1)CC(CO)O)N2CC(=CC2=O)OC3=CC=CC=C3Cl,PHASE2,metabolic_disease
2883,"Diabetes Mellitus, Type 2",Ranolazine,CC1=C(C(=CC=C1)C)NC(=O)CN2CCN(CC2)CC(COC3=CC=CC=C3OC)O,PHASE2,metabolic_disease
2884,Schizophrenia|Schizoaffective Disorder,Ziprasidone,C1CN(CCN1CCC2=C(C=C3C(=C2)CC(=O)N3)Cl)C4=NSC5=CC=CC=C54,PHASE2|PHASE3,metabolic_disease
2885,Sepsis|Hypoperfusion|Hyperlactatemia,Dobutamine,CC(CCC1=CC=C(C=C1)O)NCCC2=CC(=C(C=C2)O)O,PHASE2,metabolic_disease
2886,Type 1 Diabetes,Bromocriptine,CC(C)CC1C(=O)N2CCCC2C3(N1C(=O)C(O3)(C(C)C)NC(=O)C4CN(C5CC6=C(NC7=CC=CC(=C67)C5=C4)Br)C)O,PHASE2,metabolic_disease
2887,Post Menopausal Osteoporosis,Abaloparatide,CCC(C)C(C(=O)NC(CCC(=O)N)C(=O)NC(CC(=O)O)C(=O)NC(CC(C)C)C(=O)NC(CCCNC(=N)N)C(=O)NC(CCCNC(=N)N)C(=O)NC(CCCNC(=N)N)C(=O)NC(CCC(=O)O)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(CCC(=O)O)C(=O)NC(CCCCN)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(C)(C)C(=O)NC(CCCCN)C(=O)NC(CC(C)C)C(=O)NC(CC1=CN=CN1)C(=O)NC(C(C)O)C(=O)NC(C)C(=O)N)NC(=O)C(CO)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CCCCN)NC(=O)C(CC(=O)O)NC(=O)C(CC2=CN=CN2)NC(=O)C(CC(C)C)NC(=O)C(CC(C)C)NC(=O)C(CCC(=O)N)NC(=O)C(CC3=CN=CN3)NC(=O)C(CCC(=O)O)NC(=O)C(CO)NC(=O)C(C(C)C)NC(=O)C(C)N,PHASE2,metabolic_disease
2888,Adrenal Insufficiency,Dexamethasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,PHASE1,metabolic_disease
2889,Arterial Hypertension|Diabetes|Hypokalemia|Hyponatremia,Cicletanine,CC1=NC=C2C(OCC2=C1O)C3=CC=C(C=C3)Cl,PHASE1|PHASE2,metabolic_disease
2890,"Diabetes Mellitus, Type 2",Acarbose,CC1C(C(C(C(O1)OC2C(OC(C(C2O)O)OC3C(OC(C(C3O)O)O)CO)CO)O)O)NC4C=C(C(C(C4O)O)O)CO,PHASE1,metabolic_disease
2891,Metabolic Syndrome,Goserelin,CC(C)CC(C(=O)NC(CCCN=C(N)N)C(=O)N1CCCC1C(=O)NNC(=O)N)NC(=O)C(COC(C)(C)C)NC(=O)C(CC2=CC=C(C=C2)O)NC(=O)C(CO)NC(=O)C(CC3=CNC4=CC=CC=C43)NC(=O)C(CC5=CN=CN5)NC(=O)C6CCC(=O)N6,PHASE1,metabolic_disease
2892,Metabolic Syndrome,Anastrozole,CC(C)(C#N)C1=CC(=CC(=C1)CN2C=NC=N2)C(C)(C)C#N,PHASE1,metabolic_disease
2893,Osteoporosis,Ibandronate,CCCCCN(C)CCC(O)(P(=O)(O)O)P(=O)(O)O,PHASE2,metabolic_disease
2894,Fanconi Anemia|Squamous Cell Carcinoma,Quercetin,C1=CC(=C(C=C1C2=C(C(=O)C3=C(C=C(C=C3O2)O)O)O)O)O,PHASE2,metabolic_disease
2895,Type 1 Diabetes Mellitus,Lisofylline,CC(CCCCN1C(=O)C2=C(N=CN2C)N(C1=O)C)O,PHASE1|PHASE2,metabolic_disease
2896,Gestational Diabetes Mellitus,Isoxaflutole,CS(=O)(=O)C1=C(C=CC(=C1)C(F)(F)F)C(=O)C2=C(ON=C2)C3CC3,PHASE2,metabolic_disease
2897,Friedreich Ataxia,Artesunate,CC1CCC2C(C(OC3C24C1CCC(O3)(OO4)C)OC(=O)CCC(=O)O)C,PHASE1|PHASE2,metabolic_disease
2898,Type 2 Diabetes Mellitus,Tirzepatide,CCC(C)C(C(=O)NC(C)C(=O)NC(CCC(=O)N)C(=O)NC(CCCCNC(=O)COCCOCCNC(=O)COCCOCCNC(=O)CCC(C(=O)O)NC(=O)CCCCCCCCCCCCCCCCCCC(=O)O)C(=O)NC(C)C(=O)NC(CC1=CC=CC=C1)C(=O)NC(C(C)C)C(=O)NC(CCC(=O)N)C(=O)NC(CC2=CNC3=CC=CC=C32)C(=O)NC(CC(C)C)C(=O)NC(C(C)CC)C(=O)NC(C)C(=O)NCC(=O)NCC(=O)N4CCCC4C(=O)NC(CO)C(=O)NC(CO)C(=O)NCC(=O)NC(C)C(=O)N5CCCC5C(=O)N6CCCC6C(=O)N7CCCC7C(=O)NC(CO)C(=O)N)NC(=O)C(CCCCN)NC(=O)C(CC(=O)O)NC(=O)C(CC(C)C)NC(=O)C(C)(C)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(CC8=CC=C(C=C8)O)NC(=O)C(CC(=O)O)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C(CC9=CC=CC=C9)NC(=O)C(C(C)O)NC(=O)CNC(=O)C(CCC(=O)O)NC(=O)C(C)(C)NC(=O)C(CC1=CC=C(C=C1)O)N,PHASE1,metabolic_disease
2899,Iron Deficiency Anemia,Lactoferrin,CCC(C)C(C(=NC(C(C)O)C(=NC(CS)C(=NC(C(C)C)C(=NC(CCCNC(=N)N)C(=NC(CCCNC(=N)N)C(=NC(C)C(=NC(CC1=CC=CC=C1)C(=O)O)O)O)O)O)O)O)O)N=C(C(CO)N=C(C2CCCN2C(=O)C(C)N=C(CN=C(C(CC(C)C)N=C(C(CCCCN)N=C(C(CCCCN)N=C(C(CCSC)N=C(C(CCCNC(=N)N)N=C(C(CC3=CNC4=CC=CC=C43)N=C(C(CCC(=N)O)N=C(C(CC5=CNC6=CC=CC=C65)N=C(C(CCCNC(=N)N)N=C(C(CCCNC(=N)N)N=C(C(CS)N=C(C(CCCCN)N=C(C(CC7=CC=CC=C7)N)O)O)O)O)O)O)O)O)O)O)O)O)O)O)O)O,PHASE2|PHASE3,metabolic_disease
2900,Type 1 Diabetes|Diabetic Kidney Disease|Cardiovascular Diseases|Endothelial Dysfunction|Insulin Sensitivity,Iohexol,CC(=O)N(CC(CO)O)C1=C(C(=C(C(=C1I)C(=O)NCC(CO)O)I)C(=O)NCC(CO)O)I,PHASE1,metabolic_disease
2901,Amyotrophic Lateral Sclerosis (ALS),Olanzapine,CC1=CC2=C(S1)NC3=CC=CC=C3N=C2N4CCN(CC4)C,PHASE2|PHASE3,metabolic_disease
2902,Amyotrophic Lateral Sclerosis (ALS),Tamoxifen,CCC(=C(C1=CC=CC=C1)C2=CC=C(C=C2)OCCN(C)C)C3=CC=CC=C3,PHASE2,metabolic_disease
2903,Pre-Diabetes,Vancomycin,CC1C(C(CC(O1)OC2C(C(C(OC2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)C(C(C(=O)NC(C(=O)NC5C(=O)NC7C8=CC(=C(C=C8)O)C9=C(C=C(C=C9O)O)C(NC(=O)C(C(C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)CC(=O)N)NC(=O)C(CC(C)C)NC)O)Cl)CO)O)O)(C)N)O,PHASE2,metabolic_disease
2904,Pre-Diabetes,Neomycin,C1C(C(C(C(C1N)OC2C(C(C(C(O2)CN)O)O)N)OC3C(C(C(O3)CO)OC4C(C(C(C(O4)CN)O)O)N)O)O)N,PHASE2,metabolic_disease
2905,Pre-Diabetes,Clindamycin,CCCC1CC(N(C1)C)C(=O)NC(C2C(C(C(C(O2)SC)O)O)O)C(C)Cl,PHASE2,metabolic_disease
2906,"Diabetes Mellitus, Type 2",Albiglutide,CCC(C)C(C(=O)NC(C)C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(CC(C)C)C(=O)NC(C(C)C)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCNC(=N)N)C(=O)N)NC(=O)C(CC3=CC=CC=C3)NC(=O)C(CCC(=O)O)NC(=O)C(CCCCN)NC(=O)C(C)NC(=O)C(C)NC(=O)C(CCC(=O)N)NC(=O)CNC(=O)C(CCC(=O)O)NC(=O)C(CC(C)C)NC(=O)C(CC4=CC=C(C=C4)O)NC(=O)C(CO)NC(=O)C(CO)NC(=O)C(C(C)C)NC(=O)C(CC(=O)O)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C(CC5=CC=CC=C5)NC(=O)C(C(C)O)NC(=O)CNC(=O)C(CCC(=O)O)NC(=O)CNC(=O)C(CC6=CN=CN6)N,PHASE1,metabolic_disease
2907,"Diabetes Mellitus, Type 2",Moxifloxacin,COC1=C2C(=CC(=C1N3CC4CCCNC4C3)F)C(=O)C(=CN2C5CC5)C(=O)O,PHASE1,metabolic_disease
2908,Hypertriglyceridemia|Obesity,Setmelanotide,CC1C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(C(=O)N1)NC(=O)C(CCCN=C(N)N)NC(=O)C)C(=O)N)CC2=CNC3=CC=CC=C32)CCCN=C(N)N)CC4=CC=CC=C4)CC5=CN=CN5,PHASE2,metabolic_disease
2909,Hyperlipidemias,Teduglutide,CCC(C)C(C(=O)NC(C(C)O)C(=O)NC(CC(=O)O)C(=O)O)NC(=O)C(CCCCN)NC(=O)C(C(C)O)NC(=O)C(CCC(=O)N)NC(=O)C(C(C)CC)NC(=O)C(CC(C)C)NC(=O)C(CC1=CNC2=CC=CC=C21)NC(=O)C(CC(=O)N)NC(=O)C(C(C)CC)NC(=O)C(CC3=CC=CC=C3)NC(=O)C(CC(=O)O)NC(=O)C(CCCNC(=N)N)NC(=O)C(C)NC(=O)C(C)NC(=O)C(CC(C)C)NC(=O)C(CC(=O)N)NC(=O)C(CC(=O)O)NC(=O)C(CC(C)C)NC(=O)C(C(C)CC)NC(=O)C(C(C)O)NC(=O)C(CC(=O)N)NC(=O)C(CCSC)NC(=O)C(CCC(=O)O)NC(=O)C(CC(=O)O)NC(=O)C(CO)NC(=O)C(CC4=CC=CC=C4)NC(=O)C(CO)NC(=O)CNC(=O)C(CC(=O)O)NC(=O)CNC(=O)C(CC5=CN=CN5)N,PHASE2|PHASE3,metabolic_disease
2910,Osteoporosis,Odanacatib,CC(C)(CC(C(=O)NC1(CC1)C#N)NC(C2=CC=C(C=C2)C3=CC=C(C=C3)S(=O)(=O)C)C(F)(F)F)F,PHASE1,metabolic_disease
2911,Polycystic Ovary Syndrome,Mirabegron,C1=CC=C(C=C1)C(CNCCC2=CC=C(C=C2)NC(=O)CC3=CSC(=N3)N)O,PHASE1,metabolic_disease
2912,Hepatitis C|Diabetes Mellitus|Insulin Resistance,Daclatasvir,CC(C)C(C(=O)N1CCCC1C2=NC=C(N2)C3=CC=C(C=C3)C4=CC=C(C=C4)C5=CN=C(N5)C6CCCN6C(=O)C(C(C)C)NC(=O)OC)NC(=O)OC,PHASE1,metabolic_disease
2913,21-hydroxylase Deficiency,Abiraterone,CC12CCC(CC1=CCC3C2CCC4(C3CC=C4C5=CN=CC=C5)C)O,PHASE1,metabolic_disease
2914,Hormone-Resistant Prostate Cancer|Metastatic Prostate Carcinoma|Recurrent Prostate Carcinoma|Stage IV Prostate Cancer,Carboplatin,C1CC(C1)(C(=O)O)C(=O)O.[NH2-].[NH2-].[Pt+2],PHASE2,metabolic_disease
2915,Hormone-Resistant Prostate Cancer|Metastatic Prostate Carcinoma|Recurrent Prostate Carcinoma|Stage IV Prostate Cancer,Docetaxel,CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O,PHASE2,metabolic_disease
2916,Primary Hypercholesterolemia,Eprotirome,CC(C)C1=C(C=CC(=C1)OC2=C(C=C(C=C2Br)NC(=O)CC(=O)O)Br)O,PHASE2,metabolic_disease
2917,Hermansky-Pudlak Syndrome (HPS)|Pulmonary Fibrosis|Oculocutaneous Albinism|Platelet Storage Pool Deficiency|Metabolic Disease,Losartan,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl,PHASE1|PHASE2,metabolic_disease
2918,Hermansky-Pudlak Syndrome (HPS)|Pulmonary Fibrosis|Oculocutaneous Albinism|Platelet Storage Pool Deficiency|Metabolic Disease,Zileuton,CC(C1=CC2=CC=CC=C2S1)N(C(=O)N)O,PHASE1|PHASE2,metabolic_disease
2919,Hermansky-Pudlak Syndrome (HPS)|Pulmonary Fibrosis|Oculocutaneous Albinism|Platelet Storage Pool Deficiency|Metabolic Disease,Acetylcysteine,CC(=O)NC(CS)C(=O)O,PHASE1|PHASE2,metabolic_disease
2920,Hermansky-Pudlak Syndrome (HPS)|Pulmonary Fibrosis|Oculocutaneous Albinism|Platelet Storage Pool Deficiency|Metabolic Disease,Pravastatin,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O,PHASE1|PHASE2,metabolic_disease
2921,Hermansky-Pudlak Syndrome (HPS)|Pulmonary Fibrosis|Oculocutaneous Albinism|Platelet Storage Pool Deficiency|Metabolic Disease,Erythromycin,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)O)(C)O,PHASE1|PHASE2,metabolic_disease
2922,Alzheimer Disease,Azeliragon,CCCCC1=NC(=CN1C2=CC=C(C=C2)OC3=CC=C(C=C3)Cl)C4=CC=C(C=C4)OCCCN(CC)CC,PHASE2,metabolic_disease
2923,Metabolic Syndrome,Aspirin,CC(=O)OC1=CC=CC=C1C(=O)O,PHASE2,metabolic_disease
2924,Pmm2-CDG|CDG1A,Acetazolamide,CC(=O)NC1=NN=C(S1)S(=O)(=O)N,PHASE2|PHASE3,metabolic_disease
2925,Hyperlipidemia|Hypertension,Valsartan,CCCCC(=O)N(CC1=CC=C(C=C1)C2=CC=CC=C2C3=NNN=N3)C(C(C)C)C(=O)O,PHASE1,metabolic_disease
2926,Osteopenia|Osteoporosis,Pamidronate,C(CN)C(O)(P(=O)(O)O)P(=O)(O)O,PHASE2,metabolic_disease
2927,ALS (Amyotrophic Lateral Sclerosis),Lunasine,CC(C)C1CC2=C(C3=C(C(=CC=C3)OC)[N+](=C2O1)C)OC,PHASE2,metabolic_disease
2928,Acute Liver Failure|Fulminant Hepatic Failure|Hepatic Encephalopathy|Acute Liver Injury|Immune Dysregulation,Prednisolone,CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O,PHASE2,metabolic_disease
2929,Fanconi Anemia|Severe Marrow Failure|Myelodysplastic Syndrome (MDS)|Acute Myelogenous Leukemia (AML),Busulfan,CS(=O)(=O)OCCCCOS(=O)(=O)C,PHASE2,metabolic_disease
2930,Coronary Artery Disease,Gefarnate,CC(=CCCC(=CCCC(=CCCC(=O)OCC=C(C)CCC=C(C)C)C)C)C,PHASE2|PHASE3,metabolic_disease
2931,Diabete Type 2|Cataract|Triamcinolone Acetonide|Intravitreal Injection,Triamcinolone,CC12CC(C3(C(C1CC(C2(C(=O)CO)O)O)CCC4=CC(=O)C=CC43C)F)O,PHASE2|PHASE3,metabolic_disease
2932,Wilson Disease,Tetrathiomolybdate,[SH-].[SH-].S=[Mo]=S,PHASE2,metabolic_disease
2933,HIV/AIDS|HIV-1-infection|Osteopenia,Dolutegravir,CC1CCOC2N1C(=O)C3=C(C(=O)C(=CN3C2)C(=O)NCC4=C(C=C(C=C4)F)F)O,PHASE2,metabolic_disease
2934,Dyslipidemias|High Cholesterol|Hypercholesterolemia,Obicetrapib,CCC1CC(C2=C(N1C(=O)OCC)C=CC(=C2)C(F)(F)F)N(CC3=CC(=CC(=C3)C(F)(F)F)C(F)(F)F)C4=NC=C(C=N4)OCCCC(=O)O,PHASE2,metabolic_disease
2935,Cerebral Amyloid Angiopathy,Minocycline,CN(C)C1C2CC3CC4=C(C=CC(=C4C(=C3C(=O)C2(C(=C(C1=O)C(=O)N)O)O)O)O)N(C)C,PHASE1|PHASE2,metabolic_disease
2936,Cachexia; Cancer|Anorexia,Mirtazapine,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4,PHASE2,metabolic_disease
2937,Metabolic Syndrome,Diltiazem,CC(=O)OC1C(SC2=CC=CC=C2N(C1=O)CCN(C)C)C3=CC=C(C=C3)OC,PHASE1|PHASE2,metabolic_disease
2938,Osteoporosis,Ketoconazole,CC(=O)N1CCN(CC1)C2=CC=C(C=C2)OCC3COC(O3)(CN4C=CN=C4)C5=C(C=C(C=C5)Cl)Cl,PHASE1,metabolic_disease
2939,Type 2 Diabetes Mellitus,Bumetanide,CCCCNC1=C(C(=CC(=C1)C(=O)O)S(=O)(=O)N)OC2=CC=CC=C2,PHASE1,metabolic_disease
2940,Wilson Disease,Bupropion,CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C,PHASE1,metabolic_disease
2941,"Diabetes Mellitus, Type 2",Glipizide,CC1=CN=C(C=N1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCCCC3,PHASE1,metabolic_disease
2942,Beta-Thalassemia,Deferitrin,CC1(CSC(=N1)C2=C(C=C(C=C2)O)O)C(=O)O,PHASE1|PHASE2,metabolic_disease
2943,Osteoporosis,Teriparatide,CCC(C)C(C(=O)NC(CCC(=O)N)C(=O)NC(CC(C)C)C(=O)NC(CCSC)C(=O)NC(CC1=CNC=N1)C(=O)NC(CC(=O)N)C(=O)NC(CC(C)C)C(=O)NCC(=O)NC(CCCCN)C(=O)NC(CC2=CNC=N2)C(=O)NC(CC(C)C)C(=O)NC(CC(=O)N)C(=O)NC(CO)C(=O)NC(CCSC)C(=O)NC(CCC(=O)O)C(=O)NC(CCCNC(=N)N)C(=O)NC(C(C)C)C(=O)NC(CCC(=O)O)C(=O)NC(CC3=CNC4=CC=CC=C43)C(=O)NC(CC(C)C)C(=O)NC(CCCNC(=N)N)C(=O)NC(CCCCN)C(=O)NC(CCCCN)C(=O)NC(CC(C)C)C(=O)NC(CCC(=O)N)C(=O)NC(CC(=O)O)C(=O)NC(C(C)C)C(=O)NC(CC5=CNC=N5)C(=O)NC(CC(=O)N)C(=O)NC(CC6=CC=CC=C6)C(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(CO)NC(=O)C(C(C)C)NC(=O)C(CO)N,PHASE1,metabolic_disease
2944,Secondary Hyperparathyroidism,Etelcalcetide,CC(C(=O)NC(CCCN=C(N)N)C(=O)N)NC(=O)C(CCCN=C(N)N)NC(=O)C(CCCN=C(N)N)NC(=O)C(CCCN=C(N)N)NC(=O)C(C)NC(=O)C(CSSCC(C(=O)O)N)NC(=O)C,PHASE2,metabolic_disease
2945,Amyotrophic Lateral Sclerosis,Verdiperstat,CC(C)OCCN1C2=C(C(=O)NC1=S)NC=C2,PHASE2|PHASE3,metabolic_disease
2946,Anatomic Stage IV Breast Cancer AJCC v8|Invasive Breast Lobular Carcinoma|Metastatic Breast Lobular Carcinoma|Prognostic Stage IV Breast Cancer AJCC v8,Fluciclovine,C1C(CC1(C(=O)O)N)F,PHASE1,metabolic_disease
2947,MELAS Syndrome,Idebenone,CC1=C(C(=O)C(=C(C1=O)OC)OC)CCCCCCCCCCO,PHASE2,metabolic_disease
2948,Hyponatremia,Tolvaptan,CC1=CC=CC=C1C(=O)NC2=CC(=C(C=C2)C(=O)N3CCCC(C4=C3C=CC(=C4)Cl)O)C,PHASE2,metabolic_disease
2949,Diabetes,Ramipril,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCC3CC2C(=O)O,PHASE2|PHASE3,metabolic_disease
2950,Diabetes,Candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,PHASE2|PHASE3,metabolic_disease
2951,REM Sleep Behavior Disorder|Parkinson Disease|Synucleinopathies,Rasagiline,C#CCNC1CCC2=CC=CC=C12,PHASE2|PHASE3,metabolic_disease
2952,Transfusional Iron Overload|Transfusional Hemosiderosis,Deferasirox,C1=CC=C(C(=C1)C2=NN(C(=N2)C3=CC=CC=C3O)C4=CC=C(C=C4)C(=O)O)O,PHASE2,metabolic_disease
2953,Transfusional Iron Overload|Transfusional Hemosiderosis,Deferoxamine,CC(=O)N(CCCCCNC(=O)CCC(=O)N(CCCCCNC(=O)CCC(=O)N(CCCCCN)O)O)O,PHASE2,metabolic_disease
2954,NASH - Nonalcoholic Steatohepatitis|NAFLD|T2DM (Type 2 Diabetes Mellitus),Omeprazole,CC1=CN=C(C(=C1OC)C)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC,PHASE2,metabolic_disease
2955,Multiple Myeloma|Myeloma-Associated Amyloidosis,Selinexor,C1=CN=C(C=N1)NNC(=O)C=CN2C=NC(=N2)C3=CC(=CC(=C3)C(F)(F)F)C(F)(F)F,PHASE2,metabolic_disease
2956,Multiple Myeloma|Myeloma-Associated Amyloidosis,Lenalidomide,C1CC(=O)NC(=O)C1N2CC3=C(C2=O)C=CC=C3N,PHASE2,metabolic_disease
2957,Lynch Syndrome|Colon Cancer|Colon Neoplasm,Mesalazine,C1=CC(=C(C=C1N)C(=O)O)O,PHASE2,metabolic_disease
2958,Lynch Syndrome|Colon Cancer|Colon Neoplasm,Mesalamine,C1=CC(=C(C=C1N)C(=O)O)O,PHASE2,metabolic_disease
2959,Prediabetic State|Non-alcoholic Fatty Liver Disease|Type 2 Diabetes Mellitus,Cenicriviroc,CCCCOCCOC1=CC=C(C=C1)C2=CC3=C(C=C2)N(CCCC(=C3)C(=O)NC4=CC=C(C=C4)S(=O)CC5=CN=CN5CCC)CC(C)C,PHASE2,metabolic_disease
2960,NAFLD|TYPE 2 DIABETES|METABOLIC SYNDROME,Resveratrol,C1=CC(=CC=C1C=CC2=CC(=CC(=C2)O)O)O,PHASE2|PHASE3,metabolic_disease
2961,"Diabetes Mellitus, Type 2|Diabetic Cardiomyopathies",Trimetazidine,COC1=C(C(=C(C=C1)CN2CCNCC2)OC)OC,PHASE2,metabolic_disease
2962,"Acute Lymphoblastic Leukemia|Leukemia, Acute Myeloid (AML), Child|Lymphoma, Non-Hodgkin|Myelodysplastic Syndromes|Primary Immunodeficiency|Anemia, Aplastic|Hemoglobinopathies|Cytopenia|Fanconi Anemia|Diamond Blackfan Anemia|Thalassemia|Anemia, Sickle Cell",Rimiducid,CCC(C1=CC(=C(C(=C1)OC)OC)OC)C(=O)N2CCCCC2C(=O)OC(CCC3=CC(=C(C=C3)OC)OC)C4=CC(=CC=C4)OCC(=O)NCCNC(=O)COC5=CC=CC(=C5)C(CCC6=CC(=C(C=C6)OC)OC)OC(=O)C7CCCCN7C(=O)C(CC)C8=CC(=C(C(=C8)OC)OC)OC,PHASE1|PHASE2,metabolic_disease
2963,Diabetes Mellitus Type 2 With Hyperglycemia,Hydroxychloroquine,CCN(CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl)CCO,PHASE2,metabolic_disease
2964,Type 2 Diabetes Mellitus|Chronic Kidney Diseases,Cotadutide,CCCCCCCCCCCCCCCC(=O)NC(CCC(=O)NCCCCC(C(=O)NC(CO)C(=O)NC(CCC(=O)O)C(=O)NC(CC1=CC=C(C=C1)O)C(=O)NC(CC(C)C)C(=O)NC(CC(=O)O)C(=O)NC(CO)C(=O)NC(CCC(=O)O)C(=O)NC(CCCNC(=N)N)C(=O)NC(C)C(=O)NC(CCCNC(=N)N)C(=O)NC(CC(=O)O)C(=O)NC(CC2=CC=CC=C2)C(=O)NC(C(C)C)C(=O)NC(C)C(=O)NC(CC3=CNC4=CC=CC=C43)C(=O)NC(CC(C)C)C(=O)NC(CCC(=O)O)C(=O)NC(C)C(=O)NCC(=O)NCC(=O)O)NC(=O)C(CC(=O)O)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C(CC5=CC=CC=C5)NC(=O)C(C(C)O)NC(=O)CNC(=O)C(CCC(=O)N)NC(=O)C(CO)NC(=O)C(CC6=CNC=N6)N)C(=O)O,PHASE2,metabolic_disease
2965,Advanced Renal Cell Carcinoma|Metastatic Renal Cell Carcinoma,Cabozantinib,COC1=CC2=C(C=CN=C2C=C1OC)OC3=CC=C(C=C3)NC(=O)C4(CC4)C(=O)NC5=CC=C(C=C5)F,PHASE2,metabolic_disease
2966,Osteoporosis,Apomine,CC(C)OP(=O)(C(CC1=CC(=C(C(=C1)C(C)(C)C)O)C(C)(C)C)P(=O)(OC(C)C)OC(C)C)OC(C)C,PHASE1|PHASE2,metabolic_disease
2967,MPS IVA|MPS VI,Vosoritide,CCC(C)C1C(=O)NCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)NCC(=O)NC(C(=O)NCC(=O)NC(CSSCC(C(=O)NC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCNC(=N)N)CC(=O)O)CC(C)C)CCCCN)CC(C)C)CC2=CC=CC=C2)NC(=O)CNC(=O)C(CCCCN)NC(=O)C(CO)NC(=O)C(CC(C)C)NC(=O)CNC(=O)C(CCCCN)NC(=O)C(CCCCN)NC(=O)C(CC(=O)N)NC(=O)C(C)NC(=O)CNC(=O)C(CCCCN)NC(=O)C(CC3=CC=C(C=C3)O)NC(=O)C(CCCCN)NC(=O)C(CCCNC(=N)N)NC(=O)C(C)NC(=O)C(CC(=O)N)NC(=O)C4CCCN4C(=O)C(CC5=CN=CN5)NC(=O)C(CCC(=O)O)NC(=O)C(CCC(=O)N)NC(=O)CNC(=O)C6CCCN6)C(=O)O)CC(C)C)CO)CCSC)CO,PHASE1|PHASE2,metabolic_disease
2968,"Infant, Newborn, Diseases|Pregnancy in Diabetics|Infant, Diabetic Mother|Hypoglycemia|Infant, Large for Gestational Age",Diazoxide,CC1=NS(=O)(=O)C2=C(N1)C=CC(=C2)Cl,PHASE2|PHASE3,metabolic_disease
2969,"Diabetes Mellitus, Type 2",Gemigliptin,C1CC(CN(C1=O)CC(CC(=O)N2CCC3=C(C2)N=C(N=C3C(F)(F)F)C(F)(F)F)N)(F)F,PHASE1,metabolic_disease
2970,Hepatic Encephalopathy,Nitazoxanide,CC(=O)OC1=CC=CC=C1C(=O)NC2=NC=C(S2)[N+](=O)[O-],PHASE2,metabolic_disease
2971,Hepatic Encephalopathy,Metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-],PHASE2,metabolic_disease
2972,Amyotrophic Lateral Sclerosis,Pramipexole,CCCNC1CCC2=C(C1)SC(=N2)N,PHASE1,metabolic_disease
2973,Amyotrophic Lateral Sclerosis,Dexpramipexole,CCCNC1CCC2=C(C1)SC(=N2)N,PHASE1,metabolic_disease
2974,Amyotrophic Lateral Sclerosis,Cimetidine,CC1=C(N=CN1)CSCCNC(=NC)NC#N,PHASE1,metabolic_disease
2975,Mitochondrial Disease,Dextromethorphan,CN1CCC23CCCCC2C1CC4=C3C=C(C=C4)OC,PHASE1,metabolic_disease
2976,Mitochondrial Disease,Repaglinide,CCOC1=C(C=CC(=C1)CC(=O)NC(CC(C)C)C2=CC=CC=C2N3CCCCC3)C(=O)O,PHASE1,metabolic_disease
2977,Hyperkalemia|Resistant Hypertension,Spironolactone,CC(=O)SC1CC2=CC(=O)CCC2(C3C1C4CCC5(C4(CC3)C)CCC(=O)O5)C,PHASE2,metabolic_disease
2978,HIV Infections|Lipodystrophy,Abacavir,C1CC1NC2=C3C(=NC(=N2)N)N(C=N3)C4CC(C=C4)CO,PHASE2,metabolic_disease
2979,HIV Infections|Lipodystrophy,Lamivudine,C1C(OC(S1)CO)N2C=CC(=NC2=O)N,PHASE2,metabolic_disease
2980,HIV Infections|Lipodystrophy,Zidovudine,CC1=CN(C(=O)NC1=O)C2CC(C(O2)CO)N=[N+]=[N-],PHASE2,metabolic_disease
2981,HIV Infections|Lipodystrophy,Nevirapine,CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4,PHASE2,metabolic_disease
2982,Congenital Adrenal Hyperplasia,Nevanimibe,CC(C)C1=C(C(=CC=C1)C(C)C)NC(=O)NCC2(CCCC2)C3=CC=C(C=C3)N(C)C,PHASE2,metabolic_disease
2983,Diabetic Nephropathy,Sevelamer,C=CCN.C1C(O1)CCl,PHASE2,metabolic_disease
2984,Type 2 Diabetes Mellitus,Imeglimin,CC1N=C(NC(=N1)N(C)C)N,PHASE1,metabolic_disease
2985,Hypoglycemia Unawareness,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,PHASE2,metabolic_disease
2986,"Diabetes Mellitus, Type 1",Deoxyspergualin,C(CCCN=C(N)N)CCC(=O)NC(C(=O)NCCCCNCCCN)O,PHASE2,metabolic_disease
2987,Osteopenia/Osteoporosis,Calcifediol,CC(CCCC(C)(C)O)C1CCC2C1(CCCC2=CC=C3CC(CCC3=C)O)C,PHASE2,metabolic_disease
2988,Thyroid Nodules|Hypocalcemia,Calcitriol,CC(CCCC(C)(C)O)C1CCC2C1(CCCC2=CC=C3CC(CC(C3=C)O)O)C,PHASE2,metabolic_disease
2989,"Diabetes Mellitus, Type 2",Alogliptin,CN1C(=O)C=C(N(C1=O)CC2=CC=CC=C2C#N)N3CCCC(C3)N,PHASE1,metabolic_disease
2990,Primary Immunodeficiency (PID)|Congenital Bone Marrow Failure Syndromes|Inherited Metabolic Disorders (IMD)|Hereditary Anemias|Inflammatory Conditions,Hydroxyurea,C(=O)(N)NO,PHASE2,metabolic_disease
2991,Primary Immunodeficiency (PID)|Congenital Bone Marrow Failure Syndromes|Inherited Metabolic Disorders (IMD)|Hereditary Anemias|Inflammatory Conditions,Melphalan,C1=CC(=CC=C1CC(C(=O)O)N)N(CCCl)CCCl,PHASE2,metabolic_disease
2992,Primary Immunodeficiency (PID)|Congenital Bone Marrow Failure Syndromes|Inherited Metabolic Disorders (IMD)|Hereditary Anemias|Inflammatory Conditions,Thiotepa,C1CN1P(=S)(N2CC2)N3CC3,PHASE2,metabolic_disease
2993,Type I Diabetes,Ladarixin,CC(C1=CC=C(C=C1)OS(=O)(=O)C(F)(F)F)C(=O)NS(=O)(=O)C,PHASE2,metabolic_disease
2994,Amyotrophic Lateral Sclerosis,Fasudil,C1CNCCN(C1)S(=O)(=O)C2=CC=CC3=C2C=CN=C3,PHASE2,metabolic_disease
2995,Erythropoietic Protoporphyria,Colestipol,C1C(O1)CCl.C(CNCCNCCNCCN)N,PHASE2|PHASE3,metabolic_disease
2996,Type 2 Diabetes Mellitus|Overweight|Obesity,Diacerein,CC(=O)OC1=CC=CC2=C1C(=O)C3=C(C2=O)C=C(C=C3OC(=O)C)C(=O)O,PHASE2,metabolic_disease
2997,"Hypertension, Hyperlipidemia",Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,PHASE1,metabolic_disease
2998,Diabetes Mellitus|Diabetes Mellitus Complications|Gastroparesis,Relamorelin,C1CC(CNC1)C(=O)NC(CC2=CSC3=CC=CC=C32)C(=O)NC(CC4=CNC5=CC=CC=C54)C(=O)NC(CC6=CC=CC=C6)C(=O)NC7(CCNCC7)C(=O)N,PHASE2,metabolic_disease
2999,Chronic Obstructive Pulmonary Disease (COPD),Tesamorelin,CCC=CCC(=O)NC(CC1=CC=C(C=C1)O)C(=O)NC(C)C(=O)NC(CC(=O)O)C(=O)NC(C)C(=O)NC(C(C)CC)C(=O)NC(CC2=CC=CC=C2)C(=O)NC(C(C)O)C(=O)NC(CC(=O)N)C(=O)NC(CO)C(=O)NC(CC3=CC=C(C=C3)O)C(=O)NC(CCCNC(=N)N)C(=O)NC(CCCCN)C(=O)NC(C(C)C)C(=O)NC(CC(C)C)C(=O)NCC(=O)NC(CCC(=O)N)C(=O)NC(CC(C)C)C(=O)NC(CO)C(=O)NC(C)C(=O)NC(CCCNC(=N)N)C(=O)NC(CCCCN)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(CCC(=O)N)C(=O)NC(CC(=O)O)C(=O)NC(C(C)CC)C(=O)NC(CCSC)C(=O)NC(CO)C(=O)NC(CCCNC(=N)N)C(=O)NC(CCC(=O)N)C(=O)NC(CCC(=O)N)C(=O)NCC(=O)NC(CCC(=O)O)C(=O)NC(CO)C(=O)NC(CC(=O)N)C(=O)NC(CCC(=O)N)C(=O)NC(CCC(=O)O)C(=O)NC(CCCNC(=N)N)C(=O)NCC(=O)NC(C)C(=O)NC(CCCNC(=N)N)C(=O)NC(C)C(=O)NC(CCCNC(=N)N)C(=O)NC(CC(C)C)C(=O)N,PHASE2,metabolic_disease
3000,Gestational Diabetes Mellitus,Glyburide,COC1=C(C=C(C=C1)Cl)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCCCC3,PHASE1|PHASE2,metabolic_disease
3001,Hypoglycemia Unawareness,Metoclopramide,CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl,PHASE2,metabolic_disease
3002,Type1 Diabetes Mellitus|Enterovirus,Ribavirin,C1=NC(=NN1C2C(C(C(O2)CO)O)O)C(=O)N,PHASE2,metabolic_disease
3003,Type1 Diabetes Mellitus|Enterovirus,Pleconaril,CC1=CC(=CC(=C1OCCCC2=CC(=NO2)C)C)C3=NOC(=N3)C(F)(F)F,PHASE2,metabolic_disease
3004,Metabolic Diseases|Diabetes Mellitus|Endocrine System Diseases|Glucose Metabolism Disorders,Hydrochlorothiazide,C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl,PHASE1,metabolic_disease
3005,Metabolic Diseases|Diabetes Mellitus|Endocrine System Diseases|Glucose Metabolism Disorders,Aliskiren,CC(C)C(CC1=CC(=C(C=C1)OC)OCCCOC)CC(C(CC(C(C)C)C(=O)NCC(C)(C)C(=O)N)O)N,PHASE1,metabolic_disease
3006,Congenital Hyperinsulinism,Octreotide,CC(C1C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=CC=C4)NC(=O)C(CC5=CC=CC=C5)N)C(=O)NC(CO)C(C)O)O,PHASE2,metabolic_disease
3007,Alzheimer's Disease,Tricaprylin,CCCCCCCC(=O)OCC(COC(=O)CCCCCCC)OC(=O)CCCCCCC,PHASE2,metabolic_disease
3008,Heart Failure With Preserved Ejection Fraction,Carnitine,C[N+](C)(C)CC(CC(=O)[O-])O,PHASE2,metabolic_disease
3009,Heart Failure With Preserved Ejection Fraction,Levocarnitine,C[N+](C)(C)CC(CC(=O)[O-])O,PHASE2,metabolic_disease
3010,HIV Infections|Lipodystrophy,Leptin,CC(C)CC(C(=NC(CCC(=N)O)C(=NCC(=NC(CO)C(=NC(CC(C)C)C(=NC(CCC(=N)O)C(=NC(CC(=O)O)C(=NC(CCSC)C(=NC(CC(C)C)C(=NC(CC1=CNC2=CC=CC=C21)C(=NC(CCC(=N)O)C(=NC(CC(C)C)C(=NC(CC(=O)O)C(=NC(CC(C)C)C(=NC(CO)C(=O)N3CCCC3C(=NCC(=NC(CS)C(=O)O)O)O)O)O)O)O)O)O)O)O)O)O)O)O)O)O)N,PHASE2,metabolic_disease
3011,Type 1 Diabetes Mellitus|Type 2 Diabetes Mellitus,Ruboxistaurin,CN(C)CC1CCN2C=C(C3=CC=CC=C32)C4=C(C5=CN(CCO1)C6=CC=CC=C65)C(=O)NC4=O,PHASE2|PHASE3,metabolic_disease
3012,Hermanski-Pudlak Syndrome|Colitis|Cytokines|Lymphocytes|Drug Evaluation,Mercaptopurine,C1=NC2=C(N1)C(=S)N=CN2,PHASE2,metabolic_disease
3013,Amyotrophic Lateral Sclerosis,Inosine,C1=NC2=C(C(=O)N1)N=CN2C3C(C(C(O3)CO)O)O,PHASE1,metabolic_disease
3014,Frontotemporal Lobar Degeneration,Tolcapone,CC1=CC=C(C=C1)C(=O)C2=CC(=C(C(=C2)O)O)[N+](=O)[O-],PHASE2,metabolic_disease
3015,Nonalcoholic Fatty Liver Disease|HIV,Aramchol,CCCCCCCCCCCCCCCCCCCC(=O)NC1CCC2(C(C1)CC(C3C2CC(C4(C3CCC4C(C)CCC(=O)O)C)O)O)C,PHASE2,metabolic_disease
3016,Sarcopenia|Osteopenia,Anamorelin,CC(C)(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)N3CCCC(C3)(CC4=CC=CC=C4)C(=O)N(C)N(C)C)N,PHASE1,metabolic_disease
3017,Type 2 Diabetes,Paricalcitol,CC(C=CC(C)C(C)(C)O)C1CCC2C1(CCCC2=CC=C3CC(CC(C3)O)O)C,PHASE2,metabolic_disease
3018,Fatty Liver|Liver Dysfunction|Insulin Resistance,Amoxicillin,CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=C(C=C3)O)N)C(=O)O)C,PHASE2,metabolic_disease
3019,Fatty Liver|Liver Dysfunction|Insulin Resistance,Azithromycin,CCC1C(C(C(N(CC(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)C)O)(C)O,PHASE2,metabolic_disease
3020,Acute Leukemia|Immune Deficiency Disorder|Congenital Hematological Disorder|Metabolism Disorder|Aplastic Anemia|Myelodysplastic Syndromes|Chronic Leukemia|Lymphoma|Multiple Myeloma|Solid Tumor,Mesna,C(CS(=O)(=O)[O-])S.[Na+],PHASE1,metabolic_disease
3021,Type 1 Diabetes,Ergocalciferol,CC(C)C(C)C=CC(C)C1CCC2C1(CCCC2=CC=C3CC(CCC3=C)O)C,PHASE2|PHASE3,metabolic_disease
3022,Microvascular Coronary Artery Disease,Sildenafil,CCCC1=NN(C2=C1N=C(NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C,PHASE1,metabolic_disease
3023,Type 2 Diabetes Mellitus in Obese|Obesity|Type2Diabetes,Cortisone,CC12CCC(=O)C=C1CCC3C2C(=O)CC4(C3CCC4(C(=O)CO)O)C,PHASE1,metabolic_disease
3024,"Diabetes Mellitus, Type 1",Plerixafor,C1CNCCNCCCN(CCNC1)CC2=CC=C(C=C2)CN3CCCNCCNCCCNCC3,PHASE1|PHASE2,metabolic_disease
3025,Menopause|Postmenopausal Bone Loss|Breast Cancer,Tibolone,CC1CC2=C(CCC(=O)C2)C3C1C4CCC(C4(CC3)C)(C#C)O,PHASE2,metabolic_disease
3026,Nephrolithiasis|Nephrocalcinosis|Hypercalciuria,Fluconazole,C1=CC(=C(C=C1F)F)C(CN2C=NC=N2)(CN3C=NC=N3)O,PHASE2,metabolic_disease
3027,HIV Infections,Saquinavir,CC(C)(C)NC(=O)C1CC2CCCCC2CN1CC(C(CC3=CC=CC=C3)NC(=O)C(CC(=O)N)NC(=O)C4=NC5=CC=CC=C5C=C4)O,PHASE1,metabolic_disease
3028,HIV Infections,Methadone,CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2,PHASE1,metabolic_disease
3029,"Diabetes Mellitus, Type 1",Ibuprofen,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O,PHASE2,metabolic_disease
3030,Type 2 Diabetes Mellitus,Bosentan,CC(C)(C)C1=CC=C(C=C1)S(=O)(=O)NC2=C(C(=NC(=N2)C3=NC=CC=N3)OCCO)OC4=CC=CC=C4OC,PHASE2,metabolic_disease
3031,Diabetic Kidney Disease,Fulacimstat,CN1C2=C(C=C(C=C2)N3C=C(C(=O)N(C3=O)C4CCC5=C4C=CC=C5C(F)(F)F)C(=O)O)OC1=O,PHASE2,metabolic_disease
3032,Acute Gout,Betamethasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,PHASE1|PHASE2,metabolic_disease
3033,Abdominal Obesity|Insulin Resistance|Hypertriglyceridemia,Acipimox,CC1=CN=C(C=[N+]1[O-])C(=O)O,PHASE2,metabolic_disease
3034,Obesity-Associated Insulin Resistance,Moxonidine,CC1=NC(=C(C(=N1)Cl)NC2=NCCN2)OC,PHASE1,metabolic_disease
3035,Amyotrophic Lateral Sclerosis|Alzheimer Disease|Mild Cognitive Impairment,Baricitinib,CCS(=O)(=O)N1CC(C1)(CC#N)N2C=C(C=N2)C3=C4C=CNC4=NC=N3,PHASE1|PHASE2,metabolic_disease
3036,Post-menopausal Osteoporosis,Risedronate,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O,PHASE2,metabolic_disease
3037,Hyperlipidemias,Lapaquistat,CC(C)(CN1C2=C(C=C(C=C2)Cl)C(OC(C1=O)CC(=O)N3CCC(CC3)CC(=O)O)C4=C(C(=CC=C4)OC)OC)CO,PHASE2,metabolic_disease
3038,"Diabetes Mellitus, Type 1|Insulin-dependent Diabetes Mellitus",Pramlintide,CCC(C)C(C(=O)NC(CC(C)C)C(=O)N1CCCC1C(=O)N2CCCC2C(=O)NC(C(C)O)C(=O)NC(CC(=O)N)C(=O)NC(C(C)C)C(=O)NCC(=O)NC(CO)C(=O)NC(CC(=O)N)C(=O)NC(C(C)O)C(=O)NC(CC3=CC=C(C=C3)O)C(=O)N)NC(=O)C4CCCN4C(=O)CNC(=O)C(CC5=CC=CC=C5)NC(=O)C(CC(=O)N)NC(=O)C(CC(=O)N)NC(=O)C(CO)NC(=O)C(CO)NC(=O)C(CC6=CNC=N6)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC7=CC=CC=C7)NC(=O)C(CC(=O)N)NC(=O)C(C)NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CCC(=O)N)NC(=O)C(C(C)O)NC(=O)C(C)NC(=O)C8CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N8)C(C)O)C)C(C)O)CC(=O)N)NC(=O)C(CCCCN)N,PHASE2,metabolic_disease
3039,Lynch Syndrome,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,PHASE1,metabolic_disease
3040,Amyotrophic Lateral Sclerosis,Perampanel,C1=CC=C(C=C1)N2C=C(C=C(C2=O)C3=CC=CC=C3C#N)C4=CC=CC=N4,PHASE2,metabolic_disease
3041,Amyotrophic Lateral Sclerosis,Clenbuterol,CC(C)(C)NCC(C1=CC(=C(C(=C1)Cl)N)Cl)O,PHASE2,metabolic_disease
3042,Primary Immunodeficiencies|Inborn Errors of Metabolism|Haemoglobinopathies|Bone Marrow Failure Syndromes,Treosulfan,CS(=O)(=O)OCC(C(COS(=O)(=O)C)O)O,PHASE2,metabolic_disease
3043,"Light Chain (AL) Amyloidosis, Stage 3B",Bortezomib,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O,PHASE2,metabolic_disease
3044,Type 2 Diabetes,Rivoglitazone,CN1C2=C(C=CC(=C2)OC)N=C1COC3=CC=C(C=C3)CC4C(=O)NC(=O)S4,PHASE2,metabolic_disease
3045,Insulin Resistance,Trimethaphan,C1CC2C3C(C[S+]2C1)N(C(=O)N3CC4=CC=CC=C4)CC5=CC=CC=C5,PHASE1,metabolic_disease
3046,Osteoporosis,Raloxifene,C1CCN(CC1)CCOC2=CC=C(C=C2)C(=O)C3=C(SC4=C3C=CC(=C4)O)C5=CC=C(C=C5)O,PHASE1,metabolic_disease
3047,Type 1 Diabetes Mellitus|Type 2 Diabetes Mellitus,Ebselen,C1=CC=C(C=C1)N2C(=O)C3=CC=CC=C3[Se]2,PHASE2|PHASE3,metabolic_disease
3048,Batten Disease,Miglustat,CCCCN1CC(C(C(C1CO)O)O)O,PHASE1|PHASE2,metabolic_disease
3049,HIV Infections|Lipodystrophy|Metabolic Diseases|Nutrition Disorders,Tenofovir,CC(CN1C=NC2=C(N=CN=C21)N)OCP(=O)(O)O,PHASE2,metabolic_disease
3050,Chronic Heart Failure,Perhexiline,C1CCC(CC1)C(CC2CCCCN2)C3CCCCC3,PHASE2,metabolic_disease
3051,AL Amyloidosis,Venetoclax,CC1(CCC(=C(C1)C2=CC=C(C=C2)Cl)CN3CCN(CC3)C4=CC(=C(C=C4)C(=O)NS(=O)(=O)C5=CC(=C(C=C5)NCC6CCOCC6)[N+](=O)[O-])OC7=CN=C8C(=C7)C=CN8)C,PHASE1|PHASE2,metabolic_disease
3052,AL Amyloidosis,Bendamustine,CN1C2=C(C=C(C=C2)N(CCCl)CCCl)N=C1CCCC(=O)O,PHASE1|PHASE2,metabolic_disease
3053,AL Amyloidosis,Pomalidomide,C1CC(=O)NC(=O)C1N2C(=O)C3=C(C2=O)C(=CC=C3)N,PHASE1|PHASE2,metabolic_disease
3054,"Schizophrenia|Diabetes Mellitus, Type 2|Obesity",Naltrexone,C1CC1CN2CCC34C5C(=O)CCC3(C2CC6=C4C(=C(C=C6)O)O5)O,PHASE2,metabolic_disease
3055,Healthy Volunteers,Clopidogrel,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,PHASE1,metabolic_disease
3056,Healthy Volunteers,Esomeprazole,CC1=CN=C(C(=C1OC)C)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC,PHASE1,metabolic_disease
3057,Nonalcoholic Fatty Liver Disease (NAFLD)|Type 2 Diabetes (T2DM),Lanifibranor,C1=CC2=C(C=C1S(=O)(=O)N3C4=C(C=C(C=C4)Cl)C=C3CCCC(=O)O)SC=N2,PHASE2,metabolic_disease
3058,Acquired Hyperinsulinemic Hypoglycemia,Avexitide,CCC(C)C(C(=O)NC(CCC(=O)O)C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(CC(C)C)C(=O)NC(CCCCN)C(=O)NC(CC(=O)N)C(=O)NCC(=O)NCC(=O)N3CCCC3C(=O)NC(CO)C(=O)NC(CO)C(=O)NCC(=O)NC(C)C(=O)N4CCCC4C(=O)N5CCCC5C(=O)N6CCCC6C(=O)NC(CO)C(=O)N)NC(=O)C(CC7=CC=CC=C7)NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(C(C)C)NC(=O)C(C)NC(=O)C(CCC(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(CCSC)NC(=O)C(CCC(=O)N)NC(=O)C(CCCCN)NC(=O)C(CO)NC(=O)C(CC(C)C)NC(=O)C(CC(=O)O)N,PHASE2,metabolic_disease
3059,Fabry Disease,Migalastat,C1C(C(C(C(N1)CO)O)O)O,PHASE2,metabolic_disease
3060,Healthy Volunteers|Overweight,Sucralose,C(C1C(C(C(C(O1)OC2(C(C(C(O2)CCl)O)O)CCl)O)O)Cl)O,PHASE2,metabolic_disease
3061,Microbial Colonization,Duloxetine,CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32,PHASE1,metabolic_disease
3062,"Carcinoma, Renal Cell",Sorafenib,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,PHASE1,metabolic_disease
3063,Prostate Cancer,Leuprolide,CCNC(=O)C1CCCN1C(=O)C(CCCN=C(N)N)NC(=O)C(CC(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC2=CC=C(C=C2)O)NC(=O)C(CO)NC(=O)C(CC3=CNC4=CC=CC=C43)NC(=O)C(CC5=CN=CN5)NC(=O)C6CCC(=O)N6,PHASE2,metabolic_disease
3064,Prostate Cancer,Apalutamide,CNC(=O)C1=C(C=C(C=C1)N2C(=S)N(C(=O)C23CCC3)C4=CC(=C(N=C4)C#N)C(F)(F)F)F,PHASE2,metabolic_disease
3065,Idiopathic Pulmonary Hemosiderosis|Leflunomide,Leflunomide,CC1=C(C=NO1)C(=O)NC2=CC=C(C=C2)C(F)(F)F,PHASE1|PHASE2,metabolic_disease
3066,Crohn Disease,Xanthohumol,CC(=CCC1=C(C(=C(C=C1O)OC)C(=O)C=CC2=CC=C(C=C2)O)O)C,PHASE2,metabolic_disease
3067,Type 2 Diabetes Mellitus,Tesofensine,CCOCC1C2CCC(N2C)CC1C3=CC(=C(C=C3)Cl)Cl,PHASE2,metabolic_disease
3068,Hepatic Encephalopathy|Acute-On-Chronic Liver Failure,Lactulose,C(C1C(C(C(C(O1)OC2C(OC(C2O)(CO)O)CO)O)O)O)O,PHASE1,metabolic_disease
3069,AML|ALL|MDS|MPD Withou Myelofibrosis|NHL or HL|Inherited Metabolic Disorders|Hemoglobinopathies|Bone Marrow Failure|HLH,Clofarabine,C1=NC2=C(N=C(N=C2N1C3C(C(C(O3)CO)O)F)Cl)N,PHASE2,metabolic_disease
3070,Congenital Hyperinsulinism|Insulinoma,Fluorodopa,C1=C(C(=CC(=C1O)O)F)CC(C(=O)O)N,PHASE1,metabolic_disease
3071,HIV|Fenofibrate|Protease Inhibitors|Hypertriglyceridemia|Glucuronosyltransferase,Lopinavir,CC1=C(C(=CC=C1)C)OCC(=O)NC(CC2=CC=CC=C2)C(CC(CC3=CC=CC=C3)NC(=O)C(C(C)C)N4CCCNC4=O)O,PHASE1,metabolic_disease
3072,HIV Infections|HIV Wasting Syndrome,Thalidomide,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O,PHASE2,metabolic_disease
3073,Homozygous Familial Hypercholesterolemia,Lomitapide,C1CN(CCC1NC(=O)C2=CC=CC=C2C3=CC=C(C=C3)C(F)(F)F)CCCCC4(C5=CC=CC=C5C6=CC=CC=C64)C(=O)NCC(F)(F)F,PHASE2,metabolic_disease
3074,Obstructive Sleep Apnea,Propranolol,CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O,PHASE2,metabolic_disease
3075,Postmenopausal Osteoporosis,Bazedoxifene,CC1=C(N(C2=C1C=C(C=C2)O)CC3=CC=C(C=C3)OCCN4CCCCCC4)C5=CC=C(C=C5)O,PHASE2,metabolic_disease
3076,Heart Failure,Glutamine,C(CC(=O)N)C(C(=O)O)N,PHASE2|PHASE3,metabolic_disease
3077,Metabolic Syndrome,Treamid,C1=CN=C(N1)CCNC(=O)CCCC(=O)NCCC2=NC=CN2,PHASE1,metabolic_disease
3078,Amyotrophic Lateral Sclerosis,Ezogabine,CCOC(=O)NC1=C(C=C(C=C1)NCC2=CC=C(C=C2)F)N,PHASE2,metabolic_disease
3079,"Diabetes Mellitus, Type 1",Benfotiamine,CC1=NC=C(C(=N1)N)CN(C=O)C(=C(CCOP(=O)(O)O)SC(=O)C2=CC=CC=C2)C,PHASE1|PHASE2,metabolic_disease
3080,Friedreich Ataxia,Vatiquinone,CC1=C(C(=O)C(=C(C1=O)C)CCC(C)(CCC=C(C)CCC=C(C)CCC=C(C)C)O)C,PHASE2|PHASE3,metabolic_disease
3081,Mitochondrial Diseases,Cysteamine,C(CS)N,PHASE2,metabolic_disease
3082,Diabetes Mellitus|Hypoglycemia|Autonomic Failure,Morphine,CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O,PHASE2,metabolic_disease
3083,Diabetes Mellitus|Hypoglycemia|Autonomic Failure,Epinephrine,CNCC(C1=CC(=C(C=C1)O)O)O,PHASE2,metabolic_disease
3084,Advanced Solid Tumors|Lymphomas,Lenvatinib,COC1=CC2=NC=CC(=C2C=C1C(=O)N)OC3=CC(=C(C=C3)NC(=O)NC4CC4)Cl,PHASE1,metabolic_disease
3085,Functional Iron Deficiency|Trauma|Anemia,Oxandrolone,CC12CCC3C(C1CCC2(C)O)CCC4C3(COC(=O)C4)C,PHASE2,metabolic_disease
3086,EGFR Gene Amplification|EGFR Gene Mutation|Glioblastoma|Recurrent Glioblastoma|Supratentorial Glioblastoma|TP53 wt Allele,Fludeoxyglucose,C(C(C(C(C(C=O)F)O)O)O)O,PHASE2,metabolic_disease
3087,EGFR Gene Amplification|EGFR Gene Mutation|Glioblastoma|Recurrent Glioblastoma|Supratentorial Glioblastoma|TP53 wt Allele,Osimertinib,CN1C=C(C2=CC=CC=C21)C3=NC(=NC=C3)NC4=C(C=C(C(=C4)NC(=O)C=C)N(C)CCN(C)C)OC,PHASE2,metabolic_disease
3088,Insulin Sensitivity,Eritoran,CCCCCCCCCCCC(=O)CC(=O)NC1C(C(C(OC1OP(=O)(O)O)COC2C(C(C(C(O2)COC)OP(=O)(O)O)OCCC(CCCCCCC)OC)NC(=O)CCCCCCCCCC=CCCCCCC)O)OCCCCCCCCCC,PHASE2,metabolic_disease
3089,Osteoporosis,Eldecalcitol,CC(CCCC(C)(C)O)C1CCC2C1(CCCC2=CC=C3CC(C(C(C3=C)O)OCCCO)O)C,PHASE2,metabolic_disease
3090,Tumor-Induced Osteomalacia,Dotatate,CC(C1C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=C(C=C4)O)NC(=O)C(CC5=CC=CC=C5)NC(=O)CN6CCN(CCN(CCN(CC6)CC(=O)O)CC(=O)O)CC(=O)O)C(=O)NC(C(C)O)C(=O)O)O,PHASE1,metabolic_disease
3091,Xeroderma Pigmentosum,Afamelanotide,CCCCC(C(=O)NC(CCC(=O)O)C(=O)NC(CC1=CN=CN1)C(=O)NC(CC2=CC=CC=C2)C(=O)NC(CCCNC(=N)N)C(=O)NC(CC3=CNC4=CC=CC=C43)C(=O)NCC(=O)NC(CCCCN)C(=O)N5CCCC5C(=O)NC(C(C)C)C(=O)N)NC(=O)C(CO)NC(=O)C(CC6=CC=C(C=C6)O)NC(=O)C(CO)NC(=O)C,PHASE2,metabolic_disease
3092,Hypoglycemia; Iatrogenic,Somatostatin,CC(C1C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=CC=C4)CC5=CC=CC=C5)CC(=O)N)CCCCN)NC(=O)CNC(=O)C(C)N)C(=O)O)CO)C(C)O)CC6=CC=CC=C6)O,PHASE1,metabolic_disease
3093,Overweight and Obesity|Insulin Resistance,Amiloride,C1(=C(N=C(C(=N1)Cl)N)N)C(=O)N=C(N)N,PHASE2|PHASE3,metabolic_disease
3094,Achlorhydria,Itraconazole,CCC(C)N1C(=O)N(C=N1)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(C=C4)OCC5COC(O5)(CN6C=NC=N6)C7=C(C=C(C=C7)Cl)Cl,PHASE1,metabolic_disease
3095,"Frontotemporal Dementia|Dementia|Aphasia, Primary Progressive|Pick Disease of the Brain|Brain Diseases|Central Nervous System Diseases|Nervous System Diseases|Neurocognitive Disorders|Mental Disorders|Neurodegenerative Diseases|Frontotemporal Lobar Degeneration|TDP-43 Proteinopathies|Proteostasis Deficiencies|Metabolic Disease|Aphasia|Speech Disorders|Language Disorders|Communication Disorders|Neurobehavioral Manifestations|Neurologic Manifestations",Rotigotine,CCCN(CCC1=CC=CS1)C2CCC3=C(C2)C=CC=C3O,PHASE2,metabolic_disease
3096,Type 1 Diabetes Mellitus,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,PHASE1|PHASE2,metabolic_disease
3097,Diabetes Mellitus With Periodontal Disease,Doxycycline,CC1C2C(C3C(C(=O)C(=C(C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O,PHASE2|PHASE3,metabolic_disease
3098,Subarachnoid Hemorrhage,Prostacyclin,CCCCCC(C=CC1C(CC2C1CC(=CCCCC(=O)O)O2)O)O,PHASE2,metabolic_disease
3099,Subarachnoid Hemorrhage,Epoprostenol,CCCCCC(C=CC1C(CC2C1CC(=CCCCC(=O)O)O2)O)O,PHASE2,metabolic_disease
3100,Albinism|Inborn Errors of Metabolism|Oculocutaneous Albinism|Platelet Storage Pool Deficiency|Pulmonary Fibrosis,Pirfenidone,CC1=CN(C(=O)C=C1)C2=CC=CC=C2,PHASE2,metabolic_disease
3101,Type 2 Diabetes Mellitus (T2DM)|Endothelial Dysfunction|Erectile Dysfunction,Vardenafil,CCCC1=NC(=C2N1N=C(NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)CC)OCC)C,PHASE2,metabolic_disease
3102,Amyloidosis|Systemic Light Chain Amyloidosis,Carfilzomib,CC(C)CC(C(=O)C1(CO1)C)NC(=O)C(CC2=CC=CC=C2)NC(=O)C(CC(C)C)NC(=O)C(CCC3=CC=CC=C3)NC(=O)CN4CCOCC4,PHASE1,metabolic_disease
3103,Hepatic Encephalopathy|Liver Cirrhosis,Flumazenil,CCOC(=O)C1=C2CN(C(=O)C3=C(N2C=N1)C=CC(=C3)F)C,PHASE1|PHASE2,metabolic_disease
3104,Motor Neuron Disease|Amyotrophic Lateral Sclerosis|Primary Lateral Sclerosis|Progressive Muscular Atrophy,Levetiracetam,CCC(C(=O)N)N1CCCC1=O,PHASE2,metabolic_disease
3105,Amyotrophic Lateral Sclerosis,Trametinib,CC1=C2C(=C(N(C1=O)C)NC3=C(C=C(C=C3)I)F)C(=O)N(C(=O)N2C4=CC=CC(=C4)NC(=O)C)C5CC5,PHASE1|PHASE2,metabolic_disease
3106,"Esophageal Adenocarcinoma|Esophagus SCC|Cholangiocarcinoma|Urothelial/Bladder Cancer, Nos|Endometrial Cancer",Abemaciclib,CCN1CCN(CC1)CC2=CN=C(C=C2)NC3=NC=C(C(=N3)C4=CC5=C(C(=C4)F)N=C(N5C(C)C)C)F,PHASE2,metabolic_disease
3107,Familial Amyotrophic Lateral Sclerosis,Pyrimethamine,CCC1=C(C(=NC(=N1)N)N)C2=CC=C(C=C2)Cl,PHASE1|PHASE2,metabolic_disease
3108,Hypertension|Obesity|Type 2 Diabetes Mellitus,Azilsartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NOC(=O)N5)C(=O)O,PHASE2|PHASE3,metabolic_disease
3109,"Diabetes Mellitus, Type 2",Gliclazide,CC1=CC=C(C=C1)S(=O)(=O)NC(=O)NN2CC3CCCC3C2,PHASE1,metabolic_disease
3110,Locally Advanced Prostate Cancer,Gefitinib,COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4,PHASE2,metabolic_disease
3111,Progeria,Lonafarnib,C1CN(CCC1CC(=O)N2CCC(CC2)C3C4=C(CCC5=C3N=CC(=C5)Br)C=C(C=C4Br)Cl)C(=O)N,PHASE2,metabolic_disease
3112,Friedreich's Ataxia,Catechin,C1C(C(OC2=CC(=CC(=C21)O)O)C3=CC(=C(C=C3)O)O)O,PHASE2,metabolic_disease
3113,Friedreich's Ataxia,Epicatechin,C1C(C(OC2=CC(=CC(=C21)O)O)C3=CC(=C(C=C3)O)O)O,PHASE2,metabolic_disease
3114,Type 1 Diabetes Mellitus,Atazanavir,CC(C)(C)C(C(=O)NC(CC1=CC=CC=C1)C(CN(CC2=CC=C(C=C2)C3=CC=CC=N3)NC(=O)C(C(C)(C)C)NC(=O)OC)O)NC(=O)OC,PHASE1,metabolic_disease
3115,"Attention Deficit Disorder With Hyperactivity|Diabetes Mellitus, Type 1",Lisdexamfetamine,CC(CC1=CC=CC=C1)NC(=O)C(CCCCN)N,PHASE2,metabolic_disease
3116,"Attention Deficit Disorder With Hyperactivity|Diabetes Mellitus, Type 1",Methylphenidate,COC(=O)C(C1CCCCN1)C2=CC=CC=C2,PHASE2,metabolic_disease
3117,Fatty Liver Disease|Fatty Liver,Itopride,CN(C)CCOC1=CC=C(C=C1)CNC(=O)C2=CC(=C(C=C2)OC)OC,PHASE2,metabolic_disease
3118,Gout Attack,Diclofenac,C1=CC=C(C(=C1)CC(=O)O)NC2=C(C=CC=C2Cl)Cl,PHASE2,metabolic_disease
3119,Light Chain (AL) Amyloidosis|Cardiac Involvement,Epigallocatechin,C1C(C(OC2=CC(=CC(=C21)O)O)C3=CC(=C(C(=C3)O)O)O)O,PHASE2,metabolic_disease
3120,Diabetes Mellitus Type 2|Non Alcoholic Fatty Liver Disease|Obesity,Amlexanox,CC(C)C1=CC2=C(C=C1)OC3=NC(=C(C=C3C2=O)C(=O)O)N,PHASE2,metabolic_disease
3121,Diffuse Large B Cell Lymphoma|Primary Mediastinal Lymphoma|Mantle-Cell Lymphoma|Follicular Lymphoma|Marginal Zone Lymphoma|Advanced Solid Tumors,Tazemetostat,CCN(C1CCOCC1)C2=CC(=CC(=C2C)C(=O)NCC3=C(C=C(NC3=O)C)C)C4=CC=C(C=C4)CN5CCOCC5,PHASE1,metabolic_disease
3122,Amyotrophic Lateral Sclerosis,Talampanel,CC1CC2=CC3=C(C=C2C(=NN1C(=O)C)C4=CC=C(C=C4)N)OCO3,PHASE2,metabolic_disease
3123,Neimann-Pick Disease,Vorinostat,C1=CC=C(C=C1)NC(=O)CCCCCCC(=O)NO,PHASE1|PHASE2,metabolic_disease
3124,"Diabetes Mellitus, Type 2",Zanamivir,CC(=O)NC1C(C=C(OC1C(C(CO)O)O)C(=O)O)N=C(N)N,PHASE2,metabolic_disease
3125,Celiac Disease,Teriflunomide,CC(=C(C#N)C(=O)NC1=CC=C(C=C1)C(F)(F)F)O,PHASE1|PHASE2,metabolic_disease
3126,Fabry Disease|Neuropathic Pain,Gabapentin,C1CCC(CC1)(CC(=O)O)CN,PHASE2,metabolic_disease
3127,Amyotrophic Lateral Sclerosis,Rabeprazole,CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCCCOC,PHASE1,metabolic_disease
3128,Type 1 Diabetes Mellitus|Hypercalciuria,Chlorthalidone,C1=CC=C2C(=C1)C(=O)NC2(C3=CC(=C(C=C3)Cl)S(=O)(=O)N)O,PHASE2,metabolic_disease
3129,HIV Infections,Raltegravir,CC1=NN=C(O1)C(=O)NC(C)(C)C2=NC(=C(C(=O)N2C)O)C(=O)NCC3=CC=C(C=C3)F,PHASE1,metabolic_disease
3130,Type 2 Diabetes Mellitus,Gemfibrozil,CC1=CC(=C(C=C1)C)OCCCC(C)(C)C(=O)O,PHASE1,metabolic_disease
3131,Insulin Resistance|Hyperinsulinemia|Dyslipidemias,Alpelisib,CC1=C(SC(=N1)NC(=O)N2CCCC2C(=O)N)C3=CC(=NC=C3)C(C)(C)C(F)(F)F,PHASE1,metabolic_disease
3132,Obesity|Insulin Resistance,Fenretinide,CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CC(=O)NC2=CC=C(C=C2)O)C)C,PHASE2,metabolic_disease
3133,Fabry Disease,Lucerastat,CCCCN1CC(C(C(C1CO)O)O)O,PHASE1,metabolic_disease
3134,Amyloidosis|Immunoglobulin Light Chain Deposition,Ibrutinib,C=CC(=O)N1CCCC(C1)N2C3=NC=NC(=C3C(=N2)C4=CC=C(C=C4)OC5=CC=CC=C5)N,PHASE2,metabolic_disease
3135,Type 2 Diabetes|Hypertension,Aprepitant,CC(C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)OC2C(N(CCO2)CC3=NNC(=O)N3)C4=CC=C(C=C4)F,PHASE2,metabolic_disease
3136,Amyotrophic Lateral Sclerosis,Tretinoin,CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CC(=O)O)C)C,PHASE1|PHASE2,metabolic_disease
3137,Type 2 Diabetes,Teneligliptin,CC1=NN(C(=C1)N2CCN(CC2)C3CC(NC3)C(=O)N4CCSC4)C5=CC=CC=C5,PHASE2,metabolic_disease
3138,Cardiac Arrest,Ubiquinol,CC1=C(C(=C(C(=C1O)OC)OC)O)CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C,PHASE2,metabolic_disease
3139,Hyperphosphatemia,Tenapanor,CN1CC(C2=C(C1)C(=CC(=C2)Cl)Cl)C3=CC(=CC=C3)S(=O)(=O)NCCOCCOCCNC(=O)NCCCCNC(=O)NCCOCCOCCNS(=O)(=O)C4=CC=CC(=C4)C5CN(CC6=C5C=C(C=C6Cl)Cl)C,PHASE2|PHASE3,metabolic_disease
3140,Type2 Diabetes Mellitus|Albuminuria|Renal Insufficiency,Evogliptin,CC(C)(C)OCC1C(=O)NCCN1C(=O)CC(CC2=CC(=C(C=C2F)F)F)N,PHASE2,metabolic_disease
3141,Gouty Arthritis,Etoricoxib,CC1=NC=C(C=C1)C2=C(C=C(C=N2)Cl)C3=CC=C(C=C3)S(=O)(=O)C,PHASE2,metabolic_disease
3142,Hyperlipidemia,Tetraethylammonium,CC[N+](CC)(CC)CC,PHASE2,metabolic_disease
3143,Hyperlipidemia,Bradykinin,C1CC(N(C1)C(=O)C2CCCN2C(=O)C(CCCN=C(N)N)N)C(=O)NCC(=O)NC(CC3=CC=CC=C3)C(=O)NC(CO)C(=O)N4CCCC4C(=O)NC(CC5=CC=CC=C5)C(=O)NC(CCCN=C(N)N)C(=O)O,PHASE2,metabolic_disease
3144,Amyotrophic Lateral Sclerosis,Biotin,C1C2C(C(S1)CCCCC(=O)O)NC(=O)N2,PHASE2,metabolic_disease
3145,Thyroid Diseases,Levothyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,PHASE2,metabolic_disease
3146,"Gaucher Disease, Type 1|Gaucher Disease, Type 3",Arimoclomol,C1CCN(CC1)CC(CON=C(C2=C[N+](=CC=C2)[O-])Cl)O,PHASE2,metabolic_disease
3147,Amyotrophic Lateral Sclerosis,Nitrofural,C1=C(OC(=C1)[N+](=O)[O-])C=NNC(=O)N,PHASE2,metabolic_disease
3148,Amyotrophic Lateral Sclerosis,Nitrofurazone,C1=C(OC(=C1)[N+](=O)[O-])C=NNC(=O)N,PHASE2,metabolic_disease
3149,Post-menopausal Osteoporosis,Phylloquinone,CC1=C(C(=O)C2=CC=CC=C2C1=O)CC=C(C)CCCC(C)CCCC(C)CCCC(C)C,PHASE2|PHASE3,metabolic_disease
3150,Post-menopausal Osteoporosis,Menatetrenone,CC1=C(C(=O)C2=CC=CC=C2C1=O)CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C,PHASE2|PHASE3,metabolic_disease
3151,Cachexia|HIV Infections|HIV Wasting Syndrome,Dronabinol,CCCCCC1=CC(=C2C3C=C(CCC3C(OC2=C1)(C)C)C)O,PHASE1,metabolic_disease
3152,Osteoporosis,Ronacaleret,CC(C)(CC1CC2=CC=CC=C2C1)NCC(COC3=C(C(=CC(=C3)CCC(=O)O)F)F)O,PHASE2,metabolic_disease
3153,Type 2 Diabetes Mellitus|Insulin Resistance,Mifepristone,CC#CC1(CCC2C1(CC(C3=C4CCC(=O)C=C4CCC23)C5=CC=C(C=C5)N(C)C)C)O,PHASE2,metabolic_disease
3154,Amyotrophic Lateral Sclerosis,Zilucoplan,CCCCCCCCCCCCCCCC(=O)NC(CCC(=O)NCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCC(=O)NCCCCC(C(=O)O)NC(=O)C(C1CCCCC1)NC(=O)C2CCCN2C(=O)C(CC3=CC=C(C=C3)O)NC(=O)C(CCC(=O)O)NC(=O)C(CC4=CNC5=C4C=CC=N5)NC(=O)C(CC6=CC=C(C=C6)O)NC(=O)C(C(C)(C)C)NC(=O)C(CC(=O)O)N(C)C(=O)C7CC(=O)NCCCCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N7)CC8=CC=CC=C8)CCCNC(=N)N)CCC(=O)O)C(C)C)NC(=O)C)C(=O)O,PHASE2|PHASE3,metabolic_disease
3155,Diabetes,Phentermine,CC(C)(CC1=CC=CC=C1)N,PHASE2,metabolic_disease
3156,Diabetes,Topiramate,CC1(OC2COC3(C(C2O1)OC(O3)(C)C)COS(=O)(=O)N)C,PHASE2,metabolic_disease
3157,Lymphoma|Advanced Cancer,Tolbutamide,CCCCNC(=O)NS(=O)(=O)C1=CC=C(C=C1)C,PHASE1,metabolic_disease
3158,Lymphoma|Advanced Cancer,Tasisulam,C1=CC(=C(C=C1Cl)Cl)C(=O)NS(=O)(=O)C2=CC=C(S2)Br,PHASE1,metabolic_disease
3159,Type 2 Diabetes Mellitus,Digoxin,CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,PHASE1,metabolic_disease
3160,"Gaucher Disease, Type 1|Type 1 Gaucher Disease|Gaucher Disease",Afegostat,C1C(C(C(CN1)O)O)CO,PHASE2,metabolic_disease
3161,MItochondrial Myopathies,Omaveloxolone,CC1(CCC2(CCC3(C(C2C1)C(=O)C=C4C3(CCC5C4(C=C(C(=O)C5(C)C)C#N)C)C)C)NC(=O)C(C)(F)F)C,PHASE2,metabolic_disease
3162,Primary Hyperoxaluria,Stiripentol,CC(C)(C)C(C=CC1=CC2=C(C=C1)OCO2)O,PHASE2,metabolic_disease
3163,Metabolic Syndrome|Coronary Microvascular Dysfunction,Vericiguat,COC(=O)NC1=C(N=C(N=C1N)C2=NN(C3=C2C=C(C=N3)F)CC4=CC=CC=C4F)N,PHASE2,metabolic_disease
3164,Type 2 Diabetes Mellitus,Amantadine,C1C2CC3CC1CC(C2)(C3)N,PHASE2,metabolic_disease
3165,Fanconi Anemia,Eltrombopag,CC1=C(C=C(C=C1)N2C(=O)C(=C(N2)C)N=NC3=CC=CC(=C3O)C4=CC(=CC=C4)C(=O)O)C,PHASE2,metabolic_disease
3166,"Gangliosidoses, GM2|Sandhoff Disease|Tay-Sachs Disease",Leucovorin,C1C(N(C2=C(N1)N=C(NC2=O)N)C=O)CNC3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,PHASE1|PHASE2,metabolic_disease
3167,Cancer|Pancreatic Cancer|Pancreatic Carcinoma,Gemcitabine,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)(F)F,PHASE1|PHASE2,metabolic_disease
3168,Type 1 Diabetes,Pantoprazole,COC1=C(C(=NC=C1)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC(F)F)OC,PHASE2,metabolic_disease
3169,Morbid Obesity|Bariatric Surgery Candidate,Bupivacaine,CCCCN1CCCCC1C(=O)NC2=C(C=CC=C2C)C,PHASE1,metabolic_disease
3170,Dyslipidemias,Saroglitazar,CCOC(CC1=CC=C(C=C1)OCCN2C(=CC=C2C3=CC=C(C=C3)SC)C)C(=O)O,PHASE2,metabolic_disease
3171,Type 2 Diabetes Mellitus,Voglibose,C1C(C(C(C(C1(CO)O)O)O)O)NC(CO)CO,PHASE2|PHASE3,metabolic_disease
3172,Amyotrophic Lateral Sclerosis,Pridopidine,CCCN1CCC(CC1)C2=CC(=CC=C2)S(=O)(=O)C,PHASE2|PHASE3,metabolic_disease
3173,Type 2 Diabetes,Yohimbine,COC(=O)C1C(CCC2C1CC3C4=C(CCN3C2)C5=CC=CC=C5N4)O,PHASE2,metabolic_disease
3174,Gout|Moderate Renal Impairment,Lansoprazole,CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCC(F)(F)F,PHASE2,metabolic_disease
3175,Bone Marrow Failure Syndrome|Congenital Amegakaryocytic Thrombocytopenia|Congenital Pure Red Cell Aplasia|Hereditary Sideroblastic Anemia|Myeloid Neoplasms With Germline GATA2 Mutation|Paroxysmal Nocturnal Hemoglobinuria|Shwachman-Diamond Syndrome,Methotrexate,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,PHASE2,metabolic_disease
3176,Pancreatic Islet Transplantation in Type 1 Diabetes Mellitus,Reparixin,CC(C)CC1=CC=C(C=C1)C(C)C(=O)NS(=O)(=O)C,PHASE2,metabolic_disease
3177,Hyperinsulinism|Insulin Resistance|Insulin Sensitivity|Glucose Intolerance|Hypertension,Vigabatrin,C=CC(CCC(=O)O)N,PHASE2,metabolic_disease
3178,Cancer Cachexia,Macimorelin,CC(C)(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(CC3=CNC4=CC=CC=C43)NC=O)N,PHASE2,metabolic_disease
3179,Indigestion|Diabetes Mellitus,Ondansetron,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C,PHASE2,metabolic_disease
3180,T2DM (Type 2 Diabetes Mellitus)|Metformin|SGLT2-Inhibitors,Tofogliflozin,CCC1=CC=C(C=C1)CC2=CC3=C(COC34C(C(C(C(O4)CO)O)O)O)C=C2,PHASE2,metabolic_disease
3181,Familial Hypercholesterolemia,Implitapide,CC1=CC(=NC2=C1C3=CC=CC=C3N2CC4=CC(=CC=C4)C(C5CCCC5)C(=O)NC(CO)C6=CC=CC=C6)C,PHASE2,metabolic_disease
3182,Breast Cancer|Osteoporosis,Letrozole,C1=CC(=CC=C1C#N)C(C2=CC=C(C=C2)C#N)N3C=NC=N3,PHASE2,metabolic_disease
3183,Sporadic Amyotrophic Lateral Sclerosis,Mexiletine,CC1=C(C(=CC=C1)C)OCC(C)N,PHASE2,metabolic_disease
3184,Malignant Gliomas|CNS|Brain Cancer|Cancer,Perifosine,CCCCCCCCCCCCCCCCCCOP(=O)([O-])OC1CC[N+](CC1)(C)C,PHASE2,metabolic_disease
3185,Type 2 Diabetes Mellitus,Mitiglinide,C1CCC2CN(CC2C1)C(=O)CC(CC3=CC=CC=C3)C(=O)O,PHASE1,metabolic_disease
3186,"Diabetes Mellitus, Type I|Diabetes Mellitus, Insulin-Dependent, 1|Type 1 Diabetes Mellitus|Insulin-Dependent Diabetes Mellitus 1|IDDM",Imatinib,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,PHASE2,metabolic_disease
3187,"Amino Acid Metabolism, Inborn Errors",Ataluren,C1=CC=C(C(=C1)C2=NC(=NO2)C3=CC(=CC=C3)C(=O)O)F,PHASE2,metabolic_disease
3188,Acute Gout Flare|Gout Attack|Gout Flare|Gouty Arthritis|Gout|Arthritis|Joint Pain,Dapansutrile,CS(=O)(=O)CCC#N,PHASE2|PHASE3,metabolic_disease
3189,HIV Infections|HIV Wasting Syndrome,Nandrolone,CC12CCC3C(C1CCC2O)CCC4=CC(=O)CCC34,PHASE1,metabolic_disease
3190,ATM Gene Mutation|BRCA1 Gene Mutation|BRCA2 Gene Mutation|Castration Levels of Testosterone|Castration-Resistant Prostate Carcinoma|Homologous Recombination Deficiency|Prostate Carcinoma Metastatic in the Bone|PSA Level Greater Than or Equal to Two|PSA Progression|Stage IV Prostate Adenocarcinoma AJCC v7,Rucaparib,CNCC1=CC=C(C=C1)C2=C3CCNC(=O)C4=C3C(=CC(=C4)F)N2,PHASE2,metabolic_disease
3191,Osteoarthritis,Relacatib,CC1CCC(C(=O)CN1S(=O)(=O)C2=CC=CC=N2)NC(=O)C(CC(C)C)NC(=O)C3=CC4=CC=CC=C4O3,PHASE1,metabolic_disease
3192,Parkinson's Disease,Istradefylline,CCN1C2=C(C(=O)N(C1=O)CC)N(C(=N2)C=CC3=CC(=C(C=C3)OC)OC)C,PHASE1,metabolic_disease
3193,Dyslipidemia,Dalcetrapib,CCC(CC)CC1(CCCCC1)C(=O)NC2=CC=CC=C2SC(=O)C(C)C,PHASE2,metabolic_disease
3194,Type 1 Diabetes,Terbutaline,CC(C)(C)NCC(C1=CC(=CC(=C1)O)O)O,PHASE1,metabolic_disease
3195,Breast Cancer,Epirubicin,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)N)O,PHASE2,metabolic_disease
3196,Breast Cancer,Fluorouracil,C1=C(C(=O)NC(=O)N1)F,PHASE2,metabolic_disease
3197,Pre-diabetes,Atropine,CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3,PHASE1,metabolic_disease
3198,Atherosclerotic Cardiovascular Disease|Symptomatic Atherosclerosis|Type2 Diabetes|Familial Hypercholesterolemia,Inclisiran,CC(=O)NC1C(C(C(OC1OCCCCC(=O)NCCCNC(=O)CCOCC(COCCC(=O)NCCCNC(=O)CCCCOC2C(C(C(C(O2)CO)O)O)NC(=O)C)(COCCC(=O)NCCCNC(=O)CCCCOC3C(C(C(C(O3)CO)O)O)NC(=O)C)NC(=O)CCCCCCCCCCC(=O)N4CC(CC4COP(=O)(O)O)O)CO)O)O,PHASE2,metabolic_disease
3199,Type 2 Diabetes Mellitus,Fasiglifam,CC1=CC(=CC(=C1C2=CC=CC(=C2)COC3=CC4=C(C=C3)C(CO4)CC(=O)O)C)OCCCS(=O)(=O)C,PHASE2,metabolic_disease
3200,Type 2 Diabetes Mellitus,Omarigliptin,CS(=O)(=O)N1C=C2CN(CC2=N1)C3CC(C(OC3)C4=C(C=CC(=C4)F)F)N,PHASE2,metabolic_disease
3201,Mucopolysaccharidosis VI,Odiparcil,CC1=CC(=O)OC2=C1C=CC(=C2)OC3C(C(C(CS3)O)O)O,PHASE2,metabolic_disease
3202,"Acute Intermittent Porphyria (AIP)|Acute Hepatic Porphyria (AHP)|Porphyria, Acute Intermittent|Acute Porphyria",Givosiran,CC1CC(CN1C(=O)CCCCCCCCCCC(=O)NC(COCCC(=O)NCCCNC(=O)CCCCOC2C(C(C(C(O2)CO)O)O)NC(=O)C)(COCCC(=O)NCCCNC(=O)CCCCOC3C(C(C(C(O3)CO)O)O)NC(=O)C)COCCC(=O)NCCCNC(=O)CCCCOC4C(C(C(C(O4)CO)O)O)NC(=O)C)O,PHASE1,metabolic_disease
3203,Hypertension|Insulin Resistance,Norepinephrine,C1=CC(=C(C=C1C(CN)O)O)O,PHASE1,metabolic_disease
3204,Neuromuscular Diseases,Edaravone,CC1=NN(C(=O)C1)C2=CC=CC=C2,PHASE2|PHASE3,metabolic_disease
3205,Arterial Calcification|CD73 Deficiency,Etidronate,CC(O)(P(=O)(O)O)P(=O)(O)O,PHASE2,metabolic_disease
3206,Osteoporosis,Lasofoxifene,C1CCN(C1)CCOC2=CC=C(C=C2)C3C(CCC4=C3C=CC(=C4)O)C5=CC=CC=C5,PHASE2,metabolic_disease
3207,Macular Edema Following Cataract Surgery,Triethylenetetramine,C(CNCCNCCN)N,PHASE2,metabolic_disease
3208,Macular Edema Following Cataract Surgery,Trientine,C(CNCCNCCN)N,PHASE2,metabolic_disease
3209,Celiac Disease,Larazotide,CC(C)CC(C(=O)NC(C(C)C)C(=O)NC(CCC(=O)N)C(=O)N1CCCC1C(=O)NCC(=O)O)NC(=O)C(C(C)C)NC(=O)CNC(=O)CN,PHASE2,metabolic_disease
3210,Type 2 Diabetes Mellitus|Pulmonary Function,Mecobalamin,[CH3-].CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)([O-])OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=C(C7=NC(=CC8=NC(=C(C4=N5)C)C(C8(C)C)CCC(=O)N)C(C7(C)CC(=O)N)CCC(=O)N)C)[N-]6)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[Co+3],PHASE2|PHASE3,metabolic_disease
3211,Amyotrophic Lateral Sclerosis,Bosutinib,CN1CCN(CC1)CCCOC2=C(C=C3C(=C2)N=CC(=C3NC4=CC(=C(C=C4Cl)Cl)OC)C#N)OC,PHASE1|PHASE2,metabolic_disease
3212,Breast Cancer|Metastatic Triple-Negative Breast Cancer,Eribulin,CC1CC2CCC3C(=C)CC(O3)CCC45CC6C(O4)C7C(O6)C(O5)C8C(O7)CCC(O8)CC(=O)CC9C(CC(C1=C)O2)OC(C9OC)CC(CN)O,PHASE2,metabolic_disease
3213,Walking Capacity|Amyotrophic Lateral Sclerosis,Albuterol,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,PHASE2,metabolic_disease
3214,Walking Capacity|Amyotrophic Lateral Sclerosis,Salbutamol,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,PHASE2,metabolic_disease
3215,Type 1 Diabetes Mellitus|Hypoglycemia,Everolimus,CC1CCC2CC(C(=CC=CC=CC(CC(C(=O)C(C(C(=CC(C(=O)CC(OC(=O)C3CCCCN3C(=O)C(=O)C1(O2)O)C(C)CC4CCC(C(C4)OC)OCCO)C)C)O)OC)C)C)C)OC,PHASE1|PHASE2,metabolic_disease
3216,Amyotrophic Lateral Sclerosis,Quinidine,COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O,PHASE1|PHASE2,metabolic_disease
3217,Amyotrophic Lateral Sclerosis,Fingolimod,CCCCCCCCC1=CC=C(C=C1)CCC(CO)(CO)N,PHASE2,metabolic_disease
3218,Type 2 Diabetes Mellitus,Ursodiol,CC(CCC(=O)O)C1CCC2C1(CCC3C2C(CC4C3(CCC(C4)O)C)O)C,PHASE2,metabolic_disease
3219,Epilepsy|Seizures|Bipolar Disorder|Bipolar Depression,Lamotrigine,C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N,PHASE1|PHASE2,metabolic_disease
3220,Diabetes Complications|Diabetes; Nephropathy (Manifestation),Roxadustat,CC1=C2C=C(C=CC2=C(C(=N1)C(=O)NCC(=O)O)O)OC3=CC=CC=C3,PHASE2,metabolic_disease
3221,"Diabetes Mellitus, Insulin-Dependent",Sulfamethoxazole,CC1=CC(=NO1)NS(=O)(=O)C2=CC=C(C=C2)N,PHASE2,metabolic_disease
3222,"Diabetes Mellitus, Insulin-Dependent",Ganciclovir,C1=NC2=C(N1COC(CO)CO)N=C(NC2=O)N,PHASE2,metabolic_disease
3223,"Diabetes Mellitus, Insulin-Dependent",Trimethoprim,COC1=CC(=CC(=C1OC)OC)CC2=CN=C(N=C2N)N,PHASE2,metabolic_disease
3224,"Diabetes Mellitus, Insulin-Dependent",Pentamidine,C1=CC(=CC=C1C(=N)N)OCCCCCOC2=CC=C(C=C2)C(=N)N,PHASE2,metabolic_disease
3225,Gout|Hyperuricemia|Arthritis|Joint Disease|Renal Insufficiency,Ulodesine,C1C(C(CN1CC2=CNC3=C2N=CNC3=O)O)CO,PHASE2,metabolic_disease
3226,Cachexia|Lung Cancer,Clarithromycin,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)O)(C)O,PHASE2,metabolic_disease
3227,Amyotrophic Lateral Sclerosis,Lacosamide,CC(=O)NC(COC)C(=O)NCC1=CC=CC=C1,PHASE1|PHASE2,metabolic_disease
3228,Cancer Cachexia,Ruxolitinib,C1CCC(C1)C(CC#N)N2C=C(C=N2)C3=C4C=CNC4=NC=N3,PHASE2,metabolic_disease
3229,Type 2 Diabetes Mellitus,Rebaudioside A,CC12CCCC(C1CCC34C2CCC(C3)(C(=C)C4)OC5C(C(C(C(O5)CO)O)OC6C(C(C(C(O6)CO)O)O)O)OC7C(C(C(C(O7)CO)O)O)O)(C)C(=O)OC8C(C(C(C(O8)CO)O)O)O,PHASE1,metabolic_disease
3230,Hemodialysis-Induced Symptom|Mitochondrial Diseases,Icatibant,C1CCC2C(C1)CC(N2C(=O)C3CC4=CC=CC=C4CN3C(=O)C(CO)NC(=O)C(CC5=CC=CS5)NC(=O)CNC(=O)C6CC(CN6C(=O)C7CCCN7C(=O)C(CCCN=C(N)N)NC(=O)C(CCCN=C(N)N)N)O)C(=O)NC(CCCN=C(N)N)C(=O)O,PHASE2,metabolic_disease
3231,Lipid Disorder|Triglycerides High|Dyslipidemias,Icosapent,CCC=CCC=CCC=CCC=CCC=CCCCC(=O)O,PHASE1,metabolic_disease
3232,Multiple Myeloma|Amyloidosis,Vinorelbine,CCC1=CC2CC(C3=C(CN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC,PHASE2,metabolic_disease
3233,Gout and Asymptomatic Hyperuricemia,Benzbromarone,CCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)Br)O)Br,PHASE1|PHASE2,metabolic_disease
3234,B-Cell Non-Hodgkin Lymphoma,Doxorubicin,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)N)O,PHASE2,metabolic_disease
3235,B-Cell Non-Hodgkin Lymphoma,Vincristine,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O,PHASE2,metabolic_disease
3236,Schizophrenia,Aripiprazole,C1CC(=O)NC2=C1C=CC(=C2)OCCCCN3CCN(CC3)C4=C(C(=CC=C4)Cl)Cl,PHASE1,metabolic_disease
3237,Schizophrenia,Risperidone,CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F,PHASE1,metabolic_disease
3238,Congenital Adrenal Hyperplasia,Fludrocortisone,CC12CCC(=O)C=C1CCC3C2(C(CC4(C3CCC4(C(=O)CO)O)C)O)F,PHASE2,metabolic_disease
3239,Psoriasis Vulgaris,Calcipotriol,CC(C=CC(C1CC1)O)C2CCC3C2(CCCC3=CC=C4CC(CC(C4=C)O)O)C,PHASE2,metabolic_disease
3240,Primary Mitochondrial Myopathy,Bocidelpar,CC1=CN=C(N1CC2=CC=CC=C2OCCCC(C)CC(=O)O)C3=CC=C(C=C3)C(F)(F)F,PHASE2|PHASE3,metabolic_disease
3241,Hypertriglyceridemia,Maraviroc,CC1=NN=C(N1C2CC3CCC(C2)N3CCC(C4=CC=CC=C4)NC(=O)C5CCC(CC5)(F)F)C(C)C,PHASE1,metabolic_disease
3242,Schizophrenia|Schizoaffective Disorder|Obesity|Hypertension|Smoking,Rimonabant,CC1=C(N(N=C1C(=O)NN2CCCCC2)C3=C(C=C(C=C3)Cl)Cl)C4=CC=C(C=C4)Cl,PHASE2,metabolic_disease
3243,Type 2 Diabetes Mellitus,Dihydromyricetin,C1=C(C=C(C(=C1O)O)O)C2C(C(=O)C3=C(C=C(C=C3O2)O)O)O,PHASE2,metabolic_disease
3244,Alzheimer's Disease,Bexarotene,CC1=CC2=C(C=C1C(=C)C3=CC=C(C=C3)C(=O)O)C(CCC2(C)C)(C)C,PHASE1,metabolic_disease
3245,Autosomal Dominant Hypocalcemia OR Primary Hypoparathyroidism Related to Other Cause But Complicated by Hypercalciuria Under Treatment,Alfacalcidol,CC(C)CCCC(C)C1CCC2C1(CCCC2=CC=C3CC(CC(C3=C)O)O)C,PHASE2,metabolic_disease
3246,Body Weight|Impaired Glucose Tolerance in Obese,Cabergoline,CCNC(=O)N(CCCN(C)C)C(=O)C1CC2C(CC3=CNC4=CC=CC2=C34)N(C1)CC=C,PHASE1|PHASE2,metabolic_disease
3247,"Diabetes Mellitus, Type 1|Diabetic Nephropathy",Alagebrium,CC1=C(SC=[N+]1CC(=O)C2=CC=CC=C2)C,PHASE2,metabolic_disease
3248,Insulin Resistance|Healthy|Obesity,Phentolamine,CC1=CC=C(C=C1)N(CC2=NCCN2)C3=CC(=CC=C3)O,PHASE1,metabolic_disease
3249,Amyotrophic Lateral Sclerosis,Tideglusib,C1=CC=C(C=C1)CN2C(=O)N(SC2=O)C3=CC=CC4=CC=CC=C43,PHASE2,metabolic_disease
3250,Amyotrophic Lateral Sclerosis,Enoxacin,CCN1C=C(C(=O)C2=CC(=C(N=C21)N3CCNCC3)F)C(=O)O,PHASE1|PHASE2,metabolic_disease
3251,Pancreatic Leak|Pancreatic Fistula|Pancreaticoduodenal; Fistula|Pancreatectomy; Hyperglycemia,Lanreotide,CC(C)C1C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=C(C=C4)O)NC(=O)C(CC5=CC6=CC=CC=C6C=C5)N)C(=O)NC(C(C)O)C(=O)N,PHASE2,metabolic_disease
3252,Fungal Disease,Ibrexafungerp,CC(C)C(C)C1(CCC2(C3CCC4C5(COCC4(C3=CCC2(C1C(=O)O)C)CC(C5OCC(C)(C(C)(C)C)N)N6C(=NC=N6)C7=CC=NC=C7)C)C)C,PHASE1,metabolic_disease
3253,Amyloidosis,Inotersen,CC1=CN(C(=O)NC1=O)C2CC(C(O2)COP(=S)(O)OC3CC(OC3COP(=S)(O)OC4CC(OC4COP(=S)(O)OC5C(OC(C5OCCOC)N6C=NC7=C6N=C(NC7=O)N)COP(=S)(O)OC8C(OC(C8OCCOC)N9C=C(C(=O)NC9=O)C)COP(=S)(O)OC1C(OC(C1OCCOC)N1C=C(C(=O)NC1=O)C)COP(=O)(OC1C(OC(C1OCCOC)N1C=C(C(=NC1=O)N)C)COP(=S)(O)OC1C(OC(C1OCCOC)N1C=C(C(=O)NC1=O)C)CO)S)N1C=NC2=C1N=C(NC2=O)N)N1C=C(C(=O)NC1=O)C)OP(=S)(O)OCC1C(CC(O1)N1C=NC2=C(N=CN=C21)N)OP(=S)(O)OCC1C(CC(O1)N1C=C(C(=NC1=O)N)C)OP(=S)(O)OCC1C(CC(O1)N1C=NC2=C(N=CN=C21)N)OP(=S)(O)OCC1C(CC(O1)N1C=C(C(=O)NC1=O)C)OP(=S)(O)OCC1C(CC(O1)N1C=NC2=C1N=C(NC2=O)N)OP(=S)(O)OCC1C(CC(O1)N1C=NC2=C(N=CN=C21)N)OP(=S)(O)OCC1C(CC(O1)N1C=NC2=C(N=CN=C21)N)OP(=S)(O)OCC1C(C(C(O1)N1C=NC2=C(N=CN=C21)N)OCCOC)OP(=S)(O)OCC1C(C(C(O1)N1C=C(C(=O)NC1=O)C)OCCOC)OP(=S)(O)OCC1C(C(C(O1)N1C=C(C(=NC1=O)N)C)OCCOC)OP(=S)(O)OCC1C(C(C(O1)N1C=C(C(=NC1=O)N)C)OCCOC)OP(=S)(O)OCC1C(C(C(O1)N1C=C(C(=NC1=O)N)C)OCCOC)O,PHASE2,metabolic_disease
3254,Dyslipidemia|HIV Infections,Policosanol,CCCO,PHASE2,metabolic_disease
3255,Anorexia|Weight Loss|Cachexia,Flurandrenolone,CC1(OC2CC3C4CC(C5=CC(=O)CCC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C)F)C,PHASE2,metabolic_disease
3256,Type1 Diabetes Mellitus|Hypoglycemia Unawareness,Amitriptyline,CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31,PHASE2,metabolic_disease
3257,"Diabetes Mellitus, Type 1",Abrocitinib,CCCS(=O)(=O)NC1CC(C1)N(C)C2=NC=NC3=C2C=CN3,PHASE2,metabolic_disease
3258,HIV Infections|HIV Seronegativity|Lipodystrophy,Nelfinavir,CC1=C(C=CC=C1O)C(=O)NC(CSC2=CC=CC=C2)C(CN3CC4CCCCC4CC3C(=O)NC(C)(C)C)O,PHASE1,metabolic_disease
3259,"Blood Glucose, Low|Hypoglycemia",Gemifloxacin,CON=C1CN(CC1CN)C2=C(C=C3C(=O)C(=CN(C3=N2)C4CC4)C(=O)O)F,PHASE1,metabolic_disease
3260,Secondary Hyperparathyroidism|Hypercalcemia,Cinacalcet,CC(C1=CC=CC2=CC=CC=C21)NCCCC3=CC(=CC=C3)C(F)(F)F,PHASE1|PHASE2,metabolic_disease
3261,Aortic Valve Stenosis,Ataciguat,C1COCCN1S(=O)(=O)C2=CC=C(C=C2)NC(=O)C3=C(C=CC(=C3)Cl)NS(=O)(=O)C4=CC=C(S4)Cl,PHASE2,metabolic_disease
3262,"CLOPIDOGREL, POOR METABOLISM of (Disorder)",Ticagrelor,CCCSC1=NC(=C2C(=N1)N(N=N2)C3CC(C(C3O)O)OCCO)NC4CC4C5=CC(=C(C=C5)F)F,PHASE2|PHASE3,metabolic_disease
3263,Lesch-Nyhan Disease,Ecopipam,CN1CCC2=CC(=C(C=C2C3C1CCC4=CC=CC=C34)O)Cl,PHASE1,metabolic_disease
3264,Adenocarcinoma of the Esophagus|Adenocarcinoma of the Gastroesophageal Junction|Squamous Cell Carcinoma of the Esophagus,Oxaliplatin,C1CCC(C(C1)[NH-])[NH-].C(=O)(C(=O)O)O.[Pt+2],PHASE1|PHASE2,metabolic_disease
3265,Mitochondrial Diseases|Mitochondrial DNA tRNALeu(UUR) m.3243A<G Mutation|MELAS|Subacute Necrotizing Encephalomyelopathy,Sonlicromanol,CC1=C(C2=C(CCC(O2)(C)C(=O)NC3CCCNC3)C(=C1O)C)C,PHASE2,metabolic_disease
3266,Atherosclerosis,Darapladib,CCN(CC)CCN(CC1=CC=C(C=C1)C2=CC=C(C=C2)C(F)(F)F)C(=O)CN3C4=C(CCC4)C(=O)N=C3SCC5=CC=C(C=C5)F,PHASE1,metabolic_disease
3267,Mitochondrial Diseases,Bezafibrate,CC(C)(C(=O)O)OC1=CC=C(C=C1)CCNC(=O)C2=CC=C(C=C2)Cl,PHASE2,metabolic_disease
3268,Multiple Myeloma|Amyloidosis,Pegfilgrastim,CC(C(C(=O)O)N)OC1C(C(C(C(O1)COC2(CC(C(C(O2)C(C(CO)O)O)NC(=O)CNC(=O)OCCOC)O)C(=O)O)O)O)NC(=O)C,PHASE1,metabolic_disease
3269,Type1 Diabetes Mellitus,Methyldopa,CC(CC1=CC(=C(C=C1)O)O)(C(=O)O)N,PHASE2,metabolic_disease
3270,Insulin Sensitivity|Oxidative Stress,Galantamine,CN1CCC23C=CC(CC2OC4=C(C=CC(=C34)C1)OC)O,PHASE1,metabolic_disease
3271,Type 2 Diabetes Mellitus,Bethanechol,CC(C[N+](C)(C)C)OC(=O)N,PHASE1,metabolic_disease
3272,Dehydrated Hereditary Stomatocytosis,Senicapoc,C1=CC=C(C=C1)C(C2=CC=C(C=C2)F)(C3=CC=C(C=C3)F)C(=O)N,PHASE1|PHASE2,metabolic_disease
3273,Amyotrophic Lateral Sclerosis,Reldesemtiv,C1C(CC1(CNC2=NC=C(C=N2)N3C=CC(=C3)C(=O)N)C4=C(C=CC=N4)F)F,PHASE2,metabolic_disease
3274,"Hepatic Encephalopathy|Cirrhosis, Liver",Rifamycin,CC1C=CC=C(C(=O)NC2=CC(=C3C(=C2O)C(=C(C4=C3C(=O)C(O4)(OC=CC(C(C(C(C(C(C1O)C)O)C)OC(=O)C)C)OC)C)C)O)O)C,PHASE2,metabolic_disease
3275,Autoimmune Diseases|Fibrosis,Belumosudil,CC(C)NC(=O)COC1=CC=CC(=C1)C2=NC3=CC=CC=C3C(=N2)NC4=CC5=C(C=C4)NN=C5,PHASE1,metabolic_disease
3276,Obesity,Nabilone,CCCCCCC(C)(C)C1=CC(=C2C3CC(=O)CCC3C(OC2=C1)(C)C)O,PHASE2,metabolic_disease
3277,Diabetes Mellitus|Cardiovascular Diseases|Insulin Sensitivity/Resistance|Metabolic Disease|Natriuretic Peptides|Metabolism|Energy Expenditure,Sacubitril,CCOC(=O)C(C)CC(CC1=CC=C(C=C1)C2=CC=CC=C2)NC(=O)CCC(=O)O,PHASE2,metabolic_disease
3278,Hyperlipidemias,Antroquinonol,CC1C(C(C(=C(C1=O)OC)OC)O)CC=C(C)CCC=C(C)CCC=C(C)C,PHASE2,metabolic_disease
3279,Insulin Resistance|Type 2 Diabetes Mellitus|Obesity|Androgen Deficiency|Metabolic Disease,Acyline,CC(C)CC(C(=O)NC(CCCCNC(C)C)C(=O)N1CCCC1C(=O)NC(C)C(=O)N)NC(=O)C(CC2=CC=C(C=C2)NC(=O)C)NC(=O)C(CC3=CC=C(C=C3)NC(=O)C)NC(=O)C(CO)NC(=O)C(CC4=CN=CC=C4)NC(=O)C(CC5=CC=C(C=C5)Cl)NC(=O)C(CC6=CC7=CC=CC=C7C=C6)NC(=O)C,PHASE1|PHASE2,metabolic_disease
3280,MELAS Syndrome,Citrulline,C(CC(C(=O)O)N)CNC(=O)N,PHASE1,metabolic_disease
3281,Lean Body Mass|Cannabis|Cancer|Nausea|Cachexia|Emesis|Appetitive Behavior,Cannabidiol,CCCCCC1=CC(=C(C(=C1)O)C2C=C(CCC2C(=C)C)C)O,PHASE1,metabolic_disease
3282,Healthy,Licarbazepine,C1C(C2=CC=CC=C2N(C3=CC=CC=C31)C(=O)N)O,PHASE1,metabolic_disease
3283,Chronic Myeloid Leukemia,Nilotinib,CC1=C(C=C(C=C1)C(=O)NC2=CC(=CC(=C2)C(F)(F)F)N3C=C(N=C3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,PHASE1,metabolic_disease
3284,Type 2 Diabetes Mellitus,Retagliptin,COC(=O)C1=C2CN(CCN2C(=N1)C(F)(F)F)C(=O)CC(CC3=CC(=C(C=C3F)F)F)N,PHASE1,metabolic_disease
3285,Albinism|Oculocutaneous Albinism,Levodopa,C1=CC(=C(C=C1CC(C(=O)O)N)O)O,PHASE2,metabolic_disease
3286,Type 1 Diabetes Mellitus,Treprostinil,CCCCCC(CCC1C(CC2C1CC3=C(C2)C(=CC=C3)OCC(=O)O)O)O,PHASE1,metabolic_disease
3287,Insulin Resistance,Triflusal,CC(=O)OC1=C(C=CC(=C1)C(F)(F)F)C(=O)O,PHASE2,metabolic_disease
3288,Gout,Bucillamine,CC(C)(C(=O)NC(CS)C(=O)O)S,PHASE2,metabolic_disease
3289,Frontotemporal Dementia,Flortaucipir,C1=CC2=C(C=C1C3=CN=C(C=C3)F)NC4=C2C=NC=C4,PHASE1,metabolic_disease
3290,Solid Tumor|Clear Cell Renal Cell Carcinoma|TNBC - Triple-Negative Breast Cancer|Colorectal Cancer|CRC|RCC|ccRCC,Talazoparib,CN1C(=NC=N1)C2C(NC3=CC(=CC4=C3C2=NNC4=O)F)C5=CC=C(C=C5)F,PHASE1|PHASE2,metabolic_disease
3291,"Diabetes Mellitus, Type II|Periodontitis",Chlorhexidine,C1=CC(=CC=C1NC(=NC(=NCCCCCCN=C(N)N=C(N)NC2=CC=C(C=C2)Cl)N)N)Cl,PHASE2,metabolic_disease
3292,Type 2 Diabetes Mellitus,Captopril,CC(CS)C(=O)N1CCCC1C(=O)O,PHASE1|PHASE2,metabolic_disease
3293,"Motor Neuron Disease, Amyotrophic Lateral Sclerosis",Trazodone,C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl,PHASE2|PHASE3,metabolic_disease
3294,Anti-Psychotic|Management of Manifestations of Psychotic Disorders|Treatment of Schizophrenia|Control Nausea and Vomiting|Relief of Restlessness and Apprehension Before Surgery|Acute Intermittent Porphyria|Adjunct in the Treatment of Tetanus|Control Manifestations of the Manic Type of Mani-depressive Illness|Relief of Intractable Hiccups,Chlorpromazine,CN(C)CCCN1C2=CC=CC=C2SC3=C1C=C(C=C3)Cl,PHASE1,metabolic_disease
3295,Amyotrophic Lateral Sclerosis (ALS),Masitinib,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC(=CS4)C5=CN=CC=C5,PHASE2|PHASE3,metabolic_disease
3296,Blood Pressure|Diabetes|Obesity|Insulin Resistance|Diuretics Drug Reactions|Sympathetic Nerve Activity,Clonidine,C1CN=C(N1)NC2=C(C=CC=C2Cl)Cl,PHASE1,metabolic_disease
3297,Diabetes Mellitus Type 2,Taspoglutide,CCC(C)C(C(=O)NC(C)C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(CC(C)C)C(=O)NC(C(C)C)C(=O)NC(CCCCN)C(=O)NC(C)(C)C(=O)NC(CCCNC(=N)N)C(=O)N)NC(=O)C(CC3=CC=CC=C3)NC(=O)C(CCC(=O)O)NC(=O)C(CCCCN)NC(=O)C(C)NC(=O)C(C)NC(=O)C(CCC(=O)N)NC(=O)CNC(=O)C(CCC(=O)O)NC(=O)C(CC(C)C)NC(=O)C(CC4=CC=C(C=C4)O)NC(=O)C(CO)NC(=O)C(CO)NC(=O)C(C(C)C)NC(=O)C(CC(=O)O)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C(CC5=CC=CC=C5)NC(=O)C(C(C)O)NC(=O)CNC(=O)C(CCC(=O)O)NC(=O)C(C)(C)NC(=O)C(CC6=CN=CN6)N,PHASE2,metabolic_disease
3298,"Diabetes Mellitus, Type 1",Naloxone,C=CCN1CCC23C4C(=O)CCC2(C1CC5=C3C(=C(C=C5)O)O4)O,PHASE2,metabolic_disease
3299,"Type 2 Diabetes Mellitus|Diabetes Mellitus, Type 2",Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,PHASE1,metabolic_disease
3300,Dyslipidemias|Peripheral Artery Disease,Cilostazol,C1CCC(CC1)N2C(=NN=N2)CCCCOC3=CC4=C(C=C3)NC(=O)CC4,PHASE1,metabolic_disease
3301,Hyperglycemia|Sepsis,Dopamine,C1=CC(=C(C=C1CCN)O)O,PHASE1,metabolic_disease
3302,Medulloblastoma|Central Nervous System Tumors|Neuroblastoma|Osteosarcoma,Gemcitabine,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)(F)F,PHASE2,nervous_system_disease
3303,Medulloblastoma|Central Nervous System Tumors|Neuroblastoma|Osteosarcoma,Oxaliplatin,C1CCC(C(C1)[NH-])[NH-].C(=O)(C(=O)O)O.[Pt+2],PHASE2,nervous_system_disease
3304,Minimal Hepatic Encephalopathy,Rifaximin,CC1C=CC=C(C(=O)NC2=C(C3=C(C4=C(C(=C3O)C)OC(C4=O)(OC=CC(C(C(C(C(C(C1O)C)O)C)OC(=O)C)C)OC)C)C5=C2N6C=CC(=CC6=N5)C)O)C,PHASE1|PHASE2,nervous_system_disease
3305,Cryptococcal Meningitis,Amphotericin B,CC1C=CC=CC=CC=CC=CC=CC=CC(CC2C(C(CC(O2)(CC(CC(C(CCC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)O)C(=O)O)OC3C(C(C(C(O3)C)O)N)O,PHASE1|PHASE2,nervous_system_disease
3306,SIADH,Empagliflozin,C1COCC1OC2=CC=C(C=C2)CC3=C(C=CC(=C3)C4C(C(C(C(O4)CO)O)O)O)Cl,PHASE2|PHASE3,nervous_system_disease
3307,SIADH,Ciclosporin,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,PHASE2|PHASE3,nervous_system_disease
3308,SIADH,Chloroquine,CCN(CC)CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl,PHASE2|PHASE3,nervous_system_disease
3309,Intracranial Aneurysm|Inflammation Vascular,Atorvastatin,CC(C)C1=C(C(=C(N1CCC(CC(CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4,PHASE2,nervous_system_disease
3310,Malignant Peripheral Nerve Sheath Tumors|Neurofibromatosis 1,Selumetinib,CN1C=NC2=C1C=C(C(=C2F)NC3=C(C=C(C=C3)Br)Cl)C(=O)NOCCO,PHASE2,nervous_system_disease
3311,Malignant Peripheral Nerve Sheath Tumors|Neurofibromatosis 1,Sirolimus,CC1CCC2CC(C(=CC=CC=CC(CC(C(=O)C(C(C(=CC(C(=O)CC(OC(=O)C3CCCCN3C(=O)C(=O)C1(O2)O)C(C)CC4CCC(C(C4)OC)O)C)C)O)OC)C)C)C)OC,PHASE2,nervous_system_disease
3312,Insomnia Chronic,Zopiclone,CN1CCN(CC1)C(=O)OC2C3=NC=CN=C3C(=O)N2C4=NC=C(C=C4)Cl,PHASE2,nervous_system_disease
3313,"Sleep Apnea, Obstructive|Pulmonary Disease, Chronic Obstructive|Respiration Disorders",Lemborexant,CC1=NC(=NC=C1OCC2(CC2C(=O)NC3=NC=C(C=C3)F)C4=CC(=CC=C4)F)C,PHASE1,nervous_system_disease
3314,Fibromyalgia,Pregabalin,CC(C)CC(CC(=O)O)CN,PHASE2|PHASE3,nervous_system_disease
3315,Neurofibromatosis Type I|Plexiform Neurofibroma,Sorafenib,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,PHASE1,nervous_system_disease
3316,Neurodegenerative Disease|Iron Overload,Deferiprone,CC1=C(C(=O)C=CN1C)O,PHASE2,nervous_system_disease
3317,Brain Metastases,Memantine,CC12CC3CC(C1)(CC(C3)(C2)N)C,PHASE2,nervous_system_disease
3318,Recurrent Central Nervous System Lymphoma|Recurrent Diffuse Large B-Cell Lymphoma|Refractory Central Nervous System Lymphoma|Refractory Diffuse Large B-Cell Lymphoma,Lenalidomide,C1CC(=O)NC(=O)C1N2CC3=C(C2=O)C=CC=C3N,PHASE1,nervous_system_disease
3319,Amyotrophic Lateral Sclerosis|ALS,Ciprofloxacin,C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O,PHASE2,nervous_system_disease
3320,Amyotrophic Lateral Sclerosis|ALS,Celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,PHASE2,nervous_system_disease
3321,Age-Associated Memory Impairment,Tricaprylin,CCCCCCCC(=O)OCC(COC(=O)CCCCCCC)OC(=O)CCCCCCC,PHASE2,nervous_system_disease
3322,Tinnitus,Gabapentin,C1CCC(CC1)(CC(=O)O)CN,PHASE2|PHASE3,nervous_system_disease
3323,Migraine Disorders|Headache Disorders,Bimatoprost,CCNC(=O)CCCC=CCC1C(CC(C1C=CC(CCC2=CC=CC=C2)O)O)O,PHASE2,nervous_system_disease
3324,"Gaucher Disease, Type 1|Cerebroside Lipidosis Syndrome|Glucocerebrosidase Deficiency Disease|Glucosylceramide Beta-Glucosidase Deficiency Disease|Gaucher Disease, Non-Neuronopathic Form",Eliglustat,CCCCCCCC(=O)NC(CN1CCCC1)C(C2=CC3=C(C=C2)OCCO3)O,PHASE2,nervous_system_disease
3325,Brain Tumors,Nicardipine,CC1=C(C(C(=C(N1)C)C(=O)OCCN(C)CC2=CC=CC=C2)C3=CC(=CC=C3)[N+](=O)[O-])C(=O)OC,PHASE1,nervous_system_disease
3326,Brain Tumors,Esmolol,CC(C)NCC(COC1=CC=C(C=C1)CCC(=O)OC)O,PHASE1,nervous_system_disease
3327,Lennox Gastaut Syndrome,Carisbamate,C1=CC=C(C(=C1)C(COC(=O)N)O)Cl,PHASE1,nervous_system_disease
3328,"Stroke, Acute|Vessels; Occlusion|Blood Pressure|Endovascular Thrombectomy|Mechanical Thrombectomy",Labetalol,CC(CCC1=CC=CC=C1)NCC(C2=CC(=C(C=C2)O)C(=O)N)O,PHASE2,nervous_system_disease
3329,"Stroke, Acute|Vessels; Occlusion|Blood Pressure|Endovascular Thrombectomy|Mechanical Thrombectomy",Hydralazine,C1=CC=C2C(=C1)C=NN=C2NN,PHASE2,nervous_system_disease
3330,"Stroke, Acute|Vessels; Occlusion|Blood Pressure|Endovascular Thrombectomy|Mechanical Thrombectomy",Enalapril,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O,PHASE2,nervous_system_disease
3331,Non-Small Cell Lung Cancer (NSCLC),Almonertinib,CN(C)CCN(C)C1=CC(=C(C=C1NC(=O)C=C)NC2=NC=CC(=N2)C3=CN(C4=CC=CC=C43)C5CC5)OC,PHASE2,nervous_system_disease
3332,"Gaucher Disease, Type 1",Ambroxol,C1CC(CCC1NCC2=C(C(=CC(=C2)Br)Br)N)O,PHASE2,nervous_system_disease
3333,Diffuse Intrinsic Pontine Glioma,Erlotinib,COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC,PHASE2,nervous_system_disease
3334,Diffuse Intrinsic Pontine Glioma,Temozolomide,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N,PHASE2,nervous_system_disease
3335,"Cavernous Malformations,Cerebral and/or Spinal",Propranolol,CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O,PHASE1,nervous_system_disease
3336,Epilepsy,Levetiracetam,CCC(C(=O)N)N1CCCC1=O,PHASE2,nervous_system_disease
3337,"Subarachnoid Hemorrhage|Intracerebral Hemorrhage|Ventriculitis, Cerebral|Hydrocephalus",Nafcillin,CCOC1=C(C2=CC=CC=C2C=C1)C(=O)NC3C4N(C3=O)C(C(S4)(C)C)C(=O)O,PHASE1,nervous_system_disease
3338,"Subarachnoid Hemorrhage|Intracerebral Hemorrhage|Ventriculitis, Cerebral|Hydrocephalus",Doxycycline,CC1C2C(C3C(C(=O)C(=C(C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O,PHASE1,nervous_system_disease
3339,"Fragile X Syndrome|Fragile X Mental Retardation Syndrome|Mental Retardation, X-Linked|Genetic Diseases, X-Linked|Trinucleotide Repeat Expansion|Fra(X) Syndrome|Intellectual Disability|FXS|Neurobehavioral Manifestations|Sex Chromosome Disorders",Metformin,CN(C)C(=N)N=C(N)N,PHASE2,nervous_system_disease
3340,Central Neuropathic Pain|Allodynia|Spinal Cord Injury,Dextromethorphan,CN1CCC23CCCCC2C1CC4=C3C=C(C=C4)OC,PHASE2,nervous_system_disease
3341,Central Neuropathic Pain|Allodynia|Spinal Cord Injury,Lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C,PHASE2,nervous_system_disease
3342,Sleep Disorder|Restless Legs Syndrome|Opioid-use Disorder|Opioid Withdrawal,Pramipexole,CCCNC1CCC2=C(C1)SC(=N2)N,PHASE2|PHASE3,nervous_system_disease
3343,Aicardi-Goutires Syndrome,Abacavir,C1CC1NC2=C3C(=NC(=N2)N)N(C=N3)C4CC(C=C4)CO,PHASE2,nervous_system_disease
3344,Aicardi-Goutires Syndrome,Lamivudine,C1C(OC(S1)CO)N2C=CC(=NC2=O)N,PHASE2,nervous_system_disease
3345,Aicardi-Goutires Syndrome,Zidovudine,CC1=CN(C(=O)NC1=O)C2CC(C(O2)CO)N=[N+]=[N-],PHASE2,nervous_system_disease
3346,Occipital Neuralgia|Headache,Methylprednisolone,CC1CC2C3CCC(C3(CC(C2C4(C1=CC(=O)C=C4)C)O)C)(C(=O)CO)O,PHASE1,nervous_system_disease
3347,Obstructive Sleep Apnea|Sleep-Disordered Breathing|Blood Pressure|Hypertension,Acetazolamide,CC(=O)NC1=NN=C(S1)S(=O)(=O)N,PHASE2,nervous_system_disease
3348,Insomnia Disorders,Zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C,PHASE2,nervous_system_disease
3349,Obstructive Sleep Apnea|Down Syndrome,Atomoxetine,CC1=CC=CC=C1OC(CCNC)C2=CC=CC=C2,PHASE2,nervous_system_disease
3350,Obstructive Sleep Apnea|Down Syndrome,Oxybutynin,CCN(CC)CC#CCOC(=O)C(C1CCCCC1)(C2=CC=CC=C2)O,PHASE2,nervous_system_disease
3351,Down Syndrome,Sevoflurane,C(OC(C(F)(F)F)C(F)(F)F)F,PHASE2,nervous_system_disease
3352,Down Syndrome,Desflurane,C(C(F)(F)F)(OC(F)F)F,PHASE2,nervous_system_disease
3353,Alzheimer's Disease,Flortaucipir,C1=CC2=C(C=C1C3=CN=C(C=C3)F)NC4=C2C=NC=C4,PHASE1,nervous_system_disease
3354,Migraine|Migraine With Aura|Migraine Without Aura,Dihydroergotamine,CC1(C(=O)N2C(C(=O)N3CCCC3C2(O1)O)CC4=CC=CC=C4)NC(=O)C5CC6C(CC7=CNC8=CC=CC6=C78)N(C5)C,PHASE1,nervous_system_disease
3355,Dental Pain,Acetaminophen,CC(=O)NC1=CC=C(C=C1)O,PHASE2,nervous_system_disease
3356,Brain Metastases,Rivoceranib,C1CCC(C1)(C#N)C2=CC=C(C=C2)NC(=O)C3=C(N=CC=C3)NCC4=CC=NC=C4,PHASE2,nervous_system_disease
3357,Stroke|Inflammation,Fingolimod,CCCCCCCCC1=CC=C(C=C1)CCC(CO)(CO)N,PHASE2,nervous_system_disease
3358,Spinal Muscular Atrophy Type II|Spinal Muscular Atrophy Type III Non Ambulant,Olesoxime,CC(C)CCCC(C)C1CCC2C1(CCC3C2CCC4=CC(=NO)CCC34C)C,PHASE2,nervous_system_disease
3359,Childhood Absence Epilepsy,Cannabidiol,CCCCCC1=CC(=C(C(=C1)O)C2C=C(CCC2C(=C)C)C)O,PHASE2,nervous_system_disease
3360,Pain Syndrome,Etoricoxib,CC1=NC=C(C=C1)C2=C(C=C(C=N2)Cl)C3=CC=C(C=C3)S(=O)(=O)C,PHASE2,nervous_system_disease
3361,Brain Metastases|CNS Metastases,Bleomycin,CC1=C(N=C(N=C1N)C(CC(=O)N)NCC(C(=O)N)N)C(=O)NC(C(C2=CN=CN2)OC3C(C(C(C(O3)CO)O)O)OC4C(C(C(C(O4)CO)O)OC(=O)N)O)C(=O)NC(C)C(C(C)C(=O)NC(C(C)O)C(=O)NCCC5=NC(=CS5)C6=NC(=CS6)C(=O)NCCC[S+](C)C)O,PHASE1,nervous_system_disease
3362,Myotonia|Non-Dystrophic Myotonia,Mexiletine,CC1=C(C(=CC=C1)C)OCC(C)N,PHASE2,nervous_system_disease
3363,Epilepsy,Talampanel,CC1CC2=CC3=C(C=C2C(=NN1C(=O)C)C4=CC=C(C=C4)N)OCO3,PHASE2,nervous_system_disease
3364,Migraine Headache,Loxapine,CN1CCN(CC1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl,PHASE2,nervous_system_disease
3365,Obstructive Sleep Apnea,Trazodone,C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl,PHASE1|PHASE2,nervous_system_disease
3366,Multiple Sclerosis,Methylphenidate,COC(=O)C(C1CCCCN1)C2=CC=CC=C2,PHASE2|PHASE3,nervous_system_disease
3367,Primary Central Nervous Lymphoma|Intraocular Lymphoma,Ibrutinib,C=CC(=O)N1CCCC(C1)N2C3=NC=NC(=C3C(=N2)C4=CC=C(C=C4)OC5=CC=CC=C5)N,PHASE2,nervous_system_disease
3368,Mild Alzheimer Disease,Donepezil,COC1=C(C=C2C(=C1)CC(C2=O)CC3CCN(CC3)CC4=CC=CC=C4)OC,PHASE2|PHASE3,nervous_system_disease
3369,Parkinson Disease|Perioperative Care,Amantadine,C1C2CC3CC1CC(C2)(C3)N,PHASE2,nervous_system_disease
3370,Subarachnoid Hemorrhage|Delayed Vasospasm,Simvastatin,CCC(C)(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,PHASE1|PHASE2,nervous_system_disease
3371,Delirium|Cognition Disorders,Ziprasidone,C1CN(CCN1CCC2=C(C=C3C(=C2)CC(=O)N3)Cl)C4=NSC5=CC=CC=C54,PHASE2,nervous_system_disease
3372,Delirium|Cognition Disorders,Haloperidol,C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F,PHASE2,nervous_system_disease
3373,Pain|Cancer|Sickle Cell Anemia|Severe Burns,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,PHASE2,nervous_system_disease
3374,Parkinson's Disease,Istradefylline,CCN1C2=C(C(=O)N(C1=O)CC)N(C(=N2)C=CC3=CC(=C(C=C3)OC)OC)C,PHASE2,nervous_system_disease
3375,Stroke,Aspirin,CC(=O)OC1=CC=CC=C1C(=O)O,PHASE2,nervous_system_disease
3376,Stroke,Urokinase,CC(C)OC(=O)NC1=CC2=C(C=C1)N=C(N2)C3=CSC=N3,PHASE2,nervous_system_disease
3377,Inflamed Meninges|Suspected Meningitis|Ventriculitis,Ceftobiprole,C1CNCC1N2CCC(=CC3=C(N4C(C(C4=O)NC(=O)C(=NO)C5=NSC(=N5)N)SC3)C(=O)O)C2=O,PHASE2,nervous_system_disease
3378,Moderate to Severe Cyclic Mastalgia,Danazol,CC12CCC3C(C1CCC2(C#C)O)CCC4=CC5=C(CC34C)C=NO5,PHASE2,nervous_system_disease
3379,Autonomic Failure|Pure Autonomic Failure|Multiple System Atrophy|Parkinson Disease|Orthostatic Hypotension,Droxidopa,C1=CC(=C(C=C1C(C(C(=O)O)N)O)O)O,PHASE1,nervous_system_disease
3380,Autonomic Failure|Pure Autonomic Failure|Multiple System Atrophy|Parkinson Disease|Orthostatic Hypotension,Midodrine,COC1=CC(=C(C=C1)OC)C(CNC(=O)CN)O,PHASE1,nervous_system_disease
3381,Tourette Syndrome,Valbenazine,CC(C)CC1CN2CCC3=CC(=C(C=C3C2CC1OC(=O)C(C(C)C)N)OC)OC,PHASE2,nervous_system_disease
3382,Cerebral Hemorrhage|Atrial Fibrillation,Apixaban,COC1=CC=C(C=C1)N2C3=C(CCN(C3=O)C4=CC=C(C=C4)N5CCCCC5=O)C(=N2)C(=O)N,PHASE2,nervous_system_disease
3383,Cerebral Hemorrhage|Atrial Fibrillation,Clopidogrel,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,PHASE2,nervous_system_disease
3384,Cerebral Hemorrhage|Atrial Fibrillation,Dipyridamole,C1CCN(CC1)C2=NC(=NC3=C2N=C(N=C3N4CCCCC4)N(CCO)CCO)N(CCO)CCO,PHASE2,nervous_system_disease
3385,Optic Neuritis|Multiple Sclerosis,Phenytoin,C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=CC=C3,PHASE2,nervous_system_disease
3386,Alzheimer's Disease,Nefiracetam,CC1=C(C(=CC=C1)C)NC(=O)CN2CCCC2=O,PHASE2,nervous_system_disease
3387,Hearing Loss Ototoxic,Azasetron,CN1C(=O)COC2=C(C=C(C=C21)Cl)C(=O)NC3CN4CCC3CC4,PHASE2,nervous_system_disease
3388,Acute Sciatica,Betamethasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,PHASE2,nervous_system_disease
3389,Acute Sciatica,Dexamethasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,PHASE2,nervous_system_disease
3390,Neonatal Encephalopathy,Sildenafil,CCCC1=NN(C2=C1N=C(NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C,PHASE1,nervous_system_disease
3391,Diffuse Intrinsic Pontine Glioma,Cilengitide,CC(C)C1C(=O)NC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)N1C)CC2=CC=CC=C2)CC(=O)O)CCCN=C(N)N,PHASE1,nervous_system_disease
3392,Adult Anaplastic Astrocytoma|Adult Anaplastic Oligodendroglioma|Adult Giant Cell Glioblastoma|Adult Glioblastoma|Adult Gliosarcoma|Recurrent Adult Brain Neoplasm,Bendamustine,CN1C2=C(C=C(C=C2)N(CCCl)CCCl)N=C1CCCC(=O)O,PHASE2,nervous_system_disease
3393,Chronic Insomnia,Mirtazapine,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4,PHASE1,nervous_system_disease
3394,Duchenne Muscular Dystrophy|Becker Muscular Dystrophy|Limb Girdle Muscular Dystrophy,Lisinopril,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,PHASE2|PHASE3,nervous_system_disease
3395,Pediatric Brain Tumor|Diffuse Intrinsic Pontine Glioma,Veledimex,CCCC(C(C)(C)C)N(C(=O)C1=CC(=CC(=C1)C)C)NC(=O)C2=C(C(=CC=C2)OC)CC,PHASE1|PHASE2,nervous_system_disease
3396,Estrogen Receptor Negative (ER-Negative) Breast Cancer|Progesterone Receptor Negative (PR-Negative) Breast Cancer|Human Epidermal Growth Factor Receptor 2 Negative (HER2-Negative) Breast Cancer|Brain Metastases,Iniparib,C1=CC(=C(C=C1C(=O)N)[N+](=O)[O-])I,PHASE2,nervous_system_disease
3397,Pompe Disease,Diphenhydramine,CN(C)CCOC(C1=CC=CC=C1)C2=CC=CC=C2,PHASE1,nervous_system_disease
3398,"Alcohol Abuse, Nervous System",Pitolisant,C1CCN(CC1)CCCOCCCC2=CC=C(C=C2)Cl,PHASE2,nervous_system_disease
3399,Renal Colic,Piroxicam,CN1C(=C(C2=CC=CC=C2S1(=O)=O)O)C(=O)NC3=CC=CC=N3,PHASE1|PHASE2,nervous_system_disease
3400,Brain Stem Neoplasms|Glioma|Pinealoma,Temsirolimus,CC1CCC2CC(C(=CC=CC=CC(CC(C(=O)C(C(C(=CC(C(=O)CC(OC(=O)C3CCCCN3C(=O)C(=O)C1(O2)O)C(C)CC4CCC(C(C4)OC)OC(=O)C(C)(CO)CO)C)C)O)OC)C)C)C)OC,PHASE1,nervous_system_disease
3401,Diabetic Polyneuropathy,Lidorestat,C1=CC=C2C(=C1)C(=CN2CC(=O)O)CC3=NC4=C(C(=CC(=C4S3)F)F)F,PHASE2,nervous_system_disease
3402,Brain Metastasis|Non-small Cell Lung Cancer,Patupilone,CC1CCCC2(C(O2)CC(OC(=O)CC(C(C(=O)C(C1O)C)(C)C)O)C(=CC3=CSC(=N3)C)C)C,PHASE2,nervous_system_disease
3403,Meningiomas,Tricyclazole,CC1=C2C(=CC=C1)SC3=NN=CN23,PHASE2,nervous_system_disease
3404,Cognitive Fatigue,Dalfampridine,C1=CN=CC=C1N,PHASE2|PHASE3,nervous_system_disease
3405,Pompe Disease,Duvoglustat,C1C(C(C(C(N1)CO)O)O)O,PHASE2,nervous_system_disease
3406,Neurofibromatosis Type 2|Vestibular Schwannomas,Axitinib,CNC(=O)C1=CC=CC=C1SC2=CC3=C(C=C2)C(=NN3)C=CC4=CC=CC=N4,PHASE2,nervous_system_disease
3407,Fibromyalgia,Melatonin,CC(=O)NCCC1=CNC2=C1C=C(C=C2)OC,PHASE2|PHASE3,nervous_system_disease
3408,Fibromyalgia,Amitriptyline,CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31,PHASE2|PHASE3,nervous_system_disease
3409,Traumatic Brain Injury,Minocycline,CN(C)C1C2CC3CC4=C(C=CC(=C4C(=C3C(=O)C2(C(=C(C1=O)C(=O)N)O)O)O)O)N(C)C,PHASE2,nervous_system_disease
3410,Traumatic Brain Injury,Candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,PHASE2,nervous_system_disease
3411,Hypersomnia|Primary Hypersomnia|Idiopathic Hypersomnia|Narcolepsy Without Cataplexy,Flumazenil,CCOC(=O)C1=C2CN(C(=O)C3=C(N2C=N1)C=CC(=C3)F)C,PHASE1|PHASE2,nervous_system_disease
3412,Pain,Reboxetine,CCOC1=CC=CC=C1OC(C2CNCCO2)C3=CC=CC=C3,PHASE2,nervous_system_disease
3413,Frontotemporal Dementia,Prednisone,CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C,PHASE1|PHASE2,nervous_system_disease
3414,Attention Deficit Disorder With Hyperactivity,Guanfacine,C1=CC(=C(C(=C1)Cl)CC(=O)N=C(N)N)Cl,PHASE2,nervous_system_disease
3415,Amyotrophic Lateral Sclerosis (ALS),Pimozide,C1CN(CCC1N2C3=CC=CC=C3NC2=O)CCCC(C4=CC=C(C=C4)F)C5=CC=C(C=C5)F,PHASE2,nervous_system_disease
3416,Epilepsy,Brivaracetam,CCCC1CC(=O)N(C1)C(CC)C(=O)N,PHASE2,nervous_system_disease
3417,Neonatal Seizures,Bumetanide,CCCCNC1=C(C(=CC(=C1)C(=O)O)S(=O)(=O)N)OC2=CC=CC=C2,PHASE1|PHASE2,nervous_system_disease
3418,Corneal Abrasion,Tetracaine,CCCCNC1=CC=C(C=C1)C(=O)OCCN(C)C,PHASE2|PHASE3,nervous_system_disease
3419,ICAD - Intracranial Atherosclerotic Disease,Colchicine,CC(=O)NC1CCC2=CC(=C(C(=C2C3=CC=C(C(=O)C=C13)OC)OC)OC)OC,PHASE2,nervous_system_disease
3420,CNS Tumor|Solid Tumor,Entinostat,C1=CC=C(C(=C1)N)NC(=O)C2=CC=C(C=C2)CNC(=O)OCC3=CN=CC=C3,PHASE1|PHASE2,nervous_system_disease
3421,"Niemann-Pick Disease, Type C",Adrabetadex,CC(COCC1C2CC(C(O1)OC3C(OC(C(C3O)OCC(C)O)OC4C(OC(C(C4O)O)OC5C(OC(C(C5O)O)OC6C(OC(C(C6O)O)OC7C(OC(C(C7O)O)OC8C(OC(O2)C(C8O)O)COCC(C)O)CO)COCC(C)O)CO)CO)CO)O)O,PHASE2|PHASE3,nervous_system_disease
3422,Chronic Prostatitis With Chronic Pelvic Pain Syndrome,Tamsulosin,CCOC1=CC=CC=C1OCCNC(C)CC2=CC(=C(C=C2)OC)S(=O)(=O)N,PHASE2,nervous_system_disease
3423,Emergence Delirium,Clonidine,C1CN=C(N1)NC2=C(C=CC=C2Cl)Cl,PHASE2|PHASE3,nervous_system_disease
3424,Head Trauma|Subarachnoid Hemorrhage|Close Head Injury,Morphine,CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O,PHASE1|PHASE2,nervous_system_disease
3425,Ischemic Stroke,Meglumine,CNCC(C(C(C(CO)O)O)O)O,PHASE2|PHASE3,nervous_system_disease
3426,Migraine|Headache,Topiramate,CC1(OC2COC3(C(C2O1)OC(O3)(C)C)COS(=O)(=O)N)C,PHASE2,nervous_system_disease
3427,Postherpetic Neuralgia,Prilocaine,CCCNC(C)C(=O)NC1=CC=CC=C1C,PHASE2,nervous_system_disease
3428,Migraine|Acute Treatment of Migraine,Rimegepant,C1CC(C2=C(C=CC=N2)C(C1C3=C(C(=CC=C3)F)F)N)OC(=O)N4CCC(CC4)N5C6=C(NC5=O)N=CC=C6,PHASE2,nervous_system_disease
3429,Migraine|Acute Treatment of Migraine,Sumatriptan,CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C,PHASE2,nervous_system_disease
3430,Alzheimer Disease|Healthy,Lecozotan,CC(CN(C1=CC=CC=N1)C(=O)C2=CC=C(C=C2)C#N)N3CCN(CC3)C4=C5C(=CC=C4)OCCO5,PHASE1,nervous_system_disease
3431,Alzheimer Disease|Healthy,Moxifloxacin,COC1=C2C(=CC(=C1N3CC4CCCNC4C3)F)C(=O)C(=CN2C5CC5)C(=O)O,PHASE1,nervous_system_disease
3432,Tourettes Syndrome|Tic,Acetylcysteine,CC(=O)NC(CS)C(=O)O,PHASE2,nervous_system_disease
3433,"Malignant Melanoma|Carcinoma, Non-Small-Cell Lung|Brain Neoplasms, Primary|Brain Neoplasms|Malignant Neoplasms",Binimetinib,CN1C=NC2=C1C=C(C(=C2F)NC3=C(C=C(C=C3)Br)F)C(=O)NOCCO,PHASE1,nervous_system_disease
3434,"Malignant Melanoma|Carcinoma, Non-Small-Cell Lung|Brain Neoplasms, Primary|Brain Neoplasms|Malignant Neoplasms",Midazolam,CC1=NC=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4F,PHASE1,nervous_system_disease
3435,Irritable Bowel Syndrome,Lubiprostone,CCCCC(C1(CCC2C(O1)CC(=O)C2CCCCCCC(=O)O)O)(F)F,PHASE1,nervous_system_disease
3436,Migraine,Lasmiditan,CN1CCC(CC1)C(=O)C2=NC(=CC=C2)NC(=O)C3=C(C=C(C=C3F)F)F,PHASE1,nervous_system_disease
3437,Parkinson Disease,Nilotinib,CC1=C(C=C(C=C1)C(=O)NC2=CC(=CC(=C2)C(F)(F)F)N3C=C(N=C3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,PHASE2,nervous_system_disease
3438,Brain Cancer|Pediatric Cancers,Lapatinib,CS(=O)(=O)CCNCC1=CC=C(O1)C2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=CC(=CC=C5)F)Cl,PHASE2,nervous_system_disease
3439,Epilepsy,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,PHASE1|PHASE2,nervous_system_disease
3440,Alzheimer Disease,Montelukast,CC(C)(C1=CC=CC=C1CCC(C2=CC=CC(=C2)C=CC3=NC4=C(C=CC(=C4)Cl)C=C3)SCC5(CC5)CC(=O)O)O,PHASE2,nervous_system_disease
3441,Alzheimer's Disease,Benfotiamine,CC1=NC=C(C(=N1)N)CN(C=O)C(=C(CCOP(=O)(O)O)SC(=O)C2=CC=CC=C2)C,PHASE2,nervous_system_disease
3442,"Central Nervous System Tumor, Pediatric",Dactinomycin,CC1C(C(=O)NC(C(=O)N2CCCC2C(=O)N(CC(=O)N(C(C(=O)O1)C(C)C)C)C)C(C)C)NC(=O)C3=C4C(=C(C=C3)C)OC5=C(C(=O)C(=C(C5=N4)C(=O)NC6C(OC(=O)C(N(C(=O)CN(C(=O)C7CCCN7C(=O)C(NC6=O)C(C)C)C)C)C(C)C)C)N)C,PHASE2,nervous_system_disease
3443,Parkinson Disease|Movement Disorders|Neuro-Degenerative Disease|Nervous System Diseases|Brain Diseases,Dopamine,C1=CC(=C(C=C1CCN)O)O,PHASE1|PHASE2,nervous_system_disease
3444,Neuromyelitis Optica Spectrum Disorder,Azathioprine,CN1C=NC(=C1SC2=NC=NC3=C2NC=N3)[N+](=O)[O-],PHASE2|PHASE3,nervous_system_disease
3445,HIV|Depression|Anhedonia,Baricitinib,CCS(=O)(=O)N1CC(C1)(CC#N)N2C=C(C=N2)C3=C4C=CNC4=NC=N3,PHASE2,nervous_system_disease
3446,Parkinson Disease,Carbidopa,CC(CC1=CC(=C(C=C1)O)O)(C(=O)O)NN,PHASE2,nervous_system_disease
3447,Parkinson Disease,Levodopa,C1=CC(=C(C=C1CC(C(=O)O)N)O)O,PHASE2,nervous_system_disease
3448,"Acute Pain|Chronic Pain, Widespread|Schizophrenia",Ketamine,CNC1(CCCCC1=O)C2=CC=CC=C2Cl,PHASE2|PHASE3,nervous_system_disease
3449,Parkinson Disease|Depression,Nortriptyline,CNCCC=C1C2=CC=CC=C2CCC3=CC=CC=C31,PHASE2,nervous_system_disease
3450,Myasthenia Gravis,Albuterol,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,PHASE2|PHASE3,nervous_system_disease
3451,Myasthenia Gravis,Salbutamol,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,PHASE2|PHASE3,nervous_system_disease
3452,Gastroparesis,Metoclopramide,CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl,PHASE2,nervous_system_disease
3453,Multiple Sclerosis,Duloxetine,CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32,PHASE2|PHASE3,nervous_system_disease
3454,Acute Migraine,Zolmitriptan,CN(C)CCC1=CNC2=C1C=C(C=C2)CC3COC(=O)N3,PHASE2|PHASE3,nervous_system_disease
3455,Restless Legs Syndrome,Ropinirole,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1,PHASE1,nervous_system_disease
3456,Diabetic Peripheral Neuropathy,Bicifadine,CC1=CC=C(C=C1)C23CC2CNC3,PHASE2,nervous_system_disease
3457,Refractory Cancer|Refractory Neoplasm|Cancer Pediatric|Refractory Tumor|Pediatric Cancer|Pediatric Brain Tumor|Neuroblastoma|Neuroblastoma Recurrent|Pediatric Lymphoma|Pediatric Meningioma|Diffuse Intrinsic Pontine Glioma,Irinotecan,CCC1=C2CN3C(=CC4=C(C3=O)COC(=O)C4(CC)O)C2=NC5=C1C=C(C=C5)OC(=O)N6CCC(CC6)N7CCCCC7,PHASE1,nervous_system_disease
3458,Refractory Cancer|Refractory Neoplasm|Cancer Pediatric|Refractory Tumor|Pediatric Cancer|Pediatric Brain Tumor|Neuroblastoma|Neuroblastoma Recurrent|Pediatric Lymphoma|Pediatric Meningioma|Diffuse Intrinsic Pontine Glioma,Cyclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,PHASE1,nervous_system_disease
3459,Refractory Cancer|Refractory Neoplasm|Cancer Pediatric|Refractory Tumor|Pediatric Cancer|Pediatric Brain Tumor|Neuroblastoma|Neuroblastoma Recurrent|Pediatric Lymphoma|Pediatric Meningioma|Diffuse Intrinsic Pontine Glioma,Topotecan,CCC1(C2=C(COC1=O)C(=O)N3CC4=CC5=C(C=CC(=C5CN(C)C)O)N=C4C3=C2)O,PHASE1,nervous_system_disease
3460,Creutzfeldt-Jakob Disease,Quinacrine,CCN(CC)CCCC(C)NC1=C2C=C(C=CC2=NC3=C1C=CC(=C3)Cl)OC,PHASE2,nervous_system_disease
3461,Ureteral Obstruction|Flank Pain,Mirabegron,C1=CC=C(C=C1)C(CNCCC2=CC=C(C=C2)NC(=O)CC3=CSC(=N3)N)O,PHASE2,nervous_system_disease
3462,Newly Diagnosed High Grade Glioma,Lomustine,C1CCC(CC1)NC(=O)N(CCCl)N=O,PHASE1,nervous_system_disease
3463,Primary Progressive Multiple Sclerosis,Idebenone,CC1=C(C(=O)C(=C(C1=O)OC)OC)CCCCCCCCCCO,PHASE1|PHASE2,nervous_system_disease
3464,Parkinson Disease|Parkinsonian Syndrome,Citrulline,C(CC(C(=O)O)N)CNC(=O)N,PHASE2,nervous_system_disease
3465,Complex Regional Pain Syndromes,Ethosuximide,CCC1(CC(=O)NC1=O)C,PHASE2,nervous_system_disease
3466,"Alzheimer Disease, Early Onset",Efavirenz,C1CC1C#CC2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F,PHASE1,nervous_system_disease
3467,Traumatic Brain Injury (TBI),Pregnanolone,CC(=O)C1CCC2C1(CCC3C2CCC4C3(CCC(C4)O)C)C,PHASE2,nervous_system_disease
3468,Traumatic Brain Injury (TBI),Allopregnanolone,CC(=O)C1CCC2C1(CCC3C2CCC4C3(CCC(C4)O)C)C,PHASE2,nervous_system_disease
3469,Traumatic Brain Injury (TBI),Brexanolone,CC(=O)C1CCC2C1(CCC3C2CCC4C3(CCC(C4)O)C)C,PHASE2,nervous_system_disease
3470,Cushing's Disease,Bexarotene,CC1=CC2=C(C=C1C(=C)C3=CC=C(C=C3)C(=O)O)C(CCC2(C)C)(C)C,PHASE1|PHASE2,nervous_system_disease
3471,Advanced Malignant Neoplasm|Delirium|Locally Advanced Malignant Neoplasm|Metastatic Malignant Neoplasm|Recurrent Malignant Neoplasm,Chlorpromazine,CN(C)CCCN1C2=CC=CC=C2SC3=C1C=C(C=C3)Cl,PHASE2|PHASE3,nervous_system_disease
3472,Nonsmall Cell Lung Cancer|Brain Metastases,Ensartinib,CC1CN(CC(N1)C)C(=O)C2=CC=C(C=C2)NC(=O)C3=NN=C(C(=C3)OC(C)C4=C(C=CC(=C4Cl)F)Cl)N,PHASE2,nervous_system_disease
3473,Aging,Dasatinib,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=CC(=NC(=N3)C)N4CCN(CC4)CCO,PHASE1|PHASE2,nervous_system_disease
3474,Aging,Quercetin,C1=CC(=C(C=C1C2=C(C(=O)C3=C(C=C(C=C3O2)O)O)O)O)O,PHASE1|PHASE2,nervous_system_disease
3475,"Diffuse Intrinsic Pontine Glioma|Diffuse Midline Glioma, H3 K27M-Mutant|Recurrent Diffuse Intrinsic Pontine Glioma|Recurrent Diffuse Midline Glioma, H3 K27M-Mutant|Recurrent WHO Grade III Glioma|WHO Grade III Glioma",Paxalisib,CC1(C2=NC3=C(N2CCO1)N=C(N=C3N4CCOCC4)C5=CN=C(N=C5)N)C,PHASE2,nervous_system_disease
3476,Epilepsy,Muscimol,C1=C(ONC1=O)CN,PHASE1,nervous_system_disease
3477,Intracerebral Hemorrhage,Deferoxamine,CC(=O)N(CCCCCNC(=O)CCC(=O)N(CCCCCNC(=O)CCC(=O)N(CCCCCN)O)O)O,PHASE2,nervous_system_disease
3478,Giant Cell Arteritis,Methotrexate,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,PHASE2,nervous_system_disease
3479,Fibromyalgia,Desvenlafaxine,CN(C)CC(C1=CC=C(C=C1)O)C2(CCCCC2)O,PHASE2|PHASE3,nervous_system_disease
3480,HER2 Positive Metastatic Breast Cancer,Pyrotinib,CCOC1=C(C=C2C(=C1)N=CC(=C2NC3=CC(=C(C=C3)OCC4=CC=CC=N4)Cl)C#N)NC(=O)C=CC5CCCN5C,PHASE2,nervous_system_disease
3481,HER2 Positive Metastatic Breast Cancer,Capecitabine,CCCCCOC(=O)NC1=NC(=O)N(C=C1F)C2C(C(C(O2)C)O)O,PHASE2,nervous_system_disease
3482,Alzheimer's Disease,Rosiglitazone,CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3,PHASE1,nervous_system_disease
3483,Coronary Artery Disease|Cerebrovascular Disease|Peripheral Vascular Disease,Rifalazil,CC1C=CC=C(C(=O)NC2=C3C(=C4C(=C(C(=C5C4=C(C(O5)(OC=CC(C(C(C(C(C(C1O)C)O)C)OC(=O)C)C)OC)C)O)C)O)C2=O)N=C6C(=CC(=CC6=O)N7CCN(CC7)CC(C)C)O3)C,PHASE2,nervous_system_disease
3484,Pain|Delayed Onset Muscle Soreness,Ibuprofen,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O,PHASE2,nervous_system_disease
3485,Progressive Supranuclear Palsy,Salsalate,C1=CC=C(C(=C1)C(=O)OC2=CC=CC=C2C(=O)O)O,PHASE1,nervous_system_disease
3486,Myasthenia Gravis|Ocular Myasthenia Gravis,Apraclonidine,C1CN=C(N1)NC2=C(C=C(C=C2Cl)N)Cl,PHASE2,nervous_system_disease
3487,"HIV Infections|Leukoencephalopathy, Progressive Multifocal",Cytarabine,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,PHASE2,nervous_system_disease
3488,"HIV Infections|Leukoencephalopathy, Progressive Multifocal",Zalcitabine,C1CC(OC1CO)N2C=CC(=NC2=O)N,PHASE2,nervous_system_disease
3489,"HIV Infections|Leukoencephalopathy, Progressive Multifocal",Didanosine,C1CC(OC1CO)N2C=NC3=C2N=CNC3=O,PHASE2,nervous_system_disease
3490,Fibromyalgia,Naltrexone,C1CC1CN2CCC34C5C(=O)CCC3(C2CC6=C4C(=C(C=C6)O)O5)O,PHASE2|PHASE3,nervous_system_disease
3491,Multiple Sclerosis,Famciclovir,CC(=O)OCC(CCN1C=NC2=CN=C(N=C21)N)COC(=O)C,PHASE2,nervous_system_disease
3492,Epilepsy,Carbamazepine,C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N,PHASE1,nervous_system_disease
3493,Meningitis,Doripenem,CC1C2C(C(=O)N2C(=C1SC3CC(NC3)CNS(=O)(=O)N)C(=O)O)C(C)O,PHASE1,nervous_system_disease
3494,Duchenne Muscular Dystrophy,Deflazacort,CC1=NC2(C(O1)CC3C2(CC(C4C3CCC5=CC(=O)C=CC45C)O)C)C(=O)COC(=O)C,PHASE1,nervous_system_disease
3495,Phenylketonuria,Sapropterin,CC(C(C1CNC2=C(N1)C(=O)NC(=N2)N)O)O,PHASE2,nervous_system_disease
3496,Phenylketonuria,Tetrahydrobiopterin,CC(C(C1CNC2=C(N1)C(=O)NC(=N2)N)O)O,PHASE2,nervous_system_disease
3497,Delirium,Dexmedetomidine,CC1=C(C(=CC=C1)C(C)C2=CN=CN2)C,PHASE2|PHASE3,nervous_system_disease
3498,Parkinson Disease Psychosis,Iloperidone,CC(=O)C1=CC(=C(C=C1)OCCCN2CCC(CC2)C3=NOC4=C3C=CC(=C4)F)OC,PHASE2,nervous_system_disease
3499,Parkinson Disease,Sulforaphane,CS(=O)CCCCN=C=S,PHASE2,nervous_system_disease
3500,Brain and Central Nervous System Tumors|Drug/Agent Toxicity by Tissue/Organ|Lymphoma|Thrombocytopenia,Etoposide,CC1OCC2C(O1)C(C(C(O2)OC3C4COC(=O)C4C(C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)O)OC)O)O,PHASE2,nervous_system_disease
3501,Brain and Central Nervous System Tumors|Drug/Agent Toxicity by Tissue/Organ|Lymphoma|Thrombocytopenia,Carboplatin,C1CC(C1)(C(=O)O)C(=O)O.[NH2-].[NH2-].[Pt+2],PHASE2,nervous_system_disease
3502,Epilepsy,Sulthiame,C1CCS(=O)(=O)N(C1)C2=CC=C(C=C2)S(=O)(=O)N,PHASE1,nervous_system_disease
3503,Cerebral Vasospasm,Milrinone,CC1=C(C=C(C(=O)N1)C#N)C2=CC=NC=C2,PHASE2,nervous_system_disease
3504,Acute Ischemic Stroke,Tromethamine,C(C(CO)(CO)N)O,PHASE1,nervous_system_disease
3505,Back Pain|Acute Pain|Back Spasm Upper Back|Back Strain|Muscle Cramp|Muscle Spasm|Low Back Pain,Tolperisone,CC1=CC=C(C=C1)C(=O)C(C)CN2CCCCC2,PHASE2,nervous_system_disease
3506,Optic Neuritis|Multiple Sclerosis,Amiloride,C1(=C(N=C(C(=N1)Cl)N)N)C(=O)N=C(N)N,PHASE2,nervous_system_disease
3507,"Stuttering, Adult|Childhood-onset Fluency Disorder|Speech Disorders|Language Disorders|Communication Disorder",Ecopipam,CN1CCC2=CC(=C(C=C2C3C1CCC4=CC=CC=C34)O)Cl,PHASE2|PHASE3,nervous_system_disease
3508,Advanced Solid Tumor|CNS Tumor|Recurrent WHO Grade II Glioma,Infigratinib,CCN1CCN(CC1)C2=CC=C(C=C2)NC3=CC(=NC=N3)N(C)C(=O)NC4=C(C(=CC(=C4Cl)OC)OC)Cl,PHASE1|PHASE2,nervous_system_disease
3509,Amyotrophic Lateral Sclerosis,Riluzole,C1=CC2=C(C=C1OC(F)(F)F)SC(=N2)N,PHASE2|PHASE3,nervous_system_disease
3510,Attention Deficit Hyperactivity Disorder,Dasotraline,C1CC(C2=CC=CC=C2C1C3=CC(=C(C=C3)Cl)Cl)N,PHASE2|PHASE3,nervous_system_disease
3511,Relapsing Multiple Sclerosis,Glatiramer,CC(C(=O)O)N.C1=CC(=CC=C1CC(C(=O)O)N)O.C(CCN)CC(C(=O)O)N.C(CC(=O)O)C(C(=O)O)N,PHASE2,nervous_system_disease
3512,Brain Cancer|Head and Neck Cancer|Cervix Cancer|Central Nervous System Neoplasms,Bortezomib,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O,PHASE1,nervous_system_disease
3513,Ischemic Stroke,Argatroban,CC1CCN(C(C1)C(=O)O)C(=O)C(CCCN=C(N)N)NS(=O)(=O)C2=CC=CC3=C2NCC(C3)C,PHASE2,nervous_system_disease
3514,Multiple Sclerosis,Pioglitazone,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3,PHASE1|PHASE2,nervous_system_disease
3515,Multiple Sclerosis,Dantrolene,C1C(=O)NC(=O)N1N=CC2=CC=C(O2)C3=CC=C(C=C3)[N+](=O)[O-],PHASE1|PHASE2,nervous_system_disease
3516,Multiple Sclerosis,Pirfenidone,CC1=CN(C(=O)C=C1)C2=CC=CC=C2,PHASE1|PHASE2,nervous_system_disease
3517,"Hereditary Tyrosinemia, Type I",Nitisinone,C1CC(=O)C(C(=O)C1)C(=O)C2=C(C=C(C=C2)C(F)(F)F)[N+](=O)[O-],PHASE1,nervous_system_disease
3518,Friedreich Ataxia,Etravirine,CC1=CC(=CC(=C1OC2=NC(=NC(=C2Br)N)NC3=CC=C(C=C3)C#N)C)C#N,PHASE2,nervous_system_disease
3519,Eye Pain,Loteprednol,CC12CC(C3C(C1CCC2(C(=O)OCCl)O)CCC4=CC(=O)C=CC34C)O,PHASE1,nervous_system_disease
3520,"Neural Tube Defects|Anemia|Leukemia, Myeloid|Bone Marrow Transplant Failure|Myelodysplastic Syndromes (MDS)|Myeloproliferative Disorders",Cyclosporine,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,PHASE2,nervous_system_disease
3521,"Neural Tube Defects|Anemia|Leukemia, Myeloid|Bone Marrow Transplant Failure|Myelodysplastic Syndromes (MDS)|Myeloproliferative Disorders",Mycophenolate,CC1=C2COC(=O)C2=C(C(=C1OC)CC=C(C)CCC(=O)O)O,PHASE2,nervous_system_disease
3522,Recurrent Meningiomas|Resistant Meningiomas,Everolimus,CC1CCC2CC(C(=CC=CC=CC(CC(C(=O)C(C(C(=CC(C(=O)CC(OC(=O)C3CCCCN3C(=O)C(=O)C1(O2)O)C(C)CC4CCC(C(C4)OC)OCCO)C)C)O)OC)C)C)C)OC,PHASE2,nervous_system_disease
3523,Recurrent Meningiomas|Resistant Meningiomas,Octreotide,CC(C1C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=CC=C4)NC(=O)C(CC5=CC=CC=C5)N)C(=O)NC(CO)C(C)O)O,PHASE2,nervous_system_disease
3524,Migraine Headache,Psilocybin,CN(C)CCC1=CNC2=C1C(=CC=C2)OP(=O)(O)O,PHASE1,nervous_system_disease
3525,Breast Cancer,Cisplatin,N.N.Cl[Pt]Cl,PHASE2,nervous_system_disease
3526,Stroke,Exenatide,CCC(C)C(C(=O)NC(CCC(=O)O)C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(CC(C)C)C(=O)NC(CCCCN)C(=O)NC(CC(=O)N)C(=O)NCC(=O)NCC(=O)N3CCCC3C(=O)NC(CO)C(=O)NC(CO)C(=O)NCC(=O)NC(C)C(=O)N4CCCC4C(=O)N5CCCC5C(=O)N6CCCC6C(=O)NC(CO)C(=O)N)NC(=O)C(CC7=CC=CC=C7)NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(C(C)C)NC(=O)C(C)NC(=O)C(CCC(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(CCSC)NC(=O)C(CCC(=O)N)NC(=O)C(CCCCN)NC(=O)C(CO)NC(=O)C(CC(C)C)NC(=O)C(CC(=O)O)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C(CC8=CC=CC=C8)NC(=O)C(C(C)O)NC(=O)CNC(=O)C(CCC(=O)O)NC(=O)CNC(=O)C(CC9=CNC=N9)N,PHASE2,nervous_system_disease
3527,HAM/TSP,Teriflunomide,CC(=C(C#N)C(=O)NC1=CC=C(C=C1)C(F)(F)F)O,PHASE1|PHASE2,nervous_system_disease
3528,Multiple Sclerosis,Dexrazoxane,CC(CN1CC(=O)NC(=O)C1)N2CC(=O)NC(=O)C2,PHASE2,nervous_system_disease
3529,Multiple Sclerosis,Mitoxantrone,C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO,PHASE2,nervous_system_disease
3530,X-Linked Adrenoleukodystrophy,Sobetirome,CC1=CC(=CC(=C1CC2=CC(=C(C=C2)O)C(C)C)C)OCC(=O)O,PHASE1|PHASE2,nervous_system_disease
3531,Acute Pain,Lorazepam,C1=CC=C(C(=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O)Cl,PHASE2,nervous_system_disease
3532,Myasthenia Gravis,Mesna,C(CS(=O)(=O)[O-])S.[Na+],PHASE1,nervous_system_disease
3533,Cognitive Symptom|Schizophrenia,Modafinil,C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N,PHASE1,nervous_system_disease
3534,Giant Cell Arteritis,Prednisolone,CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O,PHASE2,nervous_system_disease
3535,VHL - Von Hippel-Lindau Syndrome|VHL Gene Mutation|VHL Syndrome|VHL Gene Inactivation|VHL-Associated Renal Cell Carcinoma|VHL-Associated Clear Cell Renal Cell Carcinoma,Belzutifan,CS(=O)(=O)C1=C2C(C(C(C2=C(C=C1)OC3=CC(=CC(=C3)C#N)F)F)F)O,PHASE2,nervous_system_disease
3536,Non-functioning Pituitary Adenomas|Prolactinomas,Pasireotide,C1C(CN2C1C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C2=O)CC3=CC=CC=C3)CC4=CC=C(C=C4)OCC5=CC=CC=C5)CCCCN)CC6=CNC7=CC=CC=C76)C8=CC=CC=C8)OC(=O)NCCN,PHASE2|PHASE3,nervous_system_disease
3537,Muscle Weakness|Anterior Cruciate Ligament Rupture,Tramadol,CN(C)CC1CCCCC1(C2=CC(=CC=C2)OC)O,PHASE2|PHASE3,nervous_system_disease
3538,Muscle Weakness|Anterior Cruciate Ligament Rupture,Paracetamol,CC(=O)NC1=CC=C(C=C1)O,PHASE2|PHASE3,nervous_system_disease
3539,Spinal Muscular Atrophy,Nusinersen,CC1=CN(C(=O)NC1=O)C2C(C(C(O2)CO)OP(=S)(O)OCC3C(C(C(O3)N4C=C(C(=NC4=O)N)C)OCCOC)OP(=S)(O)OCC5C(C(C(O5)N6C=NC7=C(N=CN=C76)N)OCCOC)OP(=S)(O)OCC8C(C(C(O8)N9C=C(C(=NC9=O)N)C)OCCOC)OP(=S)(O)OCC1C(C(C(O1)N1C=C(C(=O)NC1=O)C)OCCOC)OP(=S)(O)OCC1C(C(C(O1)N1C=C(C(=O)NC1=O)C)OCCOC)OP(=S)(O)OCC1C(C(C(O1)N1C=C(C(=O)NC1=O)C)OCCOC)OP(=S)(O)OCC1C(C(C(O1)N1C=C(C(=NC1=O)N)C)OCCOC)OP(=S)(O)OCC1C(C(C(O1)N1C=NC2=C(N=CN=C21)N)OCCOC)OP(=S)(O)OCC1C(C(C(O1)N1C=C(C(=O)NC1=O)C)OCCOC)OP(=S)(O)OCC1C(C(C(O1)N1C=NC2=C(N=CN=C21)N)OCCOC)OP(=S)(O)OCC1C(C(C(O1)N1C=NC2=C(N=CN=C21)N)OCCOC)OP(=S)(O)OCC1C(C(C(O1)N1C=C(C(=O)NC1=O)C)OCCOC)OP(=S)(O)OCC1C(C(C(O1)N1C=NC2=C1N=C(NC2=O)N)OCCOC)OP(=S)(O)OCC1C(C(C(O1)N1C=C(C(=NC1=O)N)C)OCCOC)OP(=S)(O)OCC1C(C(C(O1)N1C=C(C(=O)NC1=O)C)OCCOC)OP(=S)(O)OCC1C(C(C(O1)N1C=NC2=C1N=C(NC2=O)N)OCCOC)OP(=S)(O)OCC1C(C(C(O1)N1C=NC2=C1N=C(NC2=O)N)OCCOC)O)OCCOC,PHASE1|PHASE2,nervous_system_disease
3540,Parkinson's Disease|Dyskinesia,Sarizotan,C1CC2=CC=CC=C2OC1CNCC3=CC(=CN=C3)C4=CC=C(C=C4)F,PHASE2,nervous_system_disease
3541,Neuropathic Pain|Chemotherapy Effect,Telmisartan,CCCC1=NC2=C(N1CC3=CC=C(C=C3)C4=CC=CC=C4C(=O)O)C=C(C=C2C)C5=NC6=CC=CC=C6N5C,PHASE2,nervous_system_disease
3542,Parkinson's Disease|Apomorphine-induced Skin Reactions,Apomorphine,CN1CCC2=C3C1CC4=C(C3=CC=C2)C(=C(C=C4)O)O,PHASE2,nervous_system_disease
3543,Parkinson's Disease|Apomorphine-induced Skin Reactions,Hydrocortisone,CC12CCC(=O)C=C1CCC3C2C(CC4(C3CCC4(C(=O)CO)O)C)O,PHASE2,nervous_system_disease
3544,Parkinson's Disease|Peripheral Edema,Domperidone,C1CN(CCC1N2C3=C(C=C(C=C3)Cl)NC2=O)CCCN4C5=CC=CC=C5NC4=O,PHASE2,nervous_system_disease
3545,Fibromyalgia,Mecobalamin,[CH3-].CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)([O-])OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=C(C7=NC(=CC8=NC(=C(C4=N5)C)C(C8(C)C)CCC(=O)N)C(C7(C)CC(=O)N)CCC(=O)N)C)[N-]6)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[Co+3],PHASE1|PHASE2,nervous_system_disease
3546,"Carcinoma, Non-Small-Cell Lung|Epidermal Growth Factor Receptor|Leptomeningeal Metastasis",Pemetrexed,C1=CC(=CC=C1CCC2=CNC3=C2C(=O)NC(=N3)N)C(=O)NC(CCC(=O)O)C(=O)O,PHASE2,nervous_system_disease
3547,"Sleep Apnea, Obstructive",Desipramine,CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31,PHASE2,nervous_system_disease
3548,Neuropathic Pain,Milnacipran,CCN(CC)C(=O)C1(CC1CN)C2=CC=CC=C2,PHASE2,nervous_system_disease
3549,Restless Legs Syndrome,Rotigotine,CCCN(CCC1=CC=CS1)C2CCC3=C(C2)C=CC=C3O,PHASE2,nervous_system_disease
3550,"Malaria|Malaria, Cerebral",Artesunate,CC1CCC2C(C(OC3C24C1CCC(O3)(OO4)C)OC(=O)CCC(=O)O)C,PHASE1,nervous_system_disease
3551,Non-Small Cell Lung Cancer|Brain Metastases,Icotinib,C#CC1=CC(=CC=C1)NC2=NC=NC3=CC4=C(C=C32)OCCOCCOCCO4,PHASE2,nervous_system_disease
3552,Dental Pain,Indomethacin,CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)Cl)C=CC(=C2)OC)CC(=O)O,PHASE2,nervous_system_disease
3553,Parkinson Disease,Mesdopetam,CCCNCCOC1=CC(=CC(=C1)S(=O)(=O)C)F,PHASE2,nervous_system_disease
3554,Stroke,Enecadin,CC1=NC(=CC(=N1)OCCCCCN2CCCCC2)C3=CC=C(C=C3)F,PHASE2,nervous_system_disease
3555,Oxidative Stress|Diabetic Polyneuropathy,Ezetimibe,C1=CC(=CC=C1C2C(C(=O)N2C3=CC=C(C=C3)F)CCC(C4=CC=C(C=C4)F)O)O,PHASE2,nervous_system_disease
3556,Oxidative Stress|Diabetic Polyneuropathy,Rosuvastatin,CC(C)C1=NC(=NC(=C1C=CC(CC(CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C,PHASE2,nervous_system_disease
3557,Epilepsy,Digoxin,CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,PHASE1,nervous_system_disease
3558,Refractory/Recurrent Primary Central Nervous System Lymphoma (PCNSL),Copanlisib,COC1=C(C=CC2=C3NCCN3C(=NC(=O)C4=CN=C(N=C4)N)N=C21)OCCCN5CCOCC5,PHASE1|PHASE2,nervous_system_disease
3559,Traumatic Brain Injury|TBI,Pregnenolone,CC(=O)C1CCC2C1(CCC3C2CC=C4C3(CCC(C4)O)C)C,PHASE2,nervous_system_disease
3560,Tinnitus,Acamprosate,CC(=O)NCCCS(=O)(=O)O,PHASE1,nervous_system_disease
3561,Brain Metastasis,Pentoxifylline,CC(=O)CCCCN1C(=O)C2=C(N=CN2C)N(C1=O)C,PHASE2,nervous_system_disease
3562,Post-Dural Puncture Headache,Neostigmine,CN(C)C(=O)OC1=CC=CC(=C1)[N+](C)(C)C,PHASE2,nervous_system_disease
3563,Post-Dural Puncture Headache,Atropine,CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3,PHASE2,nervous_system_disease
3564,Breast Cancer|Brain Metastases,Palbociclib,CC1=C(C(=O)N(C2=NC(=NC=C12)NC3=NC=C(C=C3)N4CCNCC4)C5CCCC5)C(=O)C,PHASE2,nervous_system_disease
3565,Breast Cancer|Brain Metastases,Fulvestrant,CC12CCC3C(C1CCC2O)C(CC4=C3C=CC(=C4)O)CCCCCCCCCS(=O)CCCC(C(F)(F)F)(F)F,PHASE2,nervous_system_disease
3566,Post Acute Sequelae Covid-19 Hyposmia,Beclomethasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)Cl)C,PHASE2,nervous_system_disease
3567,Stroke,Warfarin,CC(=O)CC(C1=CC=CC=C1)C2=C(C3=CC=CC=C3OC2=O)O,PHASE1,nervous_system_disease
3568,Stroke,Edaravone,CC1=NN(C(=O)C1)C2=CC=CC=C2,PHASE1,nervous_system_disease
3569,Ovarian Cancer|Fallopian Tube Cancer|Peritoneal Neoplasms,Paclitaxel,CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C,PHASE2,nervous_system_disease
3570,Pediatric Solid Tumor|Osteosarcoma|Rhabdomyosarcoma|Neuroblastoma|Ewing Sarcoma|Wilms Tumor|Adrenocortical Cancer|Desmoplastic Small Round Cell Tumor|Germ Cell Cancer|Rhabdoid Tumor|Clear Cell Sarcoma|Hepatoblastoma|Melanoma|Carcinoma|Malignant Peripheral Nerve Sheath Tumors|Soft Tissue Sarcoma,Fludarabine,C1=NC2=C(N=C(N=C2N1C3C(C(C(O3)CO)O)O)F)N,PHASE1,nervous_system_disease
3571,Meningioma,Dotatate,CC(C1C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=C(C=C4)O)NC(=O)C(CC5=CC=CC=C5)NC(=O)CN6CCN(CCN(CCN(CC6)CC(=O)O)CC(=O)O)CC(=O)O)C(=O)NC(C(C)O)C(=O)O)O,PHASE1,nervous_system_disease
3572,Breast Cancer|Brain Tumor - Metastatic,Cabozantinib,COC1=CC2=C(C=CN=C2C=C1OC)OC3=CC=C(C=C3)NC(=O)C4(CC4)C(=O)NC5=CC=C(C=C5)F,PHASE2,nervous_system_disease
3573,Nausea|Vomiting|Familial Dysautonomia,Dronabinol,CCCCCC1=CC(=C2C3C=C(CCC3C(OC2=C1)(C)C)C)O,PHASE2,nervous_system_disease
3574,Chronic Stable Angina,Capadenoson,C1=CC(=CC=C1C2=C(C(=NC(=C2C#N)SCC3=CSC(=N3)C4=CC=C(C=C4)Cl)N)C#N)OCCO,PHASE2,nervous_system_disease
3575,Autism Spectrum Disorder|Language Disorders,Levoleucovorin,C1C(N(C2=C(N1)N=C(NC2=O)N)C=O)CNC3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,PHASE2,nervous_system_disease
3576,Acute Stroke|Visual Field Loss,Fluoxetine,CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F,PHASE2,nervous_system_disease
3577,"Muscular Dystrophy, Duchenne",Glutamine,C(CC(=O)N)C(C(=O)O)N,PHASE2,nervous_system_disease
3578,Restless Legs Syndrome,Suvorexant,CC1CCN(CCN1C(=O)C2=C(C=CC(=C2)C)N3N=CC=N3)C4=NC5=C(O4)C=CC(=C5)Cl,PHASE2,nervous_system_disease
3579,"Epilepsies, Partial",Seletracetam,CCC(C(=O)N)N1CC(CC1=O)C=C(F)F,PHASE2|PHASE3,nervous_system_disease
3580,Cataract|Miosis,Ketorolac,C1CN2C(=CC=C2C(=O)C3=CC=CC=C3)C1C(=O)O,PHASE2,nervous_system_disease
3581,Cataract|Miosis,Nepafenac,C1=CC=C(C=C1)C(=O)C2=CC=CC(=C2N)CC(=O)N,PHASE2,nervous_system_disease
3582,Cataract|Miosis,Cyclopentolate,CN(C)CCOC(=O)C(C1=CC=CC=C1)C2(CCCC2)O,PHASE2,nervous_system_disease
3583,Advanced Cancer|Malignant Neoplasm of Breast|Malignant Neoplasms of Bone and Articular Cartilage|Malignant Neoplasms of Digestive Organs|Malignant Neoplasms of Eye Brain and Other Parts of Central Nervous System|Malignant Neoplasms of Female Genital Organs|Malignant Neoplasms of Ill-defined Secondary and Unspecified Sites|Malignant Neoplasms of Independent (Primary) Multiple Sites|Malignant Neoplasms of Lip Oral Cavity and Pharynx|Malignant Neoplasms of Male Genital Organs|Malignant Neoplasms of Mesothelial and Soft Tissue|Malignant Neoplasms of Respiratory and Intrathoracic Organs|Malignant Neoplasms of Thyroid and Other Endocrine Glands|Malignant Neoplasms of Urinary Tract,Lenvatinib,COC1=CC2=NC=CC(=C2C=C1C(=O)N)OC3=CC(=C(C=C3)NC(=O)NC4CC4)Cl,PHASE1,nervous_system_disease
3584,Breast Cancer,Tesetaxel,CC1=C2C3C(C4(CCC5C(C4C(C(C2(C)C)(CC1OC(=O)C(C(C6=C(C=CC=N6)F)NC(=O)OC(C)(C)C)O)O)OC(=O)C7=CC=CC=C7)(CO5)OC(=O)C)C)OC(O3)CN(C)C,PHASE2,nervous_system_disease
3585,Chronic Stable Angina,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,PHASE1,nervous_system_disease
3586,Obsessive-Compulsive Disorder,Clomipramine,CN(C)CCCN1C2=CC=CC=C2CCC3=C1C=C(C=C3)Cl,PHASE2,nervous_system_disease
3587,Amyotrophic Lateral Sclerosis (ALS),Olanzapine,CC1=CC2=C(S1)NC3=CC=CC=C3N=C2N4CCN(CC4)C,PHASE2|PHASE3,nervous_system_disease
3588,Neurofibromatosis Type 1|Plexiform Neurofibroma|Spinal Cord Neurofibroma,Cediranib,CC1=CC2=C(N1)C=CC(=C2F)OC3=NC=NC4=CC(=C(C=C43)OC)OCCCN5CCCC5,PHASE2,nervous_system_disease
3589,Multiple Sclerosis,Tacrolimus,CC1CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC(=O)C(C=C(C1)C)CC=C)O)C)C(=CC4CCC(C(C4)OC)O)C)O)C)OC)OC,PHASE2,nervous_system_disease
3590,Polymyalgia Rheumatica|Effect of Drug|Safety Issues,Tofacitinib,CC1CCN(CC1N(C)C2=NC=NC3=C2C=CN3)C(=O)CC#N,PHASE2,nervous_system_disease
3591,Amyotrophic Lateral Sclerosis (ALS),Tamoxifen,CCC(=C(C1=CC=CC=C1)C2=CC=C(C=C2)OCCN(C)C)C3=CC=CC=C3,PHASE2,nervous_system_disease
3592,Acromegaly,Lanreotide,CC(C)C1C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=C(C=C4)O)NC(=O)C(CC5=CC6=CC=CC=C6C=C5)N)C(=O)NC(C(C)O)C(=O)N,PHASE2|PHASE3,nervous_system_disease
3593,Hypogonadism|Diabetes|Sarcopenia|Osteoporosis|Depression,Anastrozole,CC(C)(C#N)C1=CC(=CC(=C1)CN2C=NC=N2)C(C)(C)C#N,PHASE2,nervous_system_disease
3594,Brain and Central Nervous System Tumors,Pamiparib,CC12CCCN1CC3=NNC(=O)C4=C5C3=C2NC5=CC(=C4)F,PHASE1|PHASE2,nervous_system_disease
3595,Huntington's Disease,Pridopidine,CCCN1CCC(CC1)C2=CC(=CC=C2)S(=O)(=O)C,PHASE2,nervous_system_disease
3596,Sleep Apnea Syndrome|Hypertension,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,PHASE2|PHASE3,nervous_system_disease
3597,"Seizure, Absence",Lamotrigine,C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N,PHASE1,nervous_system_disease
3598,Brain Tumor - Metastatic,Carmustine,C(CCl)NC(=O)N(CCCl)N=O,PHASE2,nervous_system_disease
3599,Becker Muscular Dystrophy,Catechin,C1C(C(OC2=CC(=CC(=C21)O)O)C3=CC(=C(C=C3)O)O)O,PHASE2,nervous_system_disease
3600,Becker Muscular Dystrophy,Epicatechin,C1C(C(OC2=CC(=CC(=C21)O)O)C3=CC(=C(C=C3)O)O)O,PHASE2,nervous_system_disease
3601,Advanced Malignant Solid Neoplasm|Ann Arbor Stage III Hodgkin Lymphoma|Ann Arbor Stage III Non-Hodgkin Lymphoma|Ann Arbor Stage IV Hodgkin Lymphoma|Ann Arbor Stage IV Non-Hodgkin Lymphoma|Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor|Low Grade Glioma|Recurrent Ependymoma|Recurrent Ewing Sarcoma|Recurrent Glioma|Recurrent Hepatoblastoma|Recurrent Hodgkin Lymphoma|Recurrent Langerhans Cell Histiocytosis|Recurrent Malignant Germ Cell Tumor|Recurrent Malignant Glioma|Recurrent Malignant Solid Neoplasm|Recurrent Medulloblastoma|Recurrent Neuroblastoma|Recurrent Non-Hodgkin Lymphoma|Recurrent Osteosarcoma|Recurrent Peripheral Primitive Neuroectodermal Tumor|Recurrent Primary Central Nervous System Neoplasm|Recurrent Rhabdoid Tumor|Recurrent Rhabdomyosarcoma|Recurrent Soft Tissue Sarcoma|Refractory Hodgkin Lymphoma|Refractory Langerhans Cell Histiocytosis|Refractory Malignant Germ Cell Tumor|Refractory Malignant Glioma|Refractory Malignant Solid Neoplasm|Refractory Medulloblastoma|Refractory Neuroblastoma|Refractory Non-Hodgkin Lymphoma|Refractory Osteosarcoma|Refractory Peripheral Primitive Neuroectodermal Tumor|Refractory Rhabdoid Tumor|Refractory Soft Tissue Sarcoma|Rhabdoid Tumor|Stage III Soft Tissue Sarcoma AJCC v7|Stage IV Soft Tissue Sarcoma AJCC v7|Wilms Tumor,Tazemetostat,CCN(C1CCOCC1)C2=CC(=CC(=C2C)C(=O)NCC3=C(C=C(NC3=O)C)C)C4=CC=C(C=C4)CN5CCOCC5,PHASE2,nervous_system_disease
3602,Brain Metastases|HR+ Metastatic Breast Cancer,Abemaciclib,CCN1CCN(CC1)CC2=CN=C(C=C2)NC3=NC=C(C(=N3)C4=CC5=C(C(=C4)F)N=C(N5C(C)C)C)F,PHASE1|PHASE2,nervous_system_disease
3603,Parkinson Disease,Liraglutide,CCCCCCCCCCCCCCCC(=O)NC(CCC(=O)NCCCCC(C(=O)NC(CCC(=O)O)C(=O)NC(CC1=CC=CC=C1)C(=O)NC(C(C)CC)C(=O)NC(C)C(=O)NC(CC2=CNC3=CC=CC=C32)C(=O)NC(CC(C)C)C(=O)NC(C(C)C)C(=O)NC(CCCNC(=N)N)C(=O)NCC(=O)NC(CCCNC(=N)N)C(=O)NCC(=O)O)NC(=O)C(C)NC(=O)C(C)NC(=O)C(CCC(=O)N)NC(=O)CNC(=O)C(CCC(=O)O)NC(=O)C(CC(C)C)NC(=O)C(CC4=CC=C(C=C4)O)NC(=O)C(CO)NC(=O)C(CO)NC(=O)C(C(C)C)NC(=O)C(CC(=O)O)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C(CC5=CC=CC=C5)NC(=O)C(C(C)O)NC(=O)CNC(=O)C(CCC(=O)O)NC(=O)C(C)NC(=O)C(CC6=CN=CN6)N)C(=O)O,PHASE2,nervous_system_disease
3604,Gastroparesis,Buspirone,C1CCC2(C1)CC(=O)N(C(=O)C2)CCCCN3CCN(CC3)C4=NC=CC=N4,PHASE2,nervous_system_disease
3605,Alzheimer Disease,Azeliragon,CCCCC1=NC(=CN1C2=CC=C(C=C2)OC3=CC=C(C=C3)Cl)C4=CC=C(C=C4)OCCCN(CC)CC,PHASE2,nervous_system_disease
3606,Growth Hormone Disorder|Adult Growth Hormone Deficiency|Growth Hormone Deficiency in Children,Somapacitan,C(CCCCCCCC1=NNN=N1)CCCCCCCC(=O)NS(=O)(=O)CCCC(=O)NCCOCCOCC(=O)NC(CCC(=O)NC(CCC(=O)NCCOCCOCC(=O)NC(CCCCNC(=O)CSCC(C(=O)O)N)C(=O)N)C(=O)O)C(=O)O,PHASE1,nervous_system_disease
3607,Epilepsy,Lacosamide,CC(=O)NC(COC)C(=O)NCC1=CC=CC=C1,PHASE2,nervous_system_disease
3608,"Recurrent Childhood CNS Tumor|Ependymoma, Recurrent Childhood|Childhood Solid Tumor",Azacitidine,C1=NC(=NC(=O)N1C2C(C(C(O2)CO)O)O)N,PHASE1,nervous_system_disease
3609,Brain Metastases,Niraparib,C1CC(CNC1)C2=CC=C(C=C2)N3C=C4C=CC=C(C4=N3)C(=O)N,PHASE2,nervous_system_disease
3610,Dravet Syndrome,Clemizole,C1CCN(C1)CC2=NC3=CC=CC=C3N2CC4=CC=C(C=C4)Cl,PHASE1,nervous_system_disease
3611,Meningitis Streptococcal|Hiv|Meningitis|Meningoencephalitis,Fluconazole,C1=CC(=C(C=C1F)F)C(CN2C=NC=N2)(CN3C=NC=N3)O,PHASE2,nervous_system_disease
3612,Aneurysmal Subarachnoid Hemorrhage,Tiopronin,CC(C(=O)NCC(=O)O)S,PHASE2,nervous_system_disease
3613,Central Nervous System Neoplasms|Medulloblastoma,Pomalidomide,C1CC(=O)NC(=O)C1N2C(=O)C3=C(C2=O)C(=CC=C3)N,PHASE2,nervous_system_disease
3614,Opioid Induced Bowel Dysfunction,Naldemedine,CC(C)(C1=NC(=NO1)C2=CC=CC=C2)NC(=O)C3=C(C4C56CCN(C(C5(C3)O)CC7=C6C(=C(C=C7)O)O4)CC8CC8)O,PHASE2,nervous_system_disease
3615,Brain and Central Nervous System Tumors|Lymphoma|Metastatic Cancer,Melphalan,C1=CC(=CC=C1CC(C(=O)O)N)N(CCCl)CCCl,PHASE1,nervous_system_disease
3616,Postural Orthostatic Tachycardia Syndrome|Orthostatic Intolerance,Atenolol,CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O,PHASE1|PHASE2,nervous_system_disease
3617,ALS (Amyotrophic Lateral Sclerosis),Lunasine,CC(C)C1CC2=C(C3=C(C(=CC=C3)OC)[N+](=C2O1)C)OC,PHASE2,nervous_system_disease
3618,"Agitation, Emergence|Post Operative Pain",Nalbuphine,C1CC(C1)CN2CCC34C5C(CCC3(C2CC6=C4C(=C(C=C6)O)O5)O)O,PHASE1,nervous_system_disease
3619,Non Small Cell Lung Cancer Metastatic|Leptomeningeal Metastasis|Brain Metastases|EGFR Activating Mutation,Osimertinib,CN1C=C(C2=CC=CC=C21)C3=NC(=NC=C3)NC4=C(C=C(C(=C4)NC(=O)C=C)N(C)CCN(C)C)OC,PHASE2,nervous_system_disease
3620,Neurofibromatosis 1,Vincristine,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O,PHASE2,nervous_system_disease
3621,"Stroke, Acute",Desmopressin,C1CC(N(C1)C(=O)C2CSSCCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N2)CC(=O)N)CCC(=O)N)CC3=CC=CC=C3)CC4=CC=C(C=C4)O)C(=O)NC(CCCN=C(N)N)C(=O)NCC(=O)N,PHASE2,nervous_system_disease
3622,"Hypertension|Hypertension, Essential",Trimethaphan,C1CC2C3C(C[S+]2C1)N(C(=O)N3CC4=CC=CC=C4)CC5=CC=CC=C5,PHASE1,nervous_system_disease
3623,"Hypertension|Hypertension, Essential",Phenylephrine,CNCC(C1=CC(=CC=C1)O)O,PHASE1,nervous_system_disease
3624,Wilson Disease,Tetrathiomolybdate,[SH-].[SH-].S=[Mo]=S,PHASE2,nervous_system_disease
3625,Spinal Cord Injuries|Constipation|Neurogenic Bowel,Glycopyrrolate,C[N+]1(CCC(C1)OC(=O)C(C2CCCC2)(C3=CC=CC=C3)O)C.[Br-],PHASE1,nervous_system_disease
3626,Inclusion Body Myositis,Arimoclomol,C1CCN(CC1)CC(CON=C(C2=C[N+](=CC=C2)[O-])Cl)O,PHASE2,nervous_system_disease
3627,Epilepsy,Eslicarbazepine,C1C(C2=CC=CC=C2N(C3=CC=CC=C31)C(=O)N)O,PHASE1,nervous_system_disease
3628,Parosmia,Ivermectin,CCC(C)C1C(CCC2(O1)CC3CC(O2)CC=C(C(C(C=CC=C4COC5C4(C(C=C(C5O)C)C(=O)O3)O)C)OC6CC(C(C(O6)C)OC7CC(C(C(O7)C)O)OC)OC)C)C,PHASE2,nervous_system_disease
3629,Parosmia,Budesonide,CCCC1OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C,PHASE2,nervous_system_disease
3630,Spinal Cord Injuries|Polytrauma|Burn Injury,Oxycodone,CN1CCC23C4C(=O)CCC2(C1CC5=C3C(=C(C=C5)OC)O4)O,PHASE2,nervous_system_disease
3631,Chronic Shoulder Pain,Ropivacaine,CCCN1CCCCC1C(=O)NC2=C(C=CC=C2C)C,PHASE2|PHASE3,nervous_system_disease
3632,Craniocerebral Injury,Oxiracetam,C1C(CN(C1=O)CC(=O)N)O,PHASE2,nervous_system_disease
3633,Epilepsy,Oxcarbazepine,C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N,PHASE1,nervous_system_disease
3634,Epilepsy,Zonisamide,C1=CC=C2C(=C1)C(=NO2)CS(=O)(=O)N,PHASE1,nervous_system_disease
3635,Alzheimer's Disease,Perindopril,CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O,PHASE2,nervous_system_disease
3636,"Muscular Atrophy, Spinal",Risdiplam,CC1=CC(=NN2C1=NC(=C2)C)C3=CC(=O)N4C=C(C=CC4=N3)N5CCNC6(C5)CC6,PHASE1,nervous_system_disease
3637,Duchenne Muscular Dystrophy,Viltolarsen,CC1=CN(C(=O)NC1=O)C2CN(CC(O2)COP(=O)(N3CC(OC(C3)N4C=C(C(=O)NC4=O)C)COP(=O)(N5CC(OC(C5)N6C=NC7=C6N=C(NC7=O)N)COP(=O)(N8CC(OC(C8)N9C=C(C(=O)NC9=O)C)COP(=O)(N1CC(OC(C1)N1C=NC2=C1N=C(NC2=O)N)COP(=O)(N1CC(OC(C1)N1C=NC2=C1N=C(NC2=O)N)COP(=O)(N1CC(OC(C1)N1C=NC2=C(N=CN=C21)N)COP(=O)(N1CC(OC(C1)N1C=NC2=C(N=CN=C21)N)COP(=O)(N1CC(OC(C1)N1C=NC2=C1N=C(NC2=O)N)COP(=O)(N1CC(OC(C1)N1C=C(C(=O)NC1=O)C)COP(=O)(N1CC(OC(C1)N1C=CC(=NC1=O)N)COP(=O)(N1CC(OC(C1)N1C=C(C(=O)NC1=O)C)COP(=O)(N1CC(OC(C1)N1C=C(C(=O)NC1=O)C)COP(=O)(N1CC(OC(C1)N1C=NC2=C1N=C(NC2=O)N)COP(=O)(N1CC(OC(C1)N1C=NC2=C1N=C(NC2=O)N)COP(=O)(N1CC(OC(C1)N1C=CC(=NC1=O)N)COP(=O)(N1CC(OC(C1)N1C=CC(=NC1=O)N)COP(=O)(N1CC(OC(C1)N1C=C(C(=O)NC1=O)C)COP(=O)(N1CC(OC(C1)N1C=CC(=NC1=O)N)COP(=O)(N1CC(OC(C1)N1C=CC(=NC1=O)N)CO)N(C)C)N(C)C)N(C)C)N(C)C)N(C)C)N(C)C)N(C)C)N(C)C)N(C)C)N(C)C)N(C)C)N(C)C)N(C)C)N(C)C)N(C)C)N(C)C)N(C)C)N(C)C)N(C)C)P(=O)(N(C)C)OCC1CNCC(O1)N1C=CC(=NC1=O)N,PHASE2,nervous_system_disease
3638,Endometriosis,Cabergoline,CCNC(=O)N(CCCN(C)C)C(=O)C1CC2C(CC3=CNC4=CC=CC2=C34)N(C1)CC=C,PHASE2,nervous_system_disease
3639,Apathy|Huntington's Disease,Bupropion,CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C,PHASE2,nervous_system_disease
3640,AIDS-Related-Primary Central Nervous System Lymphoma,Leucovorin,C1C(N(C2=C(N1)N=C(NC2=O)N)C=O)CNC3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,PHASE2,nervous_system_disease
3641,"Stroke|Stroke, Acute|Stroke, Ischemic|Brain Diseases",Semaglutide,CCC(C)C(C(=O)NC(C)C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(CC(C)C)C(=O)NC(C(C)C)C(=O)NC(CCCNC(=N)N)C(=O)NCC(=O)NC(CCCNC(=N)N)C(=O)NCC(=O)O)NC(=O)C(CC3=CC=CC=C3)NC(=O)C(CCC(=O)O)NC(=O)C(CCCCNC(=O)COCCOCCNC(=O)COCCOCCNC(=O)CCC(C(=O)O)NC(=O)CCCCCCCCCCCCCCCCC(=O)O)NC(=O)C(C)NC(=O)C(C)NC(=O)C(CCC(=O)N)NC(=O)CNC(=O)C(CCC(=O)O)NC(=O)C(CC(C)C)NC(=O)C(CC4=CC=C(C=C4)O)NC(=O)C(CO)NC(=O)C(CO)NC(=O)C(C(C)C)NC(=O)C(CC(=O)O)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C(CC5=CC=CC=C5)NC(=O)C(C(C)O)NC(=O)CNC(=O)C(CCC(=O)O)NC(=O)C(C)(C)NC(=O)C(CC6=CN=CN6)N,PHASE2,nervous_system_disease
3642,Compliance|Chronic Pain,Quinine,COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O,PHASE2,nervous_system_disease
3643,"Lymphoma, Non-Hodgkin|HIV Infections",Doxorubicin,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)N)O,PHASE1,nervous_system_disease
3644,Prader-Willi Syndrome|Hyperphagia,Livoletide,CC(C)C1C(=O)NC(C(=O)NC(C(=O)N2CCCC2C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCN=C(N)N)CCC(=O)N)CC3=CN=CN3)CCC(=O)O)CO)CCC(=O)N,PHASE2|PHASE3,nervous_system_disease
3645,Parkinson Disease,Tavapadon,CC1=C(C=CC(=C1)OC2=C(C=CC=N2)C(F)(F)F)C3=C(C(=O)NC(=O)N3C)C,PHASE1,nervous_system_disease
3646,Primary Insomnia,Eszopiclone,CN1CCN(CC1)C(=O)OC2C3=NC=CN=C3C(=O)N2C4=NC=C(C=C4)Cl,PHASE2|PHASE3,nervous_system_disease
3647,Alzheimer Disease,Tesofensine,CCOCC1C2CCC(N2C)CC1C3=CC(=C(C=C3)Cl)Cl,PHASE2,nervous_system_disease
3648,Ischemic Optic Neuropathy,Alprostadil,CCCCCC(C=CC1C(CC(=O)C1CCCCCCC(=O)O)O)O,PHASE2,nervous_system_disease
3649,Amyotrophic Lateral Sclerosis,Verdiperstat,CC(C)OCCN1C2=C(C(=O)NC1=S)NC=C2,PHASE2|PHASE3,nervous_system_disease
3650,Bulimia Nervosa,Lisdexamfetamine,CC(CC1=CC=CC=C1)NC(=O)C(CCCCN)N,PHASE2,nervous_system_disease
3651,Tourette Syndrome|Tourette Syndrome in Adolescence,Sepranolone,CC(=O)C1CCC2C1(CCC3C2CCC4C3(CCC(C4)O)C)C,PHASE2,nervous_system_disease
3652,Anaplastic Ependymoma|Atypical Teratoid/Rhabdoid Tumor|Central Nervous System Germ Cell Tumor|Choroid Plexus Carcinoma|Intracranial Myeloid Sarcoma|Malignant Brain Neoplasm|Malignant Glioma|Medulloblastoma|Primitive Neuroectodermal Tumor|Recurrent Anaplastic Ependymoma|Recurrent Atypical Teratoid/Rhabdoid Tumor|Recurrent Malignant Brain Neoplasm|Recurrent Malignant Glioma|Recurrent Medulloblastoma|Recurrent Primitive Neuroectodermal Tumor,Thiotepa,C1CN1P(=S)(N2CC2)N3CC3,PHASE1,nervous_system_disease
3653,"Concussion, Brain|Traumatic Brain Injury",Lenomorelin,CCCCCCCC(=O)OCC(C(=O)NC(CO)C(=O)NC(CC1=CC=CC=C1)C(=O)NC(CC(C)C)C(=O)NC(CO)C(=O)N2CCCC2C(=O)NC(CCC(=O)O)C(=O)NC(CC3=CNC=N3)C(=O)NC(CCC(=O)N)C(=O)NC(CCCNC(=N)N)C(=O)NC(C(C)C)C(=O)NC(CCC(=O)N)C(=O)NC(CCC(=O)N)C(=O)NC(CCCNC(=N)N)C(=O)NC(CCCCN)C(=O)NC(CCC(=O)O)C(=O)NC(CO)C(=O)NC(CCCCN)C(=O)NC(CCCCN)C(=O)N4CCCC4C(=O)N5CCCC5C(=O)NC(C)C(=O)NC(CCCCN)C(=O)NC(CC(C)C)C(=O)NC(CCC(=O)N)C(=O)N6CCCC6C(=O)NC(CCCNC(=N)N)C(=O)O)NC(=O)CN,PHASE2,nervous_system_disease
3654,Postthoracotomy Pain|Postthoracoscopy Neuropathic Pain,Terbutaline,CC(C)(C)NCC(C1=CC(=CC(=C1)O)O)O,PHASE2,nervous_system_disease
3655,Chemotherapeutic Agent Toxicity|Cognitive/Functional Effects|Lymphoma|Neurotoxicity|Radiation Toxicity,Procarbazine,CC(C)NC(=O)C1=CC=C(C=C1)CNNC,PHASE2,nervous_system_disease
3656,Cancer|Head and Neck Cancer|Pelvic Cancer|Nervous System Neoplasms|Thoracic Neoplasms,Sunitinib,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C,PHASE1,nervous_system_disease
3657,Duchenne Muscular Dystrophy,Ezutromid,CCS(=O)(=O)C1=CC2=C(C=C1)OC(=N2)C3=CC4=CC=CC=C4C=C3,PHASE2,nervous_system_disease
3658,Glioma|Glioblastoma|Glioblastoma Multiforme|GBM|Brain Cancer,Dianhydrogalactitol,C1C(O1)C(C(C2CO2)O)O,PHASE2,nervous_system_disease
3659,"Brain Injuries|Brain Injuries, Traumatic|Brain Injury, Chronic",Tolcapone,CC1=CC=C(C=C1)C(=O)C2=CC(=C(C(=C2)O)O)[N+](=O)[O-],PHASE2,nervous_system_disease
3660,Huntington Disease,Triheptanoin,CCCCCCC(=O)OCC(COC(=O)CCCCCC)OC(=O)CCCCCC,PHASE2,nervous_system_disease
3661,Obesity|Prehypertension|Hypertension,Hydrochlorothiazide,C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl,PHASE2,nervous_system_disease
3662,Diffuse Intrinsic Pontine Glioma,Imiquimod,CC(C)CN1C=NC2=C1C3=CC=CC=C3N=C2N,PHASE1,nervous_system_disease
3663,REM Sleep Behavior Disorder|Parkinson Disease|Synucleinopathies,Rasagiline,C#CCNC1CCC2=CC=CC=C12,PHASE2|PHASE3,nervous_system_disease
3664,Insomnia,Ramelteon,CCC(=O)NCCC1CCC2=C1C3=C(C=C2)OCC3,PHASE1,nervous_system_disease
3665,"Epilepsy, Partial",Ezogabine,CCOC(=O)NC1=C(C=C(C=C1)NCC2=CC=C(C=C2)F)N,PHASE1,nervous_system_disease
3666,Carpal Tunnel Syndrome,Triamcinolone,CC12CC(C3(C(C1CC(C2(C(=O)CO)O)O)CCC4=CC(=O)C=CC43C)F)O,PHASE2|PHASE3,nervous_system_disease
3667,Primary Central Nervous System Lymphoma,Orelabrutinib,C=CC(=O)N1CCC(CC1)C2=NC(=C(C=C2)C(=O)N)C3=CC=C(C=C3)OC4=CC=CC=C4,PHASE2,nervous_system_disease
3668,Relapsing-remitting Multiple Sclerosis,Evobrutinib,C=CC(=O)N1CCC(CC1)CNC2=NC=NC(=C2C3=CC=C(C=C3)OC4=CC=CC=C4)N,PHASE2,nervous_system_disease
3669,Brain Cancer,Palonosetron,C1CC2CN(C(=O)C3=CC=CC(=C23)C1)C4CN5CCC4CC5,PHASE2,nervous_system_disease
3670,Anovulatory Infertility|Abnormal Uterine Bleeding-Ovulatory Disorders|Polycystic Ovarian Syndrome|Hyperprolactinemia|Luteinized Unruptured Follicle Syndrome|Corpus Luteum Insufficiency|Ovarian Insufficiency,Clomifene,CCN(CC)CCOC1=CC=C(C=C1)C(=C(C2=CC=CC=C2)Cl)C3=CC=CC=C3,PHASE2,nervous_system_disease
3671,Anovulatory Infertility|Abnormal Uterine Bleeding-Ovulatory Disorders|Polycystic Ovarian Syndrome|Hyperprolactinemia|Luteinized Unruptured Follicle Syndrome|Corpus Luteum Insufficiency|Ovarian Insufficiency,Clomiphene,CCN(CC)CCOC1=CC=C(C=C1)C(=C(C2=CC=CC=C2)Cl)C3=CC=CC=C3,PHASE2,nervous_system_disease
3672,Acute Stroke,Glyburide,COC1=C(C=C(C=C1)Cl)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCCCC3,PHASE2|PHASE3,nervous_system_disease
3673,Fragile X Syndrome,Baclofen,C1=CC(=CC=C1C(CC(=O)O)CN)Cl,PHASE2,nervous_system_disease
3674,Fragile X Syndrome,Roflumilast,C1CC1COC2=C(C=CC(=C2)C(=O)NC3=C(C=NC=C3Cl)Cl)OC(F)F,PHASE2,nervous_system_disease
3675,"Multiple Sclerosis, Relapsing-Remitting",Firategrast,CCOCC1=CC(=C(C(=C1)OC)C2=CC=C(C=C2)CC(C(=O)O)NC(=O)C3=C(C=CC=C3F)F)OC,PHASE1,nervous_system_disease
3676,Aphasia|Stroke,Escitalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,PHASE2,nervous_system_disease
3677,Acromegaly,Somatostatin,CC(C1C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=CC=C4)CC5=CC=CC=C5)CC(=O)N)CCCCN)NC(=O)CNC(=O)C(C)N)C(=O)O)CO)C(C)O)CC6=CC=CC=C6)O,PHASE2,nervous_system_disease
3678,"Multiple Myeloma|Multiple Myeloma in Relapse|Multiple Myeloma, Refractory",Marizomib,CC12C(C(=O)NC1(C(=O)O2)C(C3CCCC=C3)O)CCCl,PHASE2,nervous_system_disease
3679,Vincristine Induced Neurotoxicity|Acute Lymphoblastic Leukaemia,Pyridoxine,CC1=NC=C(C(=C1O)CO)CO,PHASE2|PHASE3,nervous_system_disease
3680,"Obstructive Sleep Apnea|Tonsillitis|Pain, Procedural",Hydromorphone,CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(=O)CC4,PHASE2,nervous_system_disease
3681,"Obstructive Sleep Apnea|Tonsillitis|Pain, Procedural",Methadone,CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2,PHASE2,nervous_system_disease
3682,Parkinson Disease,Opicapone,CC1=C(C(=[N+](C(=C1Cl)C)[O-])Cl)C2=NOC(=N2)C3=CC(=C(C(=C3)O)O)[N+](=O)[O-],PHASE1,nervous_system_disease
3683,"Prolonged First Stage of Labor|Failure of Cervical Dilation as Antepartum Condition|Labor Pain|Mild Birth Asphyxia, APGAR 4-7",Drotaverine,CCOC1=C(C=C(C=C1)C=C2C3=CC(=C(C=C3CCN2)OCC)OCC)OCC,PHASE2|PHASE3,nervous_system_disease
3684,Partial Epilepsy|Catamenial Epilepsy,Ganaxolone,CC(=O)C1CCC2C1(CCC3C2CCC4C3(CCC(C4)(C)O)C)C,PHASE2,nervous_system_disease
3685,Glioma|Diffuse Intrinsic Pontine Glioma,Panobinostat,CC1=C(C2=CC=CC=C2N1)CCNCC3=CC=C(C=C3)C=CC(=O)NO,PHASE2,nervous_system_disease
3686,"Multiple Sclerosis, Relapsing-Remitting",Inosine,C1=NC2=C(C(=O)N1)N=CN2C3C(C(C(O3)CO)O)O,PHASE2,nervous_system_disease
3687,Preterm Labor|Cerebral Palsy,Nifedipine,CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC,PHASE2|PHASE3,nervous_system_disease
3688,Vestibular Migraine|Chronic Subjective Dizziness,Verapamil,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,PHASE1,nervous_system_disease
3689,Vestibular Migraine|Chronic Subjective Dizziness,Sertraline,CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl,PHASE1,nervous_system_disease
3690,Down Syndrome,Ubiquinol,CC1=C(C(=C(C(=C1O)OC)OC)O)CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C,PHASE2,nervous_system_disease
3691,Alzheimer Disease|Cognitive Decline Due to Alzheimer Disease|Mild Cognitive Impairment Due to Alzheimer Disease,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,PHASE2,nervous_system_disease
3692,Stroke,Maraviroc,CC1=NN=C(N1C2CC3CCC(C2)N3CCC(C4=CC=CC=C4)NC(=O)C5CCC(CC5)(F)F)C(C)C,PHASE2|PHASE3,nervous_system_disease
3693,Adult Anaplastic Oligodendroglioma|Adult Mixed Glioma|Adult Oligodendroglioma|Recurrent Adult Brain Neoplasm,Imatinib,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,PHASE1|PHASE2,nervous_system_disease
3694,Neuropathic Pain,Ergocalciferol,CC(C)C(C)C=CC(C)C1CCC2C1(CCCC2=CC=C3CC(CCC3=C)O)C,PHASE2,nervous_system_disease
3695,Neuropathic Pain,Cholecalciferol,CC(C)CCCC(C)C1CCC2C1(CCCC2=CC=C3CC(CCC3=C)O)C,PHASE2,nervous_system_disease
3696,"Subarachnoid Hemorrhage, Aneurysmal",Tirofiban,CCCCS(=O)(=O)NC(CC1=CC=C(C=C1)OCCCCC2CCNCC2)C(=O)O,PHASE1|PHASE2,nervous_system_disease
3697,Adrenoleukodystrophy|Metachromatic Leukodystrophy|Globoid Cell Leukodystrophy|Gaucher's Disease|Fucosidosis|Wolman Disease|Niemann-Pick Disease|Batten Disease|GM1 Gangliosidosis|Tay Sachs Disease|Sandhoff Disease,Busulfan,CS(=O)(=O)OCCCCOS(=O)(=O)C,PHASE2|PHASE3,nervous_system_disease
3698,Transient Ischemic Attack|Stroke,Levosimendan,CC1CC(=O)NN=C1C2=CC=C(C=C2)NN=C(C#N)C#N,PHASE2,nervous_system_disease
3699,Transient Ischemic Attack|Stroke,Simendan,CC1CC(=O)NN=C1C2=CC=C(C=C2)NN=C(C#N)C#N,PHASE2,nervous_system_disease
3700,Meningitis,Daptomycin,CCCCCCCCCC(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(CC(=O)N)C(=O)NC(CC(=O)O)C(=O)NC3C(OC(=O)C(NC(=O)C(NC(=O)C(NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)CNC3=O)CCCN)CC(=O)O)C)CC(=O)O)CO)C(C)CC(=O)O)CC(=O)C4=CC=CC=C4N)C,PHASE1,nervous_system_disease
3701,Alzheimer's Disease,Mifepristone,CC#CC1(CCC2C1(CC(C3=C4CCC(=O)C=C4CCC23)C5=CC=C(C=C5)N(C)C)C)O,PHASE2,nervous_system_disease
3702,Symptomatic Neurogenic Orthostatic Hypotension (NOH)|Parkinson's Disease|Multiple System Atrophy,Fipamezole,CCC1(CC2=C(C1)C=C(C=C2)F)C3=CN=CN3,PHASE2,nervous_system_disease
3703,Metastatic BRCA-Associated Breast Carcinoma|Metastatic Breast Carcinoma|Metastatic Malignant Neoplasm in the Brain|Metastatic Triple-Negative Breast Carcinoma|Recurrent Breast Carcinoma|Stage IV Breast Cancer AJCC v6 and v7,Veliparib,CC1(CCCN1)C2=NC3=C(C=CC=C3N2)C(=O)N,PHASE2,nervous_system_disease
3704,Attention Deficit Hyperactivity Disorder,Centanafadine,C1C2C1(CNC2)C3=CC4=CC=CC=C4C=C3,PHASE2,nervous_system_disease
3705,"Multiple Sclerosis, Secondary Progressive",Hydroxychloroquine,CCN(CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl)CCO,PHASE2,nervous_system_disease
3706,"Multiple Sclerosis, Secondary Progressive",Indapamide,CC1CC2=CC=CC=C2N1NC(=O)C3=CC(=C(C=C3)Cl)S(=O)(=O)N,PHASE2,nervous_system_disease
3707,Hepatic Encephalopathy,Nitazoxanide,CC(=O)OC1=CC=CC=C1C(=O)NC2=NC=C(S2)[N+](=O)[O-],PHASE2,nervous_system_disease
3708,Hepatic Encephalopathy,Metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-],PHASE2,nervous_system_disease
3709,CADASIL,Dabigatran,CN1C2=C(C=C(C=C2)C(=O)N(CCC(=O)O)C3=CC=CC=N3)N=C1CNC4=CC=C(C=C4)C(=N)N,PHASE2,nervous_system_disease
3710,Muscular Dystrophies,Drisapersen,COC1C(C(OC1N2C=CC(=O)NC2=O)COP(=S)(O)OC3C(OC(C3OC)N4C=CC(=NC4=O)N)COP(=S)(O)OC5C(OC(C5OC)N6C=CC(=O)NC6=O)COP(=S)(O)OC7C(OC(C7OC)N8C=CC(=O)NC8=O)COP(=S)(O)OC9C(OC(C9OC)N1C=CC(=O)NC1=O)COP(=S)(O)OC1C(OC(C1OC)N1C=NC2=C(N=CN=C21)N)COP(=S)(O)OC1C(OC(C1OC)N1C=CC(=NC1=O)N)COP(=S)(O)OC1C(OC(C1OC)N1C=NC2=C1N=C(NC2=O)N)COP(=S)(O)OC1C(OC(C1OC)N1C=NC2=C1N=C(NC2=O)N)COP(=S)(O)OC1C(OC(C1OC)N1C=CC(=O)NC1=O)COP(=S)(O)OC1C(OC(C1OC)N1C=NC2=C(N=CN=C21)N)COP(=S)(O)OC1C(OC(C1OC)N1C=NC2=C1N=C(NC2=O)N)COP(=S)(O)OC1C(OC(C1OC)N1C=NC2=C(N=CN=C21)N)COP(=S)(O)OC1C(OC(C1OC)N1C=NC2=C(N=CN=C21)N)COP(=S)(O)OC1C(OC(C1OC)N1C=NC2=C1N=C(NC2=O)N)COP(=S)(O)OC1C(OC(C1OC)N1C=NC2=C1N=C(NC2=O)N)COP(=S)(O)OC1C(OC(C1OC)N1C=NC2=C(N=CN=C21)N)COP(=S)(O)OC1C(OC(C1OC)N1C=NC2=C(N=CN=C21)N)COP(=O)(OC1C(OC(C1OC)N1C=CC(=NC1=O)N)COP(=S)(O)OC1C(OC(C1OC)N1C=CC(=O)NC1=O)CO)S)O,PHASE2,nervous_system_disease
3711,Multiple System Atrophy,Safinamide,CC(C(=O)N)NCC1=CC=C(C=C1)OCC2=CC(=CC=C2)F,PHASE2,nervous_system_disease
3712,Alzheimer's Disease|Central Nervous System Diseases,Rivastigmine,CCN(C)C(=O)OC1=CC=CC(=C1)C(C)N(C)C,PHASE1,nervous_system_disease
3713,Tuberous Sclerosis Complex,Vigabatrin,C=CC(CCC(=O)O)N,PHASE2|PHASE3,nervous_system_disease
3714,Amyotrophic Lateral Sclerosis,Dexpramipexole,CCCNC1CCC2=C(C1)SC(=N2)N,PHASE1,nervous_system_disease
3715,Amyotrophic Lateral Sclerosis,Cimetidine,CC1=C(N=CN1)CSCCNC(=NC)NC#N,PHASE1,nervous_system_disease
3716,Solid Tumors|Central Nervous System Tumors,Vinblastine,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O,PHASE1,nervous_system_disease
3717,Brain and Central Nervous System Tumors,Mechlorethamine,CN(CCCl)CCCl,PHASE2,nervous_system_disease
3718,Brain and Central Nervous System Tumors,Mibefradil,CC(C)C1C2=C(CCC1(CCN(C)CCCC3=NC4=CC=CC=C4N3)OC(=O)COC)C=C(C=C2)F,PHASE1,nervous_system_disease
3719,Alzheimer's Disease,Latrepirdine,CC1=CC2=C(C=C1)N(C3=C2CN(CC3)C)CCC4=CN=C(C=C4)C,PHASE2,nervous_system_disease
3720,Cerebrovascular Accident,Isoxaflutole,CS(=O)(=O)C1=C(C=CC(=C1)C(F)(F)F)C(=O)C2=C(ON=C2)C3CC3,PHASE1,nervous_system_disease
3721,Gastroparesis,Tradipitant,C1=CC=C(C(=C1)C(=O)C2=C(N=CC=C2)C3=C(N(N=N3)CC4=CC(=CC(=C4)C(F)(F)F)C(F)(F)F)C5=CC=NC=C5)Cl,PHASE2,nervous_system_disease
3722,Migraine,Atogepant,CC1C(CC(C(=O)N1CC(F)(F)F)NC(=O)C2=CC3=C(CC4(C3)C5=C(NC4=O)N=CC=C5)N=C2)C6=C(C=CC(=C6F)F)F,PHASE1,nervous_system_disease
3723,Migraine,Ubrogepant,CC1C(CC(C(=O)N1CC(F)(F)F)NC(=O)C2=CC3=C(CC4(C3)C5=C(NC4=O)N=CC=C5)N=C2)C6=CC=CC=C6,PHASE1,nervous_system_disease
3724,Relapsing Remitting Multiple Sclerosis,Laquinimod,CCN(C1=CC=CC=C1)C(=O)C2=C(C3=C(C=CC=C3Cl)N(C2=O)C)O,PHASE2,nervous_system_disease
3725,Non-small Cell Lung Cancer,Lazertinib,CN(C)CC1=CN(N=C1C2=CC=CC=C2)C3=NC(=NC=C3)NC4=C(C=C(C(=C4)NC(=O)C=C)N5CCOCC5)OC,PHASE2,nervous_system_disease
3726,Acute Ischemic Stroke,Balovaptan,CN1CC2=C(C=CC(=C2)Cl)N3C(=NN=C3C4CCC(CC4)OC5=CC=CC=N5)C1,PHASE2,nervous_system_disease
3727,Duchenne Muscular Dystrophy,Givinostat,CCN(CC)CC1=CC2=C(C=C1)C=C(C=C2)COC(=O)NC3=CC=C(C=C3)C(=O)NO,PHASE2|PHASE3,nervous_system_disease
3728,Memory Impairment,Vilazodone,C1CN(CCN1CCCCC2=CNC3=C2C=C(C=C3)C#N)C4=CC5=C(C=C4)OC(=C5)C(=O)N,PHASE2,nervous_system_disease
3729,"Cerebral Stroke|Cerebrovascular Accident, Acute|Cerebrovascular Stroke|Stroke, Acute|Stroke",Dapsone,C1=CC(=CC=C1N)S(=O)(=O)C2=CC=C(C=C2)N,PHASE2|PHASE3,nervous_system_disease
3730,Cerebral Palsy,Erythropoietin,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NN=N[N-]4)CO)Cl.[K+],PHASE2,nervous_system_disease
3731,"Neoplasms|Colorectal Neoplasms|Melanoma|Pancreatic Neoplasms|Sarcoma|Ovarian Neoplasms|Brain Neoplasms|Thyroid Neoplasms|Neuroendocrine Tumors|Cholangiocarcinoma|Salivary Gland Neoplasms|Head and Neck Neoplasms|Thyroid Cancer, Papillary|Lymphoma, Large-Cell, Anaplastic|Neoplasms by Site|Respiratory Tract Neoplasms|Thoracic Neoplasms|Respiratory Tract Diseases|Carcinoma, Bronchogenic|Bronchial Neoplasms|Intestinal Neoplasms|Gastrointestinal Neoplasms|Digestive System Neoplasms|Digestive System Diseases|Gastrointestinal Diseases|Colonic Diseases|Intestinal Diseases|Central Nervous System",Alectinib,CCC1=CC2=C(C=C1N3CCC(CC3)N4CCOCC4)C(C5=C(C2=O)C6=C(N5)C=C(C=C6)C#N)(C)C,PHASE2,nervous_system_disease
3732,Lymphoma,Glucarpidase,[Zn+2].[Zn+2].[Zn+2].[Zn+2],PHASE2,nervous_system_disease
3733,Metastatic Breast Cancer,Eribulin,CC1CC2CCC3C(=C)CC(O3)CCC45CC6C(O4)C7C(O6)C(O5)C8C(O7)CCC(O8)CC(=O)CC9C(CC(C1=C)O2)OC(C9OC)CC(CN)O,PHASE2,nervous_system_disease
3734,Parkinson Disease|Constipation,Pyridostigmine,C[N+]1=CC=CC(=C1)OC(=O)N(C)C,PHASE2,nervous_system_disease
3735,Stroke|Acute Ischemic Stroke,Repinotan,C1CC2=CC=CC=C2OC1CNCCCCN3C(=O)C4=CC=CC=C4S3(=O)=O,PHASE2,nervous_system_disease
3736,Childhood Solid Neoplasm|Recurrent Malignant Solid Neoplasm|Recurrent Primary Central Nervous System Neoplasm|Refractory Malignant Solid Neoplasm|Refractory Primary Central Nervous System Neoplasm,Prexasertib,COC1=C(C(=CC=C1)OCCCN)C2=CC(=NN2)NC3=NC=C(N=C3)C#N,PHASE1,nervous_system_disease
3737,Non-Small Cell Lung Cancer,Gefitinib,COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4,PHASE1,nervous_system_disease
3738,Malignant Melanoma,Vemurafenib,CCCS(=O)(=O)NC1=C(C(=C(C=C1)F)C(=O)C2=CNC3=C2C=C(C=N3)C4=CC=C(C=C4)Cl)F,PHASE2,nervous_system_disease
3739,Alzheimer's Disease,Posiphen,CC12CCN(C1N(C3=C2C=C(C=C3)OC(=O)NC4=CC=CC=C4)C)C,PHASE1|PHASE2,nervous_system_disease
3740,Multiple Sclerosis,Mangafodipir,[H+].[H+].[H+].[H+].CC1=NC=C(C(=C1O)CN(CCN(CC2=C(C(=NC=C2COP(=O)([O-])[O-])C)O)CC(=O)[O-])CC(=O)[O-])COP(=O)([O-])[O-].[Mn+2],PHASE1,nervous_system_disease
3741,Cerebral Infarction,Vorapaxar,CCOC(=O)NC1CCC2C(C1)CC3C(C2C=CC4=NC=C(C=C4)C5=CC(=CC=C5)F)C(OC3=O)C,PHASE2,nervous_system_disease
3742,Spinal Muscular Atrophy,Reldesemtiv,C1C(CC1(CNC2=NC=C(C=N2)N3C=CC(=C3)C(=O)N)C4=C(C=CC=N4)F)F,PHASE2,nervous_system_disease
3743,Early Alzheimer's Disease,Obicetrapib,CCC1CC(C2=C(N1C(=O)OCC)C=CC(=C2)C(F)(F)F)N(CC3=CC(=CC(=C3)C(F)(F)F)C(F)(F)F)C4=NC=C(C=N4)OCCCC(=O)O,PHASE2,nervous_system_disease
3744,Parkinson Disease,Entacapone,CCN(CC)C(=O)C(=CC1=CC(=C(C(=C1)O)O)[N+](=O)[O-])C#N,PHASE1,nervous_system_disease
3745,Alzheimer Disease,Acitretin,CC1=CC(=C(C(=C1C=CC(=CC=CC(=CC(=O)O)C)C)C)C)OC,PHASE2,nervous_system_disease
3746,Parkinson Disease,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,PHASE2,nervous_system_disease
3747,Amyotrophic Lateral Sclerosis,Fasudil,C1CNCCN(C1)S(=O)(=O)C2=CC=CC3=C2C=CN=C3,PHASE2,nervous_system_disease
3748,Attention Deficit Disorder With Hyperactivity,Tipepidine,CN1CCCC(=C(C2=CC=CS2)C3=CC=CS3)C1,PHASE2,nervous_system_disease
3749,"Tuberculosis, Meningeal",Rifampin,CC1C=CC=C(C(=O)NC2=C(C(=C3C(=C2O)C(=C(C4=C3C(=O)C(O4)(OC=CC(C(C(C(C(C(C1O)C)O)C)OC(=O)C)C)OC)C)C)O)O)C=NN5CCN(CC5)C)C,PHASE2|PHASE3,nervous_system_disease
3750,"Tuberculosis, Meningeal",Rifampicin,CC1C=CC=C(C(=O)NC2=C(C(=C3C(=C2O)C(=C(C4=C3C(=O)C(O4)(OC=CC(C(C(C(C(C(C1O)C)O)C)OC(=O)C)C)OC)C)C)O)O)C=NN5CCN(CC5)C)C,PHASE2|PHASE3,nervous_system_disease
3751,Huntington Disease,Deutetrabenazine,CC(C)CC1CN2CCC3=CC(=C(C=C3C2CC1=O)OC)OC,PHASE2|PHASE3,nervous_system_disease
3752,Diabetes Mellitus|Diabetes Mellitus Complications|Gastroparesis,Relamorelin,C1CC(CNC1)C(=O)NC(CC2=CSC3=CC=CC=C32)C(=O)NC(CC4=CNC5=CC=CC=C54)C(=O)NC(CC6=CC=CC=C6)C(=O)NC7(CCNCC7)C(=O)N,PHASE2,nervous_system_disease
3753,Chronic Obstructive Pulmonary Disease (COPD),Tesamorelin,CCC=CCC(=O)NC(CC1=CC=C(C=C1)O)C(=O)NC(C)C(=O)NC(CC(=O)O)C(=O)NC(C)C(=O)NC(C(C)CC)C(=O)NC(CC2=CC=CC=C2)C(=O)NC(C(C)O)C(=O)NC(CC(=O)N)C(=O)NC(CO)C(=O)NC(CC3=CC=C(C=C3)O)C(=O)NC(CCCNC(=N)N)C(=O)NC(CCCCN)C(=O)NC(C(C)C)C(=O)NC(CC(C)C)C(=O)NCC(=O)NC(CCC(=O)N)C(=O)NC(CC(C)C)C(=O)NC(CO)C(=O)NC(C)C(=O)NC(CCCNC(=N)N)C(=O)NC(CCCCN)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(CCC(=O)N)C(=O)NC(CC(=O)O)C(=O)NC(C(C)CC)C(=O)NC(CCSC)C(=O)NC(CO)C(=O)NC(CCCNC(=N)N)C(=O)NC(CCC(=O)N)C(=O)NC(CCC(=O)N)C(=O)NCC(=O)NC(CCC(=O)O)C(=O)NC(CO)C(=O)NC(CC(=O)N)C(=O)NC(CCC(=O)N)C(=O)NC(CCC(=O)O)C(=O)NC(CCCNC(=N)N)C(=O)NCC(=O)NC(C)C(=O)NC(CCCNC(=N)N)C(=O)NC(C)C(=O)NC(CCCNC(=N)N)C(=O)NC(CC(C)C)C(=O)N,PHASE2,nervous_system_disease
3754,Duchenne Muscular Dystrophy (DMD),Bocidelpar,CC1=CN=C(N1CC2=CC=CC=C2OCCCC(C)CC(=O)O)C3=CC=C(C=C3)C(F)(F)F,PHASE1,nervous_system_disease
3755,Alzheimer Disease|Mild Cognitive Impairment|Herpes Simplex,Valaciclovir,CC(C)C(C(=O)OCCOCN1C=NC2=C1N=C(NC2=O)N)N,PHASE2,nervous_system_disease
3756,Alzheimer Disease|Mild Cognitive Impairment|Herpes Simplex,Valacyclovir,CC(C)C(C(=O)OCCOCN1C=NC2=C1N=C(NC2=O)N)N,PHASE2,nervous_system_disease
3757,OSA|Obstructive Sleep Apnea,Venlafaxine,CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O,PHASE2,nervous_system_disease
3758,Tardive Dyskinesia,Pyridoxal,CC1=NC=C(C(=C1O)C=O)CO,PHASE2,nervous_system_disease
3759,Epilepsy|Seizures,Perampanel,C1=CC=C(C=C1)N2C=C(C=C(C2=O)C3=CC=CC=C3C#N)C4=CC=CC=N4,PHASE2,nervous_system_disease
3760,Breast Cancer|Brain Metastases,Vinorelbine,CCC1=CC2CC(C3=C(CN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC,PHASE2,nervous_system_disease
3761,Wolfram Syndrome,Tirzepatide,CCC(C)C(C(=O)NC(C)C(=O)NC(CCC(=O)N)C(=O)NC(CCCCNC(=O)COCCOCCNC(=O)COCCOCCNC(=O)CCC(C(=O)O)NC(=O)CCCCCCCCCCCCCCCCCCC(=O)O)C(=O)NC(C)C(=O)NC(CC1=CC=CC=C1)C(=O)NC(C(C)C)C(=O)NC(CCC(=O)N)C(=O)NC(CC2=CNC3=CC=CC=C32)C(=O)NC(CC(C)C)C(=O)NC(C(C)CC)C(=O)NC(C)C(=O)NCC(=O)NCC(=O)N4CCCC4C(=O)NC(CO)C(=O)NC(CO)C(=O)NCC(=O)NC(C)C(=O)N5CCCC5C(=O)N6CCCC6C(=O)N7CCCC7C(=O)NC(CO)C(=O)N)NC(=O)C(CCCCN)NC(=O)C(CC(=O)O)NC(=O)C(CC(C)C)NC(=O)C(C)(C)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(CC8=CC=C(C=C8)O)NC(=O)C(CC(=O)O)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C(CC9=CC=CC=C9)NC(=O)C(C(C)O)NC(=O)CNC(=O)C(CCC(=O)O)NC(=O)C(C)(C)NC(=O)C(CC1=CC=C(C=C1)O)N,PHASE2,nervous_system_disease
3762,Juvenile Myelomonocytic Leukemia|Neurofibromatosis Type 1,Trametinib,CC1=C2C(=C(N(C1=O)C)NC3=C(C=C(C=C3)I)F)C(=O)N(C(=O)N2C4=CC=CC(=C4)NC(=O)C)C5CC5,PHASE2,nervous_system_disease
3763,Persistent Developmental Stuttering,Pagoclone,CC(C)CCC(=O)CC1C2=CC=CC=C2C(=O)N1C3=NC4=C(C=C3)C=CC(=N4)Cl,PHASE2,nervous_system_disease
3764,Central Nervous System Nongerminomatous Germ Cell Tumor|Choriocarcinoma|Embryonal Carcinoma|Immature Teratoma|Malignant Teratoma|Mixed Germ Cell Tumor|Pineal Region Germ Cell Tumor|Pineal Region Immature Teratoma|Pineal Region Yolk Sac Tumor|Suprasellar Germ Cell Tumor,Ifosfamide,C1CN(P(=O)(OC1)NCCCl)CCCl,PHASE2,nervous_system_disease
3765,Central Nervous System Nongerminomatous Germ Cell Tumor|Choriocarcinoma|Embryonal Carcinoma|Immature Teratoma|Malignant Teratoma|Mixed Germ Cell Tumor|Pineal Region Germ Cell Tumor|Pineal Region Immature Teratoma|Pineal Region Yolk Sac Tumor|Suprasellar Germ Cell Tumor,Pegfilgrastim,CC(C(C(=O)O)N)OC1C(C(C(C(O1)COC2(CC(C(C(O2)C(C(CO)O)O)NC(=O)CNC(=O)OCCOC)O)C(=O)O)O)O)NC(=O)C,PHASE2,nervous_system_disease
3766,Japanese Encephalitis,Ribavirin,C1=NC(=NN1C2C(C(C(O2)CO)O)O)C(=O)N,PHASE2,nervous_system_disease
3767,Brain Tumors With Ill-defined Margins,Indigo,C1=CC=C2C(=C1)C(=C(N2)C3=NC4=CC=CC=C4C3=O)O,PHASE1|PHASE2,nervous_system_disease
3768,Fibromyalgia,Esreboxetine,CCOC1=CC=CC=C1OC(C2CNCCO2)C3=CC=CC=C3,PHASE2,nervous_system_disease
3769,Spinal Cord Injury,Tiotropium,C[N+]1(C2CC(CC1C3C2O3)OC(=O)C(C4=CC=CS4)(C5=CC=CS5)O)C,PHASE2,nervous_system_disease
3770,Chronic Prostatitis|Pelvic Pain,Thalidomide,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O,PHASE2,nervous_system_disease
3771,Attention Deficit Disorder With Hyperactivity,Amphetamine,CC(CC1=CC=CC=C1)N,PHASE2,nervous_system_disease
3772,Neurofibromatosis Type 2|Vestibular Schwannoma|Non-vestibular Schwannoma|Meningioma|Ependymoma,Brigatinib,CN1CCN(CC1)C2CCN(CC2)C3=CC(=C(C=C3)NC4=NC=C(C(=N4)NC5=CC=CC=C5P(=O)(C)C)Cl)OC,PHASE2,nervous_system_disease
3773,Neurofibromatosis Type 2|Vestibular Schwannoma|Non-vestibular Schwannoma|Meningioma|Ependymoma,Neratinib,CCOC1=C(C=C2C(=C1)N=CC(=C2NC3=CC(=C(C=C3)OCC4=CC=CC=N4)Cl)C#N)NC(=O)C=CCN(C)C,PHASE2,nervous_system_disease
3774,Migraine Headache,Ibudilast,CC(C)C1=NN2C=CC=CC2=C1C(=O)C(C)C,PHASE1,nervous_system_disease
3775,Early Manifest Huntington Disease,Branaplam,CC1(CC(CC(N1)(C)C)OC2=NN=C(C=C2)C3=C(C=C(C=C3)C4=CNN=C4)O)C,PHASE2,nervous_system_disease
3776,Spinocerebellar Ataxias|Spinocerebellar Ataxia Genotype Type 1|Spinocerebellar Ataxia Genotype Type 2|Spinocerebellar Ataxia Genotype Type 3|Spinocerebellar Ataxia Genotype Type 6|Spinocerebellar Ataxia Genotype Type 7|Spinocerebellar Ataxia Genotype Type 8|Spinocerebellar Ataxia Genotype Type 10,Troriluzole,CN(CC(=O)NC1=NC2=C(S1)C=C(C=C2)OC(F)(F)F)C(=O)CNC(=O)CN,PHASE2|PHASE3,nervous_system_disease
3777,Brain Neoplasms,Ferumoxytol,O[Fe]=O.O[Fe]=O.[Fe],PHASE1,nervous_system_disease
3778,Non-Small Cell Lung Cancer|Leptomeningeal Metastases|Brain Metastases,Tesevatinib,CN1CC2CC(CC2C1)COC3=C(C=C4C(=C3)N=CN=C4NC5=C(C(=C(C=C5)Cl)Cl)F)OC,PHASE2,nervous_system_disease
3779,Heart Failure|Sleep Disordered Breathing,Dapagliflozin,CCOC1=CC=C(C=C1)CC2=C(C=CC(=C2)C3C(C(C(C(O3)CO)O)O)O)Cl,PHASE2,nervous_system_disease
3780,Spasticity,Tizanidine,C1CN=C(N1)NC2=C(C=CC3=NSN=C32)Cl,PHASE2,nervous_system_disease
3781,Fragile X Syndrome,Lovastatin,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,PHASE2,nervous_system_disease
3782,"Muscular Dystrophy, Duchenne",Rimeporide,CC1=CC(=C(C=C1C(=O)N=C(N)N)S(=O)(=O)C)S(=O)(=O)C,PHASE1,nervous_system_disease
3783,REM Sleep Behavior Disorder,Clonazepam,C1C(=O)NC2=C(C=C(C=C2)[N+](=O)[O-])C(=N1)C3=CC=CC=C3Cl,PHASE2,nervous_system_disease
3784,Autonomic Failure|Orthostatic Hypotension,Acarbose,CC1C(C(C(C(O1)OC2C(OC(C(C2O)O)OC3C(OC(C(C3O)O)O)CO)CO)O)O)NC4C=C(C(C(C4O)O)O)CO,PHASE1,nervous_system_disease
3785,Autonomic Failure|Orthostatic Hypotension,Yohimbine,COC(=O)C1C(CCC2C1CC3C4=C(CCN3C2)C5=CC=CC=C5N4)O,PHASE1,nervous_system_disease
3786,Autonomic Failure|Orthostatic Hypotension,Ranitidine,CNC(=C[N+](=O)[O-])NCCSCC1=CC=C(O1)CN(C)C,PHASE1,nervous_system_disease
3787,Autonomic Failure|Orthostatic Hypotension,Tranylcypromine,C1C(C1N)C2=CC=CC=C2,PHASE1,nervous_system_disease
3788,Autonomic Failure|Orthostatic Hypotension,Oxymetazoline,CC1=CC(=C(C(=C1CC2=NCCN2)C)O)C(C)(C)C,PHASE1,nervous_system_disease
3789,Vestibular Migraine|Migrainous Vertigo,Rizatriptan,CN(C)CCC1=CNC2=C1C=C(C=C2)CN3C=NC=N3,PHASE2|PHASE3,nervous_system_disease
3790,Sarcopenia|Osteopenia,Anamorelin,CC(C)(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)N3CCCC(C3)(CC4=CC=CC=C4)C(=O)N(C)N(C)C)N,PHASE1,nervous_system_disease
3791,DLBCL|Neurotoxicity Syndromes,Defibrotide,CC(C)C1=C(C=C(C(=C1)C2=NNC(=O)N2C3=CC4=C(C=C3)N(C=C4)C)O)OP(=O)(O)O,PHASE2,nervous_system_disease
3792,Tinnitus,Vardenafil,CCCC1=NC(=C2N1N=C(NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)CC)OCC)C,PHASE2,nervous_system_disease
3793,Active Melanoma Brain Metastases,Cobimetinib,C1CCNC(C1)C2(CN(C2)C(=O)C3=C(C(=C(C=C3)F)F)NC4=C(C=C(C=C4)I)F)O,PHASE2,nervous_system_disease
3794,Wolfram Syndrome,Valproate,CCCC(CCC)C(=O)O,PHASE2,nervous_system_disease
3795,Spinal Muscular Atrophy,Itraconazole,CCC(C)N1C(=O)N(C=N1)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(C=C4)OCC5COC(O5)(CN6C=NC=N6)C7=C(C=C(C=C7)Cl)Cl,PHASE1,nervous_system_disease
3796,Ischemic Stroke,Citicoline,C[N+](C)(C)CCOP(=O)([O-])OP(=O)(O)OCC1C(C(C(O1)N2C=CC(=NC2=O)N)O)O,PHASE1,nervous_system_disease
3797,Insomnia Disorder,Flurazepam,CCN(CC)CCN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3F,PHASE1,nervous_system_disease
3798,High Grade Sarcoma|Metastatic Leiomyosarcoma|Metastatic Malignant Peripheral Nerve Sheath Tumor|Metastatic Synovial Sarcoma|Metastatic Undifferentiated Pleomorphic Sarcoma|Metastatic Unresectable Sarcoma|Myxofibrosarcoma|Recurrent Leiomyosarcoma|Recurrent Malignant Peripheral Nerve Sheath Tumor|Recurrent Synovial Sarcoma|Recurrent Undifferentiated Pleomorphic Sarcoma|Stage III Uterine Corpus Leiomyosarcoma AJCC v8|Stage IIIA Uterine Corpus Leiomyosarcoma AJCC v8|Stage IIIB Uterine Corpus Leiomyosarcoma AJCC v8|Stage IIIC Uterine Corpus Leiomyosarcoma AJCC v8|Stage IV Uterine Corpus Leiomyosarcoma AJCC v8|Stage IVA Uterine Corpus Leiomyosarcoma AJCC v8|Stage IVB Uterine Corpus Leiomyosarcoma AJCC v8|Unresectable Leiomyosarcoma,Pazopanib,CC1=C(C=C(C=C1)NC2=NC=CC(=N2)N(C)C3=CC4=NN(C(=C4C=C3)C)C)S(=O)(=O)N,PHASE1|PHASE2,nervous_system_disease
3799,High Grade Sarcoma|Metastatic Leiomyosarcoma|Metastatic Malignant Peripheral Nerve Sheath Tumor|Metastatic Synovial Sarcoma|Metastatic Undifferentiated Pleomorphic Sarcoma|Metastatic Unresectable Sarcoma|Myxofibrosarcoma|Recurrent Leiomyosarcoma|Recurrent Malignant Peripheral Nerve Sheath Tumor|Recurrent Synovial Sarcoma|Recurrent Undifferentiated Pleomorphic Sarcoma|Stage III Uterine Corpus Leiomyosarcoma AJCC v8|Stage IIIA Uterine Corpus Leiomyosarcoma AJCC v8|Stage IIIB Uterine Corpus Leiomyosarcoma AJCC v8|Stage IIIC Uterine Corpus Leiomyosarcoma AJCC v8|Stage IV Uterine Corpus Leiomyosarcoma AJCC v8|Stage IVA Uterine Corpus Leiomyosarcoma AJCC v8|Stage IVB Uterine Corpus Leiomyosarcoma AJCC v8|Unresectable Leiomyosarcoma,Sapanisertib,CC(C)N1C2=NC=NC(=C2C(=N1)C3=CC4=C(C=C3)OC(=N4)N)N,PHASE1|PHASE2,nervous_system_disease
3800,Dental Pain,Buprenorphine,CC(C)(C)C(C)(C1CC23CCC1(C4C25CCN(C3CC6=C5C(=C(C=C6)O)O4)CC7CC7)OC)O,PHASE2,nervous_system_disease
3801,Parkinson's Disease,Nebicapone,C1=CC=C(C=C1)CC(=O)C2=CC(=C(C(=C2)O)O)[N+](=O)[O-],PHASE1,nervous_system_disease
3802,Vertigo,Levophencynonate,CN1CC2CCCC(C1)C2OC(=O)C(C3CCCC3)(C4=CC=CC=C4)O,PHASE2,nervous_system_disease
3803,"Pain|Low Back Pain|Back Pain|Osteoarthritis, Knee",Tapentadol,CCC(C1=CC(=CC=C1)O)C(C)CN(C)C,PHASE2,nervous_system_disease
3804,Hypertension,Bosentan,CC(C)(C)C1=CC=C(C=C1)S(=O)(=O)NC2=C(C(=NC(=N2)C3=NC=CC=N3)OCCO)OC4=CC=CC=C4OC,PHASE1,nervous_system_disease
3805,Hypertension,Diltiazem,CC(=O)OC1C(SC2=CC=CC=C2N(C1=O)CCN(C)C)C3=CC=C(C=C3)OC,PHASE1,nervous_system_disease
3806,Hypertension,Eplerenone,CC12CCC(=O)C=C1CC(C3C24C(O4)CC5(C3CCC56CCC(=O)O6)C)C(=O)OC,PHASE1,nervous_system_disease
3807,Myocardial Infarction|Acute Coronary Syndromes|Unstable Angina,Eptifibatide,C1CC2C(=O)NC(CSSCCC(=O)NC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)N2C1)CC3=CNC4=CC=CC=C43)CC(=O)O)CCCCN=C(N)N)C(=O)N,PHASE2,nervous_system_disease
3808,REM Sleep Behavior Disorder|Pre-motor Parkinson's Disease|Symptomatic Parkinson Disease,Terazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4CCCO4)N)OC,PHASE2,nervous_system_disease
3809,Tuberous Sclerosis Complex,Basimglurant,CC1=C(N=C(N1C2=CC=C(C=C2)F)C)C#CC3=CC(=NC=C3)Cl,PHASE2,nervous_system_disease
3810,Aicardi Goutires Syndrome,Tenofovir,CC(CN1C=NC2=C(N=CN=C21)N)OCP(=O)(O)O,PHASE1|PHASE2,nervous_system_disease
3811,Aicardi Goutires Syndrome,Emtricitabine,C1C(OC(S1)CO)N2C=C(C(=NC2=O)N)F,PHASE1|PHASE2,nervous_system_disease
3812,"Sleep Apnea, Obstructive",Seltorexant,CC1=CC(=NC(=N1)N2CC3CN(CC3C2)C(=O)C4=C(C=CC=C4F)N5N=CC=N5)C,PHASE1,nervous_system_disease
3813,Orthostatic Hypertension,Norepinephrine,C1=CC(=C(C=C1C(CN)O)O)O,PHASE1|PHASE2,nervous_system_disease
3814,Becker Muscular Dystrophy,Vamorolone,CC1CC2C3CCC4=CC(=O)C=CC4(C3=CCC2(C1(C(=O)CO)O)C)C,PHASE2,nervous_system_disease
3815,Infantile Spasms (IS),Radiprodil,C1CN(CCC1CC2=CC=C(C=C2)F)C(=O)C(=O)NC3=CC4=C(C=C3)NC(=O)O4,PHASE2,nervous_system_disease
3816,Migraine,Prochlorperazine,CN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl,PHASE1,nervous_system_disease
3817,Parkinson Disease|Neurodegenerative Diseases|Central Nervous System Diseases|Movement Disorders|Brain Diseases,Preladenant,COCCOC1=CC=C(C=C1)N2CCN(CC2)CCN3C4=C(C=N3)C5=NC(=NN5C(=N4)N)C6=CC=CO6,PHASE2,nervous_system_disease
3818,Intracerebral Hemorrhage|Spironolactone,Spironolactone,CC(=O)SC1CC2=CC(=O)CCC2(C3C1C4CCC5(C4(CC3)C)CCC(=O)O5)C,PHASE2,nervous_system_disease
3819,Advanced Malignant Solid Neoplasm|Metastatic Malignant Solid Neoplasm|NF1 Mutation Positive Malignant Peripheral Nerve Sheath Tumor|Unresectable Malignant Solid Neoplasm,Telaglenastat,C1=CC=NC(=C1)CC(=O)NC2=NN=C(S2)CCCCC3=NN=C(C=C3)NC(=O)CC4=CC(=CC=C4)OC(F)(F)F,PHASE2,nervous_system_disease
3820,Degenerative Disc Disease|Intervertebral Disc Disease|Low Back Pain,Mepivacaine,CC1=C(C(=CC=C1)C)NC(=O)C2CCCCN2C,PHASE1|PHASE2,nervous_system_disease
3821,"Postoperative Pain|Thyroid Diseases|Anesthesia, Local",Bupivacaine,CCCCN1CCCCC1C(=O)NC2=C(C=CC=C2C)C,PHASE2,nervous_system_disease
3822,"Postoperative Pain|Thyroid Diseases|Anesthesia, Local",Epinephrine,CNCC(C1=CC(=C(C=C1)O)O)O,PHASE2,nervous_system_disease
3823,"Headache, Migraine",Norgestimate,CCC12CCC3C(C1CCC2(C#C)OC(=O)C)CCC4=CC(=NO)CCC34,PHASE1,nervous_system_disease
3824,Normal Tension Glaucoma (NTG),Timolol,CC(C)(C)NCC(COC1=NSN=C1N2CCOCC2)O,PHASE2,nervous_system_disease
3825,Parkinson Disease|Healthy,Foliglurax,C1COCCN1CCCC2=CC3=C(C=C2)OC(=CC3=NO)C4=NC=C5C=CSC5=C4,PHASE1,nervous_system_disease
3826,Postural Orthostatic Tachycardia Syndrome,Metoprolol,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O,PHASE2,nervous_system_disease
3827,Amyotrophic Lateral Sclerosis,Clenbuterol,CC(C)(C)NCC(C1=CC(=C(C(=C1)Cl)N)Cl)O,PHASE2,nervous_system_disease
3828,Glioblastoma Multiforme|Glioma|Gliosarcoma|Malignant Brain Tumor|Ependymoma|Medulloblastoma|Diffuse Intrinsic Pontine Glioma|Primary CNS Tumor,Indoximod,CN1C=C(C2=CC=CC=C21)CC(C(=O)O)N,PHASE1,nervous_system_disease
3829,Breast Neoplasms|Brain Neoplasms|Neoplasms by Site|Neoplasms|Breast Diseases|Central Nervous System Neoplasms|Brain Diseases|Central Nervous System Diseases,Elacestrant,CCNCCC1=CC=C(C=C1)CN(CC)C2=C(C=CC(=C2)OC)C3CCC4=C(C3)C=CC(=C4)O,PHASE1|PHASE2,nervous_system_disease
3830,Glioblastoma|Adult-type Diffuse Gliomas,Pemigatinib,CCN1C2=C3C=C(NC3=NC=C2CN(C1=O)C4=C(C(=CC(=C4F)OC)OC)F)CN5CCOCC5,PHASE2,nervous_system_disease
3831,"Spastic Paraplegia, Hereditary",Resveratrol,C1=CC(=CC=C1C=CC2=CC(=CC(=C2)O)O)O,PHASE2,nervous_system_disease
3832,Pediatric Traumatic Brain Injury,Probenecid,CCCN(CCC)S(=O)(=O)C1=CC=C(C=C1)C(=O)O,PHASE1|PHASE2,nervous_system_disease
3833,Acute Myeloid Leukemia Post Cytotoxic Therapy|Down Syndrome|Myelodysplastic Syndrome Post Cytotoxic Therapy|Recurrent Acute Myeloid Leukemia|Recurrent Mixed Phenotype Acute Leukemia|Recurrent Myelodysplastic Syndrome|Refractory Acute Myeloid Leukemia|Refractory Mixed Phenotype Acute Leukemia|Refractory Myelodysplastic Syndrome,Uproleselan,CCC1CC(CC(C1OC2C(C(C(C(O2)C)O)O)O)OC3C(C(C(C(O3)CO)O)OC(CC4CCCCC4)C(=O)O)NC(=O)C)C(=O)NCCNC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC,PHASE1,nervous_system_disease
3834,Hyperalgesia,Remifentanil,CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCC(=O)OC)C(=O)OC,PHASE2,nervous_system_disease
3835,Batten Disease,Miglustat,CCCCN1CC(C(C(C1CO)O)O)O,PHASE1|PHASE2,nervous_system_disease
3836,Functional Abdominal Pain|Irritable Bowel Syndrome|Functional Dyspepsia,Simethicone,CO[Si](C)(C)O[Si](C)(C)C.O=[Si]=O,PHASE1,nervous_system_disease
3837,Epilepsy,Vinpocetine,CCC12CCCN3C1C4=C(CC3)C5=CC=CC=C5N4C(=C2)C(=O)OCC,PHASE1|PHASE2,nervous_system_disease
3838,Dental Pain,Diclofenac,C1=CC=C(C(=C1)CC(=O)O)NC2=C(C=CC=C2Cl)Cl,PHASE2,nervous_system_disease
3839,"Muscular Atrophy, Spinal",Amifampridine,C1=CN=CC(=C1N)N,PHASE2,nervous_system_disease
3840,"Medulloblastoma|Astrocytoma, Grade III|Glioblastoma|Anaplastic Astrocytoma|Brain Stem Neoplasms, Malignant|Oligodendroblastoma|Anaplastic Oligodendroglioma|Malignant Glioma",Mebendazole,COC(=O)NC1=NC2=C(N1)C=C(C=C2)C(=O)C3=CC=CC=C3,PHASE1,nervous_system_disease
3841,Huntington Disease,Risperidone,CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F,PHASE1,nervous_system_disease
3842,Anatomic Stage I Breast Cancer AJCC v8|Anatomic Stage IA Breast Cancer AJCC v8|Anatomic Stage IB Breast Cancer AJCC v8|Anatomic Stage II Breast Cancer AJCC v8|Anatomic Stage IIA Breast Cancer AJCC v8|Anatomic Stage IIB Breast Cancer AJCC v8|Anatomic Stage III Breast Cancer AJCC v8|Anatomic Stage IIIA Breast Cancer AJCC v8|Anatomic Stage IIIB Breast Cancer AJCC v8|Anatomic Stage IIIC Breast Cancer AJCC v8|Anatomic Stage IV Breast Cancer AJCC v8|Chemotherapy-Induced Peripheral Neuropathy|Digestive System Carcinoma|Prognostic Stage I Breast Cancer AJCC v8|Prognostic Stage IA Breast Cancer AJCC v8|Prognostic Stage IB Breast Cancer AJCC v8|Prognostic Stage II Breast Cancer AJCC v8|Prognostic Stage IIA Breast Cancer AJCC v8|Prognostic Stage IIB Breast Cancer AJCC v8|Prognostic Stage III Breast Cancer AJCC v8|Prognostic Stage IIIA Breast Cancer AJCC v8|Prognostic Stage IIIB Breast Cancer AJCC v8|Prognostic Stage IIIC Breast Cancer AJCC v8|Prognostic Stage IV Breast Cancer AJCC v8,Lorcaserin,CC1CNCCC2=C1C=C(C=C2)Cl,PHASE1,nervous_system_disease
3843,Cmv Congenital|CMV|Congenital Cmv|SNHL|Sensorineural Hearing Loss,Valganciclovir,CC(C)C(C(=O)OCC(CO)OCN1C=NC2=C1N=C(NC2=O)N)N,PHASE2,nervous_system_disease
3844,Fabry Disease,Migalastat,C1C(C(C(C(N1)CO)O)O)O,PHASE2,nervous_system_disease
3845,Migraine With Hypertension,Ramipril,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCC3CC2C(=O)O,PHASE2,nervous_system_disease
3846,"Dyskinesia, Drug-Induced",Quetiapine,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42,PHASE1,nervous_system_disease
3847,Myotonic Dystrophy 1,Tideglusib,C1=CC=C(C=C1)CN2C(=O)N(SC2=O)C3=CC=CC4=CC=CC=C43,PHASE2,nervous_system_disease
3848,Solid Tumors|Brain Tumors|Brain Metastases,Satraplatin,CC(=O)O.CC(=O)O.C1CCC(CC1)N.N.Cl[Pt]Cl,PHASE1,nervous_system_disease
3849,Epilepsy,Gliclazide,CC1=CC=C(C=C1)S(=O)(=O)NC(=O)NN2CC3CCCC3C2,PHASE1,nervous_system_disease
3850,Stroke,Dextroamphetamine,CC(CC1=CC=CC=C1)N,PHASE2,nervous_system_disease
3851,Musculoskeletal Pain,Ketoprofen,CC(C1=CC(=CC=C1)C(=O)C2=CC=CC=C2)C(=O)O,PHASE1,nervous_system_disease
3852,Spinal Cord Injury|Bone Loss|Osteoporosis,Teriparatide,CCC(C)C(C(=O)NC(CCC(=O)N)C(=O)NC(CC(C)C)C(=O)NC(CCSC)C(=O)NC(CC1=CNC=N1)C(=O)NC(CC(=O)N)C(=O)NC(CC(C)C)C(=O)NCC(=O)NC(CCCCN)C(=O)NC(CC2=CNC=N2)C(=O)NC(CC(C)C)C(=O)NC(CC(=O)N)C(=O)NC(CO)C(=O)NC(CCSC)C(=O)NC(CCC(=O)O)C(=O)NC(CCCNC(=N)N)C(=O)NC(C(C)C)C(=O)NC(CCC(=O)O)C(=O)NC(CC3=CNC4=CC=CC=C43)C(=O)NC(CC(C)C)C(=O)NC(CCCNC(=N)N)C(=O)NC(CCCCN)C(=O)NC(CCCCN)C(=O)NC(CC(C)C)C(=O)NC(CCC(=O)N)C(=O)NC(CC(=O)O)C(=O)NC(C(C)C)C(=O)NC(CC5=CNC=N5)C(=O)NC(CC(=O)N)C(=O)NC(CC6=CC=CC=C6)C(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(CO)NC(=O)C(C(C)C)NC(=O)C(CO)N,PHASE2,nervous_system_disease
3853,Morton's Neuroma,Resiniferatoxin,CC1CC2(C3C4C1(C5C=C(C(=O)C5(CC(=C4)COC(=O)CC6=CC(=C(C=C6)O)OC)O)C)OC(O3)(O2)CC7=CC=CC=C7)C(=C)C,PHASE1,nervous_system_disease
3854,Metastatic Breast Cancer|Brain Metastases,Ondansetron,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C,PHASE2,nervous_system_disease
3855,Abacterial Chronic Prostatitis/Chronic Pelvic Pain Syndrome,Silodosin,CC(CC1=CC2=C(C(=C1)C(=O)N)N(CC2)CCCO)NCCOC3=CC=CC=C3OCC(F)(F)F,PHASE2,nervous_system_disease
3856,"Cerebral Small Vessel Diseases|Stroke, Lacunar",Isosorbide,C1C(C2C(O1)C(CO2)O)O,PHASE2|PHASE3,nervous_system_disease
3857,"Cerebral Small Vessel Diseases|Stroke, Lacunar",Cilostazol,C1CCC(CC1)N2C(=NN=N2)CCCCOC3=CC4=C(C=C3)NC(=O)CC4,PHASE2|PHASE3,nervous_system_disease
3858,Duchenne Muscular Dystrophy|Becker Muscular Dystrophy,Ataluren,C1=CC=C(C(=C1)C2=NC(=NO2)C3=CC(=CC=C3)C(=O)O)F,PHASE2,nervous_system_disease
3859,Gastroparesis|Opioid Use,Naloxegol,COCCOCCOCCOCCOCCOCCOCCOC1CCC2(C3CC4=C5C2(C1OC5=C(C=C4)O)CCN3CC=C)O,PHASE2,nervous_system_disease
3860,Hepatic Encephalopathy|Acute-On-Chronic Liver Failure,Lactulose,C(C1C(C(C(C(O1)OC2C(OC(C2O)(CO)O)CO)O)O)O)O,PHASE1,nervous_system_disease
3861,High Blood Pressure|Migraine Headaches|Chest Pain,Nadolol,CC(C)(C)NCC(COC1=CC=CC2=C1CC(C(C2)O)O)O,PHASE1,nervous_system_disease
3862,"Breast Cancer|Lung Cancer|Neurotoxicity|Ovarian Cancer|Prostate Cancer|Unspecified Adult Solid Tumor, Protocol Specific",Amifostine,C(CN)CNCCSP(=O)(O)O,PHASE2,nervous_system_disease
3863,Subarachnoid Hemorrhage|Subdural Hematoma|Traumatic Brain Injury|Ischemic Stroke|Fever|Intracerebral Hemorrhage,Bromocriptine,CC(C)CC1C(=O)N2CCCC2C3(N1C(=O)C(O3)(C(C)C)NC(=O)C4CN(C5CC6=C(NC7=CC=CC(=C67)C5=C4)Br)C)O,PHASE1|PHASE2,nervous_system_disease
3864,Stroke|Prevention,Rivaroxaban,C1COCC(=O)N1C2=CC=C(C=C2)N3CC(OC3=O)CNC(=O)C4=CC=C(S4)Cl,PHASE2|PHASE3,nervous_system_disease
3865,Brain Injury|Intracranial Pressure,Propofol,CC(C)C1=C(C(=CC=C1)C(C)C)O,PHASE1|PHASE2,nervous_system_disease
3866,Agitation,Levosulpiride,CCN1CCCC1CNC(=O)C2=C(C=CC(=C2)S(=O)(=O)N)OC,PHASE2|PHASE3,nervous_system_disease
3867,Dementia,Megestrol,CC1=CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C,PHASE2|PHASE3,nervous_system_disease
3868,Neuropathic Pain,Tolterodine,CC1=CC(=C(C=C1)O)C(CCN(C(C)C)C(C)C)C2=CC=CC=C2,PHASE1|PHASE2,nervous_system_disease
3869,Parkinson Disease,Isradipine,CC1=C(C(C(=C(N1)C)C(=O)OC(C)C)C2=CC=CC3=NON=C32)C(=O)OC,PHASE2,nervous_system_disease
3870,Crohn's Disease|Abdominal Pain,Olorinab,CC(C)(C)C(CO)NC(=O)C1=NN(C2=C1CC3C2C3)C4=NC=C[N+](=C4)[O-],PHASE2,nervous_system_disease
3871,Carotid Artery Stenosis,Ticagrelor,CCCSC1=NC(=C2C(=N1)N(N=N2)C3CC(C(C3O)O)OCCO)NC4CC4C5=CC(=C(C=C5)F)F,PHASE2,nervous_system_disease
3872,Advanced Malignant Solid Neoplasm|Ann Arbor Stage III Childhood Non-Hodgkin Lymphoma|Ann Arbor Stage IV Childhood Non-Hodgkin Lymphoma|Low Grade Glioma|Malignant Glioma|Recurrent Childhood Central Nervous System Neoplasm|Recurrent Childhood Ependymoma|Recurrent Childhood Malignant Germ Cell Tumor|Recurrent Childhood Non-Hodgkin Lymphoma|Recurrent Childhood Rhabdomyosarcoma|Recurrent Childhood Soft Tissue Sarcoma|Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor|Recurrent Glioma|Recurrent Hepatoblastoma|Recurrent Langerhans Cell Histiocytosis|Recurrent Malignant Solid Neoplasm|Recurrent Medulloblastoma|Recurrent Neuroblastoma|Recurrent Osteosarcoma|Refractory Childhood Malignant Germ Cell Tumor|Refractory Ependymoma|Refractory Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor|Refractory Glioma|Refractory Hepatoblastoma|Refractory Langerhans Cell Histiocytosis|Refractory Malignant Glioma|Refractory Malignant Solid Neoplasm|Refractory Medulloblastoma|Refractory Neuroblastoma|Refractory Non-Hodgkin Lymphoma|Refractory Osteosarcoma|Refractory Primary Central Nervous System Neoplasm|Refractory Rhabdomyosarcoma|Refractory Soft Tissue Sarcoma|Rhabdoid Tumor|Wilms Tumor,Olaparib,C1CC1C(=O)N2CCN(CC2)C(=O)C3=C(C=CC(=C3)CC4=NNC(=O)C5=CC=CC=C54)F,PHASE2,nervous_system_disease
3873,Advanced Malignant Solid Neoplasm|Recurrent Ependymoma|Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor|Recurrent Glioma|Recurrent Hepatoblastoma|Recurrent Kidney Wilms Tumor|Recurrent Langerhans Cell Histiocytosis|Recurrent Malignant Germ Cell Tumor|Recurrent Malignant Glioma|Recurrent Malignant Solid Neoplasm|Recurrent Medulloblastoma|Recurrent Neuroblastoma|Recurrent Non-Hodgkin Lymphoma|Recurrent Osteosarcoma|Recurrent Rhabdoid Tumor|Recurrent Rhabdomyosarcoma|Recurrent Soft Tissue Sarcoma|Refractory Ependymoma|Refractory Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor|Refractory Glioma|Refractory Hepatoblastoma|Refractory Langerhans Cell Histiocytosis|Refractory Malignant Germ Cell Tumor|Refractory Malignant Glioma|Refractory Malignant Solid Neoplasm|Refractory Medulloblastoma|Refractory Neuroblastoma|Refractory Non-Hodgkin Lymphoma|Refractory Osteosarcoma|Refractory Primary Central Nervous System Neoplasm|Refractory Rhabdoid Tumor|Refractory Rhabdomyosarcoma|Refractory Soft Tissue Sarcoma,Larotrectinib,C1CC(N(C1)C2=NC3=C(C=NN3C=C2)NC(=O)N4CCC(C4)O)C5=C(C=CC(=C5)F)F,PHASE2,nervous_system_disease
3874,Sarcopenia,Nandrolone,CC12CCC3C(C1CCC2O)CCC4=CC(=O)CCC34,PHASE2,nervous_system_disease
3875,Anatomic Stage IV Breast Cancer AJCC v8|Clinical Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8|Clinical Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8|Clinical Stage IVB Gastroesophageal Junction Adenocarcinoma AJCC v8|Locally Advanced Malignant Solid Neoplasm|Locally Advanced Melanoma|Locally Advanced Primary Malignant Central Nervous System Neoplasm|Locally Advanced Sarcoma|Metastatic Malignant Solid Neoplasm|Metastatic Melanoma|Metastatic Primary Malignant Central Nervous System Neoplasm|Metastatic Sarcoma|Pathologic Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8|Pathologic Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8|Pathologic Stage IVB Gastroesophageal Junction Adenocarcinoma AJCC v8|Postneoadjuvant Therapy Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8|Postneoadjuvant Therapy Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8|Postneoadjuvant Therapy Stage IVB Gastroesophageal Junction Adenocarcinoma AJCC v8|Prognostic Stage IIIC Breast Cancer AJCC v8|Prognostic Stage IV Breast Cancer AJCC v8|Stage IIIC Colorectal Cancer AJCC v8|Stage IIIC Lung Cancer AJCC v8|Stage IV Colorectal Cancer AJCC v8|Stage IV Lung Cancer AJCC v8|Stage IVA Colorectal Cancer AJCC v8|Stage IVA Lung Cancer AJCC v8|Stage IVB Colorectal Cancer AJCC v8|Stage IVB Lung Cancer AJCC v8|Stage IVC Colorectal Cancer AJCC v8,Avapritinib,CC(C1=CC=C(C=C1)F)(C2=CN=C(N=C2)N3CCN(CC3)C4=NC=NN5C4=CC(=C5)C6=CN(N=C6)C)N,PHASE2,nervous_system_disease
3876,Alzheimer's Disease,Idalopirdine,C1=CC(=CC(=C1)OCC(C(F)F)(F)F)CNCCC2=CNC3=C2C=CC(=C3)F,PHASE1,nervous_system_disease
3877,Intellectual Disability|Developmental Disability|Aggression|Behavior Problem,Nabilone,CCCCCCC(C)(C)C1=CC(=C2C3CC(=O)CCC3C(OC2=C1)(C)C)O,PHASE1,nervous_system_disease
3878,Meningitis|Ventriculitis,Ceftaroline,CCON=C(C1=NSC(=N1)NP(=O)(O)O)C(=O)NC2C3N(C2=O)C(=C(CS3)SC4=NC(=CS4)C5=CC=[N+](C=C5)C)C(=O)[O-],PHASE1,nervous_system_disease
3879,"NMO Spectrum Disorder|Spasticity, Muscle",Nabiximols,CCCCCC1=CC(=C(C(=C1)O)C2C=C(CCC2C(=C)C)C)O.CCCCCC1=CC(=C2C3C=C(CCC3C(OC2=C1)(C)C)C)O,PHASE2,nervous_system_disease
3880,Progressive Supranuclear Palsy,Davunetide,CCC(C)C(C(=O)N1CCCC1C(=O)NC(CCC(=O)N)C(=O)O)NC(=O)C(CO)NC(=O)C(C(C)C)NC(=O)C2CCCN2C(=O)C(C)NC(=O)C(CC(=O)N)N,PHASE2|PHASE3,nervous_system_disease
3881,Gastroparesis,Erythromycin,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)O)(C)O,PHASE2,nervous_system_disease
3882,Gastroparesis,Azithromycin,CCC1C(C(C(N(CC(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)C)O)(C)O,PHASE2,nervous_system_disease
3883,Alzheimer Disease,Rofecoxib,CS(=O)(=O)C1=CC=C(C=C1)C2=C(C(=O)OC2)C3=CC=CC=C3,PHASE2|PHASE3,nervous_system_disease
3884,Amyotrophic Lateral Sclerosis|Motor Neuron Disease,Trimetazidine,COC1=C(C(=C(C=C1)CN2CCNCC2)OC)OC,PHASE2,nervous_system_disease
3885,Epilepsy,Clobazam,CN1C(=O)CC(=O)N(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,PHASE2,nervous_system_disease
3886,Malignant Solid Tumor - Malignant Nervous System Neoplasm,Cabazitaxel,CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)OC)C)OC,PHASE1|PHASE2,nervous_system_disease
3887,Gastroparesis,Nizatidine,CNC(=C[N+](=O)[O-])NCCSCC1=CSC(=N1)CN(C)C,PHASE1,nervous_system_disease
3888,Neurogenic Bladder|Spinal Cord Injuries,Gentamicin,CC(C1CCC(C(O1)OC2C(CC(C(C2O)OC3C(C(C(CO3)(C)O)NC)O)N)N)N)NC,PHASE2,nervous_system_disease
3889,Non Small Cell Lung Cancer|Brain Metastases,Dacomitinib,COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)NC(=O)C=CCN4CCCCC4,PHASE2,nervous_system_disease
3890,Malignant Brain Stem Tumor|Glioma,Anlotinib,CC1=CC2=C(N1)C=CC(=C2F)OC3=C4C=C(C(=CC4=NC=C3)OCC5(CC5)N)OC,PHASE2,nervous_system_disease
3891,Spinal Cord Injury,Salmeterol,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O,PHASE1,nervous_system_disease
3892,Complex Regional Pain Syndrome,Soticlestat,C1CN(CCC1(CC2=CC=CC=C2)O)C(=O)C3=C(N=CC=C3)C4=CC=NC=C4,PHASE2,nervous_system_disease
3893,Tourette Syndrome,Palmidrol,CCCCCCCCCCCCCCCC(=O)NCCO,PHASE2,nervous_system_disease
3894,Obstructive Sleep Apnea of Adult,Daridorexant,CC1=C(C=CC2=C1N=C(N2)C3(CCCN3C(=O)C4=C(C=CC(=C4)OC)N5N=CC=N5)C)Cl,PHASE1,nervous_system_disease
3895,Multiple Sclerosis,Ponesimod,CCCN=C1N(C(=O)C(=CC2=CC(=C(C=C2)OCC(CO)O)Cl)S1)C3=CC=CC=C3C,PHASE2,nervous_system_disease
3896,Adult Alveolar Soft Part Sarcoma|Adult Angiosarcoma|Adult Desmoplastic Small Round Cell Tumor|Adult Epithelioid Hemangioendothelioma|Adult Epithelioid Sarcoma|Adult Extraskeletal Myxoid Chondrosarcoma|Adult Extraskeletal Osteosarcoma|Adult Fibrosarcoma|Adult Leiomyosarcoma|Adult Liposarcoma|Adult Malignant Mesenchymoma|Adult Malignant Peripheral Nerve Sheath Tumor|Adult Rhabdomyosarcoma|Adult Synovial Sarcoma|Adult Unclassified Pleomorphic Sarcoma|Chondrosarcoma|Clear Cell Sarcoma of the Kidney|Conjunctival Kaposi Sarcoma|Dermatofibrosarcoma Protuberans|Gastrointestinal Stromal Tumor|Metastatic Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor|Metastatic Osteosarcoma|Ovarian Sarcoma|Recurrent Adult Soft Tissue Sarcoma|Recurrent Adult Unclassified Pleomorphic Sarcoma of Bone|Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor|Recurrent Kaposi Sarcoma|Recurrent Osteosarcoma|Recurrent Uterine Corpus Sarcoma|Small Intestine Leiomyosarcoma|Stage III Adult Soft Tissue Sarcoma|Stage III Uterine Sarcoma|Stage IV Adult Soft Tissue Sarcoma|Stage IV Uterine Sarcoma|Unclassified Pleomorphic Sarcoma of Bone,Vismodegib,CS(=O)(=O)C1=CC(=C(C=C1)C(=O)NC2=CC(=C(C=C2)Cl)C3=CC=CC=N3)Cl,PHASE1|PHASE2,nervous_system_disease
3897,"Subarachnoid Hemorrhage, Aneurysmal",Nimodipine,CC1=C(C(C(=C(N1)C)C(=O)OC(C)C)C2=CC(=CC=C2)[N+](=O)[O-])C(=O)OCCOC,PHASE1,nervous_system_disease
3898,Multiple Sclerosis,Cladribine,C1C(C(OC1N2C=NC3=C(N=C(N=C32)Cl)N)CO)O,PHASE2,nervous_system_disease
3899,Fabry Disease,Iohexol,CC(=O)N(CC(CO)O)C1=C(C(=C(C(=C1I)C(=O)NCC(CO)O)I)C(=O)NCC(CO)O)I,PHASE1,nervous_system_disease
3900,Friedreich Ataxia,Vatiquinone,CC1=C(C(=O)C(=C(C1=O)C)CCC(C)(CCC=C(C)CCC=C(C)CCC=C(C)C)O)C,PHASE2|PHASE3,nervous_system_disease
3901,Alzheimer's Disease,Velusetrag,CC(C)N1C2=CC=CC=C2C=C(C1=O)C(=O)NC3CC4CCC(C3)N4CC(CN(C)S(=O)(=O)C)O,PHASE1,nervous_system_disease
3902,Advanced Malignant Solid Neoplasm|Ann Arbor Stage III Non-Hodgkin Lymphoma|Ann Arbor Stage IV Non-Hodgkin Lymphoma|Histiocytic Sarcoma|Juvenile Xanthogranuloma|Langerhans Cell Histiocytosis|Malignant Glioma|Recurrent Childhood Rhabdomyosarcoma|Recurrent Ependymoma|Recurrent Ewing Sarcoma|Recurrent Glioma|Recurrent Hepatoblastoma|Recurrent Langerhans Cell Histiocytosis|Recurrent Malignant Germ Cell Tumor|Recurrent Malignant Solid Neoplasm|Recurrent Medulloblastoma|Recurrent Neuroblastoma|Recurrent Non-Hodgkin Lymphoma|Recurrent Osteosarcoma|Recurrent Peripheral Primitive Neuroectodermal Tumor|Recurrent Primary Central Nervous System Neoplasm|Recurrent Rhabdoid Tumor|Recurrent Soft Tissue Sarcoma|Refractory Ewing Sarcoma|Refractory Glioma|Refractory Hepatoblastoma|Refractory Langerhans Cell Histiocytosis|Refractory Malignant Germ Cell Tumor|Refractory Malignant Solid Neoplasm|Refractory Medulloblastoma|Refractory Neuroblastoma|Refractory Non-Hodgkin Lymphoma|Refractory Osteosarcoma|Refractory Peripheral Primitive Neuroectodermal Tumor|Refractory Primary Central Nervous System Neoplasm|Refractory Rhabdoid Tumor|Refractory Rhabdomyosarcoma|Rhabdoid Tumor|Stage III Osteosarcoma AJCC v7|Stage III Soft Tissue Sarcoma AJCC v7|Stage IV Osteosarcoma AJCC v7|Stage IV Soft Tissue Sarcoma AJCC v7|Stage IVA Osteosarcoma AJCC v7|Stage IVB Osteosarcoma AJCC v7|Wilms Tumor,Erdafitinib,CC(C)NCCN(C1=CC2=NC(=CN=C2C=C1)C3=CN(N=C3)C)C4=CC(=CC(=C4)OC)OC,PHASE2,nervous_system_disease
3903,Advanced Malignant Solid Neoplasm|Ann Arbor Stage III Non-Hodgkin Lymphoma|Ann Arbor Stage IV Non-Hodgkin Lymphoma|Histiocytic Sarcoma|Juvenile Xanthogranuloma|Langerhans Cell Histiocytosis|Malignant Glioma|Recurrent Childhood Rhabdomyosarcoma|Recurrent Ependymoma|Recurrent Ewing Sarcoma|Recurrent Glioma|Recurrent Hepatoblastoma|Recurrent Langerhans Cell Histiocytosis|Recurrent Malignant Germ Cell Tumor|Recurrent Malignant Solid Neoplasm|Recurrent Medulloblastoma|Recurrent Neuroblastoma|Recurrent Non-Hodgkin Lymphoma|Recurrent Osteosarcoma|Recurrent Peripheral Primitive Neuroectodermal Tumor|Recurrent Primary Central Nervous System Neoplasm|Recurrent Rhabdoid Tumor|Recurrent Soft Tissue Sarcoma|Refractory Ewing Sarcoma|Refractory Glioma|Refractory Hepatoblastoma|Refractory Langerhans Cell Histiocytosis|Refractory Malignant Germ Cell Tumor|Refractory Malignant Solid Neoplasm|Refractory Medulloblastoma|Refractory Neuroblastoma|Refractory Non-Hodgkin Lymphoma|Refractory Osteosarcoma|Refractory Peripheral Primitive Neuroectodermal Tumor|Refractory Primary Central Nervous System Neoplasm|Refractory Rhabdoid Tumor|Refractory Rhabdomyosarcoma|Rhabdoid Tumor|Stage III Osteosarcoma AJCC v7|Stage III Soft Tissue Sarcoma AJCC v7|Stage IV Osteosarcoma AJCC v7|Stage IV Soft Tissue Sarcoma AJCC v7|Stage IVA Osteosarcoma AJCC v7|Stage IVB Osteosarcoma AJCC v7|Wilms Tumor,Selpercatinib,CC(C)(COC1=CN2C(=C(C=N2)C#N)C(=C1)C3=CN=C(C=C3)N4CC5CC(C4)N5CC6=CN=C(C=C6)OC)O,PHASE2,nervous_system_disease
3904,Advanced Malignant Solid Neoplasm|Ann Arbor Stage III Non-Hodgkin Lymphoma|Ann Arbor Stage IV Non-Hodgkin Lymphoma|Histiocytic Sarcoma|Juvenile Xanthogranuloma|Langerhans Cell Histiocytosis|Malignant Glioma|Recurrent Childhood Rhabdomyosarcoma|Recurrent Ependymoma|Recurrent Ewing Sarcoma|Recurrent Glioma|Recurrent Hepatoblastoma|Recurrent Langerhans Cell Histiocytosis|Recurrent Malignant Germ Cell Tumor|Recurrent Malignant Solid Neoplasm|Recurrent Medulloblastoma|Recurrent Neuroblastoma|Recurrent Non-Hodgkin Lymphoma|Recurrent Osteosarcoma|Recurrent Peripheral Primitive Neuroectodermal Tumor|Recurrent Primary Central Nervous System Neoplasm|Recurrent Rhabdoid Tumor|Recurrent Soft Tissue Sarcoma|Refractory Ewing Sarcoma|Refractory Glioma|Refractory Hepatoblastoma|Refractory Langerhans Cell Histiocytosis|Refractory Malignant Germ Cell Tumor|Refractory Malignant Solid Neoplasm|Refractory Medulloblastoma|Refractory Neuroblastoma|Refractory Non-Hodgkin Lymphoma|Refractory Osteosarcoma|Refractory Peripheral Primitive Neuroectodermal Tumor|Refractory Primary Central Nervous System Neoplasm|Refractory Rhabdoid Tumor|Refractory Rhabdomyosarcoma|Rhabdoid Tumor|Stage III Osteosarcoma AJCC v7|Stage III Soft Tissue Sarcoma AJCC v7|Stage IV Osteosarcoma AJCC v7|Stage IV Soft Tissue Sarcoma AJCC v7|Stage IVA Osteosarcoma AJCC v7|Stage IVB Osteosarcoma AJCC v7|Wilms Tumor,Tipifarnib,CN1C=NC=C1C(C2=CC=C(C=C2)Cl)(C3=CC4=C(C=C3)N(C(=O)C=C4C5=CC(=CC=C5)Cl)C)N,PHASE2,nervous_system_disease
3905,Advanced Malignant Solid Neoplasm|Ann Arbor Stage III Non-Hodgkin Lymphoma|Ann Arbor Stage IV Non-Hodgkin Lymphoma|Histiocytic Sarcoma|Juvenile Xanthogranuloma|Langerhans Cell Histiocytosis|Malignant Glioma|Recurrent Childhood Rhabdomyosarcoma|Recurrent Ependymoma|Recurrent Ewing Sarcoma|Recurrent Glioma|Recurrent Hepatoblastoma|Recurrent Langerhans Cell Histiocytosis|Recurrent Malignant Germ Cell Tumor|Recurrent Malignant Solid Neoplasm|Recurrent Medulloblastoma|Recurrent Neuroblastoma|Recurrent Non-Hodgkin Lymphoma|Recurrent Osteosarcoma|Recurrent Peripheral Primitive Neuroectodermal Tumor|Recurrent Primary Central Nervous System Neoplasm|Recurrent Rhabdoid Tumor|Recurrent Soft Tissue Sarcoma|Refractory Ewing Sarcoma|Refractory Glioma|Refractory Hepatoblastoma|Refractory Langerhans Cell Histiocytosis|Refractory Malignant Germ Cell Tumor|Refractory Malignant Solid Neoplasm|Refractory Medulloblastoma|Refractory Neuroblastoma|Refractory Non-Hodgkin Lymphoma|Refractory Osteosarcoma|Refractory Peripheral Primitive Neuroectodermal Tumor|Refractory Primary Central Nervous System Neoplasm|Refractory Rhabdoid Tumor|Refractory Rhabdomyosarcoma|Rhabdoid Tumor|Stage III Osteosarcoma AJCC v7|Stage III Soft Tissue Sarcoma AJCC v7|Stage IV Osteosarcoma AJCC v7|Stage IV Soft Tissue Sarcoma AJCC v7|Stage IVA Osteosarcoma AJCC v7|Stage IVB Osteosarcoma AJCC v7|Wilms Tumor,Ulixertinib,CC(C)NC1=NC=C(C(=C1)C2=CNC(=C2)C(=O)NC(CO)C3=CC(=CC=C3)Cl)Cl,PHASE2,nervous_system_disease
3906,Drug-Resistant Epilepsy|Focal-Onset Seizures,Padsevonil,COCC1=NN2C(=C(N=C2S1)C(F)(F)F)CN3CC(CC3=O)CC(F)(F)Cl,PHASE2,nervous_system_disease
3907,HIV Infections|Peripheral Nervous System Disease,Benztropine,CN1C2CCC1CC(C2)OC(C3=CC=CC=C3)C4=CC=CC=C4,PHASE2,nervous_system_disease
3908,HIV Infections|Peripheral Nervous System Disease,Benzatropine,CN1C2CCC1CC(C2)OC(C3=CC=CC=C3)C4=CC=CC=C4,PHASE2,nervous_system_disease
3909,Relapsing Remitting Multiple Sclerosis|Primary Progressive Multiple Sclerosis|Secondary Progressive Multiple Sclerosis,Ixazomib,B(C(CC(C)C)NC(=O)CNC(=O)C1=C(C=CC(=C1)Cl)Cl)(O)O,PHASE1,nervous_system_disease
3910,"Muscular Dystrophy, Duchenne",Edasalonexent,CCC=CCC=CCC=CCC=CCC=CCC=CCCC(=O)NCCNC(=O)C1=CC=CC=C1O,PHASE1|PHASE2,nervous_system_disease
3911,Patient Compliance,Carnitine,C[N+](C)(C)CC(CC(=O)[O-])O,PHASE2,nervous_system_disease
3912,Patient Compliance,Levocarnitine,C[N+](C)(C)CC(CC(=O)[O-])O,PHASE2,nervous_system_disease
3913,Sleep Apnea,Danavorexton,COC(=O)N1CCCC(C1COC2CCC(CC2)C3=CC=CC=C3)NS(=O)(=O)C,PHASE2,nervous_system_disease
3914,Brain Metastases|Non-small Cell Lung Cancer,Lucanthone,CCN(CC)CCNC1=C2C(=C(C=C1)C)SC3=CC=CC=C3C2=O,PHASE2,nervous_system_disease
3915,Alzheimer Disease,Talsaclidine,C#CCOC1CN2CCC1CC2,PHASE2|PHASE3,nervous_system_disease
3916,Intervertebral Disc Degeneration|Modic I Discopathy|Back Pain|Low Back Pain|Magnetic Resonance Imaging (MRI),Pamidronate,C(CN)C(O)(P(=O)(O)O)P(=O)(O)O,PHASE2,nervous_system_disease
3917,"Schizophrenia|Drug Induced Movement Disorder, Unspecified|Oxidative Stress",Cobalamin,CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)([O-])OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[Co+2],PHASE2|PHASE3,nervous_system_disease
3918,Osteomyelitis|Septic Arthritis|Pyomyositis,Cefadroxil,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=C(C=C3)O)N)SC1)C(=O)O,PHASE1,nervous_system_disease
3919,Osteomyelitis|Septic Arthritis|Pyomyositis,Cephalexin,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O,PHASE1,nervous_system_disease
3920,Stroke,Basmisanil,CC1=C(C(=NO1)C2=CC=C(C=C2)F)COC3=NC=C(C=C3)C(=O)N4CCS(=O)(=O)CC4,PHASE2,nervous_system_disease
3921,Memory Losses|Amnesia-Memory Loss,Thiopental,CCCC(C)C1(C(=O)NC(=S)NC1=O)CC,PHASE1,nervous_system_disease
3922,Schizophrenia|Psychotic Disorders|Mood Disorders|Schizophrenia Spectrum|Mental Disorders|Antipsychotic Agents|Tranquilizing Agents|Central Nervous System Depressants|Physiological Effects of Drugs|Psychotropic Drugs|Neurotransmitter Agents|Molecular Mechanisms of Pharmacological Action,Paliperidone,CC1=C(C(=O)N2CCCC(C2=N1)O)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F,PHASE1,nervous_system_disease
3923,Relapsing Multiple Sclerosis,Ozanimod,CC(C)OC1=C(C=C(C=C1)C2=NC(=NO2)C3=C4CCC(C4=CC=C3)NCCO)C#N,PHASE2|PHASE3,nervous_system_disease
3924,Primary Central Nervous System Lymphoma,Isavuconazole,CC(C1=NC(=CS1)C2=CC=C(C=C2)C#N)C(CN3C=NC=N3)(C4=C(C=CC(=C4)F)F)O,PHASE1,nervous_system_disease
3925,Generalized Convulsive Status Epilepticus,Phenobarbital,CCC1(C(=O)NC(=O)NC1=O)C2=CC=CC=C2,PHASE2,nervous_system_disease
3926,Hyperalgesia|Pain|Naloxone|Opioid Antagonist,Naloxone,C=CCN1CCC23C4C(=O)CCC2(C1CC5=C3C(=C(C=C5)O)O4)O,PHASE1,nervous_system_disease
3927,Charcot-Marie-Tooth Disease (CMT),Epalrestat,CC(=CC1=CC=CC=C1)C=C2C(=O)N(C(=S)S2)CC(=O)O,PHASE2,nervous_system_disease
3928,Dementia With Lewy Bodies (DLB),Neflamapimod,C1=CC(=C(C(=C1)Cl)C2=C3C=CC(=NN3C=NC2=O)SC4=C(C=C(C=C4)F)F)Cl,PHASE2,nervous_system_disease
3929,Parkinson Disease|Movement Disorders,Altropane,COC(=O)C1C2CCC(N2CC=CI)CC1C3=CC=C(C=C3)F,PHASE2,nervous_system_disease
3930,"Neurofibroma, Plexiform|Precursor Cell Lymphoblastic Leukemia-Lymphoma|Leukemia, Promyelocytic, Acute|Sarcoma",Pexidartinib,C1=CC(=NC=C1CC2=CNC3=C2C=C(C=N3)Cl)NCC4=CN=C(C=C4)C(F)(F)F,PHASE1,nervous_system_disease
3931,Fragile X Syndrome,Sulindac,CC1=C(C2=C(C1=CC3=CC=C(C=C3)S(=O)C)C=CC(=C2)F)CC(=O)O,PHASE2,nervous_system_disease
3932,Fragile X Syndrome,Gaboxadol,C1CNCC2=C1C(=O)NO2,PHASE2,nervous_system_disease
3933,Multiple Myeloma,Selinexor,C1=CN=C(C=N1)NNC(=O)C=CN2C=NC(=N2)C3=CC(=CC(=C3)C(F)(F)F)C(F)(F)F,PHASE2,nervous_system_disease
3934,Methamphetamine Use Disorder,Metamfetamine,CC(CC1=CC=CC=C1)NC,PHASE1,nervous_system_disease
3935,Methamphetamine Use Disorder,Methamphetamine,CC(CC1=CC=CC=C1)NC,PHASE1,nervous_system_disease
3936,Sarcopenia,Losartan,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl,PHASE2,nervous_system_disease
3937,Parkinson Disease|Idiopathic Parkinson Disease,Fluorodopa,C1=C(C(=CC(=C1O)O)F)CC(C(=O)O)N,PHASE2,nervous_system_disease
3938,Psychosis|Intellectual Disability,Clozapine,CN1CCN(CC1)C2=NC3=C(C=CC(=C3)Cl)NC4=CC=CC=C42,PHASE2,nervous_system_disease
3939,Refractory Epilepsy,Vorinostat,C1=CC=C(C=C1)NC(=O)CCCCCCC(=O)NO,PHASE2,nervous_system_disease
3940,Lewy Body Dementia|Dementia With Lewy Bodies|Parkinson's Disease Dementia|Visual Hallucinations|REM Sleep Behavior Disorder,Nelotanserin,CN1C(=C(C=N1)Br)C2=C(C=CC(=C2)NC(=O)NC3=C(C=C(C=C3)F)F)OC,PHASE2,nervous_system_disease
3941,"CNS Embryonal Tumor, Not Otherwise Specified|Malignant Glioma|Recurrent Atypical Teratoid/Rhabdoid Tumor|Recurrent Childhood Ependymoma|Recurrent Diffuse Intrinsic Pontine Glioma|Recurrent Medulloblastoma|Refractory Diffuse Intrinsic Pontine Glioma",Ribociclib,CN(C)C(=O)C1=CC2=CN=C(N=C2N1C3CCCC3)NC4=NC=C(C=C4)N5CCNCC5,PHASE1,nervous_system_disease
3942,Brain and Central Nervous System Tumors,Laromustine,CNC(=O)N(N(CCCl)S(=O)(=O)C)S(=O)(=O)C,PHASE1,nervous_system_disease
3943,Brain Tumor,Demeclocycline,CN(C)C1C2CC3C(C4=C(C=CC(=C4C(=C3C(=O)C2(C(=C(C1=O)C(=O)N)O)O)O)O)Cl)O,PHASE1,nervous_system_disease
3944,Lymphoma|Autonomic Imbalance|Cancer Survivorship,Ivabradine,CN(CCCN1CCC2=CC(=C(C=C2CC1=O)OC)OC)CC3CC4=CC(=C(C=C34)OC)OC,PHASE2,nervous_system_disease
3945,Lung Cancer|Breast Cancer|Brain Cancer|Advanced Breast Cancer|Advanced Lung Cancer,Afatinib,CN(C)CC=CC(=O)NC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC(=C(C=C3)F)Cl)OC4CCOC4,PHASE1|PHASE2,nervous_system_disease
3946,"Cerebral Small Vessel Diseases|Stroke, Ischemic",Tadalafil,CN1CC(=O)N2C(C1=O)CC3=C(C2C4=CC5=C(C=C4)OCO5)NC6=CC=CC=C36,PHASE2,nervous_system_disease
3947,"Brain Tumor, Recurrent|Glioblastoma|Anaplastic Astrocytoma|Anaplastic Oligodendroglioma|Mixed Glioma",Perifosine,CCCCCCCCCCCCCCCCCCOP(=O)([O-])OC1CC[N+](CC1)(C)C,PHASE1,nervous_system_disease
3948,Subarachnoid Hemorrhage,Prostacyclin,CCCCCC(C=CC1C(CC2C1CC(=CCCCC(=O)O)O2)O)O,PHASE2,nervous_system_disease
3949,Subarachnoid Hemorrhage,Epoprostenol,CCCCCC(C=CC1C(CC2C1CC(=CCCCC(=O)O)O2)O)O,PHASE2,nervous_system_disease
3950,Spinal Cord Injury|Bone Loss|Osteoporosis,Alendronate,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,PHASE2,nervous_system_disease
3951,Hematopoietic and Lymphoid Cell Neoplasm|Malignant Solid Neoplasm|Metastatic Malignant Neoplasm in the Brain,Ropidoxuridine,C1C(C(OC1N2C=C(C=NC2=O)I)CO)O,PHASE1,nervous_system_disease
3952,Parkinson's Disease|Psychotic Disorders,Melperone,CC1CCN(CC1)CCCC(=O)C2=CC=C(C=C2)F,PHASE2,nervous_system_disease
3953,Leukemia|Lymphoma|Meningeal Neoplasm,Mafosfamide,C1COP(=O)(NC1SCCS(=O)(=O)O)N(CCCl)CCCl,PHASE1,nervous_system_disease
3954,Angina,Febuxostat,CC1=C(SC(=N1)C2=CC(=C(C=C2)OCC(C)C)C#N)C(=O)O,PHASE2,nervous_system_disease
3955,Parkinson's Disease,Tozadenant,CC1(CCN(CC1)C(=O)NC2=NC3=C(C=CC(=C3S2)N4CCOCC4)OC)O,PHASE2|PHASE3,nervous_system_disease
3956,Progressive Multiple Sclerosis,Acyclovir,C1=NC2=C(N1COCCO)N=C(NC2=O)N,PHASE1,nervous_system_disease
3957,Progressive Multiple Sclerosis,Loratadine,CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1,PHASE1,nervous_system_disease
3958,Progressive Multiple Sclerosis,Dexchlorpheniramine,CN(C)CCC(C1=CC=C(C=C1)Cl)C2=CC=CC=N2,PHASE1,nervous_system_disease
3959,Sleep Apnea Syndromes,Cycloserine,C1C(C(=O)NO1)N,PHASE1,nervous_system_disease
3960,Peripheral Nervous System Diseases,Ricolinostat,C1=CC=C(C=C1)N(C2=CC=CC=C2)C3=NC=C(C=N3)C(=O)NCCCCCCC(=O)NO,PHASE1,nervous_system_disease
3961,Facioscapulohumeral Muscular Dystrophy (FSHD),Losmapimod,CC1=C(C=C(C=C1F)C(=O)NC2CC2)C3=NC=C(C=C3)C(=O)NCC(C)(C)C,PHASE2,nervous_system_disease
3962,"Nystagmus, Congenital|Nystagmus, Acquired|Multiple Sclerosis",Neramexane,CC1(CC(CC(C1)(C)N)(C)C)C,PHASE2,nervous_system_disease
3963,Alzheimer's Disease|Disruptive Behavior,Prazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4=CC=CO4)N)OC,PHASE2,nervous_system_disease
3964,Stroke,Serotonin,C1=CC2=C(C=C1O)C(=CN2)CCN,PHASE2,nervous_system_disease
3965,Multiple Sclerosis|Overactive Detrusor,Darifenacin,C1CN(CC1C(C2=CC=CC=C2)(C3=CC=CC=C3)C(=O)N)CCC4=CC5=C(C=C4)OCC5,PHASE2,nervous_system_disease
3966,Tuberculous Meningitis,Isoniazid,C1=CN=CC=C1C(=O)NN,PHASE2,nervous_system_disease
3967,Tuberculous Meningitis,Linezolid,CC(=O)NCC1CN(C(=O)O1)C2=CC(=C(C=C2)N3CCOCC3)F,PHASE2,nervous_system_disease
3968,Tuberculous Meningitis,Pyrazinamide,C1=CN=C(C=N1)C(=O)N,PHASE2,nervous_system_disease
3969,Spinal Cord Injuries,Rimonabant,CC1=C(N(N=C1C(=O)NN2CCCCC2)C3=C(C=C(C=C3)Cl)Cl)C4=CC=C(C=C4)Cl,PHASE2,nervous_system_disease
3970,Migraine Without Aura|Migraine With Aura,Tonabersat,CC(=O)C1=CC2=C(C=C1)OC(C(C2NC(=O)C3=CC(=C(C=C3)F)Cl)O)(C)C,PHASE2,nervous_system_disease
3971,Hypertension|Pure Autonomic Failure|Multiple System Atrophy,Captopril,CC(CS)C(=O)N1CCCC1C(=O)O,PHASE1,nervous_system_disease
3972,Subarachnoid Hemorrhage|Aneurysmal Subarachnoid Hemorrhage,Isoflurane,C(C(F)(F)F)(OC(F)F)Cl,PHASE2,nervous_system_disease
3973,"Post-COVID-19 Syndrome|Long COVID|Long Covid19|COVID-19|POTS - Postural Orthostatic Tachycardia Syndrome|Post COVID-19 Condition|Post-COVID Syndrome|Post COVID-19 Condition, Unspecified|Postinfectious Inflammation|Postinfectious Disorder",Nirmatrelvir,CC1(C2C1C(N(C2)C(=O)C(C(C)(C)C)NC(=O)C(F)(F)F)C(=O)NC(CC3CCNC3=O)C#N)C,PHASE2,nervous_system_disease
3974,Primary Central Nervous System Lymphoma|Secondary Central Nervous System Lymphoma|Relapsed Cancer|Refractory Cancer,Zanubrutinib,C=CC(=O)N1CCC(CC1)C2CCNC3=C(C(=NN23)C4=CC=C(C=C4)OC5=CC=CC=C5)C(=O)N,PHASE2,nervous_system_disease
3975,Diabetes Mellitus|Gastroparesis,Lixisenatide,CCC(C)C(C(=O)NC(CCC(=O)O)C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(CC(C)C)C(=O)NC(CCCCN)C(=O)NC(CC(=O)N)C(=O)NCC(=O)NCC(=O)N3CCCC3C(=O)NC(CO)C(=O)NC(CO)C(=O)NCC(=O)NC(C)C(=O)N4CCCC4C(=O)N5CCCC5C(=O)NC(CO)C(=O)NC(CCCCN)C(=O)NC(CCCCN)C(=O)NC(CCCCN)C(=O)NC(CCCCN)C(=O)NC(CCCCN)C(=O)NC(CCCCN)C(=O)N)NC(=O)C(CC6=CC=CC=C6)NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(C(C)C)NC(=O)C(C)NC(=O)C(CCC(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(CCSC)NC(=O)C(CCC(=O)N)NC(=O)C(CCCCN)NC(=O)C(CO)NC(=O)C(CC(C)C)NC(=O)C(CC(=O)O)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C(CC7=CC=CC=C7)NC(=O)C(C(C)O)NC(=O)CNC(=O)C(CCC(=O)O)NC(=O)CNC(=O)C(CC8=CNC=N8)N,PHASE1|PHASE2,nervous_system_disease
3976,"Duchenne Muscular Dystrophy Cardiomyopathy|Cardiomyopathy, Dilated",Ifetroban,CCCCCNC(=O)C1=COC(=N1)C2C3CCC(C2CC4=CC=CC=C4CCC(=O)O)O3,PHASE2,nervous_system_disease
3977,Leber Congenital Amaurosis|LCA|LCA1,Trimethoprim,COC1=CC(=CC(=C1OC)OC)CC2=CN=C(N=C2N)N,PHASE1|PHASE2,nervous_system_disease
3978,Cerebral Hemorrhage|Cerebral Edema|Intracerebral Hemorrhage|Stroke,Conivaptan,CC1=NC2=C(N1)CCN(C3=CC=CC=C32)C(=O)C4=CC=C(C=C4)NC(=O)C5=CC=CC=C5C6=CC=CC=C6,PHASE1,nervous_system_disease
3979,Rett Syndrome,Trofinetide,CC1(CCCN1C(=O)CN)C(=O)NC(CCC(=O)O)C(=O)O,PHASE2|PHASE3,nervous_system_disease
3980,Infantile Spasm,Fenfluramine,CCNC(C)CC1=CC(=CC=C1)C(F)(F)F,PHASE2,nervous_system_disease
3981,"Breast Cancer|Cholangiocarcinoma|Colorectal Cancer|Head and Neck Neoplasms|Lymphoma, Large-Cell, Anaplastic|Melanoma|Neuroendocrine Tumors|Non-Small Cell Lung Cancer|Ovarian Cancer|Pancreatic Cancer|Papillary Thyroid Cancer|Primary Brain Tumors|Renal Cell Carcinoma|Sarcomas|Salivary Gland Cancers|Adult Solid Tumor",Entrectinib,CN1CCN(CC1)C2=CC(=C(C=C2)C(=O)NC3=NNC4=C3C=C(C=C4)CC5=CC(=CC(=C5)F)F)NC6CCOCC6,PHASE2,nervous_system_disease
3982,Familial Amyotrophic Lateral Sclerosis,Pyrimethamine,CCC1=C(C(=NC(=N1)N)N)C2=CC=C(C=C2)Cl,PHASE1|PHASE2,nervous_system_disease
3983,Multiple Sclerosis,Isoxsuprine,CC(COC1=CC=CC=C1)NC(C)C(C2=CC=C(C=C2)O)O,PHASE1|PHASE2,nervous_system_disease
3984,Migraine,Telcagepant,C1CC(C(=O)N(CC1C2=C(C(=CC=C2)F)F)CC(F)(F)F)NC(=O)N3CCC(CC3)N4C5=C(NC4=O)N=CC=C5,PHASE2,nervous_system_disease
3985,Epilepsy,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,PHASE1,nervous_system_disease
3986,Duchenne Muscular Dystrophy,Epigallocatechin,C1C(C(OC2=CC(=CC(=C21)O)O)C3=CC(=C(C(=C3)O)O)O)O,PHASE2|PHASE3,nervous_system_disease
3987,Huntington Disease,Rolipram,COC1=C(C=C(C=C1)C2CC(=O)NC2)OC3CCCC3,PHASE1,nervous_system_disease
3988,Multiple Sclerosis|Fatigue,Mitoquinone,CC1=C(C(=O)C(=C(C1=O)OC)OC)CCCCCCCCCC[P+](C2=CC=CC=C2)(C3=CC=CC=C3)C4=CC=CC=C4,PHASE1|PHASE2,nervous_system_disease
3989,Temporomandibular Joint Disorders|Temporomandibular Joint Dysfunction Syndrome|Temporomandibular Joint Pain,Nimesulide,CS(=O)(=O)NC1=C(C=C(C=C1)[N+](=O)[O-])OC2=CC=CC=C2,PHASE2,nervous_system_disease
3990,Neuropathic Pain,Tariquidar,COC1=C(C=C2CN(CCC2=C1)CCC3=CC=C(C=C3)NC(=O)C4=CC(=C(C=C4NC(=O)C5=CC6=CC=CC=C6N=C5)OC)OC)OC,PHASE1|PHASE2,nervous_system_disease
3991,Dementia|Mild Cognitive Impairment,Nicorandil,C1=CC(=CN=C1)C(=O)NCCO[N+](=O)[O-],PHASE2,nervous_system_disease
3992,Chronic Pain|Diabetic Neuropathies|Diabetes Mellitus,Cebranopadol,CN(C)C1(CCC2(CC1)C3=C(CCO2)C4=C(N3)C=CC(=C4)F)C5=CC=CC=C5,PHASE2,nervous_system_disease
3993,Central Nervous System Lymphoma,Acalabrutinib,CC#CC(=O)N1CCCC1C2=NC(=C3N2C=CN=C3N)C4=CC=C(C=C4)C(=O)NC5=CC=CC=N5,PHASE2,nervous_system_disease
3994,Multiple Sclerosis|Bladder Dysfunction,Alfuzosin,CN(CCCNC(=O)C1CCCO1)C2=NC3=CC(=C(C=C3C(=N2)N)OC)OC,PHASE2|PHASE3,nervous_system_disease
3995,Parkinson Disease,Repaglinide,CCOC1=C(C=CC(=C1)CC(=O)NC(CC(C)C)C2=CC=CC=C2N3CCCCC3)C(=O)O,PHASE1,nervous_system_disease
3996,Alzheimers Disease,Lornoxicam,CN1C(=C(C2=C(S1(=O)=O)C=C(S2)Cl)O)C(=O)NC3=CC=CC=N3,PHASE2,nervous_system_disease
3997,Impulse Control Disorders|Parkinson Disease,Nalmefene,C=C1CCC2(C3CC4=C5C2(C1OC5=C(C=C4)O)CCN3CC6CC6)O,PHASE2,nervous_system_disease
3998,Schizophrenia|Mental Disorder|Nervous System Diseases,Aripiprazole,C1CC(=O)NC2=C1C=CC(=C2)OCCCCN3CCN(CC3)C4=C(C(=CC=C4)Cl)Cl,PHASE1,nervous_system_disease
3999,Neurocysticercosis|Epilepsy,Praziquantel,C1CCC(CC1)C(=O)N2CC3C4=CC=CC=C4CCN3C(=O)C2,PHASE2|PHASE3,nervous_system_disease
4000,Neurocysticercosis|Epilepsy,Albendazole,CCCSC1=CC2=C(C=C1)N=C(N2)NC(=O)OC,PHASE2|PHASE3,nervous_system_disease
4001,Attention Deficit Hyperactivity Disorder,Metadoxine,CC1=NC=C(C(=C1O)CO)CO.C1CC(=O)NC1C(=O)O,PHASE1,nervous_system_disease
4002,Melanoma and Brain Metastases,Dabrafenib,CC(C)(C)C1=NC(=C(S1)C2=NC(=NC=C2)N)C3=C(C(=CC=C3)NS(=O)(=O)C4=C(C=CC=C4F)F)F,PHASE2,nervous_system_disease
4003,Parkinson Disease,Lisuride,CCN(CC)C(=O)NC1CN(C2CC3=CNC4=CC=CC(=C34)C2=C1)C,PHASE2,nervous_system_disease
4004,Alzheimer's Disease,Isotretinoin,CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CC(=O)O)C)C,PHASE1|PHASE2,nervous_system_disease
4005,Cirrhosis|Hepatic Encephalopathy|Ascites|Varices|SBP - Spontaneous Bacterial Peritonitis,Allopurinol,C1=NNC2=C1C(=O)NC=N2,PHASE2|PHASE3,nervous_system_disease
4006,Malignant Supratentorial Neoplasm|Recurrent Glioblastoma|Recurrent Gliosarcoma,Lonafarnib,C1CN(CCC1CC(=O)N2CCC(CC2)C3C4=C(CCC5=C3N=CC(=C5)Br)C=C(C=C4Br)Cl)C(=O)N,PHASE1,nervous_system_disease
4007,Apnea|Snoring,Polidocanol,CCCCCCCCCCCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO,PHASE1|PHASE2,nervous_system_disease
4008,Familial Dysautonomia,Kinetin,C1=COC(=C1)CNC2=NC=NC3=C2NC=N3,PHASE1,nervous_system_disease
4009,Parkinson's Disease|Dyskinesia,Eltoprazine,C1CN(CCN1)C2=C3C(=CC=C2)OCCO3,PHASE2,nervous_system_disease
4010,Non-small Cell Lung Cancer,Capmatinib,CNC(=O)C1=C(C=C(C=C1)C2=NN3C(=CN=C3N=C2)CC4=CC5=C(C=C4)N=CC=C5)F,PHASE2,nervous_system_disease
4011,Treatment of Depression in Adults With Parkinson's Disease (PD),Pimavanserin,CC(C)COC1=CC=C(C=C1)CNC(=O)N(CC2=CC=C(C=C2)F)C3CCN(CC3)C,PHASE2,nervous_system_disease
4012,"Leukoencephalopathy, Progressive Multifocal|HIV Infections",Enfuvirtide,CCC(C)C(C(=O)NC(CCC(=O)O)C(=O)NC(CCC(=O)O)C(=O)NC(CO)C(=O)NC(CCC(=O)N)C(=O)NC(CC(=O)N)C(=O)NC(CCC(=O)N)C(=O)NC(CCC(=O)N)C(=O)NC(CCC(=O)O)C(=O)NC(CCCCN)C(=O)NC(CC(=O)N)C(=O)NC(CCC(=O)O)C(=O)NC(CCC(=O)N)C(=O)NC(CCC(=O)O)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(CCC(=O)O)C(=O)NC(CC(C)C)C(=O)NC(CC(=O)O)C(=O)NC(CCCCN)C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(C)C(=O)NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC3=CNC4=CC=CC=C43)C(=O)NC(CC(=O)N)C(=O)NC(CC5=CNC6=CC=CC=C65)C(=O)NC(CC7=CC=CC=C7)C(=O)N)NC(=O)C(CC(C)C)NC(=O)C(CO)NC(=O)C(CC8=CN=CN8)NC(=O)C(C(C)CC)NC(=O)C(CC(C)C)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C(CC9=CC=C(C=C9)O)NC(=O)C,PHASE2,nervous_system_disease
4013,Insomnia,Zaleplon,CCN(C1=CC=CC(=C1)C2=CC=NC3=C(C=NN23)C#N)C(=O)C,PHASE2,nervous_system_disease
4014,Plexiform Neurofibroma|Neurofibromatosis Type 1 (NF1),Mirdametinib,C1=CC(=C(C=C1I)F)NC2=C(C=CC(=C2F)F)C(=O)NOCC(CO)O,PHASE2,nervous_system_disease
4015,Clinical Stage IV Cutaneous Melanoma AJCC v8|Metastatic Melanoma|Pathologic Stage IV Cutaneous Melanoma AJCC v8,Encorafenib,CC(C)N1C=C(C(=N1)C2=C(C(=CC(=C2)Cl)NS(=O)(=O)C)F)C3=NC(=NC=C3)NCC(C)NC(=O)OC,PHASE2,nervous_system_disease
4016,Angina Pectoris,Lacidipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2C=CC(=O)OC(C)(C)C)C(=O)OCC)C)C,PHASE2,nervous_system_disease
4017,Intracranial Meningioma|Recurrent Meningioma|NF2 Gene Mutation,Capivasertib,C1CN(CCC1(C(=O)NC(CCO)C2=CC=C(C=C2)Cl)N)C3=NC=NC4=C3C=CN4,PHASE2,nervous_system_disease
4018,Alzheimers Disease,Lanabecestat,CC#CC1=CC(=CN=C1)C2=CC3=C(CC4(C35N=C(C(=N5)N)C)CCC(CC4)OC)C=C2,PHASE2|PHASE3,nervous_system_disease
4019,Chemotherapy-induced Neuropathic Pain|Chemotherapy-induced Peripheral Neuropathy,Tetrodotoxin,C(C1(C2C3C(N=C(NC34C(C1OC(C4O)(O2)O)O)N)O)O)O,PHASE2,nervous_system_disease
4020,Amyotrophic Lateral Sclerosis,Rabeprazole,CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCCCOC,PHASE1,nervous_system_disease
4021,Microvascular Angina,Zibotentan,CC1=CN=C(C(=N1)OC)NS(=O)(=O)C2=C(N=CC=C2)C3=CC=C(C=C3)C4=NN=CO4,PHASE2,nervous_system_disease
4022,COVID-19|Olfactory Disorder|Parosmia,Fluvoxamine,COCCCCC(=NOCCN)C1=CC=C(C=C1)C(F)(F)F,PHASE2,nervous_system_disease
4023,"Influenza, Human|Arthralgia",Zanamivir,CC(=O)NC1C(C=C(OC1C(C(CO)O)O)C(=O)O)N=C(N)N,PHASE2,nervous_system_disease
4024,HTLV-I-Associated Myelopathy,Tamibarotene,CC1(CCC(C2=C1C=CC(=C2)NC(=O)C3=CC=C(C=C3)C(=O)O)(C)C)C,PHASE2|PHASE3,nervous_system_disease
4025,Fabry Disease,Lucerastat,CCCCN1CC(C(C(C1CO)O)O)O,PHASE1,nervous_system_disease
4026,Acromegaly,Paltusotine,C1CN(CCC1N)C2=C3C=C(C=CC3=NC=C2C4=CC(=CC(=C4)F)F)C5=CC=CC(=C5O)C#N,PHASE2,nervous_system_disease
4027,Adrenoleukodystrophy|Metachromatic Leukodystrophy|Globoid Cell Leukodystrophy|Tay Sachs Disease|Sandhoffs Disease|Wolman Disease|I-Cell Disease|Sanfilippo Syndrome|GM1 Gangliosidosis,Clofarabine,C1=NC2=C(N=C(N=C2N1C3C(C(C(O3)CO)O)F)Cl)N,PHASE2,nervous_system_disease
4028,Adrenoleukodystrophy|Metachromatic Leukodystrophy|Globoid Cell Leukodystrophy|Tay Sachs Disease|Sandhoffs Disease|Wolman Disease|I-Cell Disease|Sanfilippo Syndrome|GM1 Gangliosidosis,Hydroxyurea,C(=O)(N)NO,PHASE2,nervous_system_disease
4029,Hearing Loss,Ofloxacin,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O,PHASE1,nervous_system_disease
4030,Post-dural Puncture Headache,Cosyntropin,CC(C)C(C(=O)NCC(=O)NC(CCCCN)C(=O)NC(CCCCN)C(=O)NC(CCCNC(=N)N)C(=O)NC(CCCNC(=N)N)C(=O)N1CCCC1C(=O)NC(C(C)C)C(=O)NC(CCCCN)C(=O)NC(C(C)C)C(=O)NC(CC2=CC=C(C=C2)O)C(=O)N3CCCC3C(=O)O)NC(=O)C4CCCN4C(=O)C(CCCCN)NC(=O)CNC(=O)C(CC5=CNC6=CC=CC=C65)NC(=O)C(CCCNC(=N)N)NC(=O)C(CC7=CC=CC=C7)NC(=O)C(CC8=CNC=N8)NC(=O)C(CCC(=O)O)NC(=O)C(CCSC)NC(=O)C(CO)NC(=O)C(CC9=CC=C(C=C9)O)NC(=O)C(CO)N,PHASE2,nervous_system_disease
4031,Post-dural Puncture Headache,Tetracosactide,CC(C)C(C(=O)NCC(=O)NC(CCCCN)C(=O)NC(CCCCN)C(=O)NC(CCCNC(=N)N)C(=O)NC(CCCNC(=N)N)C(=O)N1CCCC1C(=O)NC(C(C)C)C(=O)NC(CCCCN)C(=O)NC(C(C)C)C(=O)NC(CC2=CC=C(C=C2)O)C(=O)N3CCCC3C(=O)O)NC(=O)C4CCCN4C(=O)C(CCCCN)NC(=O)CNC(=O)C(CC5=CNC6=CC=CC=C65)NC(=O)C(CCCNC(=N)N)NC(=O)C(CC7=CC=CC=C7)NC(=O)C(CC8=CNC=N8)NC(=O)C(CCC(=O)O)NC(=O)C(CCSC)NC(=O)C(CO)NC(=O)C(CC9=CC=C(C=C9)O)NC(=O)C(CO)N,PHASE2,nervous_system_disease
4032,Acute Cerebrovascular Accident|Cerebral Edema,Pantoprazole,COC1=C(C(=NC=C1)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC(F)F)OC,PHASE2,nervous_system_disease
4033,Acute Cerebrovascular Accident|Cerebral Edema,Famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,PHASE2,nervous_system_disease
4034,Multiple Sclerosis|Optic Nerve|Neuritis,Nerispirdine,CCCN(C1=C(C=NC=C1)F)N2C=C(C3=CC=CC=C32)C,PHASE2,nervous_system_disease
4035,Brain Metastases|Human Epidermal Growth Factor 2 Positive Carcinoma of Breast|Advanced Breast Cancer,Tucatinib,CC1=C(C=CC(=C1)NC2=NC=NC3=C2C=C(C=C3)NC4=NC(CO4)(C)C)OC5=CC6=NC=NN6C=C5,PHASE2,nervous_system_disease
4036,Postural Tachycardia Syndrome,Galantamine,CN1CCC23C=CC(CC2OC4=C(C=CC(=C34)C1)OC)O,PHASE1,nervous_system_disease
4037,Parkinson Disease,Clarithromycin,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)O)(C)O,PHASE1|PHASE2,nervous_system_disease
4038,"Dermatomyositis, Adult Type",Apremilast,CCOC1=C(C=CC(=C1)C(CS(=O)(=O)C)N2C(=O)C3=C(C2=O)C(=CC=C3)NC(=O)C)OC,PHASE2,nervous_system_disease
4039,Diffuse Intrinsic Pontine Glioma|Progressive or Refractory High-Grade Glioma,Crenolanib,CC1(COC1)COC2=CC3=C(C=C2)N(C=N3)C4=NC5=C(C=CC=C5N6CCC(CC6)N)C=C4,PHASE1,nervous_system_disease
4040,Amyotrophic Lateral Sclerosis,Tretinoin,CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CC(=O)O)C)C,PHASE1|PHASE2,nervous_system_disease
4041,Partial Epilepsy,Cenobamate,C1=CC=C(C(=C1)C(CN2N=CN=N2)OC(=O)N)Cl,PHASE1,nervous_system_disease
4042,Mild to Moderate Diabetic Sensorimotor Polyneuropathy,Ranirestat,C1C(=O)NC(=O)C12C(=O)N(C(=O)C3=CC=CN23)CC4=C(C=C(C=C4)Br)F,PHASE2|PHASE3,nervous_system_disease
4043,Relapsing-remitting Multiple Sclerosis|Secondary-progressive Multiple Sclerosis|Primary-progressive Multiple Sclerosis,Norethisterone,CC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34,PHASE2,nervous_system_disease
4044,Relapsing-remitting Multiple Sclerosis|Secondary-progressive Multiple Sclerosis|Primary-progressive Multiple Sclerosis,Norethindrone,CC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34,PHASE2,nervous_system_disease
4045,"Lymphoma, B-Cell",Idarubicin,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=CC=CC=C5C4=O)O)(C(=O)C)O)N)O,PHASE2,nervous_system_disease
4046,Amyotrophic Lateral Sclerosis,Biotin,C1C2C(C(S1)CCCCC(=O)O)NC(=O)N2,PHASE2,nervous_system_disease
4047,Deep Endometriosis|Pelvic Pain,Gestrinone,CCC12C=CC3=C4CCC(=O)C=C4CCC3C1CCC2(C#C)O,PHASE2,nervous_system_disease
4048,Glioblastoma|Brain Cancer,Flucytosine,C1=NC(=O)NC(=C1F)N,PHASE1|PHASE2,nervous_system_disease
4049,Refractory Primary Central Nervous System Lymphoma|Primary CNS Lymphoma,Tirabrutinib,CC#CC(=O)N1CCC(C1)N2C3=NC=NC(=C3N(C2=O)C4=CC=C(C=C4)OC5=CC=CC=C5)N,PHASE2,nervous_system_disease
4050,Amyotrophic Lateral Sclerosis,Nitrofural,C1=C(OC(=C1)[N+](=O)[O-])C=NNC(=O)N,PHASE2,nervous_system_disease
4051,Amyotrophic Lateral Sclerosis,Nitrofurazone,C1=C(OC(=C1)[N+](=O)[O-])C=NNC(=O)N,PHASE2,nervous_system_disease
4052,Embolic Stroke,Enoxaparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,PHASE2,nervous_system_disease
4053,Gastroparesis,Camicinal,CC1CN(CCN1)CC2=CC=C(C=C2)CC(=O)N3CCC(CC3)NC4=CC(=CC=C4)F,PHASE2,nervous_system_disease
4054,Brain Tumors|Nervous System Tumors|Cognition Disorders|Fatigue,Armodafinil,C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N,PHASE2,nervous_system_disease
4055,Williams Beuren Syndrome,Minoxidil,C1CCN(CC1)C2=NC(=N)N(C(=C2)N)O,PHASE2,nervous_system_disease
4056,Sleep Initiation and Maintenance Disorders,Eplivanserin,CN(C)CCON=C(C=CC1=CC=C(C=C1)O)C2=CC=CC=C2F,PHASE1,nervous_system_disease
4057,Amyotrophic Lateral Sclerosis,Zilucoplan,CCCCCCCCCCCCCCCC(=O)NC(CCC(=O)NCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCC(=O)NCCCCC(C(=O)O)NC(=O)C(C1CCCCC1)NC(=O)C2CCCN2C(=O)C(CC3=CC=C(C=C3)O)NC(=O)C(CCC(=O)O)NC(=O)C(CC4=CNC5=C4C=CC=N5)NC(=O)C(CC6=CC=C(C=C6)O)NC(=O)C(C(C)(C)C)NC(=O)C(CC(=O)O)N(C)C(=O)C7CC(=O)NCCCCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N7)CC8=CC=CC=C8)CCCNC(=N)N)CCC(=O)O)C(C)C)NC(=O)C)C(=O)O,PHASE2|PHASE3,nervous_system_disease
4058,Vascular Dementia|Subcortical Vascular Dementia,Udenafil,CCCC1=NN(C2=C1N=C(NC2=O)C3=C(C=CC(=C3)S(=O)(=O)NCCC4CCCN4C)OCCC)C,PHASE2,nervous_system_disease
4059,Hypotonia Cystinuria Syndrome|Isolated PREPL Deficiency,Sulfamethoxazole,CC1=CC(=NO1)NS(=O)(=O)C2=CC=C(C=C2)N,PHASE2,nervous_system_disease
4060,Sarcoma|Synovial Sarcoma|Leiomyosarcoma|Malignant Peripheral Nerve Sheath Tumor,Dacarbazine,CN(C)N=NC1=C(NC=N1)C(=O)N,PHASE2,nervous_system_disease
4061,Endometriosis|Pelvic Pain,Raloxifene,C1CCN(CC1)CCOC2=CC=C(C=C2)C(=O)C3=C(SC4=C3C=CC(=C4)O)C5=CC=C(C=C5)O,PHASE2,nervous_system_disease
4062,Attention Deficit Hyperactivity Disorder,Edivoxetine,COC1=C(C=C(C=C1)F)CC(C2CCOCC2)(C3CNCCO3)O,PHASE2|PHASE3,nervous_system_disease
4063,Melanoma,Fludrocortisone,CC12CCC(=O)C=C1CCC3C2(C(CC4(C3CCC4(C(=O)CO)O)C)O)F,PHASE2,nervous_system_disease
4064,Melanoma,Meprednisone,CC1CC2C3CCC4=CC(=O)C=CC4(C3C(=O)CC2(C1(C(=O)CO)O)C)C,PHASE2,nervous_system_disease
4065,Neuropathic Pain,Priralfinamide,CC(C(=O)N)NCC1=CC=C(C=C1)OCC2=CC=CC=C2F,PHASE2,nervous_system_disease
4066,"Inherited Mitochondrial Disease, Including Leigh Syndrome",Cysteamine,C(CS)N,PHASE2,nervous_system_disease
4067,Diabetic Gastroparesis,Promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C,PHASE2,nervous_system_disease
4068,Head Trauma,Sufentanil,CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCC3=CC=CS3)COC,PHASE2,nervous_system_disease
4069,Metastatic Lung Neuroendocrine Neoplasm|Metastatic Lung Non-Small Cell Carcinoma|Metastatic Lung Small Cell Carcinoma|Metastatic Malignant Neoplasm in the Brain|Stage IV Lung Cancer AJCC v8|Stage IVA Lung Cancer AJCC v8|Stage IVB Lung Cancer AJCC v8,Berzosertib,CC(C)S(=O)(=O)C1=CC=C(C=C1)C2=CN=C(C(=N2)C3=CC(=NO3)C4=CC=C(C=C4)CNC)N,PHASE1,nervous_system_disease
4070,"Gaucher Disease, Type 1|Type 1 Gaucher Disease|Gaucher Disease",Afegostat,C1C(C(C(CN1)O)O)CO,PHASE2,nervous_system_disease
4071,MItochondrial Myopathies,Omaveloxolone,CC1(CCC2(CCC3(C(C2C1)C(=O)C=C4C3(CCC5C4(C=C(C(=O)C5(C)C)C#N)C)C)C)NC(=O)C(C)(F)F)C,PHASE2,nervous_system_disease
4072,Vincristine Induced Neuropathy,Acetylcarnitine,CC(=O)OC(CC(=O)[O-])C[N+](C)(C)C,PHASE2,nervous_system_disease
4073,Ischemic Stroke|Post-stroke Cognitive Impairment,Cromolyn,C1=CC2=C(C(=C1)OCC(COC3=CC=CC4=C3C(=O)C=C(O4)C(=O)O)O)C(=O)C=C(O2)C(=O)O,PHASE2,nervous_system_disease
4074,Subarachnoid Hemorrhage|Hypertension,Clevidipine,CCCC(=O)OCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C,PHASE2,nervous_system_disease
4075,Dementia With Lewy Bodies,Bosutinib,CN1CCN(CC1)CCCOC2=C(C=C3C(=C2)N=CC(=C3NC4=CC(=C(C=C4Cl)Cl)OC)C#N)OC,PHASE2,nervous_system_disease
4076,Endometriosis|Pelvic Pain,Nafarelin,CC(C)CC(C(=O)NC(CCCN=C(N)N)C(=O)N1CCCC1C(=O)NCC(=O)N)NC(=O)C(CC2=CC3=CC=CC=C3C=C2)NC(=O)C(CC4=CC=C(C=C4)O)NC(=O)C(CO)NC(=O)C(CC5=CNC6=CC=CC=C65)NC(=O)C(CC7=CN=CN7)NC(=O)C8CCC(=O)N8,PHASE1|PHASE2,nervous_system_disease
4077,Alzheimer's Disease,Huperzine A,CC=C1C2CC3=C(C1(CC(=C2)C)N)C=CC(=O)N3,PHASE2|PHASE3,nervous_system_disease
4078,Migraine,Tezampanel,C1CC2CNC(CC2CC1CCC3=NNN=N3)C(=O)O,PHASE2,nervous_system_disease
4079,ADHD|Autism|Bipolar I Disorder|Conduct Disorder|Oppositional Defiant Disorder,Brexpiprazole,C1CN(CCN1CCCCOC2=CC3=C(C=C2)C=CC(=O)N3)C4=C5C=CSC5=CC=C4,PHASE1,nervous_system_disease
4080,Alzheimer's Disease,Verubecestat,CC1(CS(=O)(=O)N(C(=N1)N)C)C2=C(C=CC(=C2)NC(=O)C3=NC=C(C=C3)F)F,PHASE2|PHASE3,nervous_system_disease
4081,Medication Overuse Headache|Analgesic Overuse Headache,Frovatriptan,CNC1CCC2=C(C1)C3=C(N2)C=CC(=C3)C(=O)N,PHASE2,nervous_system_disease
4082,Idiopathic Hypersomnia,Pentetrazol,C1CCC2=NN=NN2CC1,PHASE2,nervous_system_disease
4083,Aneurysmal Subarachnoid Hemorrhage,Clazosentan,CC1=CN=C(C=C1)S(=O)(=O)NC2=C(C(=NC(=N2)C3=CC(=NC=C3)C4=NNN=N4)OCCO)OC5=CC=CC=C5OC,PHASE2,nervous_system_disease
4084,"Multiple Sclerosis, Relapsing-Remitting|Multiple Sclerosis",Guanabenz,C1=CC(=C(C(=C1)Cl)C=NN=C(N)N)Cl,PHASE1,nervous_system_disease
4085,Constipation|Fecal Incontinence|Multiple Sclerosis,Bisacodyl,CC(=O)OC1=CC=C(C=C1)C(C2=CC=C(C=C2)OC(=O)C)C3=CC=CC=N3,PHASE2,nervous_system_disease
4086,Brain and Central Nervous System Tumors,Cytochlor,C1C(C(OC1N2C=C(C(=NC2=O)N)Cl)CO)O,PHASE1,nervous_system_disease
4087,Brain and Central Nervous System Tumors,Tetrahydrouridine,C1CN(C(=O)NC1O)C2C(C(C(O2)CO)O)O,PHASE1,nervous_system_disease
4088,Relapsing Remitting Multiple Sclerosis,Flupirtine,CCOC(=O)NC1=C(N=C(C=C1)NCC2=CC=C(C=C2)F)N,PHASE2,nervous_system_disease
4089,ALS,Ranolazine,CC1=C(C(=CC=C1)C)NC(=O)CN2CCN(CC2)CC(COC3=CC=CC=C3OC)O,PHASE2,nervous_system_disease
4090,Multiple Sclerosis,Liothyronine,C1=CC(=C(C=C1OC2=C(C=C(C=C2I)CC(C(=O)O)N)I)I)O,PHASE1,nervous_system_disease
4091,Blepharospasm|Dystonia,Dipraglurant,C1=CC=NC(=C1)C#CCCC2=CN3C=C(C=CC3=N2)F,PHASE2,nervous_system_disease
4092,Brain Cancer,Dexanabinol,CCCCCCC(C)(C)C1=CC(=C2C3CC(=CCC3C(OC2=C1)(C)C)CO)O,PHASE1,nervous_system_disease
4093,Obesity|Diabetes|Obstructive Sleep Apnea,Orlistat,CCCCCCCCCCCC(CC1C(C(=O)O1)CCCCCC)OC(=O)C(CC(C)C)NC=O,PHASE2,nervous_system_disease
4094,Abnormal Uterine Bleeding|Dysmenorrhea,Etonogestrel,CCC12CC(=C)C3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34,PHASE2,nervous_system_disease
4095,Endometriosis,Leuprorelin,CCNC(=O)C1CCCN1C(=O)C(CCCN=C(N)N)NC(=O)C(CC(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC2=CC=C(C=C2)O)NC(=O)C(CO)NC(=O)C(CC3=CNC4=CC=CC=C43)NC(=O)C(CC5=CN=CN5)NC(=O)C6CCC(=O)N6,PHASE2,nervous_system_disease
4096,Endometriosis,Leuprolide,CCNC(=O)C1CCCN1C(=O)C(CCCN=C(N)N)NC(=O)C(CC(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC2=CC=C(C=C2)O)NC(=O)C(CO)NC(=O)C(CC3=CNC4=CC=CC=C43)NC(=O)C(CC5=CN=CN5)NC(=O)C6CCC(=O)N6,PHASE2,nervous_system_disease
4097,Corneal Abrasions,Proparacaine,CCCOC1=C(C=C(C=C1)C(=O)OCCN(CC)CC)N,PHASE1,nervous_system_disease
4098,"Brain Tumor, Recurrent, Adult",Fluciclovine,C1C(CC1(C(=O)O)N)F,PHASE2,nervous_system_disease
4099,Fibromyalgia,Paroxetine,C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4,PHASE1|PHASE2,nervous_system_disease
4100,Alzheimer Disease,Ketoconazole,CC(=O)N1CCN(CC1)C2=CC=C(C=C2)OCC3COC(O3)(CN4C=CN=C4)C5=C(C=C(C=C5)Cl)Cl,PHASE1,nervous_system_disease
4101,Megalencephaly-capillary Malformation Polymicrogyria Syndrome (MCAP),Alpelisib,CC1=C(SC(=N1)NC(=O)N2CCCC2C(=O)N)C3=CC(=NC=C3)C(C)(C)C(F)(F)F,PHASE2,nervous_system_disease
4102,Autonomic Dysreflexia,Fesoterodine,CC(C)C(=O)OC1=C(C=C(C=C1)CO)C(CCN(C(C)C)C(C)C)C2=CC=CC=C2,PHASE2,nervous_system_disease
4103,Idiopathic Hypersomnia,Serdexmethylphenidate,COC(=O)C(C1CCCCN1C(=O)OC[N+]2=CC=CC(=C2)C(=O)NC(CO)C(=O)[O-])C3=CC=CC=C3,PHASE2,nervous_system_disease
4104,Alzheimer's Disease,Avagacestat,C1=CC(=CC=C1S(=O)(=O)N(CC2=C(C=C(C=C2)C3=NOC=N3)F)C(CCC(F)(F)F)C(=O)N)Cl,PHASE2,nervous_system_disease
4105,Musculoskeletal Pain,Codeine,CN1CCC23C4C1CC5=C2C(=C(C=C5)OC)OC3C(C=C4)O,PHASE2,nervous_system_disease
4106,Neurogenic Bladder,Methantheline,CC[N+](C)(CC)CCOC(=O)C1C2=CC=CC=C2OC3=CC=CC=C13,PHASE1,nervous_system_disease
4107,Arterial Ischemic Stroke,Afamelanotide,CCCCC(C(=O)NC(CCC(=O)O)C(=O)NC(CC1=CN=CN1)C(=O)NC(CC2=CC=CC=C2)C(=O)NC(CCCNC(=N)N)C(=O)NC(CC3=CNC4=CC=CC=C43)C(=O)NCC(=O)NC(CCCCN)C(=O)N5CCCC5C(=O)NC(C(C)C)C(=O)N)NC(=O)C(CO)NC(=O)C(CC6=CC=C(C=C6)O)NC(=O)C(CO)NC(=O)C,PHASE2,nervous_system_disease
4108,Acute Gout Flare|Gout Attack|Gout Flare|Gouty Arthritis|Gout|Arthritis|Joint Pain,Dapansutrile,CS(=O)(=O)CCC#N,PHASE2|PHASE3,nervous_system_disease
4109,Cognitive Disorders|HIV Infections,Selegiline,CC(CC1=CC=CC=C1)N(C)CC#C,PHASE2,nervous_system_disease
4110,Childhood Cerebral Anaplastic Astrocytoma|Childhood Oligodendroglioma|Childhood Spinal Cord Neoplasm|Recurrent Childhood Brain Stem Glioma|Recurrent Childhood Ependymoma|Recurrent Childhood Medulloblastoma,Fludeoxyglucose,C(C(C(C(C(C=O)F)O)O)O)O,PHASE2,nervous_system_disease
4111,Vascular Cognitive Impairment no Dementia,Butylphthalide,CCCCC1C2=CC=CC=C2C(=O)O1,PHASE2|PHASE3,nervous_system_disease
4112,Eye Injuries,Anecortave,CC12CCC(=O)C=C1CCC3C2=CCC4(C3CCC4(C(=O)CO)O)C,PHASE2,nervous_system_disease
4113,Migraine,Levonorgestrel,CCC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34,PHASE2,nervous_system_disease
4114,Neuromyelitis Optica Spectrum Disorder Relapse,Ruxolitinib,C1CCC(C1)C(CC#N)N2C=C(C=N2)C3=C4C=CNC4=NC=N3,PHASE1|PHASE2,nervous_system_disease
4115,Epilepsy Intractable,Clioquinol,C1=CC2=C(C(=C(C=C2Cl)I)O)N=C1,PHASE2,nervous_system_disease
4116,Hepatitis C|Chronic Pain,Alisporivir,CCC1C(=O)N(C(C(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)C(C)C)CC)C)C,PHASE2,nervous_system_disease
4117,Carotid Artery Diseases|Atherosclerosis,Valsartan,CCCCC(=O)N(CC1=CC=C(C=C1)C2=CC=CC=C2C3=NNN=N3)C(C(C)C)C(=O)O,PHASE2,nervous_system_disease
4118,Brain Diseases|Spinal Cord Diseases,Gadobutrol,C1CN(CCN(CCN(CCN1CC(=O)[O-])CC(=O)[O-])C(CO)C(CO)O)CC(=O)[O-].[Gd+3],PHASE2,nervous_system_disease
4119,Recurrent High Grade Meningioma,Trabectedin,CC1=CC2=C(C3C4C5C6=C(C(=C7C(=C6C(N4C(C(C2)N3C)O)COC(=O)C8(CS5)C9=CC(=C(C=C9CCN8)O)OC)OCO7)C)OC(=O)C)C(=C1OC)O,PHASE2,nervous_system_disease
4120,Tinnitus,Vestipitant,CC1=C(C=CC(=C1)F)C2CNCCN2C(=O)N(C)C(C)C3=CC(=CC(=C3)C(F)(F)F)C(F)(F)F,PHASE2,nervous_system_disease
4121,Encephalopathy|HIV Infections|Radiculitis,Foscarnet,C(=O)(O)P(=O)(O)O,PHASE1,nervous_system_disease
4122,Encephalopathy|HIV Infections|Radiculitis,Ganciclovir,C1=NC2=C(N1COC(CO)CO)N=C(NC2=O)N,PHASE1,nervous_system_disease
4123,Primary Mitochondrial Disease,Elamipretide,CC1=CC(=CC(=C1CC(C(=O)NC(CCCCN)C(=O)NC(CC2=CC=CC=C2)C(=O)N)NC(=O)C(CCCN=C(N)N)N)C)O,PHASE2,nervous_system_disease
4124,Mental Disorder Diagnosed in Childhood|Obsessive Compulsive Disorder|Streptococcal Infection|Tic Disorder,Phenoxymethylpenicillin,CC1(C(N2C(S1)C(C2=O)NC(=O)COC3=CC=CC=C3)C(=O)O)C,PHASE2,nervous_system_disease
4125,Mental Disorder Diagnosed in Childhood|Obsessive Compulsive Disorder|Streptococcal Infection|Tic Disorder,Penicillin,CC1(C(N2C(S1)C(C2=O)NC(=O)CC3=CC=CC=C3)C(=O)O)C,PHASE2,nervous_system_disease
4126,Migraine Disorders,Eletriptan,CN1CCCC1CC2=CNC3=C2C=C(C=C3)CCS(=O)(=O)C4=CC=CC=C4,PHASE2,nervous_system_disease
4127,Prader-Willi Syndrome,Diazoxide,CC1=NS(=O)(=O)C2=C(N1)C=CC(=C2)Cl,PHASE2,nervous_system_disease
4128,Traumatic Brain Injury|Computed Tomography|Procedural Sedation,Trichloroacetaldehyde,C(=O)C(Cl)(Cl)Cl,PHASE2,nervous_system_disease
4129,Sleep Initiation and Maintenance Disorders,Doxepin,CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31,PHASE2,nervous_system_disease
4130,Hyperalgesia|Allodynia,Fenobam,CN1CC(=O)NC1=NC(=O)NC2=CC(=CC=C2)Cl,PHASE1,nervous_system_disease
4131,Sleep Initiation and Maintenance Disorders|Pain,Cyclobenzaprine,CN(C)CCC=C1C2=CC=CC=C2C=CC3=CC=CC=C31,PHASE2,nervous_system_disease
4132,Dementia of Alzheimer's Type,Solifenacin,C1CN2CCC1C(C2)OC(=O)N3CCC4=CC=CC=C4C3C5=CC=CC=C5,PHASE2,nervous_system_disease
4133,CDK Gene Mutation|Metastatic Malignant Neoplasm in the Brain|Metastatic Malignant Solid Neoplasm|NTRK Family Gene Mutation|PI3K Gene Mutation|ROS1 Gene Mutation|KRAS G12C Mutation,Adagrasib,CN1CCCC1COC2=NC3=C(CCN(C3)C4=CC=CC5=C4C(=CC=C5)Cl)C(=N2)N6CCN(C(C6)CC#N)C(=O)C(=C)F,PHASE2,nervous_system_disease
4134,Adult Solid Neoplasm|Childhood Solid Neoplasm|Recurrent Childhood Central Nervous System Neoplasm|Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor|Recurrent Malignant Solid Neoplasm|Refractory Central Nervous System Neoplasm,Talazoparib,CN1C(=NC=N1)C2C(NC3=CC(=CC4=C3C2=NNC4=O)F)C5=CC=C(C=C5)F,PHASE1|PHASE2,nervous_system_disease
4135,Multiple Sclerosis,Vancomycin,CC1C(C(CC(O1)OC2C(C(C(OC2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)C(C(C(=O)NC(C(=O)NC5C(=O)NC7C8=CC(=C(C=C8)O)C9=C(C=C(C=C9O)O)C(NC(=O)C(C(C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)CC(=O)N)NC(=O)C(CC(C)C)NC)O)Cl)CO)O)O)(C)N)O,PHASE1,nervous_system_disease
4136,Alzheimer's Disease,Flutemetamol,CNC1=C(C=C(C=C1)C2=NC3=C(S2)C=C(C=C3)O)F,PHASE2,nervous_system_disease
4137,Chorioamnionitis|Puerperal Endometritis|Neonatal Early Onset Sepsis|Neonatal Meningitis|Neonatal Pneumonia,Ampicillin,CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=CC=C3)N)C(=O)O)C,PHASE2|PHASE3,nervous_system_disease
4138,Migraine,Zavegepant,CC1=CC(=CC2=C1NN=C2)CC(C(=O)N3CCN(CC3)C4CCN(CC4)C)NC(=O)N5CCC(CC5)C6=CC7=CC=CC=C7NC6=O,PHASE2|PHASE3,nervous_system_disease
4139,Movement Disorders|Parkinson Disease,Eliprodil,C1CN(CCC1CC2=CC=C(C=C2)F)CC(C3=CC=C(C=C3)Cl)O,PHASE2,nervous_system_disease
4140,Alzheimer's Disease,Equol,C1C(COC2=C1C=CC(=C2)O)C3=CC=C(C=C3)O,PHASE1,nervous_system_disease
4141,"Toxoplasmosis, Cerebral|HIV Infections",Sulfadiazine,C1=CN=C(N=C1)NS(=O)(=O)C2=CC=C(C=C2)N,PHASE2,nervous_system_disease
4142,"Toxoplasmosis, Cerebral|HIV Infections",Atovaquone,C1CC(CCC1C2=CC=C(C=C2)Cl)C3=C(C4=CC=CC=C4C(=O)C3=O)O,PHASE2,nervous_system_disease
4143,Diabetes Mellitus|Iron Metabolism Disorders|Gastroduodenal Ulcer|Optic Atrophy|Sensorineural Hearing Loss|Platelet Dysfunction,Sitagliptin,C1CN2C(=NN=C2C(F)(F)F)CN1C(=O)CC(CC3=CC(=C(C=C3F)F)F)N,PHASE2|PHASE3,nervous_system_disease
4144,Fragile X Syndrome,Ergoloid,CCC(C)C1C(=O)N2CCCC2C3(N1C(=O)C(O3)(C(C)C)NC(=O)C4CC5C(CC6=CNC7=CC=CC5=C67)N(C4)C)O.CC(C)CC1C(=O)N2CCCC2C3(N1C(=O)C(O3)(C(C)C)NC(=O)C4CC5C(CC6=CNC7=CC=CC5=C67)N(C4)C)O.CC(C)C1C(=O)N2CCCC2C3(N1C(=O)C(O3)(C(C)C)NC(=O)C4CC5C(CC6=CNC7=CC=CC5=C67)N(C4)C)O.CC(C)C1(C(=O)N2C(C(=O)N3CCCC3C2(O1)O)CC4=CC=CC=C4)NC(=O)C5CC6C(CC7=CNC8=CC=CC6=C78)N(C5)C,PHASE2,nervous_system_disease
4145,Bipolar Disorder,Cariprazine,CN(C)C(=O)NC1CCC(CC1)CCN2CCN(CC2)C3=C(C(=CC=C3)Cl)Cl,PHASE2,nervous_system_disease
4146,Diffuse Intrinsic Pontine Glioma|High-grade Glioma,Crizotinib,CC(C1=C(C=CC(=C1Cl)F)Cl)OC2=C(N=CC(=C2)C3=CN(N=C3)C4CCNCC4)N,PHASE1,nervous_system_disease
4147,Prader-Willi Syndrome,Setmelanotide,CC1C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(C(=O)N1)NC(=O)C(CCCN=C(N)N)NC(=O)C)C(=O)N)CC2=CNC3=CC=CC=C32)CCCN=C(N)N)CC4=CC=CC=C4)CC5=CN=CN5,PHASE2,nervous_system_disease
4148,Brain Tumor|Astrocytoma|Astroglioma|Glioblastoma|Gliosarcoma,Zotiraciclib,CN1CC=CCCOC2=CC=CC(=C2)C3=NC(=NC=C3)NC4=CC=CC(=C4)C1,PHASE1|PHASE2,nervous_system_disease
4149,Fibromyalgia|Chronic Fatigue Syndrome|Multiple Sclerosis|Healthy,Oxyquinoline,C1=CC2=C(C(=C1)O)N=CC=C2,PHASE1,nervous_system_disease
4150,Episodic Migraine,Quinidine,COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O,PHASE2,nervous_system_disease
4151,Malignant Melanoma|Metastases,Buparlisib,C1COCCN1C2=NC(=NC(=C2)C3=CN=C(C=C3C(F)(F)F)N)N4CCOCC4,PHASE2,nervous_system_disease
4152,"Multiple Sclerosis (MS)|Multiple Sclerosis, Relapsing-Remitting|Multiple Sclerosis, Primary Progressive|Multiple Sclerosis, Chronic Progressive|Multiple Sclerosis Relapse|Multiple Sclerosis Brain Lesion|Multiple Sclerosis Benign",Clemastine,CC(C1=CC=CC=C1)(C2=CC=C(C=C2)Cl)OCCC3CCCN3C,PHASE1|PHASE2,nervous_system_disease
4153,Tourette's Syndrome,Tetrabenazine,CC(C)CC1CN2CCC3=CC(=C(C=C3C2CC1=O)OC)OC,PHASE2,nervous_system_disease
4154,Delayed Onset Muscle Soreness,Loxoprofen,CC(C1=CC=C(C=C1)CC2CCCC2=O)C(=O)O,PHASE2,nervous_system_disease
4155,Anatomic Stage I Breast Cancer AJCC v8|Anatomic Stage IA Breast Cancer AJCC v8|Anatomic Stage IB Breast Cancer AJCC v8|Anatomic Stage II Breast Cancer AJCC v8|Anatomic Stage IIA Breast Cancer AJCC v8|Anatomic Stage IIB Breast Cancer AJCC v8|Anatomic Stage III Breast Cancer AJCC v8|Anatomic Stage IIIA Breast Cancer AJCC v8|Anatomic Stage IIIB Breast Cancer AJCC v8|Anatomic Stage IIIC Breast Cancer AJCC v8|Invasive Breast Carcinoma|Prognostic Stage I Breast Cancer AJCC v8|Prognostic Stage IA Breast Cancer AJCC v8|Prognostic Stage IB Breast Cancer AJCC v8|Prognostic Stage II Breast Cancer AJCC v8|Prognostic Stage IIA Breast Cancer AJCC v8|Prognostic Stage IIB Breast Cancer AJCC v8|Prognostic Stage III Breast Cancer AJCC v8|Prognostic Stage IIIA Breast Cancer AJCC v8|Prognostic Stage IIIB Breast Cancer AJCC v8|Prognostic Stage IIIC Breast Cancer AJCC v8,Docetaxel,CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O,PHASE2,nervous_system_disease
4156,Cushing Disease,Seliciclib,CCC(CO)NC1=NC(=C2C(=N1)N(C=N2)C(C)C)NCC3=CC=CC=C3,PHASE2,nervous_system_disease
4157,"Duchenne Muscular Dystrophy|Cardiomyopathy, Dilated",Bisoprolol,CC(C)NCC(COC1=CC=C(C=C1)COCCOC(C)C)O,PHASE2|PHASE3,nervous_system_disease
4158,"Sleep Apnea, Obstructive",Tiagabine,CC1=C(SC=C1)C(=CCCN2CCCC(C2)C(=O)O)C3=C(C=CS3)C,PHASE2,nervous_system_disease
4159,Asymptomatic Amyloid-positive,Atabecestat,CC1(C=CSC(=N1)N)C2=C(C=CC(=C2)NC(=O)C3=NC=C(C=C3)C#N)F,PHASE2|PHASE3,nervous_system_disease
4160,Shoulder Pain|Post-operative Pain,Parecoxib,CCC(=O)NS(=O)(=O)C1=CC=C(C=C1)C2=C(ON=C2C3=CC=CC=C3)C,PHASE2,nervous_system_disease
4161,Congenital Muscular Dystrophy,Omigapil,CN(CC#C)CC1=CC2=CC=CC=C2OC3=CC=CC=C31,PHASE1,nervous_system_disease
4162,"Von-Hippel Lindau|Kidney Disease, Chronic",Perflutren,C(C(F)(F)F)(C(F)(F)F)(F)F,PHASE2,nervous_system_disease
4163,Spinal Cord Injury,Mometasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CCl)O)C)O)Cl)C,PHASE1,nervous_system_disease
4164,Correction of Cancer-related Coagulopathy With Novel Oral Anticoagulant (Edoxaban),Edoxaban,CN1CCC2=C(C1)SC(=N2)C(=O)NC3CC(CCC3NC(=O)C(=O)NC4=NC=C(C=C4)Cl)C(=O)N(C)C,PHASE2|PHASE3,nervous_system_disease
4165,Pain|Chronic Disease,Tropisetron,CN1C2CCC1CC(C2)OC(=O)C3=CNC4=CC=CC=C43,PHASE2,nervous_system_disease
4166,Parkinson's Disease,Varenicline,C1C2CNCC1C3=CC4=NC=CN=C4C=C23,PHASE2,nervous_system_disease
4167,Peripheral Nerve Injuries|Pain,Rufinamide,C1=CC(=C(C(=C1)F)CN2C=C(N=N2)C(=O)N)F,PHASE2,nervous_system_disease
4168,Down Syndrome|Recurrent B Acute Lymphoblastic Leukemia,Mercaptopurine,C1=NC2=C(N1)C(=S)N=CN2,PHASE2,nervous_system_disease
4169,Down Syndrome|Recurrent B Acute Lymphoblastic Leukemia,Pegaspargase,CC1=CC(=C(C=C1)C(=O)C(=C)CN(C)C)C,PHASE2,nervous_system_disease
4170,Down Syndrome|Recurrent B Acute Lymphoblastic Leukemia,Tioguanine,C1=NC2=C(N1)C(=S)N=C(N2)N,PHASE2,nervous_system_disease
4171,Down Syndrome|Recurrent B Acute Lymphoblastic Leukemia,Thioguanine,C1=NC2=C(N1)C(=S)N=C(N2)N,PHASE2,nervous_system_disease
4172,Orthostatic Intolerance,Ganirelix,CCNC(=NCCCCC(C(=O)NC(CC(C)C)C(=O)NC(CCCCN=C(NCC)NCC)C(=O)N1CCCC1C(=O)NC(C)C(=O)N)NC(=O)C(CC2=CC=C(C=C2)O)NC(=O)C(CO)NC(=O)C(CC3=CN=CC=C3)NC(=O)C(CC4=CC=C(C=C4)Cl)NC(=O)C(CC5=CC6=CC=CC=C6C=C5)NC(=O)C)NCC,PHASE2,nervous_system_disease
4173,Gastroparesis|Diabetes Mellitus,Prucalopride,COCCCN1CCC(CC1)NC(=O)C2=CC(=C(C3=C2OCC3)N)Cl,PHASE2|PHASE3,nervous_system_disease
4174,Attention Deficit Disorder With Hyperactivity,Betahistine,CNCCC1=CC=CC=N1,PHASE1,nervous_system_disease
4175,Breast Cancer|Chronic Pain Due to Malignancy (Finding),Sulfasalazine,C1=CC=NC(=C1)NS(=O)(=O)C2=CC=C(C=C2)N=NC3=CC(=C(C=C3)O)C(=O)O,PHASE2,nervous_system_disease
4176,Postherpetic Neuralgia,Zucapsaicin,CC(C)C=CCCCCC(=O)NCC1=CC(=C(C=C1)O)OC,PHASE2,nervous_system_disease
4177,Microvascular Coronary Artery Disease,Regadenoson,CNC(=O)C1=CN(N=C1)C2=NC(=C3C(=N2)N(C=N3)C4C(C(C(O4)CO)O)O)N,PHASE2,nervous_system_disease
4178,Atrial Remodeling|Myocardial Dysfunction|Left Ventricular Remodeling|Left Ventricular Diastolic Dysfunction|Hypertension|Cardiovascular Morbidity|Fibrosis Myocardial|Inflammatory Myopathy|Atrial Arrhythmia,Sacubitril,CCOC(=O)C(C)CC(CC1=CC=C(C=C1)C2=CC=CC=C2)NC(=O)CCC(=O)O,PHASE2,nervous_system_disease
4179,Neuralgia,Carfentanil,CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCC3=CC=CC=C3)C(=O)OC,PHASE2,nervous_system_disease
4180,Post-COVID ME/CFS,Vericiguat,COC(=O)NC1=C(N=C(N=C1N)C2=NN(C3=C2C=C(C=N3)F)CC4=CC=CC=C4F)N,PHASE2,nervous_system_disease
4181,Recurrent Diffuse Intrinsic Pontine Glioma|Recurrent Malignant Glioma|Recurrent Medulloblastoma|Recurrent Primary Central Nervous System Neoplasm|Refractory Diffuse Intrinsic Pontine Glioma|Refractory Malignant Glioma|Refractory Medulloblastoma|Refractory Primary Central Nervous System Neoplasm,Savolitinib,CC(C1=CN2C=CN=C2C=C1)N3C4=NC(=CN=C4N=N3)C5=CN(N=C5)C,PHASE1,nervous_system_disease
4182,Idiopathic Parkinson Disease,Trimethobenzamide,CN(C)CCOC1=CC=C(C=C1)CNC(=O)C2=CC(=C(C(=C2)OC)OC)OC,PHASE1,nervous_system_disease
4183,"Ischemic Stroke, Acute",Sarecycline,CN(C)C1C2CC3CC4=C(C=CC(=C4C(=C3C(=O)C2(C(=C(C1=O)C(=O)N)O)O)O)O)CN(C)OC,PHASE2,nervous_system_disease
4184,"Kidney Failure, Chronic|Arthralgia",Lumiracoxib,CC1=CC(=C(C=C1)NC2=C(C=CC=C2Cl)F)CC(=O)O,PHASE2,nervous_system_disease
4185,Parkinson Disease,Radotinib,CC1=C(C=C(C=C1)C(=O)NC2=CC(=CC(=C2)C(F)(F)F)N3C=C(N=C3)C)NC4=NC=CC(=N4)C5=NC=CN=C5,PHASE2,nervous_system_disease
4186,Metabolism|Alzheimer's Disease,Omeprazole,CC1=CN=C(C(=C1OC)C)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC,PHASE1,nervous_system_disease
4187,"Ischemic Stroke, Acute",Riociguat,CN(C1=C(N=C(N=C1N)C2=NN(C3=C2C=CC=N3)CC4=CC=CC=C4F)N)C(=O)OC,PHASE2,nervous_system_disease
4188,"Ischemic Stroke, Acute",Propylthiouracil,CCCC1=CC(=O)NC(=S)N1,PHASE2,nervous_system_disease
4189,"Ischemic Stroke, Acute",Perphenazine,C1CN(CCN1CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl)CCO,PHASE2,nervous_system_disease
4190,Morbid Obesity|Postoperative Pain|Postoperative Bowel Function|Postoperative Ambulation,Levobupivacaine,CCCCN1CCCCC1C(=O)NC2=C(C=CC=C2C)C,PHASE2|PHASE3,nervous_system_disease
4191,Kennedy's Disease|Spinal and Bulbar Muscular Atrophy,Dutasteride,CC12CCC3C(C1CCC2C(=O)NC4=C(C=CC(=C4)C(F)(F)F)C(F)(F)F)CCC5C3(C=CC(=O)N5)C,PHASE2,nervous_system_disease
4192,Diffuse Large B Cell Lymphoma|Relapse/Recurrence|Extranodal Extension|Central Nervous System Lymphoma,Decitabine,C1C(C(OC1N2C=NC(=NC2=O)N)CO)O,PHASE2,nervous_system_disease
4193,Neurogenic Bladder|Catheter-Related Infections,Octenidine,CCCCCCCCN=C1C=CN(C=C1)CCCCCCCCCCN2C=CC(=NCCCCCCCC)C=C2,PHASE2|PHASE3,nervous_system_disease
4194,Severe Traumatic Brain Injury With High Cerebral Pressure,Dobutamine,CC(CCC1=CC=C(C=C1)O)NCCC2=CC(=C(C=C2)O)O,PHASE2,nervous_system_disease
4195,Attention Deficit Hyperactivity Disorder,Solriamfetol,C1=CC=C(C=C1)CC(COC(=O)N)N,PHASE2|PHASE3,nervous_system_disease
4196,Amyotrophic Lateral Sclerosis,Darunavir,CC(C)CN(CC(C(CC1=CC=CC=C1)NC(=O)OC2COC3C2CCO3)O)S(=O)(=O)C4=CC=C(C=C4)N,PHASE1,nervous_system_disease
4197,Amyotrophic Lateral Sclerosis,Ritonavir,CC(C)C1=NC(=CS1)CN(C)C(=O)NC(C(C)C)C(=O)NC(CC2=CC=CC=C2)CC(C(CC3=CC=CC=C3)NC(=O)OCC4=CN=CS4)O,PHASE1,nervous_system_disease
4198,Amyotrophic Lateral Sclerosis,Dolutegravir,CC1CCOC2N1C(=O)C3=C(C(=O)C(=CN3C2)C(=O)NCC4=C(C=C(C=C4)F)F)O,PHASE1,nervous_system_disease
4199,"Candidiasis, Systemic|Candida Meningitis",Micafungin,CCCCCOC1=CC=C(C=C1)C2=CC(=NO2)C3=CC=C(C=C3)C(=O)NC4CC(C(NC(=O)C5C(C(CN5C(=O)C(NC(=O)C(NC(=O)C6CC(CN6C(=O)C(NC4=O)C(C)O)O)C(C(C7=CC(=C(C=C7)O)OS(=O)(=O)O)O)O)C(CC(=O)N)O)C)O)O)O,PHASE2,nervous_system_disease
4200,"Brain Neoplasms|Malignant Neoplasms, Brain|Brain Tumors",Cositecan,CCC1(C2=C(COC1=O)C(=O)N3CC4=C(C5=CC=CC=C5N=C4C3=C2)CC[Si](C)(C)C)O,PHASE2,nervous_system_disease
4201,Insulin Resistance|Healthy|Obesity,Phentolamine,CC1=CC=C(C=C1)N(CC2=NCCN2)C3=CC(=CC=C3)O,PHASE1,nervous_system_disease
4202,Restless Legs Syndrome,Aplindore,C1C(OC2=C(O1)C=CC3=C2CC(=O)N3)CNCC4=CC=CC=C4,PHASE2,nervous_system_disease
4203,Alzheimer's Disease,Rilapladib,COCCN1CCC(CC1)N(CC2=CC=C(C=C2)C3=CC=C(C=C3)C(F)(F)F)C(=O)CN4C5=CC=CC=C5C(=O)C=C4SCC6=C(C(=CC=C6)F)F,PHASE1,nervous_system_disease
4204,Hereditary Angioedema (HAE),Icatibant,C1CCC2C(C1)CC(N2C(=O)C3CC4=CC=CC=C4CN3C(=O)C(CO)NC(=O)C(CC5=CC=CS5)NC(=O)CNC(=O)C6CC(CN6C(=O)C7CCCN7C(=O)C(CCCN=C(N)N)NC(=O)C(CCCN=C(N)N)N)O)C(=O)NC(CCCN=C(N)N)C(=O)O,PHASE1,nervous_system_disease
4205,Mild Cognitive Impairment|MCI|Aging|Alzheimer's Disease|AD,Phenazopyridine,C1=CC=C(C=C1)N=NC2=C(N=C(C=C2)N)N,PHASE2,nervous_system_disease
4206,"Stroke, Ischemic",Olmesartan,CCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)C(=O)O)C(C)(C)O,PHASE2,nervous_system_disease
4207,"Stroke, Ischemic",Nebivolol,C1CC2=C(C=CC(=C2)F)OC1C(CNCC(C3CCC4=C(O3)C=CC(=C4)F)O)O,PHASE2,nervous_system_disease
4208,Amyotrophic Lateral Sclerosis,Enoxacin,CCN1C=C(C(=O)C2=CC(=C(N=C21)N3CCNCC3)F)C(=O)O,PHASE1|PHASE2,nervous_system_disease
4209,Advanced Non-Small Cell Lung Cancer With MET Mutations,Tepotinib,CN1CCC(CC1)COC2=CN=C(N=C2)C3=CC=CC(=C3)CN4C(=O)C=CC(=N4)C5=CC=CC(=C5)C#N,PHASE1|PHASE2,nervous_system_disease
4210,Jaw Fractures|Infection,Clindamycin,CCCC1CC(N(C1)C)C(=O)NC(C2C(C(C(C(O2)SC)O)O)O)C(C)Cl,PHASE1,nervous_system_disease
4211,Dyslipidemia|Sleep Apnea Syndrome|Overweight|Obesity,Fenofibrate,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl,PHASE2,nervous_system_disease
4212,"Stress Disorders, Post-Traumatic",Doxazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4COC5=CC=CC=C5O4)N)OC,PHASE2,nervous_system_disease
4213,Corneal Abrasion|Eye Trauma,Hydrocodone,CN1CCC23C4C1CC5=C2C(=C(C=C5)OC)OC3C(=O)CC4,PHASE2,nervous_system_disease
4214,Cushing Disease,Fimepinostat,CN(CC1=CC2=C(S1)C(=NC(=N2)C3=CN=C(C=C3)OC)N4CCOCC4)C5=NC=C(C=N5)C(=O)NO,PHASE2,nervous_system_disease
4215,Alzheimer's Disease,Piromelatine,COC1=CC2=C(C=C1)NC=C2CCNC(=O)C3=CC(=O)C=CO3,PHASE2,nervous_system_disease
4216,Primary Ciliary Dyskinesia,Ivacaftor,CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C,PHASE2,nervous_system_disease
4217,Migraine,Naratriptan,CNS(=O)(=O)CCC1=CC2=C(C=C1)NC=C2C3CCN(CC3)C,PHASE1|PHASE2,nervous_system_disease
4218,Parkinson Disease,Gemfibrozil,CC1=CC(=C(C=C1)C)OCCCC(C)(C)C(=O)O,PHASE2,nervous_system_disease
4219,Infected Corneal Ulcers|Bacterial Keratitis|Corneal Ulcer|Childhood Blindness,Povidone,C=CN1CCCC1=O,PHASE2,nervous_system_disease
4220,Central Nervous System Diseases|Pediatric Disorder|Body Indication,Gadopiclenol,C1CN(CC2=NC(=CC=C2)CN(CCN1C(CCC(=O)NCC(CO)O)C(=O)[O-])C(CCC(=O)NCC(CO)O)C(=O)[O-])C(CCC(=O)NCC(CO)O)C(=O)[O-].[Gd+3],PHASE2,nervous_system_disease
4221,Nicotine Withdrawal|Marijuana Dependence|Cannabis Dependence|Nicotine Dependence|Cannabis Abuse,Aprepitant,CC(C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)OC2C(N(CCO2)CC3=NNC(=O)N3)C4=CC=C(C=C4)F,PHASE1,nervous_system_disease
4222,Bipolar Disorder|Schizoaffective Disorder|Manic Disorder|Mania|Manic State,Pentazocine,CC1C2CC3=C(C1(CCN2CC=C(C)C)C)C=C(C=C3)O,PHASE2,nervous_system_disease
4223,Painful Diabetic Neuropathy,Astaxanthin,CC1=C(C(CC(C1=O)O)(C)C)C=CC(=CC=CC(=CC=CC=C(C)C=CC=C(C)C=CC2=C(C(=O)C(CC2(C)C)O)C)C)C,PHASE2|PHASE3,nervous_system_disease
4224,Mitochondrial Diseases|Mitochondrial DNA tRNALeu(UUR) m.3243A<G Mutation|MELAS|Subacute Necrotizing Encephalomyelopathy,Sonlicromanol,CC1=C(C2=C(CCC(O2)(C)C(=O)NC3CCCNC3)C(=C1O)C)C,PHASE2,nervous_system_disease
4225,Recurrent Lymphoma|Recurrent Malignant Solid Neoplasm|Recurrent Primary Central Nervous System Neoplasm|Refractory Lymphoma|Refractory Malignant Solid Neoplasm|Refractory Primary Central Nervous System Neoplasm,Pevonedistat,C1CC2=CC=CC=C2C1NC3=C4C=CN(C4=NC=N3)C5CC(C(C5)O)COS(=O)(=O)N,PHASE1,nervous_system_disease
4226,Obstructive Sleep Apnea (OSA),Gefapixant,CC(C)C1=CC(=C(C=C1OC2=CN=C(N=C2N)N)S(=O)(=O)N)OC,PHASE1,nervous_system_disease
4227,Male Hypogonadism|Muscle Atrophy|Sarcopenia|Benign Prostate Hypertrophy,Finasteride,CC12CCC3C(C1CCC2C(=O)NC(C)(C)C)CCC4C3(C=CC(=O)N4)C,PHASE2,nervous_system_disease
4228,Mitochondrial Diseases,Bezafibrate,CC(C)(C(=O)O)OC1=CC=C(C=C1)CCNC(=O)C2=CC=C(C=C2)Cl,PHASE2,nervous_system_disease
4229,Jet Lag Disorder,Tasimelteon,CCC(=O)NCC1CC1C2=C3CCOC3=CC=C2,PHASE2,nervous_system_disease
4230,Parkinson's Disease Dementia,Ceftriaxone,CN1C(=NC(=O)C(=O)N1)SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)O,PHASE2,nervous_system_disease
4231,Myxofibrosarcoma|Recurrent Adult Soft Tissue Sarcoma|Recurrent Leiomyosarcoma|Recurrent Liposarcoma|Recurrent Malignant Peripheral Nerve Sheath Tumor|Recurrent Undifferentiated Pleomorphic Sarcoma|Stage III Soft Tissue Sarcoma AJCC v7|Stage IV Soft Tissue Sarcoma AJCC v7,Alisertib,COC1=C(C(=CC=C1)F)C2=NCC3=CN=C(N=C3C4=C2C=C(C=C4)Cl)NC5=CC(=C(C=C5)C(=O)O)OC,PHASE2,nervous_system_disease
4232,Vestibular Schwannoma|Neurofibromatosis Type 2,Endostatin,CN(CC(=O)C1=CC=CC=C1)N=O,PHASE2,nervous_system_disease
4233,Neurogenic Detrusor Overactivity,Trospium,C1CC[N+]2(C1)C3CCC2CC(C3)OC(=O)C(C4=CC=CC=C4)(C5=CC=CC=C5)O,PHASE1,nervous_system_disease
4234,Alzheimer's Disease|Cognitive Dysfunction,Formoterol,CC(CC1=CC=C(C=C1)OC)NCC(C2=CC(=C(C=C2)O)NC=O)O,PHASE2,nervous_system_disease
4235,FAP|Familial Amyloid Polyneuropathy|TTR|Transthyretin|Amyloidosis,Inotersen,CC1=CN(C(=O)NC1=O)C2CC(C(O2)COP(=S)(O)OC3CC(OC3COP(=S)(O)OC4CC(OC4COP(=S)(O)OC5C(OC(C5OCCOC)N6C=NC7=C6N=C(NC7=O)N)COP(=S)(O)OC8C(OC(C8OCCOC)N9C=C(C(=O)NC9=O)C)COP(=S)(O)OC1C(OC(C1OCCOC)N1C=C(C(=O)NC1=O)C)COP(=O)(OC1C(OC(C1OCCOC)N1C=C(C(=NC1=O)N)C)COP(=S)(O)OC1C(OC(C1OCCOC)N1C=C(C(=O)NC1=O)C)CO)S)N1C=NC2=C1N=C(NC2=O)N)N1C=C(C(=O)NC1=O)C)OP(=S)(O)OCC1C(CC(O1)N1C=NC2=C(N=CN=C21)N)OP(=S)(O)OCC1C(CC(O1)N1C=C(C(=NC1=O)N)C)OP(=S)(O)OCC1C(CC(O1)N1C=NC2=C(N=CN=C21)N)OP(=S)(O)OCC1C(CC(O1)N1C=C(C(=O)NC1=O)C)OP(=S)(O)OCC1C(CC(O1)N1C=NC2=C1N=C(NC2=O)N)OP(=S)(O)OCC1C(CC(O1)N1C=NC2=C(N=CN=C21)N)OP(=S)(O)OCC1C(CC(O1)N1C=NC2=C(N=CN=C21)N)OP(=S)(O)OCC1C(C(C(O1)N1C=NC2=C(N=CN=C21)N)OCCOC)OP(=S)(O)OCC1C(C(C(O1)N1C=C(C(=O)NC1=O)C)OCCOC)OP(=S)(O)OCC1C(C(C(O1)N1C=C(C(=NC1=O)N)C)OCCOC)OP(=S)(O)OCC1C(C(C(O1)N1C=C(C(=NC1=O)N)C)OCCOC)OP(=S)(O)OCC1C(C(C(O1)N1C=C(C(=NC1=O)N)C)OCCOC)O,PHASE2|PHASE3,nervous_system_disease
4236,Secondary-progressive Multiple Sclerosis,Siponimod,CCC1=C(C=CC(=C1)C(=NOCC2=CC(=C(C=C2)C3CCCCC3)C(F)(F)F)C)CN4CC(C4)C(=O)O,PHASE2|PHASE3,nervous_system_disease
4237,Alzheimer Disease,Medroxyprogesterone,CC1CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C,PHASE2|PHASE3,nervous_system_disease
4238,"Hepatic Encephalopathy|Cirrhosis, Liver",Rifamycin,CC1C=CC=C(C(=O)NC2=CC(=C3C(=C2O)C(=C(C4=C3C(=O)C(O4)(OC=CC(C(C(C(C(C(C1O)C)O)C)OC(=O)C)C)OC)C)C)O)O)C,PHASE2,nervous_system_disease
4239,Primary Insomnia|Chronic Insomnia,Chamomile,C1=CC(=CC=C1C2=CC(=O)C3=C(C=C(C=C3O2)O)O)O,PHASE2,nervous_system_disease
4240,Non-Small Cell Lung Cancer (NSCLC),Lorlatinib,CC1C2=C(C=CC(=C2)F)C(=O)N(CC3=NN(C(=C3C4=CC(=C(N=C4)N)O1)C#N)C)C,PHASE2,nervous_system_disease
4241,"Hyperalgesia|Pain, Postoperative|Pain, Chronic Disease",Nefopam,CN1CCOC(C2=CC=CC=C2C1)C3=CC=CC=C3,PHASE2|PHASE3,nervous_system_disease
4242,Relapsing Remitting Multiple Sclerosis,Raltegravir,CC1=NN=C(O1)C(=O)NC(C)(C)C2=NC(=C(C(=O)N2C)O)C(=O)NCC3=CC=C(C=C3)F,PHASE2,nervous_system_disease
4243,"Multiple Sclerosis|Multiple Sclerosis, Relapsing-Remitting",Bazedoxifene,CC1=C(N(C2=C1C=C(C=C2)O)CC3=CC=C(C=C3)OCCN4CCCCCC4)C5=CC=C(C=C5)O,PHASE2,nervous_system_disease
4244,Down Syndrome|Acute Lymphoblastic Leukemia|Childhood Cancer,Daunorubicin,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)C)O)N)O,PHASE2,nervous_system_disease
4245,Down Syndrome|Acute Lymphoblastic Leukemia|Childhood Cancer,Epirubicin,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)N)O,PHASE2,nervous_system_disease
4246,Primary Diffuse Large B-cell Lymphoma of the Central Nervous System (CNS)|Aggressive B-cell Lymphoma With Secondary Involvement of the CNS,Venetoclax,CC1(CCC(=C(C1)C2=CC=C(C=C2)Cl)CN3CCN(CC3)C4=CC(=C(C=C4)C(=O)NS(=O)(=O)C5=CC(=C(C=C5)NCC6CCOCC6)[N+](=O)[O-])OC7=CN=C8C(=C7)C=CN8)C,PHASE1,nervous_system_disease
4247,Dementia of the Alzheimer Type|Age-related Cognitive Decline|Mild Cognitive Impairment Due to Alzheimer Disease,Probucol,CC(C)(C)C1=CC(=CC(=C1O)C(C)(C)C)SC(C)(C)SC2=CC(=C(C(=C2)C(C)(C)C)O)C(C)(C)C,PHASE1|PHASE2,nervous_system_disease
4248,Primary Insomnia,Adipiplon,CCCC1=C(N=CN2C1=NC(=N2)C)CN3C=CN=C3C4=C(C=CC=N4)F,PHASE2,nervous_system_disease
4249,Mild Cognitive Impairment|Alzheimer Disease,Senicapoc,C1=CC=C(C=C1)C(C2=CC=C(C=C2)F)(C3=CC=C(C=C3)F)C(=O)N,PHASE2,nervous_system_disease
4250,Gastroparesis,Itopride,CN(C)CCOC1=CC=C(C=C1)CNC(=O)C2=CC(=C(C=C2)OC)OC,PHASE1|PHASE2,nervous_system_disease
4251,Fragile X Syndrome,Arbaclofen,C1=CC(=CC=C1C(CC(=O)O)CN)Cl,PHASE2,nervous_system_disease
4252,Meningitis,Meropenem,CC1C2C(C(=O)N2C(=C1SC3CC(NC3)C(=O)N(C)C)C(=O)O)C(C)O,PHASE1|PHASE2,nervous_system_disease
4253,Narcolepsy With Cataplexy|Narcolepsy|Narcolepsy Without Cataplexy,Mazindol,C1CN2C(=N1)C3=CC=CC=C3C2(C4=CC=C(C=C4)Cl)O,PHASE2,nervous_system_disease
4254,Gastroparesis,Methylnaltrexone,C[N+]1(CCC23C4C(=O)CCC2(C1CC5=C3C(=C(C=C5)O)O4)O)CC6CC6,PHASE2,nervous_system_disease
4255,Von Hippel-Lindau Syndrome,Dovitinib,CN1CCN(CC1)C2=CC3=C(C=C2)N=C(N3)C4=C(C5=C(C=CC=C5F)NC4=O)N,PHASE2,nervous_system_disease
4256,Neurocysticercosis,Oxfendazole,COC(=O)NC1=NC2=C(N1)C=C(C=C2)S(=O)C3=CC=CC=C3,PHASE1,nervous_system_disease
4257,Insomnia Disorder,Cannabinol,CCCCCC1=CC(=C2C(=C1)OC(C3=C2C=C(C=C3)C)(C)C)O,PHASE1|PHASE2,nervous_system_disease
4258,Brain Metastases,Endostar,CN(CC(=O)C1=CC=CC=C1)N=O,PHASE2,nervous_system_disease
4259,Renal Cancer|Von Hippel Lindau,Vandetanib,CN1CCC(CC1)COC2=C(C=C3C(=C2)N=CN=C3NC4=C(C=C(C=C4)Br)F)OC,PHASE2,nervous_system_disease
4260,Tachycardia|Chronic Orthostatic Intolerance,Mecamylamine,CC1(C2CCC(C2)C1(C)NC)C,PHASE1|PHASE2,nervous_system_disease
4261,Gastroparesis,Naronapride,COC1CN(CCC1NC(=O)C2=CC(=C(C=C2OC)N)Cl)CCCCCC(=O)OC3CN4CCC3CC4,PHASE2,nervous_system_disease
4262,Gastroparesis,Granisetron,CN1C2CCCC1CC(C2)NC(=O)C3=NN(C4=CC=CC=C43)C,PHASE2,nervous_system_disease
4263,Diabetic Neuropathy,Ruboxistaurin,CN(C)CC1CCN2C=C(C3=CC=CC=C32)C4=C(C5=CN(CCO1)C6=CC=CC=C65)C(=O)NC4=O,PHASE2,nervous_system_disease
4264,"Muscular Dystrophy, Duchenne",Oxatomide,C1CN(CCN1CCCN2C3=CC=CC=C3NC2=O)C(C4=CC=CC=C4)C5=CC=CC=C5,PHASE2,nervous_system_disease
4265,Aneurysmal Subarachnoid Hemorrhage|Delayed Cerebral Ischemia,Nadroparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,PHASE2,nervous_system_disease
4266,Parkinson Disease|Excessive Daytime Somnolence,Valiloxybate,CC(C)C(C(=O)OCCCC(=O)O)N,PHASE2,nervous_system_disease
4267,Amyotrophic Lateral Sclerosis (ALS),Masitinib,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC(=CS4)C5=CN=CC=C5,PHASE2|PHASE3,nervous_system_disease
4268,"Tinnitus, Subjective",Sulodexide,CNC1=C2C(=NC=N1)N(C=N2)C3C(C(C(O3)CO)O)OC,PHASE2,nervous_system_disease
4269,Pain|Thermal Injury|Burns|Hyperalgesia,Voriconazole,CC(C1=NC=NC=C1F)C(CN2C=NC=N2)(C3=C(C=C(C=C3)F)F)O,PHASE2,nervous_system_disease
4270,Relapsing Multiple Sclerosis,Fenebrutinib,CC1CN(CCN1C2=CN=C(C=C2)NC3=CC(=CN(C3=O)C)C4=C(C(=NC=C4)N5CCN6C7=C(CC(C7)(C)C)C=C6C5=O)CO)C8COC8,PHASE2,nervous_system_disease
4271,Metastatic Renal Cell Carcinoma,Lenvatinib,COC1=CC2=NC=CC(=C2C=C1C(=O)N)OC3=CC(=C(C=C3)NC(=O)NC4CC4)Cl,PHASE1|PHASE2,urinary_system_disease
4272,Metastatic Renal Cell Carcinoma,Everolimus,CC1CCC2CC(C(=CC=CC=CC(CC(C(=O)C(C(C(=CC(C(=O)CC(OC(=O)C3CCCCN3C(=O)C(=O)C1(O2)O)C(C)CC4CCC(C(C4)OC)OCCO)C)C)O)OC)C)C)C)OC,PHASE1|PHASE2,urinary_system_disease
4273,"Cancer|Pancreatic Cancer|Sarcoma|Renal Cancer|Refractory Cancer|Refractory Neoplasm|Refractory Non-Hodgkin Lymphoma|Pancreatic Adenocarcinoma|Resistant Cancer|Neoplasm Metastasis|Neoplasm of Bone|Neoplasm, Breast|Neoplasm of Lung|Neoplasms,Colorectal|Neoplasms Pancreatic|Malignant Glioma|Malignancies|Malignancies Multiple|Bone Metastases|Bone Neoplasm|Bone Cancer|Pancreas Cancer|Pancreatic Neoplasms|Breast Neoplasms|Acute T Cell Leukemia Lymphoma",Gemcitabine,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)(F)F,PHASE2,urinary_system_disease
4274,"Cancer|Pancreatic Cancer|Sarcoma|Renal Cancer|Refractory Cancer|Refractory Neoplasm|Refractory Non-Hodgkin Lymphoma|Pancreatic Adenocarcinoma|Resistant Cancer|Neoplasm Metastasis|Neoplasm of Bone|Neoplasm, Breast|Neoplasm of Lung|Neoplasms,Colorectal|Neoplasms Pancreatic|Malignant Glioma|Malignancies|Malignancies Multiple|Bone Metastases|Bone Neoplasm|Bone Cancer|Pancreas Cancer|Pancreatic Neoplasms|Breast Neoplasms|Acute T Cell Leukemia Lymphoma",Doxorubicin,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)N)O,PHASE2,urinary_system_disease
4275,"Cancer|Pancreatic Cancer|Sarcoma|Renal Cancer|Refractory Cancer|Refractory Neoplasm|Refractory Non-Hodgkin Lymphoma|Pancreatic Adenocarcinoma|Resistant Cancer|Neoplasm Metastasis|Neoplasm of Bone|Neoplasm, Breast|Neoplasm of Lung|Neoplasms,Colorectal|Neoplasms Pancreatic|Malignant Glioma|Malignancies|Malignancies Multiple|Bone Metastases|Bone Neoplasm|Bone Cancer|Pancreas Cancer|Pancreatic Neoplasms|Breast Neoplasms|Acute T Cell Leukemia Lymphoma",Lomustine,C1CCC(CC1)NC(=O)N(CCCl)N=O,PHASE2,urinary_system_disease
4276,"Cancer|Pancreatic Cancer|Sarcoma|Renal Cancer|Refractory Cancer|Refractory Neoplasm|Refractory Non-Hodgkin Lymphoma|Pancreatic Adenocarcinoma|Resistant Cancer|Neoplasm Metastasis|Neoplasm of Bone|Neoplasm, Breast|Neoplasm of Lung|Neoplasms,Colorectal|Neoplasms Pancreatic|Malignant Glioma|Malignancies|Malignancies Multiple|Bone Metastases|Bone Neoplasm|Bone Cancer|Pancreas Cancer|Pancreatic Neoplasms|Breast Neoplasms|Acute T Cell Leukemia Lymphoma",Carboplatin,C1CC(C1)(C(=O)O)C(=O)O.[NH2-].[NH2-].[Pt+2],PHASE2,urinary_system_disease
4277,"Cancer|Pancreatic Cancer|Sarcoma|Renal Cancer|Refractory Cancer|Refractory Neoplasm|Refractory Non-Hodgkin Lymphoma|Pancreatic Adenocarcinoma|Resistant Cancer|Neoplasm Metastasis|Neoplasm of Bone|Neoplasm, Breast|Neoplasm of Lung|Neoplasms,Colorectal|Neoplasms Pancreatic|Malignant Glioma|Malignancies|Malignancies Multiple|Bone Metastases|Bone Neoplasm|Bone Cancer|Pancreas Cancer|Pancreatic Neoplasms|Breast Neoplasms|Acute T Cell Leukemia Lymphoma",Paclitaxel,CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C,PHASE2,urinary_system_disease
4278,"Cancer|Pancreatic Cancer|Sarcoma|Renal Cancer|Refractory Cancer|Refractory Neoplasm|Refractory Non-Hodgkin Lymphoma|Pancreatic Adenocarcinoma|Resistant Cancer|Neoplasm Metastasis|Neoplasm of Bone|Neoplasm, Breast|Neoplasm of Lung|Neoplasms,Colorectal|Neoplasms Pancreatic|Malignant Glioma|Malignancies|Malignancies Multiple|Bone Metastases|Bone Neoplasm|Bone Cancer|Pancreas Cancer|Pancreatic Neoplasms|Breast Neoplasms|Acute T Cell Leukemia Lymphoma",Irinotecan,CCC1=C2CN3C(=CC4=C(C3=O)COC(=O)C4(CC)O)C2=NC5=C1C=C(C=C5)OC(=O)N6CCC(CC6)N7CCCCC7,PHASE2,urinary_system_disease
4279,Renal Impairment,Saroglitazar,CCOC(CC1=CC=C(C=C1)OCCN2C(=CC=C2C3=CC=C(C=C3)SC)C)C(=O)O,PHASE1,urinary_system_disease
4280,Diabetes Mellitus|Diabetic Nephropathy,Pirfenidone,CC1=CN(C(=O)C=C1)C2=CC=CC=C2,PHASE1|PHASE2,urinary_system_disease
4281,Glioma|Hematopoietic and Lymphoid Cell Neoplasm|Lymphoma|Metastatic Malignant Solid Neoplasm|Neuroendocrine Neoplasm|Recurrent Adult Soft Tissue Sarcoma|Recurrent Bladder Carcinoma|Recurrent Breast Carcinoma|Recurrent Chronic Lymphocytic Leukemia|Recurrent Colorectal Carcinoma|Recurrent Head and Neck Carcinoma|Recurrent Lung Carcinoma|Recurrent Malignant Solid Neoplasm|Recurrent Melanoma|Recurrent Pancreatic Carcinoma|Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma|Recurrent Prostate Carcinoma|Recurrent Renal Cell Carcinoma|Recurrent Thyroid Gland Carcinoma|Refractory Chronic Lymphocytic Leukemia|Refractory Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma|Refractory Primary Cutaneous T-Cell Non-Hodgkin Lymphoma|Stage III Breast Cancer AJCC v7|Stage III Colorectal Cancer AJCC v7|Stage III Cutaneous Melanoma AJCC v7|Stage III Lung Cancer AJCC v7|Stage III Pancreatic Cancer AJCC v6 and v7|Stage III Prostate Cancer AJCC v7|Stage III Renal Cell Cancer AJCC v7|Stage III Soft Tissue Sarcoma AJCC v7|Stage IIIA Breast Cancer AJCC v7|Stage IIIA Colorectal Cancer AJCC v7|Stage IIIA Cutaneous Melanoma AJCC v7|Stage IIIB Breast Cancer AJCC v7|Stage IIIB Colorectal Cancer AJCC v7|Stage IIIB Cutaneous Melanoma AJCC v7|Stage IIIC Breast Cancer AJCC v7|Stage IIIC Colorectal Cancer AJCC v7|Stage IIIC Cutaneous Melanoma AJCC v7|Stage IV Breast Cancer AJCC v6 and v7|Stage IV Colorectal Cancer AJCC v7|Stage IV Cutaneous Melanoma AJCC v6 and v7|Stage IV Lung Cancer AJCC v7|Stage IV Pancreatic Cancer AJCC v6 and v7|Stage IV Prostate Cancer AJCC v7|Stage IV Renal Cell Cancer AJCC v7|Stage IV Soft Tissue Sarcoma AJCC v7|Stage IVA Colorectal Cancer AJCC v7|Stage IVB Colorectal Cancer AJCC v7|Unresectable Solid Neoplasm,Ciclosporin,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,PHASE1,urinary_system_disease
4282,Glioma|Hematopoietic and Lymphoid Cell Neoplasm|Lymphoma|Metastatic Malignant Solid Neoplasm|Neuroendocrine Neoplasm|Recurrent Adult Soft Tissue Sarcoma|Recurrent Bladder Carcinoma|Recurrent Breast Carcinoma|Recurrent Chronic Lymphocytic Leukemia|Recurrent Colorectal Carcinoma|Recurrent Head and Neck Carcinoma|Recurrent Lung Carcinoma|Recurrent Malignant Solid Neoplasm|Recurrent Melanoma|Recurrent Pancreatic Carcinoma|Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma|Recurrent Prostate Carcinoma|Recurrent Renal Cell Carcinoma|Recurrent Thyroid Gland Carcinoma|Refractory Chronic Lymphocytic Leukemia|Refractory Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma|Refractory Primary Cutaneous T-Cell Non-Hodgkin Lymphoma|Stage III Breast Cancer AJCC v7|Stage III Colorectal Cancer AJCC v7|Stage III Cutaneous Melanoma AJCC v7|Stage III Lung Cancer AJCC v7|Stage III Pancreatic Cancer AJCC v6 and v7|Stage III Prostate Cancer AJCC v7|Stage III Renal Cell Cancer AJCC v7|Stage III Soft Tissue Sarcoma AJCC v7|Stage IIIA Breast Cancer AJCC v7|Stage IIIA Colorectal Cancer AJCC v7|Stage IIIA Cutaneous Melanoma AJCC v7|Stage IIIB Breast Cancer AJCC v7|Stage IIIB Colorectal Cancer AJCC v7|Stage IIIB Cutaneous Melanoma AJCC v7|Stage IIIC Breast Cancer AJCC v7|Stage IIIC Colorectal Cancer AJCC v7|Stage IIIC Cutaneous Melanoma AJCC v7|Stage IV Breast Cancer AJCC v6 and v7|Stage IV Colorectal Cancer AJCC v7|Stage IV Cutaneous Melanoma AJCC v6 and v7|Stage IV Lung Cancer AJCC v7|Stage IV Pancreatic Cancer AJCC v6 and v7|Stage IV Prostate Cancer AJCC v7|Stage IV Renal Cell Cancer AJCC v7|Stage IV Soft Tissue Sarcoma AJCC v7|Stage IVA Colorectal Cancer AJCC v7|Stage IVB Colorectal Cancer AJCC v7|Unresectable Solid Neoplasm,Chloroquine,CCN(CC)CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl,PHASE1,urinary_system_disease
4283,Glioma|Hematopoietic and Lymphoid Cell Neoplasm|Lymphoma|Metastatic Malignant Solid Neoplasm|Neuroendocrine Neoplasm|Recurrent Adult Soft Tissue Sarcoma|Recurrent Bladder Carcinoma|Recurrent Breast Carcinoma|Recurrent Chronic Lymphocytic Leukemia|Recurrent Colorectal Carcinoma|Recurrent Head and Neck Carcinoma|Recurrent Lung Carcinoma|Recurrent Malignant Solid Neoplasm|Recurrent Melanoma|Recurrent Pancreatic Carcinoma|Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma|Recurrent Prostate Carcinoma|Recurrent Renal Cell Carcinoma|Recurrent Thyroid Gland Carcinoma|Refractory Chronic Lymphocytic Leukemia|Refractory Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma|Refractory Primary Cutaneous T-Cell Non-Hodgkin Lymphoma|Stage III Breast Cancer AJCC v7|Stage III Colorectal Cancer AJCC v7|Stage III Cutaneous Melanoma AJCC v7|Stage III Lung Cancer AJCC v7|Stage III Pancreatic Cancer AJCC v6 and v7|Stage III Prostate Cancer AJCC v7|Stage III Renal Cell Cancer AJCC v7|Stage III Soft Tissue Sarcoma AJCC v7|Stage IIIA Breast Cancer AJCC v7|Stage IIIA Colorectal Cancer AJCC v7|Stage IIIA Cutaneous Melanoma AJCC v7|Stage IIIB Breast Cancer AJCC v7|Stage IIIB Colorectal Cancer AJCC v7|Stage IIIB Cutaneous Melanoma AJCC v7|Stage IIIC Breast Cancer AJCC v7|Stage IIIC Colorectal Cancer AJCC v7|Stage IIIC Cutaneous Melanoma AJCC v7|Stage IV Breast Cancer AJCC v6 and v7|Stage IV Colorectal Cancer AJCC v7|Stage IV Cutaneous Melanoma AJCC v6 and v7|Stage IV Lung Cancer AJCC v7|Stage IV Pancreatic Cancer AJCC v6 and v7|Stage IV Prostate Cancer AJCC v7|Stage IV Renal Cell Cancer AJCC v7|Stage IV Soft Tissue Sarcoma AJCC v7|Stage IVA Colorectal Cancer AJCC v7|Stage IVB Colorectal Cancer AJCC v7|Unresectable Solid Neoplasm,Romidepsin,CC=C1C(=O)NC(C(=O)OC2CC(=O)NC(C(=O)NC(CSSCCC=C2)C(=O)N1)C(C)C)C(C)C,PHASE1,urinary_system_disease
4284,"Carcinoma, Renal Cell",Sunitinib,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C,PHASE2,urinary_system_disease
4285,"Renal Disease, End Stage",Amisulpride,CCN1CCCC1CNC(=O)C2=CC(=C(C=C2OC)N)S(=O)(=O)CC,PHASE1,urinary_system_disease
4286,Bladder Cancer,Vinflunine,CCC12C=CCN3C1C4(CC3)C(C(C2OC(=O)C)(C(=O)OC)O)N(C5=CC(=C(C=C45)C6(CC7CC(CN(C7)CC8=C6NC9=CC=CC=C89)C(C)(F)F)C(=O)OC)OC)C,PHASE1|PHASE2,urinary_system_disease
4287,Bladder Cancer,Cisplatin,N.N.Cl[Pt]Cl,PHASE1|PHASE2,urinary_system_disease
4288,Malignant Rhabdoid Tumors (MRT)|Rhabdoid Tumors of the Kidney (RTK)|Atypical Teratoid Rhabdoid Tumors (ATRT)|Selected Tumors With Rhabdoid Features|Synovial Sarcoma|INI1-negative Tumors|Malignant Rhabdoid Tumor of Ovary|Renal Medullary Carcinoma|Epithelioid Sarcoma|Poorly Differentiated Chordoma (or Other Chordoma With Sponsor Approval)|Any Solid Tumor With an EZH2 GOF Mutation,Tazemetostat,CCN(C1CCOCC1)C2=CC(=CC(=C2C)C(=O)NCC3=C(C=C(NC3=O)C)C)C4=CC=C(C=C4)CN5CCOCC5,PHASE2,urinary_system_disease
4289,Kidney Cancer,Sorafenib,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,PHASE1,urinary_system_disease
4290,Cervical Cancer|Renal Cancer|Urothelial Cancer|Melanoma|Breast Cancer,Cyclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,PHASE1|PHASE2,urinary_system_disease
4291,Cervical Cancer|Renal Cancer|Urothelial Cancer|Melanoma|Breast Cancer,Fludarabine,C1=NC2=C(N=C(N=C2N1C3C(C(C(O3)CO)O)O)F)N,PHASE1|PHASE2,urinary_system_disease
4292,Melanoma|Prostate Cancer|Renal Cancer,Naltrexone,C1CC1CN2CCC34C5C(=O)CCC3(C2CC6=C4C(=C(C=C6)O)O5)O,PHASE2,urinary_system_disease
4293,Clear Cell Renal Cell Carcinoma|Recurrent Renal Cell Carcinoma|Stage IV Renal Cell Cancer AJCC v7,Temsirolimus,CC1CCC2CC(C(=CC=CC=CC(CC(C(=O)C(C(C(=CC(C(=O)CC(OC(=O)C3CCCCN3C(=O)C(=O)C1(O2)O)C(C)CC4CCC(C(C4)OC)OC(=O)C(C)(CO)CO)C)C)O)OC)C)C)C)OC,PHASE2,urinary_system_disease
4294,Renal Impairment,Fruquintinib,CC1=C(C2=C(O1)C=C(C=C2)OC3=NC=NC4=CC(=C(C=C43)OC)OC)C(=O)NC,PHASE1,urinary_system_disease
4295,Renal Cell Carcinoma|Hereditary Leiomyomatosis|Renal Cell Cancer,Vandetanib,CN1CCC(CC1)COC2=C(C=C3C(=C2)N=CN=C3NC4=C(C=C(C=C4)Br)F)OC,PHASE1|PHASE2,urinary_system_disease
4296,Renal Cell Carcinoma|Hereditary Leiomyomatosis|Renal Cell Cancer,Metformin,CN(C)C(=N)N=C(N)N,PHASE1|PHASE2,urinary_system_disease
4297,Chronic Kidney Diseases|Heart Failure With Preserved Ejection Fraction|Kidney Diseases|Heart Failure,Dapagliflozin,CCOC1=CC=C(C=C1)CC2=C(C=CC(=C2)C3C(C(C(C(O3)CO)O)O)O)Cl,PHASE1|PHASE2,urinary_system_disease
4298,Urinary Tract Infections,Cefiderocol,CC(C)(C(=O)O)ON=C(C1=CSC(=N1)N)C(=O)NC2C3N(C2=O)C(=C(CS3)C[N+]4(CCCC4)CCNC(=O)C5=C(C(=C(C=C5)O)O)Cl)C(=O)[O-],PHASE2,urinary_system_disease
4299,Urinary Tract Infections,Imipenem,CC(C1C2CC(=C(N2C1=O)C(=O)O)SCCN=CN)O,PHASE2,urinary_system_disease
4300,Systemic Lupus Erythematosus|Lupus Nephritis,Cyclosporine,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,PHASE2,urinary_system_disease
4301,Renal Artery Obstruction|Stents|Lipids|Glomerular Filtration Rate|Blood Pressure,Rosuvastatin,CC(C)C1=NC(=NC(=C1C=CC(CC(CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C,PHASE2|PHASE3,urinary_system_disease
4302,RCC|Renal Cell Carcinoma,Cabozantinib,COC1=CC2=C(C=CN=C2C=C1OC)OC3=CC=C(C=C3)NC(=O)C4(CC4)C(=O)NC5=CC=C(C=C5)F,PHASE2,urinary_system_disease
4303,Erectile Dysfunction|Overactive Bladder|Urinary Incontinence,Mirabegron,C1=CC=C(C=C1)C(CNCCC2=CC=C(C=C2)NC(=O)CC3=CSC(=N3)N)O,PHASE1|PHASE2,urinary_system_disease
4304,Anemia of Chronic Kidney Disease|Chemotherapy Effect,Desidustat,C1CC1CON2C3=CC=CC=C3C(=C(C2=O)C(=O)NCC(=O)O)O,PHASE1,urinary_system_disease
4305,Renal Cell Carcinoma|Colorectal Adenocarcinoma|Non-squamous Non-small Cell Lung Cancer|Platinum-refractory Ovarian Carcinoma|Cervical Carcinoma,Nintedanib,CN1CCN(CC1)CC(=O)N(C)C2=CC=C(C=C2)N=C(C3=CC=CC=C3)C4=C(NC5=C4C=CC(=C5)C(=O)OC)O,PHASE1,urinary_system_disease
4306,Glomerulonephritis|Nephrotic Syndrome,Dexamethasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,PHASE2,urinary_system_disease
4307,Chronic Kidney Diseases,Bardoxolone,CC1(CCC2(CCC3(C(C2C1)C(=O)C=C4C3(CCC5C4(C=C(C(=O)C5(C)C)C#N)C)C)C)C(=O)O)C,PHASE2,urinary_system_disease
4308,Renal Cancer|Non Small Cell Lung Cancer (NSCLC)|Soft Tissue Sarcoma,Panobinostat,CC1=C(C2=CC=CC=C2N1)CCNCC3=CC=C(C=C3)C=CC(=O)NO,PHASE1,urinary_system_disease
4309,"Polycystic Liver Disease|Hepatomegaly|Liver Diseases|Polycystic Kidney, Autosomal Dominant",Lanreotide,CC(C)C1C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=C(C=C4)O)NC(=O)C(CC5=CC6=CC=CC=C6C=C5)N)C(=O)NC(C(C)O)C(=O)N,PHASE2|PHASE3,urinary_system_disease
4310,Kidney Cancer,Pazopanib,CC1=C(C=C(C=C1)NC2=NC=CC(=N2)N(C)C3=CC4=NN(C(=C4C=C3)C)C)S(=O)(=O)N,PHASE2,urinary_system_disease
4311,Kidney Cancer,Diphenhydramine,CN(C)CCOC(C1=CC=CC=C1)C2=CC=CC=C2,PHASE2,urinary_system_disease
4312,Renal Failure,Tacrolimus,CC1CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC(=O)C(C=C(C1)C)CC=C)O)C)C(=CC4CCC(C(C4)OC)O)C)O)C)OC)OC,PHASE2,urinary_system_disease
4313,Polycystic Liver Disease|Autosomal Dominant Polycystic Kidney,Leuprorelin,CCNC(=O)C1CCCN1C(=O)C(CCCN=C(N)N)NC(=O)C(CC(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC2=CC=C(C=C2)O)NC(=O)C(CO)NC(=O)C(CC3=CNC4=CC=CC=C43)NC(=O)C(CC5=CN=CN5)NC(=O)C6CCC(=O)N6,PHASE2,urinary_system_disease
4314,Polycystic Liver Disease|Autosomal Dominant Polycystic Kidney,Leuprolide,CCNC(=O)C1CCCN1C(=O)C(CCCN=C(N)N)NC(=O)C(CC(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC2=CC=C(C=C2)O)NC(=O)C(CO)NC(=O)C(CC3=CNC4=CC=CC=C43)NC(=O)C(CC5=CN=CN5)NC(=O)C6CCC(=O)N6,PHASE2,urinary_system_disease
4315,Renal Impairment,Buparlisib,C1COCCN1C2=NC(=NC(=C2)C3=CN=C(C=C3C(F)(F)F)N)N4CCOCC4,PHASE1,urinary_system_disease
4316,Overactive Bladder|Urinary Incontinence,Tolterodine,CC1=CC(=C(C=C1)O)C(CCN(C(C)C)C(C)C)C2=CC=CC=C2,PHASE2,urinary_system_disease
4317,Hypertension,Daglutril,CCOC(=O)C(CCC1=CC=CC=C1)CC2(CCCC2)C(=O)NC3CCC4=CC=CC=C4N(C3=O)CC(=O)O,PHASE2,urinary_system_disease
4318,"Homocysteine|Coronary Disease|Angioplasty,Balloon,Coronary|Contrast Media|Nephropathy|Hypertension",Enalapril,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O,PHASE2|PHASE3,urinary_system_disease
4319,Relapsed/Refractory Solid Tumors/Hematological Malignancies,Belinostat,C1=CC=C(C=C1)NS(=O)(=O)C2=CC=CC(=C2)C=CC(=O)NO,PHASE1,urinary_system_disease
4320,Acute Kidney Injury,Aminophylline,CN1C2=C(C(=O)N(C1=O)C)NC=N2.CN1C2=C(C(=O)N(C1=O)C)NC=N2.C(CN)N,PHASE2|PHASE3,urinary_system_disease
4321,Acute Kidney Injury,Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,PHASE2|PHASE3,urinary_system_disease
4322,Diabetic Nephropathies,Colchicine,CC(=O)NC1CCC2=CC(=C(C(=C2C3=CC=C(C(=O)C=C13)OC)OC)OC)OC,PHASE1|PHASE2,urinary_system_disease
4323,Urothelial Carcinoma|Bladder Cancer|Myelosuppression Adult|Chemotherapy-induced Neutropenia|Metastatic Bladder Cancer,Trilaciclib,CN1CCN(CC1)C2=CN=C(C=C2)NC3=NC=C4C=C5C(=O)NCC6(N5C4=N3)CCCCC6,PHASE2,urinary_system_disease
4324,Anlotinib|RCC,Anlotinib,CC1=CC2=C(N1)C=CC(=C2F)OC3=C4C=C(C(=CC4=NC=C3)OCC5(CC5)N)OC,PHASE2,urinary_system_disease
4325,Locally Advanced or Metastatic Urothelial Cell Carcinoma|Urinary Bladder Disease|Urological Diseases,Docetaxel,CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O,PHASE1|PHASE2,urinary_system_disease
4326,Kidney Cancer,Perflutren,C(C(F)(F)F)(C(F)(F)F)(F)F,PHASE2,urinary_system_disease
4327,Advanced Clear Cell Renal Cell Carcinoma,Axitinib,CNC(=O)C1=CC=CC=C1SC2=CC3=C(C=C2)C(=NN3)C=CC4=CC=CC=N4,PHASE2,urinary_system_disease
4328,Advanced Clear Cell Renal Cell Carcinoma,Palbociclib,CC1=C(C(=O)N(C2=NC(=NC=C12)NC3=NC=C(C=C3)N4CCNCC4)C5CCCC5)C(=O)C,PHASE2,urinary_system_disease
4329,Acute Myeloid Leukemia in Remission|de Novo Myelodysplastic Syndrome|Fanconi Anemia|Previously Treated Myelodysplastic Syndrome,Mycophenolate,CC1=C2COC(=O)C2=C(C(=C1OC)CC=C(C)CCC(=O)O)O,PHASE2,urinary_system_disease
4330,Inflammatory Disease,Lanraplenib,C1CN(CCN1C2COC2)C3=CC=C(C=C3)NC4=NC(=CN5C4=NC=C5)C6=CN=CC(=N6)N,PHASE1,urinary_system_disease
4331,IGA Nephropathy,Fostamatinib,CC1(C(=O)N(C2=C(O1)C=CC(=N2)NC3=NC(=NC=C3F)NC4=CC(=C(C(=C4)OC)OC)OC)COP(=O)(O)O)C,PHASE2,urinary_system_disease
4332,"Infections, Bacterial",Gepotidacin,C1CC2=CC(=NC=C2OC1)CNC3CCN(CC3)CC4CN5C(=O)C=CC6=C5N4C(=O)C=N6,PHASE1,urinary_system_disease
4333,IgA Nephropathy|Immunoglobulin A Nephropathy,Atrasentan,CCCCN(CCCC)C(=O)CN1CC(C(C1C2=CC=C(C=C2)OC)C(=O)O)C3=CC4=C(C=C3)OCO4,PHASE2,urinary_system_disease
4334,Renal Impairment,Lorcaserin,CC1CNCCC2=C1C=C(C=C2)Cl,PHASE1,urinary_system_disease
4335,Urinary Bladder Neoplasms,Lenalidomide,C1CC(=O)NC(=O)C1N2CC3=C(C2=O)C=CC=C3N,PHASE1|PHASE2,urinary_system_disease
4336,Cancer|Cisplatin Adverse Reaction,Gemigliptin,C1CC(CN(C1=O)CC(CC(=O)N2CCC3=C(C2)N=C(N=C3C(F)(F)F)C(F)(F)F)N)(F)F,PHASE2|PHASE3,urinary_system_disease
4337,Complicated Urinary Tract Infection|Pyelonephritis,Ceftolozane,CC(C)(C(=O)O)ON=C(C1=NSC(=N1)N)C(=O)NC2C3N(C2=O)C(=C(CS3)C[N+]4=CC(=C(N4C)N)NC(=O)NCCN)C(=O)[O-],PHASE2,urinary_system_disease
4338,Complicated Urinary Tract Infection|Pyelonephritis,Tazobactam,CC1(C(N2C(S1(=O)=O)CC2=O)C(=O)O)CN3C=CN=N3,PHASE2,urinary_system_disease
4339,Complicated Urinary Tract Infection|Pyelonephritis,Meropenem,CC1C2C(C(=O)N2C(=C1SC3CC(NC3)C(=O)N(C)C)C(=O)O)C(C)O,PHASE2,urinary_system_disease
4340,Neurogenic Detrusor Overactivity,Fesoterodine,CC(C)C(=O)OC1=C(C=C(C=C1)CO)C(CCN(C(C)C)C(C)C)C2=CC=CC=C2,PHASE1,urinary_system_disease
4341,"Advanced Solid Tumors|Solid Tumor|Solid Carcinoma|Solid Tumor, Adult|ccRCC|RCC, Clear Cell Adenocarcinoma|RCC|Kidney Cancer|Clear Cell Renal Cell Carcinoma|Renal Cell Carcinoma, Metastatic|Renal Cell Carcinoma Recurrent|Renal Cell Carcinoma, Clear Cell Adenocarcinoma|Glioblastoma|Glioblastoma, Adult|GBM|Glioblastoma Multiforme",Belzutifan,CS(=O)(=O)C1=C2C(C(C(C2=C(C=C1)OC3=CC(=CC(=C3)C#N)F)F)F)O,PHASE1,urinary_system_disease
4342,"Clinical Trial, Phase I",Fulacimstat,CN1C2=C(C=C(C=C2)N3C=C(C(=O)N(C3=O)C4CCC5=C4C=CC=C5C(F)(F)F)C(=O)O)OC1=O,PHASE1,urinary_system_disease
4343,Healthy|Renal Impairment,Lacosamide,CC(=O)NC(COC)C(=O)NCC1=CC=CC=C1,PHASE1,urinary_system_disease
4344,"Kidney Failure, Acute",Erythropoietin,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NN=N[N-]4)CO)Cl.[K+],PHASE2|PHASE3,urinary_system_disease
4345,Acute Kidney Injury,Levosimendan,CC1CC(=O)NN=C1C2=CC=C(C=C2)NN=C(C#N)C#N,PHASE2|PHASE3,urinary_system_disease
4346,Acute Kidney Injury,Simendan,CC1CC(=O)NN=C1C2=CC=C(C=C2)NN=C(C#N)C#N,PHASE2|PHASE3,urinary_system_disease
4347,End Stage Renal Disease,Cholecalciferol,CC(C)CCCC(C)C1CCC2C1(CCCC2=CC=C3CC(CCC3=C)O)C,PHASE2|PHASE3,urinary_system_disease
4348,Urinary Tract Infections|Bladder Cancer|Urologic Surgical Procedures,Fosfomycin,CC1C(O1)P(=O)(O)O,PHASE2,urinary_system_disease
4349,Urinary Tract Infections|Bladder Cancer|Urologic Surgical Procedures,Tromethamine,C(C(CO)(CO)N)O,PHASE2,urinary_system_disease
4350,Urinary Tract Infections|Bladder Cancer|Urologic Surgical Procedures,Amikacin,C1C(C(C(C(C1NC(=O)C(CCN)O)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(C(C(C(O3)CN)O)O)O)N,PHASE2,urinary_system_disease
4351,Hepatorenal Syndrome|Acute Kidney Injury,Terlipressin,C1CC(N(C1)C(=O)C2CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N2)CC(=O)N)CCC(=O)N)CC3=CC=CC=C3)CC4=CC=C(C=C4)O)NC(=O)CNC(=O)CNC(=O)CN)C(=O)NC(CCCCN)C(=O)NCC(=O)N,PHASE2,urinary_system_disease
4352,"Leukemia|Lymphoma|Hodgkin's Disease|Hematologic Neoplasms|Multiple Myeloma|Carcinoma, Renal Cell",Pentostatin,C1C(C(OC1N2C=NC3=C2NC=NCC3O)CO)O,PHASE2,urinary_system_disease
4353,Urinary Tract Infection,Nitrofurantoin,C1C(=O)NC(=O)N1N=CC2=CC=C(O2)[N+](=O)[O-],PHASE2,urinary_system_disease
4354,Recurrent Bladder Urothelial Carcinoma|Recurrent Renal Pelvis Urothelial Carcinoma|Recurrent Ureter Urothelial Carcinoma|Recurrent Urethral Urothelial Carcinoma|Stage 0a Bladder Cancer AJCC v8|Stage 0a Renal Pelvis Cancer AJCC v8|Stage 0a Ureter Cancer AJCC v8|Stage 0a Urethral Cancer AJCC v8|Stage 0is Bladder Cancer AJCC v8|Stage 0is Renal Pelvis Cancer AJCC v8|Stage 0is Ureter Cancer AJCC v8|Stage 0is Urethral Cancer AJCC v8|Stage II Bladder Cancer AJCC v8|Stage II Renal Pelvis Cancer AJCC v8|Stage II Ureter Cancer AJCC v8|Stage II Urethral Cancer AJCC v8|Stage III Renal Pelvis Cancer AJCC v8|Stage III Ureter Cancer AJCC v8|Stage III Urethral Cancer AJCC v8|Stage IIIA Bladder Cancer AJCC v8,Erlotinib,COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC,PHASE2,urinary_system_disease
4355,Nephrotic Syndrome,Enoxaparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,PHASE2|PHASE3,urinary_system_disease
4356,Lupus Nephritis,Ixazomib,B(C(CC(C)C)NC(=O)CNC(=O)C1=C(C=CC(=C1)Cl)Cl)(O)O,PHASE1,urinary_system_disease
4357,HIV Infections|Kidney Disease,Zidovudine,CC1=CN(C(=O)NC1=O)C2CC(C(O2)CO)N=[N+]=[N-],PHASE1,urinary_system_disease
4358,Renal Cell Carcinoma|Kidney Cancer,Capecitabine,CCCCCOC(=O)NC1=NC(=O)N(C=C1F)C2C(C(C(O2)C)O)O,PHASE2,urinary_system_disease
4359,Clear Cell Renal Cell Carcinoma,Dovitinib,CN1CCN(CC1)C2=CC3=C(C=C2)N=C(N3)C4=C(C5=C(C=CC=C5F)NC4=O)N,PHASE2,urinary_system_disease
4360,Hypertension|Chronic Kidney Disease|Nephrotic Syndrome,Valsartan,CCCCC(=O)N(CC1=CC=C(C=C1)C2=CC=CC=C2C3=NNN=N3)C(C(C)C)C(=O)O,PHASE1,urinary_system_disease
4361,"Renal Insufficiency, Chronic",Beraprost,CC#CCC(C)C(C=CC1C(CC2C1C3=CC=CC(=C3O2)CCCC(=O)O)O)O,PHASE2,urinary_system_disease
4362,Insomnia,Suvorexant,CC1CCN(CCN1C(=O)C2=C(C=CC(=C2)C)N3N=CC=N3)C4=NC5=C(O4)C=CC(=C5)Cl,PHASE1,urinary_system_disease
4363,Healthy|Renal Impairment,Quinine,COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O,PHASE1,urinary_system_disease
4364,"Urinary Bladder Neoplasms|Receptors, Fibroblast Growth Factor",Erdafitinib,CC(C)NCCN(C1=CC2=NC(=CN=C2C=C1)C3=CN(N=C3)C)C4=CC(=CC(=C4)OC)OC,PHASE1,urinary_system_disease
4365,Hepatorenal Syndrome,Ifetroban,CCCCCNC(=O)C1=COC(=N1)C2C3CCC(C2CC4=CC=CC=C4CCC(=O)O)O3,PHASE2,urinary_system_disease
4366,Benign Prostatic Hyperplasia|Lower Urinary Tract Symptoms,Talaporfin,CCC1=C(C2=CC3=C(C(=C(N3)C=C4C(C(C(=N4)C(=C5C(=C(C(=N5)C=C1N2)C)C(=O)O)CC(=O)NC(CC(=O)O)C(=O)O)CCC(=O)O)C)C)C=C)C,PHASE1,urinary_system_disease
4367,Hematopoietic and Lymphoid System Neoplasm|Recurrent Ependymoma|Recurrent Ewing Sarcoma|Recurrent Hepatoblastoma|Recurrent Histiocytic and Dendritic Cell Neoplasm|Recurrent Langerhans Cell Histiocytosis|Recurrent Lymphoma|Recurrent Malignant Germ Cell Tumor|Recurrent Malignant Glioma|Recurrent Malignant Solid Neoplasm|Recurrent Medulloblastoma|Recurrent Neuroblastoma|Recurrent Non-Hodgkin Lymphoma|Recurrent Osteosarcoma|Recurrent Peripheral Primitive Neuroectodermal Tumor|Recurrent Rhabdoid Tumor|Recurrent Rhabdomyosarcoma|Recurrent Soft Tissue Sarcoma|Recurrent WHO Grade 2 Glioma|Refractory Ependymoma|Refractory Ewing Sarcoma|Refractory Hepatoblastoma|Refractory Histiocytic and Dendritic Cell Neoplasm|Refractory Langerhans Cell Histiocytosis|Refractory Lymphoma|Refractory Malignant Germ Cell Tumor|Refractory Malignant Glioma|Refractory Malignant Solid Neoplasm|Refractory Medulloblastoma|Refractory Neuroblastoma|Refractory Non-Hodgkin Lymphoma|Refractory Osteosarcoma|Refractory Peripheral Primitive Neuroectodermal Tumor|Refractory Rhabdoid Tumor|Refractory Rhabdomyosarcoma|Refractory Soft Tissue Sarcoma|Refractory WHO Grade 2 Glioma|Wilms Tumor,Selpercatinib,CC(C)(COC1=CN2C(=C(C=N2)C#N)C(=C1)C3=CN=C(C=C3)N4CC5CC(C4)N5CC6=CN=C(C=C6)OC)O,PHASE2,urinary_system_disease
4368,"Carcinoma, Renal Cell|Glioblastoma|Carcinoma, Hepatocellular",Crizotinib,CC(C1=C(C=CC(=C1Cl)F)Cl)OC2=C(N=CC(=C2)C3=CN(N=C3)C4CCNCC4)N,PHASE1,urinary_system_disease
4369,Clear Cell Renal Cell Carcinoma|Locally Advanced Pancreatic Cancer|Locally Advanced Malignant Solid Neoplasm|Metastatic Malignant Solid Neoplasm|Metastatic Renal Cell Carcinoma|Metastatic Urothelial Carcinoma|Metastatic Pancreatic Cancer|Stage III Pancreatic Cancer|Stage III Renal Cell Cancer|Stage IV Pancreatic Cancer|Stage IV Renal Cell Cancer|Endometrial Cancer|Metastatic Castration-resistant Prostate Cancer,Ceralasertib,CC1COCCN1C2=NC(=NC(=C2)C3(CC3)S(=N)(=O)C)C4=C5C=CNC5=NC=C4,PHASE2,urinary_system_disease
4370,Clear Cell Renal Cell Carcinoma|Locally Advanced Pancreatic Cancer|Locally Advanced Malignant Solid Neoplasm|Metastatic Malignant Solid Neoplasm|Metastatic Renal Cell Carcinoma|Metastatic Urothelial Carcinoma|Metastatic Pancreatic Cancer|Stage III Pancreatic Cancer|Stage III Renal Cell Cancer|Stage IV Pancreatic Cancer|Stage IV Renal Cell Cancer|Endometrial Cancer|Metastatic Castration-resistant Prostate Cancer,Olaparib,C1CC1C(=O)N2CCN(CC2)C(=O)C3=C(C=CC(=C3)CC4=NNC(=O)C5=CC=CC=C54)F,PHASE2,urinary_system_disease
4371,Phase 1|Healthy|Benign Prostatic Hyperplasia|Lower Urinary Tract Symptoms,Tamsulosin,CCOC1=CC=CC=C1OCCNC(C)CC2=CC(=C(C=C2)OC)S(=O)(=O)N,PHASE1,urinary_system_disease
4372,Phase 1|Healthy|Benign Prostatic Hyperplasia|Lower Urinary Tract Symptoms,Solifenacin,C1CN2CCC1C(C2)OC(=O)N3CCC4=CC=CC=C4C3C5=CC=CC=C5,PHASE1,urinary_system_disease
4373,Secondary Hyperparathyroidism,Cinacalcet,CC(C1=CC=CC2=CC=CC=C21)NCCCC3=CC(=CC=C3)C(F)(F)F,PHASE2|PHASE3,urinary_system_disease
4374,Renal Impairment,Surufatinib,CC1=CC2=C(N1)C=CC(=C2)OC3=NC(=NC=C3)NC4=CC=CC(=C4)CS(=O)(=O)NCCN(C)C,PHASE1,urinary_system_disease
4375,Kidney Transplantation|Primary Focal Segmental Glomerulosclerosis (FSGS),Methylprednisone,CC1CC2C3CCC4=CC(=O)C=CC4(C3C(=O)CC2(C1(C(=O)CO)O)C)C,PHASE2,urinary_system_disease
4376,Kidney Transplantation|Primary Focal Segmental Glomerulosclerosis (FSGS),Prednisone,CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C,PHASE2,urinary_system_disease
4377,Healthy|Renal Insufficiency,Rivaroxaban,C1COCC(=O)N1C2=CC=C(C=C2)N3CC(OC3=O)CNC(=O)C4=CC=C(S4)Cl,PHASE1,urinary_system_disease
4378,Healthy|Renal Insufficiency,Erythromycin,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)O)(C)O,PHASE1,urinary_system_disease
4379,"Nephrolithiasis, Calcium Oxalate|Nephrolithiasis, Calcium Phosphate",Tolvaptan,CC1=CC=CC=C1C(=O)NC2=CC(=C(C=C2)C(=O)N3CCCC(C4=C3C=CC(=C4)Cl)O)C,PHASE1,urinary_system_disease
4380,Clear Cell Papillary Renal Neoplasm|Collecting Duct Carcinoma|Hereditary Leiomyomatosis and Renal Cell Carcinoma|Hereditary Papillary Renal Cell Carcinoma|Metastatic Renal Cell Carcinoma|Metastatic Unclassified Renal Cell Carcinoma|Papillary Renal Cell Carcinoma|Stage III Renal Cell Cancer American Joint Committee on Cancer (AJCC) v8|Stage IV Renal Cell Cancer AJCC v8|Tubulocystic Renal Cell Carcinoma|Unresectable Renal Cell Carcinoma,Pamiparib,CC12CCCN1CC3=NNC(=O)C4=C5C3=C2NC5=CC(=C4)F,PHASE2,urinary_system_disease
4381,Clear Cell Papillary Renal Neoplasm|Collecting Duct Carcinoma|Hereditary Leiomyomatosis and Renal Cell Carcinoma|Hereditary Papillary Renal Cell Carcinoma|Metastatic Renal Cell Carcinoma|Metastatic Unclassified Renal Cell Carcinoma|Papillary Renal Cell Carcinoma|Stage III Renal Cell Cancer American Joint Committee on Cancer (AJCC) v8|Stage IV Renal Cell Cancer AJCC v8|Tubulocystic Renal Cell Carcinoma|Unresectable Renal Cell Carcinoma,Temozolomide,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N,PHASE2,urinary_system_disease
4382,Chronic Kidney Diseases,Baricitinib,CCS(=O)(=O)N1CC(C1)(CC#N)N2C=C(C=N2)C3=C4C=CNC4=NC=N3,PHASE2,urinary_system_disease
4383,Stress Urinary Incontinence|Fecal Incontinence,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,PHASE1,urinary_system_disease
4384,Stress Urinary Incontinence|Fecal Incontinence,Reboxetine,CCOC1=CC=CC=C1OC(C2CNCCO2)C3=CC=CC=C3,PHASE1,urinary_system_disease
4385,Chronic Kidney Disease,Isoquercetin,C1=CC(=C(C=C1C2=C(C(=O)C3=C(C=C(C=C3O2)O)O)OC4C(C(C(C(O4)CO)O)O)O)O)O,PHASE2,urinary_system_disease
4386,Interstitial Cystitis|Bladder Pain Syndrome,Cannabidiol,CCCCCC1=CC(=C(C(=C1)O)C2C=C(CCC2C(=C)C)C)O,PHASE1,urinary_system_disease
4387,Heart Failure,Finerenone,CCOC1=NC=C(C2=C1C(C(=C(N2)C)C(=O)N)C3=C(C=C(C=C3)C#N)OC)C,PHASE2,urinary_system_disease
4388,Heart Failure,Eplerenone,CC12CCC(=O)C=C1CC(C3C24C(O4)CC5(C3CCC56CCC(=O)O6)C)C(=O)OC,PHASE2,urinary_system_disease
4389,Chronic Kidney Disease,Runcaciguat,CC(C(C1=CC=C(C=C1)Cl)C(=O)NC2=C(C=CC(=C2)C(CC(=O)O)C3CC3)Cl)C(F)(F)F,PHASE1,urinary_system_disease
4390,Interstitial Cystitis|Bladder Pain Syndrome,Lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C,PHASE2,urinary_system_disease
4391,"Kidney Failure, Chronic|Prediabetic State",Liraglutide,CCCCCCCCCCCCCCCC(=O)NC(CCC(=O)NCCCCC(C(=O)NC(CCC(=O)O)C(=O)NC(CC1=CC=CC=C1)C(=O)NC(C(C)CC)C(=O)NC(C)C(=O)NC(CC2=CNC3=CC=CC=C32)C(=O)NC(CC(C)C)C(=O)NC(C(C)C)C(=O)NC(CCCNC(=N)N)C(=O)NCC(=O)NC(CCCNC(=N)N)C(=O)NCC(=O)O)NC(=O)C(C)NC(=O)C(C)NC(=O)C(CCC(=O)N)NC(=O)CNC(=O)C(CCC(=O)O)NC(=O)C(CC(C)C)NC(=O)C(CC4=CC=C(C=C4)O)NC(=O)C(CO)NC(=O)C(CO)NC(=O)C(C(C)C)NC(=O)C(CC(=O)O)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C(CC5=CC=CC=C5)NC(=O)C(C(C)O)NC(=O)CNC(=O)C(CCC(=O)O)NC(=O)C(C)NC(=O)C(CC6=CN=CN6)N)C(=O)O,PHASE2,urinary_system_disease
4392,End Stage Renal Disease,Escitalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,PHASE2,urinary_system_disease
4393,Clear Cell Renal Cell Carcinoma,Sitravatinib,COCCNCC1=CN=C(C=C1)C2=CC3=NC=CC(=C3S2)OC4=C(C=C(C=C4)NC(=O)C5(CC5)C(=O)NC6=CC=C(C=C6)F)F,PHASE2,urinary_system_disease
4394,Chronic Kidney Disease,Dasatinib,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=CC(=NC(=N3)C)N4CCN(CC4)CCO,PHASE2,urinary_system_disease
4395,Chronic Kidney Disease,Quercetin,C1=CC(=C(C=C1C2=C(C(=O)C3=C(C=C(C=C3O2)O)O)O)O)O,PHASE2,urinary_system_disease
4396,Urinary Tract Infections|Urinary Retention Postoperative|Pelvic Organ Prolapse,Methenamine,C1N2CN3CN1CN(C2)C3,PHASE2,urinary_system_disease
4397,IGA Nephropathy,Budesonide,CCCC1OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C,PHASE2,urinary_system_disease
4398,Renal Cell Carcinoma,Ranitidine,CNC(=C[N+](=O)[O-])NCCSCC1=CC=C(O1)CN(C)C,PHASE2,urinary_system_disease
4399,Clear Cell Renal Cell Carcinoma|Clear Cell Renal Cell Carcinoma Metastatic,Selenomethionine,C[Se]CCC(C(=O)O)N,PHASE1|PHASE2,urinary_system_disease
4400,Metastatic Renal Cell Carcinoma|Fumarate Hydratase Deficient Renal Cell Carcinoma|Succinate Dehydrogenase Deficient Renal Cell Carcinoma,Talazoparib,CN1C(=NC=N1)C2C(NC3=CC(=CC4=C3C2=NNC4=O)F)C5=CC=C(C=C5)F,PHASE2,urinary_system_disease
4401,Wilms Tumor,Topotecan,CCC1(C2=C(COC1=O)C(=O)N3CC4=CC5=C(C=CC(=C5CN(C)C)O)N=C4C3=C2)O,PHASE2,urinary_system_disease
4402,Wilms Tumor,Pegfilgrastim,CC(C(C(=O)O)N)OC1C(C(C(C(O1)COC2(CC(C(C(O2)C(C(CO)O)O)NC(=O)CNC(=O)OCCOC)O)C(=O)O)O)O)NC(=O)C,PHASE2,urinary_system_disease
4403,Contrast-induced Nephropathy,Iohexol,CC(=O)N(CC(CO)O)C1=C(C(=C(C(=C1I)C(=O)NCC(CO)O)I)C(=O)NCC(CO)O)I,PHASE2,urinary_system_disease
4404,Renal Disease,Sugammadex,C(CSCC1C2C(C(C(O1)OC3C(OC(C(C3O)O)OC4C(OC(C(C4O)O)OC5C(OC(C(C5O)O)OC6C(OC(C(C6O)O)OC7C(OC(C(C7O)O)OC8C(OC(C(C8O)O)OC9C(OC(O2)C(C9O)O)CSCCC(=O)O)CSCCC(=O)O)CSCCC(=O)O)CSCCC(=O)O)CSCCC(=O)O)CSCCC(=O)O)CSCCC(=O)O)O)O)C(=O)O,PHASE1,urinary_system_disease
4405,Pediatric Solid Tumor|Osteosarcoma|Rhabdomyosarcoma|Neuroblastoma|Ewing Sarcoma|Wilms Tumor|Adrenocortical Cancer|Desmoplastic Small Round Cell Tumor|Germ Cell Cancer|Rhabdoid Tumor|Clear Cell Sarcoma|Hepatoblastoma|Melanoma|Carcinoma|Malignant Peripheral Nerve Sheath Tumors|Soft Tissue Sarcoma,Mesna,C(CS(=O)(=O)[O-])S.[Na+],PHASE1,urinary_system_disease
4406,"Urinary Bladder, Overactive",Vibegron,C1CC(NC1CC2=CC=C(C=C2)NC(=O)C3CCC4=NC=CC(=O)N34)C(C5=CC=CC=C5)O,PHASE2,urinary_system_disease
4407,Urothelial Carcinoma|Bladder Cancer,Abiraterone,CC12CCC(CC1=CCC3C2CCC4(C3CC=C4C5=CN=CC=C5)C)O,PHASE2,urinary_system_disease
4408,Urothelial Carcinoma|Bladder Cancer,Methotrexate,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,PHASE2,urinary_system_disease
4409,Urothelial Carcinoma|Bladder Cancer,Vinblastine,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O,PHASE2,urinary_system_disease
4410,Urinary Tract Infections,Ceftaroline,CCON=C(C1=NSC(=N1)NP(=O)(O)O)C(=O)NC2C3N(C2=O)C(=C(CS3)SC4=NC(=CS4)C5=CC=[N+](C=C5)C)C(=O)[O-],PHASE2,urinary_system_disease
4411,Urinary Tract Infections,Doripenem,CC1C2C(C(=O)N2C(=C1SC3CC(NC3)CNS(=O)(=O)N)C(=O)O)C(C)O,PHASE2,urinary_system_disease
4412,"Bladder Cancer|Carcinoma, Transitional Cell|Renal Pelvis Cancer|Ureter Cancer|Urethra Cancer",Enzalutamide,CC1(C(=O)N(C(=S)N1C2=CC(=C(C=C2)C(=O)NC)F)C3=CC(=C(C=C3)C#N)C(F)(F)F)C,PHASE1,urinary_system_disease
4413,Renal Impairment,Tavapadon,CC1=C(C=CC(=C1)OC2=C(C=CC=N2)C(F)(F)F)C3=C(C(=O)NC(=O)N3C)C,PHASE1,urinary_system_disease
4414,Bladder Neoplasms,Apaziquone,CN1C(=C(C2=C1C(=O)C=C(C2=O)N3CC3)CO)C=CCO,PHASE2,urinary_system_disease
4415,Chronic Kidney Disease,Flucloxacillin,CC1=C(C(=NO1)C2=C(C=CC=C2Cl)F)C(=O)NC3C4N(C3=O)C(C(S4)(C)C)C(=O)O,PHASE1,urinary_system_disease
4416,Chronic Kidney Disease,Floxacillin,CC1=C(C(=NO1)C2=C(C=CC=C2Cl)F)C(=O)NC3C4N(C3=O)C(C(S4)(C)C)C(=O)O,PHASE1,urinary_system_disease
4417,Acute Urinary Retention,Alfuzosin,CN(CCCNC(=O)C1CCCO1)C2=NC3=CC(=C(C=C3C(=N2)N)OC)OC,PHASE2,urinary_system_disease
4418,Autosomal Dominant Polycystic Kidney|ADPKD,Tesevatinib,CN1CC2CC(CC2C1)COC3=C(C=C4C(=C3)N=CN=C4NC5=C(C(=C(C=C5)Cl)Cl)F)OC,PHASE2,urinary_system_disease
4419,Lupus Nephritis,Iptacopan,CCOC1CCN(C(C1)C2=CC=C(C=C2)C(=O)O)CC3=C(C=C(C4=C3C=CN4)C)OC,PHASE2,urinary_system_disease
4420,Staphylococcal Skin Infections|Streptococcal Infections,Ceftobiprole,C1CNCC1N2CCC(=CC3=C(N4C(C(C4=O)NC(=O)C(=NO)C5=NSC(=N5)N)SC3)C(=O)O)C2=O,PHASE1,urinary_system_disease
4421,"Kidney Failure, Chronic",Sevelamer,C=CCN.C1C(O1)CCl,PHASE2,urinary_system_disease
4422,Renal Cell Carcinoma Metastatic,Abemaciclib,CCN1CCN(CC1)CC2=CN=C(C=C2)NC3=NC=C(C(=N3)C4=CC5=C(C(=C4)F)N=C(N5C(C)C)C)F,PHASE1,urinary_system_disease
4423,Schistosomiasis Haematobia,Artesunate,CC1CCC2C(C(OC3C24C1CCC(O3)(OO4)C)OC(=O)CCC(=O)O)C,PHASE2,urinary_system_disease
4424,Schistosomiasis Haematobia,Pyronaridine,COC1=NC2=C(C3=C(C=C(C=C3)Cl)N=C2C=C1)NC4=CC(=C(C(=C4)CN5CCCC5)O)CN6CCCC6,PHASE2,urinary_system_disease
4425,Schistosomiasis Haematobia,Artemether,CC1CCC2C(C(OC3C24C1CCC(O3)(OO4)C)OC)C,PHASE2,urinary_system_disease
4426,Schistosomiasis Haematobia,Lumefantrine,CCCCN(CCCC)CC(C1=CC(=CC2=C1C3=C(C2=CC4=CC=C(C=C4)Cl)C=C(C=C3)Cl)Cl)O,PHASE2,urinary_system_disease
4427,Schistosomiasis Haematobia,Artefenomel,C1CC2(CCC1C3=CC=C(C=C3)OCCN4CCOCC4)OC5(C6CC7CC(C6)CC5C7)OO2,PHASE2,urinary_system_disease
4428,Ewing Sarcoma|Rhabdomyosarcoma|Wilms Tumor|Neuroblastoma|Hepatoblastoma|Germ Cell Tumor,Vorinostat,C1=CC=C(C=C1)NC(=O)CCCCCCC(=O)NO,PHASE1,urinary_system_disease
4429,Sickle Cell Disease|Sickle Cell Nephropathy,Voxelotor,CC(C)N1C(=CC=N1)C2=C(C=CC=N2)COC3=CC=CC(=C3C=O)O,PHASE1|PHASE2,urinary_system_disease
4430,Wilms Tumor,Vincristine,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O,PHASE1|PHASE2,urinary_system_disease
4431,Wilms Tumor,Etoposide,CC1OCC2C(O1)C(C(C(O2)OC3C4COC(=O)C4C(C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)O)OC)O)O,PHASE1|PHASE2,urinary_system_disease
4432,"Glomerulonephritis, IGA|Nephropathy, IGA|IGA Nephropathy",Sirolimus,CC1CCC2CC(C(=CC=CC=CC(CC(C(=O)C(C(C(=CC(C(=O)CC(OC(=O)C3CCCCN3C(=O)C(=O)C1(O2)O)C(C)CC4CCC(C(C4)OC)O)C)C)O)OC)C)C)C)OC,PHASE2,urinary_system_disease
4433,Fanconi Anemia|Severe Marrow Failure|Myelodysplastic Syndrome (MDS)|Acute Myelogenous Leukemia (AML),Busulfan,CS(=O)(=O)OCCCCOS(=O)(=O)C,PHASE2,urinary_system_disease
4434,Kidney Cancer,Carfilzomib,CC(C)CC(C(=O)C1(CO1)C)NC(=O)C(CC2=CC=CC=C2)NC(=O)C(CC(C)C)NC(=O)C(CCC3=CC=CC=C3)NC(=O)CN4CCOCC4,PHASE2,urinary_system_disease
4435,Renal Cell Carcinoma,Perifosine,CCCCCCCCCCCCCCCCCCOP(=O)([O-])OC1CC[N+](CC1)(C)C,PHASE2,urinary_system_disease
4436,Renal Cell Carcinoma,Ixabepilone,CC1CCCC2(C(O2)CC(NC(=O)CC(C(C(=O)C(C1O)C)(C)C)O)C(=CC3=CSC(=N3)C)C)C,PHASE2,urinary_system_disease
4437,Chronic Kidney Disease|End Stage Renal Disease|Anemia,Roxadustat,CC1=C2C=C(C=CC2=C(C(=N1)C(=O)NCC(=O)O)O)OC3=CC=CC=C3,PHASE2,urinary_system_disease
4438,Bladder Cancer,Propranolol,CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O,PHASE2,urinary_system_disease
4439,Fecal Incontinence|Accidental Bowel Leakage|Anal Incontinence|Diarrhea|Urge Incontinence,Eluxadoline,CC1=CC(=CC(=C1CC(C(=O)N(CC2=CC(=C(C=C2)OC)C(=O)O)C(C)C3=NC=C(N3)C4=CC=CC=C4)N)C)C(=O)N,PHASE2,urinary_system_disease
4440,"Neoplasm, Ureter|Neoplasm, Bladder",Epirubicin,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)N)O,PHASE2,urinary_system_disease
4441,End Stage Renal Disease,Vancomycin,CC1C(C(CC(O1)OC2C(C(C(OC2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)C(C(C(=O)NC(C(=O)NC5C(=O)NC7C8=CC(=C(C=C8)O)C9=C(C=C(C=C9O)O)C(NC(=O)C(C(C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)CC(=O)N)NC(=O)C(CC(C)C)NC)O)Cl)CO)O)O)(C)N)O,PHASE2,urinary_system_disease
4442,Acute Kidney Injury,Deferoxamine,CC(=O)N(CCCCCNC(=O)CCC(=O)N(CCCCCNC(=O)CCC(=O)N(CCCCCN)O)O)O,PHASE2,urinary_system_disease
4443,Stage I Bladder Cancer|Stage II Bladder Cancer|Stage III Bladder Cancer,Catechin,C1C(C(OC2=CC(=CC(=C21)O)O)C3=CC(=C(C=C3)O)O)O,PHASE2,urinary_system_disease
4444,Stage I Bladder Cancer|Stage II Bladder Cancer|Stage III Bladder Cancer,Cianidanol,C1C(C(OC2=CC(=CC(=C21)O)O)C3=CC(=C(C=C3)O)O)O,PHASE2,urinary_system_disease
4445,Secondary Hyperparathyroidism,Etelcalcetide,CC(C(=O)NC(CCCN=C(N)N)C(=O)N)NC(=O)C(CCCN=C(N)N)NC(=O)C(CCCN=C(N)N)NC(=O)C(CCCN=C(N)N)NC(=O)C(C)NC(=O)C(CSSCC(C(=O)O)N)NC(=O)C,PHASE2,urinary_system_disease
4446,Migraine,Lasmiditan,CN1CCC(CC1)C(=O)C2=NC(=CC=C2)NC(=O)C3=C(C=C(C=C3F)F)F,PHASE1,urinary_system_disease
4447,Urothelial Carcinoma of the Urinary Bladder,Cabazitaxel,CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)OC)C)OC,PHASE1|PHASE2,urinary_system_disease
4448,Renal Failure,Midazolam,CC1=NC=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4F,PHASE1,urinary_system_disease
4449,"Diabetic Kidney Disease|Diabetes Mellitus, Type 2|Diabetic Nephropathies",Acetylcysteine,CC(=O)NC(CS)C(=O)O,PHASE2|PHASE3,urinary_system_disease
4450,Sickle Cell Disease,Hydroxycarbamide,C(=O)(N)NO,PHASE2,urinary_system_disease
4451,Sickle Cell Disease,Hydroxyurea,C(=O)(N)NO,PHASE2,urinary_system_disease
4452,Retroperitoneal Fibrosis,Tamoxifen,CCC(=C(C1=CC=CC=C1)C2=CC=C(C=C2)OCCN(C)C)C3=CC=CC=C3,PHASE2,urinary_system_disease
4453,Renal Cell Carcinoma,Folate,C1=CC(=CC=C1C(=O)NC(CCC(=O)O)C(=O)O)NCC2=CN=C3C(=N2)C(=O)NC(=N3)N,PHASE2,urinary_system_disease
4454,Kidney Disease,Losartan,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl,PHASE1,urinary_system_disease
4455,Kidney Disease,Eprosartan,CCCCC1=NC=C(N1CC2=CC=C(C=C2)C(=O)O)C=C(CC3=CC=CS3)C(=O)O,PHASE1,urinary_system_disease
4456,Type 2 Diabetes Mellitus|Chronic Kidney Diseases,Cotadutide,CCCCCCCCCCCCCCCC(=O)NC(CCC(=O)NCCCCC(C(=O)NC(CO)C(=O)NC(CCC(=O)O)C(=O)NC(CC1=CC=C(C=C1)O)C(=O)NC(CC(C)C)C(=O)NC(CC(=O)O)C(=O)NC(CO)C(=O)NC(CCC(=O)O)C(=O)NC(CCCNC(=N)N)C(=O)NC(C)C(=O)NC(CCCNC(=N)N)C(=O)NC(CC(=O)O)C(=O)NC(CC2=CC=CC=C2)C(=O)NC(C(C)C)C(=O)NC(C)C(=O)NC(CC3=CNC4=CC=CC=C43)C(=O)NC(CC(C)C)C(=O)NC(CCC(=O)O)C(=O)NC(C)C(=O)NCC(=O)NCC(=O)O)NC(=O)C(CC(=O)O)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C(CC5=CC=CC=C5)NC(=O)C(C(C)O)NC(=O)CNC(=O)C(CCC(=O)N)NC(=O)C(CO)NC(=O)C(CC6=CNC=N6)N)C(=O)O,PHASE2,urinary_system_disease
4457,Type 2 Diabetes Mellitus|Chronic Kidney Diseases,Semaglutide,CCC(C)C(C(=O)NC(C)C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(CC(C)C)C(=O)NC(C(C)C)C(=O)NC(CCCNC(=N)N)C(=O)NCC(=O)NC(CCCNC(=N)N)C(=O)NCC(=O)O)NC(=O)C(CC3=CC=CC=C3)NC(=O)C(CCC(=O)O)NC(=O)C(CCCCNC(=O)COCCOCCNC(=O)COCCOCCNC(=O)CCC(C(=O)O)NC(=O)CCCCCCCCCCCCCCCCC(=O)O)NC(=O)C(C)NC(=O)C(C)NC(=O)C(CCC(=O)N)NC(=O)CNC(=O)C(CCC(=O)O)NC(=O)C(CC(C)C)NC(=O)C(CC4=CC=C(C=C4)O)NC(=O)C(CO)NC(=O)C(CO)NC(=O)C(C(C)C)NC(=O)C(CC(=O)O)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C(CC5=CC=CC=C5)NC(=O)C(C(C)O)NC(=O)CNC(=O)C(CCC(=O)O)NC(=O)C(C)(C)NC(=O)C(CC6=CN=CN6)N,PHASE2,urinary_system_disease
4458,Dense Deposit Disease,Sulodexide,CNC1=C2C(=NC=N1)N(C=N2)C3C(C(C(O3)CO)O)OC,PHASE1,urinary_system_disease
4459,Chronic Kidney Disease|End Stage Renal Disease,Metolazone,CC1NC2=CC(=C(C=C2C(=O)N1C3=CC=CC=C3C)S(=O)(=O)N)Cl,PHASE2,urinary_system_disease
4460,Diabetic Nephropathy,Captopril,CC(CS)C(=O)N1CCCC1C(=O)O,PHASE2|PHASE3,urinary_system_disease
4461,Diabetic Nephropathy,Pentoxifylline,CC(=O)CCCCN1C(=O)C2=C(N=CN2C)N(C1=O)C,PHASE2|PHASE3,urinary_system_disease
4462,Lupus Nephritis,Azathioprine,CN1C=NC(=C1SC2=NC=NC3=C2NC=N3)[N+](=O)[O-],PHASE2,urinary_system_disease
4463,Lupus Nephritis,Prednisolone,CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O,PHASE2,urinary_system_disease
4464,Chronic Kidney Diseases,Zibotentan,CC1=CN=C(C(=N1)OC)NS(=O)(=O)C2=C(N=CC=C2)C3=CC=C(C=C3)C4=NN=CO4,PHASE2,urinary_system_disease
4465,Renal Impairment,Lorlatinib,CC1C2=C(C=CC(=C2)F)C(=O)N(CC3=NN(C(=C3C4=CC(=C(N=C4)N)O1)C#N)C)C,PHASE1,urinary_system_disease
4466,Melanoma|Prostate Cancer|Ovarian Cancer|Renal Cell Carcinoma|Colorectal Carcinoma|Pancreatic Carcinoma|Non-small Cell Lung Carcinoma|Solid Tumors|Breast Cancer,Oxaliplatin,C1CCC(C(C1)[NH-])[NH-].C(=O)(C(=O)O)O.[Pt+2],PHASE1,urinary_system_disease
4467,Melanoma|Prostate Cancer|Ovarian Cancer|Renal Cell Carcinoma|Colorectal Carcinoma|Pancreatic Carcinoma|Non-small Cell Lung Carcinoma|Solid Tumors|Breast Cancer,Leucovorin,C1C(N(C2=C(N1)N=C(NC2=O)N)C=O)CNC3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,PHASE1,urinary_system_disease
4468,Melanoma|Prostate Cancer|Ovarian Cancer|Renal Cell Carcinoma|Colorectal Carcinoma|Pancreatic Carcinoma|Non-small Cell Lung Carcinoma|Solid Tumors|Breast Cancer,Fluorouracil,C1=C(C(=O)NC(=O)N1)F,PHASE1,urinary_system_disease
4469,"Myelodysplastic Syndromes|Leukemia, Myelomonocytic, Chronic|Leukemia, Myeloid, Acute|Renal Insufficiency|Liver Disease|Neoplasms",Azacitidine,C1=NC(=NC(=O)N1C2C(C(C(O2)CO)O)O)N,PHASE1,urinary_system_disease
4470,"Myelodysplastic Syndromes|Leukemia, Myelomonocytic, Chronic|Leukemia, Myeloid, Acute|Renal Insufficiency|Liver Disease|Neoplasms",Pevonedistat,C1CC2=CC=CC=C2C1NC3=C4C=CN(C4=NC=N3)C5CC(C(C5)O)COS(=O)(=O)N,PHASE1,urinary_system_disease
4471,Neoplasms|Solid Tumors|Bone Cancer|Kidney Tumor|Neuroblastoma,Ifosfamide,C1CN(P(=O)(OC1)NCCCl)CCCl,PHASE1,urinary_system_disease
4472,Renal Impairment,Lemborexant,CC1=NC(=NC=C1OCC2(CC2C(=O)NC3=NC=C(C=C3)F)C4=CC(=CC=C4)F)C,PHASE1,urinary_system_disease
4473,Hyperkalemia|Resistant Hypertension,Spironolactone,CC(=O)SC1CC2=CC(=O)CCC2(C3C1C4CCC5(C4(CC3)C)CCC(=O)O5)C,PHASE2,urinary_system_disease
4474,End Stage Renal Disease on Hemodialysis,Difelikefalin,CC(C)CC(C(=O)NC(CCCCN)C(=O)N1CCC(CC1)(C(=O)O)N)NC(=O)C(CC2=CC=CC=C2)NC(=O)C(CC3=CC=CC=C3)N,PHASE1,urinary_system_disease
4475,Renal Insufficiency,Exenatide,CCC(C)C(C(=O)NC(CCC(=O)O)C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(CC(C)C)C(=O)NC(CCCCN)C(=O)NC(CC(=O)N)C(=O)NCC(=O)NCC(=O)N3CCCC3C(=O)NC(CO)C(=O)NC(CO)C(=O)NCC(=O)NC(C)C(=O)N4CCCC4C(=O)N5CCCC5C(=O)N6CCCC6C(=O)NC(CO)C(=O)N)NC(=O)C(CC7=CC=CC=C7)NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(C(C)C)NC(=O)C(C)NC(=O)C(CCC(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(CCSC)NC(=O)C(CCC(=O)N)NC(=O)C(CCCCN)NC(=O)C(CO)NC(=O)C(CC(C)C)NC(=O)C(CC(=O)O)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C(CC8=CC=CC=C8)NC(=O)C(C(C)O)NC(=O)CNC(=O)C(CCC(=O)O)NC(=O)CNC(=O)C(CC9=CNC=N9)N,PHASE1,urinary_system_disease
4476,Hepatitis C Virus,Grazoprevir,CC(C)(C)C1C(=O)N2CC(CC2C(=O)NC3(CC3C=C)C(=O)NS(=O)(=O)C4CC4)OC5=NC6=C(C=CC(=C6)OC)N=C5CCCCCC7CC7OC(=O)N1,PHASE2|PHASE3,urinary_system_disease
4477,Hepatitis C Virus,Elbasvir,CC(C)C(C(=O)N1CCCC1C2=NC=C(N2)C3=CC4=C(C=C3)N5C(OC6=C(C5=C4)C=CC(=C6)C7=CN=C(N7)C8CCCN8C(=O)C(C(C)C)NC(=O)OC)C9=CC=CC=C9)NC(=O)OC,PHASE2|PHASE3,urinary_system_disease
4478,Chronic Kidney Disease|Tuberculosis,Rifampin,CC1C=CC=C(C(=O)NC2=C(C(=C3C(=C2O)C(=C(C4=C3C(=O)C(O4)(OC=CC(C(C(C(C(C(C1O)C)O)C)OC(=O)C)C)OC)C)C)O)O)C=NN5CCN(CC5)C)C,PHASE2,urinary_system_disease
4479,Chronic Kidney Disease|Tuberculosis,Rifampicin,CC1C=CC=C(C(=O)NC2=C(C(=C3C(=C2O)C(=C(C4=C3C(=O)C(O4)(OC=CC(C(C(C(C(C(C1O)C)O)C)OC(=O)C)C)OC)C)C)O)O)C=NN5CCN(CC5)C)C,PHASE2,urinary_system_disease
4480,"End-stage Kidney Disease|Kidney Disease, Chronic|Dialysis|Diabetic|Non-diabetic|Kidney Dysfunction|Kidney Failure|Hemodialysis",Empagliflozin,C1COCC1OC2=CC=C(C=C2)CC3=C(C=CC(=C3)C4C(C(C(C(O4)CO)O)O)O)Cl,PHASE1,urinary_system_disease
4481,Head and Neck Neoplasms|Lung Neoplasms|Urinary Bladder Neoplasms|Breast Neoplasms,Tetrahydrouridine,C1CN(C(=O)NC1O)C2C(C(C(O2)CO)O)O,PHASE2,urinary_system_disease
4482,Neuromuscular Blockade|Renal Impairment,Cisatracurium,C[N+]1(CCC2=CC(=C(C=C2C1CC3=CC(=C(C=C3)OC)OC)OC)OC)CCC(=O)OCCCCCOC(=O)CC[N+]4(CCC5=CC(=C(C=C5C4CC6=CC(=C(C=C6)OC)OC)OC)OC)C,PHASE2,urinary_system_disease
4483,Neuromuscular Blockade|Renal Impairment,Neostigmine,CN(C)C(=O)OC1=CC=CC(=C1)[N+](C)(C)C,PHASE2,urinary_system_disease
4484,Neuromuscular Blockade|Renal Impairment,Rocuronium,CC(=O)OC1C(CC2C1(CCC3C2CCC4C3(CC(C(C4)O)N5CCOCC5)C)C)[N+]6(CCCC6)CC=C,PHASE2,urinary_system_disease
4485,Nephrolithiasis,Fexofenadine,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,PHASE2,urinary_system_disease
4486,"C3 Glomerulonephritis|Dense Deposit Disease|C3 Glomerulopathy|Immune Complex Mediated Membranoproliferative Glomerulonephritis|Membranoproliferative Glomerulonephritis Types I, II, and III",Danicopan,CC1=NC=C(C=N1)C2=CC3=C(C=C2)N(N=C3C(=O)C)CC(=O)N4CC(CC4C(=O)NC5=NC(=CC=C5)Br)F,PHASE2,urinary_system_disease
4487,"Kidney Failure, Chronic|Cardiovascular Disease|Arteriosclerosis",Hydroxychloroquine,CCN(CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl)CCO,PHASE2,urinary_system_disease
4488,Anemia|Dialysis Dependent Chronic Kidney Disease,Vadadustat,C1=CC(=CC(=C1)Cl)C2=CC(=C(N=C2)C(=O)NCC(=O)O)O,PHASE2,urinary_system_disease
4489,Renal Cell Carcinoma,Brivanib,CC1=CC2=C(N1)C=CC(=C2F)OC3=NC=NN4C3=C(C(=C4)OCC(C)O)C,PHASE2,urinary_system_disease
4490,Dent's Disease|Nephrolithiasis,Hydrochlorothiazide,C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl,PHASE2|PHASE3,urinary_system_disease
4491,"Renal Disease, End-Stage|Renal Insufficiency, Chronic|Renal Insufficiency, Acute",Bosutinib,CN1CCN(CC1)CCCOC2=C(C=C3C(=C2)N=CC(=C3NC4=CC(=C(C=C4Cl)Cl)OC)C#N)OC,PHASE1,urinary_system_disease
4492,Cystinuria,Bucillamine,CC(C)(C(=O)NC(CS)C(=O)O)S,PHASE2,urinary_system_disease
4493,"Multiple Myeloma|Renal Impairment|Neoplasms, Plasma Cell|Neoplasms by Histologic Type|Neoplasms|Paraproteinemias|Blood Protein Disorders|Hematologic Diseases",Bortezomib,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O,PHASE2,urinary_system_disease
4494,Lower Urinary Tract Symptoms (LUTS),Degarelix,CC(C)CC(C(=O)NC(CCCCNC(C)C)C(=O)N1CCCC1C(=O)NC(C)C(=O)N)NC(=O)C(CC2=CC=C(C=C2)NC(=O)N)NC(=O)C(CC3=CC=C(C=C3)NC(=O)C4CC(=O)NC(=O)N4)NC(=O)C(CO)NC(=O)C(CC5=CN=CC=C5)NC(=O)C(CC6=CC=C(C=C6)Cl)NC(=O)C(CC7=CC8=CC=CC=C8C=C7)NC(=O)C,PHASE2,urinary_system_disease
4495,Wolfram Syndrome,Tirzepatide,CCC(C)C(C(=O)NC(C)C(=O)NC(CCC(=O)N)C(=O)NC(CCCCNC(=O)COCCOCCNC(=O)COCCOCCNC(=O)CCC(C(=O)O)NC(=O)CCCCCCCCCCCCCCCCCCC(=O)O)C(=O)NC(C)C(=O)NC(CC1=CC=CC=C1)C(=O)NC(C(C)C)C(=O)NC(CCC(=O)N)C(=O)NC(CC2=CNC3=CC=CC=C32)C(=O)NC(CC(C)C)C(=O)NC(C(C)CC)C(=O)NC(C)C(=O)NCC(=O)NCC(=O)N4CCCC4C(=O)NC(CO)C(=O)NC(CO)C(=O)NCC(=O)NC(C)C(=O)N5CCCC5C(=O)N6CCCC6C(=O)N7CCCC7C(=O)NC(CO)C(=O)N)NC(=O)C(CCCCN)NC(=O)C(CC(=O)O)NC(=O)C(CC(C)C)NC(=O)C(C)(C)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(CC8=CC=C(C=C8)O)NC(=O)C(CC(=O)O)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C(CC9=CC=CC=C9)NC(=O)C(C(C)O)NC(=O)CNC(=O)C(CCC(=O)O)NC(=O)C(C)(C)NC(=O)C(CC1=CC=C(C=C1)O)N,PHASE2,urinary_system_disease
4496,Chronic Kidney Disease|Proteinuria,Nifedipine,CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC,PHASE1,urinary_system_disease
4497,Renal Impairment,Teduglutide,CCC(C)C(C(=O)NC(C(C)O)C(=O)NC(CC(=O)O)C(=O)O)NC(=O)C(CCCCN)NC(=O)C(C(C)O)NC(=O)C(CCC(=O)N)NC(=O)C(C(C)CC)NC(=O)C(CC(C)C)NC(=O)C(CC1=CNC2=CC=CC=C21)NC(=O)C(CC(=O)N)NC(=O)C(C(C)CC)NC(=O)C(CC3=CC=CC=C3)NC(=O)C(CC(=O)O)NC(=O)C(CCCNC(=N)N)NC(=O)C(C)NC(=O)C(C)NC(=O)C(CC(C)C)NC(=O)C(CC(=O)N)NC(=O)C(CC(=O)O)NC(=O)C(CC(C)C)NC(=O)C(C(C)CC)NC(=O)C(C(C)O)NC(=O)C(CC(=O)N)NC(=O)C(CCSC)NC(=O)C(CCC(=O)O)NC(=O)C(CC(=O)O)NC(=O)C(CO)NC(=O)C(CC4=CC=CC=C4)NC(=O)C(CO)NC(=O)CNC(=O)C(CC(=O)O)NC(=O)CNC(=O)C(CC5=CN=CN5)N,PHASE1,urinary_system_disease
4498,Kidney Cancer|Leukemia|Lymphoma|Neurotoxicity|Peripheral Neuropathy|Sarcoma,Glutamine,C(CC(=O)N)C(C(=O)O)N,PHASE2,urinary_system_disease
4499,Platelet Aggregation|Adenosine|Coronary Artery Disease|Kidney Dysfunction|Antiplatelet Therapy,Clopidogrel,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,PHASE2,urinary_system_disease
4500,Platelet Aggregation|Adenosine|Coronary Artery Disease|Kidney Dysfunction|Antiplatelet Therapy,Ticagrelor,CCCSC1=NC(=C2C(=N1)N(N=N2)C3CC(C(C3O)O)OCCO)NC4CC4C5=CC(=C(C=C5)F)F,PHASE2,urinary_system_disease
4501,Diabetic Nephropathies,Calcitriol,CC(CCCC(C)(C)O)C1CCC2C1(CCCC2=CC=C3CC(CC(C3=C)O)O)C,PHASE2|PHASE3,urinary_system_disease
4502,Paroxysmal Nocturnal Hemoglobinuria (PNH),Zilucoplan,CCCCCCCCCCCCCCCC(=O)NC(CCC(=O)NCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCC(=O)NCCCCC(C(=O)O)NC(=O)C(C1CCCCC1)NC(=O)C2CCCN2C(=O)C(CC3=CC=C(C=C3)O)NC(=O)C(CCC(=O)O)NC(=O)C(CC4=CNC5=C4C=CC=N5)NC(=O)C(CC6=CC=C(C=C6)O)NC(=O)C(C(C)(C)C)NC(=O)C(CC(=O)O)N(C)C(=O)C7CC(=O)NCCCCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N7)CC8=CC=CC=C8)CCCNC(=N)N)CCC(=O)O)C(C)C)NC(=O)C)C(=O)O,PHASE2,urinary_system_disease
4503,Respiratory Tract Infections|Urinary Tract Infections,Cefoperazone,CCN1CCN(C(=O)C1=O)C(=O)NC(C2=CC=C(C=C2)O)C(=O)NC3C4N(C3=O)C(=C(CS4)CSC5=NN=NN5C)C(=O)O,PHASE2,urinary_system_disease
4504,Respiratory Tract Infections|Urinary Tract Infections,Sulbactam,CC1(C(N2C(S1(=O)=O)CC2=O)C(=O)O)C,PHASE2,urinary_system_disease
4505,Bladder Cancer,Mitomycin C,CC1=C(C(=O)C2=C(C1=O)N3CC4C(C3(C2COC(=O)N)OC)N4)N,PHASE2,urinary_system_disease
4506,Bladder Cancer,Mitomycin,CC1=C(C(=O)C2=C(C1=O)N3CC4C(C3(C2COC(=O)N)OC)N4)N,PHASE2,urinary_system_disease
4507,"Anemia|Renal Insufficiency, Chronic",Molidustat,C1COCCN1C2=NC=NC(=C2)N3C(=O)C(=CN3)N4C=CN=N4,PHASE2,urinary_system_disease
4508,Idiopathic Overactive Bladder With Urinary Incontinence,Trospium,C1CC[N+]2(C1)C3CCC2CC(C3)OC(=O)C(C4=CC=CC=C4)(C5=CC=CC=C5)O,PHASE1,urinary_system_disease
4509,Contrast Induced Nephropathy,Acetazolamide,CC(=O)NC1=NN=C(S1)S(=O)(=O)N,PHASE2,urinary_system_disease
4510,BK Virus Infection|Nephropathy|Kidney Transplantation,Brincidofovir,CCCCCCCCCCCCCCCCOCCCOP(=O)(COC(CN1C=CC(=NC1=O)N)CO)O,PHASE2,urinary_system_disease
4511,Renal Insufficiency|Hepatic Insufficiency,Nevirapine,CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4,PHASE1,urinary_system_disease
4512,Recurrent Renal Cell Carcinoma|Stage IV Renal Cell Cancer,Suramin,CC1=C(C=C(C=C1)C(=O)NC2=C3C(=CC(=CC3=C(C=C2)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O)NC(=O)C4=CC(=CC=C4)NC(=O)NC5=CC=CC(=C5)C(=O)NC6=C(C=CC(=C6)C(=O)NC7=C8C(=CC(=CC8=C(C=C7)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O)C,PHASE1|PHASE2,urinary_system_disease
4513,Renal Impairment,Besifovir,C1CC1(CN2C=NC3=CN=C(N=C32)N)OCP(=O)(O)O,PHASE1,urinary_system_disease
4514,Acute Kidney Injury,Dexmedetomidine,CC1=C(C(=CC=C1)C(C)C2=CN=CN2)C,PHASE2|PHASE3,urinary_system_disease
4515,Wolfram Syndrome,Valproate,CCCC(CCC)C(=O)O,PHASE2,urinary_system_disease
4516,Overactive Bladder,Solabegron,C1=CC(=CC(=C1)C(=O)O)C2=CC(=CC=C2)NCCNCC(C3=CC(=CC=C3)Cl)O,PHASE2,urinary_system_disease
4517,Urinary Stress Incontinence,Duloxetine,CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32,PHASE2,urinary_system_disease
4518,Renal Cell Cancer,Melphalan,C1=CC(=CC=C1CC(C(=O)O)N)N(CCCl)CCCl,PHASE2,urinary_system_disease
4519,Renal Cell Cancer,Cediranib,CC1=CC2=C(N1)C=CC(=C2F)OC3=NC=NC4=CC(=C(C=C43)OC)OCCCN5CCCC5,PHASE2,urinary_system_disease
4520,Multiple Myeloma,Pomalidomide,C1CC(=O)NC(=O)C1N2C(=O)C3=C(C2=O)C(=CC=C3)N,PHASE2,urinary_system_disease
4521,Contrast-induced Acute Kidney Injury,Alprostadil,CCCCCC(C=CC1C(CC(=O)C1CCCCCCC(=O)O)O)O,PHASE2,urinary_system_disease
4522,"Carcinoma, Renal Cell",Regorafenib,CNC(=O)C1=NC=CC(=C1)OC2=CC(=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F)F,PHASE2,urinary_system_disease
4523,"Immunoglobulin A Nephropathy|Kidney Diseases|Glomerulonephritis, IGA|Glomerulonephritis|Autoimmune Diseases|Immune System Diseases",Sparsentan,CCCCC1=NC2(CCCC2)C(=O)N1CC3=CC(=C(C=C3)C4=CC=CC=C4S(=O)(=O)NC5=NOC(=C5C)C)COCC,PHASE2,urinary_system_disease
4524,Renal Failure|Anesthesia,Sevoflurane,C(OC(C(F)(F)F)C(F)(F)F)F,PHASE1,urinary_system_disease
4525,Renal Insufficiency,Tiotropium,C[N+]1(C2CC(CC1C3C2O3)OC(=O)C(C4=CC=CS4)(C5=CC=CS5)O)C,PHASE1,urinary_system_disease
4526,Nephrolithiasis|Nephrocalcinosis|Hypercalciuria,Fluconazole,C1=CC(=C(C=C1F)F)C(CN2C=NC=N2)(CN3C=NC=N3)O,PHASE2,urinary_system_disease
4527,Kidney|Cancer,Thalidomide,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O,PHASE1|PHASE2,urinary_system_disease
4528,Polycystic Kidney Disease,Pioglitazone,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3,PHASE2,urinary_system_disease
4529,Renal Impairment,Phentermine,CC(C)(CC1=CC=CC=C1)N,PHASE1,urinary_system_disease
4530,"Carcinoma, Renal Cell",Tivozanib,CC1=CC(=NO1)NC(=O)NC2=C(C=C(C=C2)OC3=C4C=C(C(=CC4=NC=C3)OC)OC)Cl,PHASE1|PHASE2,urinary_system_disease
4531,Urinary Urgency|Urinary Frequency|Nocturia|Incontinence|Detrusor Uninhibited Activity|Quality of Life,Gabapentin,C1CCC(CC1)(CC(=O)O)CN,PHASE2|PHASE3,urinary_system_disease
4532,Renal Impairment,Methylnaltrexone,C[N+]1(CCC23C4C(=O)CCC2(C1CC5=C3C(=C(C=C5)O)O4)O)CC6CC6,PHASE1,urinary_system_disease
4533,Henoch-Schnlein Purpura Nephritis,Benazepril,CCOC(=O)C(CCC1=CC=CC=C1)NC2CCC3=CC=CC=C3N(C2=O)CC(=O)O,PHASE1|PHASE2,urinary_system_disease
4534,Henoch-Schnlein Purpura Nephritis,Dipyridamole,C1CCN(CC1)C2=NC(=NC3=C2N=C(N=C3N4CCCCC4)N(CCO)CCO)N(CCO)CCO,PHASE1|PHASE2,urinary_system_disease
4535,"Cardiovascular Diseases|Kidney Failure, Chronic",Dabigatran,CN1C2=C(C=C(C=C2)C(=O)N(CCC(=O)O)C3=CC=CC=N3)N=C1CNC4=CC=C(C=C4)C(=N)N,PHASE1,urinary_system_disease
4536,Heart Failure|Kidney Failure,Aliskiren,CC(C)C(CC1=CC(=C(C=C1)OC)OCCCOC)CC(C(CC(C(C)C)C(=O)NCC(C)(C)C(=O)N)O)N,PHASE2,urinary_system_disease
4537,Advanced Cancer|Advanced Malignancies|Bladder Cancer|Cervical Cancer|Esophageal Cancer|Gastric Cancer|Gastroesophageal-junction Cancer (GEJ)|Head and Neck Squamous Cell Carcinoma (HNSCC)|Non-Small Cell Lung Cancer (NSCLC)|Ovarian Cancer|Renal Cell Carcinoma (RCC)|Triple Negative Breast Cancer (TNBC),Pemetrexed,C1=CC(=CC=C1CCC2=CNC3=C2C(=O)NC(=N3)N)C(=O)NC(CCC(=O)O)C(=O)O,PHASE1,urinary_system_disease
4538,Urinary Incontinence,Litoxetine,C1CNCCC1OCC2=CC3=CC=CC=C3C=C2,PHASE1|PHASE2,urinary_system_disease
4539,Hyperuricemia|Albuminuria|Type 2 Diabetes,Verinurad,CC(C)(C(=O)O)SC1=C(C=NC=C1)C2=CC=C(C3=CC=CC=C32)C#N,PHASE2,urinary_system_disease
4540,Hyperuricemia|Albuminuria|Type 2 Diabetes,Febuxostat,CC1=C(SC(=N1)C2=CC(=C(C=C2)OCC(C)C)C#N)C(=O)O,PHASE2,urinary_system_disease
4541,Hematuria|Hematospermia,Finasteride,CC12CCC3C(C1CCC2C(=O)NC(C)(C)C)CCC4C3(C=CC(=O)N4)C,PHASE2,urinary_system_disease
4542,Renal Insufficiency|Chronic Hypertension,Chlorthalidone,C1=CC=C2C(=C1)C(=O)NC2(C3=CC(=C(C=C3)Cl)S(=O)(=O)N)O,PHASE2,urinary_system_disease
4543,Urinary Tract Infections|Catheter Infection|Catheter-Related Infections,Povidone,C=CN1CCCC1=O,PHASE2,urinary_system_disease
4544,"Kidney, Polycystic, Autosomal Dominant",Cilnidipine,CC1=C(C(C(=C(N1)C)C(=O)OCC=CC2=CC=CC=C2)C3=CC(=CC=C3)[N+](=O)[O-])C(=O)OCCOC,PHASE2,urinary_system_disease
4545,"Kidney, Polycystic, Autosomal Dominant",Imidapril,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C(CN(C2=O)C)C(=O)O,PHASE2,urinary_system_disease
4546,HIV/AIDS|Albuminuria|Kidney Diseases|Genetic Predisposition,Lisinopril,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,PHASE2,urinary_system_disease
4547,Cirrhosis|Hepatorenal Syndrome,Midodrine,COC1=CC(=C(C=C1)OC)C(CNC(=O)CN)O,PHASE2|PHASE3,urinary_system_disease
4548,Iron Deficiency|Anemia|Kidney Disease,Ferumoxytol,O[Fe]=O.O[Fe]=O.[Fe],PHASE2,urinary_system_disease
4549,Neurogenic Bladder|Post-operative Urinary Tract Infections,Ciprofloxacin,C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O,PHASE2,urinary_system_disease
4550,Prostatic Hyperplasia,Lemuteporfin,CC1=C(C2=CC3=NC(=CC4=C(C(=C(N4)C=C5C6(C(C(=CC=C6C(=N5)C=C1N2)C(=O)OC)C(=O)OC)C)C)CCC(=O)OCCO)C(=C3C)CCC(=O)OCCO)C=C,PHASE2,urinary_system_disease
4551,Renal Impairment|Diabetes,Vildagliptin,C1CC(N(C1)C(=O)CNC23CC4CC(C2)CC(C4)(C3)O)C#N,PHASE1|PHASE2,urinary_system_disease
4552,Diabetic Nephropathies,Fenofibrate,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl,PHASE2,urinary_system_disease
4553,"Paroxysmal Nocturnal Hemoglobinuria|Hemoglobinuria|Hemoglobinuria, Paroxysmal|Proteinuria|Urination Disorders|Thrombosis|Bone Marrow Failure|Aplastic Anemia,|Anemia, Hemolytic",Levamisole,C1CSC2=NC(CN21)C3=CC=CC=C3,PHASE2,urinary_system_disease
4554,Congestive Heart Failure|Renal Insufficiency,Nesiritide,CCC(C)C1C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NCC(=O)NC(C(=O)NCC(=O)NC(CSSCC(C(=O)NC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCNC(=N)N)CC(=O)O)CCSC)CCCCN)CCCNC(=N)N)CC2=CC=CC=C2)NC(=O)CNC(=O)C(CO)NC(=O)CNC(=O)C(CCC(=O)N)NC(=O)C(C(C)C)NC(=O)C(CCSC)NC(=O)C(CCCCN)NC(=O)C3CCCN3C(=O)C(CO)N)C(=O)NC(CCCCN)C(=O)NC(C(C)C)C(=O)NC(CC(C)C)C(=O)NC(CCCNC(=N)N)C(=O)NC(CCCNC(=N)N)C(=O)NC(CC4=CN=CN4)C(=O)O)CC(C)C)CO)CO)CO)CO,PHASE2,urinary_system_disease
4555,Diabetic Nephropathy,Nidufexor,CN1C2=C(COC3=C2C=C(C=C3)Cl)C(=N1)C(=O)N(CC4=CC=CC=C4)CC5=CC=C(C=C5)C(=O)O,PHASE2,urinary_system_disease
4556,Hepatoblastoma|Previously Treated Childhood Rhabdomyosarcoma|Recurrent Childhood Acute Lymphoblastic Leukemia|Recurrent Childhood Acute Myeloid Leukemia|Recurrent Childhood Kidney Neoplasm|Recurrent Childhood Malignant Germ Cell Tumor|Recurrent Childhood Rhabdomyosarcoma|Recurrent Childhood Soft Tissue Sarcoma|Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor|Recurrent Neuroblastoma|Recurrent Osteosarcoma,Alisertib,COC1=C(C(=CC=C1)F)C2=NCC3=CN=C(N=C3C4=C2C=C(C=C4)Cl)NC5=CC(=C(C=C5)C(=O)O)OC,PHASE2,urinary_system_disease
4557,"Urinary Incontinence, Stress|Fecal Incontinence",Imipramine,CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31,PHASE1,urinary_system_disease
4558,Renal Insufficiency|Heart Failure,Tonapofylline,CCCN1C2=C(C(=O)N(C1=O)CCC)NC(=N2)C34CCC(CC3)(CC4)CCC(=O)O,PHASE2,urinary_system_disease
4559,Paroxysmal Nocturnal Hemoglobinuria,Cemdisiran,CC(=O)NC1C(C(C(OC1OCCCCC(=O)NCCCNC(=O)CCOCC(COCCC(=O)NCCCNC(=O)CCCCOC2C(C(C(C(O2)CO)O)O)NC(=O)C)(COCCC(=O)NCCCNC(=O)CCCCOC3C(C(C(C(O3)CO)O)O)NC(=O)C)NC(=O)CCCCCCCCCCC(=O)N4CC(CC4COP(=O)(O)O)O)CO)O)O,PHASE2,urinary_system_disease
4560,Renal Impairment,Inclisiran,CC(=O)NC1C(C(C(OC1OCCCCC(=O)NCCCNC(=O)CCOCC(COCCC(=O)NCCCNC(=O)CCCCOC2C(C(C(C(O2)CO)O)O)NC(=O)C)(COCCC(=O)NCCCNC(=O)CCCCOC3C(C(C(C(O3)CO)O)O)NC(=O)C)NC(=O)CCCCCCCCCCC(=O)N4CC(CC4COP(=O)(O)O)O)CO)O)O,PHASE1,urinary_system_disease
4561,Diabetic Nephropathy,Probucol,CC(C)(C)C1=CC(=CC(=C1O)C(C)(C)C)SC(C)(C)SC2=CC(=C(C(=C2)C(C)(C)C)O)C(C)(C)C,PHASE2,urinary_system_disease
4562,Fanconi Anemia,Plerixafor,C1CNCCNCCCN(CCNC1)CC2=CC=C(C=C2)CN3CCCNCCNCCCNCC3,PHASE1|PHASE2,urinary_system_disease
4563,Advanced Malignant Solid Neoplasm|Recurrent Ependymoma|Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor|Recurrent Glioma|Recurrent Hepatoblastoma|Recurrent Kidney Wilms Tumor|Recurrent Langerhans Cell Histiocytosis|Recurrent Malignant Germ Cell Tumor|Recurrent Malignant Glioma|Recurrent Malignant Solid Neoplasm|Recurrent Medulloblastoma|Recurrent Neuroblastoma|Recurrent Non-Hodgkin Lymphoma|Recurrent Osteosarcoma|Recurrent Rhabdoid Tumor|Recurrent Rhabdomyosarcoma|Recurrent Soft Tissue Sarcoma|Refractory Ependymoma|Refractory Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor|Refractory Glioma|Refractory Hepatoblastoma|Refractory Langerhans Cell Histiocytosis|Refractory Malignant Germ Cell Tumor|Refractory Malignant Glioma|Refractory Malignant Solid Neoplasm|Refractory Medulloblastoma|Refractory Neuroblastoma|Refractory Non-Hodgkin Lymphoma|Refractory Osteosarcoma|Refractory Primary Central Nervous System Neoplasm|Refractory Rhabdoid Tumor|Refractory Rhabdomyosarcoma|Refractory Soft Tissue Sarcoma,Larotrectinib,C1CC(N(C1)C2=NC3=C(C=NN3C=C2)NC(=O)N4CCC(C4)O)C5=C(C=CC(=C5)F)F,PHASE2,urinary_system_disease
4564,Renal Impairment,Cefepime,C[N+]1(CCCC1)CC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-],PHASE1,urinary_system_disease
4565,Neurogenic Bladder|Spinal Cord Injuries,Gentamicin,CC(C1CCC(C(O1)OC2C(CC(C(C2O)OC3C(C(C(CO3)(C)O)NC)O)N)N)N)NC,PHASE2,urinary_system_disease
4566,Advanced Malignant Solid Neoplasm|Malignant Solid Neoplasm|Recurrent Ependymoma|Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor|Recurrent Hepatoblastoma|Recurrent Langerhans Cell Histiocytosis|Recurrent Malignant Germ Cell Tumor|Recurrent Malignant Glioma|Recurrent Malignant Solid Neoplasm|Recurrent Medulloblastoma|Recurrent Neuroblastoma|Recurrent Non-Hodgkin Lymphoma|Recurrent Osteosarcoma|Recurrent Primary Central Nervous System Neoplasm|Recurrent Rhabdoid Tumor|Recurrent Rhabdomyosarcoma|Recurrent Soft Tissue Sarcoma|Refractory Ependymoma|Refractory Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor|Refractory Hepatoblastoma|Refractory Langerhans Cell Histiocytosis|Refractory Malignant Germ Cell Tumor|Refractory Malignant Glioma|Refractory Malignant Solid Neoplasm|Refractory Medulloblastoma|Refractory Neuroblastoma|Refractory Non-Hodgkin Lymphoma|Refractory Osteosarcoma|Refractory Primary Central Nervous System Neoplasm|Refractory Rhabdoid Tumor|Refractory Rhabdomyosarcoma|Refractory Soft Tissue Sarcoma|Wilms Tumor,Ensartinib,CC1CN(CC(N1)C)C(=O)C2=CC=C(C=C2)NC(=O)C3=NN=C(C(=C3)OC(C)C4=C(C=CC(=C4Cl)F)Cl)N,PHASE2,urinary_system_disease
4567,Secondary Hyperparathyroidism|Hemodialysis,Paricalcitol,CC(C=CC(C)C(C)(C)O)C1CCC2C1(CCCC2=CC=C3CC(CC(C3)O)O)C,PHASE2,urinary_system_disease
4568,Ascites Infection,Rifaximin,CC1C=CC=C(C(=O)NC2=C(C3=C(C4=C(C(=C3O)C)OC(C4=O)(OC=CC(C(C(C(C(C(C1O)C)O)C)OC(=O)C)C)OC)C)C5=C2N6C=CC(=CC6=N5)C)O)C,PHASE2,urinary_system_disease
4569,"Beta-thalassemia|Myelodysplastic Syndromes|Fanconi Syndrome|Anemia, Diamond-Blackfan|Anemia, Aplastic",Deferasirox,C1=CC=C(C(=C1)C2=NN(C(=N2)C3=CC=CC=C3O)C4=CC=C(C=C4)C(=O)O)O,PHASE2,urinary_system_disease
4570,Postoperative Ileus|Bladder Cancer,Prucalopride,COCCCN1CCC(CC1)NC(=O)C2=CC(=C(C3=C2OCC3)N)Cl,PHASE2,urinary_system_disease
4571,Malignant Neoplasm of Breast|Malignant Neoplasms of Digestive Organs|Malignant Neoplasms of Eye Brain and Other Parts of Central Nervous System|Malignant Neoplasms of Female Genital Organs|Malignant Neoplasms of Ill-defined Secondary and Unspecified Sites|Malignant Neoplasms of Independent (Primary) Multiple Sites|Malignant Neoplasms of Lip Oral Cavity and Pharynx|Malignant Neoplasms of Male Genital Organs|Malignant Neoplasms of Mesothelial and Soft Tissue|Malignant Neoplasms of Respiratory and Intrathoracic Organs|Malignant Neoplasms of Thyroid and Other Endocrine Glands|Malignant Neoplasms of Urinary Tract,Doxycycline,CC1C2C(C3C(C(=O)C(=C(C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O,PHASE1,urinary_system_disease
4572,Subjects With Impaired Renal Function and Healthy Subjects,Rivoceranib,C1CCC(C1)(C#N)C2=CC=C(C=C2)NC(=O)C3=C(N=CC=C3)NCC4=CC=NC=C4,PHASE1,urinary_system_disease
4573,"Diabetes Mellitus, Type 1",Benfotiamine,CC1=NC=C(C(=N1)N)CN(C=O)C(=C(CCOP(=O)(O)O)SC(=O)C2=CC=CC=C2)C,PHASE1|PHASE2,urinary_system_disease
4574,"Collapsing Glomerulopathy|Glomerulosclerosis, Focal Segmental",Isotretinoin,CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CC(=O)O)C)C,PHASE2,urinary_system_disease
4575,Advanced Malignant Solid Neoplasm|Ann Arbor Stage III Non-Hodgkin Lymphoma|Ann Arbor Stage IV Non-Hodgkin Lymphoma|Histiocytic Sarcoma|Juvenile Xanthogranuloma|Langerhans Cell Histiocytosis|Malignant Glioma|Recurrent Childhood Rhabdomyosarcoma|Recurrent Ependymoma|Recurrent Ewing Sarcoma|Recurrent Glioma|Recurrent Hepatoblastoma|Recurrent Langerhans Cell Histiocytosis|Recurrent Malignant Germ Cell Tumor|Recurrent Malignant Solid Neoplasm|Recurrent Medulloblastoma|Recurrent Neuroblastoma|Recurrent Non-Hodgkin Lymphoma|Recurrent Osteosarcoma|Recurrent Peripheral Primitive Neuroectodermal Tumor|Recurrent Primary Central Nervous System Neoplasm|Recurrent Rhabdoid Tumor|Recurrent Soft Tissue Sarcoma|Refractory Ewing Sarcoma|Refractory Glioma|Refractory Hepatoblastoma|Refractory Langerhans Cell Histiocytosis|Refractory Malignant Germ Cell Tumor|Refractory Malignant Solid Neoplasm|Refractory Medulloblastoma|Refractory Neuroblastoma|Refractory Non-Hodgkin Lymphoma|Refractory Osteosarcoma|Refractory Peripheral Primitive Neuroectodermal Tumor|Refractory Primary Central Nervous System Neoplasm|Refractory Rhabdoid Tumor|Refractory Rhabdomyosarcoma|Rhabdoid Tumor|Stage III Osteosarcoma AJCC v7|Stage III Soft Tissue Sarcoma AJCC v7|Stage IV Osteosarcoma AJCC v7|Stage IV Soft Tissue Sarcoma AJCC v7|Stage IVA Osteosarcoma AJCC v7|Stage IVB Osteosarcoma AJCC v7|Wilms Tumor,Selumetinib,CN1C=NC2=C1C=C(C(=C2F)NC3=C(C=C(C=C3)Br)Cl)C(=O)NOCCO,PHASE2,urinary_system_disease
4576,Advanced Malignant Solid Neoplasm|Ann Arbor Stage III Non-Hodgkin Lymphoma|Ann Arbor Stage IV Non-Hodgkin Lymphoma|Histiocytic Sarcoma|Juvenile Xanthogranuloma|Langerhans Cell Histiocytosis|Malignant Glioma|Recurrent Childhood Rhabdomyosarcoma|Recurrent Ependymoma|Recurrent Ewing Sarcoma|Recurrent Glioma|Recurrent Hepatoblastoma|Recurrent Langerhans Cell Histiocytosis|Recurrent Malignant Germ Cell Tumor|Recurrent Malignant Solid Neoplasm|Recurrent Medulloblastoma|Recurrent Neuroblastoma|Recurrent Non-Hodgkin Lymphoma|Recurrent Osteosarcoma|Recurrent Peripheral Primitive Neuroectodermal Tumor|Recurrent Primary Central Nervous System Neoplasm|Recurrent Rhabdoid Tumor|Recurrent Soft Tissue Sarcoma|Refractory Ewing Sarcoma|Refractory Glioma|Refractory Hepatoblastoma|Refractory Langerhans Cell Histiocytosis|Refractory Malignant Germ Cell Tumor|Refractory Malignant Solid Neoplasm|Refractory Medulloblastoma|Refractory Neuroblastoma|Refractory Non-Hodgkin Lymphoma|Refractory Osteosarcoma|Refractory Peripheral Primitive Neuroectodermal Tumor|Refractory Primary Central Nervous System Neoplasm|Refractory Rhabdoid Tumor|Refractory Rhabdomyosarcoma|Rhabdoid Tumor|Stage III Osteosarcoma AJCC v7|Stage III Soft Tissue Sarcoma AJCC v7|Stage IV Osteosarcoma AJCC v7|Stage IV Soft Tissue Sarcoma AJCC v7|Stage IVA Osteosarcoma AJCC v7|Stage IVB Osteosarcoma AJCC v7|Wilms Tumor,Tipifarnib,CN1C=NC=C1C(C2=CC=C(C=C2)Cl)(C3=CC4=C(C=C3)N(C(=O)C=C4C5=CC(=CC=C5)Cl)C)N,PHASE2,urinary_system_disease
4577,Advanced Malignant Solid Neoplasm|Ann Arbor Stage III Non-Hodgkin Lymphoma|Ann Arbor Stage IV Non-Hodgkin Lymphoma|Histiocytic Sarcoma|Juvenile Xanthogranuloma|Langerhans Cell Histiocytosis|Malignant Glioma|Recurrent Childhood Rhabdomyosarcoma|Recurrent Ependymoma|Recurrent Ewing Sarcoma|Recurrent Glioma|Recurrent Hepatoblastoma|Recurrent Langerhans Cell Histiocytosis|Recurrent Malignant Germ Cell Tumor|Recurrent Malignant Solid Neoplasm|Recurrent Medulloblastoma|Recurrent Neuroblastoma|Recurrent Non-Hodgkin Lymphoma|Recurrent Osteosarcoma|Recurrent Peripheral Primitive Neuroectodermal Tumor|Recurrent Primary Central Nervous System Neoplasm|Recurrent Rhabdoid Tumor|Recurrent Soft Tissue Sarcoma|Refractory Ewing Sarcoma|Refractory Glioma|Refractory Hepatoblastoma|Refractory Langerhans Cell Histiocytosis|Refractory Malignant Germ Cell Tumor|Refractory Malignant Solid Neoplasm|Refractory Medulloblastoma|Refractory Neuroblastoma|Refractory Non-Hodgkin Lymphoma|Refractory Osteosarcoma|Refractory Peripheral Primitive Neuroectodermal Tumor|Refractory Primary Central Nervous System Neoplasm|Refractory Rhabdoid Tumor|Refractory Rhabdomyosarcoma|Rhabdoid Tumor|Stage III Osteosarcoma AJCC v7|Stage III Soft Tissue Sarcoma AJCC v7|Stage IV Osteosarcoma AJCC v7|Stage IV Soft Tissue Sarcoma AJCC v7|Stage IVA Osteosarcoma AJCC v7|Stage IVB Osteosarcoma AJCC v7|Wilms Tumor,Ulixertinib,CC(C)NC1=NC=C(C(=C1)C2=CNC(=C2)C(=O)NC(CO)C3=CC(=CC=C3)Cl)Cl,PHASE2,urinary_system_disease
4578,Advanced Malignant Solid Neoplasm|Ann Arbor Stage III Non-Hodgkin Lymphoma|Ann Arbor Stage IV Non-Hodgkin Lymphoma|Histiocytic Sarcoma|Juvenile Xanthogranuloma|Langerhans Cell Histiocytosis|Malignant Glioma|Recurrent Childhood Rhabdomyosarcoma|Recurrent Ependymoma|Recurrent Ewing Sarcoma|Recurrent Glioma|Recurrent Hepatoblastoma|Recurrent Langerhans Cell Histiocytosis|Recurrent Malignant Germ Cell Tumor|Recurrent Malignant Solid Neoplasm|Recurrent Medulloblastoma|Recurrent Neuroblastoma|Recurrent Non-Hodgkin Lymphoma|Recurrent Osteosarcoma|Recurrent Peripheral Primitive Neuroectodermal Tumor|Recurrent Primary Central Nervous System Neoplasm|Recurrent Rhabdoid Tumor|Recurrent Soft Tissue Sarcoma|Refractory Ewing Sarcoma|Refractory Glioma|Refractory Hepatoblastoma|Refractory Langerhans Cell Histiocytosis|Refractory Malignant Germ Cell Tumor|Refractory Malignant Solid Neoplasm|Refractory Medulloblastoma|Refractory Neuroblastoma|Refractory Non-Hodgkin Lymphoma|Refractory Osteosarcoma|Refractory Peripheral Primitive Neuroectodermal Tumor|Refractory Primary Central Nervous System Neoplasm|Refractory Rhabdoid Tumor|Refractory Rhabdomyosarcoma|Rhabdoid Tumor|Stage III Osteosarcoma AJCC v7|Stage III Soft Tissue Sarcoma AJCC v7|Stage IV Osteosarcoma AJCC v7|Stage IV Soft Tissue Sarcoma AJCC v7|Stage IVA Osteosarcoma AJCC v7|Stage IVB Osteosarcoma AJCC v7|Wilms Tumor,Vemurafenib,CCCS(=O)(=O)NC1=C(C(=C(C=C1)F)C(=O)C2=CNC3=C2C=C(C=N3)C4=CC=C(C=C4)Cl)F,PHASE2,urinary_system_disease
4579,"Anti-Infective Agents, Urinary|Escherichia Coli Infections|Klebsiella Infections|Kidney Transplantation|Urinary Tract Infections",Sitafloxacin,C1CC12CN(CC2N)C3=C(C=C4C(=C3Cl)N(C=C(C4=O)C(=O)O)C5CC5F)F,PHASE2|PHASE3,urinary_system_disease
4580,"Anti-Infective Agents, Urinary|Escherichia Coli Infections|Klebsiella Infections|Kidney Transplantation|Urinary Tract Infections",Ertapenem,CC1C2C(C(=O)N2C(=C1SC3CC(NC3)C(=O)NC4=CC=CC(=C4)C(=O)O)C(=O)O)C(C)O,PHASE2|PHASE3,urinary_system_disease
4581,Transplantation Infection,Cidofovir,C1=CN(C(=O)N=C1N)CC(CO)OCP(=O)(O)O,PHASE2,urinary_system_disease
4582,"Renal Insufficiency, Acute|Renal Insufficiency, Chronic|Healthy Subjects",Minocycline,CN(C)C1C2CC3CC4=C(C=CC(=C4C(=C3C(=O)C2(C(=C(C1=O)C(=O)N)O)O)O)O)N(C)C,PHASE1,urinary_system_disease
4583,Chronic Kidney Diseases|Major Depressive Disorder,Bupropion,CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C,PHASE2,urinary_system_disease
4584,Chronic Renal Insufficiency|Peritoneal Dialysis,Apixaban,COC1=CC=C(C=C1)N2C3=C(CCN(C3=O)C4=CC=C(C=C4)N5CCCCC5=O)C(=N2)C(=O)N,PHASE1,urinary_system_disease
4585,Cardiorenal Syndrome,Chlortalidone,C1=CC=C2C(=C1)C(=O)NC2(C3=CC(=C(C=C3)Cl)S(=O)(=O)N)O,PHASE2,urinary_system_disease
4586,Chronic Kidney Disease Stage 3|Chronic Kidney Disease Stage 4,Sulforaphane,CS(=O)CCCCN=C=S,PHASE2,urinary_system_disease
4587,HCV Infection,Voxilaprevir,CCC1C2CN(C1C(=O)NC3(CC3C(F)F)C(=O)NS(=O)(=O)C4(CC4)C)C(=O)C(NC(=O)OC5CC5CCCCC(C6=NC7=C(C=C(C=C7)OC)N=C6O2)(F)F)C(C)(C)C,PHASE1,urinary_system_disease
4588,Lupus Nephritis,Methylprednisolone,CC1CC2C3CCC(C3(CC(C2C4(C1=CC(=O)C=C4)C)O)C)(C(=O)CO)O,PHASE2,urinary_system_disease
4589,"Neoplasms|Neoplasms, Glandular and Epithelial|Neoplasms by Histologic Type|Bronchial Neoplasms|Lung Neoplasms|Respiratory Tract Neoplasms|Thoracic Neoplasms|Digestive System Neoplasms|Endocrine Gland Neoplasms|Carcinoma, Non-Small-Cell Lung|Lung Diseases|Breast Diseases|Renal Neoplasm|Solid Tumors",Entinostat,C1=CC=C(C(=C1)N)NC(=O)C2=CC=C(C=C2)CNC(=O)OCC3=CN=CC=C3,PHASE1,urinary_system_disease
4590,Chronic Kidney Disease,Allopurinol,C1=NNC2=C1C(=O)NC=N2,PHASE2,urinary_system_disease
4591,Heart Failure|Renal Insufficiency,Cenderitide,CCC(C)C(C(=O)NCC(=O)NC(CO)C(=O)NC(CCSC)C(=O)NC(CO)C(=O)NCC(=O)NC(CC(C)C)C(=O)NCC(=O)NC(CS)C(=O)N1CCCC1C(=O)NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CCCN=C(N)N)C(=O)NC(CC(=O)O)C(=O)N2CCCC2C(=O)NC(CCCN=C(N)N)C(=O)N3CCCC3C(=O)NC(CC(=O)O)C(=O)NC(C)C(=O)N4CCCC4C(=O)NC(CO)C(=O)NC(C(C)O)C(=O)NC(CO)C(=O)NC(C)C(=O)O)NC(=O)C(CCCN=C(N)N)NC(=O)C(CC(=O)O)NC(=O)C(CC(C)C)NC(=O)C(CCCCN)NC(=O)C(CC(C)C)NC(=O)CNC(=O)C(CC5=CC=CC=C5)NC(=O)C(CS)NC(=O)CNC(=O)C(CCCCN)NC(=O)C(CO)NC(=O)C(CC(C)C)NC(=O)CN,PHASE1|PHASE2,urinary_system_disease
4592,"Kidney Failure, Chronic",Alisporivir,CCC1C(=O)N(C(C(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)C(C)C)CC)C)C,PHASE1,urinary_system_disease
4593,Restless Legs Syndrome|End Stage Renal Disease,Ropinirole,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1,PHASE2,urinary_system_disease
4594,Renal Diseases,Levofloxacin,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O,PHASE1,urinary_system_disease
4595,Advanced Malignant Solid Neoplasm|Clinical Stage III Cutaneous Melanoma AJCC v8|Clinical Stage IV Cutaneous Melanoma AJCC v8|Fallopian Tube Carcinoma|Metastatic Lung Non-Small Cell Carcinoma|Metastatic Malignant Solid Neoplasm|Metastatic Melanoma|Metastatic Renal Cell Carcinoma|Ovarian Carcinoma|Pathologic Stage III Cutaneous Melanoma AJCC v8|Pathologic Stage IIIA Cutaneous Melanoma AJCC v8|Pathologic Stage IIIB Cutaneous Melanoma AJCC v8|Pathologic Stage IIIC Cutaneous Melanoma AJCC v8|Pathologic Stage IIID Cutaneous Melanoma AJCC v8|Pathologic Stage IV Cutaneous Melanoma AJCC v8|Primary Peritoneal Carcinoma|Stage III Lung Cancer AJCC v8|Stage III Renal Cell Cancer AJCC v8|Stage IIIA Lung Cancer AJCC v8|Stage IIIB Lung Cancer AJCC v8|Stage IIIC Lung Cancer AJCC v8|Stage IV Lung Cancer AJCC v8|Stage IV Renal Cell Cancer AJCC v8|Stage IVA Lung Cancer AJCC v8|Stage IVB Lung Cancer AJCC v8|Triple-Negative Breast Carcinoma|Unresectable Lung Non-Small Cell Carcinoma|Unresectable Melanoma|Unresectable Renal Cell Carcinoma,Eribulin,CC1CC2CCC3C(=C)CC(O3)CCC45CC6C(O4)C7C(O6)C(O5)C8C(O7)CCC(O8)CC(=O)CC9C(CC(C1=C)O2)OC(C9OC)CC(CN)O,PHASE1,urinary_system_disease
4596,Advanced Malignant Solid Neoplasm|Clinical Stage III Cutaneous Melanoma AJCC v8|Clinical Stage IV Cutaneous Melanoma AJCC v8|Fallopian Tube Carcinoma|Metastatic Lung Non-Small Cell Carcinoma|Metastatic Malignant Solid Neoplasm|Metastatic Melanoma|Metastatic Renal Cell Carcinoma|Ovarian Carcinoma|Pathologic Stage III Cutaneous Melanoma AJCC v8|Pathologic Stage IIIA Cutaneous Melanoma AJCC v8|Pathologic Stage IIIB Cutaneous Melanoma AJCC v8|Pathologic Stage IIIC Cutaneous Melanoma AJCC v8|Pathologic Stage IIID Cutaneous Melanoma AJCC v8|Pathologic Stage IV Cutaneous Melanoma AJCC v8|Primary Peritoneal Carcinoma|Stage III Lung Cancer AJCC v8|Stage III Renal Cell Cancer AJCC v8|Stage IIIA Lung Cancer AJCC v8|Stage IIIB Lung Cancer AJCC v8|Stage IIIC Lung Cancer AJCC v8|Stage IV Lung Cancer AJCC v8|Stage IV Renal Cell Cancer AJCC v8|Stage IVA Lung Cancer AJCC v8|Stage IVB Lung Cancer AJCC v8|Triple-Negative Breast Carcinoma|Unresectable Lung Non-Small Cell Carcinoma|Unresectable Melanoma|Unresectable Renal Cell Carcinoma,Selinexor,C1=CN=C(C=N1)NNC(=O)C=CN2C=NC(=N2)C3=CC(=CC(=C3)C(F)(F)F)C(F)(F)F,PHASE1,urinary_system_disease
4597,Breast Cancer|Breast Neoplasms|Colon Cancer|Colonic Cancer|Colon Neoplasms|Lung Cancer|Melanoma|Kidney Cancer,Dacarbazine,CN(C)N=NC1=C(NC=N1)C(=O)N,PHASE1,urinary_system_disease
4598,Renal Impairment|End-stage Renal Disease,Simeprevir,CC1=C(C=CC2=C1N=C(C=C2OC3CC4C(C3)C(=O)N(CCCCC=CC5CC5(NC4=O)C(=O)NS(=O)(=O)C6CC6)C)C7=NC(=CS7)C(C)C)OC,PHASE2,urinary_system_disease
4599,Renal Impairment|End-stage Renal Disease,Daclatasvir,CC(C)C(C(=O)N1CCCC1C2=NC=C(N2)C3=CC=C(C=C3)C4=CC=C(C=C4)C5=CN=C(N5)C6CCCN6C(=O)C(C(C)C)NC(=O)OC)NC(=O)OC,PHASE2,urinary_system_disease
4600,Uncomplicated Urinary Tract Infection|Cystitis,Omadacycline,CC(C)(C)CNCC1=CC(=C2CC3CC4C(C(=O)C(=C(C4(C(=O)C3=C(C2=C1O)O)O)O)C(=O)N)N(C)C)N(C)C,PHASE2,urinary_system_disease
4601,Renal Clear Cell Carcinoma|Renal Papillary Cell Carcinoma,Savolitinib,CC(C1=CN2C=CN=C2C=C1)N3C4=NC(=CN=C4N=N3)C5=CN(N=C5)C,PHASE2,urinary_system_disease
4602,Diabetic Nephropathy,Pyridoxamine,CC1=NC=C(C(=C1O)CN)CO,PHASE2,urinary_system_disease
4603,Bladder Pain Syndrome,Gefapixant,CC(C)C1=CC(=C(C=C1OC2=CN=C(N=C2N)N)S(=O)(=O)N)OC,PHASE2,urinary_system_disease
4604,Lupus Nephritis,Voclosporin,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC=C)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,PHASE2,urinary_system_disease
4605,Renal Impairment,Tasimelteon,CCC(=O)NCC1CC1C2=C3CCOC3=CC=C2,PHASE1,urinary_system_disease
4606,Renal Insufficiency,Epetraborole,B1(C2=C(C=CC=C2OCCCO)C(O1)CN)O,PHASE1,urinary_system_disease
4607,End-Stage Renal Disease,Carnitine,C[N+](C)(C)CC(CC(=O)[O-])O,PHASE2,urinary_system_disease
4608,End-Stage Renal Disease,Levocarnitine,C[N+](C)(C)CC(CC(=O)[O-])O,PHASE2,urinary_system_disease
4609,Urothelial Bladder Cancer|Gastric Adenocarcinoma|Gastro-oesophageal Adenocarcinoma|Head and Neck Cancer|Biliary Tract Cancer|Platinum-sensitive Urothelial Bladder Cancer|Clear Cell Renal Cell Carcinoma|Pancreatic Ductal Adenocarcinoma,Niraparib,C1CC(CNC1)C2=CC=C(C=C2)N3C=C4C=CC=C(C4=N3)C(=O)N,PHASE2,urinary_system_disease
4610,Muscle-invasive Urothelial Cancer of the Bladder,Tricyclazole,CC1=C2C(=CC=C1)SC3=NN=CN23,PHASE2,urinary_system_disease
4611,Multiple Myeloma|Chronic Kidney Disease,Bendamustine,CN1C2=C(C=C(C=C2)N(CCCl)CCCl)N=C1CCCC(=O)O,PHASE2,urinary_system_disease
4612,Heart Failure With Preserved Ejection Fraction|Chronic Kidney Diseases,Sacubitril,CCOC(=O)C(C)CC(CC1=CC=C(C=C1)C2=CC=CC=C2)NC(=O)CCC(=O)O,PHASE1|PHASE2,urinary_system_disease
4613,Multiple Sclerosis|Overactive Detrusor,Darifenacin,C1CN(CC1C(C2=CC=CC=C2)(C3=CC=CC=C3)C(=O)N)CCC4=CC5=C(C=C4)OCC5,PHASE2,urinary_system_disease
4614,Urethritis,Tinidazole,CCS(=O)(=O)CCN1C(=NC=C1[N+](=O)[O-])C,PHASE2,urinary_system_disease
4615,Urethritis,Azithromycin,CCC1C(C(C(N(CC(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)C)O)(C)O,PHASE2,urinary_system_disease
4616,Bladder Cancer|Urothelial Carcinoma|Metastatic Urothelial Carcinoma|Renal Pelvis Carcinoma|Ureter Carcinoma|Urinary Bladder Carcinoma|Urethra Carcinoma|Muscle Invasive Bladder Cancer,Rucaparib,CNCC1=CC=C(C=C1)C2=C3CCNC(=O)C4=C3C(=CC(=C4)F)N2,PHASE2,urinary_system_disease
4617,Advanced Kidney Cancer|Kidney Cancer|Clear Cell Renal Cell Carcinoma,Guadecitabine,C1C(C(OC1N2C=NC3=C2N=C(NC3=O)N)COP(=O)(O)OC4CC(OC4CO)N5C=NC(=NC5=O)N)O,PHASE1|PHASE2,urinary_system_disease
4618,Metastatic Renal Cell Carcinoma,Enzastaurin,CN1C=C(C2=CC=CC=C21)C3=C(C(=O)NC3=O)C4=CN(C5=CC=CC=C54)C6CCN(CC6)CC7=CC=CC=N7,PHASE2,urinary_system_disease
4619,"Kidney Failure, Acute",Ambrisentan,CC1=CC(=NC(=N1)OC(C(=O)O)C(C2=CC=CC=C2)(C3=CC=CC=C3)OC)C,PHASE2,urinary_system_disease
4620,Advanced or Metastatic Hepatocellular Cancer|Advanced or Metastatic Ovarian Cancer|Metastatic Renal Cell Cancer|Advanced or Metastatic Gastric Carcinoma,Tasquinimod,CN1C2=C(C(=CC=C2)OC)C(=C(C1=O)C(=O)N(C)C3=CC=C(C=C3)C(F)(F)F)O,PHASE2,urinary_system_disease
4621,Renal Cell Carcinoma,Ciforadenant,CC1=CC=C(O1)C2=C3C(=NC(=N2)N)N(N=N3)CC4=NC(=CC=C4)COC5CCOC5,PHASE1|PHASE2,urinary_system_disease
4622,Renal Impairment,Glasdegib,CN1CCC(CC1C2=NC3=CC=CC=C3N2)NC(=O)NC4=CC=C(C=C4)C#N,PHASE1,urinary_system_disease
4623,"Hepatorenal Syndrome|Cirrhosis|Kidney Failure, Acute",Octreotide,CC(C1C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=CC=C4)NC(=O)C(CC5=CC=CC=C5)N)C(=O)NC(CO)C(C)O)O,PHASE2,urinary_system_disease
4624,HIV,Bictegravir,C1CC2CC1N3C(O2)CN4C=C(C(=O)C(=C4C3=O)O)C(=O)NCC5=C(C=C(C=C5F)F)F,PHASE1,urinary_system_disease
4625,End Stage Renal Disease,Pibrentasvir,CC(C(C(=O)N1CCCC1C2=NC3=C(N2)C=C(C(=C3)F)C4CCC(N4C5=CC(=C(C(=C5)F)N6CCC(CC6)C7=CC=C(C=C7)F)F)C8=CC9=C(C=C8F)N=C(N9)C1CCCN1C(=O)C(C(C)OC)NC(=O)OC)NC(=O)OC)OC,PHASE1|PHASE2,urinary_system_disease
4626,"Urinary Bladder, Overactive",Warfarin,CC(=O)CC(C1=CC=CC=C1)C2=C(C3=CC=CC=C3OC2=O)O,PHASE1,urinary_system_disease
4627,Kidney Stone|Ureteroscopy,Isoproterenol,CC(C)NCC(C1=CC(=C(C=C1)O)O)O,PHASE2,urinary_system_disease
4628,Kidney Stone|Ureteroscopy,Isoprenaline,CC(C)NCC(C1=CC(=C(C=C1)O)O)O,PHASE2,urinary_system_disease
4629,Autosomal Dominant Polycystic Kidney Disease|Chronic Kidney Diseases,Atorvastatin,CC(C)C1=C(C(=C(N1CCC(CC(CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4,PHASE2,urinary_system_disease
4630,Lupus Nephritis,Acetaminophen,CC(=O)NC1=CC=C(C=C1)O,PHASE2,urinary_system_disease
4631,Chemotherapy-induced Nausea and Vomiting,Fosaprepitant,CC(C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)OC2C(N(CCO2)CC3=NN(C(=O)N3)P(=O)(O)O)C4=CC=C(C=C4)F,PHASE2,urinary_system_disease
4632,Renal Impairment,Nalmefene,C=C1CCC2(C3CC4=C5C2(C1OC5=C(C=C4)O)CCN3CC6CC6)O,PHASE1,urinary_system_disease
4633,Overactive Bladder,Desmopressin,C1CC(N(C1)C(=O)C2CSSCCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N2)CC(=O)N)CCC(=O)N)CC3=CC=CC=C3)CC4=CC=C(C=C4)O)C(=O)NC(CCCN=C(N)N)C(=O)NCC(=O)N,PHASE2,urinary_system_disease
4634,Renal Insufficiency,Iberdomide,C1CC(=O)NC(=O)C1N2CC3=C(C2=O)C=CC=C3OCC4=CC=C(C=C4)CN5CCOCC5,PHASE1,urinary_system_disease
4635,Anaemia,Daprodustat,C1CCC(CC1)N2C(=O)C(C(=O)N(C2=O)C3CCCCC3)C(=O)NCC(=O)O,PHASE2,urinary_system_disease
4636,Solid Tumor|Colorectal Cancer|Cholangiocarcinoma|Bladder Cancer|Ovarian Cancer|Gastric Cancer|Palpable Subcutaneous Malignant Lesions|Renal Cell Carcinoma|Melanoma|Epithelial Ovarian Cancer|Primary Peritoneal Cancer|Fallopian Tube Cancer,Imiquimod,CC(C)CN1C=NC2=C1C3=CC=CC=C3N=C2N,PHASE1,urinary_system_disease
4637,Renal Impairment|Healthy Volunteers,Mobocertinib,CC(C)OC(=O)C1=CN=C(N=C1C2=CN(C3=CC=CC=C32)C)NC4=C(C=C(C(=C4)NC(=O)C=C)N(C)CCN(C)C)OC,PHASE1,urinary_system_disease
4638,Parkinson Disease,Preladenant,COCCOC1=CC=C(C=C1)N2CCN(CC2)CCN3C4=C(C=N3)C5=NC(=NN5C(=N4)N)C6=CC=CO6,PHASE1,urinary_system_disease
4639,Non Muscle Invasive Bladder Cancer,Celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,PHASE2,urinary_system_disease
4640,Chronic Kidney Disease|Albuminuria,Amiloride,C1(=C(N=C(C(=N1)Cl)N)N)C(=O)N=C(N)N,PHASE2,urinary_system_disease
4641,Chronic Kidney Disease,Aspirin,CC(=O)OC1=CC=CC=C1C(=O)O,PHASE1,urinary_system_disease
4642,"Kidney Failure, Chronic",Pimodivir,C1CC2CCC1C(C2NC3=NC(=NC=C3F)C4=CNC5=C4C=C(C=N5)F)C(=O)O,PHASE1,urinary_system_disease
4643,Urinary Schistosomiasis,Mefloquine,C1CCNC(C1)C(C2=CC(=NC3=C2C=CC=C3C(F)(F)F)C(F)(F)F)O,PHASE2,urinary_system_disease
4644,Diabetic Nephropathy Type 2|Microalbuminuria Due to Type 2 Diabetes Mellitus,Ramipril,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCC3CC2C(=O)O,PHASE2,urinary_system_disease
4645,Recurrent Ependymoma|Recurrent Ewing Sarcoma|Recurrent Hepatoblastoma|Recurrent Langerhans Cell Histiocytosis|Recurrent Malignant Germ Cell Tumor|Recurrent Malignant Glioma|Recurrent Malignant Solid Neoplasm|Recurrent Medulloblastoma|Recurrent Neuroblastoma|Recurrent Non-Hodgkin Lymphoma|Recurrent Osteosarcoma|Recurrent Peripheral Primitive Neuroectodermal Tumor|Recurrent Rhabdoid Tumor|Recurrent Rhabdomyosarcoma|Recurrent Soft Tissue Sarcoma|Recurrent WHO Grade 2 Glioma|Refractory Ependymoma|Refractory Ewing Sarcoma|Refractory Hepatoblastoma|Refractory Langerhans Cell Histiocytosis|Refractory Malignant Germ Cell Tumor|Refractory Malignant Glioma|Refractory Malignant Solid Neoplasm|Refractory Medulloblastoma|Refractory Neuroblastoma|Refractory Non-Hodgkin Lymphoma|Refractory Osteosarcoma|Refractory Peripheral Primitive Neuroectodermal Tumor|Refractory Rhabdoid Tumor|Refractory Rhabdomyosarcoma|Refractory Soft Tissue Sarcoma|Refractory WHO Grade 2 Glioma|Wilms Tumor,Ivosidenib,C1CC(=O)N(C1C(=O)N(C2=CC(=CN=C2)F)C(C3=CC=CC=C3Cl)C(=O)NC4CC(C4)(F)F)C5=NC=CC(=C5)C#N,PHASE2,urinary_system_disease
4646,Renal Impairment,Telotristat,CC1=NN(C=C1)C2=C(C=CC(=C2)Cl)C(C(F)(F)F)OC3=NC(=NC(=C3)C4=CC=C(C=C4)CC(C(=O)O)N)N,PHASE1,urinary_system_disease
4647,Spinal Cord Injuries|Urinary Incontinence,Sildenafil,CCCC1=NN(C2=C1N=C(NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C,PHASE2,urinary_system_disease
4648,Contrast-Induced Acute Kidney Injury,Deferiprone,CC1=C(C(=O)C=CN1C)O,PHASE2,urinary_system_disease
4649,Bladder Cancer,Rogaratinib,CC1=CC2=C(C(=C1)OC)SC(=C2)C3=C4C(=NC=NN4C(=C3COC)CN5CCNC(=O)C5)N,PHASE2,urinary_system_disease
4650,Renal Insufficiency,Aztreonam,CC1C(C(=O)N1S(=O)(=O)O)NC(=O)C(=NOC(C)(C)C(=O)O)C2=CSC(=N2)N,PHASE1,urinary_system_disease
4651,Renal Insufficiency,Avibactam,C1CC(N2CC1N(C2=O)OS(=O)(=O)O)C(=O)N,PHASE1,urinary_system_disease
4652,Chronic Renal Insufficiency,Stiripentol,CC(C)(C)C(C=CC1=CC2=C(C=C1)OCO2)O,PHASE1,urinary_system_disease
4653,Multiple Myeloma|Renal Impairment,Dextromethorphan,CN1CCC23CCCCC2C1CC4=C3C=C(C=C4)OC,PHASE1,urinary_system_disease
4654,Diabetic Nephropathy,Bindarit,CC(C)(C(=O)O)OCC1=NN(C2=CC=CC=C21)CC3=CC=CC=C3,PHASE2,urinary_system_disease
4655,Cystinuria,Tiopronin,CC(C(=O)NCC(=O)O)S,PHASE2,urinary_system_disease
4656,End Stage Renal Disease (ESRD),Icodextrin,C1=CC(=C(C(=C1)Cl)C=NN=C(N)N)Cl,PHASE2,urinary_system_disease
4657,Renal Insufficiency,Dalfampridine,C1=CN=CC=C1N,PHASE1,urinary_system_disease
4658,Vestibulodynia|Temporomandibular Disorder|Fibromyalgia Syndrome|Irritable Bowel Syndrome|Migraines|Tension Headache|Endometriosis|Interstitial Cystitis|Back Pain|Chronic Fatigue Syndrome,Nortriptyline,CNCCC=C1C2=CC=CC=C2CCC3=CC=CC=C31,PHASE2,urinary_system_disease
4659,Kidney Dysfunction,Nemonoxacin,CC1CC(CN(C1)C2=C(C3=C(C=C2)C(=O)C(=CN3C4CC4)C(=O)O)OC)N,PHASE1,urinary_system_disease
4660,Renal Cell Carcinoma,Decitabine,C1C(C(OC1N2C=NC(=NC2=O)N)CO)O,PHASE2,urinary_system_disease
4661,Renal Impairment|Renal Insufficiency|Kidney Diseases|Pharmacokinetics,Elafibranor,CC1=CC(=CC(=C1OC(C)(C)C(=O)O)C)C=CC(=O)C2=CC=C(C=C2)SC,PHASE1,urinary_system_disease
4662,Renal Insufficiency,Lanabecestat,CC#CC1=CC(=CN=C1)C2=CC3=C(CC4(C35N=C(C(=N5)N)C)CCC(CC4)OC)C=C2,PHASE1,urinary_system_disease
4663,Renal Cell Carcinoma,Fluzoparib,C1CN2C(=NC(=N2)C(F)(F)F)CN1C(=O)C3=C(C=CC(=C3)CC4=NNC(=O)C5=CC=CC=C54)F,PHASE2,urinary_system_disease
4664,Urinary Tract Infections|Pyelonephritis Acute|Intraabdominal Infections,Sulopenem,CC(C1C2N(C1=O)C(=C(S2)SC3CCS(=O)C3)C(=O)O)O,PHASE1,urinary_system_disease
4665,Renal Cell Carcinoma|Urothelial Carcinoma|Cervical Cancer|Ovarian Cancer Recurrent|Endometrial Cancer,Famitinib,CCN(CC)CCN1CCC2=C(C1=O)C(=C(N2)C=C3C4=C(C=CC(=C4)F)NC3=O)C,PHASE2,urinary_system_disease
4666,Renal Impairment,Otamixaban,CC(C(CC1=CC(=CC=C1)C(=N)N)C(=O)OC)NC(=O)C2=CC=C(C=C2)C3=CC=[N+](C=C3)[O-],PHASE1,urinary_system_disease
4667,Renal Function,Ulipristal,CC(=O)C1(CCC2C1(CC(C3=C4CCC(=O)C=C4CCC23)C5=CC=C(C=C5)N(C)C)C)O,PHASE1,urinary_system_disease
4668,"Pain, Chronic|Urge Incontinence|Overactive Bladder Syndrome|Quality of Life",Valaciclovir,CC(C)C(C(=O)OCCOCN1C=NC2=C1N=C(NC2=O)N)N,PHASE1,urinary_system_disease
4669,"Pain, Chronic|Urge Incontinence|Overactive Bladder Syndrome|Quality of Life",Valacyclovir,CC(C)C(C(=O)OCCOCN1C=NC2=C1N=C(NC2=O)N)N,PHASE1,urinary_system_disease
4670,Type2 Diabetes Mellitus|Albuminuria|Renal Insufficiency,Evogliptin,CC(C)(C)OCC1C(=O)NCCN1C(=O)CC(CC2=CC(=C(C=C2F)F)F)N,PHASE2,urinary_system_disease
4671,Type2 Diabetes Mellitus|Albuminuria|Renal Insufficiency,Linagliptin,CC#CCN1C2=C(N=C1N3CCCC(C3)N)N(C(=O)N(C2=O)CC4=NC5=CC=CC=C5C(=N4)C)C,PHASE2,urinary_system_disease
4672,Renal Impairment,Olorofim,CC1=CC(=C(N1C)C(=O)C(=O)NC2=CC=C(C=C2)N3CCN(CC3)C4=NC=C(C=N4)F)C5=CC=CC=C5,PHASE1,urinary_system_disease
4673,End Stage Renal Disease|Chronic Pain|Opioid Dependence,Buprenorphine,CC(C)(C)C(C)(C1CC23CCC1(C4C25CCN(C3CC6=C5C(=C(C=C6)O)O4)CC7CC7)OC)O,PHASE2,urinary_system_disease
4674,Renal Impairment,Hydrocodone,CN1CCC23C4C1CC5=C2C(=C(C=C5)OC)OC3C(=O)CC4,PHASE1,urinary_system_disease
4675,Kidney Failure,Voriconazole,CC(C1=NC=NC=C1F)C(CN2C=NC=N2)(C3=C(C=C(C=C3)F)F)O,PHASE1|PHASE2,urinary_system_disease
4676,Renal Impairment|Type 2 Diabetes Mellitus,Ertugliflozin,CCOC1=CC=C(C=C1)CC2=C(C=CC(=C2)C34C(C(C(C(O3)(CO4)CO)O)O)O)Cl,PHASE1,urinary_system_disease
4677,Urologic Neoplasms,Afatinib,CN(C)CC=CC(=O)NC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC(=C(C=C3)F)Cl)OC4CCOC4,PHASE2,urinary_system_disease
4678,Lupus Nephritis,Tamibarotene,CC1(CCC(C2=C1C=CC(=C2)NC(=O)C3=CC=C(C=C3)C(=O)O)(C)C)C,PHASE2,urinary_system_disease
4679,"Renal Insufficiency, Chronic",Bumetanide,CCCCNC1=C(C(=CC(=C1)C(=O)O)S(=O)(=O)N)OC2=CC=CC=C2,PHASE2,urinary_system_disease
4680,Healthy Volunteer|Renal Impairment,Probenecid,CCCN(CCC)S(=O)(=O)C1=CC=C(C=C1)C(=O)O,PHASE1,urinary_system_disease
4681,Kidney Diseases|Kidney Transplantation|Kidney Transplant|Renal Transplantation|Renal Transplant,Ganciclovir,C1=NC2=C(N1COC(CO)CO)N=C(NC2=O)N,PHASE1|PHASE2,urinary_system_disease
4682,Kidney Diseases|Kidney Transplantation|Kidney Transplant|Renal Transplantation|Renal Transplant,Valganciclovir,CC(C)C(C(=O)OCC(CO)OCN1C=NC2=C1N=C(NC2=O)N)N,PHASE1|PHASE2,urinary_system_disease
4683,Kidney Diseases|Kidney Transplantation|Kidney Transplant|Renal Transplantation|Renal Transplant,Trimethoprim,COC1=CC(=CC(=C1OC)OC)CC2=CN=C(N=C2N)N,PHASE1|PHASE2,urinary_system_disease
4684,Urinary Tract Infections|Acute Pyelonephritis,Finafloxacin,C1CC1N2C=C(C(=O)C3=CC(=C(C(=C32)C#N)N4CC5C(C4)OCCN5)F)C(=O)O,PHASE2,urinary_system_disease
4685,Chronic Kidney Disease|Proteinuria|Blood Pressure,Sitaxentan,CC1=CC2=C(C=C1CC(=O)C3=C(C=CS3)S(=O)(=O)NC4=C(C(=NO4)C)Cl)OCO2,PHASE2,urinary_system_disease
4686,Wilms' Tumor|Sarcoma|Adenaocortical Carcinoma|Refractory Cancer|Coldrhood Cancer,Tariquidar,COC1=C(C=C2CN(CCC2=C1)CCC3=CC=C(C=C3)NC(=O)C4=CC(=C(C=C4NC(=O)C5=CC6=CC=CC=C6N=C5)OC)OC)OC,PHASE1,urinary_system_disease
4687,Breast Cancer|Ovarian Cancer|Non Small Cell Lung Cancer|Colorectal Cancer|Pancreatic Cancer|Renal Cell Carcinoma|Nasopharyngeal Cancer|Head and Neck Squamous Cell Carcinoma|Gastric Cancer,Rimiducid,CCC(C1=CC(=C(C(=C1)OC)OC)OC)C(=O)N2CCCCC2C(=O)OC(CCC3=CC(=C(C=C3)OC)OC)C4=CC(=CC=C4)OCC(=O)NCCNC(=O)COC5=CC=CC(=C5)C(CCC6=CC(=C(C=C6)OC)OC)OC(=O)C7CCCCN7C(=O)C(CC)C8=CC(=C(C(=C8)OC)OC)OC,PHASE1,urinary_system_disease
4688,Acute Kidney Injury|Melatonin|Polymyxin B Adverse Reaction,Melatonin,CC(=O)NCCC1=CNC2=C1C=C(C=C2)OC,PHASE2,urinary_system_disease
4689,Retinoblastoma|Clear Cell Sarcoma|Renal Cell Carcinoma|Rhabdoid Tumor|Wilms Tumor|Hepatoblastoma|Neuroblastoma|Germ Cell Tumors|Ewings Sarcoma|Non-rhabdomyosarcoma Soft Tissue Sarcoma|Osteosarcoma|Rhabdomyosarcoma,Simvastatin,CCC(C)(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,PHASE1,urinary_system_disease
4690,Uremic Pruritus,Nalfurafine,CN(C1CCC2(C3CC4=C5C2(C1OC5=C(C=C4)O)CCN3CC6CC6)O)C(=O)C=CC7=COC=C7,PHASE2,urinary_system_disease
4691,Hypotonia Cystinuria Syndrome|Isolated PREPL Deficiency,Sulfamethoxazole,CC1=CC(=NO1)NS(=O)(=O)C2=CC=C(C=C2)N,PHASE2,urinary_system_disease
4692,"Kidney Failure, Chronic",Sapropterin,CC(C(C1CNC2=C(N1)C(=O)NC(=N2)N)O)O,PHASE2,urinary_system_disease
4693,"Kidney Failure, Chronic",Tetrahydrobiopterin,CC(C(C1CNC2=C(N1)C(=O)NC(=N2)N)O)O,PHASE2,urinary_system_disease
4694,Focal Glomerulosclerosis,Rosiglitazone,CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3,PHASE1,urinary_system_disease
4695,Non-Muscle Invasive Bladder Cancer,Bicalutamide,CC(CS(=O)(=O)C1=CC=C(C=C1)F)(C(=O)NC2=CC(=C(C=C2)C#N)C(F)(F)F)O,PHASE2,urinary_system_disease
4696,Renal Impairment,Deflazacort,CC1=NC2(C(O1)CC3C2(CC(C4C3CCC5=CC(=O)C=CC45C)O)C)C(=O)COC(=O)C,PHASE1,urinary_system_disease
4697,Renal Impairment,Glepaglutide,CCC(C)C(C(=O)NC(C(C)O)C(=O)NC(CC(=O)O)C(=O)NC(CCCCN)C(=O)NC(CCCCN)C(=O)NC(CCCCN)C(=O)NC(CCCCN)C(=O)NC(CCCCN)C(=O)NC(CCCCN)C(=O)N)NC(=O)C(CCCCN)NC(=O)C(C(C)O)NC(=O)C(C)NC(=O)C(C(C)CC)NC(=O)C(CC(C)C)NC(=O)C(CC1=CNC2=CC=CC=C21)NC(=O)C(C)NC(=O)C(C(C)CC)NC(=O)C(CC3=CC=CC=C3)NC(=O)C(CC(=O)O)NC(=O)C(CCCN=C(N)N)NC(=O)C(C)NC(=O)C(C)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CC(=O)O)NC(=O)C(CC(C)C)NC(=O)C(C(C)CC)NC(=O)C(C(C)O)NC(=O)C(C)NC(=O)C(CC(C)C)NC(=O)C(CCC(=O)O)NC(=O)C(CO)NC(=O)C(CO)NC(=O)C(CC4=CC=CC=C4)NC(=O)C(C(C)O)NC(=O)CNC(=O)C(CCC(=O)O)NC(=O)CNC(=O)C(CC5=CNC=N5)N,PHASE1,urinary_system_disease
4698,Renal Cell Cancer|Cancer,Nelfinavir,CC1=C(C=CC=C1O)C(=O)NC(CSC2=CC=CC=C2)C(CN3CC4CCCCC4CC3C(=O)NC(C)(C)C)O,PHASE1,urinary_system_disease
4699,Colorectal Carcinoma|Endometrial Carcinoma|Melanoma|Neuroblastoma|Ovarian Carcinoma|Pancreatic Ductal Adenocarcinoma|Recurrent Desmoid Fibromatosis|Recurrent Ewing Sarcoma|Recurrent Hepatoblastoma|Recurrent Hepatocellular Carcinoma|Recurrent Malignant Solid Neoplasm|Recurrent Non-Hodgkin Lymphoma|Recurrent Osteosarcoma|Refractory Desmoid Fibromatosis|Refractory Ewing Sarcoma|Refractory Hepatoblastoma|Refractory Hepatocellular Carcinoma|Refractory Malignant Solid Neoplasm|Refractory Non-Hodgkin Lymphoma|Refractory Osteosarcoma|Solid Pseudopapillary Neoplasm of the Pancreas|Wilms Tumor,Tegavivint,CC1CC(CN(C1)S(=O)(=O)C2=CC3=C(C=C2)C(=C4C=CC(=CC4=C3N=O)S(=O)(=O)N5CC(CC(C5)C)C)NO)C,PHASE1|PHASE2,urinary_system_disease
4700,Benign Prostatic Hypertrophy,Ozarelix,CCCCC(C(=O)NC(CCCN=C(N)N)C(=O)N1CCCC1C(=O)NC(C)C(=O)N)NC(=O)C(CCCCNC(=O)N)NC(=O)C(CC2=CC=C(C=C2)O)N(C)C(=O)C(CO)NC(=O)C(CC3=CN=CC=C3)NC(=O)C(CC4=CC=C(C=C4)Cl)NC(=O)C(CC5=CC6=CC=CC=C6C=C5)NC(=O)C,PHASE2,urinary_system_disease
4701,Postural Tachycardia Syndrome|Orthostatic Intolerance,Carbidopa,CC(CC1=CC(=C(C=C1)O)O)(C(=O)O)NN,PHASE2|PHASE3,urinary_system_disease
4702,Complicated Urinary Tract Infection|Acute Pyelonephritis,Piperacillin,CCN1CCN(C(=O)C1=O)C(=O)NC(C2=CC=CC=C2)C(=O)NC3C4N(C3=O)C(C(S4)(C)C)C(=O)O,PHASE2,urinary_system_disease
4703,Fanconi Anemia,Eltrombopag,CC1=C(C=C(C=C1)N2C(=O)C(=C(N2)C)N=NC3=CC=CC(=C3O)C4=CC(=CC=C4)C(=O)O)C,PHASE2,urinary_system_disease
4704,"Carcinoma, Renal Cell",Lactoferrin,CCC(C)C(C(=NC(C(C)O)C(=NC(CS)C(=NC(C(C)C)C(=NC(CCCNC(=N)N)C(=NC(CCCNC(=N)N)C(=NC(C)C(=NC(CC1=CC=CC=C1)C(=O)O)O)O)O)O)O)O)O)N=C(C(CO)N=C(C2CCCN2C(=O)C(C)N=C(CN=C(C(CC(C)C)N=C(C(CCCCN)N=C(C(CCCCN)N=C(C(CCSC)N=C(C(CCCNC(=N)N)N=C(C(CC3=CNC4=CC=CC=C43)N=C(C(CCC(=N)O)N=C(C(CC5=CNC6=CC=CC=C65)N=C(C(CCCNC(=N)N)N=C(C(CCCNC(=N)N)N=C(C(CS)N=C(C(CCCCN)N=C(C(CC7=CC=CC=C7)N)O)O)O)O)O)O)O)O)O)O)O)O)O)O)O)O,PHASE2,urinary_system_disease
4705,Diabetic Kidney Disease,Selonsertib,CC1=CC(=C(C=C1N2C=C(N=C2)C3CC3)C(=O)NC4=CC=CC(=N4)C5=NN=CN5C(C)C)F,PHASE2,urinary_system_disease
4706,Renal Cell Carcinoma,Quinacrine,CCN(CC)CCCC(C)NC1=C2C=C(C=CC2=NC3=C1C=CC(=C3)Cl)OC,PHASE2,urinary_system_disease
4707,Renal Insufficiency|Kidney Diseases|Urologic Diseases,Udenafil,CCCC1=NN(C2=C1N=C(NC2=O)C3=C(C=CC(=C3)S(=O)(=O)NCCC4CCCN4C)OCCC)C,PHASE1,urinary_system_disease
4708,Lupus Nephritis,Laquinimod,CCN(C1=CC=CC=C1)C(=O)C2=C(C3=C(C=CC=C3Cl)N(C2=O)C)O,PHASE2,urinary_system_disease
4709,Gout|Moderate Renal Impairment,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,PHASE2,urinary_system_disease
4710,Gout|Moderate Renal Impairment,Lansoprazole,CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCC(F)(F)F,PHASE2,urinary_system_disease
4711,"Renal Insufficiency, Chronic|Hepatic Insufficiency|Healthy",Itraconazole,CCC(C)N1C(=O)N(C=N1)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(C=C4)OCC5COC(O5)(CN6C=NC=N6)C7=C(C=C(C=C7)Cl)Cl,PHASE1,urinary_system_disease
4712,"Renal Insufficiency, Chronic|Hepatic Insufficiency|Healthy",Diclofenac,C1=CC=C(C(=C1)CC(=O)O)NC2=C(C=CC=C2Cl)Cl,PHASE1,urinary_system_disease
4713,Childhood Renal Cell Carcinoma|Clear Cell Renal Cell Carcinoma|Clear Cell Sarcoma of the Kidney|Papillary Renal Cell Carcinoma|Rhabdoid Tumor of the Kidney|Stage I Renal Cell Cancer|Stage I Renal Wilms Tumor|Stage II Renal Cell Cancer|Stage II Renal Wilms Tumor|Stage III Renal Cell Cancer|Stage III Renal Wilms Tumor|Stage IV Renal Cell Cancer|Stage IV Renal Wilms Tumor,Dactinomycin,CC1C(C(=O)NC(C(=O)N2CCCC2C(=O)N(CC(=O)N(C(C(=O)O1)C(C)C)C)C)C(C)C)NC(=O)C3=C4C(=C(C=C3)C)OC5=C(C(=O)C(=C(C5=N4)C(=O)NC6C(OC(=O)C(N(C(=O)CN(C(=O)C7CCCN7C(=O)C(NC6=O)C(C)C)C)C)C(C)C)C)N)C,PHASE2,urinary_system_disease
4714,Bone Marrow Failure Syndrome|Congenital Amegakaryocytic Thrombocytopenia|Congenital Pure Red Cell Aplasia|Hereditary Sideroblastic Anemia|Myeloid Neoplasms With Germline GATA2 Mutation|Paroxysmal Nocturnal Hemoglobinuria|Shwachman-Diamond Syndrome,Treosulfan,CS(=O)(=O)OCC(C(COS(=O)(=O)C)O)O,PHASE2,urinary_system_disease
4715,Biliary Carcinoma|Gall Bladder Carcinoma|Cholangiocarcinoma|Gastrointestinal Tumor,Copanlisib,COC1=C(C=CC2=C3NCCN3C(=NC(=O)C4=CN=C(N=C4)N)N=C21)OCCCN5CCOCC5,PHASE2,urinary_system_disease
4716,Congestive Heart Failure|Renal Impairment,Pecavaptan,CC(C1=NC(=NN1C2=CC(=CC=C2)Cl)CN3C(=O)N(C(=N3)C4=CC=C(C=C4)Cl)CC(C(F)(F)F)O)O,PHASE1,urinary_system_disease
4717,"Transplant; Failure, Kidney",Desflurane,C(C(F)(F)F)(OC(F)F)F,PHASE2,urinary_system_disease
4718,T2DM (Type 2 Diabetes Mellitus)|Metformin|SGLT2-Inhibitors,Tofogliflozin,CCC1=CC=C(C=C1)CC2=CC3=C(COC34C(C(C(C(O4)CO)O)O)O)C=C2,PHASE2,urinary_system_disease
4719,Overactive Bladder|Mild Cognitive Impairment,Oxybutynin,CCN(CC)CC#CCOC(=O)C(C1CCCCC1)(C2=CC=CC=C2)O,PHASE2,urinary_system_disease
4720,"Healthy Volunteers|Polycystic Kidney, Autosomal Dominant",Venglustat,CC(C)(C1=CSC(=N1)C2=CC=C(C=C2)F)NC(=O)OC3CN4CCC3CC4,PHASE1,urinary_system_disease
4721,Diabetic Nephropathy,Topiroxostat,C1=CN=CC=C1C2=NC(=NN2)C3=CC(=NC=C3)C#N,PHASE2,urinary_system_disease
4722,Neurogenic Bladder,Methantheline,CC[N+](C)(CC)CCOC(=O)C1C2=CC=CC=C2OC3=CC=CC=C13,PHASE1,urinary_system_disease
4723,Renal Impairment,Teriflunomide,CC(=C(C#N)C(=O)NC1=CC=C(C=C1)C(F)(F)F)O,PHASE1,urinary_system_disease
4724,Renal Impairment,Cholestyramine,CCC(C)C.CCC(CC(C)C1=CC=CC=C1)C2=CC=C(C=C2)C[N+](C)(C)C.N.[Cl-],PHASE1,urinary_system_disease
4725,Chronic Kidney Disease,Irbesartan,CCCCC1=NC2(CCCC2)C(=O)N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5,PHASE2,urinary_system_disease
4726,Prostate Cancer|Erectile Dysfunction|Lower Urinary Tract Symptoms,Dutasteride,CC12CCC3C(C1CCC2C(=O)NC4=C(C=CC(=C4)C(F)(F)F)C(F)(F)F)CCC5C3(C=CC(=O)N5)C,PHASE2,urinary_system_disease
4727,Renal Insufficiency,Tirofiban,CCCCS(=O)(=O)NC(CC1=CC=C(C=C1)OCCCCC2CCNCC2)C(=O)O,PHASE1,urinary_system_disease
4728,Kidney Transplantation|Kidney Disease,Acyclovir,C1=NC2=C(N1COCCO)N=C(NC2=O)N,PHASE1|PHASE2,urinary_system_disease
4729,Kidney Transplantation|Kidney Disease,Pentamidine,C1=CC(=CC=C1C(=N)N)OCCCCCOC2=CC=C(C=C2)C(=N)N,PHASE1|PHASE2,urinary_system_disease
4730,Kidney Transplantation|Kidney Disease,Clotrimazole,C1=CC=C(C=C1)C(C2=CC=CC=C2)(C3=CC=CC=C3Cl)N4C=CN=C4,PHASE1|PHASE2,urinary_system_disease
4731,Kidney Transplantation|Kidney Disease,Nystatin,CC1C=CC=CCCC=CC=CC=CC=CC(CC2C(C(CC(O2)(CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)O)C(=O)O)OC3C(C(C(C(O3)C)O)N)O,PHASE1|PHASE2,urinary_system_disease
4732,Acute Renal Failure|Infection,Anidulafungin,CCCCCOC1=CC=C(C=C1)C2=CC=C(C=C2)C3=CC=C(C=C3)C(=O)NC4CC(C(NC(=O)C5C(C(CN5C(=O)C(NC(=O)C(NC(=O)C6CC(CN6C(=O)C(NC4=O)C(C)O)O)C(C(C7=CC=C(C=C7)O)O)O)C(C)O)C)O)O)O,PHASE2,urinary_system_disease
4733,Renal Impairment,Doravirine,CN1C(=NNC1=O)CN2C=CC(=C(C2=O)OC3=CC(=CC(=C3)C#N)Cl)C(F)(F)F,PHASE1,urinary_system_disease
4734,Kidney Cancer,Acarbose,CC1C(C(C(C(O1)OC2C(OC(C(C2O)O)OC3C(OC(C(C3O)O)O)CO)CO)O)O)NC4C=C(C(C(C4O)O)O)CO,PHASE2,urinary_system_disease
4735,Renal Disease|End Stage Renal Disease,Droxidopa,C1=CC(=C(C=C1C(C(C(=O)O)N)O)O)O,PHASE1,urinary_system_disease
4736,Renal Insufficiency,Setmelanotide,CC1C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(C(=O)N1)NC(=O)C(CCCN=C(N)N)NC(=O)C)C(=O)N)CC2=CNC3=CC=CC=C32)CCCN=C(N)N)CC4=CC=CC=C4)CC5=CN=CN5,PHASE1,urinary_system_disease
4737,End Stage Renal Disease,Plazomicin,CC1(COC(C(C1NC)O)OC2C(CC(C(C2O)OC3C(CC=C(O3)CNCCO)N)N)NC(=O)C(CCN)O)O,PHASE1,urinary_system_disease
4738,Stage III Cutaneous Melanoma|Stage IV Cutaneous Melanoma|Locally Advanced Melanoma|Locally Advanced Solid Neoplasm|Metastatic Head and Neck Squamous Cell Carcinoma|Metastatic Malignant Solid Neoplasm|Metastatic Melanoma|Metastatic Urothelial Carcinoma|Non-Small Cell Lung Carcinoma|Stage IB Lung Cancer AJCC v7|Stage III Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8|Stage III Lung Cancer AJCC v8|Stage III Ureter Cancer AJCC v8|Stage IIIA Lung Cancer AJCC v8|Stage IIIB Lung Cancer AJCC v8|Stage IIIC Lung Cancer AJCC v8|Stage IV Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8|Stage IV Lung Cancer AJCC v8|Stage IV Ureter Cancer AJCC v8|Stage IVA Lung Cancer AJCC v8|Stage IVB Lung Cancer AJCC v8,Abexinostat,CN(C)CC1=C(OC2=CC=CC=C21)C(=O)NCCOC3=CC=C(C=C3)C(=O)NO,PHASE1,urinary_system_disease
4739,Acute Renal Failure,Fenoldopam,C1CNCC(C2=CC(=C(C(=C21)Cl)O)O)C3=CC=C(C=C3)O,PHASE2|PHASE3,urinary_system_disease
4740,Lupus Nephritis,Iguratimod,CS(=O)(=O)NC1=C(C=C2C(=C1)OC=C(C2=O)NC=O)OC3=CC=CC=C3,PHASE2,urinary_system_disease
4741,Renal Impairment,Brensocatib,CN1C2=C(C=CC(=C2)C3=CC=C(C=C3)CC(C#N)NC(=O)C4CNCCCO4)OC1=O,PHASE1,urinary_system_disease
4742,Healthy,Megestrol,CC1=CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C,PHASE1,urinary_system_disease
4743,Renal Insufficiency,Certoparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,PHASE1|PHASE2,urinary_system_disease
4744,"Kidney Stone|Pain, Postoperative|Addiction|Opioid Use",Pregabalin,CC(C)CC(CC(=O)O)CN,PHASE2|PHASE3,urinary_system_disease
4745,Growth Hormone Disorder|Adult Growth Hormone Deficiency|Growth Hormone Deficiency in Children,Somapacitan,C(CCCCCCCC1=NNN=N1)CCCCCCCC(=O)NS(=O)(=O)CCCC(=O)NCCOCCOCC(=O)NC(CCC(=O)NC(CCC(=O)NCCOCCOCC(=O)NC(CCCCNC(=O)CSCC(C(=O)O)N)C(=O)N)C(=O)O)C(=O)O,PHASE1,urinary_system_disease
4746,Contrast-induced Nephropathy,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,PHASE2,urinary_system_disease
4747,"Carcinoma, Renal Cell",Gefitinib,COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4,PHASE1|PHASE2,urinary_system_disease
4748,Bladder Cancer|NMIBC|Non-Muscle Invasive Bladder Cancer|Urothelial Carcinoma Recurrent,Pemigatinib,CCN1C2=C3C=C(NC3=NC=C2CN(C1=O)C4=C(C(=CC(=C4F)OC)OC)F)CN5CCOCC5,PHASE2,urinary_system_disease
4749,Urinary Tract Infection,Cefixime,C=CC1=C(N2C(C(C2=O)NC(=O)C(=NOCC(=O)O)C3=CSC(=N3)N)SC1)C(=O)O,PHASE2,urinary_system_disease
4750,Urinary Tract Infection,Cephalexin,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O,PHASE2,urinary_system_disease
4751,Chronic Kidney Diseases,Quetiapine,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42,PHASE1,urinary_system_disease
4752,Renal Insufficiency,Odalasvir,CC(C)C(C(=O)N1C2CCCCC2CC1C3=NC4=C(N3)C=C(C=C4)C5=C6CCC7=CC(=C(CCC(=C5)C=C6)C=C7)C8=CC9=C(C=C8)N=C(N9)C1CC2CCCCC2N1C(=O)C(C(C)C)NC(=O)OC)NC(=O)OC,PHASE1,urinary_system_disease
4753,"Carcinoma, Transitional Cell|Bladder Cancer|Bladder Neoplasm",Pralatrexate,C#CCC(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,PHASE2,urinary_system_disease
4754,Renal Impairment,Asciminib,C1CN(CC1O)C2=C(C=C(C=N2)C(=O)NC3=CC=C(C=C3)OC(F)(F)Cl)C4=CC=NN4,PHASE1,urinary_system_disease
4755,"Urinary Incontinence,Stress|Fecal Incontinence",Tadalafil,CN1CC(=O)N2C(C1=O)CC3=C(C2C4=CC5=C(C=C4)OCO5)NC6=CC=CC=C36,PHASE1,urinary_system_disease
4756,Diabetes Mellitus|Iron Metabolism Disorders|Gastroduodenal Ulcer|Optic Atrophy|Sensorineural Hearing Loss|Platelet Dysfunction,Sitagliptin,C1CN2C(=NN=C2C(F)(F)F)CN1C(=O)CC(CC3=CC(=C(C=C3F)F)F)N,PHASE2|PHASE3,urinary_system_disease
4757,Renal Impaired|Gilteritinib|Normal Renal Function|Pharmacokinetics of ASP2215,Gilteritinib,CCC1=C(N=C(C(=N1)C(=O)N)NC2=CC(=C(C=C2)N3CCC(CC3)N4CCN(CC4)C)OC)NC5CCOCC5,PHASE1,urinary_system_disease
4758,Renal Impairment,Evobrutinib,C=CC(=O)N1CCC(CC1)CNC2=NC=NC(=C2C3=CC=C(C=C3)OC4=CC=CC=C4)N,PHASE1,urinary_system_disease
4759,Severe Renal Impairment,Ranolazine,CC1=C(C(=CC=C1)C)NC(=O)CN2CCN(CC2)CC(COC3=CC=CC=C3OC)O,PHASE1,urinary_system_disease
4760,Clinical Pharmacology,Riociguat,CN(C1=C(N=C(N=C1N)C2=NN(C3=C2C=CC=N3)CC4=CC=CC=C4F)N)C(=O)OC,PHASE1,urinary_system_disease
4761,Advanced/Metastasis Renal Cell Carcinoma,Lipotecan,CCC1(C2=C(COC1=O)C(=O)N3CC4=CC5=C(C=CC(=C5CN(C)C)O)N=C4C3=C2)OC(=O)C(C)ON=C6C7=C(C(=CC(=C7)[N+](=O)[O-])[N+](=O)[O-])C8=C6C=C(C=C8[N+](=O)[O-])[N+](=O)[O-],PHASE2,urinary_system_disease
4762,Renal Impairment|Healthy Participants,Linzagolix,COC1=C(C(=C(C=C1)F)F)COC2=C(C=C(C(=C2)N3C(=O)C4=C(SC=C4NC3=O)C(=O)O)F)OC,PHASE1,urinary_system_disease
4763,Diabetic Nephropathies,Trimetazidine,COC1=C(C(=C(C=C1)CN2CCNCC2)OC)OC,PHASE2,urinary_system_disease
4764,Pain|Urinary Stone|Urinary Calculi,Ketorolac,C1CN2C(=CC=C2C(=O)C3=CC=CC=C3)C1C(=O)O,PHASE2,urinary_system_disease
4765,Advanced Malignant Solid Neoplasm|Bladder Carcinoma|Breast Carcinoma|Cervical Carcinoma|Colon Carcinoma|Colorectal Carcinoma|Endometrial Carcinoma|Esophageal Carcinoma|Gastric Carcinoma|Glioma|Head and Neck Carcinoma|Kidney Carcinoma|Liver and Intrahepatic Bile Duct Carcinoma|Lung Carcinoma|Lymphoma|Malignant Uterine Neoplasm|Melanoma|Multiple Myeloma|Ovarian Carcinoma|Pancreatic Carcinoma|Prostate Carcinoma|Rectal Carcinoma|Recurrent Bladder Carcinoma|Recurrent Breast Carcinoma|Recurrent Cervical Carcinoma|Recurrent Colon Carcinoma|Recurrent Colorectal Carcinoma|Recurrent Esophageal Carcinoma|Recurrent Gastric Carcinoma|Recurrent Glioma|Recurrent Head and Neck Carcinoma|Recurrent Liver Carcinoma|Recurrent Lung Carcinoma|Recurrent Lymphoma|Recurrent Malignant Solid Neoplasm|Recurrent Melanoma|Recurrent Multiple Myeloma|Recurrent Ovarian Carcinoma|Recurrent Pancreatic Carcinoma|Recurrent Prostate Carcinoma|Recurrent Rectal Carcinoma|Recurrent Skin Carcinoma|Recurrent Thyroid Gland Carcinoma|Recurrent Uterine Corpus Cancer|Refractory Lymphoma|Refractory Malignant Solid Neoplasm|Refractory Multiple Myeloma|Skin Carcinoma|Thyroid Gland Carcinoma|Uterine Corpus Cancer,Binimetinib,CN1C=NC2=C1C=C(C(=C2F)NC3=C(C=C(C=C3)Br)F)C(=O)NOCCO,PHASE2,urinary_system_disease
4766,Advanced Malignant Solid Neoplasm|Bladder Carcinoma|Breast Carcinoma|Cervical Carcinoma|Colon Carcinoma|Colorectal Carcinoma|Endometrial Carcinoma|Esophageal Carcinoma|Gastric Carcinoma|Glioma|Head and Neck Carcinoma|Kidney Carcinoma|Liver and Intrahepatic Bile Duct Carcinoma|Lung Carcinoma|Lymphoma|Malignant Uterine Neoplasm|Melanoma|Multiple Myeloma|Ovarian Carcinoma|Pancreatic Carcinoma|Prostate Carcinoma|Rectal Carcinoma|Recurrent Bladder Carcinoma|Recurrent Breast Carcinoma|Recurrent Cervical Carcinoma|Recurrent Colon Carcinoma|Recurrent Colorectal Carcinoma|Recurrent Esophageal Carcinoma|Recurrent Gastric Carcinoma|Recurrent Glioma|Recurrent Head and Neck Carcinoma|Recurrent Liver Carcinoma|Recurrent Lung Carcinoma|Recurrent Lymphoma|Recurrent Malignant Solid Neoplasm|Recurrent Melanoma|Recurrent Multiple Myeloma|Recurrent Ovarian Carcinoma|Recurrent Pancreatic Carcinoma|Recurrent Prostate Carcinoma|Recurrent Rectal Carcinoma|Recurrent Skin Carcinoma|Recurrent Thyroid Gland Carcinoma|Recurrent Uterine Corpus Cancer|Refractory Lymphoma|Refractory Malignant Solid Neoplasm|Refractory Multiple Myeloma|Skin Carcinoma|Thyroid Gland Carcinoma|Uterine Corpus Cancer,Capivasertib,C1CN(CCC1(C(=O)NC(CCO)C2=CC=C(C=C2)Cl)N)C3=NC=NC4=C3C=CN4,PHASE2,urinary_system_disease
4767,Advanced Malignant Solid Neoplasm|Bladder Carcinoma|Breast Carcinoma|Cervical Carcinoma|Colon Carcinoma|Colorectal Carcinoma|Endometrial Carcinoma|Esophageal Carcinoma|Gastric Carcinoma|Glioma|Head and Neck Carcinoma|Kidney Carcinoma|Liver and Intrahepatic Bile Duct Carcinoma|Lung Carcinoma|Lymphoma|Malignant Uterine Neoplasm|Melanoma|Multiple Myeloma|Ovarian Carcinoma|Pancreatic Carcinoma|Prostate Carcinoma|Rectal Carcinoma|Recurrent Bladder Carcinoma|Recurrent Breast Carcinoma|Recurrent Cervical Carcinoma|Recurrent Colon Carcinoma|Recurrent Colorectal Carcinoma|Recurrent Esophageal Carcinoma|Recurrent Gastric Carcinoma|Recurrent Glioma|Recurrent Head and Neck Carcinoma|Recurrent Liver Carcinoma|Recurrent Lung Carcinoma|Recurrent Lymphoma|Recurrent Malignant Solid Neoplasm|Recurrent Melanoma|Recurrent Multiple Myeloma|Recurrent Ovarian Carcinoma|Recurrent Pancreatic Carcinoma|Recurrent Prostate Carcinoma|Recurrent Rectal Carcinoma|Recurrent Skin Carcinoma|Recurrent Thyroid Gland Carcinoma|Recurrent Uterine Corpus Cancer|Refractory Lymphoma|Refractory Malignant Solid Neoplasm|Refractory Multiple Myeloma|Skin Carcinoma|Thyroid Gland Carcinoma|Uterine Corpus Cancer,Dabrafenib,CC(C)(C)C1=NC(=C(S1)C2=NC(=NC=C2)N)C3=C(C(=CC=C3)NS(=O)(=O)C4=C(C=CC=C4F)F)F,PHASE2,urinary_system_disease
4768,Advanced Malignant Solid Neoplasm|Bladder Carcinoma|Breast Carcinoma|Cervical Carcinoma|Colon Carcinoma|Colorectal Carcinoma|Endometrial Carcinoma|Esophageal Carcinoma|Gastric Carcinoma|Glioma|Head and Neck Carcinoma|Kidney Carcinoma|Liver and Intrahepatic Bile Duct Carcinoma|Lung Carcinoma|Lymphoma|Malignant Uterine Neoplasm|Melanoma|Multiple Myeloma|Ovarian Carcinoma|Pancreatic Carcinoma|Prostate Carcinoma|Rectal Carcinoma|Recurrent Bladder Carcinoma|Recurrent Breast Carcinoma|Recurrent Cervical Carcinoma|Recurrent Colon Carcinoma|Recurrent Colorectal Carcinoma|Recurrent Esophageal Carcinoma|Recurrent Gastric Carcinoma|Recurrent Glioma|Recurrent Head and Neck Carcinoma|Recurrent Liver Carcinoma|Recurrent Lung Carcinoma|Recurrent Lymphoma|Recurrent Malignant Solid Neoplasm|Recurrent Melanoma|Recurrent Multiple Myeloma|Recurrent Ovarian Carcinoma|Recurrent Pancreatic Carcinoma|Recurrent Prostate Carcinoma|Recurrent Rectal Carcinoma|Recurrent Skin Carcinoma|Recurrent Thyroid Gland Carcinoma|Recurrent Uterine Corpus Cancer|Refractory Lymphoma|Refractory Malignant Solid Neoplasm|Refractory Multiple Myeloma|Skin Carcinoma|Thyroid Gland Carcinoma|Uterine Corpus Cancer,Defactinib,CNC(=O)C1=CC=C(C=C1)NC2=NC=C(C(=N2)NCC3=NC=CN=C3N(C)S(=O)(=O)C)C(F)(F)F,PHASE2,urinary_system_disease
4769,Advanced Malignant Solid Neoplasm|Bladder Carcinoma|Breast Carcinoma|Cervical Carcinoma|Colon Carcinoma|Colorectal Carcinoma|Endometrial Carcinoma|Esophageal Carcinoma|Gastric Carcinoma|Glioma|Head and Neck Carcinoma|Kidney Carcinoma|Liver and Intrahepatic Bile Duct Carcinoma|Lung Carcinoma|Lymphoma|Malignant Uterine Neoplasm|Melanoma|Multiple Myeloma|Ovarian Carcinoma|Pancreatic Carcinoma|Prostate Carcinoma|Rectal Carcinoma|Recurrent Bladder Carcinoma|Recurrent Breast Carcinoma|Recurrent Cervical Carcinoma|Recurrent Colon Carcinoma|Recurrent Colorectal Carcinoma|Recurrent Esophageal Carcinoma|Recurrent Gastric Carcinoma|Recurrent Glioma|Recurrent Head and Neck Carcinoma|Recurrent Liver Carcinoma|Recurrent Lung Carcinoma|Recurrent Lymphoma|Recurrent Malignant Solid Neoplasm|Recurrent Melanoma|Recurrent Multiple Myeloma|Recurrent Ovarian Carcinoma|Recurrent Pancreatic Carcinoma|Recurrent Prostate Carcinoma|Recurrent Rectal Carcinoma|Recurrent Skin Carcinoma|Recurrent Thyroid Gland Carcinoma|Recurrent Uterine Corpus Cancer|Refractory Lymphoma|Refractory Malignant Solid Neoplasm|Refractory Multiple Myeloma|Skin Carcinoma|Thyroid Gland Carcinoma|Uterine Corpus Cancer,Ipatasertib,CC1CC(C2=C1C(=NC=N2)N3CCN(CC3)C(=O)C(CNC(C)C)C4=CC=C(C=C4)Cl)O,PHASE2,urinary_system_disease
4770,Advanced Malignant Solid Neoplasm|Bladder Carcinoma|Breast Carcinoma|Cervical Carcinoma|Colon Carcinoma|Colorectal Carcinoma|Endometrial Carcinoma|Esophageal Carcinoma|Gastric Carcinoma|Glioma|Head and Neck Carcinoma|Kidney Carcinoma|Liver and Intrahepatic Bile Duct Carcinoma|Lung Carcinoma|Lymphoma|Malignant Uterine Neoplasm|Melanoma|Multiple Myeloma|Ovarian Carcinoma|Pancreatic Carcinoma|Prostate Carcinoma|Rectal Carcinoma|Recurrent Bladder Carcinoma|Recurrent Breast Carcinoma|Recurrent Cervical Carcinoma|Recurrent Colon Carcinoma|Recurrent Colorectal Carcinoma|Recurrent Esophageal Carcinoma|Recurrent Gastric Carcinoma|Recurrent Glioma|Recurrent Head and Neck Carcinoma|Recurrent Liver Carcinoma|Recurrent Lung Carcinoma|Recurrent Lymphoma|Recurrent Malignant Solid Neoplasm|Recurrent Melanoma|Recurrent Multiple Myeloma|Recurrent Ovarian Carcinoma|Recurrent Pancreatic Carcinoma|Recurrent Prostate Carcinoma|Recurrent Rectal Carcinoma|Recurrent Skin Carcinoma|Recurrent Thyroid Gland Carcinoma|Recurrent Uterine Corpus Cancer|Refractory Lymphoma|Refractory Malignant Solid Neoplasm|Refractory Multiple Myeloma|Skin Carcinoma|Thyroid Gland Carcinoma|Uterine Corpus Cancer,Osimertinib,CN1C=C(C2=CC=CC=C21)C3=NC(=NC=C3)NC4=C(C=C(C(=C4)NC(=O)C=C)N(C)CCN(C)C)OC,PHASE2,urinary_system_disease
4771,Advanced Malignant Solid Neoplasm|Bladder Carcinoma|Breast Carcinoma|Cervical Carcinoma|Colon Carcinoma|Colorectal Carcinoma|Endometrial Carcinoma|Esophageal Carcinoma|Gastric Carcinoma|Glioma|Head and Neck Carcinoma|Kidney Carcinoma|Liver and Intrahepatic Bile Duct Carcinoma|Lung Carcinoma|Lymphoma|Malignant Uterine Neoplasm|Melanoma|Multiple Myeloma|Ovarian Carcinoma|Pancreatic Carcinoma|Prostate Carcinoma|Rectal Carcinoma|Recurrent Bladder Carcinoma|Recurrent Breast Carcinoma|Recurrent Cervical Carcinoma|Recurrent Colon Carcinoma|Recurrent Colorectal Carcinoma|Recurrent Esophageal Carcinoma|Recurrent Gastric Carcinoma|Recurrent Glioma|Recurrent Head and Neck Carcinoma|Recurrent Liver Carcinoma|Recurrent Lung Carcinoma|Recurrent Lymphoma|Recurrent Malignant Solid Neoplasm|Recurrent Melanoma|Recurrent Multiple Myeloma|Recurrent Ovarian Carcinoma|Recurrent Pancreatic Carcinoma|Recurrent Prostate Carcinoma|Recurrent Rectal Carcinoma|Recurrent Skin Carcinoma|Recurrent Thyroid Gland Carcinoma|Recurrent Uterine Corpus Cancer|Refractory Lymphoma|Refractory Malignant Solid Neoplasm|Refractory Multiple Myeloma|Skin Carcinoma|Thyroid Gland Carcinoma|Uterine Corpus Cancer,Sapanisertib,CC(C)N1C2=NC=NC(=C2C(=N1)C3=CC4=C(C=C3)OC(=N4)N)N,PHASE2,urinary_system_disease
4772,Advanced Malignant Solid Neoplasm|Bladder Carcinoma|Breast Carcinoma|Cervical Carcinoma|Colon Carcinoma|Colorectal Carcinoma|Endometrial Carcinoma|Esophageal Carcinoma|Gastric Carcinoma|Glioma|Head and Neck Carcinoma|Kidney Carcinoma|Liver and Intrahepatic Bile Duct Carcinoma|Lung Carcinoma|Lymphoma|Malignant Uterine Neoplasm|Melanoma|Multiple Myeloma|Ovarian Carcinoma|Pancreatic Carcinoma|Prostate Carcinoma|Rectal Carcinoma|Recurrent Bladder Carcinoma|Recurrent Breast Carcinoma|Recurrent Cervical Carcinoma|Recurrent Colon Carcinoma|Recurrent Colorectal Carcinoma|Recurrent Esophageal Carcinoma|Recurrent Gastric Carcinoma|Recurrent Glioma|Recurrent Head and Neck Carcinoma|Recurrent Liver Carcinoma|Recurrent Lung Carcinoma|Recurrent Lymphoma|Recurrent Malignant Solid Neoplasm|Recurrent Melanoma|Recurrent Multiple Myeloma|Recurrent Ovarian Carcinoma|Recurrent Pancreatic Carcinoma|Recurrent Prostate Carcinoma|Recurrent Rectal Carcinoma|Recurrent Skin Carcinoma|Recurrent Thyroid Gland Carcinoma|Recurrent Uterine Corpus Cancer|Refractory Lymphoma|Refractory Malignant Solid Neoplasm|Refractory Multiple Myeloma|Skin Carcinoma|Thyroid Gland Carcinoma|Uterine Corpus Cancer,Taselisib,CC1=NN(C(=N1)C2=CN3CCOC4=C(C3=N2)C=CC(=C4)C5=CN(N=C5)C(C)(C)C(=O)N)C(C)C,PHASE2,urinary_system_disease
4773,Advanced Malignant Solid Neoplasm|Bladder Carcinoma|Breast Carcinoma|Cervical Carcinoma|Colon Carcinoma|Colorectal Carcinoma|Endometrial Carcinoma|Esophageal Carcinoma|Gastric Carcinoma|Glioma|Head and Neck Carcinoma|Kidney Carcinoma|Liver and Intrahepatic Bile Duct Carcinoma|Lung Carcinoma|Lymphoma|Malignant Uterine Neoplasm|Melanoma|Multiple Myeloma|Ovarian Carcinoma|Pancreatic Carcinoma|Prostate Carcinoma|Rectal Carcinoma|Recurrent Bladder Carcinoma|Recurrent Breast Carcinoma|Recurrent Cervical Carcinoma|Recurrent Colon Carcinoma|Recurrent Colorectal Carcinoma|Recurrent Esophageal Carcinoma|Recurrent Gastric Carcinoma|Recurrent Glioma|Recurrent Head and Neck Carcinoma|Recurrent Liver Carcinoma|Recurrent Lung Carcinoma|Recurrent Lymphoma|Recurrent Malignant Solid Neoplasm|Recurrent Melanoma|Recurrent Multiple Myeloma|Recurrent Ovarian Carcinoma|Recurrent Pancreatic Carcinoma|Recurrent Prostate Carcinoma|Recurrent Rectal Carcinoma|Recurrent Skin Carcinoma|Recurrent Thyroid Gland Carcinoma|Recurrent Uterine Corpus Cancer|Refractory Lymphoma|Refractory Malignant Solid Neoplasm|Refractory Multiple Myeloma|Skin Carcinoma|Thyroid Gland Carcinoma|Uterine Corpus Cancer,Trametinib,CC1=C2C(=C(N(C1=O)C)NC3=C(C=C(C=C3)I)F)C(=O)N(C(=O)N2C4=CC=CC(=C4)NC(=O)C)C5CC5,PHASE2,urinary_system_disease
4774,Advanced Malignant Solid Neoplasm|Bladder Carcinoma|Breast Carcinoma|Cervical Carcinoma|Colon Carcinoma|Colorectal Carcinoma|Endometrial Carcinoma|Esophageal Carcinoma|Gastric Carcinoma|Glioma|Head and Neck Carcinoma|Kidney Carcinoma|Liver and Intrahepatic Bile Duct Carcinoma|Lung Carcinoma|Lymphoma|Malignant Uterine Neoplasm|Melanoma|Multiple Myeloma|Ovarian Carcinoma|Pancreatic Carcinoma|Prostate Carcinoma|Rectal Carcinoma|Recurrent Bladder Carcinoma|Recurrent Breast Carcinoma|Recurrent Cervical Carcinoma|Recurrent Colon Carcinoma|Recurrent Colorectal Carcinoma|Recurrent Esophageal Carcinoma|Recurrent Gastric Carcinoma|Recurrent Glioma|Recurrent Head and Neck Carcinoma|Recurrent Liver Carcinoma|Recurrent Lung Carcinoma|Recurrent Lymphoma|Recurrent Malignant Solid Neoplasm|Recurrent Melanoma|Recurrent Multiple Myeloma|Recurrent Ovarian Carcinoma|Recurrent Pancreatic Carcinoma|Recurrent Prostate Carcinoma|Recurrent Rectal Carcinoma|Recurrent Skin Carcinoma|Recurrent Thyroid Gland Carcinoma|Recurrent Uterine Corpus Cancer|Refractory Lymphoma|Refractory Malignant Solid Neoplasm|Refractory Multiple Myeloma|Skin Carcinoma|Thyroid Gland Carcinoma|Uterine Corpus Cancer,Vismodegib,CS(=O)(=O)C1=CC(=C(C=C1)C(=O)NC2=CC(=C(C=C2)Cl)C3=CC=CC=N3)Cl,PHASE2,urinary_system_disease
4775,Long QT Syndrome,Eleclazine,C1COC2=C(C=C(C=C2)C3=CC=C(C=C3)OC(F)(F)F)C(=O)N1CC4=NC=CC=N4,PHASE1,urinary_system_disease
4776,Primary Membranous Nephropathy,Zanubrutinib,C=CC(=O)N1CCC(CC1)C2CCNC3=C(C(=NN23)C4=CC=C(C=C4)OC5=CC=CC=C5)C(=O)N,PHASE2|PHASE3,urinary_system_disease
4777,HIV Infections,Raltegravir,CC1=NN=C(O1)C(=O)NC(C)(C)C2=NC(=C(C(=O)N2C)O)C(=O)NCC3=CC=C(C=C3)F,PHASE2,urinary_system_disease
4778,HIV Infections,Lamivudine,C1C(OC(S1)CO)N2C=CC(=NC2=O)N,PHASE2,urinary_system_disease
4779,HIV Infections,Tenofovir,CC(CN1C=NC2=C(N=CN=C21)N)OCP(=O)(O)O,PHASE2,urinary_system_disease
4780,HIV Infections,Emtricitabine,C1C(OC(S1)CO)N2C=C(C(=NC2=O)N)F,PHASE2,urinary_system_disease
4781,HIV Infections,Lopinavir,CC1=C(C(=CC=C1)C)OCC(=O)NC(CC2=CC=CC=C2)C(CC(CC3=CC=CC=C3)NC(=O)C(C(C)C)N4CCCNC4=O)O,PHASE2,urinary_system_disease
4782,HIV Infections,Ritonavir,CC(C)C1=NC(=CS1)CN(C)C(=O)NC(C(C)C)C(=O)NC(CC2=CC=CC=C2)CC(C(CC3=CC=CC=C3)NC(=O)OCC4=CN=CS4)O,PHASE2,urinary_system_disease
4783,HIV Infections,Atazanavir,CC(C)(C)C(C(=O)NC(CC1=CC=CC=C1)C(CN(CC2=CC=C(C=C2)C3=CC=CC=N3)NC(=O)C(C(C)(C)C)NC(=O)OC)O)NC(=O)OC,PHASE2,urinary_system_disease
4784,HIV Infections,Darunavir,CC(C)CN(CC(C(CC1=CC=CC=C1)NC(=O)OC2COC3C2CCO3)O)S(=O)(=O)C4=CC=C(C=C4)N,PHASE2,urinary_system_disease
4785,Nocturia,Fedovapagon,CC1=C(C=CC(=C1)C(=O)N2CCCCC3=CC=CC=C32)CNC(=O)N4CCCC4C(=O)N(C)C,PHASE2|PHASE3,urinary_system_disease
4786,Myelofibrosis,Pacritinib,C1CCN(C1)CCOC2=C3COCC=CCOCC4=CC(=CC=C4)C5=NC(=NC=C5)NC(=C3)C=C2,PHASE1,urinary_system_disease
4787,Somatostatin Analogs|Polycystic Liver Disease|Autosomal Dominant Polycystic Kidney Disease|Autosomal Dominant Polycystic Liver Disease,Pasireotide,C1C(CN2C1C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C2=O)CC3=CC=CC=C3)CC4=CC=C(C=C4)OCC5=CC=CC=C5)CCCCN)CC6=CNC7=CC=CC=C76)C8=CC=CC=C8)OC(=O)NCCN,PHASE2,urinary_system_disease
4788,Recurrent Renal Cell Carcinoma|Stage III Renal Cell Cancer|Stage IV Renal Cell Cancer|Type 1 Papillary Renal Cell Carcinoma|Type 2 Papillary Renal Cell Carcinoma,Tivantinib,C1CC2=C3C(=CC=C2)C(=CN3C1)C4C(C(=O)NC4=O)C5=CNC6=CC=CC=C65,PHASE2,urinary_system_disease
4789,Restless Legs Syndrome|End Stage Renal Disease|Hemodialysis|Muscle Cachexia|Sleep Disorders,Dopamine,C1=CC(=C(C=C1CCN)O)O,PHASE2,urinary_system_disease
4790,Nocturia|Daytime Sleepiness,Modafinil,C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N,PHASE2|PHASE3,urinary_system_disease
4791,Nocturia|Daytime Sleepiness,Armodafinil,C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N,PHASE2|PHASE3,urinary_system_disease
4792,Renal Impairment|Healthy,Rivipansel,CC1C(C(C(C(O1)OC2C(CC(CC2OC3C(C(C(C(O3)CO)O)OC(CC4CCCCC4)C(=O)O)OC(=O)C5=CC=CC=C5)C(=O)NCCNC(=O)COCCOCC(=O)NC6=C7C(=CC(=C6)S(=O)(=O)O)C=C(C=C7S(=O)(=O)O)S(=O)(=O)O)NC(=O)C8=CC(=O)NC(=O)N8)O)O)O,PHASE1,urinary_system_disease
4793,Advanced Bladder Carcinoma|Advanced Lung Non-Small Cell Carcinoma|Advanced Malignant Solid Neoplasm|Advanced Melanoma|Advanced Merkel Cell Carcinoma|Advanced Renal Cell Carcinoma|Clinical Stage III Cutaneous Melanoma AJCC v8|Clinical Stage III Merkel Cell Carcinoma AJCC v8|Clinical Stage IV Cutaneous Melanoma AJCC v8|Clinical Stage IV Merkel Cell Carcinoma AJCC v8|Pathologic Stage III Cutaneous Melanoma AJCC v8|Pathologic Stage III Merkel Cell Carcinoma AJCC v8|Pathologic Stage IIIA Cutaneous Melanoma AJCC v8|Pathologic Stage IIIA Merkel Cell Carcinoma AJCC v8|Pathologic Stage IIIB Cutaneous Melanoma AJCC v8|Pathologic Stage IIIB Merkel Cell Carcinoma AJCC v8|Pathologic Stage IIIC Cutaneous Melanoma AJCC v8|Pathologic Stage IIID Cutaneous Melanoma AJCC v8|Pathologic Stage IV Cutaneous Melanoma AJCC v8|Pathologic Stage IV Merkel Cell Carcinoma AJCC v8|Stage III Bladder Cancer AJCC v8|Stage III Lung Cancer AJCC v8|Stage III Renal Cell Cancer AJCC v8|Stage IIIA Bladder Cancer AJCC v8|Stage IIIA Lung Cancer AJCC v8|Stage IIIB Bladder Cancer AJCC v8|Stage IIIB Lung Cancer AJCC v8|Stage IIIC Lung Cancer AJCC v8|Stage IV Bladder Cancer AJCC v8|Stage IV Lung Cancer AJCC v8|Stage IV Renal Cell Cancer AJCC v8|Stage IVA Bladder Cancer AJCC v8|Stage IVA Lung Cancer AJCC v8|Stage IVB Bladder Cancer AJCC v8|Stage IVB Lung Cancer AJCC v8,Plinabulin,CC(C)(C)C1=C(N=CN1)C=C2C(=O)NC(=CC3=CC=CC=C3)C(=O)N2,PHASE1|PHASE2,urinary_system_disease
4794,Renal Impairment|Renal Disease,Venetoclax,CC1(CCC(=C(C1)C2=CC=C(C=C2)Cl)CN3CCN(CC3)C4=CC(=C(C=C4)C(=O)NS(=O)(=O)C5=CC(=C(C=C5)NCC6CCOCC6)[N+](=O)[O-])OC7=CN=C8C(=C7)C=CN8)C,PHASE1,urinary_system_disease
4795,"Bladder Cancer|Brain and Central Nervous System Tumors|Carcinoma of Unknown Primary|Extragonadal Germ Cell Tumor|Head and Neck Cancer|Kidney Cancer|Lung Cancer|Ovarian Cancer|Sarcoma|Testicular Germ Cell Tumor|Unspecified Adult Solid Tumor, Protocol Specific",Amifostine,C(CN)CNCCSP(=O)(O)O,PHASE2,urinary_system_disease
4796,Chronic Kidney Disease|Secondary Hyperparathyroidism|Chronic Renal Insufficiency|Chronic Renal Failure,Doxercalciferol,CC(C)C(C)C=CC(C)C1CCC2C1(CCCC2=CC=C3CC(CC(C3=C)O)O)C,PHASE1,urinary_system_disease
4797,End Stage Renal Disease|Hemodialysis Complication,Propofol,CC(C)C1=C(C(=CC=C1)C(C)C)O,PHASE1,urinary_system_disease
4798,Complicated Urinary Tract Infections,Ceftazidime,CC(C)(C(=O)O)ON=C(C1=CSC(=N1)N)C(=O)NC2C3N(C2=O)C(=C(CS3)C[N+]4=CC=CC=C4)C(=O)[O-],PHASE2,urinary_system_disease
4799,Renal Insufficiency|Healthy,Canagliflozin,CC1=C(C=C(C=C1)C2C(C(C(C(O2)CO)O)O)O)CC3=CC=C(S3)C4=CC=C(C=C4)F,PHASE1,urinary_system_disease
4800,Chronic Renal Insufficiency|Type 2 Diabetes Mellitus,Omarigliptin,CS(=O)(=O)N1C=C2CN(CC2=N1)C3CC(C(OC3)C4=C(C=CC(=C4)F)F)N,PHASE1,urinary_system_disease
4801,Overactive Bladder|Detrusor Overactivity,Vardenafil,CCCC1=NC(=C2N1N=C(NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)CC)OCC)C,PHASE2,urinary_system_disease
4802,Chronic Kidney Disease on Hemodialysis|Secondary Hyperparathyroidism,Maxacalcitol,CC(C1CCC2C1(CCCC2=CC=C3CC(CC(C3=C)O)O)C)OCCC(C)(C)O,PHASE2,urinary_system_disease
4803,Amyotrophic Lateral Sclerosis|Renal Insufficiency,Pramipexole,CCCNC1CCC2=C(C1)SC(=N2)N,PHASE1,urinary_system_disease
4804,Amyotrophic Lateral Sclerosis|Renal Insufficiency,Dexpramipexole,CCCNC1CCC2=C(C1)SC(=N2)N,PHASE1,urinary_system_disease
4805,Hippel-Lindau Disease|Kidney Cancer,Fludeoxyglucose,C(C(C(C(C(C=O)F)O)O)O)O,PHASE2,urinary_system_disease
4806,Lupus Membranous Nephropathy,Filgotinib,C1CC1C(=O)NC2=NN3C(=N2)C=CC=C3C4=CC=C(C=C4)CN5CCS(=O)(=O)CC5,PHASE2,urinary_system_disease
4807,Benign Prostatic Hyperplasia,Doxazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4COC5=CC=CC=C5O4)N)OC,PHASE2,urinary_system_disease
4808,Healthy|Renal Impairment,Cenerimod,CCC1=C(C(=CC(=C1)C2=NOC(=N2)C3=CC(=NC(=C3)OC)C4CCCC4)C)OCC(CO)O,PHASE1,urinary_system_disease
4809,Bladder Cancer Stage IV,Tucidinostat,C1=CC(=CN=C1)C=CC(=O)NCC2=CC=C(C=C2)C(=O)NC3=C(C=C(C=C3)F)N,PHASE2,urinary_system_disease
4810,Infectious Disease,Cilastatin,CC1(CC1C(=O)NC(=CCCCCSCC(C(=O)O)N)C(=O)O)C,PHASE1,urinary_system_disease
4811,Infectious Disease,Omeprazole,CC1=CN=C(C(=C1OC)C)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC,PHASE1,urinary_system_disease
4812,Congestive Heart Failure|Chronic Kidney Diseases,Torsemide,CC1=CC(=CC=C1)NC2=C(C=NC=C2)S(=O)(=O)NC(=O)NC(C)C,PHASE1,urinary_system_disease
4813,Congestive Heart Failure|Chronic Kidney Diseases,Torasemide,CC1=CC(=CC=C1)NC2=C(C=NC=C2)S(=O)(=O)NC(=O)NC(C)C,PHASE1,urinary_system_disease
4814,Gout|Hyperuricemia|Arthritis|Joint Disease|Renal Insufficiency,Ulodesine,C1C(C(CN1CC2=CNC3=C2N=CNC3=O)O)CO,PHASE2,urinary_system_disease
4815,Fanconi Anemia,Oxandrolone,CC12CCC3C(C1CCC2(C)O)CCC4C3(COC(=O)C4)C,PHASE1,urinary_system_disease
4816,Cardiorenal Syndrome,Milrinone,CC1=C(C=C(C(=O)N1)C#N)C2=CC=NC=C2,PHASE2,urinary_system_disease
4817,Cardiorenal Syndrome,Dobutamine,CC(CCC1=CC=C(C=C1)O)NCCC2=CC(=C(C=C2)O)O,PHASE2,urinary_system_disease
4818,Renal Dysfunction|Acute Renal Failure|Mortality,Ularitide,CCC(C)C1C(=O)NCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)NCC(=O)NC(C(=O)NCC(=O)NC(CSSCC(C(=O)NC(C(=O)NCC(=O)NCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCNC(=N)N)CC(=O)O)CCSC)CCCNC(=N)N)CC2=CC=CC=C2)NC(=O)C(CO)NC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC(=O)C(CCCNC(=N)N)NC(=O)C(CC(C)C)NC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC(=O)C3CCCN3C(=O)C(C)NC(=O)C(C(C)O)N)C(=O)NC(CC(=O)N)C(=O)NC(CO)C(=O)NC(CC4=CC=CC=C4)C(=O)NC(CCCNC(=N)N)C(=O)NC(CC5=CC=C(C=C5)O)C(=O)O)CC(C)C)CO)CCC(=O)N)C,PHASE2,urinary_system_disease
4819,Non-Muscle Invasive Bladder Urothelial Carcinoma|Recurrent Non-Muscle Invasive Bladder Urothelial Carcinoma,Apalutamide,CNC(=O)C1=C(C=C(C=C1)N2C(=S)N(C(=O)C23CCC3)C4=CC(=C(N=C4)C#N)C(F)(F)F)F,PHASE1,urinary_system_disease
4820,Hemodialysis-Induced Symptom|Mitochondrial Diseases,Icatibant,C1CCC2C(C1)CC(N2C(=O)C3CC4=CC=CC=C4CN3C(=O)C(CO)NC(=O)C(CC5=CC=CS5)NC(=O)CNC(=O)C6CC(CN6C(=O)C7CCCN7C(=O)C(CCCN=C(N)N)NC(=O)C(CCCN=C(N)N)N)O)C(=O)NC(CCCN=C(N)N)C(=O)O,PHASE2,urinary_system_disease
4821,Cognitive Disorders|Delirium|Acute Kidney Injury,Ketamine,CNC1(CCCCC1=O)C2=CC=CC=C2Cl,PHASE2,urinary_system_disease
4822,Bladder Transitional Cell Carcinoma|Bladder Cancer|Fibroblast Growth Factor Receptor,Infigratinib,CCN1CCN(CC1)C2=CC=C(C=C2)NC3=CC(=NC=N3)N(C)C(=O)NC4=C(C(=CC(=C4Cl)OC)OC)Cl,PHASE1,urinary_system_disease
4823,"Kidney Failure, Chronic|Arthralgia",Lumiracoxib,CC1=CC(=C(C=C1)NC2=C(C=CC=C2Cl)F)CC(=O)O,PHASE2,urinary_system_disease
4824,Muscle-invasive Bladder Cancer,Epacadostat,C1=CC(=C(C=C1N=C(C2=NON=C2NCCNS(=O)(=O)N)NO)Br)F,PHASE2,urinary_system_disease
4825,Renal Insufficiency|Kidney Diseases|Urologic Diseases,Mirodenafil,CCCC1=CN(C2=C1N=C(NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)CCO)OCCC)CC,PHASE1,urinary_system_disease
4826,Urothelial Cancer|Bladder Cancer,Lapatinib,CS(=O)(=O)CCNCC1=CC=C(O1)C2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=CC(=CC=C5)F)Cl,PHASE2,urinary_system_disease
4827,Neurogenic Bladder|Catheter-Related Infections,Octenidine,CCCCCCCCN=C1C=CN(C=C1)CCCCCCCCCCN2C=CC(=NCCCCCCCC)C=C2,PHASE2|PHASE3,urinary_system_disease
4828,Renal Impairment|Healthy,Sotagliflozin,CCOC1=CC=C(C=C1)CC2=C(C=CC(=C2)C3C(C(C(C(O3)SC)O)O)O)Cl,PHASE1,urinary_system_disease
4829,"Diabetes Mellitus, Type 1|Diabetic Nephropathy",Alagebrium,CC1=C(SC=[N+]1CC(=O)C2=CC=CC=C2)C,PHASE2,urinary_system_disease
4830,Renal Colic|Kidney Stone,Ropivacaine,CCCN1CCCCC1C(=O)NC2=C(C=CC=C2C)C,PHASE2,urinary_system_disease
4831,"Silodosin, Tamsulosin, Medical Expulsive Therapy, Distal Ureteric Calculi",Silodosin,CC(CC1=CC2=C(C(=C1)C(=O)N)N(CC2)CCCO)NCCOC3=CC=CC=C3OCC(F)(F)F,PHASE1,urinary_system_disease
4832,Cardiorenal Syndrome (CRS),Candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,PHASE1|PHASE2,urinary_system_disease
4833,Interstitial Cystitis|Painful Bladder Syndrome|Pain,Oxycodone,CN1CCC23C4C(=O)CCC2(C1CC5=C3C(=C(C=C5)OC)O4)O,PHASE2,urinary_system_disease
4834,Secondary Hyperparathyroidism Due to Renal Causes|Chronic Kidney Diseases|Vitamin D Deficiency|Stage 5 Chronic Kidney Disease,Calcifediol,CC(CCCC(C)(C)O)C1CCC2C1(CCCC2=CC=C3CC(CCC3=C)O)C,PHASE2,urinary_system_disease
4835,HIV Infections|Kidney Diseases,Maraviroc,CC1=NN=C(N1C2CC3CCC(C2)N3CCC(C4=CC=CC=C4)NC(=O)C5CCC(CC5)(F)F)C(C)C,PHASE2,urinary_system_disease
4836,Advanced Cancer|Metastatic Cancer|Biliary Tract Carcinoma|Cholangiocarcinoma|Gall Bladder Carcinoma|Solid Tumor|Non-Hodgkin's Lymphoma,Merestinib,CC1=CC=C(C(=O)N1C2=CC=C(C=C2)F)C(=O)NC3=CC(=C(C=C3)OC4=C(C=C5C(=C4)C=NN5C)C6=CNN=C6)F,PHASE1,urinary_system_disease
4837,Muscle Invasive Bladder Cancer,Vistusertib,CC1COCCN1C2=NC(=NC3=C2C=CC(=N3)C4=CC(=CC=C4)C(=O)NC)N5CCOCC5C,PHASE1,urinary_system_disease
4838,"Carcinoma, Renal Cell",Moxifloxacin,COC1=C2C(=CC(=C1N3CC4CCCNC4C3)F)C(=O)C(=CN2C5CC5)C(=O)O,PHASE1,urinary_system_disease
4839,Henoch-Schoenlein Purpura Nephritis,Leflunomide,CC1=C(C=NO1)C(=O)NC2=CC=C(C=C2)C(F)(F)F,PHASE2,urinary_system_disease
4840,Atherosclerosis,Darapladib,CCN(CC)CCN(CC1=CC=C(C=C1)C2=CC=C(C=C2)C(F)(F)F)C(=O)CN3C4=C(CCC4)C(=O)N=C3SCC5=CC=C(C=C5)F,PHASE1,urinary_system_disease
4841,"Renal Failure, Chronic|End-Stage Renal Disease",Serelaxin,CCC(C)C1C(=O)NC(CSSCC(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C2CSSCC(C(=O)NC(CSSCC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)C)C(C)CC)CCC(=O)N)C)CCCNC(=N)N)C(C)C)CC(C)C)CCC(=O)O)CCCNC(=N)N)NC(=O)C(CC(C)C)NC(=O)C(CCCCN)NC(=O)C(C(C)CC)NC(=O)C(C(C)C)NC(=O)C(CCC(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(CCSC)NC(=O)C(CC3=CNC4=CC=CC=C43)NC(=O)C(CO)NC(=O)C(CC(=O)O)N)C(=O)NC(C(=O)NC(C(=O)NCC(=O)N2)C(C)C)CC5=CN=CN5)NC(=O)C(CCCCN)NC(=O)C(CC(=O)N)NC(=O)C(C)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CO)NC(=O)C(CC6=CC=C(C=C6)O)NC(=O)C(CC(C)C)NC(=O)C7CCC(=O)N7)C(C)O)CCCCN)CCCNC(=N)N)CO)CC(C)C)C)CCCNC(=N)N)CC8=CC=CC=C8)C(=O)O)C(=O)NCC(=O)NC(CCSC)C(=O)NC(CO)C(=O)NC(C(C)O)C(=O)NC(CC9=CNC1=CC=CC=C19)C(=O)NC(CO)C(=O)O,PHASE1,urinary_system_disease
4842,Renal Impairment,Molnupiravir,CC(C)C(=O)OCC1C(C(C(O1)N2C=CC(=NC2=O)NO)O)O,PHASE1,urinary_system_disease
4843,End Stage Renal Disease,Oseltamivir,CCC(CC)OC1C=C(CC(C1NC(=O)C)N)C(=O)OCC,PHASE1,urinary_system_disease
4844,"Renal Dialysis|Renal Failure, Chronic",Tobramycin,C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(CC(C(O3)CN)O)N)N,PHASE1,urinary_system_disease
4845,Nephrotic Syndrome|Hyperlipidemia,Pravastatin,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O,PHASE1,urinary_system_disease
4846,Diabetic Nephropathy,Corticotropin,CC(C)CC(C(=O)NC(CCC(=O)O)C(=O)NC(CC1=CC=CC=C1)C(=O)O)NC(=O)C2CCCN2C(=O)C(CC3=CC=CC=C3)NC(=O)C(C)NC(=O)C(CCC(=O)O)NC(=O)C(C)NC(=O)C(CO)NC(=O)C(CCC(=O)O)NC(=O)C(CC(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(C)NC(=O)CNC(=O)C(CC(=O)N)NC(=O)C4CCCN4C(=O)C(CC5=CC=C(C=C5)O)NC(=O)C(C(C)C)NC(=O)C(CCCCN)NC(=O)C(C(C)C)NC(=O)C6CCCN6C(=O)C(CCCNC(=N)N)NC(=O)C(CCCNC(=N)N)NC(=O)C(CCCCN)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(C(C)C)NC(=O)C7CCCN7C(=O)C(CCCCN)NC(=O)CNC(=O)C(CC8=CNC9=CC=CC=C98)NC(=O)C(CCCNC(=N)N)NC(=O)C(CC1=CC=CC=C1)NC(=O)C(CC1=CN=CN1)NC(=O)C(CCC(=O)O)NC(=O)C(CCSC)NC(=O)C(CO)NC(=O)C(CC1=CC=C(C=C1)O)NC(=O)C(CO)N,PHASE2,urinary_system_disease
4847,Schizophrenia|Renal Impairment,Paliperidone,CC1=C(C(=O)N2CCCC(C2=N1)O)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F,PHASE1,urinary_system_disease
4848,Ischemia-Reperfusion Injury|Kidney Diseases,Reparixin,CC(C)CC1=CC=C(C=C1)C(C)C(=O)NS(=O)(=O)C,PHASE2,urinary_system_disease
4849,Secondary Hypogonadism,Enclomiphene,CCN(CC)CCOC1=CC=C(C=C1)C(=C(C2=CC=CC=C2)Cl)C3=CC=CC=C3,PHASE1,urinary_system_disease
4850,Kidney Injury|Proteinuria|Hypertension,Isosorbide,C1C(C2C(O1)C(CO2)O)O,PHASE2,urinary_system_disease
4851,Stroke|Cerebrovascular Disorders|Ischemic Stroke|Brain Diseases|Central Nervous System Diseases|Nervous System Diseases|Cardiovascular Diseases|Propranolol|Beta Blocker|Molecular Mechanisms of Pharmacological Action|Immunologic Factors|Physiological Effects of Drugs,Ceftriaxone,CN1C(=NC(=O)C(=O)N1)SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)O,PHASE2,urinary_system_disease
4852,"Glomerulosclerosis, Focal Segmental",Losmapimod,CC1=C(C=C(C=C1F)C(=O)NC2CC2)C3=NC=C(C=C3)C(=O)NCC(C)(C)C,PHASE2,urinary_system_disease
4853,Alport Syndrome,Fluvastatin,CC(C)N1C2=CC=CC=C2C(=C1C=CC(CC(CC(=O)O)O)O)C3=CC=C(C=C3)F,PHASE2,urinary_system_disease
4854,"Renal Insufficiency, Chronic|Coronary Angiography|Angioplasty, Transluminal, Percutaneous Coronary",Iloprost,CC#CCC(C)C(C=CC1C(CC2C1CC(=CCCCC(=O)O)C2)O)O,PHASE2|PHASE3,urinary_system_disease
4855,Renal Impairment|Healthy,Esketamine,CNC1(CCCCC1=O)C2=CC=CC=C2Cl,PHASE1,urinary_system_disease
4856,Urinary Tract Infections|Pyelonephritis,Relebactam,C1CC(N2CC1N(C2=O)OS(=O)(=O)O)C(=O)NC3CCNCC3,PHASE2,urinary_system_disease
4857,Renal Impairment,Betrixaban,CN(C)C(=N)C1=CC=C(C=C1)C(=O)NC2=C(C=C(C=C2)OC)C(=O)NC3=NC=C(C=C3)Cl,PHASE1,urinary_system_disease
4858,Healthy,Licarbazepine,C1C(C2=CC=CC=C2N(C3=CC=CC=C31)C(=O)N)O,PHASE1,urinary_system_disease
4859,Diabetic Nephropathies,Levocetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,PHASE2,urinary_system_disease
4860,"Type 2 Diabetes Mellitus, CKD and Albuminuria",Saxagliptin,C1C2CC2N(C1C#N)C(=O)C(C34CC5CC(C3)CC(C5)(C4)O)N,PHASE2|PHASE3,urinary_system_disease
4861,Renal Impairment|Renal Disease|Kidney Disease,Nitazoxanide,CC(=O)OC1=CC=CC=C1C(=O)NC2=NC=C(S2)[N+](=O)[O-],PHASE1,urinary_system_disease
4862,Renal Impairment,Elinogrel,CNC1=C(C=C2C(=C1)NC(=O)N(C2=O)C3=CC=C(C=C3)NC(=O)NS(=O)(=O)C4=CC=C(S4)Cl)F,PHASE1,urinary_system_disease
4863,Clear Cell Sarcoma of the Kidney|Recurrent Renal Cell Carcinoma|Stage III Renal Cell Cancer|Stage IV Renal Cell Cancer,Dalteparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,PHASE1,urinary_system_disease
4864,Vomiting,Casopitant,CC1=C(C=CC(=C1)F)C2CC(CCN2C(=O)N(C)C(C)C3=CC(=CC(=C3)C(F)(F)F)C(F)(F)F)N4CCN(CC4)C(=O)C,PHASE1,urinary_system_disease
4865,Autosomal Dominant Polycystic Kidney Disease,Lixivaptan,CC1=C(C=C(C=C1)F)C(=O)NC2=CC(=C(C=C2)C(=O)N3CC4=CC=CN4CC5=CC=CC=C53)Cl,PHASE2,urinary_system_disease
4866,Overactive Bladder Associated With HTLV-1,Propantheline,CC(C)[N+](C)(CCOC(=O)C1C2=CC=CC=C2OC3=CC=CC=C13)C(C)C,PHASE1,urinary_system_disease
4867,Bladder Cancer,Amrubicin,CC(=O)C1(CC(C2=C(C1)C(=C3C(=C2O)C(=O)C4=CC=CC=C4C3=O)O)OC5CC(C(CO5)O)O)N,PHASE2,urinary_system_disease
4868,Kidney Cancer|Renal Cancer|Renal Neoplasm,Hydromorphone,CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(=O)CC4,PHASE2,urinary_system_disease
4869,Kidney Cancer|Renal Cancer|Renal Neoplasm,Ibuprofen,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O,PHASE2,urinary_system_disease
4870,Metastatic Renal Cell Cancer|Stage IV Renal Cell Cancer,Ibrutinib,C=CC(=O)N1CCCC(C1)N2C3=NC=NC(=C3C(=N2)C4=CC=C(C=C4)OC5=CC=CC=C5)N,PHASE1|PHASE2,urinary_system_disease
4871,"Interstitial Fibrosis|Kidney Transplant; Complications|Kidney Transplant Rejection|Kidney Transplant Failure and Rejection|Kidney Transplant Failure|Kidney Failure, Chronic|Graft Rejection",Fingolimod,CCCCCCCCC1=CC=C(C=C1)CCC(CO)(CO)N,PHASE2,urinary_system_disease
4872,Clear Cell Renal Cell Carcinoma,Imatinib,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,PHASE1|PHASE2,urinary_system_disease
4873,Cannabis|Chronic Kidney Diseases|Dialysis,Dronabinol,CCCCCC1=CC(=C2C3C=C(CCC3C(OC2=C1)(C)C)C)O,PHASE1,urinary_system_disease
4874,Kidney Disease,Bremelanotide,CCCCC(C(=O)NC1CC(=O)NCCCCC(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC1=O)CC2=CN=CN2)CC3=CC=CC=C3)CCCN=C(N)N)CC4=CNC5=CC=CC=C54)C(=O)O)NC(=O)C,PHASE2,urinary_system_disease
